data_6ppt_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6ppt _Structure_validation_residue.Date_analyzed 2019-09-13 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.5 ' HB3' ' NH2' ' A' ' 136' ' ' ARG . 49.9 mtm . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 109.064 -0.717 . . . . 74.24 109.064 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.1 m -62.79 137.25 58.22 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.676 0.39 . . . . 70.03 111.093 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.3 m -70.93 148.62 47.53 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.705 0.802 . . . . 73.11 110.27 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.615 HD11 ' HB2' ' A' ' 123' ' ' LEU . 13.2 pt -117.28 163.02 14.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 123.104 0.562 . . . . 74.35 110.327 -177.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -139.12 124.12 18.85 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.714 0.806 . . . . 73.34 108.938 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.658 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.2 tp -72.17 160.44 32.43 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.46 1.104 . . . . 75.34 109.81 -173.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -84.11 -43.92 14.56 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.489 0.316 . . . . 71.12 110.977 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 43.6 mt 49.35 71.97 0.34 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.063 0.945 . . . . 72.44 111.018 -168.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.612 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 86.2 mt -76.38 133.09 71.7 Favored Pre-proline 0 C--O 1.239 0.536 0 CA-C-N 115.34 -0.846 . . . . 73.41 109.718 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo . . . . . 0 C--N 1.374 1.895 0 C-N-CA 121.992 1.795 . . . . 73.22 110.15 164.621 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? . . . . . 0 CA--C 1.543 0.71 0 CA-C-O 121.166 0.508 . . . . 75.1 110.062 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -82.9 149.37 27.12 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.556 0.742 . . . . 73.41 109.653 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.5 tt -141.63 138.28 32.43 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 106.249 -1.76 . . . . 71.4 106.249 176.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.612 ' HG3' ' HB2' ' A' ' 102' ' ' LEU . 13.2 ptm180 -103.75 149.58 24.87 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.228 0.537 . . . . 75.33 110.504 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.658 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -159.63 135.89 8.92 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.765 -0.652 . . . . 72.41 109.76 -172.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -108.5 120.93 43.85 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 107.583 -1.265 . . . . 65.23 107.583 -171.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.706 HD21 ' HB3' ' A' ' 176' ' ' LEU . 3.6 pp -101.08 110.47 61.3 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 108.085 -1.08 . . . . 74.12 108.085 176.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.439 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 74.0 Cg_endo -73.61 112.29 3.5 Favored 'Trans proline' 0 C--N 1.367 1.536 0 C-N-CA 121.785 1.657 . . . . 75.53 108.994 169.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.494 HD22 HD13 ' A' ' 149' ' ' ILE . 32.1 tp -103.54 153.06 20.98 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.32 -0.622 . . . . 65.23 109.32 -169.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.7 t -92.51 146.07 23.96 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 108.024 -1.102 . . . . 71.51 108.024 178.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.494 HD21 HD21 ' A' ' 180' ' ' LEU . 87.6 mt -66.18 -24.5 66.64 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.919 0.711 . . . . 75.34 112.919 -173.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.08 -45.43 94.75 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.456 -0.572 . . . . 75.51 109.456 174.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.408 ' HB3' HD11 ' A' ' 149' ' ' ILE . 18.3 mm-40 -76.15 -31.6 58.65 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.128 -0.942 . . . . 75.11 111.83 -178.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.58 -36.36 78.34 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.936 0.494 . . . . 62.34 110.241 173.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -74.2 -57.99 3.59 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.755 -1.112 . . . . 73.41 110.945 176.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -60.95 -50.14 74.62 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.122 0.569 . . . . 73.33 111.184 -172.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.515 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 64.34 61.59 5.87 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 114.759 -1.11 . . . . 63.32 112.626 -173.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.433 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -123.92 -157.63 9.86 Favored Glycine 0 N--CA 1.467 0.749 0 N-CA-C 111.179 -0.768 . . . . 74.34 111.179 177.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -78.18 126.11 30.33 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.12 -0.696 . . . . 74.24 109.12 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.5 ' NH2' ' HB3' ' A' ' 94' ' ' MET . 8.6 tpp180 -120.05 123.06 42.51 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.727 -0.842 . . . . 73.24 108.727 175.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 72.7 t -71.58 113.7 8.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-N 114.306 -1.315 . . . . 72.35 109.677 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.527 HG21 HD12 ' A' ' 97' ' ' ILE . 35.9 t -100.88 112.17 32.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 108.394 -0.965 . . . . 73.43 108.394 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -99.8 113.72 26.42 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.102 -1.073 . . . . 70.3 108.102 174.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.0 p -152.66 132.14 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 122.92 0.488 . . . . 74.22 110.986 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 60.88 20.92 11.15 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.213 1.005 . . . . 75.32 112.792 173.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.62 -6.19 80.08 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-O 119.847 -0.418 . . . . 63.42 113.291 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.419 ' NH1' ' SD ' ' A' ' 164' ' ' MET . 35.1 ttm180 -101.71 122.77 44.54 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.908 0.883 . . . . 74.14 109.947 -178.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -97.42 108.31 21.01 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.253 1.021 . . . . 72.33 108.641 174.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 3.2 p -123.26 113.66 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.392 0.677 . . . . 71.41 109.551 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.2 t -91.27 113.92 26.32 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.789 -0.819 . . . . 64.12 108.789 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 23.3 m -108.34 133.68 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.364 0.666 . . . . 72.13 110.584 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -81.99 96.05 7.6 Favored 'General case' 0 C--N 1.349 0.548 0 N-CA-C 108.886 -0.783 . . . . 71.24 108.886 176.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.515 HG13 ' HA2' ' A' ' 133' ' ' GLY . 12.3 pt -73.4 147.24 87.32 Favored Pre-proline 0 CA--C 1.559 1.301 0 CA-C-N 114.636 -1.165 . . . . 75.53 109.609 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.6 142.01 75.62 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.915 2.41 . . . . 72.05 113.508 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.408 ' HA ' ' HA3' ' A' ' 133' ' ' GLY . 18.4 Cg_endo -61.29 117.21 3.99 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.332 2.021 . . . . 73.44 110.996 170.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 93.0 17.82 42.3 Favored Glycine 0 C--N 1.34 0.786 0 O-C-N 123.645 0.59 . . . . 75.35 112.901 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.7 p -62.93 123.79 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 C-N-CA 123.424 0.69 . . . . 72.3 110.255 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -127.44 164.31 22.16 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.278 0.631 . . . . 72.34 110.982 -172.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -40.84 127.05 2.56 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.28 1.832 . . . . 64.41 113.767 -171.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.32 -11.77 66.95 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-O 119.486 -0.619 . . . . 72.34 114.246 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.419 ' HB2' HG13 ' A' ' 178' ' ' VAL . 19.4 m -60.64 121.1 11.37 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 117.553 0.676 . . . . 62.44 110.281 173.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.407 HG22 HG21 ' A' ' 177' ' ' VAL . 61.4 t -105.52 110.97 32.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.334 0.653 . . . . 74.32 109.524 -178.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.419 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 67.0 mt -90.33 103.73 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 107.985 -1.117 . . . . 74.02 107.985 177.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -83.01 101.33 11.03 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.752 -0.658 . . . . 75.54 109.451 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.418 HG11 ' HB3' ' A' ' 174' ' ' LEU . 3.8 p -101.93 109.05 58.78 Favored Pre-proline 0 CA--C 1.558 1.251 0 C-N-CA 123.24 0.616 . . . . 75.31 110.205 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 16.5 Cg_exo -69.13 145.56 61.2 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.859 2.373 . . . . 65.24 112.799 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 87.42 0.27 84.74 Favored Glycine 0 C--N 1.344 1.02 0 CA-C-N 115.643 -0.708 . . . . 73.33 113.722 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.419 ' SD ' ' NH1' ' A' ' 143' ' ' ARG . 24.5 mmt -107.7 -12.09 15.3 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.454 0.701 . . . . 75.12 111.485 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -98.87 -87.17 1.9 Allowed Glycine 0 C--N 1.351 1.37 0 N-CA-C 112.102 -0.399 . . . . 63.11 112.102 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.26 97.02 0.22 Allowed Glycine 0 C--N 1.349 1.29 0 C-N-CA 123.249 0.452 . . . . 71.2 112.872 176.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -90.44 170.94 9.8 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.705 1.202 . . . . 72.14 110.575 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 110.96 -66.13 0.24 Allowed Glycine 0 N--CA 1.47 0.947 0 C-N-CA 123.364 0.507 . . . . 73.23 112.189 173.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -154.79 -53.96 0.02 OUTLIER Pre-proline 0 CA--C 1.558 1.287 0 CA-C-O 117.739 -1.124 . . . . 73.22 111.155 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -81.32 109.35 2.1 Favored 'Trans proline' 0 C--N 1.398 3.182 0 C-N-CA 121.929 1.752 . . . . 71.55 110.247 177.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.63 124.12 12.35 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 121.777 1.652 . . . . 63.12 110.251 -176.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -123.51 164.21 16.72 Favored Glycine 0 C--O 1.238 0.383 0 CA-C-N 115.859 -0.609 . . . . 62.3 111.684 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 6.7 p-10 -91.13 162.07 14.82 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.725 0.81 . . . . 73.52 111.055 -170.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.418 ' HB3' HG11 ' A' ' 161' ' ' VAL . 34.7 tp -126.29 116.14 20.79 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 114.727 -1.124 . . . . 72.22 108.819 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 88.6 mt -85.2 100.84 12.03 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.206 1.003 . . . . 72.43 110.026 -175.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.706 ' HB3' HD21 ' A' ' 123' ' ' LEU . 46.8 mt -90.05 99.23 12.28 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.82 0.448 . . . . 74.44 110.167 -177.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.407 HG21 HG22 ' A' ' 158' ' ' VAL . 41.5 t -86.4 113.29 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 109.333 -0.617 . . . . 74.14 109.333 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.419 HG13 ' HB2' ' A' ' 157' ' ' SER . 8.6 p -68.68 133.3 32.02 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.981 0 O-C-N 123.462 0.476 . . . . 74.44 109.945 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.439 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 30.4 mmm180 -127.47 94.19 3.92 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.109 0.964 . . . . 75.2 109.042 -174.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.494 HD21 HD21 ' A' ' 127' ' ' LEU . 97.1 mt -98.57 147.98 24.25 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.185 -0.916 . . . . 65.44 110.505 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 79.2 mt . . . . . 0 CA--C 1.553 1.084 0 N-CA-C 109.471 -0.566 . . . . 73.13 109.471 175.226 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.46 ' N ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 121.659 0.743 . . . . 74.33 109.967 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.3 m -63.38 125.14 23.2 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.132 -0.94 . . . . 71.33 110.649 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.537 ' HA ' HH11 ' A' ' 136' ' ' ARG . 92.4 m -68.21 131.97 46.32 Favored 'General case' 0 C--O 1.24 0.593 0 O-C-N 123.424 0.453 . . . . 64.54 110.164 176.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.605 HD12 ' HB2' ' A' ' 123' ' ' LEU . 23.1 pt -104.45 167.6 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 115.448 -0.796 . . . . 74.14 110.759 -171.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -112.45 -171.44 1.86 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.517 0.727 . . . . 74.41 109.707 172.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.569 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.1 tp -133.7 158.0 44.39 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 108.268 -1.012 . . . . 75.43 108.268 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.8 -47.53 25.37 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 110.129 -0.323 . . . . 74.3 110.129 176.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 54.5 mt 50.8 86.58 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.238 0 O-C-N 124.453 1.095 . . . . 73.11 111.034 -171.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.0 mt -99.31 157.77 33.43 Favored Pre-proline 0 CA--C 1.549 0.918 0 CA-C-N 115.15 -0.932 . . . . 73.41 109.491 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 C--N 1.373 1.849 0 C-N-CA 122.88 2.387 . . . . 75.45 113.859 178.846 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.415 ' O ' ' HA3' ' A' ' 172' ' ' GLY . 51.2 ttp180 . . . . . 0 N--CA 1.48 1.055 0 CA-C-O 121.066 0.46 . . . . 75.44 109.902 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -82.56 144.79 30.12 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.407 0.683 . . . . 75.32 109.808 176.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.9 tt -143.8 118.26 9.7 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 107.905 -1.146 . . . . 72.41 107.905 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -91.14 127.77 36.7 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 107.835 -1.172 . . . . 74.35 107.835 176.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.569 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -146.07 130.66 17.87 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.269 -0.641 . . . . 75.14 109.269 -176.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -117.51 120.57 38.48 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 110.037 -0.357 . . . . 75.43 110.037 -169.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.605 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.4 pp -100.82 122.89 47.49 Favored Pre-proline 0 C--N 1.349 0.564 0 N-CA-C 109.961 -0.385 . . . . 62.42 109.961 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -76.78 113.58 3.67 Favored 'Trans proline' 0 C--N 1.365 1.433 0 C-N-CA 122.309 2.006 . . . . 73.13 108.27 167.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.491 HD21 HD11 ' A' ' 149' ' ' ILE . 51.2 tp -101.73 147.09 26.88 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.6 -0.518 . . . . 75.14 109.6 -168.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.5 t -89.57 148.92 23.09 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 108.587 -0.894 . . . . 75.32 108.587 -176.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.46 -31.2 71.88 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.776 0.83 . . . . 72.23 112.629 -169.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.45 -47.59 85.45 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.855 0.722 . . . . 72.14 109.35 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -76.31 -28.84 57.1 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 114.619 -1.173 . . . . 63.21 112.055 -174.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.0 -43.12 99.5 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.331 0.586 . . . . 75.3 110.266 172.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -65.21 -54.16 33.69 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 114.421 -1.263 . . . . 74.42 110.976 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -63.58 -48.86 75.65 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.076 0.55 . . . . 74.51 111.486 -175.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.638 ' HA3' ' HA ' ' A' ' 151' ' ' PRO . . . 61.04 72.53 0.62 Allowed Glycine 0 C--N 1.341 0.832 0 CA-C-N 114.788 -1.096 . . . . 74.34 112.147 -171.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.455 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -144.37 -157.63 7.28 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 111.696 -0.561 . . . . 72.43 111.696 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -72.35 112.56 8.53 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.412 -0.588 . . . . 73.24 109.412 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.537 HH11 ' HA ' ' A' ' 96' ' ' THR . 5.9 tpp180 -113.0 122.71 48.45 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.253 -1.017 . . . . 73.21 108.253 173.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 96.8 t -77.69 125.97 37.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 CA-C-N 114.472 -1.24 . . . . 71.13 109.918 -178.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 45.1 t -103.45 121.55 54.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.423 1.089 . . . . 75.23 108.35 176.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -112.93 106.47 14.76 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.136 -1.061 . . . . 74.34 108.136 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.3 p -151.14 122.4 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 123.175 0.59 . . . . 73.41 110.639 -175.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 64.24 19.96 11.99 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.131 0.972 . . . . 73.43 112.359 174.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.53 -9.68 76.85 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 116.368 -0.378 . . . . 55.13 112.787 -174.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 18.6 ttm180 -89.47 120.9 31.19 Favored 'General case' 0 C--N 1.347 0.493 0 N-CA-C 108.507 -0.923 . . . . 75.33 108.507 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 138' ' ' VAL . 40.7 ttm180 -112.53 114.95 27.86 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.217 -0.901 . . . . 73.01 108.708 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 6.4 p -129.9 117.55 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.424 0.63 . . . . 71.31 110.529 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 43.0 t -81.48 110.1 16.57 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.563 -0.902 . . . . 73.31 108.563 174.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.6 p -107.73 123.47 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.181 0.592 . . . . 72.2 109.741 177.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 51.1 ttt85 -76.96 94.81 4.01 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 108.734 -0.839 . . . . 74.44 108.734 172.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.491 HD11 HD21 ' A' ' 125' ' ' LEU . 8.0 pt -69.9 142.83 91.2 Favored Pre-proline 0 CA--C 1.561 1.372 0 CA-C-N 114.533 -1.212 . . . . 75.2 109.146 175.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -63.01 148.72 93.17 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.396 2.064 . . . . 71.12 112.702 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.638 ' HA ' ' HA3' ' A' ' 133' ' ' GLY . 34.9 Cg_exo -62.36 124.84 15.02 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.689 2.259 . . . . 74.02 111.441 177.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 74.44 30.66 60.01 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 112.23 -0.348 . . . . 74.21 112.23 -177.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.0 p -62.27 116.95 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 123.576 0.751 . . . . 75.52 109.78 175.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.503 ' HA ' HD11 ' A' ' 180' ' ' LEU . 96.1 mtt180 -113.57 166.33 11.62 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.423 0.689 . . . . 65.11 110.886 -177.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -40.21 128.47 2.29 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 126.628 1.971 . . . . 75.34 113.692 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.69 -10.24 72.76 Favored Glycine 0 C--N 1.352 1.433 0 CA-C-O 119.442 -0.643 . . . . 64.34 114.124 175.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 25.3 t -64.77 120.57 12.72 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 117.521 0.66 . . . . 72.32 109.885 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.425 HG22 HG22 ' A' ' 177' ' ' VAL . 53.4 t -99.26 125.02 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.588 0.755 . . . . 70.22 109.224 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.556 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 54.8 mt -101.63 105.22 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 108.553 -0.906 . . . . 75.04 108.553 176.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -80.85 101.86 9.67 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.879 0.472 . . . . 72.41 109.782 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.515 HG12 ' HB3' ' A' ' 174' ' ' LEU . 5.4 p -110.63 98.12 35.73 Favored Pre-proline 0 CA--C 1.561 1.389 0 N-CA-C 109.802 -0.444 . . . . 74.22 109.802 173.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.526 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 44.4 Cg_endo -65.69 156.53 63.44 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.521 2.814 . . . . 75.22 113.291 -178.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 68.89 11.66 63.54 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.122 -0.944 . . . . 64.02 114.458 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 97.4 mmm -113.82 -26.94 7.96 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.857 0.863 . . . . 61.14 109.422 174.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -76.67 -84.87 0.44 Allowed Glycine 0 C--N 1.35 1.328 0 N-CA-C 110.705 -0.958 . . . . 63.43 110.705 172.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.412 ' HA2' ' HB3' ' A' ' 117' ' ' ARG . . . -66.22 101.29 0.6 Allowed Glycine 0 C--N 1.342 0.906 0 O-C-N 123.958 0.446 . . . . 73.51 113.791 171.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.607 ' HA ' HE21 ' A' ' 167' ' ' GLN . 0.0 OUTLIER -90.83 169.97 10.49 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.05 0.94 . . . . 75.4 110.559 174.596 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 83.0 -143.63 22.26 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-O 119.648 -0.529 . . . . 74.15 112.405 -176.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -63.07 -57.18 22.31 Favored Pre-proline 0 CA--C 1.56 1.358 0 CA-C-O 118.404 -0.807 . . . . 64.22 112.084 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -80.29 111.83 2.69 Favored 'Trans proline' 0 C--N 1.393 2.918 0 CA-C-N 121.179 1.457 . . . . 74.41 112.22 -176.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -76.07 123.9 7.59 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 122.024 1.816 . . . . 65.32 110.704 -178.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 117' ' ' ARG . . . -137.04 162.92 25.33 Favored Glycine 0 C--N 1.34 0.751 0 C-N-CA 121.406 -0.426 . . . . 61.35 113.42 -172.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.526 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 8.8 m-20 -91.23 132.23 36.25 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 123.892 0.877 . . . . 74.13 111.87 -164.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.515 ' HB3' HG12 ' A' ' 161' ' ' VAL . 33.7 tp -96.13 102.95 14.81 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.021 -1.474 . . . . 74.02 107.021 171.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 88.4 mt -87.9 100.25 12.74 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.182 0.593 . . . . 70.34 109.441 -175.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.556 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 74.3 mt -87.25 99.45 11.97 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 123.262 0.625 . . . . 73.41 110.253 -175.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.425 HG22 HG22 ' A' ' 158' ' ' VAL . 33.2 t -87.97 116.09 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 108.949 -0.76 . . . . 74.21 108.949 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 13.0 p -73.64 140.39 17.83 Favored 'Isoleucine or valine' 0 C--O 1.246 0.878 0 C-N-CA 123.003 0.521 . . . . 72.11 110.888 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -124.75 113.58 18.15 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 107.946 -1.131 . . . . 75.11 107.946 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.503 HD11 ' HA ' ' A' ' 154' ' ' ARG . 47.8 mt -111.35 134.34 53.01 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.947 0.499 . . . . 64.44 110.772 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 CA--C 1.55 0.972 0 C-N-CA 123.818 0.847 . . . . 70.34 110.362 174.846 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 73.3 mtp . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 109.333 -0.617 . . . . 74.23 109.333 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 43.5 m -71.0 125.1 25.94 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.953 -0.567 . . . . 65.32 110.575 -177.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 56.8 m -67.92 147.37 52.56 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.921 0.888 . . . . 51.42 111.153 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.616 HD12 ' HB2' ' A' ' 123' ' ' LEU . 26.8 pt -116.93 168.18 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 123.496 0.718 . . . . 75.41 110.577 -172.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -141.65 127.69 19.54 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.756 0.822 . . . . 72.41 109.41 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.707 ' HG ' ' HB2' ' A' ' 121' ' ' ALA . 12.1 tp -73.96 140.15 45.35 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.628 1.571 . . . . 73.2 110.417 -169.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.58 -33.82 76.81 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.557 0.743 . . . . 75.45 111.713 -176.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.8 mt 48.7 62.78 2.39 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.417 1.087 . . . . 75.21 111.697 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.0 mt -69.89 147.14 95.94 Favored Pre-proline 0 CA--C 1.554 1.134 0 N-CA-C 108.719 -0.845 . . . . 72.21 108.719 176.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 C--N 1.367 1.505 0 C-N-CA 122.071 1.847 . . . . 73.03 112.45 179.378 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.675 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 18.4 ttm180 . . . . . 0 N--CA 1.48 1.028 0 N-CA-C 110.468 -0.197 . . . . 74.21 110.468 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -85.28 116.74 23.8 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.43 0.634 . . . . 74.52 109.958 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.7 tt -94.34 124.19 38.21 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.399 -1.704 . . . . 74.4 106.399 175.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 23.5 tpt85 -90.98 117.73 29.8 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 107.879 -1.156 . . . . 73.33 107.879 -175.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.707 ' HB2' ' HG ' ' A' ' 99' ' ' LEU . . . -140.04 151.04 45.11 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 110.032 -0.359 . . . . 63.22 110.032 -173.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.54 ' HG2' ' HB ' ' A' ' 177' ' ' VAL . 89.1 mt-10 -129.69 120.5 25.25 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.242 -0.651 . . . . 73.22 109.242 -177.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.616 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.4 pp -97.83 113.61 63.9 Favored Pre-proline 0 C--N 1.353 0.727 0 N-CA-C 107.684 -1.228 . . . . 74.35 107.684 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.15 113.45 3.78 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 122.477 2.118 . . . . 72.05 108.549 171.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.41 HD21 HD12 ' A' ' 149' ' ' ILE . 34.0 tp -102.29 146.68 27.67 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 109.429 -0.582 . . . . 75.33 109.429 -168.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.9 t -90.47 154.06 19.92 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 108.324 -0.991 . . . . 63.31 108.324 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.82 -36.37 82.95 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.146 0.579 . . . . 74.52 111.803 -173.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -55.19 -47.74 74.82 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.233 0.613 . . . . 71.23 110.425 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.442 ' HG3' ' HE ' ' A' ' 136' ' ' ARG . 14.3 mm-40 -76.57 -31.7 57.69 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.933 -1.03 . . . . 71.04 111.829 -174.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.7 -31.94 72.94 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.779 0.431 . . . . 72.43 110.704 174.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -78.25 -49.98 12.71 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.433 -0.803 . . . . 71.44 110.895 173.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -62.72 -50.06 72.6 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.745 0.418 . . . . 75.12 111.413 -172.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.578 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 60.85 75.05 0.31 Allowed Glycine 0 C--N 1.342 0.862 0 CA-C-N 115.129 -0.942 . . . . 54.03 112.921 -177.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -162.3 -144.16 3.92 Favored Glycine 0 C--O 1.24 0.492 0 N-CA-C 110.967 -0.853 . . . . 64.43 110.967 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -72.05 113.36 9.0 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 122.787 0.435 . . . . 75.21 110.15 -175.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.442 ' HE ' ' HG3' ' A' ' 129' ' ' GLU . 6.8 tpp180 -120.21 120.83 37.29 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.24 -1.022 . . . . 74.44 108.24 170.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 146' ' ' SER . 63.8 t -77.07 131.71 34.26 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-N 115.417 -0.81 . . . . 74.34 110.416 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.4 p -125.18 119.64 56.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 124.361 1.065 . . . . 75.23 108.597 171.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -115.61 115.24 26.09 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.946 0.498 . . . . 75.14 110.259 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.5 m -149.22 144.01 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 125.017 1.327 . . . . 73.42 110.384 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.6 26.5 14.68 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.729 1.211 . . . . 71.41 111.611 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 81.37 -0.74 87.32 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 115.706 -0.679 . . . . 73.24 112.961 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -101.13 117.92 35.96 Favored 'General case' 0 C--N 1.346 0.451 0 C-N-CA 123.718 0.807 . . . . 75.41 110.036 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 37.1 ttp180 -97.78 105.79 17.99 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.351 -0.981 . . . . 74.15 108.351 174.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 5.6 p -125.96 125.97 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.298 0.639 . . . . 73.21 109.53 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 137' ' ' VAL . 38.3 t -89.95 134.5 34.19 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 109.371 -0.603 . . . . 70.25 109.371 175.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.6 p -113.79 130.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.277 0.631 . . . . 61.35 109.611 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -85.81 104.11 15.18 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.772 0.796 . . . . 75.0 109.778 173.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.578 HG13 ' HA2' ' A' ' 133' ' ' GLY . 8.2 pt -83.42 150.74 60.93 Favored Pre-proline 0 CA--C 1.558 1.269 0 CA-C-N 114.42 -1.264 . . . . 73.53 109.756 173.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -73.91 145.93 36.77 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.263 1.976 . . . . 75.11 112.191 173.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.48 120.1 7.31 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 122.391 2.06 . . . . 75.2 111.176 173.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 89.74 27.65 21.24 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 111.626 -0.59 . . . . 71.15 111.626 -170.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 4.3 p -66.6 129.95 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 109.272 -0.64 . . . . 73.44 109.272 172.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 29.3 mtm180 -127.02 157.87 38.45 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.442 0.697 . . . . 75.41 110.856 -168.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -42.17 125.49 3.07 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 126.716 2.006 . . . . 74.4 114.107 -175.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.79 2.75 69.17 Favored Glycine 0 C--N 1.351 1.392 0 N-CA-C 114.652 0.621 . . . . 63.44 114.652 176.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 33.1 t -68.29 122.42 18.32 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 117.556 0.678 . . . . 71.1 109.257 173.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.448 HG23 HG22 ' A' ' 177' ' ' VAL . 52.1 t -110.08 109.55 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.465 0.706 . . . . 72.3 109.592 -176.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.438 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 54.5 mt -90.78 111.57 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 108.551 -0.907 . . . . 71.0 108.551 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -86.41 104.29 15.77 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.732 0.813 . . . . 70.13 110.079 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.602 HG13 ' HB3' ' A' ' 174' ' ' LEU . 2.7 p -115.0 101.14 54.46 Favored Pre-proline 0 CA--C 1.564 1.494 0 C-N-CA 123.221 0.608 . . . . 74.1 110.352 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 49.1 Cg_endo -67.14 150.57 82.13 Favored 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 123.21 2.607 . . . . 72.3 113.231 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 74.0 11.05 81.44 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.785 -0.643 . . . . 74.23 114.331 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 23.1 mmt -114.92 -11.78 12.14 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.571 0.749 . . . . 63.14 110.353 173.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -97.24 -102.94 2.16 Favored Glycine 0 C--N 1.354 1.567 0 CA-C-N 116.059 -0.519 . . . . 63.43 112.246 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.675 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -70.48 90.63 0.38 Allowed Glycine 0 C--N 1.35 1.349 0 O-C-N 123.616 0.245 . . . . 74.04 113.621 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.69 HE21 ' HA ' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -81.6 158.17 24.46 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.524 0.678 . . . . 75.43 112.155 179.208 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 139.02 -145.72 17.11 Favored Glycine 0 C--N 1.342 0.885 0 CA-C-N 114.27 -1.332 . . . . 70.23 110.55 -172.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -75.94 -44.14 3.84 Favored Pre-proline 0 CA--C 1.562 1.409 0 CA-C-O 118.919 -0.563 . . . . 70.25 111.708 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -88.55 132.52 2.55 Favored 'Trans proline' 0 C--N 1.386 2.519 0 C-N-CA 121.653 1.569 . . . . 72.02 110.995 165.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.13 126.63 6.42 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 122.096 1.864 . . . . 62.15 111.484 176.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -109.25 154.01 16.65 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 116.071 -0.513 . . . . 73.15 112.74 -173.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.531 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 28.5 m-20 -77.35 144.44 38.01 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.62 0.768 . . . . 61.44 111.989 -175.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.602 ' HB3' HG13 ' A' ' 161' ' ' VAL . 45.6 tp -111.26 114.73 28.13 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.115 -1.069 . . . . 71.02 108.115 174.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 43.4 mt -87.04 112.38 21.81 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.302 1.041 . . . . 71.21 108.846 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.467 ' HB3' HD21 ' A' ' 123' ' ' LEU . 69.9 mt -101.75 99.0 9.19 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 123.576 0.547 . . . . 73.1 109.565 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.54 ' HB ' ' HG2' ' A' ' 122' ' ' GLU . 35.5 t -94.69 108.18 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 108.75 -0.833 . . . . 62.51 108.75 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 13.8 p -68.03 132.03 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 122.877 0.471 . . . . 74.41 110.904 -177.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -123.34 91.23 3.44 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.081 0.952 . . . . 73.21 109.071 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 85.8 mt -85.2 149.09 25.75 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.173 -0.921 . . . . 72.32 109.825 175.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 81.9 mt . . . . . 0 CA--C 1.549 0.935 0 N-CA-C 109.48 -0.563 . . . . 65.54 109.48 175.759 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 20.1 ptt? . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 109.799 -0.445 . . . . 75.43 109.799 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.415 ' H ' HG21 ' A' ' 126' ' ' THR . 19.9 m -77.66 140.68 39.63 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.358 0.663 . . . . 74.41 111.619 -178.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.516 ' HA ' HH11 ' A' ' 136' ' ' ARG . 90.1 m -71.41 151.52 43.97 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.315 1.046 . . . . 74.44 110.199 170.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.66 HD11 ' HB2' ' A' ' 123' ' ' LEU . 27.1 pt -118.15 159.35 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 123.105 0.562 . . . . 74.21 110.107 -173.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -127.12 129.23 47.53 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.619 -0.882 . . . . 74.24 108.619 172.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.62 ' HG ' ' HB3' ' A' ' 121' ' ' ALA . 12.5 tp -69.51 151.23 46.28 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.256 1.022 . . . . 72.12 108.737 -177.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.88 -48.58 24.15 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 122.79 0.436 . . . . 70.34 109.846 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 93.1 mt 57.43 80.51 0.16 Allowed 'General case' 0 C--N 1.359 1.012 0 O-C-N 124.566 1.166 . . . . 73.34 109.524 -170.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.3 mt -74.28 151.92 87.92 Favored Pre-proline 0 N--CA 1.471 0.592 0 CA-C-N 115.218 -0.901 . . . . 70.51 110.671 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo . . . . . 0 C--N 1.376 2.002 0 C-N-CA 122.471 2.114 . . . . 74.43 110.554 171.683 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.531 ' HB3' ' HA2' ' A' ' 166' ' ' GLY . 59.4 ttp180 . . . . . 0 CA--C 1.546 0.798 0 N-CA-C 110.13 -0.322 . . . . 75.13 110.13 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -91.55 106.87 18.8 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 106.443 -1.688 . . . . 75.21 106.443 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.6 tt -104.08 123.17 46.77 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.173 -1.047 . . . . 61.24 108.173 -172.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -90.5 128.18 36.46 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.233 -1.025 . . . . 75.33 108.233 175.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.62 ' HB3' ' HG ' ' A' ' 99' ' ' LEU . . . -140.88 149.76 42.36 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 123.788 0.835 . . . . 74.15 109.314 -172.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -119.93 122.3 40.92 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.667 -0.864 . . . . 62.43 108.667 -175.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.662 HD23 ' HB3' ' A' ' 176' ' ' LEU . 3.9 pp -99.63 108.03 48.83 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 106.912 -1.514 . . . . 74.21 106.912 173.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.562 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 63.1 Cg_endo -71.59 112.18 3.3 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 121.838 1.692 . . . . 74.4 108.373 169.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.424 HD21 HD12 ' A' ' 149' ' ' ILE . 32.8 tp -100.55 142.84 31.46 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.216 -1.031 . . . . 73.31 108.216 -170.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.415 HG21 ' H ' ' A' ' 95' ' ' SER . 1.9 t -79.47 145.1 33.44 Favored 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 107.941 -1.133 . . . . 74.24 107.941 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.84 -28.73 69.69 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.389 0.676 . . . . 74.34 112.479 -170.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.84 -41.16 97.88 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.601 -0.727 . . . . 72.24 109.794 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -75.99 -31.29 58.9 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.879 0.872 . . . . 74.24 112.461 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.32 -40.35 77.73 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.415 0.626 . . . . 73.53 110.272 169.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -73.93 -48.22 32.25 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-N 114.432 -1.258 . . . . 74.44 111.876 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -76.13 -51.33 12.4 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 120.722 0.296 . . . . 74.34 111.137 -171.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.614 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 67.33 69.1 1.45 Allowed Glycine 0 C--N 1.348 1.24 0 CA-C-N 115.25 -0.887 . . . . 71.51 113.478 -178.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -131.84 -154.65 7.8 Favored Glycine 0 N--CA 1.477 1.367 0 N-CA-C 111.684 -0.566 . . . . 71.23 111.684 178.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -70.96 114.31 8.88 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.101 -0.703 . . . . 71.34 109.101 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.516 HH11 ' HA ' ' A' ' 96' ' ' THR . 8.0 tpp180 -112.07 122.19 47.07 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.326 -0.99 . . . . 64.44 108.326 175.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 78.1 t -78.82 131.46 34.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-N 113.828 -1.533 . . . . 72.54 110.406 -177.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.9 p -136.91 122.17 26.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 124.287 1.035 . . . . 73.44 108.58 173.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -121.41 114.62 21.54 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.231 0.612 . . . . 74.15 111.088 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.4 m -148.89 146.78 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.681 1.592 . . . . 74.53 109.683 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 66.38 27.41 9.97 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.725 1.21 . . . . 71.12 110.848 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.23 15.64 72.53 Favored Glycine 0 C--N 1.356 1.687 0 CA-C-N 115.787 -0.642 . . . . 72.21 113.338 -176.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -124.26 129.37 50.64 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.002 0.921 . . . . 75.13 109.547 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 32.4 ttp180 -110.17 120.35 42.17 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.083 0.553 . . . . 71.53 110.217 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.1 p -122.34 146.18 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 123.95 0.9 . . . . 74.42 109.787 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 47.5 t -100.5 113.16 25.72 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.581 -0.896 . . . . 60.03 108.581 174.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.8 p -102.5 113.72 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 109.215 -0.661 . . . . 75.0 109.215 174.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 55.1 ttt85 -75.75 104.69 6.41 Favored 'General case' 0 C--N 1.35 0.625 0 N-CA-C 108.698 -0.853 . . . . 73.41 108.698 174.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.614 HG13 ' HA2' ' A' ' 133' ' ' GLY . 12.2 pt -81.52 145.24 54.53 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 124.524 1.129 . . . . 73.11 109.67 175.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.56 148.95 73.69 Favored 'Trans proline' 0 CA--C 1.565 2.036 0 C-N-CA 122.403 2.069 . . . . 63.12 112.982 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.439 ' HA ' ' HA3' ' A' ' 133' ' ' GLY . 37.6 Cg_endo -63.59 118.95 5.86 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.87 2.38 . . . . 70.35 111.628 174.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 88.04 23.44 38.13 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-O 119.724 -0.487 . . . . 75.43 112.414 -175.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.423 HG13 ' HB ' ' A' ' 149' ' ' ILE . 3.9 p -62.89 120.34 9.2 Favored 'Isoleucine or valine' 0 C--N 1.361 1.105 0 C-N-CA 123.343 0.657 . . . . 62.01 109.689 176.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.513 ' HA ' HD11 ' A' ' 180' ' ' LEU . 66.0 mtt85 -123.73 159.55 29.19 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.564 0.746 . . . . 75.34 111.006 -173.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -38.53 127.26 1.46 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.036 2.134 . . . . 71.43 113.794 -173.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 101.94 -9.66 56.74 Favored Glycine 0 C--N 1.355 1.625 0 CA-C-O 119.017 -0.879 . . . . 74.22 114.622 174.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.3 t -69.14 120.18 14.58 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 117.799 0.799 . . . . 72.42 109.45 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 57.3 t -104.72 114.62 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.217 0.607 . . . . 73.34 109.943 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 51.7 mt -91.86 100.9 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 107.783 -1.191 . . . . 75.33 107.783 172.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.475 HH11 HD21 ' A' ' 175' ' ' LEU . 57.9 ttt85 -84.0 103.71 13.47 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.954 -0.758 . . . . 72.13 108.954 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.72 120.31 47.64 Favored Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 123.137 0.575 . . . . 73.41 110.051 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -74.79 149.71 38.15 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.751 2.3 . . . . 72.13 113.028 -173.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 75.03 -0.3 58.9 Favored Glycine 0 N--CA 1.473 1.149 0 N-CA-C 114.451 0.541 . . . . 70.21 114.451 174.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 85.8 mmm -98.02 -25.34 14.99 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.935 0.894 . . . . 74.32 110.7 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -79.98 -82.24 0.74 Allowed Glycine 0 C--N 1.348 1.234 0 N-CA-C 111.226 -0.75 . . . . 63.43 111.226 176.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.531 ' HA2' ' HB3' ' A' ' 117' ' ' ARG . . . -61.26 94.38 0.08 OUTLIER Glycine 0 C--N 1.345 1.062 0 O-C-N 124.171 0.571 . . . . 73.1 113.221 174.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -88.13 114.65 24.95 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.015 0.926 . . . . 72.1 109.347 175.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 158.48 -149.84 20.26 Favored Glycine 0 N--CA 1.466 0.666 0 N-CA-C 111.213 -0.755 . . . . 61.54 111.213 -177.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -72.57 -52.31 6.55 Favored Pre-proline 0 CA--C 1.559 1.299 0 CA-C-O 118.019 -0.991 . . . . 75.2 111.188 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -83.88 112.42 1.78 Allowed 'Trans proline' 0 C--N 1.391 2.772 0 C-N-CA 121.733 1.622 . . . . 73.23 111.293 174.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.58 125.61 12.44 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 121.895 1.73 . . . . 74.41 111.448 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -116.29 156.52 15.58 Favored Glycine 0 C--N 1.342 0.88 0 N-CA-C 111.708 -0.557 . . . . 62.31 111.708 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -79.61 159.46 26.78 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.339 0.656 . . . . 63.11 111.4 -175.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 32.4 tp -127.12 113.16 16.03 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 114.643 -1.162 . . . . 75.21 108.061 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.475 HD21 HH11 ' A' ' 160' ' ' ARG . 86.6 mt -81.86 101.64 10.34 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.472 -0.936 . . . . 74.23 108.472 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.662 ' HB3' HD23 ' A' ' 123' ' ' LEU . 54.2 mt -90.36 97.11 10.99 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.93 -0.767 . . . . 71.14 108.93 177.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.48 118.88 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 O-C-N 121.759 -0.588 . . . . 73.45 109.611 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 14.0 p -67.55 132.52 32.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.815 0 C-N-CA 123.778 0.831 . . . . 64.2 109.839 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.562 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 17.6 mmm-85 -122.12 104.95 9.84 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.745 0.818 . . . . 73.42 109.182 -176.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.513 HD11 ' HA ' ' A' ' 154' ' ' ARG . 83.0 mt -109.79 147.82 32.57 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.49 0.716 . . . . 75.13 111.227 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 89.1 mt . . . . . 0 CA--C 1.557 1.217 0 CA-C-N 114.527 -1.215 . . . . 73.04 109.496 175.097 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 3.4 mpp? . . . . . 0 N--CA 1.482 1.129 0 N-CA-C 109.164 -0.68 . . . . 75.12 109.164 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.8 m -66.85 138.24 57.18 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.362 -0.835 . . . . 62.52 111.835 -177.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 47.3 m -74.81 150.09 39.42 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.576 -0.738 . . . . 75.23 109.073 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.58 HD11 ' HB2' ' A' ' 123' ' ' LEU . 23.5 pt -125.02 171.39 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 123.377 0.671 . . . . 74.43 110.705 -170.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -133.55 134.33 43.23 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.584 0.753 . . . . 74.4 110.27 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.563 ' HG ' ' HB3' ' A' ' 121' ' ' ALA . 12.3 tp -84.47 176.2 8.81 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.334 1.053 . . . . 74.43 109.069 -174.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -101.07 -48.15 4.52 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.41 0.284 . . . . 64.4 111.75 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.7 mt 57.36 70.45 0.65 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.113 0.965 . . . . 65.03 110.937 -168.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 20.8 mt -87.4 151.89 51.55 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-N 115.17 -0.923 . . . . 65.35 108.772 174.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo . . . . . 0 CA--C 1.558 1.675 0 C-N-CA 121.924 1.75 . . . . 73.01 111.943 174.516 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.51 ' O ' ' HA3' ' A' ' 172' ' ' GLY . 38.5 ttm180 . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 110.149 -0.315 . . . . 75.21 110.149 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -77.84 144.94 36.61 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.11 0.481 . . . . 73.35 109.972 178.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.3 tt -136.72 113.22 10.06 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 105.551 -2.018 . . . . 73.42 105.551 172.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 34.9 ttt180 -93.8 123.09 36.91 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 108.486 -0.931 . . . . 75.11 108.486 -177.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.563 ' HB3' ' HG ' ' A' ' 99' ' ' LEU . . . -140.53 131.49 26.11 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 123.534 0.734 . . . . 74.4 109.342 -172.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -117.63 128.79 55.28 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 110.05 -0.352 . . . . 74.12 110.05 -169.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.58 ' HB2' HD11 ' A' ' 97' ' ' ILE . 4.0 pp -108.16 117.77 54.1 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 123.062 0.545 . . . . 72.53 110.107 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.543 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 68.0 Cg_endo -73.33 113.75 3.86 Favored 'Trans proline' 0 C--N 1.364 1.347 0 C-N-CA 122.451 2.101 . . . . 72.2 109.088 168.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.529 HD22 HD13 ' A' ' 149' ' ' ILE . 50.6 tp -103.8 147.94 26.69 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 122.794 0.438 . . . . 73.01 110.015 -166.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.8 t -85.22 149.31 25.59 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 109.018 -0.734 . . . . 71.23 109.018 -177.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.9 mt -63.06 -30.8 71.88 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.587 0.755 . . . . 72.43 112.441 -171.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.04 -49.61 76.68 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 109.48 -0.563 . . . . 71.14 109.48 177.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -72.97 -31.69 64.71 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 114.818 -1.083 . . . . 72.43 112.164 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.53 -38.08 80.06 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.747 0.654 . . . . 72.44 110.472 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -73.52 -52.82 12.24 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.027 -0.988 . . . . 74.15 110.846 174.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -62.52 -49.69 74.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 123.531 0.52 . . . . 75.52 112.379 -169.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.568 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 67.86 52.16 30.56 Favored Glycine 0 C--N 1.34 0.751 0 O-C-N 123.853 0.721 . . . . 71.12 112.971 -172.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.43 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -113.05 -163.13 15.54 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 112.077 -0.409 . . . . 54.23 112.077 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.65 115.42 20.91 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 108.934 -0.765 . . . . 71.35 108.934 175.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -113.45 124.08 51.57 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.577 0.751 . . . . 73.34 109.323 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 86.0 t -72.06 127.97 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-N 114.198 -1.365 . . . . 70.21 109.721 175.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.435 HG21 ' HB2' ' A' ' 99' ' ' LEU . 6.1 p -134.26 111.15 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 124.151 0.981 . . . . 74.41 108.838 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -103.36 134.73 46.25 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.667 0.787 . . . . 73.31 109.988 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.9 p -152.35 132.06 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.245 1.018 . . . . 63.31 109.887 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.37 18.0 8.88 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.348 1.059 . . . . 74.15 112.506 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.67 -8.83 71.29 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 116.26 -0.427 . . . . 63.44 113.327 -175.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -92.25 118.39 30.83 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.708 0.803 . . . . 74.31 110.498 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.5 ttp180 -98.39 120.78 39.4 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.449 1.1 . . . . 75.02 109.485 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 40.5 t -123.41 125.71 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.054 0.942 . . . . 73.23 109.346 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.9 t -97.53 112.64 24.41 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.867 -0.79 . . . . 74.25 108.867 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.4 139.14 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.133 0.573 . . . . 75.41 111.013 -175.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -83.72 110.37 18.25 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.887 -0.783 . . . . 74.1 108.887 174.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.568 HG13 ' HA2' ' A' ' 133' ' ' GLY . 9.3 pt -89.55 151.46 46.01 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 124.29 1.036 . . . . 74.21 110.026 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -67.31 139.57 50.34 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.687 2.258 . . . . 72.34 112.603 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -65.5 131.85 29.26 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.561 2.174 . . . . 74.33 111.126 169.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 69.71 29.9 70.95 Favored Glycine 0 C--N 1.343 0.966 0 O-C-N 123.55 0.531 . . . . 72.54 112.391 -177.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 9.6 p -64.82 148.12 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 124.058 0.943 . . . . 70.14 110.007 178.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.414 ' HA ' HD11 ' A' ' 180' ' ' LEU . 24.4 mtp180 -134.44 161.75 34.16 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.991 0.516 . . . . 75.15 110.281 -178.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -44.59 134.71 5.23 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 125.73 1.612 . . . . 55.33 113.525 -174.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 83.9 3.85 89.01 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 115.746 -0.661 . . . . 75.44 114.322 176.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.3 t -71.87 121.11 18.45 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 108.412 -0.959 . . . . 75.12 108.412 174.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.4 t -104.74 114.71 45.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 O-C-N 123.738 0.649 . . . . 75.4 110.603 -175.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 60.8 mt -89.9 102.26 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 107.328 -1.36 . . . . 74.33 107.328 174.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -87.63 105.45 17.35 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 122.992 0.517 . . . . 73.23 109.826 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.2 p -111.17 119.64 45.11 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 123.064 0.545 . . . . 74.24 109.704 175.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.43 153.14 49.98 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 122.247 1.964 . . . . 73.41 112.044 -177.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.36 -4.12 50.51 Favored Glycine 0 C--N 1.344 0.979 0 N-CA-C 115.208 0.843 . . . . 71.05 115.208 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 95.9 mmm -102.83 -13.26 17.06 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 117.645 0.723 . . . . 75.22 110.643 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -86.31 -96.1 0.81 Allowed Glycine 0 C--N 1.355 1.584 0 N-CA-C 111.823 -0.511 . . . . 65.2 111.823 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -57.28 98.29 0.08 OUTLIER Glycine 0 C--N 1.349 1.255 0 O-C-N 123.972 0.454 . . . . 64.54 112.319 171.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -88.09 153.89 20.9 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.521 1.128 . . . . 73.21 109.581 174.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 118.93 -144.17 17.75 Favored Glycine 0 N--CA 1.468 0.794 0 N-CA-C 110.976 -0.85 . . . . 74.5 110.976 -177.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -75.32 -47.36 4.4 Favored Pre-proline 0 CA--C 1.56 1.328 0 CA-C-O 117.97 -1.015 . . . . 73.52 110.944 168.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -76.47 113.55 3.69 Favored 'Trans proline' 0 C--N 1.395 2.98 0 C-N-CA 121.609 1.539 . . . . 72.34 112.241 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -82.8 126.77 4.64 Favored 'Trans proline' 0 C--N 1.385 2.461 0 C-N-CA 122.387 2.058 . . . . 74.13 111.787 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 117' ' ' ARG . . . -130.09 -179.37 15.98 Favored Glycine 0 N--CA 1.463 0.489 0 CA-C-N 116.758 -0.201 . . . . 62.11 113.181 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -100.92 131.26 46.88 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.817 0.847 . . . . 65.11 110.924 -168.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 29.8 tp -92.51 110.35 21.77 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 108.55 -0.908 . . . . 73.03 108.55 176.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 60.2 mt -91.19 99.7 12.65 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.49 0.716 . . . . 72.54 109.367 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.541 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 96.2 mt -88.87 99.85 12.71 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.621 0.369 . . . . 75.15 111.022 -175.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 38.8 t -87.51 114.56 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 109.261 -0.644 . . . . 74.4 109.261 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.421 HG22 ' HG ' ' A' ' 180' ' ' LEU . 12.1 p -73.02 132.98 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 CA-C-O 121.188 0.518 . . . . 74.21 109.843 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.543 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 37.6 mmt180 -115.21 101.42 8.94 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.86 -1.163 . . . . 75.0 107.86 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.421 ' HG ' HG22 ' A' ' 178' ' ' VAL . 38.8 mt -108.23 141.67 39.65 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.005 0.431 . . . . 72.23 111.369 -176.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 65.3 mt . . . . . 0 CA--C 1.544 0.729 0 CA-C-N 114.464 -1.244 . . . . 75.45 107.664 172.84 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.454 ' SD ' ' O ' ' A' ' 94' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.582 0 CA-C-O 121.564 0.697 . . . . 74.2 109.793 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.7 t -77.14 133.41 38.99 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.579 -0.737 . . . . 71.54 110.726 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 52.3 m -73.67 145.28 45.39 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.152 0.981 . . . . 73.0 110.308 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.535 HD12 ' HB2' ' A' ' 123' ' ' LEU . 18.2 pt -118.01 162.23 16.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 C-N-CA 123.223 0.609 . . . . 74.44 110.681 -172.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.406 ' O ' ' HD2' ' A' ' 124' ' ' PRO . . . -104.05 177.63 4.79 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.048 0.939 . . . . 73.34 108.952 170.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.572 ' HG ' ' HB3' ' A' ' 121' ' ' ALA . 11.4 tp -113.67 -133.77 0.34 Allowed 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 107.147 -1.427 . . . . 74.25 107.147 177.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.49 -43.47 0.06 Allowed 'General case' 0 C--N 1.345 0.412 0 N-CA-C 109.107 -0.701 . . . . 71.33 109.107 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 84.3 mt 53.81 64.08 1.96 Allowed 'General case' 0 C--N 1.362 1.129 0 O-C-N 124.438 1.086 . . . . 74.24 110.117 -172.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 61.0 mt -63.54 159.72 49.14 Favored Pre-proline 0 CA--C 1.55 0.968 0 CA-C-N 113.995 -1.457 . . . . 72.14 109.717 176.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo . . . . . 0 C--N 1.378 2.093 0 C-N-CA 122.056 1.837 . . . . 74.24 112.19 173.914 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 . . . . . 0 CA--C 1.541 0.609 0 CA-C-O 121.255 0.55 . . . . 71.32 111.478 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -83.43 119.7 24.99 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 108.093 -1.077 . . . . 73.11 108.093 169.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.3 tt -103.81 121.41 42.99 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.158 -1.793 . . . . 71.21 106.158 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -89.79 133.38 34.74 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.121 -1.066 . . . . 75.05 108.121 -177.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.572 ' HB3' ' HG ' ' A' ' 99' ' ' LEU . . . -154.56 146.66 23.68 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.252 0.621 . . . . 54.24 109.579 -175.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -128.19 135.0 49.12 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.502 -0.555 . . . . 75.12 109.502 -175.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.535 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.4 pp -112.53 116.96 47.78 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 109.88 -0.415 . . . . 75.22 109.88 178.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.586 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 70.2 Cg_endo -72.87 115.32 4.3 Favored 'Trans proline' 0 C--N 1.36 1.141 0 C-N-CA 122.498 2.132 . . . . 63.53 108.592 169.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.501 HD21 HD12 ' A' ' 149' ' ' ILE . 43.3 tp -104.26 148.4 26.38 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.933 -0.395 . . . . 74.33 109.933 -167.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.3 t -88.94 156.5 18.86 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 109.134 -0.691 . . . . 72.4 109.134 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.3 mt -64.42 -32.95 74.79 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.709 0.804 . . . . 72.12 112.631 -173.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.52 -46.7 87.23 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 124.168 0.918 . . . . 72.55 109.752 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -74.68 -34.09 62.6 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.041 -0.981 . . . . 71.0 111.519 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.97 -34.23 73.02 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.169 0.509 . . . . 60.5 110.518 173.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -76.55 -54.07 7.2 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 114.913 -1.04 . . . . 74.43 110.846 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -62.88 -50.35 71.24 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 122.829 0.452 . . . . 74.24 111.285 -174.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.561 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 70.04 58.27 6.32 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 114.963 -1.017 . . . . 62.54 111.369 -169.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.406 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -121.7 -175.18 14.9 Favored Glycine 0 C--N 1.346 1.091 0 N-CA-C 112.463 -0.255 . . . . 71.31 112.463 -175.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -76.1 113.61 13.82 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.463 -0.94 . . . . 63.4 108.463 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -111.18 124.61 52.54 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.163 -1.051 . . . . 74.43 108.163 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.453 HG13 ' HG3' ' A' ' 144' ' ' ARG . 94.9 t -70.34 124.31 26.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 114.466 -1.243 . . . . 74.24 109.124 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 34.5 t -117.77 130.14 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 107.83 -1.174 . . . . 75.41 107.83 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -123.71 122.21 37.5 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 118.1 0.409 . . . . 73.21 110.409 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -149.99 128.73 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 124.855 1.262 . . . . 72.44 109.913 174.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.82 20.1 12.05 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.818 1.247 . . . . 74.05 112.203 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.12 9.14 82.77 Favored Glycine 0 C--N 1.355 1.595 0 CA-C-N 116.416 -0.357 . . . . 75.11 113.116 -175.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -101.19 120.21 39.9 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.706 1.202 . . . . 73.04 109.214 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.453 ' HG3' HG13 ' A' ' 137' ' ' VAL . 48.1 ttp180 -99.0 109.59 22.32 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.973 0.909 . . . . 74.54 109.747 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 53.8 t -107.99 112.38 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.566 -0.901 . . . . 75.53 108.566 172.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 48.2 t -91.54 104.16 16.69 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.213 -1.032 . . . . 72.34 108.213 174.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.1 p -100.94 119.17 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.521 0.729 . . . . 72.31 110.441 -175.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -73.74 101.06 3.57 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.334 -0.988 . . . . 73.41 108.334 167.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.561 HG13 ' HA2' ' A' ' 133' ' ' GLY . 10.0 pt -81.33 151.59 69.47 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 123.97 0.908 . . . . 73.52 109.675 175.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.4 ' HG2' ' HB ' ' A' ' 153' ' ' VAL . 64.5 Cg_endo -73.62 144.75 36.15 Favored 'Trans proline' 0 CA--C 1.559 1.763 0 C-N-CA 122.088 1.859 . . . . 61.41 112.556 177.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -63.18 124.5 14.0 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.18 2.587 . . . . 63.52 112.345 177.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 80.18 23.16 61.69 Favored Glycine 0 C--N 1.343 0.947 0 O-C-N 123.448 0.468 . . . . 75.43 112.906 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.4 ' HB ' ' HG2' ' A' ' 150' ' ' PRO . 7.5 p -57.57 145.99 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 124.536 1.135 . . . . 73.41 110.685 177.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -138.11 162.17 34.88 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.79 0.836 . . . . 65.31 110.547 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -43.85 129.13 5.71 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 126.366 1.866 . . . . 74.34 112.694 -174.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.17 -3.11 59.9 Favored Glycine 0 C--N 1.35 1.318 0 O-C-N 123.63 0.581 . . . . 75.22 113.81 176.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 52.2 m -69.81 119.68 14.4 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 117.724 0.762 . . . . 74.34 110.148 175.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 45.0 t -103.34 109.09 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.243 0.617 . . . . 72.23 110.026 -178.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 58.5 mt -91.25 101.92 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.438 1.095 . . . . 74.51 108.14 172.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -89.62 103.03 15.71 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.918 -0.771 . . . . 74.42 108.918 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.8 p -103.77 105.49 48.12 Favored Pre-proline 0 CA--C 1.561 1.367 0 C-N-CA 123.228 0.611 . . . . 73.4 110.316 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -66.44 146.77 81.2 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 123.093 2.528 . . . . 73.32 113.514 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 81.83 0.13 89.03 Favored Glycine 0 C--N 1.346 1.111 0 CA-C-N 115.603 -0.726 . . . . 71.35 113.666 176.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.8 mmt -101.66 -24.6 14.08 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 117.598 0.699 . . . . 74.14 111.529 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -81.84 -87.68 0.67 Allowed Glycine 0 C--N 1.347 1.171 0 CA-C-O 119.822 -0.432 . . . . 70.01 112.612 -175.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -62.65 93.49 0.1 OUTLIER Glycine 0 C--N 1.352 1.468 0 O-C-N 124.056 0.504 . . . . 61.1 112.247 174.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -88.86 158.13 18.21 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.152 0.981 . . . . 73.22 109.417 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 96.85 -142.57 16.25 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-O 119.623 -0.543 . . . . 73.34 111.879 -176.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -68.84 -53.88 14.09 Favored Pre-proline 0 CA--C 1.567 1.634 0 CA-C-O 118.032 -0.985 . . . . 73.3 112.389 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -83.92 108.51 1.41 Allowed 'Trans proline' 0 C--N 1.394 2.931 0 C-N-CA 121.709 1.606 . . . . 73.42 112.149 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.28 127.22 11.02 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.85 2.366 . . . . 63.41 110.953 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -141.19 176.27 21.78 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-N 116.443 -0.344 . . . . 74.25 112.808 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -100.33 162.21 13.1 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.279 1.032 . . . . 74.25 111.373 -172.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 37.7 tp -117.05 112.7 21.29 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 124.588 1.155 . . . . 74.43 108.033 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 66.9 mt -84.02 100.3 10.98 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.745 -0.835 . . . . 75.43 108.745 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.47 HD21 HD11 ' A' ' 99' ' ' LEU . 91.9 mt -96.89 99.7 11.24 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.075 0.55 . . . . 75.33 110.083 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.6 p -93.55 125.58 46.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 N-CA-C 109.444 -0.576 . . . . 74.12 109.444 176.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.8 137.63 23.07 Favored 'Isoleucine or valine' 0 C--O 1.249 1.043 0 C-N-CA 123.299 0.639 . . . . 73.25 109.5 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.586 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 22.3 mmm-85 -115.81 97.84 6.34 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.817 -0.809 . . . . 73.12 108.817 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 55.1 mt -119.56 131.9 55.62 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.91 0.884 . . . . 75.31 109.669 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 90.6 mt . . . . . 0 CA--C 1.543 0.686 0 CA-C-N 115.349 -0.841 . . . . 73.44 110.713 -175.792 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.427 ' SD ' ' N ' ' A' ' 94' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 109.086 -0.709 . . . . 75.15 109.086 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.3 m -67.84 115.97 7.98 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.449 -0.574 . . . . 72.22 109.449 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 98.6 m -65.18 144.83 56.94 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.702 0.801 . . . . 72.14 110.737 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.559 HD13 ' HB2' ' A' ' 123' ' ' LEU . 11.2 pt -117.41 161.07 16.5 Favored 'Isoleucine or valine' 0 C--O 1.245 0.854 0 CA-C-N 115.659 -0.7 . . . . 74.3 109.23 -174.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -136.69 129.7 31.02 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.725 0.81 . . . . 72.2 109.159 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.679 ' HG ' ' HB3' ' A' ' 121' ' ' ALA . 11.2 tp -68.78 149.67 48.74 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.956 1.303 . . . . 74.15 109.935 -174.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.22 -34.58 55.98 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.519 0.328 . . . . 73.21 110.949 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 70.3 mt 52.1 69.31 0.69 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.064 0.946 . . . . 73.23 111.059 -175.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 63.2 mt -69.14 161.09 75.45 Favored Pre-proline 0 CA--C 1.558 1.277 0 CA-C-N 115.33 -0.85 . . . . 70.42 109.913 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo . . . . . 0 C--N 1.377 2.033 0 C-N-CA 122.241 1.961 . . . . 74.14 112.941 178.769 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.597 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 11.8 tpp180 . . . . . 0 C--O 1.244 0.782 0 CA-C-O 121.132 0.492 . . . . 75.11 110.103 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -73.8 128.2 34.87 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 114.839 -1.073 . . . . 72.24 109.102 175.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.4 tt -134.79 114.85 13.04 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.335 -1.728 . . . . 73.41 106.335 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -90.31 138.05 31.85 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 107.605 -1.257 . . . . 75.43 107.605 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.679 ' HB3' ' HG ' ' A' ' 99' ' ' LEU . . . -157.25 131.83 8.61 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.253 -0.647 . . . . 72.35 109.253 -170.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -120.73 126.38 50.03 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 109.068 -0.716 . . . . 74.51 109.068 -170.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.559 ' HB2' HD13 ' A' ' 97' ' ' ILE . 3.9 pp -100.81 118.78 59.99 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 109.325 -0.62 . . . . 73.44 109.325 -177.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.596 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 74.1 Cg_endo -73.69 111.63 3.34 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.542 2.162 . . . . 64.34 109.344 171.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.452 HD23 HD12 ' A' ' 149' ' ' ILE . 28.2 tp -102.47 149.77 24.04 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 109.015 -0.735 . . . . 74.32 109.015 -168.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.6 t -95.57 158.53 15.41 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-N 115.913 -0.585 . . . . 52.42 109.479 -177.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 82.1 mt -64.3 -30.45 71.5 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.469 0.708 . . . . 75.45 112.13 -175.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.07 -48.33 82.18 Favored 'General case' 0 C--O 1.216 -0.701 0 O-C-N 123.904 0.753 . . . . 65.4 109.507 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.469 ' HG3' ' HD2' ' A' ' 136' ' ' ARG . 8.2 mm-40 -75.54 -30.95 59.9 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.51 0.724 . . . . 74.24 111.367 -175.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.87 -26.11 64.97 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 122.878 0.471 . . . . 61.31 111.044 174.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -83.96 -47.99 10.43 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.837 0.855 . . . . 73.41 110.452 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -67.68 -49.55 62.21 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.196 0.598 . . . . 75.43 110.283 -174.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.492 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 62.86 62.17 5.75 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 114.49 -1.232 . . . . 55.45 112.318 -173.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.26 -163.69 11.27 Favored Glycine 0 C--N 1.34 0.768 0 N-CA-C 111.769 -0.532 . . . . 42.34 111.769 -177.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -73.6 118.68 16.83 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.379 -0.971 . . . . 72.42 108.379 177.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.601 HH21 ' HB ' ' A' ' 137' ' ' VAL . 5.8 tpm_? -111.67 122.76 48.68 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.484 -0.932 . . . . 74.14 108.484 177.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.601 ' HB ' HH21 ' A' ' 136' ' ' ARG . 71.4 t -71.88 113.71 9.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-N 114.576 -1.193 . . . . 73.22 110.159 176.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.77 110.2 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 106.889 -1.522 . . . . 74.21 106.889 174.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -118.19 121.23 39.96 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.62 -0.511 . . . . 73.44 109.62 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 1.5 m -149.34 142.59 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 125.197 1.399 . . . . 65.44 109.69 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.35 25.58 15.27 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.696 1.198 . . . . 75.32 111.559 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 73.07 10.76 78.49 Favored Glycine 0 C--N 1.355 1.615 0 CA-C-N 115.681 -0.691 . . . . 75.21 113.567 -175.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 58.7 ttt85 -114.03 125.0 53.51 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.937 0.895 . . . . 75.41 109.066 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -105.42 126.08 51.72 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.754 0.822 . . . . 74.41 109.738 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 4.4 p -127.98 123.35 60.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 124.269 1.027 . . . . 72.42 108.803 176.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 30.0 t -99.65 104.29 16.04 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.013 -0.736 . . . . 74.42 109.013 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.1 p -101.0 123.17 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.188 0.595 . . . . 74.42 110.545 -176.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -76.44 116.06 16.77 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 109.052 -0.721 . . . . 73.33 109.052 172.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.492 HG13 ' HA2' ' A' ' 133' ' ' GLY . 10.6 pt -96.87 151.02 37.55 Favored Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 124.319 1.047 . . . . 71.0 109.006 175.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.42 145.96 49.11 Favored 'Trans proline' 0 CA--C 1.565 2.048 0 C-N-CA 122.322 2.015 . . . . 74.32 112.74 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.403 ' HA ' ' HA3' ' A' ' 133' ' ' GLY . 27.3 Cg_exo -64.68 114.4 2.73 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 123.248 2.632 . . . . 73.15 112.105 175.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 87.82 31.26 15.68 Favored Glycine 0 C--N 1.341 0.83 0 O-C-N 123.333 0.396 . . . . 70.02 112.333 -174.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.89 149.85 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.834 0.853 . . . . 75.51 110.221 173.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -134.41 154.24 51.48 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.665 0.786 . . . . 73.33 110.756 -174.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -40.51 131.54 2.23 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.726 2.01 . . . . 71.15 113.397 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.34 -9.81 69.46 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-O 119.215 -0.769 . . . . 73.02 114.596 175.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 27.1 t -62.34 122.86 16.73 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.394 0.678 . . . . 74.42 110.067 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.1 t -102.51 109.28 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.58 0.752 . . . . 73.33 109.832 -177.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 59.5 mt -92.98 113.5 28.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 108.628 -0.878 . . . . 74.42 108.628 173.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -86.6 116.95 25.06 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.911 0.484 . . . . 75.32 110.118 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.464 HG13 ' HB3' ' A' ' 174' ' ' LEU . 7.2 p -125.75 102.72 28.49 Favored Pre-proline 0 CA--C 1.564 1.482 0 C-N-CA 123.253 0.621 . . . . 74.32 110.486 175.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 51.4 Cg_endo -68.15 154.86 71.41 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 123.049 2.5 . . . . 65.23 112.873 176.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 84.06 -15.15 40.0 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 116.105 -0.498 . . . . 73.21 114.178 178.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 24.3 mmt -99.02 -13.9 19.68 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.72 0.808 . . . . 74.31 111.763 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.4 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -79.54 -113.05 0.24 Allowed Glycine 0 C--N 1.351 1.362 0 O-C-N 123.593 0.558 . . . . 72.0 112.623 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.597 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -66.83 117.59 9.46 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.651 0.225 . . . . 73.23 113.452 177.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -88.42 131.42 34.87 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.636 0.774 . . . . 70.04 109.737 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 165.55 -160.68 34.13 Favored Glycine 0 N--CA 1.468 0.775 0 N-CA-C 110.316 -1.114 . . . . 64.43 110.316 -176.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -70.77 -35.84 4.79 Favored Pre-proline 0 CA--C 1.566 1.589 0 CA-C-O 117.715 -1.136 . . . . 73.31 112.247 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -91.33 128.9 1.21 Allowed 'Trans proline' 0 C--N 1.402 3.362 0 C-N-CA 122.466 2.111 . . . . 64.45 110.617 170.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.88 122.21 9.32 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 121.413 1.409 . . . . 74.51 110.844 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -90.81 146.03 18.2 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.722 -0.672 . . . . 54.42 112.242 -176.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.472 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 16.7 t70 -91.38 146.61 23.67 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.934 0.493 . . . . 74.24 110.239 -176.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.464 ' HB3' HG13 ' A' ' 161' ' ' VAL . 22.5 tp -123.67 111.17 15.88 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.398 0.679 . . . . 72.22 109.95 -176.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 75.6 mt -90.36 101.01 13.74 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.995 0.918 . . . . 74.44 110.069 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 79.8 mt -86.22 101.73 13.29 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.501 0.72 . . . . 74.21 110.664 -177.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 47.4 t -90.65 115.96 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.386 -0.968 . . . . 75.33 108.386 174.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.3 p -71.66 138.88 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 109.814 -0.439 . . . . 74.33 109.814 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.596 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 27.0 mmt180 -120.05 94.37 4.37 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.8 0.84 . . . . 74.42 109.229 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 51.7 mt -106.71 140.82 38.95 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.072 -0.967 . . . . 75.04 109.738 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 90.0 mt . . . . . 0 CA--C 1.556 1.202 0 CA-C-N 114.922 -1.036 . . . . 60.52 110.35 178.88 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.574 ' HB2' HH12 ' A' ' 136' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 121.0 0.428 . . . . 74.35 110.688 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.4 m -80.87 133.33 35.56 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 109.355 -0.609 . . . . 71.33 109.355 175.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 94.8 m -70.49 145.43 50.93 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 123.482 0.713 . . . . 75.11 110.746 176.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.52 HD12 ' HB2' ' A' ' 123' ' ' LEU . 23.6 pt -123.15 175.96 5.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 C-N-CA 123.647 0.779 . . . . 72.45 110.022 -176.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.406 ' O ' ' HD2' ' A' ' 124' ' ' PRO . . . -128.79 167.67 16.98 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.819 0.848 . . . . 71.14 109.391 176.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.529 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.5 tp -110.41 148.83 31.22 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 108.602 -0.888 . . . . 74.31 108.602 -177.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.27 -47.21 51.84 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.409 0.284 . . . . 73.1 110.66 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.6 mt 57.09 75.08 0.38 Allowed 'General case' 0 N--CA 1.478 0.929 0 O-C-N 124.47 1.107 . . . . 73.34 110.591 -170.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.7 mt -76.74 164.05 61.84 Favored Pre-proline 0 CA--C 1.553 1.076 0 CA-C-N 114.232 -1.349 . . . . 75.25 109.045 174.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo . . . . . 0 C--N 1.371 1.713 0 C-N-CA 121.858 1.705 . . . . 75.55 112.812 175.027 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 . . . . . 0 N--CA 1.478 0.939 0 CA-C-O 120.41 0.148 . . . . 74.41 110.706 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -83.91 133.18 34.72 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.563 -0.903 . . . . 55.2 108.563 169.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.5 tt -132.69 134.21 44.52 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 107.452 -1.314 . . . . 74.42 107.452 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -92.05 127.86 37.68 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.808 -0.812 . . . . 75.54 108.808 -175.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.529 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -149.75 132.56 16.01 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.86 -0.422 . . . . 72.33 109.86 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -127.91 125.34 39.41 Favored 'General case' 0 C--O 1.245 0.839 0 N-CA-C 109.743 -0.466 . . . . 74.13 109.743 -172.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.52 ' HB2' HD12 ' A' ' 97' ' ' ILE . 3.7 pp -101.96 119.88 55.52 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 109.299 -0.63 . . . . 75.34 109.299 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.471 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 62.8 Cg_endo -72.74 115.34 4.31 Favored 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 122.721 2.28 . . . . 73.21 108.985 167.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.418 ' HA ' HG23 ' A' ' 97' ' ' ILE . 47.7 tp -102.2 150.26 23.47 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 109.79 -0.448 . . . . 72.32 109.79 -168.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.7 t -89.12 155.19 19.59 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 123.447 0.699 . . . . 75.13 109.496 -175.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.8 mt -60.89 -35.24 76.14 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.494 1.117 . . . . 72.41 112.87 -171.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -61.52 -46.83 88.31 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.388 -0.597 . . . . 73.05 109.388 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -77.42 -22.39 51.59 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 114.245 -1.343 . . . . 71.1 112.153 -177.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.0 -51.69 68.59 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 123.586 0.554 . . . . 73.33 110.401 173.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -81.06 -50.45 9.64 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 115.508 -0.769 . . . . 74.42 111.887 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -65.93 -45.02 83.39 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.235 0.614 . . . . 73.4 111.813 -175.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.477 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 73.24 -145.52 36.25 Favored Glycine 0 C--N 1.342 0.899 0 O-C-N 123.441 0.463 . . . . 73.12 112.092 -175.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.93 -147.09 25.98 Favored Glycine 0 C--N 1.345 1.041 0 O-C-N 123.687 0.286 . . . . 74.13 112.808 177.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -85.09 121.9 28.52 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.236 0.614 . . . . 74.45 109.78 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.574 HH12 ' HB2' ' A' ' 94' ' ' MET . 5.0 tpm_? -112.03 123.44 50.27 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.912 -0.774 . . . . 74.44 108.912 175.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.482 ' HB ' ' NH2' ' A' ' 136' ' ' ARG . 84.8 t -76.11 111.4 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 114.88 -1.055 . . . . 71.12 109.519 173.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 32.0 t -107.7 129.56 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 107.359 -1.348 . . . . 74.33 107.359 172.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -115.58 116.48 28.22 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.36 -0.607 . . . . 74.21 109.36 175.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.8 p -150.02 142.47 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 123.87 0.868 . . . . 73.31 109.179 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.69 19.16 11.58 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.239 1.016 . . . . 55.41 112.156 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 82.28 7.41 87.71 Favored Glycine 0 C--N 1.353 1.499 0 CA-C-N 116.214 -0.448 . . . . 74.53 113.04 -176.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.9 ttm-85 -114.58 143.02 45.66 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.056 0.943 . . . . 74.24 110.388 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.428 ' HG3' HG11 ' A' ' 137' ' ' VAL . 12.4 ttp180 -96.4 113.72 25.33 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.592 -0.892 . . . . 73.04 108.592 173.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 25.8 t -105.41 112.09 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 108.243 -1.021 . . . . 73.12 108.243 172.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 35.8 t -90.29 108.59 19.86 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 107.961 -1.126 . . . . 65.33 107.961 175.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 34.3 m -104.61 145.69 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.508 0.723 . . . . 74.53 110.656 -176.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -93.19 96.04 9.77 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.791 -0.818 . . . . 75.32 108.791 175.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.477 HG13 ' HA2' ' A' ' 133' ' ' GLY . 24.0 pt -85.51 135.53 38.4 Favored Pre-proline 0 CA--C 1.554 1.131 0 CA-C-N 115.596 -0.729 . . . . 75.13 109.18 172.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.07 141.07 51.63 Favored 'Trans proline' 0 CA--C 1.565 2.027 0 C-N-CA 122.338 2.025 . . . . 72.52 112.438 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -60.2 113.7 1.78 Allowed 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 123.148 2.566 . . . . 72.23 112.14 173.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 86.61 32.59 15.25 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.359 -0.696 . . . . 63.43 111.359 -173.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.5 p -62.67 144.49 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.608 0.763 . . . . 75.12 109.682 172.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -132.01 161.36 33.36 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.77 0.428 . . . . 74.0 110.473 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -43.17 129.04 4.7 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 125.536 1.773 . . . . 72.02 112.91 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 102.68 -13.06 56.58 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-O 119.259 -0.745 . . . . 74.42 114.119 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.0 t -62.46 120.6 11.4 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 117.589 0.695 . . . . 74.25 109.698 178.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 176' ' ' LEU . 3.1 p -115.01 112.31 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 121.539 0.685 . . . . 71.42 110.36 -172.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 59.1 mt -90.23 102.92 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 107.965 -1.124 . . . . 70.22 107.965 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -81.21 99.96 8.86 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.8 -0.815 . . . . 75.35 108.8 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.2 p -103.73 118.86 56.35 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 122.845 0.458 . . . . 72.31 109.953 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.51 155.71 59.15 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.9 2.4 . . . . 75.42 112.287 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 81.24 -24.4 4.13 Favored Glycine 0 CA--C 1.535 1.3 0 N-CA-C 114.31 0.484 . . . . 62.24 114.31 176.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.1 mmt -88.17 -27.26 21.96 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.727 0.811 . . . . 74.15 112.024 -172.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -70.27 -78.36 0.4 Allowed Glycine 0 C--N 1.345 1.053 0 N-CA-C 111.361 -0.696 . . . . 75.31 111.361 175.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -71.16 110.84 3.41 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 111.0 -0.84 . . . . 52.04 111.0 167.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -89.45 151.61 21.92 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.709 0.804 . . . . 62.13 110.457 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 81.29 -125.77 7.05 Favored Glycine 0 C--N 1.342 0.902 0 CA-C-N 115.831 -0.622 . . . . 74.21 113.224 174.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.439 ' O ' ' HD3' ' A' ' 171' ' ' PRO . 28.3 t-20 -62.84 -48.64 84.89 Favored Pre-proline 0 CA--C 1.564 1.49 0 C-N-CA 123.972 0.909 . . . . 71.24 113.01 -174.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -96.84 95.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.392 2.834 0 C-N-CA 122.633 2.222 . . . . 73.43 113.082 176.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 169' ' ' ASN . 11.3 Cg_exo -70.33 121.96 8.51 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 121.988 1.792 . . . . 75.31 110.239 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -134.93 179.76 17.32 Favored Glycine 0 C--N 1.343 0.919 0 C-N-CA 121.67 -0.3 . . . . 65.11 113.108 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -96.11 119.79 35.23 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.51 0.671 . . . . 63.01 112.124 -167.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.3 tp -89.38 111.66 22.57 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.018 -0.992 . . . . 72.55 108.529 173.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 60.8 mt -83.95 99.55 10.46 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.562 0.745 . . . . 74.0 109.048 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 158' ' ' VAL . 91.7 mt -91.05 98.67 11.91 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 123.633 0.583 . . . . 73.22 110.884 -175.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 23.7 t -90.71 123.05 42.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 109.161 -0.681 . . . . 71.21 109.161 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.6 p -74.94 132.94 32.51 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 109.125 -0.694 . . . . 74.21 109.125 177.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.471 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 34.6 mmt180 -118.57 92.9 3.93 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.323 -0.991 . . . . 75.52 108.323 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 26.3 mt -101.02 131.48 46.87 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.616 -0.72 . . . . 63.34 110.608 -176.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 CA--C 1.549 0.919 0 CA-C-N 114.778 -1.101 . . . . 75.14 109.889 178.666 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.413 ' HB3' ' NH2' ' A' ' 136' ' ' ARG . 1.1 mpt? . . . . . 0 N--CA 1.484 1.269 0 N-CA-C 109.267 -0.642 . . . . 73.35 109.267 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.4 t -69.92 140.41 53.08 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-N 115.734 -0.667 . . . . 64.41 111.058 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.451 ' HA ' HH11 ' A' ' 136' ' ' ARG . 28.6 m -78.39 148.62 33.59 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.775 0.83 . . . . 71.54 109.596 174.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.629 HD11 ' HB2' ' A' ' 123' ' ' LEU . 26.1 pt -118.03 168.61 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 123.334 0.653 . . . . 75.45 110.382 -171.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -136.74 127.38 27.05 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.37 0.668 . . . . 63.41 110.258 -176.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.542 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.5 tp -80.57 157.02 26.18 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 124.07 0.948 . . . . 75.14 110.866 -168.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.18 -54.08 6.95 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.631 0.372 . . . . 65.34 110.852 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.0 mt 55.46 84.71 0.07 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.187 0.995 . . . . 73.35 110.796 -168.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.5 mt -100.6 122.43 49.53 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 125.103 1.361 . . . . 54.21 109.219 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo . . . . . 0 C--N 1.372 1.797 0 C-N-CA 122.678 2.252 . . . . 72.22 112.869 179.985 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 . . . . . 0 C--O 1.24 0.567 0 CA-C-O 121.238 0.542 . . . . 75.52 111.132 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -91.7 107.28 19.1 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.71 -1.132 . . . . 72.55 107.974 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.8 tt -91.95 129.84 37.83 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 106.237 -1.764 . . . . 75.21 106.237 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 56.8 ttt180 -90.55 120.57 31.75 Favored 'General case' 0 C--O 1.213 -0.854 0 N-CA-C 107.998 -1.112 . . . . 73.54 107.998 -174.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.542 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -140.37 130.74 25.26 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.331 -0.618 . . . . 75.05 109.331 -174.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.502 ' HG2' ' HB ' ' A' ' 177' ' ' VAL . 84.9 mt-10 -120.63 120.96 37.26 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.316 -0.624 . . . . 74.43 109.316 -167.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.629 ' HB2' HD11 ' A' ' 97' ' ' ILE . 4.4 pp -103.13 118.71 57.34 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 109.522 -0.547 . . . . 74.53 109.522 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -74.27 113.76 3.87 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 122.819 2.346 . . . . 74.53 109.37 169.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.532 HD21 HD11 ' A' ' 149' ' ' ILE . 29.4 tp -103.75 143.92 32.17 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 110.151 -0.314 . . . . 74.11 110.151 -166.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.4 t -83.35 155.89 23.31 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.446 -0.797 . . . . 71.14 109.856 -176.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.2 mt -63.52 -30.98 72.02 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.072 0.949 . . . . 70.42 112.304 -173.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.55 -43.59 89.42 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.763 0.664 . . . . 74.05 109.52 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -77.74 -32.65 52.87 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.014 -0.994 . . . . 64.44 111.904 -178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.46 -49.19 74.65 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.489 0.661 . . . . 73.55 111.152 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -74.21 -59.76 2.58 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.251 -1.341 . . . . 73.42 110.595 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -72.81 -44.26 61.69 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.662 -0.699 . . . . 74.13 111.727 -172.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.39 178.12 50.82 Favored Glycine 0 C--N 1.351 1.399 0 O-C-N 123.629 0.581 . . . . 74.12 113.161 -175.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 127.76 -156.79 20.77 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.934 -0.466 . . . . 71.33 111.934 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.413 ' HB3' ' OG ' ' A' ' 146' ' ' SER . 3.1 mp0 -88.47 123.07 32.63 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.822 -0.807 . . . . 75.21 108.822 173.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.451 HH11 ' HA ' ' A' ' 96' ' ' THR . 8.3 tpp180 -116.29 122.42 44.89 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.484 0.714 . . . . 74.22 109.89 176.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.6 t -70.49 126.64 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 O-C-N 124.105 0.878 . . . . 75.42 109.783 175.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.74 134.83 64.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 124.699 1.2 . . . . 71.22 108.667 174.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -124.77 125.11 43.52 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.429 1.092 . . . . 73.22 109.763 -174.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.3 p -151.63 129.93 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.14 0.576 . . . . 75.02 110.785 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.82 20.04 11.1 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 123.997 0.919 . . . . 75.42 112.71 176.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.07 -13.29 67.69 Favored Glycine 0 C--N 1.353 1.498 0 CA-C-N 116.403 -0.362 . . . . 71.22 112.989 -175.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -90.82 117.97 29.86 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.565 1.146 . . . . 73.04 109.237 -175.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -114.92 129.61 56.74 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.566 0.746 . . . . 71.54 110.197 -176.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.14 144.78 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.974 0.909 . . . . 75.54 109.506 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.413 ' OG ' ' HB3' ' A' ' 135' ' ' GLU . 11.0 t -100.8 120.75 40.58 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.017 -0.734 . . . . 74.33 109.017 177.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 6.3 p -100.11 129.53 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.446 0.698 . . . . 71.14 110.332 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -75.92 99.51 4.54 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.206 -0.665 . . . . 73.13 109.206 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.532 HD11 HD21 ' A' ' 125' ' ' LEU . 10.4 pt -86.32 142.79 35.84 Favored Pre-proline 0 CA--C 1.555 1.162 0 CA-C-N 115.356 -0.838 . . . . 74.43 110.063 173.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -66.05 135.62 41.39 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.449 2.1 . . . . 73.03 112.11 172.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -55.57 124.42 16.23 Favored 'Trans proline' 0 C--N 1.367 1.504 0 C-N-CA 122.619 2.213 . . . . 75.41 111.524 166.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 81.51 24.42 56.47 Favored Glycine 0 CA--C 1.533 1.196 0 O-C-N 123.314 0.384 . . . . 71.23 112.63 -174.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 6.7 p -62.29 139.19 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.622 0.769 . . . . 74.21 109.7 173.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -127.34 152.57 47.3 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.339 0.656 . . . . 73.1 110.419 -174.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -40.67 132.01 2.25 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.475 1.91 . . . . 74.43 113.144 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.86 -6.94 77.03 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-O 119.658 -0.523 . . . . 73.42 113.992 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 29.2 m -63.0 130.27 43.97 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.216 0.606 . . . . 63.02 110.24 172.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 5.8 p -117.91 116.48 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 CA-C-O 121.312 0.577 . . . . 72.51 110.37 -177.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.411 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 58.8 mt -95.3 103.04 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.864 0.866 . . . . 73.42 108.672 176.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -80.16 109.85 15.01 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.142 0.577 . . . . 72.23 109.742 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.524 HG12 ' HB3' ' A' ' 174' ' ' LEU . 1.7 p -109.04 111.32 60.55 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 123.489 0.716 . . . . 73.12 109.266 173.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -67.56 151.7 79.29 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 123.239 2.626 . . . . 75.44 113.571 -177.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 66.6 24.7 72.63 Favored Glycine 0 C--N 1.356 1.673 0 O-C-N 123.772 0.67 . . . . 61.33 113.662 175.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.439 ' HB3' ' HB2' ' A' ' 174' ' ' LEU . 8.2 tpt -119.81 -33.79 3.91 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.263 0.625 . . . . 75.02 110.154 -171.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -91.69 -69.73 1.17 Allowed Glycine 0 C--N 1.35 1.341 0 CA-C-N 116.44 -0.346 . . . . 65.31 112.31 -177.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -62.77 90.42 0.07 OUTLIER Glycine 0 C--N 1.349 1.274 0 N-CA-C 111.46 -0.656 . . . . 62.52 111.46 169.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -92.28 170.37 9.85 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.249 1.02 . . . . 74.52 111.195 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.74 -145.5 18.33 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 115.251 -0.886 . . . . 74.24 112.179 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -78.99 -36.98 1.21 Allowed Pre-proline 0 CA--C 1.565 1.542 0 CA-C-O 118.288 -0.863 . . . . 74.24 112.083 177.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -82.68 110.38 1.88 Allowed 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 121.725 1.617 . . . . 74.14 111.314 166.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -74.62 166.82 28.52 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.619 2.213 . . . . 74.43 112.583 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 173.34 174.75 40.6 Favored Glycine 0 C--N 1.346 1.109 0 N-CA-C 114.079 0.392 . . . . 63.52 114.079 170.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -91.04 166.8 12.81 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.639 1.176 . . . . 64.53 111.088 -167.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.524 ' HB3' HG12 ' A' ' 161' ' ' VAL . 34.8 tp -124.11 118.27 26.54 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.562 -0.903 . . . . 74.11 108.562 177.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 82.6 mt -92.91 101.88 14.24 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.522 0.729 . . . . 73.24 109.649 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.411 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 94.9 mt -89.21 99.75 12.67 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.25 0.62 . . . . 75.34 111.028 -177.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.502 ' HB ' ' HG2' ' A' ' 122' ' ' GLU . 49.5 t -89.23 112.61 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 123.373 0.669 . . . . 75.33 109.493 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.02 133.56 31.49 Favored 'Isoleucine or valine' 0 C--O 1.249 1.074 0 N-CA-C 109.712 -0.477 . . . . 73.11 109.712 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -123.43 96.04 4.82 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.353 1.061 . . . . 73.52 108.471 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 180' ' ' LEU . 35.7 mt -96.84 140.81 30.84 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.642 -0.708 . . . . 74.05 111.756 -174.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 71.0 mt . . . . . 0 CA--C 1.553 1.058 0 CA-C-N 114.303 -1.317 . . . . 73.34 110.07 176.388 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 35.2 mtp . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 108.022 -1.103 . . . . 73.44 108.022 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.408 ' H ' HG23 ' A' ' 126' ' ' THR . 16.3 m -60.28 -22.31 62.96 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.065 1.135 . . . . 64.32 114.065 -172.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 45.0 m 71.3 145.91 0.07 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.754 1.222 . . . . 72.12 110.842 -172.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.626 HD12 ' HB2' ' A' ' 123' ' ' LEU . 15.3 pt -128.08 166.19 25.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 123.348 0.659 . . . . 75.05 110.861 -170.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.4 151.33 47.81 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.333 1.053 . . . . 73.4 109.649 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.598 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.5 tp -100.91 155.14 18.12 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.892 0.477 . . . . 74.51 109.936 -170.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -84.14 -40.54 18.08 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.249 0.619 . . . . 74.31 111.929 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.0 mt 48.69 66.18 1.15 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.004 0.922 . . . . 75.21 111.283 -172.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 76.1 mt -73.43 151.03 89.57 Favored Pre-proline 0 CA--C 1.548 0.89 0 CA-C-N 115.35 -0.841 . . . . 74.31 110.492 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 C--N 1.373 1.832 0 C-N-CA 122.247 1.965 . . . . 74.52 112.595 171.975 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.414 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 43.3 ttt180 . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 112.556 0.576 . . . . 74.23 112.556 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -78.35 139.38 38.82 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.433 -0.803 . . . . 72.13 109.425 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.9 tt -132.7 126.1 31.78 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.175 -1.417 . . . . 73.41 107.175 177.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -91.59 136.14 33.35 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.361 0.665 . . . . 71.55 109.321 -176.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.598 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -154.37 146.87 24.04 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.466 0.706 . . . . 75.31 110.11 -176.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -120.79 124.98 46.4 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 109.179 -0.674 . . . . 73.03 109.179 -176.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.626 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.5 pp -108.94 115.06 57.72 Favored Pre-proline 0 CA--C 1.551 0.981 0 N-CA-C 108.672 -0.862 . . . . 73.43 108.672 174.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.536 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 82.4 Cg_endo -78.15 114.74 3.62 Favored 'Trans proline' 0 C--N 1.365 1.437 0 C-N-CA 122.673 2.249 . . . . 75.21 109.124 170.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.488 HD21 HD13 ' A' ' 149' ' ' ILE . 25.5 tp -103.78 147.18 27.59 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.393 -0.595 . . . . 65.32 109.393 -166.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.408 HG23 ' H ' ' A' ' 95' ' ' SER . 11.3 t -92.63 162.97 13.96 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 109.718 -0.475 . . . . 74.31 109.718 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.5 mt -64.65 -37.02 86.15 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.85 0.86 . . . . 54.14 112.188 -168.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -59.83 -40.18 87.62 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.177 0.923 . . . . 75.42 109.68 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -76.92 -37.06 56.09 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 114.892 -1.049 . . . . 75.11 111.567 -173.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.9 -36.15 74.22 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 121.104 0.478 . . . . 73.32 110.384 172.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -77.16 -34.7 56.39 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 114.751 -1.113 . . . . 74.14 111.822 177.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 27.4 m80 -74.76 -51.16 14.9 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 117.926 0.33 . . . . 71.31 110.983 -176.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 151' ' ' PRO . . . 58.62 68.11 1.86 Allowed Glycine 0 C--N 1.344 0.994 0 O-C-N 124.239 0.962 . . . . 51.2 112.307 -172.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.413 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -155.51 -146.33 4.41 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-O 120.055 -0.303 . . . . 75.52 112.529 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.3 mp0 -75.12 117.08 16.56 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.406 0.682 . . . . 72.44 109.685 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.648 HH21 ' HB ' ' A' ' 137' ' ' VAL . 4.5 tpm_? -116.56 123.74 48.12 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.113 0.965 . . . . 74.23 108.674 173.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.648 ' HB ' HH21 ' A' ' 136' ' ' ARG . 87.8 t -72.49 122.8 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.079 0.952 . . . . 74.23 110.341 174.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.576 ' HB ' HG12 ' A' ' 145' ' ' VAL . 21.4 t -112.6 126.95 70.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.551 -0.907 . . . . 72.14 108.551 174.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -109.16 110.43 21.66 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.831 0.853 . . . . 72.3 109.466 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 10.8 p -149.75 133.22 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 123.018 0.527 . . . . 75.41 110.541 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.64 18.68 10.75 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.513 1.125 . . . . 74.25 112.645 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.79 5.57 86.27 Favored Glycine 0 C--N 1.348 1.244 0 O-C-N 123.158 0.286 . . . . 53.11 113.232 -176.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -112.12 131.46 55.44 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.406 1.082 . . . . 74.22 109.806 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.549 ' HG3' HG12 ' A' ' 137' ' ' VAL . 39.6 ttm180 -90.22 113.98 25.89 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.124 0.97 . . . . 71.33 109.618 172.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.576 HG12 ' HB ' ' A' ' 138' ' ' VAL . 2.5 p -111.3 115.14 49.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 123.398 0.679 . . . . 71.5 109.21 169.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.6 t -86.78 115.23 24.07 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 109.19 -0.67 . . . . 74.44 109.19 175.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.41 HG12 HD21 ' A' ' 123' ' ' LEU . 3.6 p -100.83 124.38 54.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 123.612 0.765 . . . . 71.35 109.795 176.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 54.2 ttt85 -80.43 93.93 6.1 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.747 -1.205 . . . . 73.53 107.747 168.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.488 HD13 HD21 ' A' ' 125' ' ' LEU . 13.8 pt -74.31 143.94 80.64 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 123.824 0.85 . . . . 64.51 109.753 177.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.8 149.07 47.39 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 122.225 1.95 . . . . 73.52 111.993 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.478 ' HA ' ' HA3' ' A' ' 133' ' ' GLY . 31.9 Cg_exo -60.54 134.45 54.75 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 123.137 2.558 . . . . 72.13 112.122 177.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 65.83 29.31 74.81 Favored Glycine 0 C--N 1.353 1.506 0 O-C-N 123.697 0.623 . . . . 74.01 112.63 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -58.21 145.65 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 C-N-CA 124.053 0.941 . . . . 74.45 109.72 176.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -136.64 158.75 43.71 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.53 0.732 . . . . 73.24 110.415 -173.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -42.69 127.18 3.87 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.895 1.678 . . . . 71.04 112.838 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.27 -4.82 80.92 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 114.385 0.514 . . . . 64.02 114.385 177.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.6 t -67.62 122.32 17.8 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.242 -0.651 . . . . 71.2 109.242 176.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 46.5 t -101.99 117.06 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 109.427 -0.583 . . . . 73.53 109.427 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.5 mt -91.92 144.1 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.813 1.245 . . . . 71.42 107.968 173.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.529 HH11 HD23 ' A' ' 175' ' ' LEU . 49.0 ttt85 -118.09 116.75 27.49 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.188 -0.671 . . . . 73.32 109.188 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 5.0 p -124.17 109.62 29.3 Favored Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 123.693 0.797 . . . . 55.34 110.531 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -70.72 153.62 64.41 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.974 2.449 . . . . 72.44 112.628 -176.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.77 -13.83 54.67 Favored Glycine 0 C--N 1.339 0.719 0 CA-C-N 115.702 -0.681 . . . . 72.44 113.954 174.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.509 ' HE2' ' HB ' ' A' ' 145' ' ' VAL . 84.7 mmm -100.14 -12.42 19.64 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 117.404 0.602 . . . . 65.22 111.452 -176.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -83.04 -111.5 0.5 Allowed Glycine 0 C--N 1.353 1.485 0 CA-C-O 119.312 -0.716 . . . . 61.12 111.936 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.414 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -53.85 108.32 0.81 Allowed Glycine 0 C--N 1.353 1.489 0 O-C-N 124.003 0.472 . . . . 53.25 113.128 174.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -91.22 169.54 10.75 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.616 1.167 . . . . 74.22 110.396 175.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 94.59 -145.41 17.68 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 115.388 -0.824 . . . . 73.02 112.147 175.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -69.13 -47.66 28.58 Favored Pre-proline 0 CA--C 1.561 1.384 0 CA-C-O 118.13 -0.938 . . . . 74.42 110.872 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.3 113.59 2.67 Favored 'Trans proline' 0 C--N 1.395 3.011 0 C-N-CA 122.232 1.955 . . . . 73.1 111.087 172.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -72.39 160.17 47.55 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.45 2.1 . . . . 74.34 111.418 177.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -161.01 -179.13 35.56 Favored Glycine 0 CA--C 1.504 -0.632 0 N-CA-C 114.732 0.653 . . . . 71.42 114.732 176.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -120.52 150.18 41.25 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.531 1.132 . . . . 75.4 109.641 -169.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 37.2 tp -117.1 114.1 23.24 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.563 0.745 . . . . 73.34 110.1 -172.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.529 HD23 HH11 ' A' ' 160' ' ' ARG . 92.8 mt -88.37 103.28 15.69 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.063 0.945 . . . . 74.21 110.162 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.465 HD21 HD11 ' A' ' 99' ' ' LEU . 77.0 mt -95.41 99.18 11.13 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.085 0.954 . . . . 74.24 110.615 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 8.5 p -90.37 133.4 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 109.372 -0.603 . . . . 74.14 109.372 175.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.3 p -87.58 144.81 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 123.238 0.615 . . . . 72.43 111.165 -171.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.536 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 35.5 mmt180 -119.25 99.74 6.89 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.742 1.217 . . . . 72.33 108.44 174.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 16.0 mt -118.86 145.86 45.35 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.973 0.909 . . . . 62.04 111.119 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 65.2 mt . . . . . 0 CA--C 1.551 0.991 0 CA-C-N 114.541 -1.209 . . . . 73.32 109.423 -178.614 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 49.8 mtt . . . . . 0 N--CA 1.484 1.264 0 N-CA-C 108.927 -0.768 . . . . 74.54 108.927 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.4 m -71.48 121.68 19.07 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.915 -0.772 . . . . 73.11 108.915 174.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 86.8 m -68.2 141.56 55.94 Favored 'General case' 0 C--N 1.35 0.63 0 C-N-CA 123.392 0.677 . . . . 72.05 110.39 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.522 HD12 ' HB2' ' A' ' 123' ' ' LEU . 14.2 pt -114.88 163.41 12.19 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 C-N-CA 123.057 0.543 . . . . 73.32 110.818 -170.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -123.15 -162.93 1.06 Allowed 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.399 -0.963 . . . . 62.34 108.399 170.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.532 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.5 tp -136.64 155.93 49.23 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.937 -0.764 . . . . 75.13 108.937 -175.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.87 -48.92 33.32 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.044 0.538 . . . . 72.43 110.723 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.583 HD13 ' HB ' ' A' ' 140' ' ' VAL . 60.2 mt 53.68 78.05 0.16 Allowed 'General case' 0 CA--C 1.546 0.809 0 O-C-N 124.469 1.106 . . . . 75.11 110.348 -171.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 60.9 mt -84.65 143.2 40.61 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 114.984 -1.007 . . . . 75.53 109.636 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 C--N 1.375 1.953 0 C-N-CA 122.571 2.18 . . . . 73.23 112.952 179.839 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.697 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 32.8 ttm180 . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 120.685 0.279 . . . . 75.43 111.01 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -76.11 139.33 41.29 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.519 0.728 . . . . 74.22 109.539 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.3 tt -141.38 115.5 9.3 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 106.393 -1.706 . . . . 74.44 106.393 -177.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -90.24 143.08 27.1 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 107.052 -1.462 . . . . 75.41 107.052 177.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.532 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -149.51 137.16 20.2 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 120.684 0.278 . . . . 62.53 110.522 -169.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -120.53 112.41 18.91 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.146 -1.057 . . . . 73.45 108.146 -172.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.522 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.6 pp -99.31 117.79 63.43 Favored Pre-proline 0 C--N 1.354 0.78 0 N-CA-C 108.396 -0.964 . . . . 73.34 108.396 177.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.457 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 95.6 Cg_endo -75.48 113.68 3.81 Favored 'Trans proline' 0 C--N 1.364 1.36 0 C-N-CA 122.208 1.939 . . . . 74.3 109.166 170.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.465 HD22 HD13 ' A' ' 149' ' ' ILE . 33.0 tp -102.0 153.08 20.22 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.615 -0.513 . . . . 73.21 109.615 -172.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.8 t -91.43 155.16 18.65 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 109.224 -0.658 . . . . 74.32 109.224 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.1 mt -63.12 -34.43 77.59 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.461 0.704 . . . . 74.51 111.947 -173.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.93 -46.39 90.87 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.834 0.853 . . . . 75.23 110.022 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -79.09 -26.59 42.96 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.24 -0.891 . . . . 65.31 112.519 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.38 -40.94 92.65 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.533 0.683 . . . . 73.35 110.064 171.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -77.62 -48.91 15.71 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 114.224 -1.353 . . . . 73.33 111.093 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -69.68 -49.43 53.57 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 122.802 0.441 . . . . 74.15 111.592 -173.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.564 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 75.11 -170.42 54.36 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 115.805 -0.634 . . . . 74.13 111.702 -163.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.445 ' O ' HG12 ' A' ' 149' ' ' ILE . . . 90.54 -166.29 31.62 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 116.557 0.179 . . . . 55.02 112.74 -177.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.446 ' HB3' ' OG ' ' A' ' 146' ' ' SER . 3.6 mp0 -71.62 130.69 41.8 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.226 0.61 . . . . 73.13 110.275 -175.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -131.24 128.58 40.17 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.19 -0.67 . . . . 75.11 109.19 172.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 38.7 t -72.39 113.08 9.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 O-C-N 124.627 1.205 . . . . 71.52 110.63 -172.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.416 HG21 HD13 ' A' ' 97' ' ' ILE . 14.5 t -106.44 112.16 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.687 1.195 . . . . 74.32 107.878 176.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -94.18 117.35 29.99 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.276 0.63 . . . . 75.32 109.44 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.583 ' HB ' HD13 ' A' ' 101' ' ' LEU . 19.5 m -135.64 120.84 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 124.502 1.121 . . . . 73.23 112.048 -169.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 57.88 20.34 6.56 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.55 1.14 . . . . 73.44 113.603 169.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.67 27.76 18.59 Favored Glycine 0 CA--C 1.535 1.342 0 N-CA-C 112.461 -0.256 . . . . 61.14 112.461 -175.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -133.64 154.02 51.23 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.405 1.082 . . . . 70.05 109.24 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -112.31 114.79 27.73 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.36 1.064 . . . . 75.44 109.044 176.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 5.7 p -130.26 124.29 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.536 -0.913 . . . . 74.33 108.536 174.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.446 ' OG ' ' HB3' ' A' ' 135' ' ' GLU . 12.7 t -103.44 122.8 45.64 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 109.228 -0.656 . . . . 63.55 109.228 -177.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.1 p -100.94 129.56 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 122.933 0.493 . . . . 73.15 110.092 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.9 ttp180 -74.73 98.82 3.55 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.573 -0.899 . . . . 75.15 108.573 170.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.564 HG13 ' HA2' ' A' ' 133' ' ' GLY . 10.7 pt -78.72 145.55 67.03 Favored Pre-proline 0 CA--C 1.563 1.444 0 C-N-CA 124.042 0.937 . . . . 75.34 109.796 171.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.86 141.34 89.58 Favored 'Trans proline' 0 CA--C 1.564 1.985 0 C-N-CA 122.78 2.32 . . . . 72.44 113.388 174.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -62.73 114.78 2.55 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.718 2.279 . . . . 70.03 111.115 168.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 87.59 30.03 19.82 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 111.444 -0.662 . . . . 74.25 111.444 -174.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -70.21 137.34 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.428 0.691 . . . . 74.51 109.358 174.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -135.11 157.56 46.61 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.997 0.519 . . . . 64.04 111.04 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -39.86 122.06 1.38 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.915 2.086 . . . . 62.14 113.202 -175.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.9 -12.08 38.04 Favored Glycine 0 C--N 1.348 1.213 0 CA-C-O 119.366 -0.685 . . . . 63.12 113.846 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 13.7 t -70.04 122.14 18.8 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 117.382 0.591 . . . . 74.21 110.138 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 46.5 t -104.41 111.24 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 123.848 0.859 . . . . 74.01 109.628 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 61.1 mt -89.69 103.63 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.912 -1.144 . . . . 73.23 107.912 171.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -82.15 119.55 24.2 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.397 -0.594 . . . . 72.4 109.397 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.508 HG13 ' HB3' ' A' ' 174' ' ' LEU . 6.5 p -124.51 98.2 38.17 Favored Pre-proline 0 CA--C 1.561 1.374 0 C-N-CA 123.68 0.792 . . . . 74.54 109.476 177.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 73.5 Cg_endo -72.35 146.68 45.67 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.954 2.436 . . . . 75.12 112.503 179.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 93.45 -18.51 56.23 Favored Glycine 0 CA--C 1.537 1.43 0 CA-C-O 120.058 -0.301 . . . . 75.25 113.726 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 69.9 mmm -97.87 -9.87 25.62 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.935 0.894 . . . . 74.34 112.904 -174.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -79.74 -100.07 0.28 Allowed Glycine 0 C--N 1.342 0.889 0 O-C-N 123.181 0.3 . . . . 73.31 112.68 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.697 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -67.56 103.04 0.89 Allowed Glycine 0 C--N 1.344 1.022 0 N-CA-C 112.416 -0.273 . . . . 75.53 112.416 175.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -79.8 131.71 35.97 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.591 0.756 . . . . 74.21 109.813 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 154.06 -163.73 31.09 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 111.495 -0.642 . . . . 72.32 111.495 -177.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -58.83 -47.17 99.2 Favored Pre-proline 0 CA--C 1.562 1.422 0 CA-C-O 118.749 -0.643 . . . . 75.33 111.524 177.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.93 119.28 3.55 Favored 'Trans proline' 0 C--N 1.39 2.733 0 C-N-CA 121.481 1.454 . . . . 70.41 110.967 168.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.6 121.96 9.3 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 121.568 1.512 . . . . 73.41 109.702 174.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -97.59 149.25 19.19 Favored Glycine 0 C--N 1.339 0.728 0 CA-C-O 119.769 -0.462 . . . . 65.33 112.539 -173.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 37.6 t70 -83.03 139.78 33.08 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 122.764 0.426 . . . . 63.33 110.575 -175.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.508 ' HB3' HG13 ' A' ' 161' ' ' VAL . 33.4 tp -122.88 130.67 53.14 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.643 0.777 . . . . 75.32 109.347 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 80.9 mt -109.34 101.9 10.86 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.602 0.761 . . . . 73.12 109.307 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 77.3 mt -88.07 101.07 13.43 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 109.583 -0.525 . . . . 72.01 109.583 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 36.5 t -95.77 124.98 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 109.116 -0.698 . . . . 62.41 109.116 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.8 p -74.96 127.61 36.66 Favored 'Isoleucine or valine' 0 C--O 1.249 1.064 0 C-N-CA 123.117 0.567 . . . . 73.33 109.966 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.457 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 5.1 mmm180 -114.42 100.61 8.44 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.769 -0.826 . . . . 74.34 108.769 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 40.3 mt -116.38 139.86 49.96 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.373 1.069 . . . . 74.32 110.035 -177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 59.3 mt . . . . . 0 CA--C 1.546 0.803 0 CA-C-N 115.347 -0.842 . . . . 73.33 108.891 178.633 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.481 ' SD ' ' N ' ' A' ' 94' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 108.108 -1.071 . . . . 74.41 108.108 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.9 t -62.2 121.56 13.41 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.067 0.547 . . . . 75.22 111.228 -172.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.498 ' HA ' ' HD2' ' A' ' 136' ' ' ARG . 56.6 m -72.59 149.65 43.78 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.534 0.733 . . . . 72.42 110.323 177.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.593 HD11 ' HB2' ' A' ' 123' ' ' LEU . 14.1 pt -118.09 161.75 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.029 0.532 . . . . 74.33 111.41 -164.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -113.18 -162.87 0.82 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.954 0.902 . . . . 62.13 109.186 173.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.749 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.6 tp -150.66 147.42 27.36 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.125 -0.694 . . . . 73.15 109.125 -172.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.14 -51.91 14.13 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.406 0.283 . . . . 73.34 111.147 -178.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 89.9 mt 60.59 73.77 0.47 Allowed 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.339 1.025 . . . . 72.4 110.435 -174.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.9 mt -77.02 109.72 9.86 Favored Pre-proline 0 CA--C 1.555 1.151 0 CA-C-N 114.986 -1.006 . . . . 55.34 109.18 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo . . . . . 0 C--N 1.383 2.352 0 C-N-CA 123.53 2.82 . . . . 70.3 114.716 -173.131 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.591 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 17.4 ttm180 . . . . . 0 N--CA 1.479 0.975 0 CA-C-O 120.42 0.152 . . . . 65.34 111.064 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -71.44 134.29 46.5 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.0 0.52 . . . . 73.12 110.094 173.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.7 tt -133.93 120.3 20.17 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 106.298 -1.741 . . . . 75.43 106.298 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -91.83 144.24 25.7 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 108.931 -0.766 . . . . 74.12 108.931 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.749 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -154.73 133.25 11.98 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.86 0.464 . . . . 54.05 110.037 -172.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -107.02 116.24 31.57 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.493 0.717 . . . . 73.11 109.365 -168.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.601 HD22 ' HB3' ' A' ' 176' ' ' LEU . 4.2 pp -101.36 115.21 65.38 Favored Pre-proline 0 C--N 1.35 0.604 0 N-CA-C 108.694 -0.854 . . . . 73.43 108.694 177.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -80.26 111.43 2.64 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.533 2.155 . . . . 70.43 110.984 172.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.544 HD21 HD12 ' A' ' 149' ' ' ILE . 30.0 tp -104.6 152.15 22.78 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 121.899 -0.501 . . . . 72.3 110.644 -166.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.9 t -90.35 154.11 19.94 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 123.498 0.719 . . . . 75.01 109.127 178.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.7 mt -68.64 -30.85 69.65 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.499 0.72 . . . . 73.34 112.251 -170.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -64.49 -48.58 74.65 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.14 0.576 . . . . 74.23 109.575 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -63.21 -38.45 91.2 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 114.695 -1.139 . . . . 64.44 112.0 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.422 ' HB2' HD23 ' A' ' 180' ' ' LEU . . . -60.02 -38.47 82.8 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 123.616 0.573 . . . . 74.14 111.505 176.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -76.32 -32.76 58.88 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 115.077 -0.965 . . . . 75.32 111.077 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -74.5 -49.75 20.91 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.096 0.474 . . . . 73.21 111.437 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.445 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 66.63 44.54 89.52 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.163 -0.926 . . . . 54.22 112.036 -164.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -97.09 -161.5 31.8 Favored Glycine 0 C--N 1.351 1.367 0 O-C-N 123.894 0.408 . . . . 75.34 112.244 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -95.71 116.68 29.23 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.772 -0.825 . . . . 74.12 108.772 176.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.498 ' HD2' ' HA ' ' A' ' 96' ' ' THR . 10.0 tpp180 -111.0 126.23 54.57 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.159 0.584 . . . . 71.31 109.527 178.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 91.6 t -73.56 132.89 32.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 114.433 -1.258 . . . . 74.34 110.333 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 28.2 t -116.59 126.76 74.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 107.302 -1.37 . . . . 65.32 107.302 174.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -126.06 110.11 13.16 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.994 0.518 . . . . 63.12 110.27 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -149.25 137.03 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 124.391 1.076 . . . . 72.33 111.072 -177.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.85 17.33 9.86 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.246 1.419 . . . . 62.34 112.732 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.33 1.68 74.82 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 116.404 -0.362 . . . . 55.13 112.987 -176.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -102.38 121.26 41.96 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.385 1.074 . . . . 74.1 110.109 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -98.48 105.49 17.64 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 109.522 -0.548 . . . . 75.42 109.522 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.433 HG13 HG12 ' A' ' 147' ' ' VAL . 49.6 t -106.17 111.86 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.778 0.831 . . . . 75.41 109.062 176.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.6 t -92.39 121.11 33.56 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.191 -1.041 . . . . 65.42 108.191 176.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.433 HG12 HG13 ' A' ' 145' ' ' VAL . 29.8 m -126.16 144.01 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.142 0.577 . . . . 72.11 110.785 -176.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 63.5 ttp85 -88.32 124.59 34.06 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.677 -0.86 . . . . 73.52 108.677 172.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.544 HD12 HD21 ' A' ' 125' ' ' LEU . 4.5 pt -93.47 149.26 36.96 Favored Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 124.295 1.038 . . . . 71.54 109.752 176.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -61.0 140.37 89.72 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 123.013 2.476 . . . . 60.21 113.74 174.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -67.58 113.88 3.1 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.89 2.393 . . . . 71.04 111.199 170.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 86.07 26.38 34.34 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 116.083 -0.508 . . . . 72.44 112.107 -173.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.21 137.22 22.92 Favored 'Isoleucine or valine' 0 C--N 1.358 0.958 0 C-N-CA 123.546 0.738 . . . . 71.1 110.671 176.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 65.3 mtm180 -134.37 164.82 26.58 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.861 0.864 . . . . 74.24 110.642 -174.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -43.29 122.28 2.5 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.177 1.791 . . . . 75.35 114.685 -171.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.18 -6.71 72.39 Favored Glycine 0 C--N 1.352 1.431 0 CA-C-O 119.376 -0.68 . . . . 73.41 114.52 176.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.1 m -60.61 123.33 17.09 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.382 0.673 . . . . 74.24 111.865 175.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.1 p -101.85 132.88 46.89 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.041 0 C-N-CA 123.172 0.589 . . . . 72.15 110.744 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.592 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 75.7 mt -106.32 104.74 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 107.465 -1.309 . . . . 70.14 107.465 176.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -78.94 105.42 10.26 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.723 -0.473 . . . . 73.32 109.723 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.527 HG13 ' HB3' ' A' ' 174' ' ' LEU . 5.8 p -113.44 100.17 51.16 Favored Pre-proline 0 CA--C 1.558 1.277 0 C-N-CA 122.717 0.407 . . . . 74.45 110.166 174.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -64.3 150.73 87.74 Favored 'Trans proline' 0 C--N 1.387 2.592 0 C-N-CA 123.713 2.942 . . . . 64.33 113.168 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 83.35 -25.38 4.99 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 116.223 -0.444 . . . . 73.0 113.988 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.54 -12.84 50.67 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.02 0.928 . . . . 72.04 111.617 -178.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -84.73 -111.87 0.66 Allowed Glycine 0 C--N 1.349 1.279 0 O-C-N 123.511 0.507 . . . . 73.33 112.654 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.591 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -61.34 120.59 23.24 Favored Glycine 0 C--N 1.346 1.136 0 O-C-N 123.818 0.364 . . . . 73.42 112.469 177.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 11.7 mm-40 -88.18 155.42 19.77 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.354 0.662 . . . . 74.01 111.269 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 129.47 -171.4 20.14 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.069 -0.969 . . . . 74.2 111.466 -175.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -60.5 -45.27 97.29 Favored Pre-proline 0 CA--C 1.564 1.487 0 CA-C-O 118.451 -0.785 . . . . 73.13 112.209 175.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -82.73 112.74 2.15 Favored 'Trans proline' 0 C--N 1.395 2.98 0 C-N-CA 121.902 1.735 . . . . 75.43 111.066 171.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.76 127.43 12.31 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.418 2.079 . . . . 75.13 112.068 -177.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -105.12 156.13 16.88 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.973 -0.558 . . . . 73.15 112.785 -175.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -84.91 135.27 34.13 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.709 0.804 . . . . 72.22 111.241 -176.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.527 ' HB3' HG13 ' A' ' 161' ' ' VAL . 23.4 tp -102.21 107.79 18.97 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.457 -0.942 . . . . 73.12 108.457 177.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 78.9 mt -86.49 100.22 12.22 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.606 0.762 . . . . 73.1 109.909 -176.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.601 ' HB3' HD22 ' A' ' 123' ' ' LEU . 75.4 mt -91.42 98.95 12.0 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.059 0.544 . . . . 71.3 110.927 -175.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 47.9 t -91.0 117.34 34.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 109.461 -0.57 . . . . 74.3 109.461 -178.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.5 p -69.73 135.43 28.28 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 C-N-CA 123.339 0.656 . . . . 73.33 110.514 -176.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -127.69 85.64 2.38 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.189 -1.041 . . . . 72.02 108.189 -178.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.422 HD23 ' HB2' ' A' ' 130' ' ' ALA . 43.5 mt -82.36 147.52 28.78 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 114.975 -1.012 . . . . 75.24 110.27 -178.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 60.4 mt . . . . . 0 CA--C 1.551 1.0 0 N-CA-C 108.644 -0.873 . . . . 74.25 108.644 176.267 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 3.7 mpp? . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 108.501 -0.926 . . . . 74.01 108.501 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.5 m -62.82 132.12 51.11 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.555 0.742 . . . . 75.33 111.741 -171.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.5 m -77.14 151.75 35.21 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.728 0.811 . . . . 73.52 110.262 176.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.647 HD11 ' HB2' ' A' ' 123' ' ' LEU . 26.7 pt -112.46 165.09 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 123.173 0.589 . . . . 75.1 110.985 -174.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -135.25 123.64 23.29 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.936 0.895 . . . . 75.42 109.528 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.572 ' HG ' ' HB2' ' A' ' 121' ' ' ALA . 13.2 tp -76.69 149.44 36.41 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 124.845 1.258 . . . . 73.31 110.231 -172.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.34 -51.37 20.92 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.951 0.501 . . . . 71.14 111.115 -175.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.1 mt 57.72 82.36 0.13 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.357 1.063 . . . . 75.54 111.236 -174.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 45.9 mt -96.6 150.47 37.04 Favored Pre-proline 0 N--CA 1.479 1.008 0 C-N-CA 124.613 1.165 . . . . 75.34 109.664 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 C--N 1.375 1.966 0 C-N-CA 122.375 2.05 . . . . 73.22 112.714 176.571 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.487 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 68.4 ttt180 . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 112.459 0.54 . . . . 74.42 112.459 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -77.21 148.71 35.71 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.263 -0.881 . . . . 63.35 109.114 174.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.2 tt -140.62 131.14 25.4 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.329 -0.989 . . . . 72.22 108.329 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -93.32 115.99 28.56 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 108.895 -0.78 . . . . 73.42 108.895 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.572 ' HB2' ' HG ' ' A' ' 99' ' ' LEU . . . -129.15 144.24 51.14 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.339 -0.615 . . . . 72.32 109.339 -176.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -126.12 120.12 29.34 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 107.962 -1.125 . . . . 74.55 107.962 -176.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.647 ' HB2' HD11 ' A' ' 97' ' ' ILE . 4.0 pp -100.98 110.62 61.58 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 107.519 -1.289 . . . . 73.41 107.519 177.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.99 112.8 3.61 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.794 2.329 . . . . 73.41 108.876 168.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.51 HD22 HD11 ' A' ' 149' ' ' ILE . 22.9 tp -103.21 140.83 36.85 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.149 -0.686 . . . . 75.41 109.149 -168.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.7 t -78.22 162.69 26.39 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 110.101 -0.333 . . . . 62.52 110.101 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.1 mt -64.01 -36.66 84.72 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.014 0.925 . . . . 73.41 112.014 -174.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -62.19 -46.48 88.74 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.487 0.715 . . . . 73.15 109.842 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -71.87 -40.05 69.22 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.398 -1.273 . . . . 70.34 111.833 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.8 -58.34 8.99 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.57 0.7 . . . . 75.13 111.187 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -67.44 -56.7 8.54 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.441 -1.254 . . . . 74.32 111.121 -175.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -77.62 -41.41 38.6 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.246 0.219 . . . . 73.11 111.314 -170.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.59 165.03 38.96 Favored Glycine 0 C--N 1.351 1.366 0 CA-C-N 116.826 -0.17 . . . . 53.11 112.986 -176.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.05 -154.69 25.83 Favored Glycine 0 C--N 1.343 0.954 0 N-CA-C 111.796 -0.522 . . . . 65.5 111.796 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -105.89 121.26 43.72 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.416 -0.957 . . . . 74.12 108.416 172.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 10.2 tpp180 -113.2 122.02 46.23 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 109.575 -0.528 . . . . 75.53 109.575 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 71.7 t -73.32 142.04 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 124.145 0.978 . . . . 72.33 110.263 175.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.485 HG21 ' HB2' ' A' ' 99' ' ' LEU . 3.1 p -135.07 126.13 45.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.866 1.266 . . . . 74.34 108.073 175.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -114.02 109.77 18.98 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.129 0.972 . . . . 74.23 109.461 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.6 m -142.72 141.83 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 124.238 1.015 . . . . 73.41 110.065 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 65.0 19.37 11.84 Favored 'General case' 0 CA--C 1.554 1.134 0 O-C-N 124.632 1.208 . . . . 72.01 111.429 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 79.99 11.34 84.6 Favored Glycine 0 C--N 1.359 1.856 0 CA-C-N 116.066 -0.515 . . . . 64.13 113.1 -174.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -116.31 124.69 50.75 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.402 1.081 . . . . 75.24 110.555 -172.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -98.21 134.22 41.56 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.894 0.877 . . . . 71.34 110.125 -179.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.1 p -147.96 141.15 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 123.544 0.738 . . . . 75.33 109.492 171.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.7 t -107.51 125.3 51.1 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.228 0.611 . . . . 51.21 109.472 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.7 p -106.96 125.9 63.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 123.381 0.672 . . . . 74.1 110.769 -177.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -78.33 102.14 7.55 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.52 0.676 . . . . 74.1 109.68 177.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.51 HD11 HD22 ' A' ' 125' ' ' LEU . 11.2 pt -92.38 144.42 28.87 Favored Pre-proline 0 CA--C 1.556 1.182 0 CA-C-N 114.507 -1.224 . . . . 74.44 109.611 174.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.2 162.12 34.41 Favored 'Trans proline' 0 CA--C 1.563 1.945 0 C-N-CA 122.636 2.224 . . . . 64.32 112.18 176.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.87 125.5 12.16 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.704 2.27 . . . . 73.03 111.803 175.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 81.81 25.81 51.83 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-O 119.892 -0.393 . . . . 71.5 112.127 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.3 p -63.94 119.92 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 C-N-CA 123.452 0.701 . . . . 75.11 110.212 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -103.63 165.89 10.76 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.126 0.97 . . . . 74.2 110.291 -171.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -49.14 134.63 17.51 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 125.37 1.669 . . . . 74.24 111.786 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.51 -11.66 68.4 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-O 119.141 -0.811 . . . . 75.24 114.35 174.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.9 t -65.54 121.19 14.35 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 117.589 0.695 . . . . 54.33 109.392 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 55.9 t -100.54 111.46 30.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 108.927 -0.768 . . . . 75.42 108.927 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 56.5 mt -88.61 103.89 14.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 107.262 -1.384 . . . . 74.34 107.262 169.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.436 ' HG3' HD23 ' A' ' 175' ' ' LEU . 59.4 ttt180 -90.44 124.7 35.18 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.249 -0.648 . . . . 73.43 109.249 -176.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.5 p -124.74 107.14 29.04 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 123.447 0.699 . . . . 73.15 109.469 174.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.2 155.19 61.33 Favored 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 122.485 2.124 . . . . 62.23 111.534 172.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.531 ' HA2' ' HB2' ' A' ' 171' ' ' PRO . . . 85.21 0.35 88.66 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 114.574 0.59 . . . . 74.05 114.574 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.427 ' HE1' ' HB3' ' A' ' 164' ' ' MET . 55.4 mtp -121.84 -7.26 9.01 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 113.623 0.972 . . . . 73.43 113.623 -173.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -82.65 -91.12 0.64 Allowed Glycine 0 N--CA 1.471 0.981 0 CA-C-N 118.013 0.369 . . . . 75.42 112.67 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.487 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -66.09 95.4 0.24 Allowed Glycine 0 C--N 1.345 1.074 0 N-CA-C 111.527 -0.629 . . . . 72.44 111.527 173.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -83.31 110.87 18.48 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.383 0.673 . . . . 75.3 110.398 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -172.9 -146.21 5.33 Favored Glycine 0 C--O 1.241 0.563 0 N-CA-C 110.526 -1.029 . . . . 74.31 110.526 -177.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -75.86 -50.97 3.08 Favored Pre-proline 0 CA--C 1.565 1.539 0 CA-C-O 118.844 -0.598 . . . . 75.24 110.432 175.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -83.6 116.68 2.29 Favored 'Trans proline' 0 C--N 1.397 3.131 0 C-N-CA 121.508 1.472 . . . . 62.41 110.751 170.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.531 ' HB2' ' HA2' ' A' ' 163' ' ' GLY . 29.4 Cg_endo -60.94 125.94 18.38 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.35 2.033 . . . . 74.54 111.368 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -99.2 163.14 20.05 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 113.864 0.306 . . . . 74.21 113.864 -174.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -86.26 144.46 27.41 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.584 0.754 . . . . 74.01 110.637 -176.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 30.7 tp -130.63 122.28 27.13 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.22 0.608 . . . . 72.41 109.525 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.436 HD23 ' HG3' ' A' ' 160' ' ' ARG . 61.6 mt -99.39 114.64 27.67 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.716 -0.846 . . . . 74.35 108.716 177.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.602 ' HB3' HD21 ' A' ' 123' ' ' LEU . 36.9 mt -102.02 100.41 10.68 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.839 -0.8 . . . . 74.4 108.839 175.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.3 p -95.53 126.09 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 109.38 -0.6 . . . . 64.13 109.38 176.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.7 p -73.23 136.05 26.32 Favored 'Isoleucine or valine' 0 C--O 1.247 0.974 0 C-N-CA 123.279 0.632 . . . . 74.13 110.256 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -123.64 103.82 8.64 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.61 -1.255 . . . . 74.21 107.61 -176.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 92.7 mt -105.8 148.29 27.68 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.995 0.918 . . . . 73.33 110.546 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 CA--C 1.549 0.923 0 C-N-CA 124.411 1.084 . . . . 73.34 111.465 -176.98 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.513 ' HA ' HG23 ' A' ' 126' ' ' THR . 23.7 ptp . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 110.085 -0.339 . . . . 65.22 110.085 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.8 m -143.3 144.86 32.28 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.394 0.678 . . . . 71.22 109.885 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.0 p -75.4 148.01 39.52 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.653 -0.703 . . . . 75.2 110.384 170.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.509 HD11 ' HB2' ' A' ' 123' ' ' LEU . 24.0 pt -128.29 162.65 34.3 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 CA-C-N 114.521 -1.218 . . . . 73.24 109.729 -167.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -128.12 129.07 45.98 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.277 0.631 . . . . 74.21 110.122 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.656 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.8 tp -72.84 155.84 39.5 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.137 1.375 . . . . 75.41 109.331 -175.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -79.25 -38.27 35.92 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.309 0.504 . . . . 73.04 111.371 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.7 mt 54.04 75.77 0.26 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.438 1.095 . . . . 73.42 111.485 -175.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 31.5 mt -86.35 136.05 35.91 Favored Pre-proline 0 CA--C 1.553 1.092 0 CA-C-N 115.35 -0.841 . . . . 64.34 109.277 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo . . . . . 0 C--N 1.377 2.043 0 C-N-CA 122.548 2.165 . . . . 75.2 112.439 175.608 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.403 ' NH2' HD11 ' A' ' 119' ' ' LEU . 6.9 tmm_? . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 110.195 -0.298 . . . . 64.43 110.195 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -78.95 128.73 33.66 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 122.981 0.512 . . . . 71.43 109.636 178.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.403 HD11 ' NH2' ' A' ' 117' ' ' ARG . 2.8 tt -119.44 117.25 27.96 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.555 -1.646 . . . . 75.3 106.555 178.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -90.4 133.38 35.04 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.272 -1.381 . . . . 75.33 107.272 176.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.656 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -156.99 140.24 15.58 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.467 -0.568 . . . . 74.32 109.467 -174.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -127.19 129.24 47.46 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 110.181 -0.303 . . . . 74.11 110.181 -172.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.509 ' HB2' HD11 ' A' ' 97' ' ' ILE . 4.1 pp -102.09 127.17 31.48 Favored Pre-proline 0 C--N 1.352 0.688 0 N-CA-C 109.575 -0.528 . . . . 71.12 109.575 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.46 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 63.0 Cg_endo -75.05 116.22 4.51 Favored 'Trans proline' 0 C--N 1.362 1.272 0 C-N-CA 122.724 2.282 . . . . 54.13 109.015 168.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.534 HD21 HD13 ' A' ' 149' ' ' ILE . 37.5 tp -103.37 146.2 28.84 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.63 0.65 . . . . 75.33 111.168 -168.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.513 HG23 ' HA ' ' A' ' 94' ' ' MET . 92.8 m -75.32 143.69 42.79 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 114.695 -1.139 . . . . 75.11 109.228 175.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.407 ' HG ' HD11 ' A' ' 181' ' ' LEU . 88.3 mt -68.26 -35.03 77.27 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.721 0.808 . . . . 72.24 112.306 -172.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -68.28 -34.46 76.2 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.023 0.529 . . . . 74.23 109.836 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.433 ' HB3' HD11 ' A' ' 149' ' ' ILE . 57.5 mm-40 -68.19 -40.13 82.29 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.342 -0.844 . . . . 74.12 110.98 176.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.471 ' HB1' HD23 ' A' ' 180' ' ' LEU . . . -68.96 -38.03 79.18 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.811 0.444 . . . . 71.13 111.96 177.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -70.66 -53.31 16.25 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.089 -0.96 . . . . 75.52 110.239 -176.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -77.16 -46.02 24.79 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.796 -0.638 . . . . 75.32 110.828 -176.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.72 94.65 0.16 Allowed Glycine 0 C--N 1.347 1.142 0 O-C-N 123.467 0.479 . . . . 63.4 112.499 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.48 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -153.17 -160.34 9.63 Favored Glycine 0 C--N 1.341 0.81 0 N-CA-C 111.989 -0.445 . . . . 63.4 111.989 -178.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -81.3 114.9 20.4 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.556 -0.535 . . . . 74.33 109.556 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -113.26 124.43 52.5 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.227 1.011 . . . . 63.21 109.163 177.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 77.3 t -78.93 111.08 15.36 Favored 'Isoleucine or valine' 0 C--O 1.245 0.824 0 CA-C-N 114.673 -1.149 . . . . 74.2 109.916 176.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.418 HG12 ' HB ' ' A' ' 145' ' ' VAL . 3.7 p -108.78 109.93 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 124.504 1.121 . . . . 65.13 108.19 170.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -110.64 133.59 53.18 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.886 0.474 . . . . 72.22 110.531 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.46 141.09 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 125.178 1.391 . . . . 74.43 110.537 175.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 60.69 25.94 15.71 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.624 1.17 . . . . 63.44 112.163 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 79.49 8.42 87.77 Favored Glycine 0 C--N 1.355 1.621 0 CA-C-N 116.062 -0.517 . . . . 70.31 113.075 -178.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.404 HH22 ' HG3' ' A' ' 167' ' ' GLN . 39.9 ttm180 -103.31 117.77 35.25 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.957 0.903 . . . . 75.01 109.475 178.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -89.53 108.34 19.6 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.908 -0.775 . . . . 75.33 108.908 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.433 HG13 HG12 ' A' ' 147' ' ' VAL . 19.0 t -104.94 112.88 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 107.9 -1.148 . . . . 63.24 107.9 178.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.1 t -101.04 107.78 19.32 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.791 -0.818 . . . . 72.11 108.791 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.433 HG12 HG13 ' A' ' 145' ' ' VAL . 27.1 m -114.27 132.35 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.251 0.62 . . . . 70.05 111.432 -174.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -88.19 97.6 11.09 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.0 0.92 . . . . 73.33 109.17 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.534 HD13 HD21 ' A' ' 125' ' ' LEU . 10.7 pt -79.96 139.05 53.27 Favored Pre-proline 0 CA--C 1.562 1.413 0 CA-C-N 115.153 -0.93 . . . . 73.43 109.652 178.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.32 149.59 63.56 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.458 2.106 . . . . 74.33 112.657 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.31 112.06 1.8 Allowed 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.525 2.15 . . . . 72.34 110.91 172.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 96.98 23.34 15.27 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-N 115.824 -0.625 . . . . 43.25 112.364 -173.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.487 HG11 ' HB ' ' A' ' 149' ' ' ILE . 6.3 p -66.78 120.17 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 108.479 -0.934 . . . . 72.54 108.479 168.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.401 ' HA ' HD13 ' A' ' 180' ' ' LEU . 24.7 mtp180 -122.45 162.52 21.52 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.235 0.614 . . . . 74.44 110.948 -173.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -42.37 128.15 3.79 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 126.276 1.83 . . . . 72.5 113.201 -175.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.46 -5.83 74.41 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-N 115.746 -0.661 . . . . 73.14 114.264 178.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 17.0 m -64.83 124.09 21.07 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.499 0.72 . . . . 71.25 111.08 174.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 176' ' ' LEU . 3.8 p -105.6 110.88 32.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 123.357 0.663 . . . . 70.04 110.079 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 58.7 mt -90.61 103.5 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 107.951 -1.129 . . . . 73.31 107.951 173.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -78.2 100.27 6.56 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.146 -0.687 . . . . 72.12 109.146 177.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.487 HG12 ' HB3' ' A' ' 174' ' ' LEU . 7.6 p -99.68 108.19 49.82 Favored Pre-proline 0 CA--C 1.56 1.357 0 N-CA-C 109.221 -0.659 . . . . 65.43 109.221 176.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.03 151.47 61.87 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 123.255 2.636 . . . . 75.51 113.539 -172.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 69.53 8.52 59.97 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-N 115.84 -0.618 . . . . 62.23 114.502 172.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 96.8 mmm -104.88 -19.72 13.79 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.127 0.971 . . . . 74.11 110.167 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -78.43 -94.73 0.27 Allowed Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.667 -0.697 . . . . 64.15 111.691 176.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -59.29 98.76 0.12 Allowed Glycine 0 C--N 1.352 1.471 0 C-N-CA 123.179 0.418 . . . . 72.3 113.4 175.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.404 ' HG3' HH22 ' A' ' 143' ' ' ARG . 12.8 mm-40 -89.51 113.55 24.95 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.38 1.072 . . . . 74.33 110.632 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 157.38 -135.19 4.27 Favored Glycine 0 C--N 1.338 0.64 0 O-C-N 123.121 0.263 . . . . 54.02 112.49 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -81.91 -43.13 1.05 Allowed Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 123.59 0.756 . . . . 73.2 111.602 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -91.69 107.24 0.26 Allowed 'Trans proline' 0 C--N 1.396 3.077 0 C-N-CA 122.337 2.025 . . . . 61.35 112.066 169.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.96 125.33 11.42 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 122.343 2.029 . . . . 70.42 111.499 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -114.49 158.67 14.17 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 116.379 -0.373 . . . . 53.15 112.502 -177.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -83.64 148.83 26.91 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.583 0.753 . . . . 71.13 110.701 -177.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.487 ' HB3' HG12 ' A' ' 161' ' ' VAL . 39.3 tp -113.72 103.78 11.56 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 107.208 -1.404 . . . . 74.13 107.208 177.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 81.5 mt -87.04 100.67 12.8 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.786 0.834 . . . . 70.33 109.595 -173.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 158' ' ' VAL . 63.5 mt -89.34 101.66 14.34 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.874 0.87 . . . . 75.24 111.517 -172.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 24.8 t -87.3 118.46 33.28 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 108.693 -0.854 . . . . 73.3 108.693 177.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.6 p -74.59 137.08 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 C-N-CA 122.681 0.393 . . . . 72.34 110.22 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.46 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 32.0 mmt180 -124.87 89.45 3.07 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.192 0.997 . . . . 73.23 109.172 -178.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.471 HD23 ' HB1' ' A' ' 130' ' ' ALA . 32.7 mt -85.65 149.88 25.01 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.593 -0.731 . . . . 73.43 111.711 -178.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.407 HD11 ' HG ' ' A' ' 127' ' ' LEU . 55.9 mt . . . . . 0 CA--C 1.561 1.403 0 CA-C-N 114.095 -1.411 . . . . 72.33 109.374 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 109.095 -0.706 . . . . 74.1 109.095 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.403 ' H ' HG21 ' A' ' 126' ' ' THR . 32.5 t -111.57 128.14 55.94 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.103 -0.703 . . . . 63.32 109.103 177.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 26.3 m -76.71 149.23 36.41 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.361 0.664 . . . . 74.14 110.652 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.664 HD13 ' HB2' ' A' ' 123' ' ' LEU . 25.1 pt -112.77 155.49 13.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 C-N-CA 123.452 0.701 . . . . 75.11 109.707 -166.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.51 129.58 48.92 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.97 -0.752 . . . . 55.1 108.97 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.583 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.4 tp -75.53 162.02 28.67 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.8 1.24 . . . . 75.43 109.848 -172.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.06 -44.49 15.11 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.399 0.28 . . . . 75.34 111.055 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 41.7 mt 46.68 69.05 0.52 Allowed 'General case' 0 N--CA 1.482 1.159 0 O-C-N 124.313 1.008 . . . . 74.3 110.214 -169.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.407 HD13 ' HG3' ' A' ' 120' ' ' ARG . 80.8 mt -65.75 119.75 63.17 Favored Pre-proline 0 CA--C 1.549 0.929 0 CA-C-N 115.152 -0.931 . . . . 75.01 108.867 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo . . . . . 0 C--N 1.38 2.201 0 C-N-CA 123.004 2.47 . . . . 73.43 112.334 -174.178 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? . . . . . 0 C--O 1.252 1.224 0 N-CA-C 108.746 -0.835 . . . . 75.45 108.746 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.445 ' HA ' ' O ' ' A' ' 173' ' ' ASP . 8.9 p-10 -84.34 149.23 26.18 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.015 -0.993 . . . . 73.21 110.81 -171.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.5 tt -130.07 136.95 49.92 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 106.998 -1.482 . . . . 64.11 106.998 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.407 ' HG3' HD13 ' A' ' 102' ' ' LEU . 10.1 tpt180 -91.43 124.89 35.95 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.766 -0.827 . . . . 74.15 108.766 -174.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.583 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -145.7 135.58 23.54 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 122.66 0.384 . . . . 74.34 110.618 -172.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -114.13 121.86 45.08 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.544 -0.91 . . . . 64.5 108.544 -172.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.664 ' HB2' HD13 ' A' ' 97' ' ' ILE . 3.1 pp -100.37 113.61 65.48 Favored Pre-proline 0 CA--C 1.546 0.823 0 N-CA-C 107.786 -1.191 . . . . 74.35 107.786 174.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.536 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 71.9 Cg_endo -75.48 116.28 4.45 Favored 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.601 2.201 . . . . 72.53 109.391 169.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 27.1 tp -101.57 145.37 29.13 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 109.459 -0.571 . . . . 72.42 109.459 -170.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.403 HG21 ' H ' ' A' ' 95' ' ' SER . 4.7 t -91.02 156.09 18.2 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 109.145 -0.687 . . . . 74.21 109.145 -177.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 93.5 mt -60.8 -34.77 75.01 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.864 0.866 . . . . 74.33 111.765 -175.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 131' ' ' PHE . 2.1 mp0 -60.41 -48.45 81.69 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.911 0.885 . . . . 63.31 110.199 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -75.47 -34.33 60.9 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.307 -0.861 . . . . 65.31 111.891 -175.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.1 -39.8 79.55 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.113 0.483 . . . . 61.31 110.319 171.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.403 ' HB3' ' O ' ' A' ' 128' ' ' GLU . 68.8 t80 -66.07 -49.17 68.55 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.865 1.266 . . . . 73.2 111.313 177.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -74.51 -50.72 17.08 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.626 0.37 . . . . 73.11 111.829 -171.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.519 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 66.32 75.73 0.41 Allowed Glycine 0 CA--C 1.532 1.114 0 CA-C-N 115.768 -0.651 . . . . 75.32 111.603 -166.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -148.15 -165.44 12.03 Favored Glycine 0 C--N 1.343 0.946 0 N-CA-C 112.08 -0.408 . . . . 73.34 112.08 -176.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -71.92 115.18 10.83 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.513 -0.551 . . . . 74.53 109.513 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -116.01 121.23 41.62 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.33 -0.989 . . . . 74.45 108.33 174.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 70.7 t -81.29 141.73 14.76 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 C-N-CA 124.489 1.115 . . . . 75.04 109.386 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.7 p -141.45 123.6 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 123.944 0.898 . . . . 73.35 108.964 174.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -124.73 125.47 44.12 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.667 0.787 . . . . 74.11 110.345 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.495 HG22 ' HB3' ' A' ' 99' ' ' LEU . 1.6 m -151.15 131.81 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.967 1.307 . . . . 72.21 109.808 -177.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 59.14 24.28 12.62 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.236 1.015 . . . . 75.53 112.587 176.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 89.6 -7.14 82.49 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-N 116.53 -0.304 . . . . 42.42 113.499 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -94.63 114.68 26.66 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 109.088 -0.708 . . . . 75.51 109.088 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -114.57 127.89 56.03 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.179 0.591 . . . . 75.51 109.616 177.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.28 132.31 45.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 123.76 0.824 . . . . 61.22 108.826 173.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 40.9 t -94.37 127.8 40.49 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.459 -1.312 . . . . 75.01 107.459 170.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 19.7 m -120.98 127.89 76.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 109.468 -0.567 . . . . 70.05 109.468 175.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 56.1 ttt85 -76.59 109.87 10.7 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.981 -1.118 . . . . 74.33 107.981 173.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.519 HG13 ' HA2' ' A' ' 133' ' ' GLY . 12.2 pt -84.01 148.44 53.72 Favored Pre-proline 0 CA--C 1.557 1.243 0 CA-C-N 115.135 -0.939 . . . . 73.13 109.371 177.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -67.58 150.36 79.87 Favored 'Trans proline' 0 C--N 1.369 1.654 0 C-N-CA 122.485 2.123 . . . . 75.43 112.941 172.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -63.4 121.11 8.79 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.652 2.235 . . . . 61.34 111.341 171.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 76.72 30.69 55.79 Favored Glycine 0 N--CA 1.465 0.614 0 CA-C-N 116.288 -0.415 . . . . 65.43 112.115 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.9 p -61.87 125.24 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 108.967 -0.753 . . . . 72.02 108.967 170.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.462 ' HA ' HD13 ' A' ' 180' ' ' LEU . 95.6 mtt180 -116.66 153.87 31.56 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.589 0.756 . . . . 74.25 110.055 -169.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -37.56 123.28 0.99 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 126.446 1.899 . . . . 73.23 113.013 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.63 -20.07 35.06 Favored Glycine 0 N--CA 1.473 1.161 0 CA-C-O 119.207 -0.774 . . . . 71.44 113.726 178.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.1 t -61.95 121.42 12.92 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 117.491 0.645 . . . . 74.01 110.423 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.422 HG22 HG22 ' A' ' 177' ' ' VAL . 55.1 t -101.11 115.3 42.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 109.703 -0.48 . . . . 64.35 109.703 -178.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 57.7 mt -90.02 105.13 15.86 Favored 'Isoleucine or valine' 0 C--N 1.343 0.306 0 N-CA-C 107.391 -1.337 . . . . 65.23 107.391 173.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -84.52 119.44 25.18 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.037 -0.727 . . . . 75.13 109.037 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.454 HG11 ' HB3' ' A' ' 174' ' ' LEU . 6.3 p -124.48 98.16 38.31 Favored Pre-proline 0 CA--C 1.558 1.269 0 C-N-CA 123.394 0.678 . . . . 73.52 109.691 177.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 32.4 Cg_exo -61.92 150.07 87.66 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.99 2.46 . . . . 75.22 112.679 172.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.47 -16.94 51.66 Favored Glycine 0 N--CA 1.474 1.208 0 CA-C-O 119.963 -0.354 . . . . 73.33 113.807 178.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -102.14 -4.4 25.92 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.94 0.896 . . . . 73.24 111.979 -176.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.479 ' HA2' HD12 ' A' ' 174' ' ' LEU . . . -88.19 -111.59 1.09 Allowed Glycine 0 C--N 1.35 1.347 0 CA-C-O 119.397 -0.668 . . . . 73.21 113.064 -175.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -61.62 102.39 0.44 Allowed Glycine 0 C--N 1.359 1.852 0 CA-C-N 117.01 0.405 . . . . 60.32 112.739 173.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -80.69 135.29 35.99 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.953 0.501 . . . . 71.23 109.95 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 152.26 -155.75 26.31 Favored Glycine 0 C--N 1.343 0.956 0 N-CA-C 111.566 -0.613 . . . . 60.2 111.566 -178.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -66.78 -49.7 47.82 Favored Pre-proline 0 CA--C 1.559 1.297 0 CA-C-O 118.309 -0.853 . . . . 75.42 110.76 178.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.56 114.34 2.98 Favored 'Trans proline' 0 C--N 1.397 3.119 0 C-N-CA 121.392 1.395 . . . . 74.33 110.375 168.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -69.75 123.93 10.59 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 121.962 1.775 . . . . 74.43 110.036 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -100.01 159.24 19.53 Favored Glycine 0 CA--C 1.507 -0.44 0 CA-C-N 116.091 -0.504 . . . . 70.45 113.391 -171.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 34.6 t70 -91.46 151.54 20.75 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.967 0.907 . . . . 64.1 110.017 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.479 HD12 ' HA2' ' A' ' 165' ' ' GLY . 19.5 tp -127.71 119.19 25.28 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 118.104 0.411 . . . . 75.34 110.197 -179.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 97.6 mt -93.53 101.19 13.37 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.639 0.776 . . . . 75.33 109.347 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.636 ' HB3' HD21 ' A' ' 123' ' ' LEU . 48.0 mt -88.68 101.38 13.93 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.276 0.631 . . . . 74.32 109.843 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.422 HG22 HG22 ' A' ' 158' ' ' VAL . 60.7 t -86.1 115.45 27.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 109.406 -0.59 . . . . 74.31 109.406 176.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.417 HG21 HD12 ' A' ' 123' ' ' LEU . 9.6 p -67.64 136.69 26.11 Favored 'Isoleucine or valine' 0 C--O 1.245 0.85 0 N-CA-C 109.346 -0.612 . . . . 74.42 109.346 178.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.536 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 34.4 mmt180 -125.16 91.23 3.38 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.593 0.757 . . . . 74.43 109.406 -175.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.462 HD13 ' HA ' ' A' ' 154' ' ' ARG . 26.2 mt -97.0 132.87 42.38 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 114.759 -1.11 . . . . 74.24 109.333 173.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 75.1 mt . . . . . 0 CA--C 1.555 1.154 0 CA-C-N 115.14 -0.937 . . . . 74.14 109.914 -178.898 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 109.263 -0.643 . . . . 61.52 109.263 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.4 m -59.9 124.12 19.18 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.051 0.941 . . . . 54.43 111.666 -171.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.524 ' HA ' ' NH1' ' A' ' 136' ' ' ARG . 81.3 m -70.76 127.9 34.23 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 123.197 0.599 . . . . 74.2 110.345 179.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.536 HD13 ' HB2' ' A' ' 123' ' ' LEU . 26.2 pt -102.87 153.62 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.588 -0.733 . . . . 73.52 110.798 -169.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -101.79 157.97 16.45 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.299 -1.0 . . . . 75.03 108.299 170.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.552 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.7 tp -90.08 -103.81 0.09 Allowed 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 109.71 -0.478 . . . . 72.44 109.71 -177.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 177.48 -56.26 0.01 OUTLIER 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.036 0.934 . . . . 71.24 108.946 -172.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.544 HD11 ' HB ' ' A' ' 140' ' ' VAL . 75.3 mt 53.21 78.55 0.14 Allowed 'General case' 0 C--N 1.361 1.099 0 C-N-CA 124.658 1.183 . . . . 73.12 110.449 -171.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 61.7 mt -83.99 139.14 39.79 Favored Pre-proline 0 C--O 1.243 0.711 0 CA-C-N 114.705 -1.134 . . . . 75.32 109.665 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo . . . . . 0 C--N 1.37 1.665 0 C-N-CA 122.987 2.458 . . . . 75.44 113.604 173.946 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.443 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 14.9 tpp85 . . . . . 0 N--CA 1.472 0.628 0 N-CA-C 109.5 -0.555 . . . . 75.54 109.5 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -83.46 145.9 28.7 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.955 -1.128 . . . . 73.14 107.955 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.2 tt -127.62 125.93 41.11 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.789 -1.56 . . . . 72.41 106.789 173.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 -91.01 131.79 36.39 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 108.042 -1.095 . . . . 75.31 108.042 -172.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.552 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -158.53 141.86 14.99 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 109.413 -0.588 . . . . 74.03 109.413 -176.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -128.87 131.45 47.65 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.725 -0.472 . . . . 73.55 109.725 -174.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.536 ' HB2' HD13 ' A' ' 97' ' ' ILE . 4.1 pp -104.2 113.79 64.91 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 120.643 0.259 . . . . 71.01 110.309 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.459 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 36.2 Cg_endo -68.44 115.73 4.03 Favored 'Trans proline' 0 C--N 1.364 1.35 0 C-N-CA 122.411 2.074 . . . . 75.25 108.962 163.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.516 HD23 HD12 ' A' ' 149' ' ' ILE . 56.6 tp -102.83 146.11 28.76 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 109.692 -0.484 . . . . 75.33 109.692 -166.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.7 t -80.99 149.9 29.12 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 123.732 0.645 . . . . 70.15 109.612 -175.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.41 -33.92 71.82 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.187 0.995 . . . . 75.44 112.373 -170.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -61.32 -51.8 67.32 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.139 0.899 . . . . 75.11 110.004 178.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.435 ' HB3' HD13 ' A' ' 149' ' ' ILE . 21.4 mm-40 -73.19 -29.87 63.14 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.838 -1.074 . . . . 73.52 112.428 -174.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.23 -48.71 74.79 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-O 121.639 0.733 . . . . 74.3 110.52 174.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -67.74 -53.94 23.34 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 113.967 -1.469 . . . . 75.33 111.089 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -86.66 -46.72 9.8 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.696 -0.684 . . . . 71.44 111.258 -171.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' A' ' 151' ' ' PRO . . . 74.71 144.42 0.99 Allowed Glycine 0 C--N 1.353 1.517 0 N-CA-C 113.996 0.358 . . . . 64.13 113.996 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 158.76 -152.23 23.3 Favored Glycine 0 C--N 1.341 0.815 0 N-CA-C 111.586 -0.606 . . . . 74.32 111.586 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -76.46 116.69 17.38 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.297 -0.631 . . . . 73.42 109.297 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.524 ' NH1' ' HA ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -112.06 133.41 54.24 Favored 'General case' 0 C--N 1.346 0.452 0 C-N-CA 123.173 0.589 . . . . 71.21 110.428 179.525 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 85.8 t -90.91 124.97 43.69 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 C-N-CA 124.487 1.115 . . . . 73.3 110.088 177.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 97' ' ' ILE . 5.8 p -134.24 126.23 49.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 124.606 1.162 . . . . 75.41 108.796 177.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -99.33 140.04 34.09 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.222 0.609 . . . . 74.44 110.726 -174.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.544 ' HB ' HD11 ' A' ' 101' ' ' LEU . 15.4 m -138.75 101.11 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 124.672 1.189 . . . . 75.5 110.303 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.0 26.63 16.09 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.924 0.89 . . . . 63.34 111.679 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.0 -6.12 58.21 Favored Glycine 0 C--N 1.352 1.462 0 CA-C-N 116.014 -0.539 . . . . 70.51 113.741 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.464 ' HB3' HG23 ' A' ' 140' ' ' VAL . 18.0 tpp85 -93.31 119.81 32.88 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.54 0.736 . . . . 75.3 109.853 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -84.08 114.31 21.66 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.25 0.62 . . . . 73.55 109.764 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.406 ' HB ' HG12 ' A' ' 138' ' ' VAL . 36.3 t -107.35 117.57 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.26 1.024 . . . . 73.11 108.698 177.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.5 t -103.5 119.08 38.19 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 108.442 -0.948 . . . . 64.13 108.442 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.6 m -125.72 135.84 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.79 0.836 . . . . 71.44 109.678 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 45.4 ttt85 -81.43 103.48 11.21 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.437 -0.579 . . . . 74.45 109.437 177.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.516 HD12 HD23 ' A' ' 125' ' ' LEU . 13.4 pt -79.93 142.05 55.7 Favored Pre-proline 0 CA--C 1.557 1.23 0 CA-C-N 115.032 -0.986 . . . . 74.3 109.218 172.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.61 138.79 42.67 Favored 'Trans proline' 0 CA--C 1.562 1.906 0 C-N-CA 121.979 1.786 . . . . 73.33 112.146 176.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.445 ' HA ' ' HA3' ' A' ' 133' ' ' GLY . 67.5 Cg_exo -55.45 123.98 15.15 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 123.169 2.58 . . . . 73.31 112.88 171.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 76.56 32.17 51.77 Favored Glycine 0 C--N 1.351 1.413 0 N-CA-C 112.23 -0.348 . . . . 40.32 112.23 -177.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.87 140.28 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 123.659 0.784 . . . . 73.13 109.707 174.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 21.0 mtp180 -118.14 152.67 35.17 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.816 0.846 . . . . 73.22 109.75 -175.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -45.4 129.24 8.33 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 124.966 1.416 . . . . 73.55 111.952 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 104.75 -16.81 46.89 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-O 119.261 -0.744 . . . . 65.42 113.742 177.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.7 m -60.48 119.72 8.57 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 117.652 0.726 . . . . 75.13 111.036 177.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.418 HG23 HG22 ' A' ' 177' ' ' VAL . 49.2 t -101.24 112.34 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 109.383 -0.599 . . . . 74.32 109.383 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 63.7 mt -91.82 106.99 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 108.176 -1.046 . . . . 73.33 108.176 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 -87.46 107.24 18.47 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.173 0.589 . . . . 75.24 109.452 -177.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.57 HG13 ' HB3' ' A' ' 174' ' ' LEU . 3.3 p -104.39 100.66 23.12 Favored Pre-proline 0 CA--C 1.56 1.341 0 N-CA-C 109.706 -0.479 . . . . 74.02 109.706 175.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 58.2 Cg_endo -68.52 156.34 65.91 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.0 2.467 . . . . 72.34 112.709 -178.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 81.91 -8.33 60.32 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 114.37 0.508 . . . . 62.55 114.37 176.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 39.3 mtp -106.29 -13.0 15.51 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.387 0.675 . . . . 70.14 112.555 -175.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -84.04 -86.1 0.88 Allowed Glycine 0 C--N 1.344 1.005 0 N-CA-C 111.539 -0.625 . . . . 44.31 111.539 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.443 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -73.32 106.15 1.93 Allowed Glycine 0 C--N 1.342 0.876 0 O-C-N 123.906 0.415 . . . . 60.4 112.58 175.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -88.25 158.92 18.34 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 123.509 0.724 . . . . 74.3 109.055 175.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 132.67 -117.29 1.95 Allowed Glycine 0 C--N 1.34 0.803 0 N-CA-C 111.181 -0.768 . . . . 75.35 111.181 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.478 ' H ' ' HD2' ' A' ' 170' ' ' PRO . 95.4 m-20 -118.87 -46.16 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 CA-C-O 118.019 -0.991 . . . . 74.32 111.565 175.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.478 ' HD2' ' H ' ' A' ' 169' ' ' ASN . 74.1 Cg_endo -75.53 111.13 3.23 Favored 'Trans proline' 0 C--N 1.392 2.864 0 CA-C-N 121.083 1.422 . . . . 74.14 110.7 168.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.85 127.92 15.21 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.336 2.024 . . . . 74.41 112.051 -175.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -115.13 159.26 13.85 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 115.876 -0.602 . . . . 45.21 112.297 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.491 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 9.2 p-10 -96.12 153.18 17.93 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.876 0.87 . . . . 53.12 111.341 -171.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.57 ' HB3' HG13 ' A' ' 161' ' ' VAL . 48.1 tp -115.02 106.97 14.76 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 107.723 -1.214 . . . . 75.53 107.723 178.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 85.5 mt -84.85 104.87 15.19 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.749 0.82 . . . . 74.4 109.834 -175.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 58.4 mt -96.42 102.07 13.8 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.449 0.699 . . . . 71.55 110.528 -177.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.418 HG22 HG23 ' A' ' 158' ' ' VAL . 25.3 t -86.42 119.22 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 108.977 -0.749 . . . . 72.5 108.977 176.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 5.4 p -71.06 138.12 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 N-CA-C 108.971 -0.752 . . . . 73.45 108.971 178.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.459 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 22.0 mmm180 -127.84 100.77 6.06 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.955 0.902 . . . . 75.4 109.015 -173.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 91.8 mt -109.24 130.23 55.49 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.629 -0.714 . . . . 74.22 109.545 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 75.3 mt . . . . . 0 CA--C 1.548 0.871 0 O-C-N 124.449 1.093 . . . . 75.13 110.926 -176.9 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 69.8 mtm . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 108.749 -0.834 . . . . 73.04 108.749 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.1 p -75.87 146.24 39.94 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.763 0.825 . . . . 75.15 111.654 -173.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 42.9 m -81.28 145.99 30.63 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.068 0.947 . . . . 74.45 110.396 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.6 pt -128.75 172.19 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.971 0.908 . . . . 75.0 110.344 -176.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -134.15 147.98 50.87 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.234 1.013 . . . . 74.43 110.044 -176.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.543 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.5 tp -85.2 173.91 10.05 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.69 -0.856 . . . . 74.25 108.69 -177.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -97.19 -33.47 11.47 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.974 -0.454 . . . . 74.11 111.855 175.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.2 mt 49.98 61.96 2.91 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.706 0.803 . . . . 74.45 110.668 -171.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 71.6 mt -64.46 111.0 4.67 Favored Pre-proline 0 CA--C 1.556 1.203 0 CA-C-N 115.616 -0.72 . . . . 75.11 109.289 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo . . . . . 0 C--N 1.377 2.039 0 C-N-CA 122.205 1.937 . . . . 71.44 112.085 -173.778 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.456 ' O ' ' HA3' ' A' ' 172' ' ' GLY . 28.6 ttm180 . . . . . 0 N--CA 1.48 1.048 0 N-CA-C 111.132 0.049 . . . . 73.33 111.132 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -84.65 135.76 34.04 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.191 -1.04 . . . . 71.44 108.191 174.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.8 tt -110.33 125.58 53.33 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 105.688 -1.967 . . . . 73.43 105.688 174.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.45 ' HG2' HD13 ' A' ' 175' ' ' LEU . 27.5 mtp180 -91.96 144.54 25.36 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.361 -0.977 . . . . 75.31 108.361 -175.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.543 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -158.75 156.44 29.83 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.625 -0.509 . . . . 71.41 109.625 -174.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -129.37 138.85 51.76 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.994 -0.743 . . . . 75.15 108.994 176.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 55.7 tp -110.43 101.7 49.3 Favored Pre-proline 0 CA--C 1.538 0.482 0 O-C-N 123.815 0.697 . . . . 74.24 109.842 -175.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.42 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 49.1 Cg_endo -69.9 112.47 3.11 Favored 'Trans proline' 0 C--N 1.372 1.81 0 N-CA-C 108.253 -1.479 . . . . 74.11 108.253 169.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.448 HD22 HD13 ' A' ' 149' ' ' ILE . 35.1 tp -104.87 138.02 41.75 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.47 -0.567 . . . . 73.32 109.47 -168.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.0 t -81.76 153.94 26.24 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 109.124 -0.695 . . . . 71.44 109.124 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 74.2 mt -61.67 -33.61 74.28 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.525 0.73 . . . . 74.33 112.195 -169.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.0 -44.16 97.82 Favored 'General case' 0 C--O 1.22 -0.488 0 O-C-N 124.311 1.007 . . . . 63.1 109.477 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -79.15 -29.22 42.95 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.369 -0.832 . . . . 74.53 112.101 -175.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.52 -39.8 89.16 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.342 0.591 . . . . 72.32 110.21 172.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -74.07 -57.22 4.11 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 114.715 -1.13 . . . . 73.54 110.748 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -61.32 -50.61 72.26 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.122 0.569 . . . . 72.15 110.923 -173.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.586 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 63.71 67.7 1.95 Allowed Glycine 0 C--N 1.337 0.616 0 CA-C-N 114.763 -1.108 . . . . 65.12 112.128 -172.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -134.15 -160.0 9.09 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 112.508 -0.237 . . . . 70.11 112.508 -177.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -82.42 116.75 22.02 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.081 -0.711 . . . . 73.32 109.081 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -114.13 126.68 55.35 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.277 0.631 . . . . 74.1 109.338 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 83.0 t -70.52 110.61 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 124.305 1.003 . . . . 74.44 108.85 173.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.9 t -113.87 109.75 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 108.286 -1.005 . . . . 73.42 108.286 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -117.15 124.52 49.36 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.351 -0.611 . . . . 73.3 109.351 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.501 HG11 ' HB3' ' A' ' 99' ' ' LEU . 5.8 p -149.63 136.09 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.71 1.204 . . . . 75.12 108.601 -175.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.89 18.76 10.09 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.086 0.954 . . . . 75.01 112.322 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 88.01 -5.93 84.19 Favored Glycine 0 C--N 1.35 1.344 0 CA-C-N 116.075 -0.511 . . . . 61.0 113.183 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -94.99 121.87 37.06 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.265 1.026 . . . . 75.51 109.525 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -108.14 115.28 29.84 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.031 0.933 . . . . 75.43 110.31 -174.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.8 p -126.04 119.37 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.239 1.015 . . . . 74.23 109.601 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 39.5 t -88.32 108.71 19.47 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 109.205 -0.665 . . . . 73.35 109.205 176.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.2 p -100.76 127.61 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 123.014 0.526 . . . . 75.52 110.802 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -85.01 103.04 13.69 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.792 -0.818 . . . . 72.23 108.792 172.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.586 HG13 ' HA2' ' A' ' 133' ' ' GLY . 11.6 pt -86.64 151.79 53.4 Favored Pre-proline 0 CA--C 1.562 1.424 0 C-N-CA 124.518 1.127 . . . . 71.43 109.507 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . 0.446 ' HG2' ' HB ' ' A' ' 153' ' ' VAL . 55.2 Cg_endo -71.37 146.32 50.22 Favored 'Trans proline' 0 CA--C 1.565 2.049 0 C-N-CA 122.108 1.872 . . . . 74.42 112.514 174.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.468 ' HA ' ' HA3' ' A' ' 133' ' ' GLY . 23.6 Cg_exo -67.11 124.92 12.79 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.991 2.461 . . . . 72.25 112.036 174.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 81.18 24.52 57.14 Favored Glycine 0 C--N 1.35 1.318 0 O-C-N 123.478 0.486 . . . . 60.25 112.101 -175.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.446 ' HB ' ' HG2' ' A' ' 150' ' ' PRO . 4.4 p -60.65 128.83 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 123.959 0.903 . . . . 74.24 109.413 173.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.462 ' HA ' HD13 ' A' ' 180' ' ' LEU . 76.9 mtp180 -123.56 166.43 15.46 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.118 0.567 . . . . 73.43 110.047 -175.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -45.31 129.62 8.16 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 125.709 1.604 . . . . 75.44 113.357 -172.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.92 -2.66 66.6 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-O 119.404 -0.664 . . . . 65.11 114.623 175.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.6 t -69.56 122.34 18.87 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 117.651 0.725 . . . . 63.42 109.57 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 45.6 t -101.2 113.18 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.186 0.594 . . . . 75.5 109.886 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 51.6 mt -91.52 117.63 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 107.886 -1.153 . . . . 72.31 107.886 170.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -104.97 101.11 10.7 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.924 -0.769 . . . . 74.21 108.924 -173.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.4 p -107.76 107.72 60.64 Favored Pre-proline 0 CA--C 1.556 1.199 0 C-N-CA 123.148 0.579 . . . . 72.13 110.722 -176.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 59.8 Cg_endo -69.37 147.34 65.19 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.561 2.174 . . . . 63.23 112.709 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.41 -3.14 87.64 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 115.794 -0.639 . . . . 64.53 113.527 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 24.7 mmt -103.42 -16.94 15.45 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.304 0.641 . . . . 73.3 110.772 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -91.58 -108.17 1.56 Allowed Glycine 0 C--N 1.349 1.302 0 CA-C-O 119.541 -0.589 . . . . 62.13 113.173 -175.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -60.43 100.39 0.22 Allowed Glycine 0 C--N 1.349 1.28 0 O-C-N 123.861 0.389 . . . . 72.3 112.661 177.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -88.34 116.26 26.43 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 124.04 0.936 . . . . 60.21 109.169 177.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 160.15 -149.21 18.5 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.5 -0.64 . . . . 54.22 111.5 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -70.97 -48.96 13.68 Favored Pre-proline 0 CA--C 1.561 1.369 0 CA-C-O 117.9 -1.047 . . . . 75.34 111.822 177.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -81.81 110.62 2.14 Favored 'Trans proline' 0 C--N 1.391 2.801 0 C-N-CA 121.572 1.514 . . . . 74.0 110.749 174.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -67.79 123.6 10.91 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.358 2.039 . . . . 75.52 110.807 -174.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 117' ' ' ARG . . . -115.67 152.09 18.16 Favored Glycine 0 C--N 1.335 0.477 0 N-CA-C 114.004 0.361 . . . . 50.05 114.004 -172.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 6.8 p-10 -91.66 155.64 18.17 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.516 1.126 . . . . 72.42 110.53 178.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 41.3 tp -112.97 115.52 28.52 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.947 -0.76 . . . . 74.22 108.947 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.45 HD13 ' HG2' ' A' ' 120' ' ' ARG . 73.5 mt -84.53 106.93 16.48 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.102 0.961 . . . . 75.31 109.513 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 27.2 mt -99.54 98.75 9.6 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.843 -0.799 . . . . 72.42 108.843 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 8.5 p -95.75 110.69 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 109.092 -0.706 . . . . 74.23 109.092 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.0 p -66.67 143.77 15.28 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 123.299 0.64 . . . . 65.12 111.275 -172.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.42 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 16.0 mmm180 -126.14 103.11 7.52 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 125.042 1.337 . . . . 75.44 108.192 -174.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.462 HD13 ' HA ' ' A' ' 154' ' ' ARG . 91.8 mt -113.45 131.42 56.03 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.53 0.732 . . . . 72.31 109.984 177.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 81.4 mt . . . . . 0 CA--C 1.548 0.896 0 N-CA-C 108.374 -0.972 . . . . 72.31 108.374 173.401 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.5 ' HB3' ' NH2' ' A' ' 136' ' ' ARG . 59.1 mtt . . . . . 0 N--CA 1.477 0.886 0 N-CA-C 109.299 -0.63 . . . . 54.22 109.299 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.1 m -70.66 134.17 47.3 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.454 0.702 . . . . 75.22 111.062 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.6 m -73.55 138.35 44.93 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.938 0.495 . . . . 74.11 109.73 174.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.554 HD12 ' HB2' ' A' ' 123' ' ' LEU . 21.3 pt -109.53 175.42 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 122.992 0.517 . . . . 64.11 111.547 -166.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -122.81 -167.62 1.61 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.388 1.075 . . . . 74.54 109.617 173.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.663 ' HG ' ' HB3' ' A' ' 121' ' ' ALA . 11.9 tp -142.06 156.26 45.4 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 108.655 -0.868 . . . . 75.22 108.655 -175.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.44 -56.99 4.01 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.269 0.228 . . . . 74.43 110.468 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 95.9 mt 60.19 73.49 0.48 Allowed 'General case' 0 CA--C 1.553 1.078 0 O-C-N 124.366 1.041 . . . . 75.52 109.902 -170.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 79.5 mt -70.89 155.94 92.69 Favored Pre-proline 0 CA--C 1.561 1.382 0 C-N-CA 125.251 1.421 . . . . 75.52 111.766 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo . . . . . 0 C--N 1.386 2.532 0 C-N-CA 123.307 2.671 . . . . 73.03 113.646 178.593 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? . . . . . 0 N--CA 1.473 0.676 0 CA-C-O 120.446 0.165 . . . . 75.25 111.293 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -74.63 116.23 15.09 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 108.736 -0.838 . . . . 70.13 108.736 172.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.7 tt -94.9 118.89 32.53 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 106.735 -1.58 . . . . 75.13 106.735 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -90.98 141.66 28.61 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 108.726 -0.842 . . . . 71.41 108.726 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.663 ' HB3' ' HG ' ' A' ' 99' ' ' LEU . . . -153.25 142.77 21.77 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.821 -0.627 . . . . 64.03 109.545 -171.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.439 ' HB3' ' HG3' ' A' ' 179' ' ' ARG . 35.3 mt-10 -119.69 118.3 30.56 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.181 -1.044 . . . . 73.24 108.181 -174.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.554 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.6 pp -100.74 113.91 65.71 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 108.914 -0.772 . . . . 74.33 108.914 176.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.13 113.95 3.91 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 121.864 1.709 . . . . 73.21 109.335 170.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.501 HD23 HD12 ' A' ' 149' ' ' ILE . 36.1 tp -103.12 151.05 23.03 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 122.004 -0.435 . . . . 74.35 110.601 -167.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 13.4 t -85.61 154.61 21.59 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.955 -0.757 . . . . 72.2 108.955 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 39.3 mt -70.78 -26.68 63.45 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.215 0.606 . . . . 72.23 111.805 -167.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -73.49 -41.82 62.63 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.397 -0.82 . . . . 63.13 110.08 -178.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.446 ' HB3' HD13 ' A' ' 149' ' ' ILE . 34.1 mm-40 -74.4 -31.26 62.27 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.185 -0.916 . . . . 73.2 111.158 177.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.71 -50.83 70.87 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.425 0.69 . . . . 73.53 110.5 176.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -66.67 -62.89 1.22 Allowed 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 114.223 -1.353 . . . . 72.1 110.641 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -70.32 -43.75 69.65 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.929 0.491 . . . . 74.24 111.89 -171.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.43 97.56 0.05 OUTLIER Glycine 0 C--N 1.346 1.103 0 O-C-N 123.816 0.697 . . . . 61.34 113.063 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -144.06 -143.64 4.09 Favored Glycine 0 C--N 1.342 0.883 0 N-CA-C 111.097 -0.801 . . . . 70.01 111.097 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -96.26 119.07 34.09 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.845 -0.798 . . . . 74.12 108.845 176.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.5 ' NH2' ' HB3' ' A' ' 94' ' ' MET . 11.0 tpp180 -116.98 123.79 47.78 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.412 0.685 . . . . 74.04 109.386 176.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 146' ' ' SER . 76.2 t -74.47 136.9 24.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 C-N-CA 123.621 0.768 . . . . 72.31 110.683 177.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.436 ' HB ' HG13 ' A' ' 145' ' ' VAL . 39.1 t -115.59 126.17 73.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.29 1.436 . . . . 74.24 107.615 174.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -115.23 101.51 9.02 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.632 -0.507 . . . . 72.14 109.632 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.66 144.16 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 123.719 0.808 . . . . 74.32 110.907 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 65.32 18.69 11.45 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.283 1.433 . . . . 74.51 111.746 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.19 21.76 69.71 Favored Glycine 0 C--N 1.351 1.37 0 CA-C-N 116.016 -0.538 . . . . 72.44 112.257 -175.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -122.45 140.06 53.15 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.923 0.889 . . . . 73.3 110.204 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -102.69 125.32 49.38 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.206 1.002 . . . . 75.4 108.719 177.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.436 HG13 ' HB ' ' A' ' 138' ' ' VAL . 3.5 p -137.78 112.26 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 CA-C-O 121.54 0.686 . . . . 73.0 110.2 176.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 137' ' ' VAL . 46.4 t -90.43 106.0 18.2 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.189 -0.671 . . . . 60.4 109.189 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 28.7 m -100.62 141.15 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.232 0.613 . . . . 73.24 110.13 -178.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.1 ttp180 -90.84 117.47 29.48 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.284 -0.635 . . . . 73.32 109.284 177.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.501 HD12 HD23 ' A' ' 125' ' ' LEU . 9.1 pt -100.49 139.77 20.89 Favored Pre-proline 0 CA--C 1.561 1.378 0 C-N-CA 124.871 1.268 . . . . 73.24 109.307 176.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -63.14 152.46 79.52 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 123.083 2.522 . . . . 74.11 113.695 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.47 121.3 9.04 Favored 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 122.272 1.981 . . . . 73.44 111.228 171.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 85.21 23.64 47.51 Favored Glycine 0 C--N 1.346 1.084 0 N-CA-C 112.13 -0.388 . . . . 73.05 112.13 -176.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.479 HG11 ' HB ' ' A' ' 149' ' ' ILE . 4.1 p -63.53 117.45 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 123.784 0.833 . . . . 63.1 109.853 177.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.496 ' HA ' HD11 ' A' ' 180' ' ' LEU . 82.0 mtm180 -132.89 161.93 32.93 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 115.923 -0.58 . . . . 75.43 110.847 -172.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -35.29 119.77 0.51 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.881 2.072 . . . . 74.52 113.838 -169.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.24 -12.14 48.13 Favored Glycine 0 N--CA 1.473 1.145 0 CA-C-O 119.297 -0.724 . . . . 71.43 114.552 177.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 33.5 t -66.22 122.3 17.15 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 117.832 0.816 . . . . 74.35 109.243 176.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.0 t -110.0 114.55 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.347 0.659 . . . . 74.14 110.402 -176.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 56.0 mt -92.48 120.6 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 108.355 -0.98 . . . . 74.43 108.355 172.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -104.67 116.63 32.38 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.305 0.642 . . . . 74.32 110.143 -176.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.467 HG12 ' HB3' ' A' ' 174' ' ' LEU . 3.3 p -120.45 108.58 37.52 Favored Pre-proline 0 CA--C 1.559 1.316 0 C-N-CA 123.031 0.532 . . . . 70.51 110.725 176.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 16.7 Cg_exo -67.59 153.46 76.23 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.886 2.391 . . . . 71.22 112.267 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.01 -24.19 8.3 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-O 119.864 -0.409 . . . . 72.24 113.909 177.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 92.9 mmm -92.44 -4.92 52.96 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.66 0.784 . . . . 64.42 111.224 -177.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -91.21 -103.02 1.3 Allowed Glycine 0 C--N 1.344 1.007 0 CA-C-O 119.719 -0.49 . . . . 71.3 112.409 -177.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.52 103.8 0.88 Allowed Glycine 0 C--N 1.352 1.418 0 N-CA-C 111.467 -0.653 . . . . 72.11 111.467 175.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.521 HE21 ' HA ' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -87.76 121.47 30.22 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.484 0.714 . . . . 74.0 110.72 -174.923 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 169.88 -146.21 9.82 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 110.633 -0.987 . . . . 75.44 110.633 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -76.79 -49.15 2.68 Favored Pre-proline 0 CA--C 1.56 1.331 0 CA-C-O 118.075 -0.964 . . . . 72.32 109.332 172.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -81.61 112.62 2.46 Favored 'Trans proline' 0 C--N 1.4 3.243 0 C-N-CA 122.173 1.915 . . . . 72.32 111.316 170.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.43 127.75 11.36 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 122.502 2.135 . . . . 74.44 112.239 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -104.88 165.88 14.62 Favored Glycine 0 C--N 1.344 1.022 0 CA-C-N 116.365 -0.38 . . . . 73.34 112.256 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 15.2 m-20 -86.25 142.71 28.37 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.855 0.862 . . . . 64.41 110.773 -177.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.467 ' HB3' HG12 ' A' ' 161' ' ' VAL . 34.5 tp -105.35 104.62 14.39 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 107.934 -1.136 . . . . 75.04 107.934 175.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 51.1 mt -88.46 101.17 13.66 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.197 -0.91 . . . . 73.52 109.282 -175.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 48.0 mt -97.1 101.11 12.61 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.896 0.878 . . . . 73.4 110.455 -174.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.3 p -92.48 130.33 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 109.893 -0.41 . . . . 75.23 109.893 175.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 14.1 p -77.54 133.81 29.83 Favored 'Isoleucine or valine' 0 C--O 1.248 0.999 0 C-N-CA 123.338 0.655 . . . . 73.31 110.053 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.439 ' HG3' ' HB3' ' A' ' 122' ' ' GLU . 9.1 mmm180 -122.6 96.38 5.01 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.167 0.987 . . . . 74.45 108.795 -174.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.496 HD11 ' HA ' ' A' ' 154' ' ' ARG . 64.5 mt -101.23 147.65 26.03 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.657 -0.701 . . . . 72.14 110.588 177.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 61.4 mt . . . . . 0 CA--C 1.556 1.186 0 CA-C-N 114.998 -1.001 . . . . 74.44 108.717 171.848 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 CA--C 1.545 0.766 0 N-CA-C 109.719 -0.474 . . . . 74.5 109.719 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.408 ' H ' HG21 ' A' ' 126' ' ' THR . 23.0 t -82.01 132.65 35.26 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.397 0.679 . . . . 72.33 110.251 178.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.412 ' HA ' HH11 ' A' ' 136' ' ' ARG . 63.9 m -76.05 143.04 41.61 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.607 0.763 . . . . 73.05 110.052 174.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.54 HD13 ' HB2' ' A' ' 123' ' ' LEU . 15.6 pt -121.4 173.02 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 123.012 0.525 . . . . 75.24 111.651 -165.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -124.86 -172.39 2.56 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.321 1.048 . . . . 75.12 109.541 174.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.65 ' HG ' ' HB3' ' A' ' 121' ' ' ALA . 11.6 tp -131.65 148.91 52.63 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 107.677 -1.231 . . . . 75.33 107.677 -177.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.48 -43.16 67.1 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 117.983 0.356 . . . . 65.32 110.949 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 41.8 mt 53.01 79.62 0.12 Allowed 'General case' 0 N--CA 1.477 0.916 0 O-C-N 124.473 1.108 . . . . 75.13 110.907 -173.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 35.0 mt -86.37 121.26 72.47 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 108.29 -1.004 . . . . 74.01 108.29 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo . . . . . 0 C--N 1.378 2.126 0 C-N-CA 122.512 2.141 . . . . 73.52 112.497 -177.148 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 . . . . . 0 CA--C 1.549 0.922 0 CA-C-O 120.83 0.348 . . . . 75.3 111.327 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -91.38 111.19 22.58 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.627 0.771 . . . . 73.33 109.984 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.0 tt -95.18 127.32 41.14 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 106.885 -1.524 . . . . 64.45 106.885 173.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -90.04 124.03 34.42 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 107.831 -1.174 . . . . 71.33 107.831 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.65 ' HB3' ' HG ' ' A' ' 99' ' ' LEU . . . -146.15 144.85 30.23 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.156 0.582 . . . . 73.3 110.121 -173.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -128.75 131.11 47.84 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.655 0.382 . . . . 75.51 110.144 -177.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.54 ' HB2' HD13 ' A' ' 97' ' ' ILE . 4.2 pp -107.61 119.71 49.66 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 109.223 -0.658 . . . . 74.44 109.223 177.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.611 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 66.9 Cg_endo -74.14 113.94 3.91 Favored 'Trans proline' 0 C--N 1.364 1.385 0 C-N-CA 122.512 2.142 . . . . 52.45 109.404 169.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 42.1 tp -102.66 154.17 19.41 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 109.326 -0.62 . . . . 74.21 109.326 -168.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.408 HG21 ' H ' ' A' ' 95' ' ' SER . 1.5 t -91.27 148.02 22.64 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 108.154 -1.054 . . . . 74.45 108.154 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.4 mt -64.41 -27.47 69.02 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.106 0.562 . . . . 65.44 111.883 -172.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.24 -41.76 85.1 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.799 0.839 . . . . 74.51 110.035 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -75.07 -34.78 61.84 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.384 0.674 . . . . 73.21 111.345 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.72 -34.62 73.16 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.287 0.635 . . . . 74.55 110.817 171.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -76.34 -46.81 25.85 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 114.773 -1.103 . . . . 74.41 111.437 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 34.3 m80 -73.54 -49.97 23.75 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 120.804 0.335 . . . . 74.25 111.457 -173.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.44 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 70.44 66.22 2.26 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-N 115.422 -0.808 . . . . 52.51 112.226 -173.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -134.44 -158.76 8.58 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 112.45 -0.26 . . . . 54.53 112.45 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -74.98 115.1 14.21 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.594 0.758 . . . . 74.34 109.058 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.412 HH11 ' HA ' ' A' ' 96' ' ' THR . 5.0 tpp180 -114.34 120.61 40.96 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.233 0.54 . . . . 74.12 109.72 178.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 88.1 t -77.17 111.73 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.712 0 CA-C-N 114.825 -1.08 . . . . 55.11 110.124 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 43.6 t -102.89 112.07 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.97 1.308 . . . . 75.24 107.905 172.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -115.13 115.2 26.37 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.008 -0.738 . . . . 74.51 109.008 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.508 HG11 ' HB3' ' A' ' 99' ' ' LEU . 7.6 p -151.61 138.29 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 124.209 1.004 . . . . 65.01 110.035 -178.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.88 18.59 10.92 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.529 1.132 . . . . 71.43 113.472 171.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.63 -2.63 80.62 Favored Glycine 0 C--N 1.351 1.369 0 C-N-CA 122.831 0.253 . . . . 73.14 112.891 -176.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.443 ' HD2' ' HE3' ' A' ' 164' ' ' MET . 18.6 tpp180 -99.01 117.51 33.68 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.279 1.031 . . . . 73.14 108.766 177.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -106.56 105.62 15.74 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.393 -0.966 . . . . 71.32 108.393 172.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.4 p -114.16 137.1 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.845 0.858 . . . . 73.34 109.225 178.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.8 t -97.89 114.89 27.09 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.51 -0.922 . . . . 73.53 108.51 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 33.7 t -100.45 111.6 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.479 1.112 . . . . 71.51 109.131 -178.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -79.88 96.66 6.42 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.589 -0.893 . . . . 72.42 108.589 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.451 ' HB ' HG13 ' A' ' 153' ' ' VAL . 10.1 pt -81.04 147.6 61.83 Favored Pre-proline 0 CA--C 1.56 1.348 0 CA-C-N 114.755 -1.111 . . . . 75.3 110.442 -179.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.43 145.15 42.18 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.41 2.073 . . . . 72.34 112.389 176.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.26 113.29 2.37 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 122.508 2.139 . . . . 71.41 111.879 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 105.14 13.65 24.46 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-N 115.514 -0.766 . . . . 75.04 112.601 -176.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.451 HG13 ' HB ' ' A' ' 149' ' ' ILE . 7.3 p -63.33 127.97 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.529 0.731 . . . . 63.42 110.546 177.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.564 ' HA ' HD12 ' A' ' 180' ' ' LEU . 28.7 mtm180 -134.78 164.26 27.95 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.312 0.645 . . . . 65.12 111.581 -172.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -38.86 125.14 1.46 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 126.314 1.846 . . . . 75.52 113.641 -174.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.25 -11.22 60.09 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-O 119.293 -0.726 . . . . 70.02 114.241 176.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.6 t -67.4 121.79 16.53 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 117.432 0.616 . . . . 71.33 110.191 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 40.6 t -104.23 111.14 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.55 0.74 . . . . 75.43 110.435 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 75.7 mt -93.6 106.45 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 125.236 1.414 . . . . 63.42 109.521 175.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 30.8 ttt-85 -79.67 106.29 11.59 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.26 0.624 . . . . 73.43 109.777 175.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.405 HG11 ' HB3' ' A' ' 174' ' ' LEU . 7.6 p -106.05 104.89 51.64 Favored Pre-proline 0 CA--C 1.562 1.432 0 N-CA-C 109.175 -0.676 . . . . 71.12 109.175 171.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 59.6 Cg_endo -69.29 154.18 69.98 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 123.04 2.494 . . . . 73.51 113.615 -175.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 75.82 2.88 72.03 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 115.47 -0.787 . . . . 72.24 113.881 177.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.443 ' HE3' ' HD2' ' A' ' 143' ' ' ARG . 92.7 mmm -110.37 -25.95 9.81 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.553 0.741 . . . . 73.33 111.916 -172.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -83.18 -73.17 1.25 Allowed Glycine 0 C--N 1.345 1.06 0 N-CA-C 111.313 -0.715 . . . . 60.44 111.313 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -62.47 96.29 0.14 Allowed Glycine 0 C--N 1.345 1.035 0 N-CA-C 111.8 -0.52 . . . . 55.03 111.8 165.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -88.79 170.58 10.63 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.458 1.103 . . . . 72.15 110.288 176.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 97.49 -147.88 18.78 Favored Glycine 0 C--N 1.341 0.807 0 CA-C-N 116.14 -0.482 . . . . 73.04 112.166 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -64.64 -49.16 71.68 Favored Pre-proline 0 CA--C 1.57 1.723 0 CA-C-O 118.458 -0.782 . . . . 72.24 111.907 177.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -84.13 129.58 4.58 Favored 'Trans proline' 0 C--N 1.392 2.832 0 C-N-CA 122.046 1.831 . . . . 74.13 111.409 175.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.33 145.52 34.39 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 121.959 1.773 . . . . 74.41 111.168 170.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -152.55 164.4 30.65 Favored Glycine 0 N--CA 1.47 0.925 0 CA-C-O 120.195 -0.225 . . . . 74.24 112.636 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.469 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 29.8 m-20 -84.23 146.33 27.86 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.143 0.577 . . . . 75.14 111.498 -167.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.405 ' HB3' HG11 ' A' ' 161' ' ' VAL . 33.7 tp -114.87 104.24 11.74 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.458 -1.312 . . . . 52.32 107.458 176.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 68.5 mt -85.82 100.36 12.0 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.613 0.765 . . . . 75.31 109.392 -174.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 67.1 mt -92.79 99.25 11.96 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.817 0.847 . . . . 74.5 110.786 -174.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.8 p -89.22 123.5 41.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 N-CA-C 109.037 -0.727 . . . . 64.31 109.037 173.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.5 p -77.7 143.76 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 123.437 0.695 . . . . 74.22 110.59 -176.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.611 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 30.0 mmt180 -123.99 96.94 5.13 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.066 0.947 . . . . 73.41 109.656 -177.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.564 HD12 ' HA ' ' A' ' 154' ' ' ARG . 49.1 mt -100.53 114.84 28.81 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.261 -0.644 . . . . 74.21 109.261 173.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 69.0 mt . . . . . 0 CA--C 1.548 0.9 0 O-C-N 123.917 0.761 . . . . 72.24 109.282 176.031 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.416 ' HB3' ' NH2' ' A' ' 136' ' ' ARG . 65.8 mtt . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 109.082 -0.71 . . . . 72.44 109.082 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.2 m -66.82 120.37 13.44 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 116.192 -0.458 . . . . 71.45 109.956 176.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.2 m -85.8 137.03 33.08 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 109.305 -0.628 . . . . 75.2 109.305 177.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.468 HD13 ' HB2' ' A' ' 123' ' ' LEU . 9.1 pt -123.73 166.29 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 112.359 0.503 . . . . 71.44 112.359 -155.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -112.37 176.63 4.94 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.783 1.233 . . . . 64.32 109.269 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.613 ' HG ' ' HB3' ' A' ' 121' ' ' ALA . 12.3 tp -126.52 150.81 48.55 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.745 -0.835 . . . . 70.14 108.745 -174.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.7 -34.33 71.83 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.881 0.472 . . . . 75.42 112.134 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.652 HD12 ' HB ' ' A' ' 140' ' ' VAL . 21.7 mt 47.35 56.35 7.06 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.146 0.978 . . . . 74.31 112.065 -176.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.6 mt -71.25 117.28 55.31 Favored Pre-proline 0 CA--C 1.553 1.064 0 N-CA-C 108.926 -0.768 . . . . 71.21 108.926 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo . . . . . 0 C--N 1.375 1.956 0 C-N-CA 122.149 1.899 . . . . 74.4 112.447 179.426 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 . . . . . 0 CA--C 1.541 0.631 0 N-CA-C 108.055 -1.091 . . . . 73.42 108.055 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -91.59 121.6 33.41 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 107.542 -1.281 . . . . 65.44 107.542 168.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.4 tt -108.37 121.6 45.27 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 106.943 -1.503 . . . . 74.13 106.943 -177.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -92.48 135.02 34.4 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.871 -0.789 . . . . 72.13 108.871 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.613 ' HB3' ' HG ' ' A' ' 99' ' ' LEU . . . -156.28 138.1 14.32 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 122.921 0.488 . . . . 74.42 109.8 -174.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -126.77 128.63 46.91 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 110.166 -0.309 . . . . 75.22 110.166 -170.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.468 ' HB2' HD13 ' A' ' 97' ' ' ILE . 3.5 pp -103.13 133.36 20.38 Favored Pre-proline 0 C--N 1.349 0.583 0 C-N-CA 123.342 0.657 . . . . 72.31 109.816 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . 0.553 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 71.9 Cg_endo -78.13 115.93 3.84 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 122.418 2.079 . . . . 75.04 109.172 166.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.476 HD23 HD11 ' A' ' 149' ' ' ILE . 39.3 tp -102.72 147.38 26.91 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.554 -0.536 . . . . 73.14 109.554 -169.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.7 t -86.59 145.22 26.83 Favored 'General case' 0 C--O 1.245 0.839 0 N-CA-C 107.833 -1.173 . . . . 62.44 107.833 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.39 -20.75 65.59 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 112.766 0.654 . . . . 73.3 112.766 -170.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -67.61 -48.15 67.61 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.424 -0.584 . . . . 75.1 109.424 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -64.32 -38.41 90.93 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.081 -0.963 . . . . 71.32 111.149 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.413 ' HB2' HD22 ' A' ' 180' ' ' LEU . . . -59.97 -48.02 83.43 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.849 0.718 . . . . 73.44 111.569 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -67.86 -60.0 2.85 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.931 -1.031 . . . . 71.32 111.078 -178.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -67.14 -36.9 82.85 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.218 0.607 . . . . 74.54 111.437 -173.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.0 79.11 0.34 Allowed Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.568 -0.742 . . . . 74.34 111.572 -173.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.44 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -118.05 -172.16 15.62 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 112.731 -0.148 . . . . 73.45 112.731 -177.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -91.82 120.08 32.2 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.564 -1.273 . . . . 74.1 107.564 171.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.416 ' NH2' ' HB3' ' A' ' 94' ' ' MET . 8.5 tpp180 -113.1 122.11 46.59 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.377 -0.601 . . . . 75.44 109.377 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.498 HG11 ' HG3' ' A' ' 144' ' ' ARG . 99.5 t -72.55 132.1 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.179 0.992 . . . . 73.11 109.985 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.46 ' HB ' HG12 ' A' ' 145' ' ' VAL . 28.8 t -127.64 128.2 69.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 107.018 -1.475 . . . . 73.12 107.018 175.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.65 99.61 9.2 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.662 0.744 . . . . 72.54 111.069 -175.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.652 ' HB ' HD12 ' A' ' 101' ' ' LEU . 14.4 m -132.79 134.56 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 112.415 0.524 . . . . 73.0 112.415 -173.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 59.84 25.44 14.53 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.929 1.291 . . . . 73.4 112.298 173.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 80.32 22.39 62.88 Favored Glycine 0 C--N 1.355 1.626 0 CA-C-N 115.813 -0.631 . . . . 64.13 112.964 -178.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 24.5 tpp180 -133.8 126.54 30.79 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.309 1.044 . . . . 74.43 109.692 -175.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.498 ' HG3' HG11 ' A' ' 137' ' ' VAL . 13.6 ttm180 -73.21 120.46 18.86 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 109.234 -0.654 . . . . 75.23 109.234 167.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.46 HG12 ' HB ' ' A' ' 138' ' ' VAL . 3.5 p -118.7 112.14 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.244 -1.021 . . . . 64.53 108.244 169.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.2 t -94.42 109.65 21.5 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.167 -1.049 . . . . 62.23 108.167 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.5 p -97.56 118.44 44.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 CA-C-O 121.572 0.701 . . . . 74.25 109.946 -177.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -82.83 114.76 21.37 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.585 -0.894 . . . . 71.0 108.585 173.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.476 HD11 HD23 ' A' ' 125' ' ' LEU . 6.6 pt -99.47 149.9 36.28 Favored Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 124.506 1.123 . . . . 63.33 109.542 179.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.99 149.84 77.52 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.246 1.964 . . . . 75.34 112.029 176.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -66.23 113.71 2.75 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 122.406 2.071 . . . . 62.51 110.845 175.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 89.44 31.34 11.72 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-N 115.836 -0.62 . . . . 72.42 113.023 -175.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.26 138.09 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.333 0.653 . . . . 75.13 109.767 173.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -127.05 162.36 26.22 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.38 0.672 . . . . 75.42 111.063 -174.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -46.78 131.84 11.56 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 126.343 1.857 . . . . 75.2 113.344 -172.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.93 -2.55 84.24 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-O 119.554 -0.581 . . . . 72.13 114.434 177.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.1 t -66.87 122.51 17.86 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 117.474 0.637 . . . . 74.21 109.443 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.7 p -101.94 135.94 36.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 123.491 0.717 . . . . 75.3 109.991 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.567 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 45.4 mt -120.55 103.67 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.362 1.065 . . . . 73.45 108.734 -176.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -80.25 110.88 16.1 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.352 0.661 . . . . 74.25 109.702 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.5 p -115.21 110.15 45.84 Favored Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 122.904 0.482 . . . . 73.11 110.101 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.84 145.08 49.97 Favored 'Trans proline' 0 C--N 1.383 2.347 0 C-N-CA 122.885 2.39 . . . . 70.04 113.392 -175.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.08 15.51 78.67 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-N 115.557 -0.747 . . . . 71.23 113.565 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 87.3 mmm -113.18 -18.19 12.18 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.462 0.705 . . . . 71.3 111.026 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -96.84 -89.58 1.84 Allowed Glycine 0 C--N 1.349 1.295 0 N-CA-C 112.155 -0.378 . . . . 74.14 112.155 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -76.03 98.48 1.21 Allowed Glycine 0 C--N 1.345 1.033 0 C-N-CA 122.848 0.261 . . . . 75.3 112.527 176.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.556 HE21 ' HA ' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -88.56 113.53 24.24 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.444 0.698 . . . . 75.5 110.065 177.759 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 166.83 -154.53 25.03 Favored Glycine 0 C--O 1.241 0.551 0 N-CA-C 111.821 -0.512 . . . . 61.53 111.821 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -73.37 -50.92 5.98 Favored Pre-proline 0 CA--C 1.563 1.454 0 CA-C-O 117.97 -1.014 . . . . 73.05 110.992 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.14 111.6 3.31 Favored 'Trans proline' 0 C--N 1.393 2.878 0 CA-C-N 121.572 1.597 . . . . 73.11 110.315 168.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -67.11 125.36 13.46 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.526 2.151 . . . . 74.34 111.901 -173.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -120.25 146.34 17.76 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 111.908 -0.477 . . . . 73.42 111.908 -176.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -105.29 170.77 7.69 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.057 0.943 . . . . 75.54 112.024 -172.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 45.4 tp -121.99 113.8 20.09 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.792 1.237 . . . . 64.45 108.758 -177.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 69.4 mt -85.25 99.99 11.48 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.7 0.8 . . . . 71.35 110.032 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . 0.567 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 87.9 mt -88.93 100.43 13.18 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.244 0.618 . . . . 74.34 111.274 -175.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 71.4 t -89.2 124.83 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 109.198 -0.668 . . . . 74.42 109.198 177.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.4 p -80.53 137.82 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 122.727 0.411 . . . . 74.13 110.524 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.553 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 33.7 mmt180 -122.09 91.6 3.54 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.201 1.0 . . . . 72.33 109.255 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.413 HD22 ' HB2' ' A' ' 130' ' ' ALA . 43.2 mt -93.74 140.33 29.78 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.334 0.654 . . . . 72.42 111.355 -178.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 70.7 mt . . . . . 0 CA--C 1.548 0.893 0 CA-C-N 114.869 -1.059 . . . . 75.11 109.182 177.694 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.5 ' HB3' ' NH2' ' A' ' 136' ' ' ARG . 49.9 mtm . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 109.064 -0.717 . . . . 74.24 109.064 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.1 m -62.79 137.25 58.22 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.676 0.39 . . . . 70.03 111.093 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.3 m -70.93 148.62 47.53 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.705 0.802 . . . . 73.11 110.27 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.615 HD11 ' HB2' ' A' ' 123' ' ' LEU . 13.2 pt -117.28 163.02 14.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 123.104 0.562 . . . . 74.35 110.327 -177.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -139.12 124.12 18.85 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.714 0.806 . . . . 73.34 108.938 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.658 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.2 tp -72.17 160.44 32.43 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.46 1.104 . . . . 75.34 109.81 -173.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -84.11 -43.92 14.56 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.489 0.316 . . . . 71.12 110.977 178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 43.6 mt 49.35 71.97 0.34 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.063 0.945 . . . . 72.44 111.018 -168.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.612 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 86.2 mt -76.38 133.09 71.7 Favored Pre-proline 0 C--O 1.239 0.536 0 CA-C-N 115.34 -0.846 . . . . 73.41 109.718 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.94 154.82 30.73 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 121.992 1.795 . . . . 73.22 110.15 164.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 104' ' ' LEU . 4.4 mm? -62.46 118.63 7.8 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.643 0.735 . . . . 74.15 112.271 -171.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 143.93 -141.34 10.19 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 114.316 -1.311 . . . . 73.42 109.909 -174.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 61.1 m 59.03 19.85 7.67 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 124.174 0.99 . . . . 75.22 112.578 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.63 36.45 29.5 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 112.382 -0.287 . . . . 61.22 112.382 -173.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.46 ' HA3' ' HD2' ' A' ' 120' ' ' ARG . . . -147.59 114.82 0.72 Allowed Glycine 0 C--N 1.348 1.22 0 N-CA-C 110.718 -0.953 . . . . 64.4 110.718 -178.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.7 t -158.28 111.95 2.46 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.646 0.778 . . . . 74.05 109.816 -175.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.1 -64.29 2.96 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 110.103 -1.199 . . . . 71.13 110.103 167.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 77.36 -68.6 2.65 Favored Glycine 0 C--N 1.347 1.181 0 C-N-CA 123.522 0.582 . . . . 64.44 112.631 176.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 59.5 p -53.37 120.18 5.73 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.618 1.167 . . . . 70.1 111.476 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 150.86 -42.78 0.73 Allowed Glycine 0 C--N 1.336 0.564 0 N-CA-C 110.944 -0.862 . . . . 64.13 110.944 -177.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 70.8 -84.25 0.38 Allowed Glycine 0 C--N 1.353 1.49 0 N-CA-C 111.305 -0.718 . . . . 73.52 111.305 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 32.3 m -78.67 86.66 4.63 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 108.734 -0.839 . . . . 74.11 108.734 169.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 151.85 73.03 0.01 OUTLIER Glycine 0 C--N 1.339 0.698 0 N-CA-C 109.985 -1.246 . . . . 60.43 109.985 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -65.14 116.65 6.74 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.401 0.681 . . . . 75.1 110.062 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -82.9 149.37 27.12 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.556 0.742 . . . . 73.41 109.653 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.5 tt -141.63 138.28 32.43 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 106.249 -1.76 . . . . 71.4 106.249 176.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.612 ' HG3' ' HB2' ' A' ' 102' ' ' LEU . 13.2 ptm180 -103.75 149.58 24.87 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.228 0.537 . . . . 75.33 110.504 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.658 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -159.63 135.89 8.92 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.765 -0.652 . . . . 72.41 109.76 -172.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -108.5 120.93 43.85 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 107.583 -1.265 . . . . 65.23 107.583 -171.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.706 HD21 ' HB3' ' A' ' 176' ' ' LEU . 3.6 pp -101.08 110.47 61.3 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 108.085 -1.08 . . . . 74.12 108.085 176.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.439 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 74.0 Cg_endo -73.61 112.29 3.5 Favored 'Trans proline' 0 C--N 1.367 1.536 0 C-N-CA 121.785 1.657 . . . . 75.53 108.994 169.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.494 HD22 HD13 ' A' ' 149' ' ' ILE . 32.1 tp -103.54 153.06 20.98 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.32 -0.622 . . . . 65.23 109.32 -169.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.7 t -92.51 146.07 23.96 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 108.024 -1.102 . . . . 71.51 108.024 178.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.494 HD21 HD21 ' A' ' 180' ' ' LEU . 87.6 mt -66.18 -24.5 66.64 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.919 0.711 . . . . 75.34 112.919 -173.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.08 -45.43 94.75 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.456 -0.572 . . . . 75.51 109.456 174.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.408 ' HB3' HD11 ' A' ' 149' ' ' ILE . 18.3 mm-40 -76.15 -31.6 58.65 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.128 -0.942 . . . . 75.11 111.83 -178.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.58 -36.36 78.34 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.936 0.494 . . . . 62.34 110.241 173.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -74.2 -57.99 3.59 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.755 -1.112 . . . . 73.41 110.945 176.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -60.95 -50.14 74.62 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.122 0.569 . . . . 73.33 111.184 -172.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.515 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 64.34 61.59 5.87 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 114.759 -1.11 . . . . 63.32 112.626 -173.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.433 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -123.92 -157.63 9.86 Favored Glycine 0 N--CA 1.467 0.749 0 N-CA-C 111.179 -0.768 . . . . 74.34 111.179 177.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -78.18 126.11 30.33 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.12 -0.696 . . . . 74.24 109.12 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.5 ' NH2' ' HB3' ' A' ' 94' ' ' MET . 8.6 tpp180 -120.05 123.06 42.51 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.727 -0.842 . . . . 73.24 108.727 175.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 72.7 t -71.58 113.7 8.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-N 114.306 -1.315 . . . . 72.35 109.677 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.527 HG21 HD12 ' A' ' 97' ' ' ILE . 35.9 t -100.88 112.17 32.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 108.394 -0.965 . . . . 73.43 108.394 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -99.8 113.72 26.42 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.102 -1.073 . . . . 70.3 108.102 174.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.0 p -152.66 132.14 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 122.92 0.488 . . . . 74.22 110.986 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 60.88 20.92 11.15 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.213 1.005 . . . . 75.32 112.792 173.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.62 -6.19 80.08 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-O 119.847 -0.418 . . . . 63.42 113.291 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.419 ' NH1' ' SD ' ' A' ' 164' ' ' MET . 35.1 ttm180 -101.71 122.77 44.54 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.908 0.883 . . . . 74.14 109.947 -178.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -97.42 108.31 21.01 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.253 1.021 . . . . 72.33 108.641 174.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 3.2 p -123.26 113.66 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.392 0.677 . . . . 71.41 109.551 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.2 t -91.27 113.92 26.32 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.789 -0.819 . . . . 64.12 108.789 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 23.3 m -108.34 133.68 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.364 0.666 . . . . 72.13 110.584 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -81.99 96.05 7.6 Favored 'General case' 0 C--N 1.349 0.548 0 N-CA-C 108.886 -0.783 . . . . 71.24 108.886 176.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.515 HG13 ' HA2' ' A' ' 133' ' ' GLY . 12.3 pt -73.4 147.24 87.32 Favored Pre-proline 0 CA--C 1.559 1.301 0 CA-C-N 114.636 -1.165 . . . . 75.53 109.609 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.6 142.01 75.62 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.915 2.41 . . . . 72.05 113.508 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.408 ' HA ' ' HA3' ' A' ' 133' ' ' GLY . 18.4 Cg_endo -61.29 117.21 3.99 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.332 2.021 . . . . 73.44 110.996 170.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 93.0 17.82 42.3 Favored Glycine 0 C--N 1.34 0.786 0 O-C-N 123.645 0.59 . . . . 75.35 112.901 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.7 p -62.93 123.79 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 C-N-CA 123.424 0.69 . . . . 72.3 110.255 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -127.44 164.31 22.16 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.278 0.631 . . . . 72.34 110.982 -172.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -40.84 127.05 2.56 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.28 1.832 . . . . 64.41 113.767 -171.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.32 -11.77 66.95 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-O 119.486 -0.619 . . . . 72.34 114.246 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.419 ' HB2' HG13 ' A' ' 178' ' ' VAL . 19.4 m -60.64 121.1 11.37 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 117.553 0.676 . . . . 62.44 110.281 173.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.407 HG22 HG21 ' A' ' 177' ' ' VAL . 61.4 t -105.52 110.97 32.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.334 0.653 . . . . 74.32 109.524 -178.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.419 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 67.0 mt -90.33 103.73 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 107.985 -1.117 . . . . 74.02 107.985 177.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -83.01 101.33 11.03 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.752 -0.658 . . . . 75.54 109.451 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.418 HG11 ' HB3' ' A' ' 174' ' ' LEU . 3.8 p -101.93 109.05 58.78 Favored Pre-proline 0 CA--C 1.558 1.251 0 C-N-CA 123.24 0.616 . . . . 75.31 110.205 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 16.5 Cg_exo -69.13 145.56 61.2 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.859 2.373 . . . . 65.24 112.799 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 87.42 0.27 84.74 Favored Glycine 0 C--N 1.344 1.02 0 CA-C-N 115.643 -0.708 . . . . 73.33 113.722 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.419 ' SD ' ' NH1' ' A' ' 143' ' ' ARG . 24.5 mmt -107.7 -12.09 15.3 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.454 0.701 . . . . 75.12 111.485 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -98.87 -87.17 1.9 Allowed Glycine 0 C--N 1.351 1.37 0 N-CA-C 112.102 -0.399 . . . . 63.11 112.102 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.26 97.02 0.22 Allowed Glycine 0 C--N 1.349 1.29 0 C-N-CA 123.249 0.452 . . . . 71.2 112.872 176.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -90.44 170.94 9.8 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.705 1.202 . . . . 72.14 110.575 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 110.96 -66.13 0.24 Allowed Glycine 0 N--CA 1.47 0.947 0 C-N-CA 123.364 0.507 . . . . 73.23 112.189 173.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -154.79 -53.96 0.02 OUTLIER Pre-proline 0 CA--C 1.558 1.287 0 CA-C-O 117.739 -1.124 . . . . 73.22 111.155 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -81.32 109.35 2.1 Favored 'Trans proline' 0 C--N 1.398 3.182 0 C-N-CA 121.929 1.752 . . . . 71.55 110.247 177.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.63 124.12 12.35 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 121.777 1.652 . . . . 63.12 110.251 -176.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -123.51 164.21 16.72 Favored Glycine 0 C--O 1.238 0.383 0 CA-C-N 115.859 -0.609 . . . . 62.3 111.684 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 6.7 p-10 -91.13 162.07 14.82 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.725 0.81 . . . . 73.52 111.055 -170.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.418 ' HB3' HG11 ' A' ' 161' ' ' VAL . 34.7 tp -126.29 116.14 20.79 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 114.727 -1.124 . . . . 72.22 108.819 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 88.6 mt -85.2 100.84 12.03 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.206 1.003 . . . . 72.43 110.026 -175.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.706 ' HB3' HD21 ' A' ' 123' ' ' LEU . 46.8 mt -90.05 99.23 12.28 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.82 0.448 . . . . 74.44 110.167 -177.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.407 HG21 HG22 ' A' ' 158' ' ' VAL . 41.5 t -86.4 113.29 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 109.333 -0.617 . . . . 74.14 109.333 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.419 HG13 ' HB2' ' A' ' 157' ' ' SER . 8.6 p -68.68 133.3 32.02 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.981 0 O-C-N 123.462 0.476 . . . . 74.44 109.945 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.439 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 30.4 mmm180 -127.47 94.19 3.92 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.109 0.964 . . . . 75.2 109.042 -174.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.494 HD21 HD21 ' A' ' 127' ' ' LEU . 97.1 mt -98.57 147.98 24.25 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.185 -0.916 . . . . 65.44 110.505 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 79.2 mt -71.05 135.53 85.05 Favored Pre-proline 0 CA--C 1.553 1.084 0 N-CA-C 109.471 -0.566 . . . . 73.13 109.471 175.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.63 -30.84 76.84 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 123.086 2.524 . . . . 72.34 113.6 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 . . . . . 0 CA--C 1.551 0.987 0 N-CA-C 109.128 -0.693 . . . . 74.14 109.128 171.528 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.46 ' N ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 121.659 0.743 . . . . 74.33 109.967 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.3 m -63.38 125.14 23.2 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.132 -0.94 . . . . 71.33 110.649 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.537 ' HA ' HH11 ' A' ' 136' ' ' ARG . 92.4 m -68.21 131.97 46.32 Favored 'General case' 0 C--O 1.24 0.593 0 O-C-N 123.424 0.453 . . . . 64.54 110.164 176.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.605 HD12 ' HB2' ' A' ' 123' ' ' LEU . 23.1 pt -104.45 167.6 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 115.448 -0.796 . . . . 74.14 110.759 -171.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -112.45 -171.44 1.86 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.517 0.727 . . . . 74.41 109.707 172.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.569 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.1 tp -133.7 158.0 44.39 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 108.268 -1.012 . . . . 75.43 108.268 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.8 -47.53 25.37 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 110.129 -0.323 . . . . 74.3 110.129 176.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 54.5 mt 50.8 86.58 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.238 0 O-C-N 124.453 1.095 . . . . 73.11 111.034 -171.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.0 mt -99.31 157.77 33.43 Favored Pre-proline 0 CA--C 1.549 0.918 0 CA-C-N 115.15 -0.932 . . . . 73.41 109.491 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -67.92 -170.35 0.28 Allowed 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 122.88 2.387 . . . . 75.45 113.859 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.555 HD12 ' HG3' ' A' ' 117' ' ' ARG . 4.6 mm? -55.86 130.58 44.13 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.076 0.95 . . . . 74.43 111.019 175.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 131.06 75.22 0.13 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 111.146 -0.781 . . . . 73.24 111.146 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 51.5 p -82.58 1.34 38.59 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.86 0.864 . . . . 73.21 112.481 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.8 22.39 21.01 Favored Glycine 0 N--CA 1.474 1.211 0 N-CA-C 112.066 -0.414 . . . . 72.22 112.066 -175.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 174.72 -30.89 0.09 OUTLIER Glycine 0 C--N 1.338 0.669 0 N-CA-C 111.326 -0.71 . . . . 71.3 111.326 -177.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.2 t 68.17 -172.79 0.19 Allowed 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 124.238 1.015 . . . . 74.43 111.54 174.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -66.3 81.9 0.1 Allowed Glycine 0 C--N 1.349 1.289 0 N-CA-C 112.399 -0.28 . . . . 75.11 112.399 173.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.99 -10.2 58.44 Favored Glycine 0 C--N 1.354 1.566 0 N-CA-C 114.857 0.703 . . . . 45.32 114.857 -172.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.2 t -77.14 -5.63 49.8 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 123.565 0.746 . . . . 74.4 111.235 175.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.06 35.55 38.3 Favored Glycine 0 C--N 1.354 1.54 0 N-CA-C 112.135 -0.386 . . . . 74.34 112.135 -176.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 123.62 -176.61 16.75 Favored Glycine 0 C--N 1.347 1.141 0 C-N-CA 122.987 0.327 . . . . 75.13 112.375 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 24.8 t 63.61 70.09 0.53 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.985 1.314 . . . . 62.45 110.794 -177.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 127.07 111.92 1.73 Allowed Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.244 -0.889 . . . . 53.42 112.115 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.555 ' HG3' HD12 ' A' ' 104' ' ' LEU . 51.2 ttp180 -84.58 125.67 32.65 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.066 0.46 . . . . 75.44 109.902 173.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -82.56 144.79 30.12 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.407 0.683 . . . . 75.32 109.808 176.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.9 tt -143.8 118.26 9.7 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 107.905 -1.146 . . . . 72.41 107.905 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -91.14 127.77 36.7 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 107.835 -1.172 . . . . 74.35 107.835 176.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.569 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -146.07 130.66 17.87 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.269 -0.641 . . . . 75.14 109.269 -176.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -117.51 120.57 38.48 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 110.037 -0.357 . . . . 75.43 110.037 -169.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.605 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.4 pp -100.82 122.89 47.49 Favored Pre-proline 0 C--N 1.349 0.564 0 N-CA-C 109.961 -0.385 . . . . 62.42 109.961 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -76.78 113.58 3.67 Favored 'Trans proline' 0 C--N 1.365 1.433 0 C-N-CA 122.309 2.006 . . . . 73.13 108.27 167.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.491 HD21 HD11 ' A' ' 149' ' ' ILE . 51.2 tp -101.73 147.09 26.88 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.6 -0.518 . . . . 75.14 109.6 -168.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.5 t -89.57 148.92 23.09 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 108.587 -0.894 . . . . 75.32 108.587 -176.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.46 -31.2 71.88 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.776 0.83 . . . . 72.23 112.629 -169.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.45 -47.59 85.45 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.855 0.722 . . . . 72.14 109.35 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -76.31 -28.84 57.1 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 114.619 -1.173 . . . . 63.21 112.055 -174.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.0 -43.12 99.5 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.331 0.586 . . . . 75.3 110.266 172.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -65.21 -54.16 33.69 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 114.421 -1.263 . . . . 74.42 110.976 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -63.58 -48.86 75.65 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.076 0.55 . . . . 74.51 111.486 -175.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.638 ' HA3' ' HA ' ' A' ' 151' ' ' PRO . . . 61.04 72.53 0.62 Allowed Glycine 0 C--N 1.341 0.832 0 CA-C-N 114.788 -1.096 . . . . 74.34 112.147 -171.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.455 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -144.37 -157.63 7.28 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 111.696 -0.561 . . . . 72.43 111.696 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -72.35 112.56 8.53 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.412 -0.588 . . . . 73.24 109.412 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.537 HH11 ' HA ' ' A' ' 96' ' ' THR . 5.9 tpp180 -113.0 122.71 48.45 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.253 -1.017 . . . . 73.21 108.253 173.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 96.8 t -77.69 125.97 37.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 CA-C-N 114.472 -1.24 . . . . 71.13 109.918 -178.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 45.1 t -103.45 121.55 54.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.423 1.089 . . . . 75.23 108.35 176.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -112.93 106.47 14.76 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.136 -1.061 . . . . 74.34 108.136 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.3 p -151.14 122.4 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 123.175 0.59 . . . . 73.41 110.639 -175.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 64.24 19.96 11.99 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.131 0.972 . . . . 73.43 112.359 174.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.53 -9.68 76.85 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 116.368 -0.378 . . . . 55.13 112.787 -174.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 18.6 ttm180 -89.47 120.9 31.19 Favored 'General case' 0 C--N 1.347 0.493 0 N-CA-C 108.507 -0.923 . . . . 75.33 108.507 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 138' ' ' VAL . 40.7 ttm180 -112.53 114.95 27.86 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.217 -0.901 . . . . 73.01 108.708 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 6.4 p -129.9 117.55 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.424 0.63 . . . . 71.31 110.529 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 43.0 t -81.48 110.1 16.57 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.563 -0.902 . . . . 73.31 108.563 174.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.6 p -107.73 123.47 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.181 0.592 . . . . 72.2 109.741 177.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 51.1 ttt85 -76.96 94.81 4.01 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 108.734 -0.839 . . . . 74.44 108.734 172.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.491 HD11 HD21 ' A' ' 125' ' ' LEU . 8.0 pt -69.9 142.83 91.2 Favored Pre-proline 0 CA--C 1.561 1.372 0 CA-C-N 114.533 -1.212 . . . . 75.2 109.146 175.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -63.01 148.72 93.17 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.396 2.064 . . . . 71.12 112.702 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.638 ' HA ' ' HA3' ' A' ' 133' ' ' GLY . 34.9 Cg_exo -62.36 124.84 15.02 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.689 2.259 . . . . 74.02 111.441 177.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 74.44 30.66 60.01 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 112.23 -0.348 . . . . 74.21 112.23 -177.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.0 p -62.27 116.95 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 123.576 0.751 . . . . 75.52 109.78 175.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.503 ' HA ' HD11 ' A' ' 180' ' ' LEU . 96.1 mtt180 -113.57 166.33 11.62 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.423 0.689 . . . . 65.11 110.886 -177.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -40.21 128.47 2.29 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 126.628 1.971 . . . . 75.34 113.692 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.69 -10.24 72.76 Favored Glycine 0 C--N 1.352 1.433 0 CA-C-O 119.442 -0.643 . . . . 64.34 114.124 175.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 25.3 t -64.77 120.57 12.72 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 117.521 0.66 . . . . 72.32 109.885 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.425 HG22 HG22 ' A' ' 177' ' ' VAL . 53.4 t -99.26 125.02 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.588 0.755 . . . . 70.22 109.224 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.556 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 54.8 mt -101.63 105.22 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 108.553 -0.906 . . . . 75.04 108.553 176.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -80.85 101.86 9.67 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.879 0.472 . . . . 72.41 109.782 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.515 HG12 ' HB3' ' A' ' 174' ' ' LEU . 5.4 p -110.63 98.12 35.73 Favored Pre-proline 0 CA--C 1.561 1.389 0 N-CA-C 109.802 -0.444 . . . . 74.22 109.802 173.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.526 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 44.4 Cg_endo -65.69 156.53 63.44 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.521 2.814 . . . . 75.22 113.291 -178.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 68.89 11.66 63.54 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.122 -0.944 . . . . 64.02 114.458 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 97.4 mmm -113.82 -26.94 7.96 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.857 0.863 . . . . 61.14 109.422 174.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -76.67 -84.87 0.44 Allowed Glycine 0 C--N 1.35 1.328 0 N-CA-C 110.705 -0.958 . . . . 63.43 110.705 172.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.412 ' HA2' ' HB3' ' A' ' 117' ' ' ARG . . . -66.22 101.29 0.6 Allowed Glycine 0 C--N 1.342 0.906 0 O-C-N 123.958 0.446 . . . . 73.51 113.791 171.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.607 ' HA ' HE21 ' A' ' 167' ' ' GLN . 0.0 OUTLIER -90.83 169.97 10.49 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.05 0.94 . . . . 75.4 110.559 174.596 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 83.0 -143.63 22.26 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-O 119.648 -0.529 . . . . 74.15 112.405 -176.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -63.07 -57.18 22.31 Favored Pre-proline 0 CA--C 1.56 1.358 0 CA-C-O 118.404 -0.807 . . . . 64.22 112.084 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -80.29 111.83 2.69 Favored 'Trans proline' 0 C--N 1.393 2.918 0 CA-C-N 121.179 1.457 . . . . 74.41 112.22 -176.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -76.07 123.9 7.59 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 122.024 1.816 . . . . 65.32 110.704 -178.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 117' ' ' ARG . . . -137.04 162.92 25.33 Favored Glycine 0 C--N 1.34 0.751 0 C-N-CA 121.406 -0.426 . . . . 61.35 113.42 -172.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.526 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 8.8 m-20 -91.23 132.23 36.25 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 123.892 0.877 . . . . 74.13 111.87 -164.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.515 ' HB3' HG12 ' A' ' 161' ' ' VAL . 33.7 tp -96.13 102.95 14.81 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.021 -1.474 . . . . 74.02 107.021 171.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 88.4 mt -87.9 100.25 12.74 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.182 0.593 . . . . 70.34 109.441 -175.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.556 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 74.3 mt -87.25 99.45 11.97 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 123.262 0.625 . . . . 73.41 110.253 -175.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.425 HG22 HG22 ' A' ' 158' ' ' VAL . 33.2 t -87.97 116.09 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 108.949 -0.76 . . . . 74.21 108.949 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 13.0 p -73.64 140.39 17.83 Favored 'Isoleucine or valine' 0 C--O 1.246 0.878 0 C-N-CA 123.003 0.521 . . . . 72.11 110.888 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -124.75 113.58 18.15 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 107.946 -1.131 . . . . 75.11 107.946 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.503 HD11 ' HA ' ' A' ' 154' ' ' ARG . 47.8 mt -111.35 134.34 53.01 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.947 0.499 . . . . 64.44 110.772 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 96.0 mt -58.53 142.18 82.95 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 123.818 0.847 . . . . 70.34 110.362 174.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -69.21 -10.09 28.06 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 122.946 2.431 . . . . 73.24 112.907 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 42.9 m80 . . . . . 0 C--O 1.252 1.193 0 N-CA-C 107.163 -1.421 . . . . 75.02 107.163 174.06 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 73.3 mtp . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 109.333 -0.617 . . . . 74.23 109.333 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 43.5 m -71.0 125.1 25.94 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.953 -0.567 . . . . 65.32 110.575 -177.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 56.8 m -67.92 147.37 52.56 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.921 0.888 . . . . 51.42 111.153 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.616 HD12 ' HB2' ' A' ' 123' ' ' LEU . 26.8 pt -116.93 168.18 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 123.496 0.718 . . . . 75.41 110.577 -172.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -141.65 127.69 19.54 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.756 0.822 . . . . 72.41 109.41 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.707 ' HG ' ' HB2' ' A' ' 121' ' ' ALA . 12.1 tp -73.96 140.15 45.35 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.628 1.571 . . . . 73.2 110.417 -169.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.58 -33.82 76.81 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.557 0.743 . . . . 75.45 111.713 -176.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.8 mt 48.7 62.78 2.39 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.417 1.087 . . . . 75.21 111.697 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.0 mt -69.89 147.14 95.94 Favored Pre-proline 0 CA--C 1.554 1.134 0 N-CA-C 108.719 -0.845 . . . . 72.21 108.719 176.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.76 172.17 9.89 Favored 'Trans proline' 0 C--N 1.367 1.505 0 C-N-CA 122.071 1.847 . . . . 73.03 112.45 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.1 pp -75.68 155.81 35.37 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 116.598 -0.274 . . . . 75.5 111.109 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 144.66 -75.9 0.29 Allowed Glycine 0 C--N 1.339 0.747 0 N-CA-C 110.884 -0.886 . . . . 61.34 110.884 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 53.4 p -101.99 89.23 3.57 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.567 0.747 . . . . 74.52 109.517 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.436 ' HA2' ' HD3' ' A' ' 120' ' ' ARG . . . -106.94 -82.41 1.5 Allowed Glycine 0 C--N 1.339 0.699 0 CA-C-N 115.908 -0.587 . . . . 72.32 111.909 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.28 162.16 32.39 Favored Glycine 0 CA--C 1.534 1.245 0 O-C-N 123.843 0.378 . . . . 75.54 113.142 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.0 m 72.45 -68.47 0.22 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 125.113 1.365 . . . . 74.11 111.901 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -94.03 -174.79 39.4 Favored Glycine 0 C--N 1.346 1.095 0 CA-C-O 120.137 -0.257 . . . . 51.21 112.551 178.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.541 ' HA3' ' HB3' ' A' ' 118' ' ' ASP . . . 68.33 57.84 7.91 Favored Glycine 0 C--N 1.345 1.075 0 N-CA-C 111.846 -0.501 . . . . 72.42 111.846 -178.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.7 m -66.42 156.13 35.52 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.671 0.788 . . . . 74.41 111.676 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -75.83 71.75 1.87 Allowed Glycine 0 C--N 1.353 1.481 0 O-C-N 123.544 0.528 . . . . 51.3 113.486 -176.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -167.34 43.88 0.25 Allowed Glycine 0 C--N 1.342 0.891 0 N-CA-C 111.102 -0.799 . . . . 52.53 111.102 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 54.0 m 67.07 93.81 0.07 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.322 1.449 . . . . 72.23 111.841 -177.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 177.65 98.25 0.11 Allowed Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.199 -0.909 . . . . 73.54 111.032 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.675 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 18.4 ttm180 -73.69 119.28 17.7 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.862 0.865 . . . . 74.21 110.468 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.541 ' HB3' ' HA3' ' A' ' 111' ' ' GLY . 10.4 p-10 -85.28 116.74 23.8 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.43 0.634 . . . . 74.52 109.958 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.7 tt -94.34 124.19 38.21 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.399 -1.704 . . . . 74.4 106.399 175.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.436 ' HD3' ' HA2' ' A' ' 107' ' ' GLY . 23.5 tpt85 -90.98 117.73 29.8 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 107.879 -1.156 . . . . 73.33 107.879 -175.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.707 ' HB2' ' HG ' ' A' ' 99' ' ' LEU . . . -140.04 151.04 45.11 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 110.032 -0.359 . . . . 63.22 110.032 -173.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.54 ' HG2' ' HB ' ' A' ' 177' ' ' VAL . 89.1 mt-10 -129.69 120.5 25.25 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.242 -0.651 . . . . 73.22 109.242 -177.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.616 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.4 pp -97.83 113.61 63.9 Favored Pre-proline 0 C--N 1.353 0.727 0 N-CA-C 107.684 -1.228 . . . . 74.35 107.684 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.15 113.45 3.78 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 122.477 2.118 . . . . 72.05 108.549 171.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.41 HD21 HD12 ' A' ' 149' ' ' ILE . 34.0 tp -102.29 146.68 27.67 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 109.429 -0.582 . . . . 75.33 109.429 -168.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.9 t -90.47 154.06 19.92 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 108.324 -0.991 . . . . 63.31 108.324 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.82 -36.37 82.95 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.146 0.579 . . . . 74.52 111.803 -173.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -55.19 -47.74 74.82 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.233 0.613 . . . . 71.23 110.425 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.442 ' HG3' ' HE ' ' A' ' 136' ' ' ARG . 14.3 mm-40 -76.57 -31.7 57.69 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.933 -1.03 . . . . 71.04 111.829 -174.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.7 -31.94 72.94 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.779 0.431 . . . . 72.43 110.704 174.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -78.25 -49.98 12.71 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.433 -0.803 . . . . 71.44 110.895 173.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -62.72 -50.06 72.6 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.745 0.418 . . . . 75.12 111.413 -172.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.578 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 60.85 75.05 0.31 Allowed Glycine 0 C--N 1.342 0.862 0 CA-C-N 115.129 -0.942 . . . . 54.03 112.921 -177.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -162.3 -144.16 3.92 Favored Glycine 0 C--O 1.24 0.492 0 N-CA-C 110.967 -0.853 . . . . 64.43 110.967 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -72.05 113.36 9.0 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 122.787 0.435 . . . . 75.21 110.15 -175.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.442 ' HE ' ' HG3' ' A' ' 129' ' ' GLU . 6.8 tpp180 -120.21 120.83 37.29 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.24 -1.022 . . . . 74.44 108.24 170.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 146' ' ' SER . 63.8 t -77.07 131.71 34.26 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-N 115.417 -0.81 . . . . 74.34 110.416 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.4 p -125.18 119.64 56.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 124.361 1.065 . . . . 75.23 108.597 171.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -115.61 115.24 26.09 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.946 0.498 . . . . 75.14 110.259 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.5 m -149.22 144.01 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 125.017 1.327 . . . . 73.42 110.384 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.6 26.5 14.68 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.729 1.211 . . . . 71.41 111.611 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 81.37 -0.74 87.32 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 115.706 -0.679 . . . . 73.24 112.961 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -101.13 117.92 35.96 Favored 'General case' 0 C--N 1.346 0.451 0 C-N-CA 123.718 0.807 . . . . 75.41 110.036 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 37.1 ttp180 -97.78 105.79 17.99 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.351 -0.981 . . . . 74.15 108.351 174.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 5.6 p -125.96 125.97 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.298 0.639 . . . . 73.21 109.53 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 137' ' ' VAL . 38.3 t -89.95 134.5 34.19 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 109.371 -0.603 . . . . 70.25 109.371 175.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.6 p -113.79 130.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.277 0.631 . . . . 61.35 109.611 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -85.81 104.11 15.18 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.772 0.796 . . . . 75.0 109.778 173.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.578 HG13 ' HA2' ' A' ' 133' ' ' GLY . 8.2 pt -83.42 150.74 60.93 Favored Pre-proline 0 CA--C 1.558 1.269 0 CA-C-N 114.42 -1.264 . . . . 73.53 109.756 173.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -73.91 145.93 36.77 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.263 1.976 . . . . 75.11 112.191 173.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.48 120.1 7.31 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 122.391 2.06 . . . . 75.2 111.176 173.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 89.74 27.65 21.24 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 111.626 -0.59 . . . . 71.15 111.626 -170.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 4.3 p -66.6 129.95 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 109.272 -0.64 . . . . 73.44 109.272 172.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 29.3 mtm180 -127.02 157.87 38.45 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.442 0.697 . . . . 75.41 110.856 -168.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -42.17 125.49 3.07 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 126.716 2.006 . . . . 74.4 114.107 -175.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.79 2.75 69.17 Favored Glycine 0 C--N 1.351 1.392 0 N-CA-C 114.652 0.621 . . . . 63.44 114.652 176.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 33.1 t -68.29 122.42 18.32 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 117.556 0.678 . . . . 71.1 109.257 173.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.448 HG23 HG22 ' A' ' 177' ' ' VAL . 52.1 t -110.08 109.55 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.465 0.706 . . . . 72.3 109.592 -176.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.438 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 54.5 mt -90.78 111.57 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 108.551 -0.907 . . . . 71.0 108.551 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -86.41 104.29 15.77 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.732 0.813 . . . . 70.13 110.079 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.602 HG13 ' HB3' ' A' ' 174' ' ' LEU . 2.7 p -115.0 101.14 54.46 Favored Pre-proline 0 CA--C 1.564 1.494 0 C-N-CA 123.221 0.608 . . . . 74.1 110.352 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 49.1 Cg_endo -67.14 150.57 82.13 Favored 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 123.21 2.607 . . . . 72.3 113.231 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 74.0 11.05 81.44 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.785 -0.643 . . . . 74.23 114.331 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 23.1 mmt -114.92 -11.78 12.14 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.571 0.749 . . . . 63.14 110.353 173.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -97.24 -102.94 2.16 Favored Glycine 0 C--N 1.354 1.567 0 CA-C-N 116.059 -0.519 . . . . 63.43 112.246 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.675 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -70.48 90.63 0.38 Allowed Glycine 0 C--N 1.35 1.349 0 O-C-N 123.616 0.245 . . . . 74.04 113.621 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.69 HE21 ' HA ' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -81.6 158.17 24.46 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.524 0.678 . . . . 75.43 112.155 179.208 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 139.02 -145.72 17.11 Favored Glycine 0 C--N 1.342 0.885 0 CA-C-N 114.27 -1.332 . . . . 70.23 110.55 -172.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -75.94 -44.14 3.84 Favored Pre-proline 0 CA--C 1.562 1.409 0 CA-C-O 118.919 -0.563 . . . . 70.25 111.708 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -88.55 132.52 2.55 Favored 'Trans proline' 0 C--N 1.386 2.519 0 C-N-CA 121.653 1.569 . . . . 72.02 110.995 165.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.13 126.63 6.42 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 122.096 1.864 . . . . 62.15 111.484 176.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -109.25 154.01 16.65 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 116.071 -0.513 . . . . 73.15 112.74 -173.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.531 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 28.5 m-20 -77.35 144.44 38.01 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.62 0.768 . . . . 61.44 111.989 -175.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.602 ' HB3' HG13 ' A' ' 161' ' ' VAL . 45.6 tp -111.26 114.73 28.13 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.115 -1.069 . . . . 71.02 108.115 174.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 43.4 mt -87.04 112.38 21.81 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.302 1.041 . . . . 71.21 108.846 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.467 ' HB3' HD21 ' A' ' 123' ' ' LEU . 69.9 mt -101.75 99.0 9.19 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 123.576 0.547 . . . . 73.1 109.565 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.54 ' HB ' ' HG2' ' A' ' 122' ' ' GLU . 35.5 t -94.69 108.18 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 108.75 -0.833 . . . . 62.51 108.75 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 13.8 p -68.03 132.03 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 122.877 0.471 . . . . 74.41 110.904 -177.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -123.34 91.23 3.44 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.081 0.952 . . . . 73.21 109.071 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 85.8 mt -85.2 149.09 25.75 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.173 -0.921 . . . . 72.32 109.825 175.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 81.9 mt -67.4 130.15 93.49 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 109.48 -0.563 . . . . 65.54 109.48 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -67.33 -16.89 49.14 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.567 2.178 . . . . 73.13 112.895 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 10.8 t60 . . . . . 0 C--O 1.249 1.072 0 N-CA-C 108.139 -1.06 . . . . 63.31 108.139 172.022 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 20.1 ptt? . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 109.799 -0.445 . . . . 75.43 109.799 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.415 ' H ' HG21 ' A' ' 126' ' ' THR . 19.9 m -77.66 140.68 39.63 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.358 0.663 . . . . 74.41 111.619 -178.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.516 ' HA ' HH11 ' A' ' 136' ' ' ARG . 90.1 m -71.41 151.52 43.97 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.315 1.046 . . . . 74.44 110.199 170.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.66 HD11 ' HB2' ' A' ' 123' ' ' LEU . 27.1 pt -118.15 159.35 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 123.105 0.562 . . . . 74.21 110.107 -173.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -127.12 129.23 47.53 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.619 -0.882 . . . . 74.24 108.619 172.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.62 ' HG ' ' HB3' ' A' ' 121' ' ' ALA . 12.5 tp -69.51 151.23 46.28 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.256 1.022 . . . . 72.12 108.737 -177.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.88 -48.58 24.15 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 122.79 0.436 . . . . 70.34 109.846 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 93.1 mt 57.43 80.51 0.16 Allowed 'General case' 0 C--N 1.359 1.012 0 O-C-N 124.566 1.166 . . . . 73.34 109.524 -170.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.3 mt -74.28 151.92 87.92 Favored Pre-proline 0 N--CA 1.471 0.592 0 CA-C-N 115.218 -0.901 . . . . 70.51 110.671 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.23 146.01 95.94 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.471 2.114 . . . . 74.43 110.554 171.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -65.59 118.85 10.1 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.3 0.852 . . . . 72.41 113.3 -168.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -165.67 35.08 0.25 Allowed Glycine 0 C--N 1.336 0.561 0 CA-C-N 114.74 -1.118 . . . . 72.44 110.403 169.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.8 m -78.07 86.64 4.23 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.982 0.913 . . . . 74.15 110.161 -174.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.02 30.69 7.74 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 116.499 -0.319 . . . . 74.14 112.597 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.03 94.11 0.6 Allowed Glycine 0 C--N 1.353 1.517 0 N-CA-C 112.067 -0.413 . . . . 64.42 112.067 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.2 t -69.22 94.37 0.68 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.233 1.013 . . . . 55.2 111.334 -173.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 164.56 18.2 0.02 OUTLIER Glycine 0 N--CA 1.471 0.989 0 CA-C-N 115.504 -0.771 . . . . 62.23 112.353 175.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -103.44 19.03 46.55 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-O 119.286 -0.73 . . . . 72.24 114.616 -171.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 26.1 p -61.77 110.62 1.57 Allowed 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.588 0.755 . . . . 74.01 111.303 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -172.15 28.44 0.1 Allowed Glycine 0 C--N 1.344 1.021 0 CA-C-N 116.389 -0.369 . . . . 72.24 113.062 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 131.8 -165.4 23.4 Favored Glycine 0 C--N 1.343 0.941 0 N-CA-C 111.74 -0.544 . . . . 74.13 111.74 -177.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 56.6 m -122.99 132.37 54.11 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.464 0.706 . . . . 63.11 109.879 175.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 172.7 175.57 40.73 Favored Glycine 0 C--O 1.243 0.673 0 N-CA-C 110.105 -1.198 . . . . 72.23 110.105 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.531 ' HB3' ' HA2' ' A' ' 166' ' ' GLY . 59.4 ttp180 -79.26 123.48 27.48 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 117.13 0.465 . . . . 75.13 110.13 179.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -91.55 106.87 18.8 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 106.443 -1.688 . . . . 75.21 106.443 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.6 tt -104.08 123.17 46.77 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.173 -1.047 . . . . 61.24 108.173 -172.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -90.5 128.18 36.46 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.233 -1.025 . . . . 75.33 108.233 175.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.62 ' HB3' ' HG ' ' A' ' 99' ' ' LEU . . . -140.88 149.76 42.36 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 123.788 0.835 . . . . 74.15 109.314 -172.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -119.93 122.3 40.92 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.667 -0.864 . . . . 62.43 108.667 -175.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.662 HD23 ' HB3' ' A' ' 176' ' ' LEU . 3.9 pp -99.63 108.03 48.83 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 106.912 -1.514 . . . . 74.21 106.912 173.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.562 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 63.1 Cg_endo -71.59 112.18 3.3 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 121.838 1.692 . . . . 74.4 108.373 169.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.424 HD21 HD12 ' A' ' 149' ' ' ILE . 32.8 tp -100.55 142.84 31.46 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.216 -1.031 . . . . 73.31 108.216 -170.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.415 HG21 ' H ' ' A' ' 95' ' ' SER . 1.9 t -79.47 145.1 33.44 Favored 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 107.941 -1.133 . . . . 74.24 107.941 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.84 -28.73 69.69 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.389 0.676 . . . . 74.34 112.479 -170.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.84 -41.16 97.88 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.601 -0.727 . . . . 72.24 109.794 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -75.99 -31.29 58.9 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.879 0.872 . . . . 74.24 112.461 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.32 -40.35 77.73 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.415 0.626 . . . . 73.53 110.272 169.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -73.93 -48.22 32.25 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-N 114.432 -1.258 . . . . 74.44 111.876 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -76.13 -51.33 12.4 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 120.722 0.296 . . . . 74.34 111.137 -171.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.614 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 67.33 69.1 1.45 Allowed Glycine 0 C--N 1.348 1.24 0 CA-C-N 115.25 -0.887 . . . . 71.51 113.478 -178.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -131.84 -154.65 7.8 Favored Glycine 0 N--CA 1.477 1.367 0 N-CA-C 111.684 -0.566 . . . . 71.23 111.684 178.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -70.96 114.31 8.88 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.101 -0.703 . . . . 71.34 109.101 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.516 HH11 ' HA ' ' A' ' 96' ' ' THR . 8.0 tpp180 -112.07 122.19 47.07 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.326 -0.99 . . . . 64.44 108.326 175.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 78.1 t -78.82 131.46 34.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-N 113.828 -1.533 . . . . 72.54 110.406 -177.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.9 p -136.91 122.17 26.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 124.287 1.035 . . . . 73.44 108.58 173.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -121.41 114.62 21.54 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.231 0.612 . . . . 74.15 111.088 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.4 m -148.89 146.78 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.681 1.592 . . . . 74.53 109.683 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 66.38 27.41 9.97 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.725 1.21 . . . . 71.12 110.848 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.23 15.64 72.53 Favored Glycine 0 C--N 1.356 1.687 0 CA-C-N 115.787 -0.642 . . . . 72.21 113.338 -176.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -124.26 129.37 50.64 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.002 0.921 . . . . 75.13 109.547 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 32.4 ttp180 -110.17 120.35 42.17 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.083 0.553 . . . . 71.53 110.217 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.1 p -122.34 146.18 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 123.95 0.9 . . . . 74.42 109.787 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 47.5 t -100.5 113.16 25.72 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.581 -0.896 . . . . 60.03 108.581 174.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.8 p -102.5 113.72 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 109.215 -0.661 . . . . 75.0 109.215 174.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 55.1 ttt85 -75.75 104.69 6.41 Favored 'General case' 0 C--N 1.35 0.625 0 N-CA-C 108.698 -0.853 . . . . 73.41 108.698 174.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.614 HG13 ' HA2' ' A' ' 133' ' ' GLY . 12.2 pt -81.52 145.24 54.53 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 124.524 1.129 . . . . 73.11 109.67 175.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.56 148.95 73.69 Favored 'Trans proline' 0 CA--C 1.565 2.036 0 C-N-CA 122.403 2.069 . . . . 63.12 112.982 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.439 ' HA ' ' HA3' ' A' ' 133' ' ' GLY . 37.6 Cg_endo -63.59 118.95 5.86 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.87 2.38 . . . . 70.35 111.628 174.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 88.04 23.44 38.13 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-O 119.724 -0.487 . . . . 75.43 112.414 -175.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.423 HG13 ' HB ' ' A' ' 149' ' ' ILE . 3.9 p -62.89 120.34 9.2 Favored 'Isoleucine or valine' 0 C--N 1.361 1.105 0 C-N-CA 123.343 0.657 . . . . 62.01 109.689 176.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.513 ' HA ' HD11 ' A' ' 180' ' ' LEU . 66.0 mtt85 -123.73 159.55 29.19 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.564 0.746 . . . . 75.34 111.006 -173.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -38.53 127.26 1.46 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.036 2.134 . . . . 71.43 113.794 -173.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 101.94 -9.66 56.74 Favored Glycine 0 C--N 1.355 1.625 0 CA-C-O 119.017 -0.879 . . . . 74.22 114.622 174.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.3 t -69.14 120.18 14.58 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 117.799 0.799 . . . . 72.42 109.45 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 57.3 t -104.72 114.62 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.217 0.607 . . . . 73.34 109.943 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 51.7 mt -91.86 100.9 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 107.783 -1.191 . . . . 75.33 107.783 172.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.475 HH11 HD21 ' A' ' 175' ' ' LEU . 57.9 ttt85 -84.0 103.71 13.47 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.954 -0.758 . . . . 72.13 108.954 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.72 120.31 47.64 Favored Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 123.137 0.575 . . . . 73.41 110.051 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -74.79 149.71 38.15 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.751 2.3 . . . . 72.13 113.028 -173.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 75.03 -0.3 58.9 Favored Glycine 0 N--CA 1.473 1.149 0 N-CA-C 114.451 0.541 . . . . 70.21 114.451 174.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 85.8 mmm -98.02 -25.34 14.99 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.935 0.894 . . . . 74.32 110.7 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -79.98 -82.24 0.74 Allowed Glycine 0 C--N 1.348 1.234 0 N-CA-C 111.226 -0.75 . . . . 63.43 111.226 176.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.531 ' HA2' ' HB3' ' A' ' 117' ' ' ARG . . . -61.26 94.38 0.08 OUTLIER Glycine 0 C--N 1.345 1.062 0 O-C-N 124.171 0.571 . . . . 73.1 113.221 174.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -88.13 114.65 24.95 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.015 0.926 . . . . 72.1 109.347 175.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 158.48 -149.84 20.26 Favored Glycine 0 N--CA 1.466 0.666 0 N-CA-C 111.213 -0.755 . . . . 61.54 111.213 -177.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -72.57 -52.31 6.55 Favored Pre-proline 0 CA--C 1.559 1.299 0 CA-C-O 118.019 -0.991 . . . . 75.2 111.188 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -83.88 112.42 1.78 Allowed 'Trans proline' 0 C--N 1.391 2.772 0 C-N-CA 121.733 1.622 . . . . 73.23 111.293 174.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.58 125.61 12.44 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 121.895 1.73 . . . . 74.41 111.448 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -116.29 156.52 15.58 Favored Glycine 0 C--N 1.342 0.88 0 N-CA-C 111.708 -0.557 . . . . 62.31 111.708 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -79.61 159.46 26.78 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.339 0.656 . . . . 63.11 111.4 -175.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 32.4 tp -127.12 113.16 16.03 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 114.643 -1.162 . . . . 75.21 108.061 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.475 HD21 HH11 ' A' ' 160' ' ' ARG . 86.6 mt -81.86 101.64 10.34 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.472 -0.936 . . . . 74.23 108.472 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.662 ' HB3' HD23 ' A' ' 123' ' ' LEU . 54.2 mt -90.36 97.11 10.99 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.93 -0.767 . . . . 71.14 108.93 177.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.48 118.88 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 O-C-N 121.759 -0.588 . . . . 73.45 109.611 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 14.0 p -67.55 132.52 32.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.815 0 C-N-CA 123.778 0.831 . . . . 64.2 109.839 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.562 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 17.6 mmm-85 -122.12 104.95 9.84 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.745 0.818 . . . . 73.42 109.182 -176.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.513 HD11 ' HA ' ' A' ' 154' ' ' ARG . 83.0 mt -109.79 147.82 32.57 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.49 0.716 . . . . 75.13 111.227 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 89.1 mt -74.21 155.44 88.07 Favored Pre-proline 0 CA--C 1.557 1.217 0 CA-C-N 114.527 -1.215 . . . . 73.04 109.496 175.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -74.95 19.39 0.49 Allowed 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 123.19 2.593 . . . . 71.1 114.549 -175.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 . . . . . 0 CA--C 1.556 1.192 0 C-N-CA 124.392 1.077 . . . . 73.24 109.537 177.061 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 3.4 mpp? . . . . . 0 N--CA 1.482 1.129 0 N-CA-C 109.164 -0.68 . . . . 75.12 109.164 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.8 m -66.85 138.24 57.18 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.362 -0.835 . . . . 62.52 111.835 -177.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 47.3 m -74.81 150.09 39.42 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.576 -0.738 . . . . 75.23 109.073 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.58 HD11 ' HB2' ' A' ' 123' ' ' LEU . 23.5 pt -125.02 171.39 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 123.377 0.671 . . . . 74.43 110.705 -170.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -133.55 134.33 43.23 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.584 0.753 . . . . 74.4 110.27 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.563 ' HG ' ' HB3' ' A' ' 121' ' ' ALA . 12.3 tp -84.47 176.2 8.81 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.334 1.053 . . . . 74.43 109.069 -174.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -101.07 -48.15 4.52 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.41 0.284 . . . . 64.4 111.75 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.7 mt 57.36 70.45 0.65 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.113 0.965 . . . . 65.03 110.937 -168.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 20.8 mt -87.4 151.89 51.55 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-N 115.17 -0.923 . . . . 65.35 108.772 174.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -64.86 169.32 11.89 Favored 'Trans proline' 0 CA--C 1.558 1.675 0 C-N-CA 121.924 1.75 . . . . 73.01 111.943 174.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -59.43 -31.81 69.62 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.109 0.564 . . . . 72.41 111.048 175.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -97.71 71.41 0.68 Allowed Glycine 0 C--N 1.345 1.034 0 N-CA-C 110.893 -0.883 . . . . 74.2 110.893 168.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 33.1 m -57.91 -50.32 73.73 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.719 0.808 . . . . 73.04 111.772 -175.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -101.82 37.97 3.39 Favored Glycine 0 C--N 1.344 1.02 0 CA-C-N 116.199 -0.455 . . . . 73.54 112.488 177.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.35 12.54 83.53 Favored Glycine 0 C--N 1.345 1.064 0 CA-C-O 119.969 -0.351 . . . . 70.11 113.918 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.7 p -71.09 145.66 49.72 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.584 0.753 . . . . 74.51 110.985 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -82.65 80.97 1.75 Allowed Glycine 0 C--N 1.35 1.33 0 N-CA-C 111.922 -0.471 . . . . 72.03 111.922 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.67 157.55 47.86 Favored Glycine 0 C--N 1.349 1.275 0 O-C-N 123.82 0.365 . . . . 65.14 113.813 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 74.9 p -131.29 127.37 37.61 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.399 0.68 . . . . 71.32 110.757 -173.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 179.12 122.81 0.78 Allowed Glycine 0 C--N 1.345 1.043 0 CA-C-O 119.605 -0.553 . . . . 71.2 111.955 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -75.63 -88.87 0.25 Allowed Glycine 0 C--N 1.355 1.605 0 CA-C-N 116.903 0.352 . . . . 73.52 112.473 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 60.3 p -82.58 -26.93 31.9 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.19 0.596 . . . . 74.41 110.203 175.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -91.38 93.6 1.85 Allowed Glycine 0 C--N 1.343 0.958 0 N-CA-C 111.015 -0.834 . . . . 74.22 111.015 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.51 ' O ' ' HA3' ' A' ' 172' ' ' GLY . 38.5 ttm180 -90.54 120.9 32.02 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.047 0.539 . . . . 75.21 110.149 176.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -77.84 144.94 36.61 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.11 0.481 . . . . 73.35 109.972 178.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.3 tt -136.72 113.22 10.06 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 105.551 -2.018 . . . . 73.42 105.551 172.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 34.9 ttt180 -93.8 123.09 36.91 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 108.486 -0.931 . . . . 75.11 108.486 -177.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.563 ' HB3' ' HG ' ' A' ' 99' ' ' LEU . . . -140.53 131.49 26.11 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 123.534 0.734 . . . . 74.4 109.342 -172.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -117.63 128.79 55.28 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 110.05 -0.352 . . . . 74.12 110.05 -169.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.58 ' HB2' HD11 ' A' ' 97' ' ' ILE . 4.0 pp -108.16 117.77 54.1 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 123.062 0.545 . . . . 72.53 110.107 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.543 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 68.0 Cg_endo -73.33 113.75 3.86 Favored 'Trans proline' 0 C--N 1.364 1.347 0 C-N-CA 122.451 2.101 . . . . 72.2 109.088 168.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.529 HD22 HD13 ' A' ' 149' ' ' ILE . 50.6 tp -103.8 147.94 26.69 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 122.794 0.438 . . . . 73.01 110.015 -166.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.8 t -85.22 149.31 25.59 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 109.018 -0.734 . . . . 71.23 109.018 -177.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.9 mt -63.06 -30.8 71.88 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.587 0.755 . . . . 72.43 112.441 -171.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.04 -49.61 76.68 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 109.48 -0.563 . . . . 71.14 109.48 177.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -72.97 -31.69 64.71 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 114.818 -1.083 . . . . 72.43 112.164 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.53 -38.08 80.06 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.747 0.654 . . . . 72.44 110.472 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -73.52 -52.82 12.24 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.027 -0.988 . . . . 74.15 110.846 174.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -62.52 -49.69 74.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 123.531 0.52 . . . . 75.52 112.379 -169.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.568 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 67.86 52.16 30.56 Favored Glycine 0 C--N 1.34 0.751 0 O-C-N 123.853 0.721 . . . . 71.12 112.971 -172.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.43 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -113.05 -163.13 15.54 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 112.077 -0.409 . . . . 54.23 112.077 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.65 115.42 20.91 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 108.934 -0.765 . . . . 71.35 108.934 175.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -113.45 124.08 51.57 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.577 0.751 . . . . 73.34 109.323 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 86.0 t -72.06 127.97 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-N 114.198 -1.365 . . . . 70.21 109.721 175.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.435 HG21 ' HB2' ' A' ' 99' ' ' LEU . 6.1 p -134.26 111.15 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 124.151 0.981 . . . . 74.41 108.838 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -103.36 134.73 46.25 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.667 0.787 . . . . 73.31 109.988 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.9 p -152.35 132.06 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.245 1.018 . . . . 63.31 109.887 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.37 18.0 8.88 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.348 1.059 . . . . 74.15 112.506 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.67 -8.83 71.29 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 116.26 -0.427 . . . . 63.44 113.327 -175.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -92.25 118.39 30.83 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.708 0.803 . . . . 74.31 110.498 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.5 ttp180 -98.39 120.78 39.4 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.449 1.1 . . . . 75.02 109.485 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 40.5 t -123.41 125.71 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.054 0.942 . . . . 73.23 109.346 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.9 t -97.53 112.64 24.41 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.867 -0.79 . . . . 74.25 108.867 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.4 139.14 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.133 0.573 . . . . 75.41 111.013 -175.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -83.72 110.37 18.25 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.887 -0.783 . . . . 74.1 108.887 174.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.568 HG13 ' HA2' ' A' ' 133' ' ' GLY . 9.3 pt -89.55 151.46 46.01 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 124.29 1.036 . . . . 74.21 110.026 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -67.31 139.57 50.34 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.687 2.258 . . . . 72.34 112.603 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -65.5 131.85 29.26 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.561 2.174 . . . . 74.33 111.126 169.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 69.71 29.9 70.95 Favored Glycine 0 C--N 1.343 0.966 0 O-C-N 123.55 0.531 . . . . 72.54 112.391 -177.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 9.6 p -64.82 148.12 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 124.058 0.943 . . . . 70.14 110.007 178.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.414 ' HA ' HD11 ' A' ' 180' ' ' LEU . 24.4 mtp180 -134.44 161.75 34.16 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.991 0.516 . . . . 75.15 110.281 -178.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -44.59 134.71 5.23 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 125.73 1.612 . . . . 55.33 113.525 -174.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 83.9 3.85 89.01 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 115.746 -0.661 . . . . 75.44 114.322 176.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.3 t -71.87 121.11 18.45 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 108.412 -0.959 . . . . 75.12 108.412 174.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.4 t -104.74 114.71 45.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 O-C-N 123.738 0.649 . . . . 75.4 110.603 -175.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 60.8 mt -89.9 102.26 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 107.328 -1.36 . . . . 74.33 107.328 174.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -87.63 105.45 17.35 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 122.992 0.517 . . . . 73.23 109.826 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.2 p -111.17 119.64 45.11 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 123.064 0.545 . . . . 74.24 109.704 175.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.43 153.14 49.98 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 122.247 1.964 . . . . 73.41 112.044 -177.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.36 -4.12 50.51 Favored Glycine 0 C--N 1.344 0.979 0 N-CA-C 115.208 0.843 . . . . 71.05 115.208 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 95.9 mmm -102.83 -13.26 17.06 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 117.645 0.723 . . . . 75.22 110.643 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -86.31 -96.1 0.81 Allowed Glycine 0 C--N 1.355 1.584 0 N-CA-C 111.823 -0.511 . . . . 65.2 111.823 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -57.28 98.29 0.08 OUTLIER Glycine 0 C--N 1.349 1.255 0 O-C-N 123.972 0.454 . . . . 64.54 112.319 171.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -88.09 153.89 20.9 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.521 1.128 . . . . 73.21 109.581 174.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 118.93 -144.17 17.75 Favored Glycine 0 N--CA 1.468 0.794 0 N-CA-C 110.976 -0.85 . . . . 74.5 110.976 -177.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -75.32 -47.36 4.4 Favored Pre-proline 0 CA--C 1.56 1.328 0 CA-C-O 117.97 -1.015 . . . . 73.52 110.944 168.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -76.47 113.55 3.69 Favored 'Trans proline' 0 C--N 1.395 2.98 0 C-N-CA 121.609 1.539 . . . . 72.34 112.241 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -82.8 126.77 4.64 Favored 'Trans proline' 0 C--N 1.385 2.461 0 C-N-CA 122.387 2.058 . . . . 74.13 111.787 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 117' ' ' ARG . . . -130.09 -179.37 15.98 Favored Glycine 0 N--CA 1.463 0.489 0 CA-C-N 116.758 -0.201 . . . . 62.11 113.181 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -100.92 131.26 46.88 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.817 0.847 . . . . 65.11 110.924 -168.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 29.8 tp -92.51 110.35 21.77 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 108.55 -0.908 . . . . 73.03 108.55 176.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 60.2 mt -91.19 99.7 12.65 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.49 0.716 . . . . 72.54 109.367 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.541 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 96.2 mt -88.87 99.85 12.71 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.621 0.369 . . . . 75.15 111.022 -175.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 38.8 t -87.51 114.56 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 109.261 -0.644 . . . . 74.4 109.261 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.421 HG22 ' HG ' ' A' ' 180' ' ' LEU . 12.1 p -73.02 132.98 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 CA-C-O 121.188 0.518 . . . . 74.21 109.843 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.543 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 37.6 mmt180 -115.21 101.42 8.94 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.86 -1.163 . . . . 75.0 107.86 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.421 ' HG ' HG22 ' A' ' 178' ' ' VAL . 38.8 mt -108.23 141.67 39.65 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.005 0.431 . . . . 72.23 111.369 -176.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 65.3 mt -73.81 110.98 10.38 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 114.464 -1.244 . . . . 75.45 107.664 172.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -61.83 -23.97 76.71 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.951 2.434 . . . . 64.54 113.554 -171.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 47.2 m80 . . . . . 0 CA--C 1.546 0.809 0 N-CA-C 107.61 -1.256 . . . . 74.41 107.61 177.666 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.454 ' SD ' ' O ' ' A' ' 94' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.582 0 CA-C-O 121.564 0.697 . . . . 74.2 109.793 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.7 t -77.14 133.41 38.99 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.579 -0.737 . . . . 71.54 110.726 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 52.3 m -73.67 145.28 45.39 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.152 0.981 . . . . 73.0 110.308 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.535 HD12 ' HB2' ' A' ' 123' ' ' LEU . 18.2 pt -118.01 162.23 16.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 C-N-CA 123.223 0.609 . . . . 74.44 110.681 -172.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.406 ' O ' ' HD2' ' A' ' 124' ' ' PRO . . . -104.05 177.63 4.79 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.048 0.939 . . . . 73.34 108.952 170.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.572 ' HG ' ' HB3' ' A' ' 121' ' ' ALA . 11.4 tp -113.67 -133.77 0.34 Allowed 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 107.147 -1.427 . . . . 74.25 107.147 177.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.49 -43.47 0.06 Allowed 'General case' 0 C--N 1.345 0.412 0 N-CA-C 109.107 -0.701 . . . . 71.33 109.107 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 84.3 mt 53.81 64.08 1.96 Allowed 'General case' 0 C--N 1.362 1.129 0 O-C-N 124.438 1.086 . . . . 74.24 110.117 -172.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 61.0 mt -63.54 159.72 49.14 Favored Pre-proline 0 CA--C 1.55 0.968 0 CA-C-N 113.995 -1.457 . . . . 72.14 109.717 176.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -55.53 158.7 12.39 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.056 1.837 . . . . 74.24 112.19 173.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.5 pp -57.57 134.76 56.41 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.697 0.799 . . . . 72.5 110.163 -177.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -97.93 -153.01 28.68 Favored Glycine 0 C--N 1.334 0.421 0 N-CA-C 112.416 -0.274 . . . . 74.34 112.416 -174.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 53.6 p -110.36 27.53 9.54 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.058 0.943 . . . . 74.11 110.113 175.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.36 -35.15 75.67 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 115.858 -0.61 . . . . 74.43 112.682 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -82.12 62.47 4.55 Favored Glycine 0 C--N 1.351 1.381 0 C-N-CA 123.137 0.399 . . . . 75.54 112.628 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 52.8 m -109.2 28.65 8.29 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.374 1.07 . . . . 75.22 110.434 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -81.61 64.34 4.21 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 116.133 -0.485 . . . . 63.2 112.454 176.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 66.63 -87.63 0.13 Allowed Glycine 0 C--N 1.35 1.31 0 C-N-CA 123.514 0.578 . . . . 34.3 112.009 -177.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.8 p -169.41 61.02 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.699 1.2 . . . . 65.24 108.948 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -58.51 -31.83 67.58 Favored Glycine 0 C--N 1.355 1.631 0 CA-C-N 115.733 -0.667 . . . . 64.41 113.719 -176.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 155.02 -84.14 0.15 Allowed Glycine 0 C--N 1.348 1.248 0 N-CA-C 110.664 -0.974 . . . . 64.52 110.664 176.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 36.1 p -158.65 24.93 0.23 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.832 0.853 . . . . 71.22 110.293 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.76 95.96 0.09 OUTLIER Glycine 0 C--N 1.357 1.714 0 N-CA-C 111.208 -0.757 . . . . 74.41 111.208 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 -74.61 116.65 15.55 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.647 0.779 . . . . 71.32 111.478 -170.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -83.43 119.7 24.99 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 108.093 -1.077 . . . . 73.11 108.093 169.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.3 tt -103.81 121.41 42.99 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.158 -1.793 . . . . 71.21 106.158 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -89.79 133.38 34.74 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.121 -1.066 . . . . 75.05 108.121 -177.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.572 ' HB3' ' HG ' ' A' ' 99' ' ' LEU . . . -154.56 146.66 23.68 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.252 0.621 . . . . 54.24 109.579 -175.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -128.19 135.0 49.12 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.502 -0.555 . . . . 75.12 109.502 -175.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.535 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.4 pp -112.53 116.96 47.78 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 109.88 -0.415 . . . . 75.22 109.88 178.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.586 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 70.2 Cg_endo -72.87 115.32 4.3 Favored 'Trans proline' 0 C--N 1.36 1.141 0 C-N-CA 122.498 2.132 . . . . 63.53 108.592 169.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.501 HD21 HD12 ' A' ' 149' ' ' ILE . 43.3 tp -104.26 148.4 26.38 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.933 -0.395 . . . . 74.33 109.933 -167.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.3 t -88.94 156.5 18.86 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 109.134 -0.691 . . . . 72.4 109.134 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.3 mt -64.42 -32.95 74.79 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.709 0.804 . . . . 72.12 112.631 -173.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.52 -46.7 87.23 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 124.168 0.918 . . . . 72.55 109.752 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -74.68 -34.09 62.6 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.041 -0.981 . . . . 71.0 111.519 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.97 -34.23 73.02 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.169 0.509 . . . . 60.5 110.518 173.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -76.55 -54.07 7.2 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 114.913 -1.04 . . . . 74.43 110.846 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -62.88 -50.35 71.24 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 122.829 0.452 . . . . 74.24 111.285 -174.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.561 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 70.04 58.27 6.32 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 114.963 -1.017 . . . . 62.54 111.369 -169.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.406 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -121.7 -175.18 14.9 Favored Glycine 0 C--N 1.346 1.091 0 N-CA-C 112.463 -0.255 . . . . 71.31 112.463 -175.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -76.1 113.61 13.82 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.463 -0.94 . . . . 63.4 108.463 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -111.18 124.61 52.54 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.163 -1.051 . . . . 74.43 108.163 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.453 HG13 ' HG3' ' A' ' 144' ' ' ARG . 94.9 t -70.34 124.31 26.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 114.466 -1.243 . . . . 74.24 109.124 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 34.5 t -117.77 130.14 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 107.83 -1.174 . . . . 75.41 107.83 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -123.71 122.21 37.5 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 118.1 0.409 . . . . 73.21 110.409 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -149.99 128.73 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 124.855 1.262 . . . . 72.44 109.913 174.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.82 20.1 12.05 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.818 1.247 . . . . 74.05 112.203 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.12 9.14 82.77 Favored Glycine 0 C--N 1.355 1.595 0 CA-C-N 116.416 -0.357 . . . . 75.11 113.116 -175.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -101.19 120.21 39.9 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.706 1.202 . . . . 73.04 109.214 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.453 ' HG3' HG13 ' A' ' 137' ' ' VAL . 48.1 ttp180 -99.0 109.59 22.32 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.973 0.909 . . . . 74.54 109.747 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 53.8 t -107.99 112.38 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.566 -0.901 . . . . 75.53 108.566 172.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 48.2 t -91.54 104.16 16.69 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.213 -1.032 . . . . 72.34 108.213 174.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.1 p -100.94 119.17 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.521 0.729 . . . . 72.31 110.441 -175.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -73.74 101.06 3.57 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.334 -0.988 . . . . 73.41 108.334 167.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.561 HG13 ' HA2' ' A' ' 133' ' ' GLY . 10.0 pt -81.33 151.59 69.47 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 123.97 0.908 . . . . 73.52 109.675 175.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.4 ' HG2' ' HB ' ' A' ' 153' ' ' VAL . 64.5 Cg_endo -73.62 144.75 36.15 Favored 'Trans proline' 0 CA--C 1.559 1.763 0 C-N-CA 122.088 1.859 . . . . 61.41 112.556 177.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -63.18 124.5 14.0 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.18 2.587 . . . . 63.52 112.345 177.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 80.18 23.16 61.69 Favored Glycine 0 C--N 1.343 0.947 0 O-C-N 123.448 0.468 . . . . 75.43 112.906 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.4 ' HB ' ' HG2' ' A' ' 150' ' ' PRO . 7.5 p -57.57 145.99 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 124.536 1.135 . . . . 73.41 110.685 177.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -138.11 162.17 34.88 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.79 0.836 . . . . 65.31 110.547 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -43.85 129.13 5.71 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 126.366 1.866 . . . . 74.34 112.694 -174.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.17 -3.11 59.9 Favored Glycine 0 C--N 1.35 1.318 0 O-C-N 123.63 0.581 . . . . 75.22 113.81 176.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 52.2 m -69.81 119.68 14.4 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 117.724 0.762 . . . . 74.34 110.148 175.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 45.0 t -103.34 109.09 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.243 0.617 . . . . 72.23 110.026 -178.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 58.5 mt -91.25 101.92 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.438 1.095 . . . . 74.51 108.14 172.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -89.62 103.03 15.71 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.918 -0.771 . . . . 74.42 108.918 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.8 p -103.77 105.49 48.12 Favored Pre-proline 0 CA--C 1.561 1.367 0 C-N-CA 123.228 0.611 . . . . 73.4 110.316 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -66.44 146.77 81.2 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 123.093 2.528 . . . . 73.32 113.514 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 81.83 0.13 89.03 Favored Glycine 0 C--N 1.346 1.111 0 CA-C-N 115.603 -0.726 . . . . 71.35 113.666 176.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.8 mmt -101.66 -24.6 14.08 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 117.598 0.699 . . . . 74.14 111.529 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -81.84 -87.68 0.67 Allowed Glycine 0 C--N 1.347 1.171 0 CA-C-O 119.822 -0.432 . . . . 70.01 112.612 -175.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -62.65 93.49 0.1 OUTLIER Glycine 0 C--N 1.352 1.468 0 O-C-N 124.056 0.504 . . . . 61.1 112.247 174.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -88.86 158.13 18.21 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.152 0.981 . . . . 73.22 109.417 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 96.85 -142.57 16.25 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-O 119.623 -0.543 . . . . 73.34 111.879 -176.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -68.84 -53.88 14.09 Favored Pre-proline 0 CA--C 1.567 1.634 0 CA-C-O 118.032 -0.985 . . . . 73.3 112.389 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -83.92 108.51 1.41 Allowed 'Trans proline' 0 C--N 1.394 2.931 0 C-N-CA 121.709 1.606 . . . . 73.42 112.149 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.28 127.22 11.02 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.85 2.366 . . . . 63.41 110.953 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -141.19 176.27 21.78 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-N 116.443 -0.344 . . . . 74.25 112.808 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -100.33 162.21 13.1 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.279 1.032 . . . . 74.25 111.373 -172.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 37.7 tp -117.05 112.7 21.29 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 124.588 1.155 . . . . 74.43 108.033 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 66.9 mt -84.02 100.3 10.98 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.745 -0.835 . . . . 75.43 108.745 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.47 HD21 HD11 ' A' ' 99' ' ' LEU . 91.9 mt -96.89 99.7 11.24 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.075 0.55 . . . . 75.33 110.083 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.6 p -93.55 125.58 46.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 N-CA-C 109.444 -0.576 . . . . 74.12 109.444 176.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.8 137.63 23.07 Favored 'Isoleucine or valine' 0 C--O 1.249 1.043 0 C-N-CA 123.299 0.639 . . . . 73.25 109.5 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.586 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 22.3 mmm-85 -115.81 97.84 6.34 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.817 -0.809 . . . . 73.12 108.817 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 55.1 mt -119.56 131.9 55.62 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.91 0.884 . . . . 75.31 109.669 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 90.6 mt -62.01 138.81 95.83 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 115.349 -0.841 . . . . 73.44 110.713 -175.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -50.92 -35.21 48.76 Favored 'Trans proline' 0 C--N 1.385 2.456 0 C-N-CA 123.762 2.975 . . . . 74.4 113.332 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 . . . . . 0 C--O 1.253 1.275 0 N-CA-C 107.785 -1.191 . . . . 71.43 107.785 168.831 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.427 ' SD ' ' N ' ' A' ' 94' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 109.086 -0.709 . . . . 75.15 109.086 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.3 m -67.84 115.97 7.98 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.449 -0.574 . . . . 72.22 109.449 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 98.6 m -65.18 144.83 56.94 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.702 0.801 . . . . 72.14 110.737 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.559 HD13 ' HB2' ' A' ' 123' ' ' LEU . 11.2 pt -117.41 161.07 16.5 Favored 'Isoleucine or valine' 0 C--O 1.245 0.854 0 CA-C-N 115.659 -0.7 . . . . 74.3 109.23 -174.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -136.69 129.7 31.02 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.725 0.81 . . . . 72.2 109.159 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.679 ' HG ' ' HB3' ' A' ' 121' ' ' ALA . 11.2 tp -68.78 149.67 48.74 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.956 1.303 . . . . 74.15 109.935 -174.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.22 -34.58 55.98 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.519 0.328 . . . . 73.21 110.949 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 70.3 mt 52.1 69.31 0.69 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.064 0.946 . . . . 73.23 111.059 -175.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 63.2 mt -69.14 161.09 75.45 Favored Pre-proline 0 CA--C 1.558 1.277 0 CA-C-N 115.33 -0.85 . . . . 70.42 109.913 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -62.28 164.18 18.23 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.241 1.961 . . . . 74.14 112.941 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 pp -64.1 126.65 28.41 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.953 -0.758 . . . . 75.44 108.953 175.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -145.32 -115.77 0.99 Allowed Glycine 0 C--N 1.338 0.691 0 N-CA-C 111.582 -0.607 . . . . 74.43 111.582 -170.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.5 t -98.68 115.19 28.16 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 108.615 -0.883 . . . . 73.23 108.615 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -171.5 -173.31 38.34 Favored Glycine 0 C--N 1.343 0.948 0 O-C-N 123.717 0.636 . . . . 74.23 111.835 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.15 21.85 77.37 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-O 120.008 -0.329 . . . . 75.22 113.426 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 70.2 p -80.6 110.39 16.03 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 109.773 -0.454 . . . . 73.13 109.773 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 167.94 132.13 1.38 Allowed Glycine 0 C--N 1.334 0.432 0 N-CA-C 110.56 -1.016 . . . . 73.12 110.56 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -79.56 66.54 3.5 Favored Glycine 0 C--N 1.346 1.095 0 C-N-CA 122.847 0.26 . . . . 74.34 112.508 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.5 t -158.77 35.26 0.22 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.297 1.039 . . . . 74.52 108.731 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 83.05 166.66 39.94 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.509 -0.769 . . . . 73.02 113.593 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -147.95 35.77 1.16 Allowed Glycine 0 C--N 1.354 1.552 0 C-N-CA 122.881 0.277 . . . . 62.53 112.505 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 73.6 m -81.72 71.41 8.74 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.482 0.658 . . . . 75.44 109.794 174.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -177.55 137.33 3.39 Favored Glycine 0 C--O 1.24 0.515 0 N-CA-C 110.362 -1.095 . . . . 44.11 110.362 -177.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.597 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 11.8 tpp180 -70.38 116.14 10.37 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 123.297 0.639 . . . . 75.11 110.103 -177.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -73.8 128.2 34.87 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 114.839 -1.073 . . . . 72.24 109.102 175.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.4 tt -134.79 114.85 13.04 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.335 -1.728 . . . . 73.41 106.335 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -90.31 138.05 31.85 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 107.605 -1.257 . . . . 75.43 107.605 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.679 ' HB3' ' HG ' ' A' ' 99' ' ' LEU . . . -157.25 131.83 8.61 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.253 -0.647 . . . . 72.35 109.253 -170.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -120.73 126.38 50.03 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 109.068 -0.716 . . . . 74.51 109.068 -170.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.559 ' HB2' HD13 ' A' ' 97' ' ' ILE . 3.9 pp -100.81 118.78 59.99 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 109.325 -0.62 . . . . 73.44 109.325 -177.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.596 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 74.1 Cg_endo -73.69 111.63 3.34 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.542 2.162 . . . . 64.34 109.344 171.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.452 HD23 HD12 ' A' ' 149' ' ' ILE . 28.2 tp -102.47 149.77 24.04 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 109.015 -0.735 . . . . 74.32 109.015 -168.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.6 t -95.57 158.53 15.41 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-N 115.913 -0.585 . . . . 52.42 109.479 -177.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 82.1 mt -64.3 -30.45 71.5 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.469 0.708 . . . . 75.45 112.13 -175.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.07 -48.33 82.18 Favored 'General case' 0 C--O 1.216 -0.701 0 O-C-N 123.904 0.753 . . . . 65.4 109.507 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.469 ' HG3' ' HD2' ' A' ' 136' ' ' ARG . 8.2 mm-40 -75.54 -30.95 59.9 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.51 0.724 . . . . 74.24 111.367 -175.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.87 -26.11 64.97 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 122.878 0.471 . . . . 61.31 111.044 174.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -83.96 -47.99 10.43 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.837 0.855 . . . . 73.41 110.452 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -67.68 -49.55 62.21 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.196 0.598 . . . . 75.43 110.283 -174.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.492 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 62.86 62.17 5.75 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 114.49 -1.232 . . . . 55.45 112.318 -173.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.26 -163.69 11.27 Favored Glycine 0 C--N 1.34 0.768 0 N-CA-C 111.769 -0.532 . . . . 42.34 111.769 -177.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -73.6 118.68 16.83 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.379 -0.971 . . . . 72.42 108.379 177.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.601 HH21 ' HB ' ' A' ' 137' ' ' VAL . 5.8 tpm_? -111.67 122.76 48.68 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.484 -0.932 . . . . 74.14 108.484 177.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.601 ' HB ' HH21 ' A' ' 136' ' ' ARG . 71.4 t -71.88 113.71 9.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-N 114.576 -1.193 . . . . 73.22 110.159 176.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.77 110.2 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 106.889 -1.522 . . . . 74.21 106.889 174.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -118.19 121.23 39.96 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.62 -0.511 . . . . 73.44 109.62 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 1.5 m -149.34 142.59 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 125.197 1.399 . . . . 65.44 109.69 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.35 25.58 15.27 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.696 1.198 . . . . 75.32 111.559 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 73.07 10.76 78.49 Favored Glycine 0 C--N 1.355 1.615 0 CA-C-N 115.681 -0.691 . . . . 75.21 113.567 -175.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 58.7 ttt85 -114.03 125.0 53.51 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.937 0.895 . . . . 75.41 109.066 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -105.42 126.08 51.72 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.754 0.822 . . . . 74.41 109.738 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 4.4 p -127.98 123.35 60.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 124.269 1.027 . . . . 72.42 108.803 176.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 30.0 t -99.65 104.29 16.04 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.013 -0.736 . . . . 74.42 109.013 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.1 p -101.0 123.17 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.188 0.595 . . . . 74.42 110.545 -176.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -76.44 116.06 16.77 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 109.052 -0.721 . . . . 73.33 109.052 172.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.492 HG13 ' HA2' ' A' ' 133' ' ' GLY . 10.6 pt -96.87 151.02 37.55 Favored Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 124.319 1.047 . . . . 71.0 109.006 175.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.42 145.96 49.11 Favored 'Trans proline' 0 CA--C 1.565 2.048 0 C-N-CA 122.322 2.015 . . . . 74.32 112.74 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.403 ' HA ' ' HA3' ' A' ' 133' ' ' GLY . 27.3 Cg_exo -64.68 114.4 2.73 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 123.248 2.632 . . . . 73.15 112.105 175.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 87.82 31.26 15.68 Favored Glycine 0 C--N 1.341 0.83 0 O-C-N 123.333 0.396 . . . . 70.02 112.333 -174.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.89 149.85 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.834 0.853 . . . . 75.51 110.221 173.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -134.41 154.24 51.48 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.665 0.786 . . . . 73.33 110.756 -174.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -40.51 131.54 2.23 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.726 2.01 . . . . 71.15 113.397 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.34 -9.81 69.46 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-O 119.215 -0.769 . . . . 73.02 114.596 175.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 27.1 t -62.34 122.86 16.73 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.394 0.678 . . . . 74.42 110.067 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.1 t -102.51 109.28 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.58 0.752 . . . . 73.33 109.832 -177.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 59.5 mt -92.98 113.5 28.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 108.628 -0.878 . . . . 74.42 108.628 173.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -86.6 116.95 25.06 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.911 0.484 . . . . 75.32 110.118 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.464 HG13 ' HB3' ' A' ' 174' ' ' LEU . 7.2 p -125.75 102.72 28.49 Favored Pre-proline 0 CA--C 1.564 1.482 0 C-N-CA 123.253 0.621 . . . . 74.32 110.486 175.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.472 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 51.4 Cg_endo -68.15 154.86 71.41 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 123.049 2.5 . . . . 65.23 112.873 176.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 84.06 -15.15 40.0 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 116.105 -0.498 . . . . 73.21 114.178 178.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 24.3 mmt -99.02 -13.9 19.68 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.72 0.808 . . . . 74.31 111.763 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.4 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -79.54 -113.05 0.24 Allowed Glycine 0 C--N 1.351 1.362 0 O-C-N 123.593 0.558 . . . . 72.0 112.623 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.597 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -66.83 117.59 9.46 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.651 0.225 . . . . 73.23 113.452 177.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -88.42 131.42 34.87 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.636 0.774 . . . . 70.04 109.737 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 165.55 -160.68 34.13 Favored Glycine 0 N--CA 1.468 0.775 0 N-CA-C 110.316 -1.114 . . . . 64.43 110.316 -176.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -70.77 -35.84 4.79 Favored Pre-proline 0 CA--C 1.566 1.589 0 CA-C-O 117.715 -1.136 . . . . 73.31 112.247 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -91.33 128.9 1.21 Allowed 'Trans proline' 0 C--N 1.402 3.362 0 C-N-CA 122.466 2.111 . . . . 64.45 110.617 170.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.88 122.21 9.32 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 121.413 1.409 . . . . 74.51 110.844 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -90.81 146.03 18.2 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.722 -0.672 . . . . 54.42 112.242 -176.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.472 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 16.7 t70 -91.38 146.61 23.67 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.934 0.493 . . . . 74.24 110.239 -176.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.464 ' HB3' HG13 ' A' ' 161' ' ' VAL . 22.5 tp -123.67 111.17 15.88 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.398 0.679 . . . . 72.22 109.95 -176.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 75.6 mt -90.36 101.01 13.74 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.995 0.918 . . . . 74.44 110.069 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 79.8 mt -86.22 101.73 13.29 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.501 0.72 . . . . 74.21 110.664 -177.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 47.4 t -90.65 115.96 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.386 -0.968 . . . . 75.33 108.386 174.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.3 p -71.66 138.88 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 109.814 -0.439 . . . . 74.33 109.814 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.596 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 27.0 mmt180 -120.05 94.37 4.37 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.8 0.84 . . . . 74.42 109.229 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 51.7 mt -106.71 140.82 38.95 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.072 -0.967 . . . . 75.04 109.738 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 90.0 mt -68.67 155.28 93.36 Favored Pre-proline 0 CA--C 1.556 1.202 0 CA-C-N 114.922 -1.036 . . . . 60.52 110.35 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -76.41 35.66 0.47 Allowed 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 123.178 2.585 . . . . 73.32 113.574 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 59.2 m80 . . . . . 0 C--O 1.252 1.221 0 N-CA-C 107.683 -1.229 . . . . 73.44 107.683 176.386 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.574 ' HB2' HH12 ' A' ' 136' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 121.0 0.428 . . . . 74.35 110.688 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.4 m -80.87 133.33 35.56 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 109.355 -0.609 . . . . 71.33 109.355 175.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 94.8 m -70.49 145.43 50.93 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 123.482 0.713 . . . . 75.11 110.746 176.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.52 HD12 ' HB2' ' A' ' 123' ' ' LEU . 23.6 pt -123.15 175.96 5.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 C-N-CA 123.647 0.779 . . . . 72.45 110.022 -176.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.406 ' O ' ' HD2' ' A' ' 124' ' ' PRO . . . -128.79 167.67 16.98 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.819 0.848 . . . . 71.14 109.391 176.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.529 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.5 tp -110.41 148.83 31.22 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 108.602 -0.888 . . . . 74.31 108.602 -177.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.27 -47.21 51.84 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.409 0.284 . . . . 73.1 110.66 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.6 mt 57.09 75.08 0.38 Allowed 'General case' 0 N--CA 1.478 0.929 0 O-C-N 124.47 1.107 . . . . 73.34 110.591 -170.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.7 mt -76.74 164.05 61.84 Favored Pre-proline 0 CA--C 1.553 1.076 0 CA-C-N 114.232 -1.349 . . . . 75.25 109.045 174.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -61.2 168.69 7.29 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 121.858 1.705 . . . . 75.55 112.812 175.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -58.2 -28.88 65.22 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.232 1.013 . . . . 73.45 111.12 176.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 62.65 -89.84 0.06 OUTLIER Glycine 0 C--N 1.361 1.947 0 O-C-N 123.937 0.773 . . . . 64.12 112.223 178.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 33.7 t -141.39 -27.89 0.67 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.105 0.962 . . . . 73.42 109.716 173.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.41 -82.12 1.29 Allowed Glycine 0 C--N 1.346 1.126 0 CA-C-N 115.815 -0.63 . . . . 73.52 112.032 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.52 -1.87 41.76 Favored Glycine 0 CA--C 1.534 1.281 0 N-CA-C 114.483 0.553 . . . . 63.21 114.483 174.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.2 m -90.14 -28.18 19.11 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.413 0.685 . . . . 74.44 110.569 -174.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -117.11 102.9 1.05 Allowed Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.32 -0.854 . . . . 74.42 111.105 174.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -60.78 -35.58 90.21 Favored Glycine 0 C--N 1.353 1.52 0 C-N-CA 122.845 0.259 . . . . 73.23 112.859 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.2 m -93.51 53.05 1.81 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.778 0.831 . . . . 72.31 109.555 173.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -75.07 81.43 0.91 Allowed Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.204 -0.907 . . . . 73.11 112.468 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.74 -47.16 0.05 OUTLIER Glycine 0 C--N 1.341 0.807 0 N-CA-C 110.936 -0.866 . . . . 65.42 110.936 176.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 29.5 m -84.44 5.39 27.5 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.234 0.614 . . . . 73.44 111.239 176.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -168.68 130.41 2.07 Favored Glycine 0 C--N 1.351 1.399 0 N-CA-C 112.063 -0.415 . . . . 74.41 112.063 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -94.58 133.87 37.75 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.112 0.565 . . . . 74.41 110.706 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -83.91 133.18 34.72 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.563 -0.903 . . . . 55.2 108.563 169.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.5 tt -132.69 134.21 44.52 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 107.452 -1.314 . . . . 74.42 107.452 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -92.05 127.86 37.68 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.808 -0.812 . . . . 75.54 108.808 -175.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.529 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -149.75 132.56 16.01 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.86 -0.422 . . . . 72.33 109.86 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -127.91 125.34 39.41 Favored 'General case' 0 C--O 1.245 0.839 0 N-CA-C 109.743 -0.466 . . . . 74.13 109.743 -172.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.52 ' HB2' HD12 ' A' ' 97' ' ' ILE . 3.7 pp -101.96 119.88 55.52 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 109.299 -0.63 . . . . 75.34 109.299 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.471 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 62.8 Cg_endo -72.74 115.34 4.31 Favored 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 122.721 2.28 . . . . 73.21 108.985 167.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.418 ' HA ' HG23 ' A' ' 97' ' ' ILE . 47.7 tp -102.2 150.26 23.47 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 109.79 -0.448 . . . . 72.32 109.79 -168.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.7 t -89.12 155.19 19.59 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 123.447 0.699 . . . . 75.13 109.496 -175.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.8 mt -60.89 -35.24 76.14 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.494 1.117 . . . . 72.41 112.87 -171.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -61.52 -46.83 88.31 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.388 -0.597 . . . . 73.05 109.388 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -77.42 -22.39 51.59 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 114.245 -1.343 . . . . 71.1 112.153 -177.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.0 -51.69 68.59 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 123.586 0.554 . . . . 73.33 110.401 173.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -81.06 -50.45 9.64 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 115.508 -0.769 . . . . 74.42 111.887 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -65.93 -45.02 83.39 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.235 0.614 . . . . 73.4 111.813 -175.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.477 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 73.24 -145.52 36.25 Favored Glycine 0 C--N 1.342 0.899 0 O-C-N 123.441 0.463 . . . . 73.12 112.092 -175.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.93 -147.09 25.98 Favored Glycine 0 C--N 1.345 1.041 0 O-C-N 123.687 0.286 . . . . 74.13 112.808 177.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -85.09 121.9 28.52 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.236 0.614 . . . . 74.45 109.78 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.574 HH12 ' HB2' ' A' ' 94' ' ' MET . 5.0 tpm_? -112.03 123.44 50.27 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.912 -0.774 . . . . 74.44 108.912 175.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.482 ' HB ' ' NH2' ' A' ' 136' ' ' ARG . 84.8 t -76.11 111.4 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 114.88 -1.055 . . . . 71.12 109.519 173.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 32.0 t -107.7 129.56 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 107.359 -1.348 . . . . 74.33 107.359 172.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -115.58 116.48 28.22 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.36 -0.607 . . . . 74.21 109.36 175.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.8 p -150.02 142.47 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 123.87 0.868 . . . . 73.31 109.179 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.69 19.16 11.58 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.239 1.016 . . . . 55.41 112.156 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 82.28 7.41 87.71 Favored Glycine 0 C--N 1.353 1.499 0 CA-C-N 116.214 -0.448 . . . . 74.53 113.04 -176.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.9 ttm-85 -114.58 143.02 45.66 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.056 0.943 . . . . 74.24 110.388 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.428 ' HG3' HG11 ' A' ' 137' ' ' VAL . 12.4 ttp180 -96.4 113.72 25.33 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.592 -0.892 . . . . 73.04 108.592 173.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 25.8 t -105.41 112.09 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 108.243 -1.021 . . . . 73.12 108.243 172.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 35.8 t -90.29 108.59 19.86 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 107.961 -1.126 . . . . 65.33 107.961 175.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 34.3 m -104.61 145.69 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.508 0.723 . . . . 74.53 110.656 -176.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -93.19 96.04 9.77 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.791 -0.818 . . . . 75.32 108.791 175.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.477 HG13 ' HA2' ' A' ' 133' ' ' GLY . 24.0 pt -85.51 135.53 38.4 Favored Pre-proline 0 CA--C 1.554 1.131 0 CA-C-N 115.596 -0.729 . . . . 75.13 109.18 172.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.07 141.07 51.63 Favored 'Trans proline' 0 CA--C 1.565 2.027 0 C-N-CA 122.338 2.025 . . . . 72.52 112.438 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -60.2 113.7 1.78 Allowed 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 123.148 2.566 . . . . 72.23 112.14 173.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 86.61 32.59 15.25 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.359 -0.696 . . . . 63.43 111.359 -173.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.5 p -62.67 144.49 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.608 0.763 . . . . 75.12 109.682 172.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -132.01 161.36 33.36 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.77 0.428 . . . . 74.0 110.473 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -43.17 129.04 4.7 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 125.536 1.773 . . . . 72.02 112.91 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 102.68 -13.06 56.58 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-O 119.259 -0.745 . . . . 74.42 114.119 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.0 t -62.46 120.6 11.4 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 117.589 0.695 . . . . 74.25 109.698 178.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 176' ' ' LEU . 3.1 p -115.01 112.31 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 121.539 0.685 . . . . 71.42 110.36 -172.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 59.1 mt -90.23 102.92 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 107.965 -1.124 . . . . 70.22 107.965 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -81.21 99.96 8.86 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.8 -0.815 . . . . 75.35 108.8 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.2 p -103.73 118.86 56.35 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 122.845 0.458 . . . . 72.31 109.953 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.51 155.71 59.15 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.9 2.4 . . . . 75.42 112.287 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 81.24 -24.4 4.13 Favored Glycine 0 CA--C 1.535 1.3 0 N-CA-C 114.31 0.484 . . . . 62.24 114.31 176.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.1 mmt -88.17 -27.26 21.96 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.727 0.811 . . . . 74.15 112.024 -172.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -70.27 -78.36 0.4 Allowed Glycine 0 C--N 1.345 1.053 0 N-CA-C 111.361 -0.696 . . . . 75.31 111.361 175.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -71.16 110.84 3.41 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 111.0 -0.84 . . . . 52.04 111.0 167.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -89.45 151.61 21.92 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.709 0.804 . . . . 62.13 110.457 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 81.29 -125.77 7.05 Favored Glycine 0 C--N 1.342 0.902 0 CA-C-N 115.831 -0.622 . . . . 74.21 113.224 174.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.439 ' O ' ' HD3' ' A' ' 171' ' ' PRO . 28.3 t-20 -62.84 -48.64 84.89 Favored Pre-proline 0 CA--C 1.564 1.49 0 C-N-CA 123.972 0.909 . . . . 71.24 113.01 -174.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -96.84 95.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.392 2.834 0 C-N-CA 122.633 2.222 . . . . 73.43 113.082 176.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 169' ' ' ASN . 11.3 Cg_exo -70.33 121.96 8.51 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 121.988 1.792 . . . . 75.31 110.239 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -134.93 179.76 17.32 Favored Glycine 0 C--N 1.343 0.919 0 C-N-CA 121.67 -0.3 . . . . 65.11 113.108 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -96.11 119.79 35.23 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.51 0.671 . . . . 63.01 112.124 -167.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.3 tp -89.38 111.66 22.57 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.018 -0.992 . . . . 72.55 108.529 173.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 60.8 mt -83.95 99.55 10.46 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.562 0.745 . . . . 74.0 109.048 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 158' ' ' VAL . 91.7 mt -91.05 98.67 11.91 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 123.633 0.583 . . . . 73.22 110.884 -175.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 23.7 t -90.71 123.05 42.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 109.161 -0.681 . . . . 71.21 109.161 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.6 p -74.94 132.94 32.51 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 109.125 -0.694 . . . . 74.21 109.125 177.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.471 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 34.6 mmt180 -118.57 92.9 3.93 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.323 -0.991 . . . . 75.52 108.323 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 26.3 mt -101.02 131.48 46.87 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.616 -0.72 . . . . 63.34 110.608 -176.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.47 136.25 96.62 Favored Pre-proline 0 CA--C 1.549 0.919 0 CA-C-N 114.778 -1.101 . . . . 75.14 109.889 178.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.4 5.4 1.57 Allowed 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 122.759 2.306 . . . . 74.12 113.683 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 . . . . . 0 C--O 1.25 1.113 0 C-N-CA 123.897 0.879 . . . . 74.2 108.77 170.796 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.413 ' HB3' ' NH2' ' A' ' 136' ' ' ARG . 1.1 mpt? . . . . . 0 N--CA 1.484 1.269 0 N-CA-C 109.267 -0.642 . . . . 73.35 109.267 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.4 t -69.92 140.41 53.08 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-N 115.734 -0.667 . . . . 64.41 111.058 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.451 ' HA ' HH11 ' A' ' 136' ' ' ARG . 28.6 m -78.39 148.62 33.59 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.775 0.83 . . . . 71.54 109.596 174.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.629 HD11 ' HB2' ' A' ' 123' ' ' LEU . 26.1 pt -118.03 168.61 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 123.334 0.653 . . . . 75.45 110.382 -171.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -136.74 127.38 27.05 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.37 0.668 . . . . 63.41 110.258 -176.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.542 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.5 tp -80.57 157.02 26.18 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 124.07 0.948 . . . . 75.14 110.866 -168.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.18 -54.08 6.95 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.631 0.372 . . . . 65.34 110.852 -178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.0 mt 55.46 84.71 0.07 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.187 0.995 . . . . 73.35 110.796 -168.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.5 mt -100.6 122.43 49.53 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 125.103 1.361 . . . . 54.21 109.219 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -69.41 161.67 44.96 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.678 2.252 . . . . 72.22 112.869 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -74.62 110.16 8.69 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.895 0.878 . . . . 72.41 111.447 -175.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.6 55.41 11.92 Favored Glycine 0 C--N 1.343 0.944 0 O-C-N 123.945 0.778 . . . . 72.24 113.138 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.7 m -71.9 -32.83 67.8 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.028 0.531 . . . . 72.13 109.885 174.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.83 40.49 0.3 Allowed Glycine 0 C--N 1.342 0.885 0 N-CA-C 109.553 -1.419 . . . . 73.32 109.553 171.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.31 -167.29 12.34 Favored Glycine 0 C--N 1.35 1.344 0 N-CA-C 111.224 -0.751 . . . . 73.13 111.224 -169.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.405 ' HB3' HH11 ' A' ' 120' ' ' ARG . 51.0 m 59.26 29.45 19.02 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.915 0.886 . . . . 63.55 112.598 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -140.38 96.06 0.21 Allowed Glycine 0 C--N 1.347 1.154 0 N-CA-C 110.231 -1.148 . . . . 75.53 110.231 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -70.08 -76.34 0.52 Allowed Glycine 0 C--N 1.349 1.292 0 N-CA-C 111.911 -0.476 . . . . 72.33 111.911 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.7 m -154.09 166.17 33.89 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.783 0.833 . . . . 74.51 109.894 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 170.23 74.79 0.04 OUTLIER Glycine 0 C--N 1.348 1.245 0 C-N-CA 121.726 -0.273 . . . . 70.14 112.882 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -92.77 -71.79 1.18 Allowed Glycine 0 C--N 1.349 1.257 0 N-CA-C 111.872 -0.491 . . . . 72.21 111.872 177.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 31.6 p -77.73 -27.59 50.55 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.583 0.753 . . . . 74.32 111.905 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -135.46 79.81 0.32 Allowed Glycine 0 C--N 1.336 0.561 0 N-CA-C 109.847 -1.301 . . . . 74.54 109.847 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -72.19 117.49 13.89 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.238 0.542 . . . . 75.52 111.132 -177.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -91.7 107.28 19.1 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.71 -1.132 . . . . 72.55 107.974 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.8 tt -91.95 129.84 37.83 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 106.237 -1.764 . . . . 75.21 106.237 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.405 HH11 ' HB3' ' A' ' 109' ' ' SER . 56.8 ttt180 -90.55 120.57 31.75 Favored 'General case' 0 C--O 1.213 -0.854 0 N-CA-C 107.998 -1.112 . . . . 73.54 107.998 -174.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.542 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -140.37 130.74 25.26 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.331 -0.618 . . . . 75.05 109.331 -174.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.502 ' HG2' ' HB ' ' A' ' 177' ' ' VAL . 84.9 mt-10 -120.63 120.96 37.26 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.316 -0.624 . . . . 74.43 109.316 -167.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.629 ' HB2' HD11 ' A' ' 97' ' ' ILE . 4.4 pp -103.13 118.71 57.34 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 109.522 -0.547 . . . . 74.53 109.522 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -74.27 113.76 3.87 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 122.819 2.346 . . . . 74.53 109.37 169.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.532 HD21 HD11 ' A' ' 149' ' ' ILE . 29.4 tp -103.75 143.92 32.17 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 110.151 -0.314 . . . . 74.11 110.151 -166.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.4 t -83.35 155.89 23.31 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.446 -0.797 . . . . 71.14 109.856 -176.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.2 mt -63.52 -30.98 72.02 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.072 0.949 . . . . 70.42 112.304 -173.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.55 -43.59 89.42 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.763 0.664 . . . . 74.05 109.52 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -77.74 -32.65 52.87 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.014 -0.994 . . . . 64.44 111.904 -178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.46 -49.19 74.65 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.489 0.661 . . . . 73.55 111.152 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -74.21 -59.76 2.58 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.251 -1.341 . . . . 73.42 110.595 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -72.81 -44.26 61.69 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.662 -0.699 . . . . 74.13 111.727 -172.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.39 178.12 50.82 Favored Glycine 0 C--N 1.351 1.399 0 O-C-N 123.629 0.581 . . . . 74.12 113.161 -175.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 127.76 -156.79 20.77 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.934 -0.466 . . . . 71.33 111.934 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.413 ' HB3' ' OG ' ' A' ' 146' ' ' SER . 3.1 mp0 -88.47 123.07 32.63 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.822 -0.807 . . . . 75.21 108.822 173.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.451 HH11 ' HA ' ' A' ' 96' ' ' THR . 8.3 tpp180 -116.29 122.42 44.89 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.484 0.714 . . . . 74.22 109.89 176.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.6 t -70.49 126.64 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 O-C-N 124.105 0.878 . . . . 75.42 109.783 175.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.74 134.83 64.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 124.699 1.2 . . . . 71.22 108.667 174.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -124.77 125.11 43.52 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.429 1.092 . . . . 73.22 109.763 -174.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.3 p -151.63 129.93 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.14 0.576 . . . . 75.02 110.785 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.82 20.04 11.1 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 123.997 0.919 . . . . 75.42 112.71 176.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.07 -13.29 67.69 Favored Glycine 0 C--N 1.353 1.498 0 CA-C-N 116.403 -0.362 . . . . 71.22 112.989 -175.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -90.82 117.97 29.86 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.565 1.146 . . . . 73.04 109.237 -175.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -114.92 129.61 56.74 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.566 0.746 . . . . 71.54 110.197 -176.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.14 144.78 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.974 0.909 . . . . 75.54 109.506 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.413 ' OG ' ' HB3' ' A' ' 135' ' ' GLU . 11.0 t -100.8 120.75 40.58 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.017 -0.734 . . . . 74.33 109.017 177.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 6.3 p -100.11 129.53 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.446 0.698 . . . . 71.14 110.332 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -75.92 99.51 4.54 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.206 -0.665 . . . . 73.13 109.206 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.532 HD11 HD21 ' A' ' 125' ' ' LEU . 10.4 pt -86.32 142.79 35.84 Favored Pre-proline 0 CA--C 1.555 1.162 0 CA-C-N 115.356 -0.838 . . . . 74.43 110.063 173.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -66.05 135.62 41.39 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.449 2.1 . . . . 73.03 112.11 172.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -55.57 124.42 16.23 Favored 'Trans proline' 0 C--N 1.367 1.504 0 C-N-CA 122.619 2.213 . . . . 75.41 111.524 166.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 81.51 24.42 56.47 Favored Glycine 0 CA--C 1.533 1.196 0 O-C-N 123.314 0.384 . . . . 71.23 112.63 -174.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 6.7 p -62.29 139.19 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.622 0.769 . . . . 74.21 109.7 173.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -127.34 152.57 47.3 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.339 0.656 . . . . 73.1 110.419 -174.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -40.67 132.01 2.25 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.475 1.91 . . . . 74.43 113.144 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.86 -6.94 77.03 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-O 119.658 -0.523 . . . . 73.42 113.992 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 29.2 m -63.0 130.27 43.97 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.216 0.606 . . . . 63.02 110.24 172.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 5.8 p -117.91 116.48 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 CA-C-O 121.312 0.577 . . . . 72.51 110.37 -177.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.411 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 58.8 mt -95.3 103.04 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.864 0.866 . . . . 73.42 108.672 176.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -80.16 109.85 15.01 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.142 0.577 . . . . 72.23 109.742 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.524 HG12 ' HB3' ' A' ' 174' ' ' LEU . 1.7 p -109.04 111.32 60.55 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 123.489 0.716 . . . . 73.12 109.266 173.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -67.56 151.7 79.29 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 123.239 2.626 . . . . 75.44 113.571 -177.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 66.6 24.7 72.63 Favored Glycine 0 C--N 1.356 1.673 0 O-C-N 123.772 0.67 . . . . 61.33 113.662 175.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.439 ' HB3' ' HB2' ' A' ' 174' ' ' LEU . 8.2 tpt -119.81 -33.79 3.91 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.263 0.625 . . . . 75.02 110.154 -171.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -91.69 -69.73 1.17 Allowed Glycine 0 C--N 1.35 1.341 0 CA-C-N 116.44 -0.346 . . . . 65.31 112.31 -177.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -62.77 90.42 0.07 OUTLIER Glycine 0 C--N 1.349 1.274 0 N-CA-C 111.46 -0.656 . . . . 62.52 111.46 169.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -92.28 170.37 9.85 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.249 1.02 . . . . 74.52 111.195 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.74 -145.5 18.33 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 115.251 -0.886 . . . . 74.24 112.179 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -78.99 -36.98 1.21 Allowed Pre-proline 0 CA--C 1.565 1.542 0 CA-C-O 118.288 -0.863 . . . . 74.24 112.083 177.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -82.68 110.38 1.88 Allowed 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 121.725 1.617 . . . . 74.14 111.314 166.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -74.62 166.82 28.52 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.619 2.213 . . . . 74.43 112.583 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 173.34 174.75 40.6 Favored Glycine 0 C--N 1.346 1.109 0 N-CA-C 114.079 0.392 . . . . 63.52 114.079 170.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -91.04 166.8 12.81 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.639 1.176 . . . . 64.53 111.088 -167.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.524 ' HB3' HG12 ' A' ' 161' ' ' VAL . 34.8 tp -124.11 118.27 26.54 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.562 -0.903 . . . . 74.11 108.562 177.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 82.6 mt -92.91 101.88 14.24 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.522 0.729 . . . . 73.24 109.649 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.411 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 94.9 mt -89.21 99.75 12.67 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.25 0.62 . . . . 75.34 111.028 -177.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.502 ' HB ' ' HG2' ' A' ' 122' ' ' GLU . 49.5 t -89.23 112.61 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 123.373 0.669 . . . . 75.33 109.493 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.02 133.56 31.49 Favored 'Isoleucine or valine' 0 C--O 1.249 1.074 0 N-CA-C 109.712 -0.477 . . . . 73.11 109.712 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -123.43 96.04 4.82 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.353 1.061 . . . . 73.52 108.471 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 180' ' ' LEU . 35.7 mt -96.84 140.81 30.84 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.642 -0.708 . . . . 74.05 111.756 -174.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 71.0 mt -61.93 146.79 90.92 Favored Pre-proline 0 CA--C 1.553 1.058 0 CA-C-N 114.303 -1.317 . . . . 73.34 110.07 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -77.16 31.56 0.42 Allowed 'Trans proline' 0 CA--C 1.559 1.726 0 C-N-CA 122.849 2.366 . . . . 74.42 113.859 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 . . . . . 0 C--O 1.251 1.154 0 C-N-CA 123.812 0.845 . . . . 71.12 109.756 173.373 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 35.2 mtp . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 108.022 -1.103 . . . . 73.44 108.022 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.408 ' H ' HG23 ' A' ' 126' ' ' THR . 16.3 m -60.28 -22.31 62.96 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.065 1.135 . . . . 64.32 114.065 -172.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 45.0 m 71.3 145.91 0.07 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.754 1.222 . . . . 72.12 110.842 -172.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.626 HD12 ' HB2' ' A' ' 123' ' ' LEU . 15.3 pt -128.08 166.19 25.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 123.348 0.659 . . . . 75.05 110.861 -170.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.4 151.33 47.81 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.333 1.053 . . . . 73.4 109.649 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.598 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.5 tp -100.91 155.14 18.12 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.892 0.477 . . . . 74.51 109.936 -170.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -84.14 -40.54 18.08 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.249 0.619 . . . . 74.31 111.929 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.0 mt 48.69 66.18 1.15 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.004 0.922 . . . . 75.21 111.283 -172.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 76.1 mt -73.43 151.03 89.57 Favored Pre-proline 0 CA--C 1.548 0.89 0 CA-C-N 115.35 -0.841 . . . . 74.31 110.492 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.12 179.65 1.08 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.247 1.965 . . . . 74.52 112.595 171.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.8 pp -122.88 -169.72 1.97 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.963 0.905 . . . . 72.3 110.313 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 140.33 -41.18 1.31 Allowed Glycine 0 C--N 1.337 0.616 0 N-CA-C 110.13 -1.188 . . . . 62.43 110.13 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.6 t -145.99 -172.52 3.94 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.281 1.032 . . . . 73.14 108.475 175.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 112.21 -0.22 26.75 Favored Glycine 0 N--CA 1.47 0.961 0 N-CA-C 111.657 -0.577 . . . . 72.21 111.657 -174.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 148.89 165.49 12.27 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 111.398 -0.681 . . . . 74.3 111.398 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.3 t -76.94 -8.86 58.14 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.31 0.644 . . . . 71.14 110.942 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 71.77 -149.25 44.53 Favored Glycine 0 C--N 1.356 1.654 0 N-CA-C 110.995 -0.842 . . . . 71.32 110.995 -174.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -106.34 9.95 42.51 Favored Glycine 0 N--CA 1.466 0.673 0 N-CA-C 111.47 -0.652 . . . . 72.04 111.47 173.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.2 m 64.25 178.98 0.17 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.91 1.284 . . . . 74.04 111.963 -177.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.93 -83.0 0.83 Allowed Glycine 0 C--N 1.349 1.271 0 CA-C-N 116.003 -0.544 . . . . 70.32 112.578 178.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 168.4 -45.96 0.23 Allowed Glycine 0 C--N 1.341 0.815 0 N-CA-C 111.78 -0.528 . . . . 72.33 111.78 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 28.3 p -64.55 136.88 57.48 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.801 0.84 . . . . 71.12 110.835 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.56 40.17 6.07 Favored Glycine 0 C--N 1.345 1.067 0 O-C-N 123.802 0.689 . . . . 55.13 111.679 -176.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.414 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 43.3 ttt180 -56.43 119.58 6.27 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.537 1.135 . . . . 74.23 112.556 -174.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -78.35 139.38 38.82 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.433 -0.803 . . . . 72.13 109.425 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.9 tt -132.7 126.1 31.78 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.175 -1.417 . . . . 73.41 107.175 177.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -91.59 136.14 33.35 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.361 0.665 . . . . 71.55 109.321 -176.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.598 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -154.37 146.87 24.04 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.466 0.706 . . . . 75.31 110.11 -176.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -120.79 124.98 46.4 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 109.179 -0.674 . . . . 73.03 109.179 -176.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.626 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.5 pp -108.94 115.06 57.72 Favored Pre-proline 0 CA--C 1.551 0.981 0 N-CA-C 108.672 -0.862 . . . . 73.43 108.672 174.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.536 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 82.4 Cg_endo -78.15 114.74 3.62 Favored 'Trans proline' 0 C--N 1.365 1.437 0 C-N-CA 122.673 2.249 . . . . 75.21 109.124 170.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.488 HD21 HD13 ' A' ' 149' ' ' ILE . 25.5 tp -103.78 147.18 27.59 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.393 -0.595 . . . . 65.32 109.393 -166.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.408 HG23 ' H ' ' A' ' 95' ' ' SER . 11.3 t -92.63 162.97 13.96 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 109.718 -0.475 . . . . 74.31 109.718 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.5 mt -64.65 -37.02 86.15 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.85 0.86 . . . . 54.14 112.188 -168.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -59.83 -40.18 87.62 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.177 0.923 . . . . 75.42 109.68 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -76.92 -37.06 56.09 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 114.892 -1.049 . . . . 75.11 111.567 -173.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.9 -36.15 74.22 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 121.104 0.478 . . . . 73.32 110.384 172.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -77.16 -34.7 56.39 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 114.751 -1.113 . . . . 74.14 111.822 177.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 27.4 m80 -74.76 -51.16 14.9 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 117.926 0.33 . . . . 71.31 110.983 -176.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 151' ' ' PRO . . . 58.62 68.11 1.86 Allowed Glycine 0 C--N 1.344 0.994 0 O-C-N 124.239 0.962 . . . . 51.2 112.307 -172.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.413 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -155.51 -146.33 4.41 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-O 120.055 -0.303 . . . . 75.52 112.529 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.3 mp0 -75.12 117.08 16.56 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.406 0.682 . . . . 72.44 109.685 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.648 HH21 ' HB ' ' A' ' 137' ' ' VAL . 4.5 tpm_? -116.56 123.74 48.12 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.113 0.965 . . . . 74.23 108.674 173.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.648 ' HB ' HH21 ' A' ' 136' ' ' ARG . 87.8 t -72.49 122.8 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.079 0.952 . . . . 74.23 110.341 174.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.576 ' HB ' HG12 ' A' ' 145' ' ' VAL . 21.4 t -112.6 126.95 70.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.551 -0.907 . . . . 72.14 108.551 174.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -109.16 110.43 21.66 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.831 0.853 . . . . 72.3 109.466 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 10.8 p -149.75 133.22 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 123.018 0.527 . . . . 75.41 110.541 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.64 18.68 10.75 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.513 1.125 . . . . 74.25 112.645 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.79 5.57 86.27 Favored Glycine 0 C--N 1.348 1.244 0 O-C-N 123.158 0.286 . . . . 53.11 113.232 -176.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -112.12 131.46 55.44 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.406 1.082 . . . . 74.22 109.806 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.549 ' HG3' HG12 ' A' ' 137' ' ' VAL . 39.6 ttm180 -90.22 113.98 25.89 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.124 0.97 . . . . 71.33 109.618 172.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.576 HG12 ' HB ' ' A' ' 138' ' ' VAL . 2.5 p -111.3 115.14 49.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 123.398 0.679 . . . . 71.5 109.21 169.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.6 t -86.78 115.23 24.07 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 109.19 -0.67 . . . . 74.44 109.19 175.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.41 HG12 HD21 ' A' ' 123' ' ' LEU . 3.6 p -100.83 124.38 54.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 123.612 0.765 . . . . 71.35 109.795 176.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 54.2 ttt85 -80.43 93.93 6.1 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.747 -1.205 . . . . 73.53 107.747 168.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.488 HD13 HD21 ' A' ' 125' ' ' LEU . 13.8 pt -74.31 143.94 80.64 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 123.824 0.85 . . . . 64.51 109.753 177.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.8 149.07 47.39 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 122.225 1.95 . . . . 73.52 111.993 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.478 ' HA ' ' HA3' ' A' ' 133' ' ' GLY . 31.9 Cg_exo -60.54 134.45 54.75 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 123.137 2.558 . . . . 72.13 112.122 177.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 65.83 29.31 74.81 Favored Glycine 0 C--N 1.353 1.506 0 O-C-N 123.697 0.623 . . . . 74.01 112.63 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -58.21 145.65 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 C-N-CA 124.053 0.941 . . . . 74.45 109.72 176.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -136.64 158.75 43.71 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.53 0.732 . . . . 73.24 110.415 -173.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -42.69 127.18 3.87 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.895 1.678 . . . . 71.04 112.838 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.27 -4.82 80.92 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 114.385 0.514 . . . . 64.02 114.385 177.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.6 t -67.62 122.32 17.8 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.242 -0.651 . . . . 71.2 109.242 176.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 46.5 t -101.99 117.06 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 109.427 -0.583 . . . . 73.53 109.427 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.5 mt -91.92 144.1 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.813 1.245 . . . . 71.42 107.968 173.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.529 HH11 HD23 ' A' ' 175' ' ' LEU . 49.0 ttt85 -118.09 116.75 27.49 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.188 -0.671 . . . . 73.32 109.188 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 5.0 p -124.17 109.62 29.3 Favored Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 123.693 0.797 . . . . 55.34 110.531 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -70.72 153.62 64.41 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.974 2.449 . . . . 72.44 112.628 -176.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.77 -13.83 54.67 Favored Glycine 0 C--N 1.339 0.719 0 CA-C-N 115.702 -0.681 . . . . 72.44 113.954 174.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.509 ' HE2' ' HB ' ' A' ' 145' ' ' VAL . 84.7 mmm -100.14 -12.42 19.64 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 117.404 0.602 . . . . 65.22 111.452 -176.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -83.04 -111.5 0.5 Allowed Glycine 0 C--N 1.353 1.485 0 CA-C-O 119.312 -0.716 . . . . 61.12 111.936 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.414 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -53.85 108.32 0.81 Allowed Glycine 0 C--N 1.353 1.489 0 O-C-N 124.003 0.472 . . . . 53.25 113.128 174.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -91.22 169.54 10.75 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.616 1.167 . . . . 74.22 110.396 175.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 94.59 -145.41 17.68 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 115.388 -0.824 . . . . 73.02 112.147 175.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -69.13 -47.66 28.58 Favored Pre-proline 0 CA--C 1.561 1.384 0 CA-C-O 118.13 -0.938 . . . . 74.42 110.872 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.3 113.59 2.67 Favored 'Trans proline' 0 C--N 1.395 3.011 0 C-N-CA 122.232 1.955 . . . . 73.1 111.087 172.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -72.39 160.17 47.55 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.45 2.1 . . . . 74.34 111.418 177.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -161.01 -179.13 35.56 Favored Glycine 0 CA--C 1.504 -0.632 0 N-CA-C 114.732 0.653 . . . . 71.42 114.732 176.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -120.52 150.18 41.25 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.531 1.132 . . . . 75.4 109.641 -169.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 37.2 tp -117.1 114.1 23.24 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.563 0.745 . . . . 73.34 110.1 -172.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.529 HD23 HH11 ' A' ' 160' ' ' ARG . 92.8 mt -88.37 103.28 15.69 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.063 0.945 . . . . 74.21 110.162 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.465 HD21 HD11 ' A' ' 99' ' ' LEU . 77.0 mt -95.41 99.18 11.13 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.085 0.954 . . . . 74.24 110.615 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 8.5 p -90.37 133.4 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 109.372 -0.603 . . . . 74.14 109.372 175.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.3 p -87.58 144.81 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 123.238 0.615 . . . . 72.43 111.165 -171.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.536 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 35.5 mmt180 -119.25 99.74 6.89 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.742 1.217 . . . . 72.33 108.44 174.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 16.0 mt -118.86 145.86 45.35 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.973 0.909 . . . . 62.04 111.119 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 65.2 mt -70.25 132.07 88.23 Favored Pre-proline 0 CA--C 1.551 0.991 0 CA-C-N 114.541 -1.209 . . . . 73.32 109.423 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.15 -19.01 67.77 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.7 2.267 . . . . 60.43 113.118 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 . . . . . 0 C--O 1.252 1.215 0 C-N-CA 124.89 1.276 . . . . 74.31 108.24 177.699 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 49.8 mtt . . . . . 0 N--CA 1.484 1.264 0 N-CA-C 108.927 -0.768 . . . . 74.54 108.927 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.4 m -71.48 121.68 19.07 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.915 -0.772 . . . . 73.11 108.915 174.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 86.8 m -68.2 141.56 55.94 Favored 'General case' 0 C--N 1.35 0.63 0 C-N-CA 123.392 0.677 . . . . 72.05 110.39 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.522 HD12 ' HB2' ' A' ' 123' ' ' LEU . 14.2 pt -114.88 163.41 12.19 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 C-N-CA 123.057 0.543 . . . . 73.32 110.818 -170.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -123.15 -162.93 1.06 Allowed 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.399 -0.963 . . . . 62.34 108.399 170.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.532 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.5 tp -136.64 155.93 49.23 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.937 -0.764 . . . . 75.13 108.937 -175.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.87 -48.92 33.32 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.044 0.538 . . . . 72.43 110.723 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.583 HD13 ' HB ' ' A' ' 140' ' ' VAL . 60.2 mt 53.68 78.05 0.16 Allowed 'General case' 0 CA--C 1.546 0.809 0 O-C-N 124.469 1.106 . . . . 75.11 110.348 -171.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 60.9 mt -84.65 143.2 40.61 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 114.984 -1.007 . . . . 75.53 109.636 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.47 -173.48 0.56 Allowed 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.571 2.18 . . . . 73.23 112.952 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -53.76 133.21 42.23 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.944 0.898 . . . . 73.33 111.712 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -172.3 -110.68 0.25 Allowed Glycine 0 C--N 1.347 1.144 0 N-CA-C 111.94 -0.464 . . . . 62.2 111.94 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.3 m -74.4 96.53 2.89 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.148 0.579 . . . . 74.12 110.06 177.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -160.67 -112.08 0.29 Allowed Glycine 0 C--N 1.35 1.359 0 CA-C-N 115.849 -0.614 . . . . 60.41 111.734 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.12 27.63 73.52 Favored Glycine 0 C--N 1.356 1.647 0 N-CA-C 112.21 -0.356 . . . . 71.54 112.21 -174.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.2 m -100.93 151.29 21.93 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.18 0.992 . . . . 74.34 112.156 -167.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -151.03 -161.07 9.78 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 115.674 -0.694 . . . . 53.24 111.847 178.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 165.41 -144.52 9.33 Favored Glycine 0 C--N 1.343 0.944 0 N-CA-C 112.099 -0.4 . . . . 70.2 112.099 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 60.3 p -78.71 -51.02 10.41 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.649 0.779 . . . . 74.33 110.91 -178.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -143.16 98.53 0.21 Allowed Glycine 0 C--N 1.352 1.431 0 N-CA-C 111.202 -0.759 . . . . 52.02 111.202 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.591 ' HA3' ' HB2' ' A' ' 162' ' ' PRO . . . 146.91 20.53 0.11 Allowed Glycine 0 N--CA 1.473 1.165 0 C-N-CA 123.03 0.348 . . . . 43.2 112.26 178.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 36.5 m -79.51 103.26 9.31 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.29 0.636 . . . . 74.34 109.499 176.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -169.88 -159.54 15.96 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 110.936 -0.866 . . . . 64.11 110.936 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.697 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 32.8 ttm180 -58.81 119.66 7.56 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 117.191 0.496 . . . . 75.43 111.01 -178.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -76.11 139.33 41.29 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.519 0.728 . . . . 74.22 109.539 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.3 tt -141.38 115.5 9.3 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 106.393 -1.706 . . . . 74.44 106.393 -177.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -90.24 143.08 27.1 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 107.052 -1.462 . . . . 75.41 107.052 177.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.532 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -149.51 137.16 20.2 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 120.684 0.278 . . . . 62.53 110.522 -169.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -120.53 112.41 18.91 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.146 -1.057 . . . . 73.45 108.146 -172.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.522 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.6 pp -99.31 117.79 63.43 Favored Pre-proline 0 C--N 1.354 0.78 0 N-CA-C 108.396 -0.964 . . . . 73.34 108.396 177.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.457 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 95.6 Cg_endo -75.48 113.68 3.81 Favored 'Trans proline' 0 C--N 1.364 1.36 0 C-N-CA 122.208 1.939 . . . . 74.3 109.166 170.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.465 HD22 HD13 ' A' ' 149' ' ' ILE . 33.0 tp -102.0 153.08 20.22 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.615 -0.513 . . . . 73.21 109.615 -172.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.8 t -91.43 155.16 18.65 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 109.224 -0.658 . . . . 74.32 109.224 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.1 mt -63.12 -34.43 77.59 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.461 0.704 . . . . 74.51 111.947 -173.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.93 -46.39 90.87 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.834 0.853 . . . . 75.23 110.022 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -79.09 -26.59 42.96 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.24 -0.891 . . . . 65.31 112.519 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.38 -40.94 92.65 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.533 0.683 . . . . 73.35 110.064 171.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -77.62 -48.91 15.71 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 114.224 -1.353 . . . . 73.33 111.093 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -69.68 -49.43 53.57 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 122.802 0.441 . . . . 74.15 111.592 -173.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.564 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 75.11 -170.42 54.36 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 115.805 -0.634 . . . . 74.13 111.702 -163.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.445 ' O ' HG12 ' A' ' 149' ' ' ILE . . . 90.54 -166.29 31.62 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 116.557 0.179 . . . . 55.02 112.74 -177.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.446 ' HB3' ' OG ' ' A' ' 146' ' ' SER . 3.6 mp0 -71.62 130.69 41.8 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.226 0.61 . . . . 73.13 110.275 -175.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -131.24 128.58 40.17 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.19 -0.67 . . . . 75.11 109.19 172.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 38.7 t -72.39 113.08 9.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 O-C-N 124.627 1.205 . . . . 71.52 110.63 -172.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.416 HG21 HD13 ' A' ' 97' ' ' ILE . 14.5 t -106.44 112.16 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.687 1.195 . . . . 74.32 107.878 176.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -94.18 117.35 29.99 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.276 0.63 . . . . 75.32 109.44 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.583 ' HB ' HD13 ' A' ' 101' ' ' LEU . 19.5 m -135.64 120.84 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 124.502 1.121 . . . . 73.23 112.048 -169.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 57.88 20.34 6.56 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.55 1.14 . . . . 73.44 113.603 169.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.67 27.76 18.59 Favored Glycine 0 CA--C 1.535 1.342 0 N-CA-C 112.461 -0.256 . . . . 61.14 112.461 -175.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -133.64 154.02 51.23 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.405 1.082 . . . . 70.05 109.24 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -112.31 114.79 27.73 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.36 1.064 . . . . 75.44 109.044 176.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 5.7 p -130.26 124.29 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.536 -0.913 . . . . 74.33 108.536 174.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.446 ' OG ' ' HB3' ' A' ' 135' ' ' GLU . 12.7 t -103.44 122.8 45.64 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 109.228 -0.656 . . . . 63.55 109.228 -177.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.1 p -100.94 129.56 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 122.933 0.493 . . . . 73.15 110.092 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.9 ttp180 -74.73 98.82 3.55 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.573 -0.899 . . . . 75.15 108.573 170.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.564 HG13 ' HA2' ' A' ' 133' ' ' GLY . 10.7 pt -78.72 145.55 67.03 Favored Pre-proline 0 CA--C 1.563 1.444 0 C-N-CA 124.042 0.937 . . . . 75.34 109.796 171.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.86 141.34 89.58 Favored 'Trans proline' 0 CA--C 1.564 1.985 0 C-N-CA 122.78 2.32 . . . . 72.44 113.388 174.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -62.73 114.78 2.55 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.718 2.279 . . . . 70.03 111.115 168.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 87.59 30.03 19.82 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 111.444 -0.662 . . . . 74.25 111.444 -174.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -70.21 137.34 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.428 0.691 . . . . 74.51 109.358 174.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -135.11 157.56 46.61 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.997 0.519 . . . . 64.04 111.04 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -39.86 122.06 1.38 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.915 2.086 . . . . 62.14 113.202 -175.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.9 -12.08 38.04 Favored Glycine 0 C--N 1.348 1.213 0 CA-C-O 119.366 -0.685 . . . . 63.12 113.846 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 13.7 t -70.04 122.14 18.8 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 117.382 0.591 . . . . 74.21 110.138 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 46.5 t -104.41 111.24 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 123.848 0.859 . . . . 74.01 109.628 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 61.1 mt -89.69 103.63 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.912 -1.144 . . . . 73.23 107.912 171.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -82.15 119.55 24.2 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.397 -0.594 . . . . 72.4 109.397 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.508 HG13 ' HB3' ' A' ' 174' ' ' LEU . 6.5 p -124.51 98.2 38.17 Favored Pre-proline 0 CA--C 1.561 1.374 0 C-N-CA 123.68 0.792 . . . . 74.54 109.476 177.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.591 ' HB2' ' HA3' ' A' ' 114' ' ' GLY . 73.5 Cg_endo -72.35 146.68 45.67 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.954 2.436 . . . . 75.12 112.503 179.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 93.45 -18.51 56.23 Favored Glycine 0 CA--C 1.537 1.43 0 CA-C-O 120.058 -0.301 . . . . 75.25 113.726 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 69.9 mmm -97.87 -9.87 25.62 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.935 0.894 . . . . 74.34 112.904 -174.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -79.74 -100.07 0.28 Allowed Glycine 0 C--N 1.342 0.889 0 O-C-N 123.181 0.3 . . . . 73.31 112.68 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.697 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -67.56 103.04 0.89 Allowed Glycine 0 C--N 1.344 1.022 0 N-CA-C 112.416 -0.273 . . . . 75.53 112.416 175.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -79.8 131.71 35.97 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.591 0.756 . . . . 74.21 109.813 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 154.06 -163.73 31.09 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 111.495 -0.642 . . . . 72.32 111.495 -177.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -58.83 -47.17 99.2 Favored Pre-proline 0 CA--C 1.562 1.422 0 CA-C-O 118.749 -0.643 . . . . 75.33 111.524 177.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.93 119.28 3.55 Favored 'Trans proline' 0 C--N 1.39 2.733 0 C-N-CA 121.481 1.454 . . . . 70.41 110.967 168.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.6 121.96 9.3 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 121.568 1.512 . . . . 73.41 109.702 174.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -97.59 149.25 19.19 Favored Glycine 0 C--N 1.339 0.728 0 CA-C-O 119.769 -0.462 . . . . 65.33 112.539 -173.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 37.6 t70 -83.03 139.78 33.08 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 122.764 0.426 . . . . 63.33 110.575 -175.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.508 ' HB3' HG13 ' A' ' 161' ' ' VAL . 33.4 tp -122.88 130.67 53.14 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.643 0.777 . . . . 75.32 109.347 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 80.9 mt -109.34 101.9 10.86 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.602 0.761 . . . . 73.12 109.307 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 77.3 mt -88.07 101.07 13.43 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 109.583 -0.525 . . . . 72.01 109.583 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 36.5 t -95.77 124.98 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 109.116 -0.698 . . . . 62.41 109.116 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.8 p -74.96 127.61 36.66 Favored 'Isoleucine or valine' 0 C--O 1.249 1.064 0 C-N-CA 123.117 0.567 . . . . 73.33 109.966 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.457 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 5.1 mmm180 -114.42 100.61 8.44 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.769 -0.826 . . . . 74.34 108.769 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 40.3 mt -116.38 139.86 49.96 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.373 1.069 . . . . 74.32 110.035 -177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 59.3 mt -91.35 131.76 35.63 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-N 115.347 -0.842 . . . . 73.33 108.891 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.84 -30.33 91.64 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 123.485 2.79 . . . . 75.03 112.951 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 . . . . . 0 C--O 1.256 1.401 0 N-CA-C 108.093 -1.077 . . . . 72.54 108.093 169.776 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.481 ' SD ' ' N ' ' A' ' 94' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 108.108 -1.071 . . . . 74.41 108.108 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.9 t -62.2 121.56 13.41 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.067 0.547 . . . . 75.22 111.228 -172.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.498 ' HA ' ' HD2' ' A' ' 136' ' ' ARG . 56.6 m -72.59 149.65 43.78 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.534 0.733 . . . . 72.42 110.323 177.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.593 HD11 ' HB2' ' A' ' 123' ' ' LEU . 14.1 pt -118.09 161.75 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.029 0.532 . . . . 74.33 111.41 -164.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -113.18 -162.87 0.82 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.954 0.902 . . . . 62.13 109.186 173.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.749 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.6 tp -150.66 147.42 27.36 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.125 -0.694 . . . . 73.15 109.125 -172.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.14 -51.91 14.13 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.406 0.283 . . . . 73.34 111.147 -178.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 89.9 mt 60.59 73.77 0.47 Allowed 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.339 1.025 . . . . 72.4 110.435 -174.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.9 mt -77.02 109.72 9.86 Favored Pre-proline 0 CA--C 1.555 1.151 0 CA-C-N 114.986 -1.006 . . . . 55.34 109.18 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -55.28 -32.35 80.58 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 123.53 2.82 . . . . 70.3 114.716 -173.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -154.18 19.93 0.5 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.634 0.774 . . . . 70.34 111.078 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -78.28 85.5 1.13 Allowed Glycine 0 C--N 1.347 1.162 0 CA-C-O 119.933 -0.37 . . . . 74.05 112.668 -177.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.7 m 62.45 84.69 0.14 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.87 1.268 . . . . 75.13 110.969 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -169.92 103.13 0.19 Allowed Glycine 0 C--N 1.346 1.092 0 CA-C-N 115.906 -0.588 . . . . 65.2 111.76 -177.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -174.75 106.55 0.22 Allowed Glycine 0 C--N 1.348 1.208 0 N-CA-C 111.169 -0.772 . . . . 62.32 111.169 176.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.8 t -141.07 177.44 8.06 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.261 1.025 . . . . 72.33 109.14 178.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 169.8 -79.87 0.1 OUTLIER Glycine 0 C--N 1.341 0.851 0 N-CA-C 110.985 -0.846 . . . . 64.43 110.985 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 63.27 -113.8 6.25 Favored Glycine 0 C--N 1.352 1.429 0 C-N-CA 123.318 0.485 . . . . 71.32 113.233 177.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 25.3 p -90.07 90.29 8.06 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.536 0.734 . . . . 74.51 110.668 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.83 78.22 0.74 Allowed Glycine 0 C--N 1.353 1.505 0 CA-C-N 115.754 -0.657 . . . . 62.34 113.658 175.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -123.47 -87.13 0.79 Allowed Glycine 0 C--N 1.348 1.197 0 N-CA-C 111.839 -0.504 . . . . 64.3 111.839 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 39.9 m 72.21 -10.81 0.86 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.547 1.539 . . . . 73.33 114.198 176.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -96.78 143.45 16.74 Favored Glycine 0 C--N 1.35 1.357 0 N-CA-C 112.139 -0.384 . . . . 64.43 112.139 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.591 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 17.4 ttm180 -79.06 120.05 23.07 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.98 0.512 . . . . 65.34 111.064 -177.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -71.44 134.29 46.5 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.0 0.52 . . . . 73.12 110.094 173.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.7 tt -133.93 120.3 20.17 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 106.298 -1.741 . . . . 75.43 106.298 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -91.83 144.24 25.7 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 108.931 -0.766 . . . . 74.12 108.931 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.749 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -154.73 133.25 11.98 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.86 0.464 . . . . 54.05 110.037 -172.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -107.02 116.24 31.57 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.493 0.717 . . . . 73.11 109.365 -168.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.601 HD22 ' HB3' ' A' ' 176' ' ' LEU . 4.2 pp -101.36 115.21 65.38 Favored Pre-proline 0 C--N 1.35 0.604 0 N-CA-C 108.694 -0.854 . . . . 73.43 108.694 177.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -80.26 111.43 2.64 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.533 2.155 . . . . 70.43 110.984 172.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.544 HD21 HD12 ' A' ' 149' ' ' ILE . 30.0 tp -104.6 152.15 22.78 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 121.899 -0.501 . . . . 72.3 110.644 -166.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.9 t -90.35 154.11 19.94 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 123.498 0.719 . . . . 75.01 109.127 178.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.7 mt -68.64 -30.85 69.65 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.499 0.72 . . . . 73.34 112.251 -170.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -64.49 -48.58 74.65 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.14 0.576 . . . . 74.23 109.575 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -63.21 -38.45 91.2 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 114.695 -1.139 . . . . 64.44 112.0 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.422 ' HB2' HD23 ' A' ' 180' ' ' LEU . . . -60.02 -38.47 82.8 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 123.616 0.573 . . . . 74.14 111.505 176.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -76.32 -32.76 58.88 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 115.077 -0.965 . . . . 75.32 111.077 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -74.5 -49.75 20.91 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.096 0.474 . . . . 73.21 111.437 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.445 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 66.63 44.54 89.52 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.163 -0.926 . . . . 54.22 112.036 -164.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -97.09 -161.5 31.8 Favored Glycine 0 C--N 1.351 1.367 0 O-C-N 123.894 0.408 . . . . 75.34 112.244 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -95.71 116.68 29.23 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.772 -0.825 . . . . 74.12 108.772 176.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.498 ' HD2' ' HA ' ' A' ' 96' ' ' THR . 10.0 tpp180 -111.0 126.23 54.57 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.159 0.584 . . . . 71.31 109.527 178.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 91.6 t -73.56 132.89 32.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 114.433 -1.258 . . . . 74.34 110.333 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 28.2 t -116.59 126.76 74.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 107.302 -1.37 . . . . 65.32 107.302 174.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -126.06 110.11 13.16 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.994 0.518 . . . . 63.12 110.27 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -149.25 137.03 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 124.391 1.076 . . . . 72.33 111.072 -177.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.85 17.33 9.86 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.246 1.419 . . . . 62.34 112.732 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.33 1.68 74.82 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 116.404 -0.362 . . . . 55.13 112.987 -176.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -102.38 121.26 41.96 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.385 1.074 . . . . 74.1 110.109 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -98.48 105.49 17.64 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 109.522 -0.548 . . . . 75.42 109.522 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.433 HG13 HG12 ' A' ' 147' ' ' VAL . 49.6 t -106.17 111.86 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.778 0.831 . . . . 75.41 109.062 176.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.6 t -92.39 121.11 33.56 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.191 -1.041 . . . . 65.42 108.191 176.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.433 HG12 HG13 ' A' ' 145' ' ' VAL . 29.8 m -126.16 144.01 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.142 0.577 . . . . 72.11 110.785 -176.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 63.5 ttp85 -88.32 124.59 34.06 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.677 -0.86 . . . . 73.52 108.677 172.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.544 HD12 HD21 ' A' ' 125' ' ' LEU . 4.5 pt -93.47 149.26 36.96 Favored Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 124.295 1.038 . . . . 71.54 109.752 176.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -61.0 140.37 89.72 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 123.013 2.476 . . . . 60.21 113.74 174.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -67.58 113.88 3.1 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.89 2.393 . . . . 71.04 111.199 170.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 86.07 26.38 34.34 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 116.083 -0.508 . . . . 72.44 112.107 -173.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.21 137.22 22.92 Favored 'Isoleucine or valine' 0 C--N 1.358 0.958 0 C-N-CA 123.546 0.738 . . . . 71.1 110.671 176.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 65.3 mtm180 -134.37 164.82 26.58 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.861 0.864 . . . . 74.24 110.642 -174.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -43.29 122.28 2.5 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.177 1.791 . . . . 75.35 114.685 -171.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.18 -6.71 72.39 Favored Glycine 0 C--N 1.352 1.431 0 CA-C-O 119.376 -0.68 . . . . 73.41 114.52 176.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.1 m -60.61 123.33 17.09 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.382 0.673 . . . . 74.24 111.865 175.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.1 p -101.85 132.88 46.89 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.041 0 C-N-CA 123.172 0.589 . . . . 72.15 110.744 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.592 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 75.7 mt -106.32 104.74 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 107.465 -1.309 . . . . 70.14 107.465 176.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -78.94 105.42 10.26 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.723 -0.473 . . . . 73.32 109.723 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.527 HG13 ' HB3' ' A' ' 174' ' ' LEU . 5.8 p -113.44 100.17 51.16 Favored Pre-proline 0 CA--C 1.558 1.277 0 C-N-CA 122.717 0.407 . . . . 74.45 110.166 174.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -64.3 150.73 87.74 Favored 'Trans proline' 0 C--N 1.387 2.592 0 C-N-CA 123.713 2.942 . . . . 64.33 113.168 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 83.35 -25.38 4.99 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 116.223 -0.444 . . . . 73.0 113.988 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.54 -12.84 50.67 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.02 0.928 . . . . 72.04 111.617 -178.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -84.73 -111.87 0.66 Allowed Glycine 0 C--N 1.349 1.279 0 O-C-N 123.511 0.507 . . . . 73.33 112.654 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.591 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -61.34 120.59 23.24 Favored Glycine 0 C--N 1.346 1.136 0 O-C-N 123.818 0.364 . . . . 73.42 112.469 177.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 11.7 mm-40 -88.18 155.42 19.77 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.354 0.662 . . . . 74.01 111.269 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 129.47 -171.4 20.14 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.069 -0.969 . . . . 74.2 111.466 -175.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -60.5 -45.27 97.29 Favored Pre-proline 0 CA--C 1.564 1.487 0 CA-C-O 118.451 -0.785 . . . . 73.13 112.209 175.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -82.73 112.74 2.15 Favored 'Trans proline' 0 C--N 1.395 2.98 0 C-N-CA 121.902 1.735 . . . . 75.43 111.066 171.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.76 127.43 12.31 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.418 2.079 . . . . 75.13 112.068 -177.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -105.12 156.13 16.88 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.973 -0.558 . . . . 73.15 112.785 -175.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -84.91 135.27 34.13 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.709 0.804 . . . . 72.22 111.241 -176.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.527 ' HB3' HG13 ' A' ' 161' ' ' VAL . 23.4 tp -102.21 107.79 18.97 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.457 -0.942 . . . . 73.12 108.457 177.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 78.9 mt -86.49 100.22 12.22 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.606 0.762 . . . . 73.1 109.909 -176.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.601 ' HB3' HD22 ' A' ' 123' ' ' LEU . 75.4 mt -91.42 98.95 12.0 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.059 0.544 . . . . 71.3 110.927 -175.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 47.9 t -91.0 117.34 34.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 109.461 -0.57 . . . . 74.3 109.461 -178.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.5 p -69.73 135.43 28.28 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 C-N-CA 123.339 0.656 . . . . 73.33 110.514 -176.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -127.69 85.64 2.38 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.189 -1.041 . . . . 72.02 108.189 -178.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.422 HD23 ' HB2' ' A' ' 130' ' ' ALA . 43.5 mt -82.36 147.52 28.78 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 114.975 -1.012 . . . . 75.24 110.27 -178.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 60.4 mt -67.01 116.0 31.17 Favored Pre-proline 0 CA--C 1.551 1.0 0 N-CA-C 108.644 -0.873 . . . . 74.25 108.644 176.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -65.05 -24.73 59.43 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.552 2.168 . . . . 72.01 112.359 176.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 . . . . . 0 CA--C 1.549 0.913 0 C-N-CA 124.806 1.242 . . . . 72.54 107.688 171.355 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 3.7 mpp? . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 108.501 -0.926 . . . . 74.01 108.501 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.5 m -62.82 132.12 51.11 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.555 0.742 . . . . 75.33 111.741 -171.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 39.5 m -77.14 151.75 35.21 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.728 0.811 . . . . 73.52 110.262 176.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.647 HD11 ' HB2' ' A' ' 123' ' ' LEU . 26.7 pt -112.46 165.09 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 123.173 0.589 . . . . 75.1 110.985 -174.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -135.25 123.64 23.29 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.936 0.895 . . . . 75.42 109.528 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.572 ' HG ' ' HB2' ' A' ' 121' ' ' ALA . 13.2 tp -76.69 149.44 36.41 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 124.845 1.258 . . . . 73.31 110.231 -172.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.34 -51.37 20.92 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.951 0.501 . . . . 71.14 111.115 -175.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.1 mt 57.72 82.36 0.13 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.357 1.063 . . . . 75.54 111.236 -174.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 45.9 mt -96.6 150.47 37.04 Favored Pre-proline 0 N--CA 1.479 1.008 0 C-N-CA 124.613 1.165 . . . . 75.34 109.664 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -83.49 -176.34 2.71 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.375 2.05 . . . . 73.22 112.714 176.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 74.0 mt -74.22 125.66 28.89 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.138 -0.937 . . . . 74.42 111.889 -176.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 60.49 40.96 98.44 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 124.45 1.094 . . . . 71.01 113.39 173.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 25.6 p -77.38 -43.22 33.5 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.923 0.889 . . . . 72.03 110.661 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 167.84 128.89 1.02 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 110.685 -0.966 . . . . 72.53 110.685 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.62 -132.55 11.0 Favored Glycine 0 C--N 1.349 1.252 0 N-CA-C 111.711 -0.556 . . . . 74.23 111.711 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.1 m -143.76 149.6 37.33 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.284 0.634 . . . . 73.1 111.018 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -141.39 -146.6 4.75 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 114.806 -1.088 . . . . 64.02 110.995 172.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -92.91 -161.53 36.3 Favored Glycine 0 C--N 1.342 0.883 0 N-CA-C 111.998 -0.441 . . . . 74.23 111.998 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 57.8 m -148.34 113.13 5.41 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.625 -0.88 . . . . 74.42 108.625 174.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -127.25 138.5 10.56 Favored Glycine 0 C--N 1.347 1.148 0 N-CA-C 111.968 -0.453 . . . . 73.01 111.968 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -103.45 -65.93 0.72 Allowed Glycine 0 C--N 1.353 1.491 0 N-CA-C 111.452 -0.659 . . . . 73.33 111.452 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.2 m -98.94 60.73 1.24 Allowed 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.624 0.726 . . . . 74.45 109.087 173.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 151.48 90.66 0.08 OUTLIER Glycine 0 C--N 1.339 0.734 0 N-CA-C 109.641 -1.383 . . . . 72.24 109.641 -175.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.487 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 68.4 ttt180 -64.12 127.5 31.73 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.216 1.006 . . . . 74.42 112.459 -171.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -77.21 148.71 35.71 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.263 -0.881 . . . . 63.35 109.114 174.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.2 tt -140.62 131.14 25.4 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.329 -0.989 . . . . 72.22 108.329 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -93.32 115.99 28.56 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 108.895 -0.78 . . . . 73.42 108.895 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.572 ' HB2' ' HG ' ' A' ' 99' ' ' LEU . . . -129.15 144.24 51.14 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.339 -0.615 . . . . 72.32 109.339 -176.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -126.12 120.12 29.34 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 107.962 -1.125 . . . . 74.55 107.962 -176.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.647 ' HB2' HD11 ' A' ' 97' ' ' ILE . 4.0 pp -100.98 110.62 61.58 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 107.519 -1.289 . . . . 73.41 107.519 177.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.99 112.8 3.61 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.794 2.329 . . . . 73.41 108.876 168.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.51 HD22 HD11 ' A' ' 149' ' ' ILE . 22.9 tp -103.21 140.83 36.85 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.149 -0.686 . . . . 75.41 109.149 -168.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.7 t -78.22 162.69 26.39 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 110.101 -0.333 . . . . 62.52 110.101 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.1 mt -64.01 -36.66 84.72 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.014 0.925 . . . . 73.41 112.014 -174.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -62.19 -46.48 88.74 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.487 0.715 . . . . 73.15 109.842 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -71.87 -40.05 69.22 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.398 -1.273 . . . . 70.34 111.833 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.8 -58.34 8.99 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.57 0.7 . . . . 75.13 111.187 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -67.44 -56.7 8.54 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.441 -1.254 . . . . 74.32 111.121 -175.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -77.62 -41.41 38.6 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.246 0.219 . . . . 73.11 111.314 -170.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.59 165.03 38.96 Favored Glycine 0 C--N 1.351 1.366 0 CA-C-N 116.826 -0.17 . . . . 53.11 112.986 -176.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.05 -154.69 25.83 Favored Glycine 0 C--N 1.343 0.954 0 N-CA-C 111.796 -0.522 . . . . 65.5 111.796 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -105.89 121.26 43.72 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.416 -0.957 . . . . 74.12 108.416 172.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 10.2 tpp180 -113.2 122.02 46.23 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 109.575 -0.528 . . . . 75.53 109.575 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 71.7 t -73.32 142.04 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 124.145 0.978 . . . . 72.33 110.263 175.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.485 HG21 ' HB2' ' A' ' 99' ' ' LEU . 3.1 p -135.07 126.13 45.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.866 1.266 . . . . 74.34 108.073 175.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -114.02 109.77 18.98 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.129 0.972 . . . . 74.23 109.461 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.6 m -142.72 141.83 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 124.238 1.015 . . . . 73.41 110.065 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 65.0 19.37 11.84 Favored 'General case' 0 CA--C 1.554 1.134 0 O-C-N 124.632 1.208 . . . . 72.01 111.429 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 79.99 11.34 84.6 Favored Glycine 0 C--N 1.359 1.856 0 CA-C-N 116.066 -0.515 . . . . 64.13 113.1 -174.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -116.31 124.69 50.75 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.402 1.081 . . . . 75.24 110.555 -172.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -98.21 134.22 41.56 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.894 0.877 . . . . 71.34 110.125 -179.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.1 p -147.96 141.15 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 123.544 0.738 . . . . 75.33 109.492 171.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.7 t -107.51 125.3 51.1 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.228 0.611 . . . . 51.21 109.472 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.7 p -106.96 125.9 63.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 123.381 0.672 . . . . 74.1 110.769 -177.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -78.33 102.14 7.55 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.52 0.676 . . . . 74.1 109.68 177.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.51 HD11 HD22 ' A' ' 125' ' ' LEU . 11.2 pt -92.38 144.42 28.87 Favored Pre-proline 0 CA--C 1.556 1.182 0 CA-C-N 114.507 -1.224 . . . . 74.44 109.611 174.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.2 162.12 34.41 Favored 'Trans proline' 0 CA--C 1.563 1.945 0 C-N-CA 122.636 2.224 . . . . 64.32 112.18 176.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.87 125.5 12.16 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.704 2.27 . . . . 73.03 111.803 175.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 81.81 25.81 51.83 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-O 119.892 -0.393 . . . . 71.5 112.127 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.3 p -63.94 119.92 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 C-N-CA 123.452 0.701 . . . . 75.11 110.212 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -103.63 165.89 10.76 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.126 0.97 . . . . 74.2 110.291 -171.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -49.14 134.63 17.51 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 125.37 1.669 . . . . 74.24 111.786 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.51 -11.66 68.4 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-O 119.141 -0.811 . . . . 75.24 114.35 174.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.9 t -65.54 121.19 14.35 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 117.589 0.695 . . . . 54.33 109.392 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 55.9 t -100.54 111.46 30.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 108.927 -0.768 . . . . 75.42 108.927 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 56.5 mt -88.61 103.89 14.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 107.262 -1.384 . . . . 74.34 107.262 169.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.436 ' HG3' HD23 ' A' ' 175' ' ' LEU . 59.4 ttt180 -90.44 124.7 35.18 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.249 -0.648 . . . . 73.43 109.249 -176.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.5 p -124.74 107.14 29.04 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 123.447 0.699 . . . . 73.15 109.469 174.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.2 155.19 61.33 Favored 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 122.485 2.124 . . . . 62.23 111.534 172.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.531 ' HA2' ' HB2' ' A' ' 171' ' ' PRO . . . 85.21 0.35 88.66 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 114.574 0.59 . . . . 74.05 114.574 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.427 ' HE1' ' HB3' ' A' ' 164' ' ' MET . 55.4 mtp -121.84 -7.26 9.01 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 113.623 0.972 . . . . 73.43 113.623 -173.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -82.65 -91.12 0.64 Allowed Glycine 0 N--CA 1.471 0.981 0 CA-C-N 118.013 0.369 . . . . 75.42 112.67 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.487 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -66.09 95.4 0.24 Allowed Glycine 0 C--N 1.345 1.074 0 N-CA-C 111.527 -0.629 . . . . 72.44 111.527 173.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -83.31 110.87 18.48 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.383 0.673 . . . . 75.3 110.398 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -172.9 -146.21 5.33 Favored Glycine 0 C--O 1.241 0.563 0 N-CA-C 110.526 -1.029 . . . . 74.31 110.526 -177.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -75.86 -50.97 3.08 Favored Pre-proline 0 CA--C 1.565 1.539 0 CA-C-O 118.844 -0.598 . . . . 75.24 110.432 175.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -83.6 116.68 2.29 Favored 'Trans proline' 0 C--N 1.397 3.131 0 C-N-CA 121.508 1.472 . . . . 62.41 110.751 170.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.531 ' HB2' ' HA2' ' A' ' 163' ' ' GLY . 29.4 Cg_endo -60.94 125.94 18.38 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.35 2.033 . . . . 74.54 111.368 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -99.2 163.14 20.05 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 113.864 0.306 . . . . 74.21 113.864 -174.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -86.26 144.46 27.41 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.584 0.754 . . . . 74.01 110.637 -176.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 30.7 tp -130.63 122.28 27.13 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.22 0.608 . . . . 72.41 109.525 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.436 HD23 ' HG3' ' A' ' 160' ' ' ARG . 61.6 mt -99.39 114.64 27.67 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.716 -0.846 . . . . 74.35 108.716 177.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.602 ' HB3' HD21 ' A' ' 123' ' ' LEU . 36.9 mt -102.02 100.41 10.68 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.839 -0.8 . . . . 74.4 108.839 175.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.3 p -95.53 126.09 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 109.38 -0.6 . . . . 64.13 109.38 176.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.7 p -73.23 136.05 26.32 Favored 'Isoleucine or valine' 0 C--O 1.247 0.974 0 C-N-CA 123.279 0.632 . . . . 74.13 110.256 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -123.64 103.82 8.64 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.61 -1.255 . . . . 74.21 107.61 -176.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 92.7 mt -105.8 148.29 27.68 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.995 0.918 . . . . 73.33 110.546 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 96.4 mt -54.3 142.04 50.29 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.411 1.084 . . . . 73.34 111.465 -176.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -56.38 -31.04 83.85 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.045 2.496 . . . . 74.5 112.678 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 . . . . . 0 N--CA 1.478 0.932 0 N-CA-C 109.359 -0.608 . . . . 64.23 109.359 171.172 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.513 ' HA ' HG23 ' A' ' 126' ' ' THR . 23.7 ptp . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 110.085 -0.339 . . . . 65.22 110.085 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.8 m -143.3 144.86 32.28 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.394 0.678 . . . . 71.22 109.885 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.0 p -75.4 148.01 39.52 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.653 -0.703 . . . . 75.2 110.384 170.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.509 HD11 ' HB2' ' A' ' 123' ' ' LEU . 24.0 pt -128.29 162.65 34.3 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 CA-C-N 114.521 -1.218 . . . . 73.24 109.729 -167.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -128.12 129.07 45.98 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.277 0.631 . . . . 74.21 110.122 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.656 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.8 tp -72.84 155.84 39.5 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.137 1.375 . . . . 75.41 109.331 -175.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -79.25 -38.27 35.92 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.309 0.504 . . . . 73.04 111.371 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.7 mt 54.04 75.77 0.26 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.438 1.095 . . . . 73.42 111.485 -175.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 31.5 mt -86.35 136.05 35.91 Favored Pre-proline 0 CA--C 1.553 1.092 0 CA-C-N 115.35 -0.841 . . . . 64.34 109.277 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.43 167.04 13.78 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.548 2.165 . . . . 75.2 112.439 175.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 pp -73.8 175.8 6.92 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.916 0.486 . . . . 74.41 112.282 -175.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 170.54 -54.25 0.19 Allowed Glycine 0 C--N 1.339 0.712 0 N-CA-C 110.145 -1.182 . . . . 72.03 110.145 176.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 27.0 t -168.04 121.2 0.89 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.541 -1.281 . . . . 74.44 107.541 177.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -175.17 -48.75 0.05 OUTLIER Glycine 0 C--N 1.345 1.039 0 N-CA-C 112.036 -0.426 . . . . 72.23 112.036 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -87.52 57.42 4.46 Favored Glycine 0 C--N 1.343 0.924 0 N-CA-C 112.45 -0.26 . . . . 54.4 112.45 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.7 m -68.49 147.91 51.34 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.61 0.764 . . . . 74.1 109.894 177.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 95.58 -63.74 1.33 Allowed Glycine 0 C--N 1.335 0.501 0 N-CA-C 110.637 -0.985 . . . . 71.04 110.637 -170.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 71.94 31.58 64.36 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 123.891 0.406 . . . . 74.35 112.884 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.6 m -70.81 109.36 4.95 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.595 0.758 . . . . 70.34 109.975 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.87 -13.6 4.43 Favored Glycine 0 C--N 1.342 0.864 0 CA-C-N 114.689 -1.141 . . . . 75.14 110.884 -168.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.0 -127.56 8.24 Favored Glycine 0 C--N 1.351 1.378 0 N-CA-C 111.542 -0.623 . . . . 74.33 111.542 -177.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 29.5 m -76.81 125.99 30.22 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.217 0.607 . . . . 64.32 110.254 179.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 179.49 105.63 0.2 Allowed Glycine 0 C--N 1.342 0.898 0 N-CA-C 110.989 -0.845 . . . . 72.53 110.989 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.403 ' NH2' HD11 ' A' ' 119' ' ' LEU . 6.9 tmm_? -62.79 117.48 6.39 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.805 0.842 . . . . 64.43 110.195 -175.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -78.95 128.73 33.66 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 122.981 0.512 . . . . 71.43 109.636 178.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.403 HD11 ' NH2' ' A' ' 117' ' ' ARG . 2.8 tt -119.44 117.25 27.96 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.555 -1.646 . . . . 75.3 106.555 178.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -90.4 133.38 35.04 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.272 -1.381 . . . . 75.33 107.272 176.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.656 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -156.99 140.24 15.58 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.467 -0.568 . . . . 74.32 109.467 -174.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -127.19 129.24 47.46 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 110.181 -0.303 . . . . 74.11 110.181 -172.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.509 ' HB2' HD11 ' A' ' 97' ' ' ILE . 4.1 pp -102.09 127.17 31.48 Favored Pre-proline 0 C--N 1.352 0.688 0 N-CA-C 109.575 -0.528 . . . . 71.12 109.575 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.46 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 63.0 Cg_endo -75.05 116.22 4.51 Favored 'Trans proline' 0 C--N 1.362 1.272 0 C-N-CA 122.724 2.282 . . . . 54.13 109.015 168.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.534 HD21 HD13 ' A' ' 149' ' ' ILE . 37.5 tp -103.37 146.2 28.84 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.63 0.65 . . . . 75.33 111.168 -168.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.513 HG23 ' HA ' ' A' ' 94' ' ' MET . 92.8 m -75.32 143.69 42.79 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 114.695 -1.139 . . . . 75.11 109.228 175.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.407 ' HG ' HD11 ' A' ' 181' ' ' LEU . 88.3 mt -68.26 -35.03 77.27 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.721 0.808 . . . . 72.24 112.306 -172.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -68.28 -34.46 76.2 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.023 0.529 . . . . 74.23 109.836 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.433 ' HB3' HD11 ' A' ' 149' ' ' ILE . 57.5 mm-40 -68.19 -40.13 82.29 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.342 -0.844 . . . . 74.12 110.98 176.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.471 ' HB1' HD23 ' A' ' 180' ' ' LEU . . . -68.96 -38.03 79.18 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.811 0.444 . . . . 71.13 111.96 177.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -70.66 -53.31 16.25 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.089 -0.96 . . . . 75.52 110.239 -176.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -77.16 -46.02 24.79 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.796 -0.638 . . . . 75.32 110.828 -176.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.72 94.65 0.16 Allowed Glycine 0 C--N 1.347 1.142 0 O-C-N 123.467 0.479 . . . . 63.4 112.499 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.48 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -153.17 -160.34 9.63 Favored Glycine 0 C--N 1.341 0.81 0 N-CA-C 111.989 -0.445 . . . . 63.4 111.989 -178.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -81.3 114.9 20.4 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.556 -0.535 . . . . 74.33 109.556 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -113.26 124.43 52.5 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.227 1.011 . . . . 63.21 109.163 177.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 77.3 t -78.93 111.08 15.36 Favored 'Isoleucine or valine' 0 C--O 1.245 0.824 0 CA-C-N 114.673 -1.149 . . . . 74.2 109.916 176.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.418 HG12 ' HB ' ' A' ' 145' ' ' VAL . 3.7 p -108.78 109.93 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 124.504 1.121 . . . . 65.13 108.19 170.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -110.64 133.59 53.18 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.886 0.474 . . . . 72.22 110.531 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.46 141.09 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 125.178 1.391 . . . . 74.43 110.537 175.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 60.69 25.94 15.71 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.624 1.17 . . . . 63.44 112.163 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 79.49 8.42 87.77 Favored Glycine 0 C--N 1.355 1.621 0 CA-C-N 116.062 -0.517 . . . . 70.31 113.075 -178.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.404 HH22 ' HG3' ' A' ' 167' ' ' GLN . 39.9 ttm180 -103.31 117.77 35.25 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.957 0.903 . . . . 75.01 109.475 178.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -89.53 108.34 19.6 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.908 -0.775 . . . . 75.33 108.908 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.433 HG13 HG12 ' A' ' 147' ' ' VAL . 19.0 t -104.94 112.88 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 107.9 -1.148 . . . . 63.24 107.9 178.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.1 t -101.04 107.78 19.32 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.791 -0.818 . . . . 72.11 108.791 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.433 HG12 HG13 ' A' ' 145' ' ' VAL . 27.1 m -114.27 132.35 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.251 0.62 . . . . 70.05 111.432 -174.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -88.19 97.6 11.09 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.0 0.92 . . . . 73.33 109.17 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.534 HD13 HD21 ' A' ' 125' ' ' LEU . 10.7 pt -79.96 139.05 53.27 Favored Pre-proline 0 CA--C 1.562 1.413 0 CA-C-N 115.153 -0.93 . . . . 73.43 109.652 178.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.32 149.59 63.56 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.458 2.106 . . . . 74.33 112.657 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.31 112.06 1.8 Allowed 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.525 2.15 . . . . 72.34 110.91 172.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 96.98 23.34 15.27 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-N 115.824 -0.625 . . . . 43.25 112.364 -173.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.487 HG11 ' HB ' ' A' ' 149' ' ' ILE . 6.3 p -66.78 120.17 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 108.479 -0.934 . . . . 72.54 108.479 168.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.401 ' HA ' HD13 ' A' ' 180' ' ' LEU . 24.7 mtp180 -122.45 162.52 21.52 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.235 0.614 . . . . 74.44 110.948 -173.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -42.37 128.15 3.79 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 126.276 1.83 . . . . 72.5 113.201 -175.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.46 -5.83 74.41 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-N 115.746 -0.661 . . . . 73.14 114.264 178.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 17.0 m -64.83 124.09 21.07 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.499 0.72 . . . . 71.25 111.08 174.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 176' ' ' LEU . 3.8 p -105.6 110.88 32.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 123.357 0.663 . . . . 70.04 110.079 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 58.7 mt -90.61 103.5 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 107.951 -1.129 . . . . 73.31 107.951 173.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -78.2 100.27 6.56 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.146 -0.687 . . . . 72.12 109.146 177.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.487 HG12 ' HB3' ' A' ' 174' ' ' LEU . 7.6 p -99.68 108.19 49.82 Favored Pre-proline 0 CA--C 1.56 1.357 0 N-CA-C 109.221 -0.659 . . . . 65.43 109.221 176.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.03 151.47 61.87 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 123.255 2.636 . . . . 75.51 113.539 -172.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 69.53 8.52 59.97 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-N 115.84 -0.618 . . . . 62.23 114.502 172.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 96.8 mmm -104.88 -19.72 13.79 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.127 0.971 . . . . 74.11 110.167 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -78.43 -94.73 0.27 Allowed Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.667 -0.697 . . . . 64.15 111.691 176.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -59.29 98.76 0.12 Allowed Glycine 0 C--N 1.352 1.471 0 C-N-CA 123.179 0.418 . . . . 72.3 113.4 175.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.404 ' HG3' HH22 ' A' ' 143' ' ' ARG . 12.8 mm-40 -89.51 113.55 24.95 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.38 1.072 . . . . 74.33 110.632 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 157.38 -135.19 4.27 Favored Glycine 0 C--N 1.338 0.64 0 O-C-N 123.121 0.263 . . . . 54.02 112.49 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -81.91 -43.13 1.05 Allowed Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 123.59 0.756 . . . . 73.2 111.602 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -91.69 107.24 0.26 Allowed 'Trans proline' 0 C--N 1.396 3.077 0 C-N-CA 122.337 2.025 . . . . 61.35 112.066 169.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.96 125.33 11.42 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 122.343 2.029 . . . . 70.42 111.499 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -114.49 158.67 14.17 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 116.379 -0.373 . . . . 53.15 112.502 -177.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -83.64 148.83 26.91 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.583 0.753 . . . . 71.13 110.701 -177.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.487 ' HB3' HG12 ' A' ' 161' ' ' VAL . 39.3 tp -113.72 103.78 11.56 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 107.208 -1.404 . . . . 74.13 107.208 177.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 81.5 mt -87.04 100.67 12.8 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.786 0.834 . . . . 70.33 109.595 -173.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 158' ' ' VAL . 63.5 mt -89.34 101.66 14.34 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.874 0.87 . . . . 75.24 111.517 -172.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 24.8 t -87.3 118.46 33.28 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 108.693 -0.854 . . . . 73.3 108.693 177.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.6 p -74.59 137.08 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 C-N-CA 122.681 0.393 . . . . 72.34 110.22 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.46 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 32.0 mmt180 -124.87 89.45 3.07 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.192 0.997 . . . . 73.23 109.172 -178.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.471 HD23 ' HB1' ' A' ' 130' ' ' ALA . 32.7 mt -85.65 149.88 25.01 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.593 -0.731 . . . . 73.43 111.711 -178.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.407 HD11 ' HG ' ' A' ' 127' ' ' LEU . 55.9 mt -64.41 139.69 97.78 Favored Pre-proline 0 CA--C 1.561 1.403 0 CA-C-N 114.095 -1.411 . . . . 72.33 109.374 178.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -63.34 -5.87 9.03 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 123.726 2.95 . . . . 74.02 115.006 -171.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 62.7 t-80 . . . . . 0 C--O 1.252 1.218 0 N-CA-C 107.795 -1.187 . . . . 71.41 107.795 171.101 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 109.095 -0.706 . . . . 74.1 109.095 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.403 ' H ' HG21 ' A' ' 126' ' ' THR . 32.5 t -111.57 128.14 55.94 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.103 -0.703 . . . . 63.32 109.103 177.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 26.3 m -76.71 149.23 36.41 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.361 0.664 . . . . 74.14 110.652 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.664 HD13 ' HB2' ' A' ' 123' ' ' LEU . 25.1 pt -112.77 155.49 13.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 C-N-CA 123.452 0.701 . . . . 75.11 109.707 -166.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.51 129.58 48.92 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.97 -0.752 . . . . 55.1 108.97 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.583 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.4 tp -75.53 162.02 28.67 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.8 1.24 . . . . 75.43 109.848 -172.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.06 -44.49 15.11 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.399 0.28 . . . . 75.34 111.055 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 41.7 mt 46.68 69.05 0.52 Allowed 'General case' 0 N--CA 1.482 1.159 0 O-C-N 124.313 1.008 . . . . 74.3 110.214 -169.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.407 HD13 ' HG3' ' A' ' 120' ' ' ARG . 80.8 mt -65.75 119.75 63.17 Favored Pre-proline 0 CA--C 1.549 0.929 0 CA-C-N 115.152 -0.931 . . . . 75.01 108.867 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -54.95 125.16 18.22 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.004 2.47 . . . . 73.43 112.334 -174.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.44 ' HG ' ' H ' ' A' ' 105' ' ' GLY 0.288 1.0 OUTLIER 50.94 -73.13 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 127.167 2.187 . . . . 63.53 114.644 -175.275 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.44 ' H ' ' HG ' ' A' ' 104' ' ' LEU . . . 102.31 -2.18 50.45 Favored Glycine 0 N--CA 1.482 1.722 0 CA-C-O 119.864 -0.409 . . . . 62.3 112.351 -174.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 46.6 m 58.7 51.03 8.11 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.51 1.524 . . . . 63.45 111.735 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.22 -53.81 3.55 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 114.915 -1.039 . . . . 44.34 112.704 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 63.83 23.29 67.25 Favored Glycine 0 C--N 1.352 1.457 0 O-C-N 123.862 0.389 . . . . 62.33 112.539 -173.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.7 m -125.49 128.14 47.55 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.619 1.168 . . . . 74.24 109.868 -172.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -179.21 56.27 0.09 OUTLIER Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.35 -1.1 . . . . 64.04 110.35 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 176.46 33.84 0.05 OUTLIER Glycine 0 C--N 1.341 0.854 0 CA-C-N 115.228 -0.486 . . . . 43.24 111.94 -177.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.0 p -117.21 110.51 18.23 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.383 1.073 . . . . 64.31 108.171 174.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.38 -6.61 56.88 Favored Glycine 0 C--N 1.351 1.409 0 O-C-N 123.541 0.526 . . . . 35.33 113.945 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 149.66 178.87 25.02 Favored Glycine 0 C--N 1.354 1.531 0 CA-C-N 116.915 0.358 . . . . 54.4 112.619 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 35.6 m -78.1 115.42 17.82 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.365 1.066 . . . . 71.15 110.443 178.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 177.42 73.17 0.06 OUTLIER Glycine 0 C--N 1.34 0.775 0 N-CA-C 111.622 -0.591 . . . . 71.03 111.622 -178.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -70.35 116.43 10.68 Favored 'General case' 0 C--O 1.252 1.224 0 N-CA-C 108.746 -0.835 . . . . 75.45 108.746 175.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.445 ' HA ' ' O ' ' A' ' 173' ' ' ASP . 8.9 p-10 -84.34 149.23 26.18 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.015 -0.993 . . . . 73.21 110.81 -171.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.5 tt -130.07 136.95 49.92 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 106.998 -1.482 . . . . 64.11 106.998 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.407 ' HG3' HD13 ' A' ' 102' ' ' LEU . 10.1 tpt180 -91.43 124.89 35.95 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.766 -0.827 . . . . 74.15 108.766 -174.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.583 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -145.7 135.58 23.54 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 122.66 0.384 . . . . 74.34 110.618 -172.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -114.13 121.86 45.08 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.544 -0.91 . . . . 64.5 108.544 -172.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.664 ' HB2' HD13 ' A' ' 97' ' ' ILE . 3.1 pp -100.37 113.61 65.48 Favored Pre-proline 0 CA--C 1.546 0.823 0 N-CA-C 107.786 -1.191 . . . . 74.35 107.786 174.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.536 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 71.9 Cg_endo -75.48 116.28 4.45 Favored 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.601 2.201 . . . . 72.53 109.391 169.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 27.1 tp -101.57 145.37 29.13 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 109.459 -0.571 . . . . 72.42 109.459 -170.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.403 HG21 ' H ' ' A' ' 95' ' ' SER . 4.7 t -91.02 156.09 18.2 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 109.145 -0.687 . . . . 74.21 109.145 -177.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 93.5 mt -60.8 -34.77 75.01 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.864 0.866 . . . . 74.33 111.765 -175.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 131' ' ' PHE . 2.1 mp0 -60.41 -48.45 81.69 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.911 0.885 . . . . 63.31 110.199 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -75.47 -34.33 60.9 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.307 -0.861 . . . . 65.31 111.891 -175.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.1 -39.8 79.55 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.113 0.483 . . . . 61.31 110.319 171.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.403 ' HB3' ' O ' ' A' ' 128' ' ' GLU . 68.8 t80 -66.07 -49.17 68.55 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.865 1.266 . . . . 73.2 111.313 177.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -74.51 -50.72 17.08 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.626 0.37 . . . . 73.11 111.829 -171.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.519 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 66.32 75.73 0.41 Allowed Glycine 0 CA--C 1.532 1.114 0 CA-C-N 115.768 -0.651 . . . . 75.32 111.603 -166.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -148.15 -165.44 12.03 Favored Glycine 0 C--N 1.343 0.946 0 N-CA-C 112.08 -0.408 . . . . 73.34 112.08 -176.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -71.92 115.18 10.83 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.513 -0.551 . . . . 74.53 109.513 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -116.01 121.23 41.62 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.33 -0.989 . . . . 74.45 108.33 174.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 70.7 t -81.29 141.73 14.76 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 C-N-CA 124.489 1.115 . . . . 75.04 109.386 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.7 p -141.45 123.6 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 123.944 0.898 . . . . 73.35 108.964 174.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -124.73 125.47 44.12 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.667 0.787 . . . . 74.11 110.345 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.495 HG22 ' HB3' ' A' ' 99' ' ' LEU . 1.6 m -151.15 131.81 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.967 1.307 . . . . 72.21 109.808 -177.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 59.14 24.28 12.62 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.236 1.015 . . . . 75.53 112.587 176.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 89.6 -7.14 82.49 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-N 116.53 -0.304 . . . . 42.42 113.499 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -94.63 114.68 26.66 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 109.088 -0.708 . . . . 75.51 109.088 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -114.57 127.89 56.03 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.179 0.591 . . . . 75.51 109.616 177.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.28 132.31 45.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 123.76 0.824 . . . . 61.22 108.826 173.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 40.9 t -94.37 127.8 40.49 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.459 -1.312 . . . . 75.01 107.459 170.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 19.7 m -120.98 127.89 76.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 109.468 -0.567 . . . . 70.05 109.468 175.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 56.1 ttt85 -76.59 109.87 10.7 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.981 -1.118 . . . . 74.33 107.981 173.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.519 HG13 ' HA2' ' A' ' 133' ' ' GLY . 12.2 pt -84.01 148.44 53.72 Favored Pre-proline 0 CA--C 1.557 1.243 0 CA-C-N 115.135 -0.939 . . . . 73.13 109.371 177.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -67.58 150.36 79.87 Favored 'Trans proline' 0 C--N 1.369 1.654 0 C-N-CA 122.485 2.123 . . . . 75.43 112.941 172.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -63.4 121.11 8.79 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.652 2.235 . . . . 61.34 111.341 171.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 76.72 30.69 55.79 Favored Glycine 0 N--CA 1.465 0.614 0 CA-C-N 116.288 -0.415 . . . . 65.43 112.115 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.9 p -61.87 125.24 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 108.967 -0.753 . . . . 72.02 108.967 170.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.462 ' HA ' HD13 ' A' ' 180' ' ' LEU . 95.6 mtt180 -116.66 153.87 31.56 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.589 0.756 . . . . 74.25 110.055 -169.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -37.56 123.28 0.99 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 126.446 1.899 . . . . 73.23 113.013 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.63 -20.07 35.06 Favored Glycine 0 N--CA 1.473 1.161 0 CA-C-O 119.207 -0.774 . . . . 71.44 113.726 178.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.1 t -61.95 121.42 12.92 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 117.491 0.645 . . . . 74.01 110.423 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.422 HG22 HG22 ' A' ' 177' ' ' VAL . 55.1 t -101.11 115.3 42.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 109.703 -0.48 . . . . 64.35 109.703 -178.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 57.7 mt -90.02 105.13 15.86 Favored 'Isoleucine or valine' 0 C--N 1.343 0.306 0 N-CA-C 107.391 -1.337 . . . . 65.23 107.391 173.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -84.52 119.44 25.18 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.037 -0.727 . . . . 75.13 109.037 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.454 HG11 ' HB3' ' A' ' 174' ' ' LEU . 6.3 p -124.48 98.16 38.31 Favored Pre-proline 0 CA--C 1.558 1.269 0 C-N-CA 123.394 0.678 . . . . 73.52 109.691 177.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.465 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 32.4 Cg_exo -61.92 150.07 87.66 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.99 2.46 . . . . 75.22 112.679 172.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.47 -16.94 51.66 Favored Glycine 0 N--CA 1.474 1.208 0 CA-C-O 119.963 -0.354 . . . . 73.33 113.807 178.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -102.14 -4.4 25.92 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.94 0.896 . . . . 73.24 111.979 -176.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.479 ' HA2' HD12 ' A' ' 174' ' ' LEU . . . -88.19 -111.59 1.09 Allowed Glycine 0 C--N 1.35 1.347 0 CA-C-O 119.397 -0.668 . . . . 73.21 113.064 -175.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -61.62 102.39 0.44 Allowed Glycine 0 C--N 1.359 1.852 0 CA-C-N 117.01 0.405 . . . . 60.32 112.739 173.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -80.69 135.29 35.99 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.953 0.501 . . . . 71.23 109.95 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 152.26 -155.75 26.31 Favored Glycine 0 C--N 1.343 0.956 0 N-CA-C 111.566 -0.613 . . . . 60.2 111.566 -178.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -66.78 -49.7 47.82 Favored Pre-proline 0 CA--C 1.559 1.297 0 CA-C-O 118.309 -0.853 . . . . 75.42 110.76 178.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.56 114.34 2.98 Favored 'Trans proline' 0 C--N 1.397 3.119 0 C-N-CA 121.392 1.395 . . . . 74.33 110.375 168.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -69.75 123.93 10.59 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 121.962 1.775 . . . . 74.43 110.036 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -100.01 159.24 19.53 Favored Glycine 0 CA--C 1.507 -0.44 0 CA-C-N 116.091 -0.504 . . . . 70.45 113.391 -171.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 34.6 t70 -91.46 151.54 20.75 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.967 0.907 . . . . 64.1 110.017 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.479 HD12 ' HA2' ' A' ' 165' ' ' GLY . 19.5 tp -127.71 119.19 25.28 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 118.104 0.411 . . . . 75.34 110.197 -179.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 97.6 mt -93.53 101.19 13.37 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.639 0.776 . . . . 75.33 109.347 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.636 ' HB3' HD21 ' A' ' 123' ' ' LEU . 48.0 mt -88.68 101.38 13.93 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.276 0.631 . . . . 74.32 109.843 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.422 HG22 HG22 ' A' ' 158' ' ' VAL . 60.7 t -86.1 115.45 27.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 109.406 -0.59 . . . . 74.31 109.406 176.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.417 HG21 HD12 ' A' ' 123' ' ' LEU . 9.6 p -67.64 136.69 26.11 Favored 'Isoleucine or valine' 0 C--O 1.245 0.85 0 N-CA-C 109.346 -0.612 . . . . 74.42 109.346 178.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.536 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 34.4 mmt180 -125.16 91.23 3.38 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.593 0.757 . . . . 74.43 109.406 -175.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.462 HD13 ' HA ' ' A' ' 154' ' ' ARG . 26.2 mt -97.0 132.87 42.38 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 114.759 -1.11 . . . . 74.24 109.333 173.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 75.1 mt -64.46 115.71 22.36 Favored Pre-proline 0 CA--C 1.555 1.154 0 CA-C-N 115.14 -0.937 . . . . 74.14 109.914 -178.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -85.9 44.43 1.31 Allowed 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 123.582 2.854 . . . . 71.12 114.286 -165.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 27.5 p-80 . . . . . 0 CA--C 1.56 1.338 0 N-CA-C 109.576 -0.528 . . . . 75.14 109.576 174.271 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 109.263 -0.643 . . . . 61.52 109.263 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.4 m -59.9 124.12 19.18 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.051 0.941 . . . . 54.43 111.666 -171.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.524 ' HA ' ' NH1' ' A' ' 136' ' ' ARG . 81.3 m -70.76 127.9 34.23 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 123.197 0.599 . . . . 74.2 110.345 179.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.536 HD13 ' HB2' ' A' ' 123' ' ' LEU . 26.2 pt -102.87 153.62 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.588 -0.733 . . . . 73.52 110.798 -169.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -101.79 157.97 16.45 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.299 -1.0 . . . . 75.03 108.299 170.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.552 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.7 tp -90.08 -103.81 0.09 Allowed 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 109.71 -0.478 . . . . 72.44 109.71 -177.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 177.48 -56.26 0.01 OUTLIER 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.036 0.934 . . . . 71.24 108.946 -172.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.544 HD11 ' HB ' ' A' ' 140' ' ' VAL . 75.3 mt 53.21 78.55 0.14 Allowed 'General case' 0 C--N 1.361 1.099 0 C-N-CA 124.658 1.183 . . . . 73.12 110.449 -171.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 61.7 mt -83.99 139.14 39.79 Favored Pre-proline 0 C--O 1.243 0.711 0 CA-C-N 114.705 -1.134 . . . . 75.32 109.665 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -59.04 172.36 1.73 Allowed 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 122.987 2.458 . . . . 75.44 113.604 173.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.58 157.42 36.11 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.71 -1.132 . . . . 74.31 111.511 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.86 -51.25 3.51 Favored Glycine 0 C--N 1.341 0.835 0 CA-C-N 115.697 -0.683 . . . . 73.53 112.433 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.0 p -73.02 93.88 1.82 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.443 0.697 . . . . 73.34 110.614 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 158.46 108.63 0.26 Allowed Glycine 0 C--N 1.341 0.808 0 N-CA-C 109.628 -1.389 . . . . 63.53 109.628 -178.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -69.08 79.71 0.27 Allowed Glycine 0 C--N 1.357 1.712 0 C-N-CA 123.327 0.489 . . . . 72.15 114.16 -172.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.554 ' HB2' HH22 ' A' ' 120' ' ' ARG . 43.7 m -152.3 -25.67 0.17 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.278 1.031 . . . . 74.04 110.588 179.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.55 -144.4 16.72 Favored Glycine 0 C--N 1.35 1.356 0 N-CA-C 110.908 -0.877 . . . . 74.43 110.908 -171.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 171.45 50.35 0.04 OUTLIER Glycine 0 C--N 1.344 0.977 0 CA-C-N 117.113 0.457 . . . . 64.43 112.617 178.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 34.8 p -150.17 109.6 3.99 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.845 -0.798 . . . . 73.51 108.845 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 170.65 59.47 0.04 OUTLIER Glycine 0 C--N 1.342 0.888 0 N-CA-C 111.269 -0.733 . . . . 73.33 111.269 -178.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.1 171.58 28.59 Favored Glycine 0 C--N 1.345 1.057 0 O-C-N 123.951 0.442 . . . . 73.03 112.342 177.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.5 m -83.28 65.61 8.36 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.918 0.887 . . . . 63.13 110.142 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -140.41 89.25 0.19 Allowed Glycine 0 CA--C 1.508 -0.367 0 N-CA-C 109.646 -1.382 . . . . 72.12 109.646 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.443 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 14.9 tpp85 -63.97 114.32 4.03 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.5 -0.555 . . . . 75.54 109.5 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -83.46 145.9 28.7 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.955 -1.128 . . . . 73.14 107.955 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.2 tt -127.62 125.93 41.11 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.789 -1.56 . . . . 72.41 106.789 173.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.554 HH22 ' HB2' ' A' ' 109' ' ' SER . 2.0 tpp180 -91.01 131.79 36.39 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 108.042 -1.095 . . . . 75.31 108.042 -172.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.552 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -158.53 141.86 14.99 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 109.413 -0.588 . . . . 74.03 109.413 -176.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -128.87 131.45 47.65 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.725 -0.472 . . . . 73.55 109.725 -174.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.536 ' HB2' HD13 ' A' ' 97' ' ' ILE . 4.1 pp -104.2 113.79 64.91 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 120.643 0.259 . . . . 71.01 110.309 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.459 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 36.2 Cg_endo -68.44 115.73 4.03 Favored 'Trans proline' 0 C--N 1.364 1.35 0 C-N-CA 122.411 2.074 . . . . 75.25 108.962 163.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.516 HD23 HD12 ' A' ' 149' ' ' ILE . 56.6 tp -102.83 146.11 28.76 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 109.692 -0.484 . . . . 75.33 109.692 -166.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.7 t -80.99 149.9 29.12 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 123.732 0.645 . . . . 70.15 109.612 -175.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.41 -33.92 71.82 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.187 0.995 . . . . 75.44 112.373 -170.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -61.32 -51.8 67.32 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.139 0.899 . . . . 75.11 110.004 178.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.435 ' HB3' HD13 ' A' ' 149' ' ' ILE . 21.4 mm-40 -73.19 -29.87 63.14 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.838 -1.074 . . . . 73.52 112.428 -174.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.23 -48.71 74.79 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-O 121.639 0.733 . . . . 74.3 110.52 174.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -67.74 -53.94 23.34 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 113.967 -1.469 . . . . 75.33 111.089 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -86.66 -46.72 9.8 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.696 -0.684 . . . . 71.44 111.258 -171.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' A' ' 151' ' ' PRO . . . 74.71 144.42 0.99 Allowed Glycine 0 C--N 1.353 1.517 0 N-CA-C 113.996 0.358 . . . . 64.13 113.996 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 158.76 -152.23 23.3 Favored Glycine 0 C--N 1.341 0.815 0 N-CA-C 111.586 -0.606 . . . . 74.32 111.586 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -76.46 116.69 17.38 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.297 -0.631 . . . . 73.42 109.297 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.524 ' NH1' ' HA ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -112.06 133.41 54.24 Favored 'General case' 0 C--N 1.346 0.452 0 C-N-CA 123.173 0.589 . . . . 71.21 110.428 179.525 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 85.8 t -90.91 124.97 43.69 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 C-N-CA 124.487 1.115 . . . . 73.3 110.088 177.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 97' ' ' ILE . 5.8 p -134.24 126.23 49.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 124.606 1.162 . . . . 75.41 108.796 177.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -99.33 140.04 34.09 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.222 0.609 . . . . 74.44 110.726 -174.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.544 ' HB ' HD11 ' A' ' 101' ' ' LEU . 15.4 m -138.75 101.11 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 124.672 1.189 . . . . 75.5 110.303 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.0 26.63 16.09 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.924 0.89 . . . . 63.34 111.679 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.0 -6.12 58.21 Favored Glycine 0 C--N 1.352 1.462 0 CA-C-N 116.014 -0.539 . . . . 70.51 113.741 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.464 ' HB3' HG23 ' A' ' 140' ' ' VAL . 18.0 tpp85 -93.31 119.81 32.88 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.54 0.736 . . . . 75.3 109.853 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -84.08 114.31 21.66 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.25 0.62 . . . . 73.55 109.764 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.406 ' HB ' HG12 ' A' ' 138' ' ' VAL . 36.3 t -107.35 117.57 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.26 1.024 . . . . 73.11 108.698 177.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.5 t -103.5 119.08 38.19 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 108.442 -0.948 . . . . 64.13 108.442 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.6 m -125.72 135.84 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.79 0.836 . . . . 71.44 109.678 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 45.4 ttt85 -81.43 103.48 11.21 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.437 -0.579 . . . . 74.45 109.437 177.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.516 HD12 HD23 ' A' ' 125' ' ' LEU . 13.4 pt -79.93 142.05 55.7 Favored Pre-proline 0 CA--C 1.557 1.23 0 CA-C-N 115.032 -0.986 . . . . 74.3 109.218 172.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.61 138.79 42.67 Favored 'Trans proline' 0 CA--C 1.562 1.906 0 C-N-CA 121.979 1.786 . . . . 73.33 112.146 176.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.445 ' HA ' ' HA3' ' A' ' 133' ' ' GLY . 67.5 Cg_exo -55.45 123.98 15.15 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 123.169 2.58 . . . . 73.31 112.88 171.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 76.56 32.17 51.77 Favored Glycine 0 C--N 1.351 1.413 0 N-CA-C 112.23 -0.348 . . . . 40.32 112.23 -177.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.87 140.28 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 123.659 0.784 . . . . 73.13 109.707 174.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 21.0 mtp180 -118.14 152.67 35.17 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.816 0.846 . . . . 73.22 109.75 -175.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -45.4 129.24 8.33 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 124.966 1.416 . . . . 73.55 111.952 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 104.75 -16.81 46.89 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-O 119.261 -0.744 . . . . 65.42 113.742 177.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.7 m -60.48 119.72 8.57 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 117.652 0.726 . . . . 75.13 111.036 177.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.418 HG23 HG22 ' A' ' 177' ' ' VAL . 49.2 t -101.24 112.34 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 109.383 -0.599 . . . . 74.32 109.383 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 63.7 mt -91.82 106.99 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 108.176 -1.046 . . . . 73.33 108.176 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 -87.46 107.24 18.47 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.173 0.589 . . . . 75.24 109.452 -177.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.57 HG13 ' HB3' ' A' ' 174' ' ' LEU . 3.3 p -104.39 100.66 23.12 Favored Pre-proline 0 CA--C 1.56 1.341 0 N-CA-C 109.706 -0.479 . . . . 74.02 109.706 175.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 58.2 Cg_endo -68.52 156.34 65.91 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.0 2.467 . . . . 72.34 112.709 -178.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 81.91 -8.33 60.32 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 114.37 0.508 . . . . 62.55 114.37 176.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 39.3 mtp -106.29 -13.0 15.51 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.387 0.675 . . . . 70.14 112.555 -175.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -84.04 -86.1 0.88 Allowed Glycine 0 C--N 1.344 1.005 0 N-CA-C 111.539 -0.625 . . . . 44.31 111.539 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.443 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -73.32 106.15 1.93 Allowed Glycine 0 C--N 1.342 0.876 0 O-C-N 123.906 0.415 . . . . 60.4 112.58 175.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -88.25 158.92 18.34 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 123.509 0.724 . . . . 74.3 109.055 175.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 132.67 -117.29 1.95 Allowed Glycine 0 C--N 1.34 0.803 0 N-CA-C 111.181 -0.768 . . . . 75.35 111.181 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.478 ' H ' ' HD2' ' A' ' 170' ' ' PRO . 95.4 m-20 -118.87 -46.16 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 CA-C-O 118.019 -0.991 . . . . 74.32 111.565 175.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.478 ' HD2' ' H ' ' A' ' 169' ' ' ASN . 74.1 Cg_endo -75.53 111.13 3.23 Favored 'Trans proline' 0 C--N 1.392 2.864 0 CA-C-N 121.083 1.422 . . . . 74.14 110.7 168.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.85 127.92 15.21 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.336 2.024 . . . . 74.41 112.051 -175.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -115.13 159.26 13.85 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 115.876 -0.602 . . . . 45.21 112.297 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.491 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 9.2 p-10 -96.12 153.18 17.93 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.876 0.87 . . . . 53.12 111.341 -171.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.57 ' HB3' HG13 ' A' ' 161' ' ' VAL . 48.1 tp -115.02 106.97 14.76 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 107.723 -1.214 . . . . 75.53 107.723 178.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 85.5 mt -84.85 104.87 15.19 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.749 0.82 . . . . 74.4 109.834 -175.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 58.4 mt -96.42 102.07 13.8 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.449 0.699 . . . . 71.55 110.528 -177.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.418 HG22 HG23 ' A' ' 158' ' ' VAL . 25.3 t -86.42 119.22 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 108.977 -0.749 . . . . 72.5 108.977 176.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 5.4 p -71.06 138.12 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 N-CA-C 108.971 -0.752 . . . . 73.45 108.971 178.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.459 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 22.0 mmm180 -127.84 100.77 6.06 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.955 0.902 . . . . 75.4 109.015 -173.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 91.8 mt -109.24 130.23 55.49 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.629 -0.714 . . . . 74.22 109.545 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 75.3 mt -60.3 145.28 86.42 Favored Pre-proline 0 CA--C 1.548 0.871 0 O-C-N 124.449 1.093 . . . . 75.13 110.926 -176.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.73 -29.86 27.28 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 123.671 2.914 . . . . 73.31 113.672 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 . . . . . 0 C--O 1.249 1.07 0 N-CA-C 108.674 -0.862 . . . . 74.2 108.674 170.807 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 69.8 mtm . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 108.749 -0.834 . . . . 73.04 108.749 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.1 p -75.87 146.24 39.94 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.763 0.825 . . . . 75.15 111.654 -173.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 42.9 m -81.28 145.99 30.63 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.068 0.947 . . . . 74.45 110.396 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.6 pt -128.75 172.19 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.971 0.908 . . . . 75.0 110.344 -176.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -134.15 147.98 50.87 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.234 1.013 . . . . 74.43 110.044 -176.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.543 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.5 tp -85.2 173.91 10.05 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.69 -0.856 . . . . 74.25 108.69 -177.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -97.19 -33.47 11.47 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.974 -0.454 . . . . 74.11 111.855 175.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.2 mt 49.98 61.96 2.91 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.706 0.803 . . . . 74.45 110.668 -171.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 71.6 mt -64.46 111.0 4.67 Favored Pre-proline 0 CA--C 1.556 1.203 0 CA-C-N 115.616 -0.72 . . . . 75.11 109.289 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.25 166.22 17.58 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.205 1.937 . . . . 71.44 112.085 -173.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.53 83.64 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.194 0 CA-C-O 121.782 0.801 . . . . 73.24 111.827 177.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.72 -30.16 45.04 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 114.955 -1.02 . . . . 64.53 111.286 174.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.1 t -120.21 166.35 13.58 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.421 1.088 . . . . 75.23 108.696 173.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.7 150.09 34.08 Favored Glycine 0 C--N 1.342 0.902 0 CA-C-N 116.251 -0.431 . . . . 75.31 112.56 178.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -85.99 -168.5 44.84 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-O 121.164 0.313 . . . . 73.15 112.978 175.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.8 m -106.0 150.69 25.48 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.89 0.876 . . . . 73.3 109.981 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -156.15 -157.74 8.47 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.851 -0.5 . . . . 74.23 111.851 178.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 164.78 -155.13 26.35 Favored Glycine 0 C--N 1.349 1.288 0 CA-C-N 117.113 0.457 . . . . 70.1 112.873 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.0 t -64.03 -42.43 97.1 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.271 1.028 . . . . 73.02 110.965 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -119.58 14.85 10.68 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.494 -0.642 . . . . 73.43 111.494 172.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -91.53 91.88 1.67 Allowed Glycine 0 C--N 1.346 1.107 0 N-CA-C 111.331 -0.707 . . . . 71.34 111.331 178.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 54.6 m -132.65 104.3 6.57 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.947 0.899 . . . . 64.53 109.368 177.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 171.81 108.83 0.22 Allowed Glycine 0 C--N 1.344 0.986 0 N-CA-C 110.801 -0.92 . . . . 75.11 110.801 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.456 ' O ' ' HA3' ' A' ' 172' ' ' GLY . 28.6 ttm180 -72.79 122.81 22.16 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.536 0.735 . . . . 73.33 111.132 -178.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -84.65 135.76 34.04 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.191 -1.04 . . . . 71.44 108.191 174.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.8 tt -110.33 125.58 53.33 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 105.688 -1.967 . . . . 73.43 105.688 174.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.45 ' HG2' HD13 ' A' ' 175' ' ' LEU . 27.5 mtp180 -91.96 144.54 25.36 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.361 -0.977 . . . . 75.31 108.361 -175.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.543 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -158.75 156.44 29.83 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.625 -0.509 . . . . 71.41 109.625 -174.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -129.37 138.85 51.76 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.994 -0.743 . . . . 75.15 108.994 176.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 55.7 tp -110.43 101.7 49.3 Favored Pre-proline 0 CA--C 1.538 0.482 0 O-C-N 123.815 0.697 . . . . 74.24 109.842 -175.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.42 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 49.1 Cg_endo -69.9 112.47 3.11 Favored 'Trans proline' 0 C--N 1.372 1.81 0 N-CA-C 108.253 -1.479 . . . . 74.11 108.253 169.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.448 HD22 HD13 ' A' ' 149' ' ' ILE . 35.1 tp -104.87 138.02 41.75 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.47 -0.567 . . . . 73.32 109.47 -168.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.0 t -81.76 153.94 26.24 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 109.124 -0.695 . . . . 71.44 109.124 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 74.2 mt -61.67 -33.61 74.28 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.525 0.73 . . . . 74.33 112.195 -169.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.0 -44.16 97.82 Favored 'General case' 0 C--O 1.22 -0.488 0 O-C-N 124.311 1.007 . . . . 63.1 109.477 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -79.15 -29.22 42.95 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.369 -0.832 . . . . 74.53 112.101 -175.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.52 -39.8 89.16 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.342 0.591 . . . . 72.32 110.21 172.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -74.07 -57.22 4.11 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 114.715 -1.13 . . . . 73.54 110.748 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -61.32 -50.61 72.26 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.122 0.569 . . . . 72.15 110.923 -173.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.586 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 63.71 67.7 1.95 Allowed Glycine 0 C--N 1.337 0.616 0 CA-C-N 114.763 -1.108 . . . . 65.12 112.128 -172.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -134.15 -160.0 9.09 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 112.508 -0.237 . . . . 70.11 112.508 -177.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -82.42 116.75 22.02 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.081 -0.711 . . . . 73.32 109.081 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -114.13 126.68 55.35 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.277 0.631 . . . . 74.1 109.338 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 83.0 t -70.52 110.61 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 124.305 1.003 . . . . 74.44 108.85 173.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.9 t -113.87 109.75 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 108.286 -1.005 . . . . 73.42 108.286 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -117.15 124.52 49.36 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.351 -0.611 . . . . 73.3 109.351 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.501 HG11 ' HB3' ' A' ' 99' ' ' LEU . 5.8 p -149.63 136.09 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.71 1.204 . . . . 75.12 108.601 -175.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.89 18.76 10.09 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.086 0.954 . . . . 75.01 112.322 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 88.01 -5.93 84.19 Favored Glycine 0 C--N 1.35 1.344 0 CA-C-N 116.075 -0.511 . . . . 61.0 113.183 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -94.99 121.87 37.06 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.265 1.026 . . . . 75.51 109.525 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -108.14 115.28 29.84 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.031 0.933 . . . . 75.43 110.31 -174.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.8 p -126.04 119.37 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.239 1.015 . . . . 74.23 109.601 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 39.5 t -88.32 108.71 19.47 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 109.205 -0.665 . . . . 73.35 109.205 176.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.2 p -100.76 127.61 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 123.014 0.526 . . . . 75.52 110.802 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -85.01 103.04 13.69 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.792 -0.818 . . . . 72.23 108.792 172.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.586 HG13 ' HA2' ' A' ' 133' ' ' GLY . 11.6 pt -86.64 151.79 53.4 Favored Pre-proline 0 CA--C 1.562 1.424 0 C-N-CA 124.518 1.127 . . . . 71.43 109.507 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.446 ' HG2' ' HB ' ' A' ' 153' ' ' VAL . 55.2 Cg_endo -71.37 146.32 50.22 Favored 'Trans proline' 0 CA--C 1.565 2.049 0 C-N-CA 122.108 1.872 . . . . 74.42 112.514 174.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.468 ' HA ' ' HA3' ' A' ' 133' ' ' GLY . 23.6 Cg_exo -67.11 124.92 12.79 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.991 2.461 . . . . 72.25 112.036 174.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 81.18 24.52 57.14 Favored Glycine 0 C--N 1.35 1.318 0 O-C-N 123.478 0.486 . . . . 60.25 112.101 -175.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.446 ' HB ' ' HG2' ' A' ' 150' ' ' PRO . 4.4 p -60.65 128.83 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 123.959 0.903 . . . . 74.24 109.413 173.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.462 ' HA ' HD13 ' A' ' 180' ' ' LEU . 76.9 mtp180 -123.56 166.43 15.46 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.118 0.567 . . . . 73.43 110.047 -175.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -45.31 129.62 8.16 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 125.709 1.604 . . . . 75.44 113.357 -172.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.92 -2.66 66.6 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-O 119.404 -0.664 . . . . 65.11 114.623 175.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.6 t -69.56 122.34 18.87 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 117.651 0.725 . . . . 63.42 109.57 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 45.6 t -101.2 113.18 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.186 0.594 . . . . 75.5 109.886 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 51.6 mt -91.52 117.63 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 107.886 -1.153 . . . . 72.31 107.886 170.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -104.97 101.11 10.7 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.924 -0.769 . . . . 74.21 108.924 -173.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.4 p -107.76 107.72 60.64 Favored Pre-proline 0 CA--C 1.556 1.199 0 C-N-CA 123.148 0.579 . . . . 72.13 110.722 -176.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 59.8 Cg_endo -69.37 147.34 65.19 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.561 2.174 . . . . 63.23 112.709 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.41 -3.14 87.64 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 115.794 -0.639 . . . . 64.53 113.527 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 24.7 mmt -103.42 -16.94 15.45 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.304 0.641 . . . . 73.3 110.772 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -91.58 -108.17 1.56 Allowed Glycine 0 C--N 1.349 1.302 0 CA-C-O 119.541 -0.589 . . . . 62.13 113.173 -175.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -60.43 100.39 0.22 Allowed Glycine 0 C--N 1.349 1.28 0 O-C-N 123.861 0.389 . . . . 72.3 112.661 177.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -88.34 116.26 26.43 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 124.04 0.936 . . . . 60.21 109.169 177.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 160.15 -149.21 18.5 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.5 -0.64 . . . . 54.22 111.5 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -70.97 -48.96 13.68 Favored Pre-proline 0 CA--C 1.561 1.369 0 CA-C-O 117.9 -1.047 . . . . 75.34 111.822 177.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -81.81 110.62 2.14 Favored 'Trans proline' 0 C--N 1.391 2.801 0 C-N-CA 121.572 1.514 . . . . 74.0 110.749 174.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -67.79 123.6 10.91 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.358 2.039 . . . . 75.52 110.807 -174.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 117' ' ' ARG . . . -115.67 152.09 18.16 Favored Glycine 0 C--N 1.335 0.477 0 N-CA-C 114.004 0.361 . . . . 50.05 114.004 -172.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 6.8 p-10 -91.66 155.64 18.17 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.516 1.126 . . . . 72.42 110.53 178.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 41.3 tp -112.97 115.52 28.52 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.947 -0.76 . . . . 74.22 108.947 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.45 HD13 ' HG2' ' A' ' 120' ' ' ARG . 73.5 mt -84.53 106.93 16.48 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.102 0.961 . . . . 75.31 109.513 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 27.2 mt -99.54 98.75 9.6 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.843 -0.799 . . . . 72.42 108.843 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 8.5 p -95.75 110.69 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 109.092 -0.706 . . . . 74.23 109.092 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.0 p -66.67 143.77 15.28 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 123.299 0.64 . . . . 65.12 111.275 -172.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.42 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 16.0 mmm180 -126.14 103.11 7.52 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 125.042 1.337 . . . . 75.44 108.192 -174.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.462 HD13 ' HA ' ' A' ' 154' ' ' ARG . 91.8 mt -113.45 131.42 56.03 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.53 0.732 . . . . 72.31 109.984 177.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 81.4 mt -71.04 125.81 92.02 Favored Pre-proline 0 CA--C 1.548 0.896 0 N-CA-C 108.374 -0.972 . . . . 72.31 108.374 173.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.37 -28.7 73.82 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.842 2.361 . . . . 73.32 113.107 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 . . . . . 0 C--O 1.246 0.897 0 C-N-CA 124.734 1.214 . . . . 73.03 107.961 174.998 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.5 ' HB3' ' NH2' ' A' ' 136' ' ' ARG . 59.1 mtt . . . . . 0 N--CA 1.477 0.886 0 N-CA-C 109.299 -0.63 . . . . 54.22 109.299 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.1 m -70.66 134.17 47.3 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.454 0.702 . . . . 75.22 111.062 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.6 m -73.55 138.35 44.93 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.938 0.495 . . . . 74.11 109.73 174.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.554 HD12 ' HB2' ' A' ' 123' ' ' LEU . 21.3 pt -109.53 175.42 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 122.992 0.517 . . . . 64.11 111.547 -166.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -122.81 -167.62 1.61 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.388 1.075 . . . . 74.54 109.617 173.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.663 ' HG ' ' HB3' ' A' ' 121' ' ' ALA . 11.9 tp -142.06 156.26 45.4 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 108.655 -0.868 . . . . 75.22 108.655 -175.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -78.44 -56.99 4.01 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.269 0.228 . . . . 74.43 110.468 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 95.9 mt 60.19 73.49 0.48 Allowed 'General case' 0 CA--C 1.553 1.078 0 O-C-N 124.366 1.041 . . . . 75.52 109.902 -170.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 79.5 mt -70.89 155.94 92.69 Favored Pre-proline 0 CA--C 1.561 1.382 0 C-N-CA 125.251 1.421 . . . . 75.52 111.766 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.16 -170.64 0.43 Allowed 'Trans proline' 0 C--N 1.386 2.532 0 C-N-CA 123.307 2.671 . . . . 73.03 113.646 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 pp -72.12 2.4 5.89 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 114.393 1.257 . . . . 75.23 114.393 -169.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -73.59 81.75 0.72 Allowed Glycine 0 C--N 1.352 1.465 0 CA-C-N 118.192 0.451 . . . . 64.12 112.606 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 73.1 p -157.19 127.55 6.44 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.774 0.83 . . . . 72.43 110.822 -178.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.44 77.56 1.68 Allowed Glycine 0 C--N 1.341 0.844 0 N-CA-C 110.7 -0.96 . . . . 62.1 110.7 172.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.54 89.17 0.04 OUTLIER Glycine 0 C--N 1.355 1.629 0 C-N-CA 123.874 0.749 . . . . 64.31 112.539 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.3 m -96.13 119.89 35.43 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.252 1.021 . . . . 64.23 110.572 -176.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -141.53 159.7 26.82 Favored Glycine 0 C--N 1.343 0.931 0 N-CA-C 111.541 -0.624 . . . . 71.02 111.541 176.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.64 -50.53 53.73 Favored Glycine 0 C--N 1.35 1.339 0 O-C-N 123.766 0.333 . . . . 73.03 112.525 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 65.1 p -89.27 141.48 28.49 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.425 0.69 . . . . 72.22 109.844 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -98.43 136.71 12.86 Favored Glycine 0 C--N 1.345 1.047 0 O-C-N 123.265 0.353 . . . . 44.2 112.397 -177.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -171.69 163.86 36.51 Favored Glycine 0 C--N 1.344 1.017 0 N-CA-C 112.244 -0.342 . . . . 74.2 112.244 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.0 t -84.27 143.26 29.67 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.285 0.634 . . . . 73.22 110.274 177.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 144.33 96.45 0.22 Allowed Glycine 0 C--N 1.34 0.769 0 N-CA-C 109.894 -1.282 . . . . 55.12 109.894 -176.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -61.2 123.69 18.41 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.584 0.753 . . . . 75.25 111.293 -175.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -74.63 116.23 15.09 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 108.736 -0.838 . . . . 70.13 108.736 172.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.7 tt -94.9 118.89 32.53 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 106.735 -1.58 . . . . 75.13 106.735 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -90.98 141.66 28.61 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 108.726 -0.842 . . . . 71.41 108.726 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.663 ' HB3' ' HG ' ' A' ' 99' ' ' LEU . . . -153.25 142.77 21.77 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.821 -0.627 . . . . 64.03 109.545 -171.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.439 ' HB3' ' HG3' ' A' ' 179' ' ' ARG . 35.3 mt-10 -119.69 118.3 30.56 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.181 -1.044 . . . . 73.24 108.181 -174.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.554 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.6 pp -100.74 113.91 65.71 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 108.914 -0.772 . . . . 74.33 108.914 176.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.13 113.95 3.91 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 121.864 1.709 . . . . 73.21 109.335 170.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.501 HD23 HD12 ' A' ' 149' ' ' ILE . 36.1 tp -103.12 151.05 23.03 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 122.004 -0.435 . . . . 74.35 110.601 -167.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 13.4 t -85.61 154.61 21.59 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.955 -0.757 . . . . 72.2 108.955 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 39.3 mt -70.78 -26.68 63.45 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.215 0.606 . . . . 72.23 111.805 -167.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -73.49 -41.82 62.63 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.397 -0.82 . . . . 63.13 110.08 -178.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.446 ' HB3' HD13 ' A' ' 149' ' ' ILE . 34.1 mm-40 -74.4 -31.26 62.27 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.185 -0.916 . . . . 73.2 111.158 177.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.71 -50.83 70.87 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.425 0.69 . . . . 73.53 110.5 176.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -66.67 -62.89 1.22 Allowed 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 114.223 -1.353 . . . . 72.1 110.641 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -70.32 -43.75 69.65 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.929 0.491 . . . . 74.24 111.89 -171.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.43 97.56 0.05 OUTLIER Glycine 0 C--N 1.346 1.103 0 O-C-N 123.816 0.697 . . . . 61.34 113.063 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -144.06 -143.64 4.09 Favored Glycine 0 C--N 1.342 0.883 0 N-CA-C 111.097 -0.801 . . . . 70.01 111.097 178.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -96.26 119.07 34.09 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.845 -0.798 . . . . 74.12 108.845 176.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.5 ' NH2' ' HB3' ' A' ' 94' ' ' MET . 11.0 tpp180 -116.98 123.79 47.78 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.412 0.685 . . . . 74.04 109.386 176.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 146' ' ' SER . 76.2 t -74.47 136.9 24.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 C-N-CA 123.621 0.768 . . . . 72.31 110.683 177.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.436 ' HB ' HG13 ' A' ' 145' ' ' VAL . 39.1 t -115.59 126.17 73.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.29 1.436 . . . . 74.24 107.615 174.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -115.23 101.51 9.02 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.632 -0.507 . . . . 72.14 109.632 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.66 144.16 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 123.719 0.808 . . . . 74.32 110.907 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 65.32 18.69 11.45 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.283 1.433 . . . . 74.51 111.746 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.19 21.76 69.71 Favored Glycine 0 C--N 1.351 1.37 0 CA-C-N 116.016 -0.538 . . . . 72.44 112.257 -175.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -122.45 140.06 53.15 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.923 0.889 . . . . 73.3 110.204 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -102.69 125.32 49.38 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.206 1.002 . . . . 75.4 108.719 177.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.436 HG13 ' HB ' ' A' ' 138' ' ' VAL . 3.5 p -137.78 112.26 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 CA-C-O 121.54 0.686 . . . . 73.0 110.2 176.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 137' ' ' VAL . 46.4 t -90.43 106.0 18.2 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.189 -0.671 . . . . 60.4 109.189 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 28.7 m -100.62 141.15 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.232 0.613 . . . . 73.24 110.13 -178.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.1 ttp180 -90.84 117.47 29.48 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.284 -0.635 . . . . 73.32 109.284 177.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.501 HD12 HD23 ' A' ' 125' ' ' LEU . 9.1 pt -100.49 139.77 20.89 Favored Pre-proline 0 CA--C 1.561 1.378 0 C-N-CA 124.871 1.268 . . . . 73.24 109.307 176.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -63.14 152.46 79.52 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 123.083 2.522 . . . . 74.11 113.695 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.47 121.3 9.04 Favored 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 122.272 1.981 . . . . 73.44 111.228 171.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 85.21 23.64 47.51 Favored Glycine 0 C--N 1.346 1.084 0 N-CA-C 112.13 -0.388 . . . . 73.05 112.13 -176.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.479 HG11 ' HB ' ' A' ' 149' ' ' ILE . 4.1 p -63.53 117.45 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 123.784 0.833 . . . . 63.1 109.853 177.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.496 ' HA ' HD11 ' A' ' 180' ' ' LEU . 82.0 mtm180 -132.89 161.93 32.93 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 115.923 -0.58 . . . . 75.43 110.847 -172.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -35.29 119.77 0.51 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.881 2.072 . . . . 74.52 113.838 -169.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.24 -12.14 48.13 Favored Glycine 0 N--CA 1.473 1.145 0 CA-C-O 119.297 -0.724 . . . . 71.43 114.552 177.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 33.5 t -66.22 122.3 17.15 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 117.832 0.816 . . . . 74.35 109.243 176.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.0 t -110.0 114.55 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.347 0.659 . . . . 74.14 110.402 -176.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 56.0 mt -92.48 120.6 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 108.355 -0.98 . . . . 74.43 108.355 172.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -104.67 116.63 32.38 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.305 0.642 . . . . 74.32 110.143 -176.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.467 HG12 ' HB3' ' A' ' 174' ' ' LEU . 3.3 p -120.45 108.58 37.52 Favored Pre-proline 0 CA--C 1.559 1.316 0 C-N-CA 123.031 0.532 . . . . 70.51 110.725 176.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 16.7 Cg_exo -67.59 153.46 76.23 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.886 2.391 . . . . 71.22 112.267 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.01 -24.19 8.3 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-O 119.864 -0.409 . . . . 72.24 113.909 177.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 92.9 mmm -92.44 -4.92 52.96 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.66 0.784 . . . . 64.42 111.224 -177.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -91.21 -103.02 1.3 Allowed Glycine 0 C--N 1.344 1.007 0 CA-C-O 119.719 -0.49 . . . . 71.3 112.409 -177.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.52 103.8 0.88 Allowed Glycine 0 C--N 1.352 1.418 0 N-CA-C 111.467 -0.653 . . . . 72.11 111.467 175.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.521 HE21 ' HA ' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -87.76 121.47 30.22 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.484 0.714 . . . . 74.0 110.72 -174.923 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 169.88 -146.21 9.82 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 110.633 -0.987 . . . . 75.44 110.633 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -76.79 -49.15 2.68 Favored Pre-proline 0 CA--C 1.56 1.331 0 CA-C-O 118.075 -0.964 . . . . 72.32 109.332 172.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -81.61 112.62 2.46 Favored 'Trans proline' 0 C--N 1.4 3.243 0 C-N-CA 122.173 1.915 . . . . 72.32 111.316 170.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.43 127.75 11.36 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 122.502 2.135 . . . . 74.44 112.239 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -104.88 165.88 14.62 Favored Glycine 0 C--N 1.344 1.022 0 CA-C-N 116.365 -0.38 . . . . 73.34 112.256 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 15.2 m-20 -86.25 142.71 28.37 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.855 0.862 . . . . 64.41 110.773 -177.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.467 ' HB3' HG12 ' A' ' 161' ' ' VAL . 34.5 tp -105.35 104.62 14.39 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 107.934 -1.136 . . . . 75.04 107.934 175.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 51.1 mt -88.46 101.17 13.66 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.197 -0.91 . . . . 73.52 109.282 -175.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 48.0 mt -97.1 101.11 12.61 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.896 0.878 . . . . 73.4 110.455 -174.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.3 p -92.48 130.33 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 109.893 -0.41 . . . . 75.23 109.893 175.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 14.1 p -77.54 133.81 29.83 Favored 'Isoleucine or valine' 0 C--O 1.248 0.999 0 C-N-CA 123.338 0.655 . . . . 73.31 110.053 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.439 ' HG3' ' HB3' ' A' ' 122' ' ' GLU . 9.1 mmm180 -122.6 96.38 5.01 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.167 0.987 . . . . 74.45 108.795 -174.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.496 HD11 ' HA ' ' A' ' 154' ' ' ARG . 64.5 mt -101.23 147.65 26.03 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.657 -0.701 . . . . 72.14 110.588 177.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 61.4 mt -74.83 157.09 86.08 Favored Pre-proline 0 CA--C 1.556 1.186 0 CA-C-N 114.998 -1.001 . . . . 74.44 108.717 171.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.13 2.26 5.11 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.267 1.978 . . . . 73.35 112.991 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 . . . . . 0 CA--C 1.554 1.117 0 C-N-CA 124.672 1.189 . . . . 73.31 108.968 174.01 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 CA--C 1.545 0.766 0 N-CA-C 109.719 -0.474 . . . . 74.5 109.719 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.408 ' H ' HG21 ' A' ' 126' ' ' THR . 23.0 t -82.01 132.65 35.26 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.397 0.679 . . . . 72.33 110.251 178.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.412 ' HA ' HH11 ' A' ' 136' ' ' ARG . 63.9 m -76.05 143.04 41.61 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.607 0.763 . . . . 73.05 110.052 174.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.54 HD13 ' HB2' ' A' ' 123' ' ' LEU . 15.6 pt -121.4 173.02 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 123.012 0.525 . . . . 75.24 111.651 -165.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -124.86 -172.39 2.56 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.321 1.048 . . . . 75.12 109.541 174.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.65 ' HG ' ' HB3' ' A' ' 121' ' ' ALA . 11.6 tp -131.65 148.91 52.63 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 107.677 -1.231 . . . . 75.33 107.677 -177.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.48 -43.16 67.1 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 117.983 0.356 . . . . 65.32 110.949 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 41.8 mt 53.01 79.62 0.12 Allowed 'General case' 0 N--CA 1.477 0.916 0 O-C-N 124.473 1.108 . . . . 75.13 110.907 -173.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 35.0 mt -86.37 121.26 72.47 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 108.29 -1.004 . . . . 74.01 108.29 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.46 87.35 0.27 Allowed 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 122.512 2.141 . . . . 73.52 112.497 -177.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.464 HD23 ' HD2' ' A' ' 117' ' ' ARG . 2.9 mm? 64.84 -81.33 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.403 1.481 . . . . 73.54 112.212 174.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -145.55 -175.62 18.8 Favored Glycine 0 C--N 1.34 0.792 0 O-C-N 123.473 0.483 . . . . 64.22 112.125 -176.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 23.2 t -65.46 130.62 43.97 Favored 'General case' 0 CA--C 1.546 0.788 0 C-N-CA 123.55 0.74 . . . . 74.11 111.189 -176.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 82.0 7.96 87.21 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 115.904 -0.589 . . . . 52.34 112.792 -177.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.38 32.76 59.56 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-N 116.76 0.28 . . . . 70.23 112.575 -176.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 35.3 p -73.78 96.55 2.57 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.071 0.548 . . . . 72.42 110.251 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.457 ' HA2' ' HG ' ' A' ' 104' ' ' LEU . . . -77.37 69.2 2.58 Favored Glycine 0 C--N 1.35 1.351 0 CA-C-N 115.872 -0.604 . . . . 72.41 112.305 177.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -92.44 49.36 2.64 Favored Glycine 0 C--N 1.343 0.971 0 C-N-CA 123.031 0.348 . . . . 71.43 113.089 -173.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 27.5 p -98.28 137.43 37.03 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 109.278 -0.638 . . . . 72.23 109.278 175.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -73.54 -81.3 0.41 Allowed Glycine 0 C--N 1.351 1.388 0 O-C-N 123.638 0.586 . . . . 73.4 113.481 -173.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -115.34 -150.82 9.84 Favored Glycine 0 C--N 1.346 1.132 0 N-CA-C 111.935 -0.466 . . . . 62.55 111.935 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 47.6 p -65.47 91.94 0.13 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.302 1.041 . . . . 64.32 111.071 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 153.93 55.94 0.01 OUTLIER Glycine 0 C--N 1.344 1.012 0 CA-C-N 115.849 -0.614 . . . . 73.44 112.132 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.464 ' HD2' HD23 ' A' ' 104' ' ' LEU . 21.4 ttp180 -68.49 124.08 22.58 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.67 0.788 . . . . 75.3 111.327 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -91.38 111.19 22.58 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.627 0.771 . . . . 73.33 109.984 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.0 tt -95.18 127.32 41.14 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 106.885 -1.524 . . . . 64.45 106.885 173.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -90.04 124.03 34.42 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 107.831 -1.174 . . . . 71.33 107.831 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.65 ' HB3' ' HG ' ' A' ' 99' ' ' LEU . . . -146.15 144.85 30.23 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.156 0.582 . . . . 73.3 110.121 -173.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -128.75 131.11 47.84 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.655 0.382 . . . . 75.51 110.144 -177.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.54 ' HB2' HD13 ' A' ' 97' ' ' ILE . 4.2 pp -107.61 119.71 49.66 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 109.223 -0.658 . . . . 74.44 109.223 177.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.611 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 66.9 Cg_endo -74.14 113.94 3.91 Favored 'Trans proline' 0 C--N 1.364 1.385 0 C-N-CA 122.512 2.142 . . . . 52.45 109.404 169.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 42.1 tp -102.66 154.17 19.41 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 109.326 -0.62 . . . . 74.21 109.326 -168.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.408 HG21 ' H ' ' A' ' 95' ' ' SER . 1.5 t -91.27 148.02 22.64 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 108.154 -1.054 . . . . 74.45 108.154 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.4 mt -64.41 -27.47 69.02 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.106 0.562 . . . . 65.44 111.883 -172.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.24 -41.76 85.1 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.799 0.839 . . . . 74.51 110.035 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -75.07 -34.78 61.84 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.384 0.674 . . . . 73.21 111.345 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.72 -34.62 73.16 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.287 0.635 . . . . 74.55 110.817 171.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -76.34 -46.81 25.85 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 114.773 -1.103 . . . . 74.41 111.437 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 34.3 m80 -73.54 -49.97 23.75 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 120.804 0.335 . . . . 74.25 111.457 -173.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.44 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 70.44 66.22 2.26 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-N 115.422 -0.808 . . . . 52.51 112.226 -173.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -134.44 -158.76 8.58 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 112.45 -0.26 . . . . 54.53 112.45 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -74.98 115.1 14.21 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.594 0.758 . . . . 74.34 109.058 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.412 HH11 ' HA ' ' A' ' 96' ' ' THR . 5.0 tpp180 -114.34 120.61 40.96 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.233 0.54 . . . . 74.12 109.72 178.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 88.1 t -77.17 111.73 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.712 0 CA-C-N 114.825 -1.08 . . . . 55.11 110.124 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 43.6 t -102.89 112.07 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.97 1.308 . . . . 75.24 107.905 172.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -115.13 115.2 26.37 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.008 -0.738 . . . . 74.51 109.008 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.508 HG11 ' HB3' ' A' ' 99' ' ' LEU . 7.6 p -151.61 138.29 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 124.209 1.004 . . . . 65.01 110.035 -178.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.88 18.59 10.92 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.529 1.132 . . . . 71.43 113.472 171.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.63 -2.63 80.62 Favored Glycine 0 C--N 1.351 1.369 0 C-N-CA 122.831 0.253 . . . . 73.14 112.891 -176.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.443 ' HD2' ' HE3' ' A' ' 164' ' ' MET . 18.6 tpp180 -99.01 117.51 33.68 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.279 1.031 . . . . 73.14 108.766 177.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -106.56 105.62 15.74 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.393 -0.966 . . . . 71.32 108.393 172.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.4 p -114.16 137.1 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.845 0.858 . . . . 73.34 109.225 178.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.8 t -97.89 114.89 27.09 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.51 -0.922 . . . . 73.53 108.51 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 33.7 t -100.45 111.6 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.479 1.112 . . . . 71.51 109.131 -178.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -79.88 96.66 6.42 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.589 -0.893 . . . . 72.42 108.589 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.451 ' HB ' HG13 ' A' ' 153' ' ' VAL . 10.1 pt -81.04 147.6 61.83 Favored Pre-proline 0 CA--C 1.56 1.348 0 CA-C-N 114.755 -1.111 . . . . 75.3 110.442 -179.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.43 145.15 42.18 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.41 2.073 . . . . 72.34 112.389 176.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.26 113.29 2.37 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 122.508 2.139 . . . . 71.41 111.879 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 105.14 13.65 24.46 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-N 115.514 -0.766 . . . . 75.04 112.601 -176.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.451 HG13 ' HB ' ' A' ' 149' ' ' ILE . 7.3 p -63.33 127.97 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.529 0.731 . . . . 63.42 110.546 177.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.564 ' HA ' HD12 ' A' ' 180' ' ' LEU . 28.7 mtm180 -134.78 164.26 27.95 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.312 0.645 . . . . 65.12 111.581 -172.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -38.86 125.14 1.46 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 126.314 1.846 . . . . 75.52 113.641 -174.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.25 -11.22 60.09 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-O 119.293 -0.726 . . . . 70.02 114.241 176.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.6 t -67.4 121.79 16.53 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 117.432 0.616 . . . . 71.33 110.191 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 40.6 t -104.23 111.14 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.55 0.74 . . . . 75.43 110.435 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 75.7 mt -93.6 106.45 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 125.236 1.414 . . . . 63.42 109.521 175.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 30.8 ttt-85 -79.67 106.29 11.59 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.26 0.624 . . . . 73.43 109.777 175.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.405 HG11 ' HB3' ' A' ' 174' ' ' LEU . 7.6 p -106.05 104.89 51.64 Favored Pre-proline 0 CA--C 1.562 1.432 0 N-CA-C 109.175 -0.676 . . . . 71.12 109.175 171.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 59.6 Cg_endo -69.29 154.18 69.98 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 123.04 2.494 . . . . 73.51 113.615 -175.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 75.82 2.88 72.03 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 115.47 -0.787 . . . . 72.24 113.881 177.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.443 ' HE3' ' HD2' ' A' ' 143' ' ' ARG . 92.7 mmm -110.37 -25.95 9.81 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.553 0.741 . . . . 73.33 111.916 -172.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -83.18 -73.17 1.25 Allowed Glycine 0 C--N 1.345 1.06 0 N-CA-C 111.313 -0.715 . . . . 60.44 111.313 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -62.47 96.29 0.14 Allowed Glycine 0 C--N 1.345 1.035 0 N-CA-C 111.8 -0.52 . . . . 55.03 111.8 165.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -88.79 170.58 10.63 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.458 1.103 . . . . 72.15 110.288 176.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 97.49 -147.88 18.78 Favored Glycine 0 C--N 1.341 0.807 0 CA-C-N 116.14 -0.482 . . . . 73.04 112.166 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -64.64 -49.16 71.68 Favored Pre-proline 0 CA--C 1.57 1.723 0 CA-C-O 118.458 -0.782 . . . . 72.24 111.907 177.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -84.13 129.58 4.58 Favored 'Trans proline' 0 C--N 1.392 2.832 0 C-N-CA 122.046 1.831 . . . . 74.13 111.409 175.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.33 145.52 34.39 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 121.959 1.773 . . . . 74.41 111.168 170.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -152.55 164.4 30.65 Favored Glycine 0 N--CA 1.47 0.925 0 CA-C-O 120.195 -0.225 . . . . 74.24 112.636 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.469 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 29.8 m-20 -84.23 146.33 27.86 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.143 0.577 . . . . 75.14 111.498 -167.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.405 ' HB3' HG11 ' A' ' 161' ' ' VAL . 33.7 tp -114.87 104.24 11.74 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.458 -1.312 . . . . 52.32 107.458 176.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 68.5 mt -85.82 100.36 12.0 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.613 0.765 . . . . 75.31 109.392 -174.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 67.1 mt -92.79 99.25 11.96 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.817 0.847 . . . . 74.5 110.786 -174.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.8 p -89.22 123.5 41.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 N-CA-C 109.037 -0.727 . . . . 64.31 109.037 173.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.5 p -77.7 143.76 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 123.437 0.695 . . . . 74.22 110.59 -176.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.611 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 30.0 mmt180 -123.99 96.94 5.13 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.066 0.947 . . . . 73.41 109.656 -177.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.564 HD12 ' HA ' ' A' ' 154' ' ' ARG . 49.1 mt -100.53 114.84 28.81 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.261 -0.644 . . . . 74.21 109.261 173.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 69.0 mt -64.59 130.15 94.59 Favored Pre-proline 0 CA--C 1.548 0.9 0 O-C-N 123.917 0.761 . . . . 72.24 109.282 176.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -58.36 -48.46 15.51 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.938 2.426 . . . . 62.53 111.604 -176.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 . . . . . 0 C--O 1.251 1.179 0 C-N-CA 125.058 1.343 . . . . 74.34 107.448 171.811 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.416 ' HB3' ' NH2' ' A' ' 136' ' ' ARG . 65.8 mtt . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 109.082 -0.71 . . . . 72.44 109.082 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.2 m -66.82 120.37 13.44 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 116.192 -0.458 . . . . 71.45 109.956 176.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.2 m -85.8 137.03 33.08 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 109.305 -0.628 . . . . 75.2 109.305 177.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.468 HD13 ' HB2' ' A' ' 123' ' ' LEU . 9.1 pt -123.73 166.29 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 112.359 0.503 . . . . 71.44 112.359 -155.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -112.37 176.63 4.94 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.783 1.233 . . . . 64.32 109.269 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.613 ' HG ' ' HB3' ' A' ' 121' ' ' ALA . 12.3 tp -126.52 150.81 48.55 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.745 -0.835 . . . . 70.14 108.745 -174.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.7 -34.33 71.83 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.881 0.472 . . . . 75.42 112.134 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.652 HD12 ' HB ' ' A' ' 140' ' ' VAL . 21.7 mt 47.35 56.35 7.06 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.146 0.978 . . . . 74.31 112.065 -176.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.6 mt -71.25 117.28 55.31 Favored Pre-proline 0 CA--C 1.553 1.064 0 N-CA-C 108.926 -0.768 . . . . 71.21 108.926 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.74 177.25 1.01 Allowed 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.149 1.899 . . . . 74.4 112.447 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.582 HD21 ' HG3' ' A' ' 117' ' ' ARG . 1.4 pp -66.19 -15.14 62.9 Favored 'General case' 0 CA--C 1.554 1.114 0 O-C-N 122.184 -0.323 . . . . 75.11 111.581 176.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.07 -90.18 0.59 Allowed Glycine 0 C--N 1.363 2.07 0 N-CA-C 110.813 -0.915 . . . . 71.33 110.813 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.8 m -128.89 87.66 2.61 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.652 -1.24 . . . . 72.32 107.652 172.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -126.44 156.86 20.07 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-N 116.086 -0.506 . . . . 75.22 111.977 -177.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -71.35 104.53 1.45 Allowed Glycine 0 C--N 1.349 1.263 0 N-CA-C 111.316 -0.714 . . . . 75.34 111.316 176.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.1 t -68.65 98.34 0.88 Allowed 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.634 0.774 . . . . 73.42 109.916 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -171.95 -107.98 0.21 Allowed Glycine 0 C--N 1.342 0.883 0 CA-C-N 115.695 -0.684 . . . . 52.43 111.96 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.482 ' HA3' ' HA2' ' A' ' 116' ' ' GLY . . . 86.73 167.24 43.46 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 111.846 -0.501 . . . . 72.15 111.846 -171.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.2 t -149.98 -52.59 0.15 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.627 0.771 . . . . 65.14 109.234 -175.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -155.9 152.15 23.61 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.543 -0.753 . . . . 75.03 111.263 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.13 -63.51 4.47 Favored Glycine 0 C--N 1.343 0.965 0 N-CA-C 111.59 -0.604 . . . . 64.12 111.59 -176.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.3 m -135.08 116.0 14.08 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 123.916 0.887 . . . . 75.53 109.273 176.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.482 ' HA2' ' HA3' ' A' ' 111' ' ' GLY . . . -72.66 -89.62 0.14 Allowed Glycine 0 C--N 1.343 0.946 0 N-CA-C 109.456 -1.458 . . . . 54.22 109.456 166.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.582 ' HG3' HD21 ' A' ' 104' ' ' LEU . 23.7 ttm180 -97.87 125.48 42.77 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.055 -1.091 . . . . 73.42 108.055 158.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -91.59 121.6 33.41 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 107.542 -1.281 . . . . 65.44 107.542 168.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.4 tt -108.37 121.6 45.27 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 106.943 -1.503 . . . . 74.13 106.943 -177.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -92.48 135.02 34.4 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.871 -0.789 . . . . 72.13 108.871 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.613 ' HB3' ' HG ' ' A' ' 99' ' ' LEU . . . -156.28 138.1 14.32 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 122.921 0.488 . . . . 74.42 109.8 -174.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -126.77 128.63 46.91 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 110.166 -0.309 . . . . 75.22 110.166 -170.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.468 ' HB2' HD13 ' A' ' 97' ' ' ILE . 3.5 pp -103.13 133.36 20.38 Favored Pre-proline 0 C--N 1.349 0.583 0 C-N-CA 123.342 0.657 . . . . 72.31 109.816 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.553 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 71.9 Cg_endo -78.13 115.93 3.84 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 122.418 2.079 . . . . 75.04 109.172 166.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.476 HD23 HD11 ' A' ' 149' ' ' ILE . 39.3 tp -102.72 147.38 26.91 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.554 -0.536 . . . . 73.14 109.554 -169.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.7 t -86.59 145.22 26.83 Favored 'General case' 0 C--O 1.245 0.839 0 N-CA-C 107.833 -1.173 . . . . 62.44 107.833 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.39 -20.75 65.59 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 112.766 0.654 . . . . 73.3 112.766 -170.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -67.61 -48.15 67.61 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.424 -0.584 . . . . 75.1 109.424 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -64.32 -38.41 90.93 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.081 -0.963 . . . . 71.32 111.149 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.413 ' HB2' HD22 ' A' ' 180' ' ' LEU . . . -59.97 -48.02 83.43 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.849 0.718 . . . . 73.44 111.569 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -67.86 -60.0 2.85 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.931 -1.031 . . . . 71.32 111.078 -178.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -67.14 -36.9 82.85 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.218 0.607 . . . . 74.54 111.437 -173.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.0 79.11 0.34 Allowed Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.568 -0.742 . . . . 74.34 111.572 -173.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.44 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -118.05 -172.16 15.62 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 112.731 -0.148 . . . . 73.45 112.731 -177.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -91.82 120.08 32.2 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.564 -1.273 . . . . 74.1 107.564 171.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.416 ' NH2' ' HB3' ' A' ' 94' ' ' MET . 8.5 tpp180 -113.1 122.11 46.59 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.377 -0.601 . . . . 75.44 109.377 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.498 HG11 ' HG3' ' A' ' 144' ' ' ARG . 99.5 t -72.55 132.1 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.179 0.992 . . . . 73.11 109.985 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.46 ' HB ' HG12 ' A' ' 145' ' ' VAL . 28.8 t -127.64 128.2 69.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 107.018 -1.475 . . . . 73.12 107.018 175.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.65 99.61 9.2 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.662 0.744 . . . . 72.54 111.069 -175.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.652 ' HB ' HD12 ' A' ' 101' ' ' LEU . 14.4 m -132.79 134.56 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 112.415 0.524 . . . . 73.0 112.415 -173.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 59.84 25.44 14.53 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.929 1.291 . . . . 73.4 112.298 173.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 80.32 22.39 62.88 Favored Glycine 0 C--N 1.355 1.626 0 CA-C-N 115.813 -0.631 . . . . 64.13 112.964 -178.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 24.5 tpp180 -133.8 126.54 30.79 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.309 1.044 . . . . 74.43 109.692 -175.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.498 ' HG3' HG11 ' A' ' 137' ' ' VAL . 13.6 ttm180 -73.21 120.46 18.86 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 109.234 -0.654 . . . . 75.23 109.234 167.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.46 HG12 ' HB ' ' A' ' 138' ' ' VAL . 3.5 p -118.7 112.14 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.244 -1.021 . . . . 64.53 108.244 169.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.2 t -94.42 109.65 21.5 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.167 -1.049 . . . . 62.23 108.167 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.5 p -97.56 118.44 44.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 CA-C-O 121.572 0.701 . . . . 74.25 109.946 -177.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -82.83 114.76 21.37 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.585 -0.894 . . . . 71.0 108.585 173.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.476 HD11 HD23 ' A' ' 125' ' ' LEU . 6.6 pt -99.47 149.9 36.28 Favored Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 124.506 1.123 . . . . 63.33 109.542 179.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.99 149.84 77.52 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.246 1.964 . . . . 75.34 112.029 176.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -66.23 113.71 2.75 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 122.406 2.071 . . . . 62.51 110.845 175.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 89.44 31.34 11.72 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-N 115.836 -0.62 . . . . 72.42 113.023 -175.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.26 138.09 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.333 0.653 . . . . 75.13 109.767 173.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -127.05 162.36 26.22 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.38 0.672 . . . . 75.42 111.063 -174.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -46.78 131.84 11.56 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 126.343 1.857 . . . . 75.2 113.344 -172.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.93 -2.55 84.24 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-O 119.554 -0.581 . . . . 72.13 114.434 177.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.1 t -66.87 122.51 17.86 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 117.474 0.637 . . . . 74.21 109.443 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.7 p -101.94 135.94 36.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 123.491 0.717 . . . . 75.3 109.991 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.567 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 45.4 mt -120.55 103.67 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.362 1.065 . . . . 73.45 108.734 -176.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -80.25 110.88 16.1 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.352 0.661 . . . . 74.25 109.702 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.5 p -115.21 110.15 45.84 Favored Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 122.904 0.482 . . . . 73.11 110.101 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.84 145.08 49.97 Favored 'Trans proline' 0 C--N 1.383 2.347 0 C-N-CA 122.885 2.39 . . . . 70.04 113.392 -175.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.08 15.51 78.67 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-N 115.557 -0.747 . . . . 71.23 113.565 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 87.3 mmm -113.18 -18.19 12.18 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.462 0.705 . . . . 71.3 111.026 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -96.84 -89.58 1.84 Allowed Glycine 0 C--N 1.349 1.295 0 N-CA-C 112.155 -0.378 . . . . 74.14 112.155 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -76.03 98.48 1.21 Allowed Glycine 0 C--N 1.345 1.033 0 C-N-CA 122.848 0.261 . . . . 75.3 112.527 176.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.556 HE21 ' HA ' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -88.56 113.53 24.24 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.444 0.698 . . . . 75.5 110.065 177.759 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 166.83 -154.53 25.03 Favored Glycine 0 C--O 1.241 0.551 0 N-CA-C 111.821 -0.512 . . . . 61.53 111.821 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -73.37 -50.92 5.98 Favored Pre-proline 0 CA--C 1.563 1.454 0 CA-C-O 117.97 -1.014 . . . . 73.05 110.992 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.14 111.6 3.31 Favored 'Trans proline' 0 C--N 1.393 2.878 0 CA-C-N 121.572 1.597 . . . . 73.11 110.315 168.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -67.11 125.36 13.46 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.526 2.151 . . . . 74.34 111.901 -173.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -120.25 146.34 17.76 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 111.908 -0.477 . . . . 73.42 111.908 -176.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -105.29 170.77 7.69 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.057 0.943 . . . . 75.54 112.024 -172.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 45.4 tp -121.99 113.8 20.09 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.792 1.237 . . . . 64.45 108.758 -177.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 69.4 mt -85.25 99.99 11.48 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.7 0.8 . . . . 71.35 110.032 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . 0.567 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 87.9 mt -88.93 100.43 13.18 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.244 0.618 . . . . 74.34 111.274 -175.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 71.4 t -89.2 124.83 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 109.198 -0.668 . . . . 74.42 109.198 177.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.4 p -80.53 137.82 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 122.727 0.411 . . . . 74.13 110.524 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.553 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 33.7 mmt180 -122.09 91.6 3.54 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.201 1.0 . . . . 72.33 109.255 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.413 HD22 ' HB2' ' A' ' 130' ' ' ALA . 43.2 mt -93.74 140.33 29.78 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.334 0.654 . . . . 72.42 111.355 -178.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 70.7 mt -75.4 119.11 75.5 Favored Pre-proline 0 CA--C 1.548 0.893 0 CA-C-N 114.869 -1.059 . . . . 75.11 109.182 177.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.35 -31.85 17.16 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.634 2.223 . . . . 74.45 111.977 -176.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 85.6 t60 . . . . . 0 CA--C 1.544 0.736 0 C-N-CA 125.034 1.333 . . . . 71.23 108.189 168.653 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.506 ' HB3' ' NH2' ' A' ' 136' ' ' ARG . 49.9 mtm . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 109.064 -0.717 . . . . 70.239999999999995 109.064 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.1 m -62.79 137.25 58.22 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.676 0.39 . . . . 62.310000000000002 111.093 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.3 m -70.93 148.62 47.53 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.705 0.802 . . . . 64.219999999999999 110.27 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.677 HD12 ' HB2' ' A' ' 123' ' ' LEU . 13.2 pt -117.28 163.02 14.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 123.104 0.562 . . . . 74.340000000000003 110.327 -177.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -139.12 124.12 18.85 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.714 0.806 . . . . 53.009999999999998 108.938 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.706 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.2 tp -72.17 160.44 32.43 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.46 1.104 . . . . 75.340000000000003 109.81 -173.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.527 ' HB3' ' H ' ' A' ' 122' ' ' GLU . . . -84.11 -43.92 14.56 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.489 0.316 . . . . 71.120000000000005 110.977 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.408 HD23 ' HB2' ' A' ' 121' ' ' ALA . 43.6 mt 49.35 71.97 0.34 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.063 0.945 . . . . 72.439999999999998 111.018 -168.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.623 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 86.2 mt -76.38 133.09 71.7 Favored Pre-proline 0 C--O 1.239 0.536 0 CA-C-N 115.34 -0.846 . . . . 73.409999999999997 109.718 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo . . . . . 0 C--N 1.374 1.895 0 C-N-CA 121.992 1.795 . . . . 64.400000000000006 110.15 164.621 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? . . . . . 0 CA--C 1.543 0.71 0 CA-C-O 121.166 0.508 . . . . 75.099999999999994 110.062 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -82.9 149.37 27.12 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.556 0.742 . . . . 73.409999999999997 109.653 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.5 tt -141.63 138.28 32.43 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 106.249 -1.76 . . . . 64.329999999999998 106.249 176.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.623 ' HG3' ' HB2' ' A' ' 102' ' ' LEU . 13.2 ptm180 -103.75 149.58 24.87 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.228 0.537 . . . . 71.109999999999999 110.504 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.706 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -159.63 135.89 8.92 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.765 -0.652 . . . . 53.43 109.76 -172.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.527 ' H ' ' HB3' ' A' ' 100' ' ' ALA . 7.0 mm-40 -108.5 120.93 43.85 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 107.583 -1.265 . . . . 64.400000000000006 107.583 -171.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.768 HD23 ' HB3' ' A' ' 176' ' ' LEU . 3.6 pp -101.08 110.47 61.3 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 108.085 -1.08 . . . . 74.120000000000005 108.085 176.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.61 112.29 3.5 Favored 'Trans proline' 0 C--N 1.367 1.536 0 C-N-CA 121.785 1.657 . . . . 75.530000000000001 108.994 169.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.54 HD21 HD12 ' A' ' 149' ' ' ILE . 32.1 tp -103.54 153.06 20.98 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.32 -0.622 . . . . 63.109999999999999 109.32 -169.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.7 t -92.51 146.07 23.96 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 108.024 -1.102 . . . . 71.510000000000005 108.024 178.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.514 HD23 HD22 ' A' ' 180' ' ' LEU . 87.6 mt -66.18 -24.5 66.64 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.919 0.711 . . . . 75.340000000000003 112.919 -173.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.08 -45.43 94.75 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.456 -0.572 . . . . 75.510000000000005 109.456 174.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.436 ' HB3' HD11 ' A' ' 149' ' ' ILE . 18.3 mm-40 -76.15 -31.6 58.65 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.128 -0.942 . . . . 75.109999999999999 111.83 -178.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.58 -36.36 78.34 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.936 0.494 . . . . 62.340000000000003 110.241 173.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -74.2 -57.99 3.59 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.755 -1.112 . . . . 63.340000000000003 110.945 176.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -60.95 -50.14 74.62 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.122 0.569 . . . . 73.329999999999998 111.184 -172.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.533 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 64.34 61.59 5.87 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 114.759 -1.11 . . . . 63.32 112.626 -173.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.445 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -123.92 -157.63 9.86 Favored Glycine 0 N--CA 1.467 0.749 0 N-CA-C 111.179 -0.768 . . . . 73.319999999999993 111.179 177.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -78.18 126.11 30.33 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.12 -0.696 . . . . 74.239999999999995 109.12 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.506 ' NH2' ' HB3' ' A' ' 94' ' ' MET . 8.6 tpp180 -120.05 123.06 42.51 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.727 -0.842 . . . . 72.409999999999997 108.727 175.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 72.7 t -71.58 113.7 8.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-N 114.306 -1.315 . . . . 44.140000000000001 109.677 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.522 HG22 HD11 ' A' ' 97' ' ' ILE . 35.9 t -100.88 112.17 32.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 108.394 -0.965 . . . . 73.430000000000007 108.394 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -99.8 113.72 26.42 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.102 -1.073 . . . . 70.299999999999997 108.102 174.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.0 p -152.66 132.14 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 122.92 0.488 . . . . 54.450000000000003 110.986 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 60.88 20.92 11.15 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.213 1.005 . . . . 75.319999999999993 112.792 173.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.62 -6.19 80.08 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-O 119.847 -0.418 . . . . 63.420000000000002 113.291 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.419 ' NH1' ' SD ' ' A' ' 164' ' ' MET . 35.1 ttm180 -101.71 122.77 44.54 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.908 0.883 . . . . 70.540000000000006 109.947 -178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -97.42 108.31 21.01 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.253 1.021 . . . . 50.039999999999999 108.641 174.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 3.2 p -123.26 113.66 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.392 0.677 . . . . 54.109999999999999 109.551 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.2 t -91.27 113.92 26.32 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.789 -0.819 . . . . 61.109999999999999 108.789 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 23.3 m -108.34 133.68 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.364 0.666 . . . . 72.0 110.584 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -81.99 96.05 7.6 Favored 'General case' 0 C--N 1.349 0.548 0 N-CA-C 108.886 -0.783 . . . . 71.239999999999995 108.886 176.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.54 HD12 HD21 ' A' ' 125' ' ' LEU . 12.3 pt -73.4 147.24 87.32 Favored Pre-proline 0 CA--C 1.559 1.301 0 CA-C-N 114.636 -1.165 . . . . 75.530000000000001 109.609 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.6 142.01 75.62 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.915 2.41 . . . . 72.049999999999997 113.508 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.29 117.21 3.99 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.332 2.021 . . . . 64.319999999999993 110.996 170.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 93.0 17.82 42.3 Favored Glycine 0 C--N 1.34 0.786 0 O-C-N 123.645 0.59 . . . . 41.149999999999999 112.901 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.7 p -62.93 123.79 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 C-N-CA 123.424 0.69 . . . . 72.299999999999997 110.255 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -127.44 164.31 22.16 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.278 0.631 . . . . 70.030000000000001 110.982 -172.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -40.84 127.05 2.56 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.28 1.832 . . . . 64.409999999999997 113.767 -171.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.32 -11.77 66.95 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-O 119.486 -0.619 . . . . 72.340000000000003 114.246 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.4 m -60.64 121.1 11.37 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 117.553 0.676 . . . . 62.439999999999998 110.281 173.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.423 HG22 HG22 ' A' ' 177' ' ' VAL . 61.4 t -105.52 110.97 32.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.334 0.653 . . . . 71.109999999999999 109.524 -178.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.416 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 67.0 mt -90.33 103.73 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 107.985 -1.117 . . . . 74.019999999999996 107.985 177.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -83.01 101.33 11.03 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.752 -0.658 . . . . 72.230000000000004 109.451 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.438 HG13 ' HB3' ' A' ' 174' ' ' LEU . 3.8 p -101.93 109.05 58.78 Favored Pre-proline 0 CA--C 1.558 1.251 0 C-N-CA 123.24 0.616 . . . . 75.310000000000002 110.205 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.461 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 16.5 Cg_exo -69.13 145.56 61.2 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.859 2.373 . . . . 65.030000000000001 112.799 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 87.42 0.27 84.74 Favored Glycine 0 C--N 1.344 1.02 0 CA-C-N 115.643 -0.708 . . . . 73.329999999999998 113.722 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.419 ' SD ' ' NH1' ' A' ' 143' ' ' ARG . 24.5 mmt -107.7 -12.09 15.3 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.454 0.701 . . . . 75.120000000000005 111.485 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -98.87 -87.17 1.9 Allowed Glycine 0 C--N 1.351 1.37 0 N-CA-C 112.102 -0.399 . . . . 63.109999999999999 112.102 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.26 97.02 0.22 Allowed Glycine 0 C--N 1.349 1.29 0 C-N-CA 123.249 0.452 . . . . 62.439999999999998 112.872 176.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -90.44 170.94 9.8 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.705 1.202 . . . . 70.329999999999998 110.575 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 110.96 -66.13 0.24 Allowed Glycine 0 N--CA 1.47 0.947 0 C-N-CA 123.364 0.507 . . . . 63.119999999999997 112.189 173.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -154.79 -53.96 0.02 OUTLIER Pre-proline 0 CA--C 1.558 1.287 0 CA-C-O 117.739 -1.124 . . . . 73.219999999999999 111.155 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -81.32 109.35 2.1 Favored 'Trans proline' 0 C--N 1.398 3.182 0 C-N-CA 121.929 1.752 . . . . 61.520000000000003 110.247 177.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.63 124.12 12.35 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 121.777 1.652 . . . . 55.329999999999998 110.251 -176.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -123.51 164.21 16.72 Favored Glycine 0 C--O 1.238 0.383 0 CA-C-N 115.859 -0.609 . . . . 62.299999999999997 111.684 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 6.7 p-10 -91.13 162.07 14.82 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.725 0.81 . . . . 73.519999999999996 111.055 -170.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.438 ' HB3' HG13 ' A' ' 161' ' ' VAL . 34.7 tp -126.29 116.14 20.79 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 114.727 -1.124 . . . . 71.319999999999993 108.819 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 88.6 mt -85.2 100.84 12.03 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.206 1.003 . . . . 72.430000000000007 110.026 -175.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.768 ' HB3' HD23 ' A' ' 123' ' ' LEU . 46.8 mt -90.05 99.23 12.28 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.82 0.448 . . . . 74.439999999999998 110.167 -177.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.423 HG22 HG22 ' A' ' 158' ' ' VAL . 41.5 t -86.4 113.29 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 109.333 -0.617 . . . . 74.140000000000001 109.333 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.6 p -68.68 133.3 32.02 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.981 0 O-C-N 123.462 0.476 . . . . 74.439999999999998 109.945 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -127.47 94.19 3.92 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.109 0.964 . . . . 75.200000000000003 109.042 -174.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.514 HD22 HD23 ' A' ' 127' ' ' LEU . 97.1 mt -98.57 147.98 24.25 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.185 -0.916 . . . . 65.439999999999998 110.505 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 79.2 mt . . . . . 0 CA--C 1.553 1.084 0 N-CA-C 109.471 -0.566 . . . . 73.129999999999995 109.471 175.226 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.46 ' N ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 121.659 0.743 . . . . 72.299999999999997 109.967 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.3 m -63.38 125.14 23.2 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.132 -0.94 . . . . 54.219999999999999 110.649 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.546 ' HA ' HH11 ' A' ' 136' ' ' ARG . 92.4 m -68.21 131.97 46.32 Favored 'General case' 0 C--O 1.24 0.593 0 O-C-N 123.424 0.453 . . . . 43.409999999999997 110.164 176.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.688 HD12 ' HB2' ' A' ' 123' ' ' LEU . 23.1 pt -104.45 167.6 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 115.448 -0.796 . . . . 74.140000000000001 110.759 -171.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -112.45 -171.44 1.86 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.517 0.727 . . . . 74.409999999999997 109.707 172.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.562 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.1 tp -133.7 158.0 44.39 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 108.268 -1.012 . . . . 71.409999999999997 108.268 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.481 ' HB3' ' H ' ' A' ' 122' ' ' GLU . . . -75.8 -47.53 25.37 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 110.129 -0.323 . . . . 74.299999999999997 110.129 176.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 54.5 mt 50.8 86.58 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.238 0 O-C-N 124.453 1.095 . . . . 73.109999999999999 111.034 -171.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.0 mt -99.31 157.77 33.43 Favored Pre-proline 0 CA--C 1.549 0.918 0 CA-C-N 115.15 -0.932 . . . . 73.409999999999997 109.491 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 C--N 1.373 1.849 0 C-N-CA 122.88 2.387 . . . . 75.450000000000003 113.859 178.846 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.424 ' O ' ' HA3' ' A' ' 172' ' ' GLY . 51.2 ttp180 . . . . . 0 N--CA 1.48 1.055 0 CA-C-O 121.066 0.46 . . . . 71.349999999999994 109.902 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -82.56 144.79 30.12 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.407 0.683 . . . . 75.319999999999993 109.808 176.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.9 tt -143.8 118.26 9.7 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 107.905 -1.146 . . . . 63.219999999999999 107.905 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -91.14 127.77 36.7 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 107.835 -1.172 . . . . 54.049999999999997 107.835 176.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.562 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -146.07 130.66 17.87 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.269 -0.641 . . . . 74.120000000000005 109.269 -176.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.481 ' H ' ' HB3' ' A' ' 100' ' ' ALA . 52.9 mt-10 -117.51 120.57 38.48 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 110.037 -0.357 . . . . 75.430000000000007 110.037 -169.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.688 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.4 pp -100.82 122.89 47.49 Favored Pre-proline 0 C--N 1.349 0.564 0 N-CA-C 109.961 -0.385 . . . . 62.420000000000002 109.961 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -76.78 113.58 3.67 Favored 'Trans proline' 0 C--N 1.365 1.433 0 C-N-CA 122.309 2.006 . . . . 73.129999999999995 108.27 167.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.549 HD21 HD12 ' A' ' 149' ' ' ILE . 51.2 tp -101.73 147.09 26.88 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.6 -0.518 . . . . 75.140000000000001 109.6 -168.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.5 t -89.57 148.92 23.09 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 108.587 -0.894 . . . . 75.319999999999993 108.587 -176.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.46 -31.2 71.88 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.776 0.83 . . . . 72.230000000000004 112.629 -169.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.45 -47.59 85.45 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.855 0.722 . . . . 70.129999999999995 109.35 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -76.31 -28.84 57.1 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 114.619 -1.173 . . . . 63.210000000000001 112.055 -174.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.0 -43.12 99.5 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.331 0.586 . . . . 72.230000000000004 110.266 172.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -65.21 -54.16 33.69 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 114.421 -1.263 . . . . 74.420000000000002 110.976 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -63.58 -48.86 75.65 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.076 0.55 . . . . 74.510000000000005 111.486 -175.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.59 ' HA3' ' HA ' ' A' ' 151' ' ' PRO . . . 61.04 72.53 0.62 Allowed Glycine 0 C--N 1.341 0.832 0 CA-C-N 114.788 -1.096 . . . . 71.129999999999995 112.147 -171.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.464 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -144.37 -157.63 7.28 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 111.696 -0.561 . . . . 61.219999999999999 111.696 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -72.35 112.56 8.53 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.412 -0.588 . . . . 52.119999999999997 109.412 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.546 HH11 ' HA ' ' A' ' 96' ' ' THR . 5.9 tpp180 -113.0 122.71 48.45 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.253 -1.017 . . . . 73.209999999999994 108.253 173.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 96.8 t -77.69 125.97 37.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 CA-C-N 114.472 -1.24 . . . . 63.439999999999998 109.918 -178.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 45.1 t -103.45 121.55 54.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.423 1.089 . . . . 75.230000000000004 108.35 176.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -112.93 106.47 14.76 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.136 -1.061 . . . . 74.340000000000003 108.136 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.3 p -151.14 122.4 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 123.175 0.59 . . . . 73.409999999999997 110.639 -175.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 64.24 19.96 11.99 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.131 0.972 . . . . 73.430000000000007 112.359 174.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.53 -9.68 76.85 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 116.368 -0.378 . . . . 52.109999999999999 112.787 -174.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 18.6 ttm180 -89.47 120.9 31.19 Favored 'General case' 0 C--N 1.347 0.493 0 N-CA-C 108.507 -0.923 . . . . 73.310000000000002 108.507 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.425 ' HA ' ' O ' ' A' ' 138' ' ' VAL . 40.7 ttm180 -112.53 114.95 27.86 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.217 -0.901 . . . . 73.010000000000005 108.708 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 6.4 p -129.9 117.55 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.424 0.63 . . . . 62.439999999999998 110.529 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 43.0 t -81.48 110.1 16.57 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.563 -0.902 . . . . 73.310000000000002 108.563 174.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.6 p -107.73 123.47 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.181 0.592 . . . . 72.200000000000003 109.741 177.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 51.1 ttt85 -76.96 94.81 4.01 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 108.734 -0.839 . . . . 74.049999999999997 108.734 172.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.549 HD12 HD21 ' A' ' 125' ' ' LEU . 8.0 pt -69.9 142.83 91.2 Favored Pre-proline 0 CA--C 1.561 1.372 0 CA-C-N 114.533 -1.212 . . . . 70.140000000000001 109.146 175.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.4 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 24.6 Cg_endo -63.01 148.72 93.17 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.396 2.064 . . . . 71.010000000000005 112.702 178.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.59 ' HA ' ' HA3' ' A' ' 133' ' ' GLY . 34.9 Cg_exo -62.36 124.84 15.02 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.689 2.259 . . . . 74.019999999999996 111.441 177.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 74.44 30.66 60.01 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 112.23 -0.348 . . . . 51.130000000000003 112.23 -177.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.0 p -62.27 116.95 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 123.576 0.751 . . . . 61.32 109.78 175.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.526 ' HA ' HD12 ' A' ' 180' ' ' LEU . 96.1 mtt180 -113.57 166.33 11.62 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.423 0.689 . . . . 65.109999999999999 110.886 -177.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -40.21 128.47 2.29 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 126.628 1.971 . . . . 75.340000000000003 113.692 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.69 -10.24 72.76 Favored Glycine 0 C--N 1.352 1.433 0 CA-C-O 119.442 -0.643 . . . . 64.340000000000003 114.124 175.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 25.3 t -64.77 120.57 12.72 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 117.521 0.66 . . . . 72.319999999999993 109.885 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.428 HG22 HG22 ' A' ' 177' ' ' VAL . 53.4 t -99.26 125.02 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.588 0.755 . . . . 65.430000000000007 109.224 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 54.8 mt -101.63 105.22 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 108.553 -0.906 . . . . 75.040000000000006 108.553 176.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -80.85 101.86 9.67 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.879 0.472 . . . . 72.409999999999997 109.782 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.551 HG13 ' HB3' ' A' ' 174' ' ' LEU . 5.4 p -110.63 98.12 35.73 Favored Pre-proline 0 CA--C 1.561 1.389 0 N-CA-C 109.802 -0.444 . . . . 74.219999999999999 109.802 173.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 44.4 Cg_endo -65.69 156.53 63.44 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.521 2.814 . . . . 75.219999999999999 113.291 -178.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 68.89 11.66 63.54 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.122 -0.944 . . . . 61.200000000000003 114.458 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 97.4 mmm -113.82 -26.94 7.96 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.857 0.863 . . . . 61.140000000000001 109.422 174.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -76.67 -84.87 0.44 Allowed Glycine 0 C--N 1.35 1.328 0 N-CA-C 110.705 -0.958 . . . . 4.0999999999999996 110.705 172.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.412 ' HA2' ' HB3' ' A' ' 117' ' ' ARG . . . -66.22 101.29 0.6 Allowed Glycine 0 C--N 1.342 0.906 0 O-C-N 123.958 0.446 . . . . 73.510000000000005 113.791 171.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.64 HE21 ' HA ' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -90.83 169.97 10.49 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.05 0.94 . . . . 75.400000000000006 110.559 174.596 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 83.0 -143.63 22.26 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-O 119.648 -0.529 . . . . 74.150000000000006 112.405 -176.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -63.07 -57.18 22.31 Favored Pre-proline 0 CA--C 1.56 1.358 0 CA-C-O 118.404 -0.807 . . . . 64.219999999999999 112.084 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -80.29 111.83 2.69 Favored 'Trans proline' 0 C--N 1.393 2.918 0 CA-C-N 121.179 1.457 . . . . 74.409999999999997 112.22 -176.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -76.07 123.9 7.59 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 122.024 1.816 . . . . 65.319999999999993 110.704 -178.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 117' ' ' ARG . . . -137.04 162.92 25.33 Favored Glycine 0 C--N 1.34 0.751 0 C-N-CA 121.406 -0.426 . . . . 53.520000000000003 113.42 -172.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.517 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 8.8 m-20 -91.23 132.23 36.25 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 123.892 0.877 . . . . 74.129999999999995 111.87 -164.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.551 ' HB3' HG13 ' A' ' 161' ' ' VAL . 33.7 tp -96.13 102.95 14.81 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.021 -1.474 . . . . 64.219999999999999 107.021 171.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 88.4 mt -87.9 100.25 12.74 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.182 0.593 . . . . 61.530000000000001 109.441 -175.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.565 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 74.3 mt -87.25 99.45 11.97 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 123.262 0.625 . . . . 73.409999999999997 110.253 -175.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.428 HG22 HG22 ' A' ' 158' ' ' VAL . 33.2 t -87.97 116.09 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 108.949 -0.76 . . . . 74.209999999999994 108.949 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 13.0 p -73.64 140.39 17.83 Favored 'Isoleucine or valine' 0 C--O 1.246 0.878 0 C-N-CA 123.003 0.521 . . . . 72.109999999999999 110.888 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -124.75 113.58 18.15 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 107.946 -1.131 . . . . 75.109999999999999 107.946 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.526 HD12 ' HA ' ' A' ' 154' ' ' ARG . 47.8 mt -111.35 134.34 53.01 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.947 0.499 . . . . 64.439999999999998 110.772 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 CA--C 1.55 0.972 0 C-N-CA 123.818 0.847 . . . . 55.43 110.362 174.846 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 73.3 mtp . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 109.333 -0.617 . . . . 74.230000000000004 109.333 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 43.5 m -71.0 125.1 25.94 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.953 -0.567 . . . . 65.319999999999993 110.575 -177.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 56.8 m -67.92 147.37 52.56 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.921 0.888 . . . . 51.420000000000002 111.153 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.689 HD12 ' HB2' ' A' ' 123' ' ' LEU . 26.8 pt -116.93 168.18 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 123.496 0.718 . . . . 75.409999999999997 110.577 -172.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -141.65 127.69 19.54 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.756 0.822 . . . . 64.439999999999998 109.41 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.724 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.1 tp -73.96 140.15 45.35 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.628 1.571 . . . . 71.109999999999999 110.417 -169.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.58 -33.82 76.81 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.557 0.743 . . . . 75.450000000000003 111.713 -176.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.8 mt 48.7 62.78 2.39 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.417 1.087 . . . . 61.450000000000003 111.697 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.0 mt -69.89 147.14 95.94 Favored Pre-proline 0 CA--C 1.554 1.134 0 N-CA-C 108.719 -0.845 . . . . 64.040000000000006 108.719 176.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 C--N 1.367 1.505 0 C-N-CA 122.071 1.847 . . . . 54.530000000000001 112.45 179.378 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.696 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 18.4 ttm180 . . . . . 0 N--CA 1.48 1.028 0 N-CA-C 110.468 -0.197 . . . . 73.329999999999998 110.468 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -85.28 116.74 23.8 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.43 0.634 . . . . 74.519999999999996 109.958 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.7 tt -94.34 124.19 38.21 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.399 -1.704 . . . . 74.400000000000006 106.399 175.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 23.5 tpt85 -90.98 117.73 29.8 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 107.879 -1.156 . . . . 73.219999999999999 107.879 -175.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.724 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -140.04 151.04 45.11 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 110.032 -0.359 . . . . 63.219999999999999 110.032 -173.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.536 ' HG2' ' HB ' ' A' ' 177' ' ' VAL . 89.1 mt-10 -129.69 120.5 25.25 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.242 -0.651 . . . . 64.519999999999996 109.242 -177.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.689 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.4 pp -97.83 113.61 63.9 Favored Pre-proline 0 C--N 1.353 0.727 0 N-CA-C 107.684 -1.228 . . . . 63.43 107.684 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.15 113.45 3.78 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 122.477 2.118 . . . . 72.049999999999997 108.549 171.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.453 HD21 HD12 ' A' ' 149' ' ' ILE . 34.0 tp -102.29 146.68 27.67 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 109.429 -0.582 . . . . 74.030000000000001 109.429 -168.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.9 t -90.47 154.06 19.92 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 108.324 -0.991 . . . . 63.310000000000002 108.324 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.82 -36.37 82.95 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.146 0.579 . . . . 41.130000000000003 111.803 -173.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -55.19 -47.74 74.82 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.233 0.613 . . . . 71.230000000000004 110.425 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.475 ' HG3' ' HE ' ' A' ' 136' ' ' ARG . 14.3 mm-40 -76.57 -31.7 57.69 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.933 -1.03 . . . . 71.040000000000006 111.829 -174.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.7 -31.94 72.94 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.779 0.431 . . . . 72.430000000000007 110.704 174.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -78.25 -49.98 12.71 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.433 -0.803 . . . . 70.329999999999998 110.895 173.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -62.72 -50.06 72.6 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.745 0.418 . . . . 75.120000000000005 111.413 -172.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.585 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 60.85 75.05 0.31 Allowed Glycine 0 C--N 1.342 0.862 0 CA-C-N 115.129 -0.942 . . . . 54.030000000000001 112.921 -177.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -162.3 -144.16 3.92 Favored Glycine 0 C--O 1.24 0.492 0 N-CA-C 110.967 -0.853 . . . . 64.430000000000007 110.967 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -72.05 113.36 9.0 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 122.787 0.435 . . . . 63.350000000000001 110.15 -175.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.475 ' HE ' ' HG3' ' A' ' 129' ' ' GLU . 6.8 tpp180 -120.21 120.83 37.29 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.24 -1.022 . . . . 73.5 108.24 170.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 146' ' ' SER . 63.8 t -77.07 131.71 34.26 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-N 115.417 -0.81 . . . . 74.150000000000006 110.416 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.4 p -125.18 119.64 56.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 124.361 1.065 . . . . 64.209999999999994 108.597 171.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -115.61 115.24 26.09 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.946 0.498 . . . . 73.329999999999998 110.259 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.461 HG21 ' HB3' ' A' ' 99' ' ' LEU . 2.5 m -149.22 144.01 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 125.017 1.327 . . . . 73.420000000000002 110.384 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.6 26.5 14.68 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.729 1.211 . . . . 63.32 111.611 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 81.37 -0.74 87.32 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 115.706 -0.679 . . . . 73.239999999999995 112.961 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -101.13 117.92 35.96 Favored 'General case' 0 C--N 1.346 0.451 0 C-N-CA 123.718 0.807 . . . . 70.310000000000002 110.036 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 37.1 ttp180 -97.78 105.79 17.99 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.351 -0.981 . . . . 65.430000000000007 108.351 174.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 5.6 p -125.96 125.97 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.298 0.639 . . . . 70.120000000000005 109.53 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 137' ' ' VAL . 38.3 t -89.95 134.5 34.19 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 109.371 -0.603 . . . . 70.25 109.371 175.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.6 p -113.79 130.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.277 0.631 . . . . 50.140000000000001 109.611 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -85.81 104.11 15.18 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.772 0.796 . . . . 75.0 109.778 173.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.585 HG13 ' HA2' ' A' ' 133' ' ' GLY . 8.2 pt -83.42 150.74 60.93 Favored Pre-proline 0 CA--C 1.558 1.269 0 CA-C-N 114.42 -1.264 . . . . 61.020000000000003 109.756 173.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -73.91 145.93 36.77 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.263 1.976 . . . . 75.109999999999999 112.191 173.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.48 120.1 7.31 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 122.391 2.06 . . . . 75.200000000000003 111.176 173.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 89.74 27.65 21.24 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 111.626 -0.59 . . . . 53.420000000000002 111.626 -170.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 4.3 p -66.6 129.95 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 109.272 -0.64 . . . . 73.439999999999998 109.272 172.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 29.3 mtm180 -127.02 157.87 38.45 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.442 0.697 . . . . 63.25 110.856 -168.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -42.17 125.49 3.07 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 126.716 2.006 . . . . 63.539999999999999 114.107 -175.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.79 2.75 69.17 Favored Glycine 0 C--N 1.351 1.392 0 N-CA-C 114.652 0.621 . . . . 53.399999999999999 114.652 176.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 33.1 t -68.29 122.42 18.32 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 117.556 0.678 . . . . 54.240000000000002 109.257 173.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.476 HG22 HG22 ' A' ' 177' ' ' VAL . 52.1 t -110.08 109.55 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.465 0.706 . . . . 72.25 109.592 -176.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.434 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 54.5 mt -90.78 111.57 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 108.551 -0.907 . . . . 54.229999999999997 108.551 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -86.41 104.29 15.77 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.732 0.813 . . . . 70.129999999999995 110.079 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.625 HG13 ' HB3' ' A' ' 174' ' ' LEU . 2.7 p -115.0 101.14 54.46 Favored Pre-proline 0 CA--C 1.564 1.494 0 C-N-CA 123.221 0.608 . . . . 63.030000000000001 110.352 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 49.1 Cg_endo -67.14 150.57 82.13 Favored 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 123.21 2.607 . . . . 72.239999999999995 113.231 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 74.0 11.05 81.44 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.785 -0.643 . . . . 74.230000000000004 114.331 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 23.1 mmt -114.92 -11.78 12.14 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.571 0.749 . . . . 55.020000000000003 110.353 173.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -97.24 -102.94 2.16 Favored Glycine 0 C--N 1.354 1.567 0 CA-C-N 116.059 -0.519 . . . . 63.43 112.246 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.696 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -70.48 90.63 0.38 Allowed Glycine 0 C--N 1.35 1.349 0 O-C-N 123.616 0.245 . . . . 74.040000000000006 113.621 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.728 ' HA ' HE21 ' A' ' 167' ' ' GLN . 0.0 OUTLIER -81.6 158.17 24.46 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.524 0.678 . . . . 75.430000000000007 112.155 179.208 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 139.02 -145.72 17.11 Favored Glycine 0 C--N 1.342 0.885 0 CA-C-N 114.27 -1.332 . . . . 70.230000000000004 110.55 -172.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -75.94 -44.14 3.84 Favored Pre-proline 0 CA--C 1.562 1.409 0 CA-C-O 118.919 -0.563 . . . . 70.25 111.708 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -88.55 132.52 2.55 Favored 'Trans proline' 0 C--N 1.386 2.519 0 C-N-CA 121.653 1.569 . . . . 71.0 110.995 165.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.13 126.63 6.42 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 122.096 1.864 . . . . 55.340000000000003 111.484 176.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -109.25 154.01 16.65 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 116.071 -0.513 . . . . 73.150000000000006 112.74 -173.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.541 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 28.5 m-20 -77.35 144.44 38.01 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.62 0.768 . . . . 52.420000000000002 111.989 -175.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.625 ' HB3' HG13 ' A' ' 161' ' ' VAL . 45.6 tp -111.26 114.73 28.13 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.115 -1.069 . . . . 71.019999999999996 108.115 174.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 43.4 mt -87.04 112.38 21.81 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.302 1.041 . . . . 65.219999999999999 108.846 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.523 ' HB3' HD23 ' A' ' 123' ' ' LEU . 69.9 mt -101.75 99.0 9.19 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 123.576 0.547 . . . . 62.119999999999997 109.565 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.536 ' HB ' ' HG2' ' A' ' 122' ' ' GLU . 35.5 t -94.69 108.18 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 108.75 -0.833 . . . . 62.119999999999997 108.75 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 13.8 p -68.03 132.03 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 122.877 0.471 . . . . 74.409999999999997 110.904 -177.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -123.34 91.23 3.44 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.081 0.952 . . . . 73.209999999999994 109.071 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 85.8 mt -85.2 149.09 25.75 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.173 -0.921 . . . . 72.319999999999993 109.825 175.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 81.9 mt . . . . . 0 CA--C 1.549 0.935 0 N-CA-C 109.48 -0.563 . . . . 65.540000000000006 109.48 175.759 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 20.1 ptt? . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 109.799 -0.445 . . . . 75.430000000000007 109.799 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.479 ' H ' HG21 ' A' ' 126' ' ' THR . 19.9 m -77.66 140.68 39.63 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.358 0.663 . . . . 44.149999999999999 111.619 -178.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.522 ' HA ' HH11 ' A' ' 136' ' ' ARG . 90.1 m -71.41 151.52 43.97 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.315 1.046 . . . . 63.409999999999997 110.199 170.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.736 HD12 ' HB2' ' A' ' 123' ' ' LEU . 27.1 pt -118.15 159.35 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 123.105 0.562 . . . . 70.230000000000004 110.107 -173.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -127.12 129.23 47.53 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.619 -0.882 . . . . 72.209999999999994 108.619 172.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.628 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.5 tp -69.51 151.23 46.28 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.256 1.022 . . . . 72.120000000000005 108.737 -177.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.88 -48.58 24.15 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 122.79 0.436 . . . . 70.340000000000003 109.846 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 93.1 mt 57.43 80.51 0.16 Allowed 'General case' 0 C--N 1.359 1.012 0 O-C-N 124.566 1.166 . . . . 73.340000000000003 109.524 -170.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.3 mt -74.28 151.92 87.92 Favored Pre-proline 0 N--CA 1.471 0.592 0 CA-C-N 115.218 -0.901 . . . . 70.510000000000005 110.671 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo . . . . . 0 C--N 1.376 2.002 0 C-N-CA 122.471 2.114 . . . . 72.299999999999997 110.554 171.683 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.529 ' HB3' ' HA2' ' A' ' 166' ' ' GLY . 59.4 ttp180 . . . . . 0 CA--C 1.546 0.798 0 N-CA-C 110.13 -0.322 . . . . 75.120000000000005 110.13 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -91.55 106.87 18.8 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 106.443 -1.688 . . . . 75.209999999999994 106.443 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.6 tt -104.08 123.17 46.77 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.173 -1.047 . . . . 55.409999999999997 108.173 -172.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -90.5 128.18 36.46 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.233 -1.025 . . . . 72.420000000000002 108.233 175.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.628 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -140.88 149.76 42.36 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 123.788 0.835 . . . . 73.420000000000002 109.314 -172.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -119.93 122.3 40.92 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.667 -0.864 . . . . 62.43 108.667 -175.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.736 ' HB2' HD12 ' A' ' 97' ' ' ILE . 3.9 pp -99.63 108.03 48.83 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 106.912 -1.514 . . . . 74.209999999999994 106.912 173.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.524 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 63.1 Cg_endo -71.59 112.18 3.3 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 121.838 1.692 . . . . 74.400000000000006 108.373 169.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.466 HD21 HD12 ' A' ' 149' ' ' ILE . 32.8 tp -100.55 142.84 31.46 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.216 -1.031 . . . . 71.129999999999995 108.216 -170.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.479 HG21 ' H ' ' A' ' 95' ' ' SER . 1.9 t -79.47 145.1 33.44 Favored 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 107.941 -1.133 . . . . 51.219999999999999 107.941 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.84 -28.73 69.69 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.389 0.676 . . . . 74.340000000000003 112.479 -170.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.84 -41.16 97.88 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.601 -0.727 . . . . 72.239999999999995 109.794 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -75.99 -31.29 58.9 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.879 0.872 . . . . 71.319999999999993 112.461 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.32 -40.35 77.73 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.415 0.626 . . . . 53.439999999999998 110.272 169.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -73.93 -48.22 32.25 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-N 114.432 -1.258 . . . . 70.430000000000007 111.876 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -76.13 -51.33 12.4 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 120.722 0.296 . . . . 74.340000000000003 111.137 -171.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.623 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 67.33 69.1 1.45 Allowed Glycine 0 C--N 1.348 1.24 0 CA-C-N 115.25 -0.887 . . . . 71.510000000000005 113.478 -178.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -131.84 -154.65 7.8 Favored Glycine 0 N--CA 1.477 1.367 0 N-CA-C 111.684 -0.566 . . . . 71.230000000000004 111.684 178.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -70.96 114.31 8.88 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.101 -0.703 . . . . 64.200000000000003 109.101 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.522 HH11 ' HA ' ' A' ' 96' ' ' THR . 8.0 tpp180 -112.07 122.19 47.07 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.326 -0.99 . . . . 54.149999999999999 108.326 175.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 78.1 t -78.82 131.46 34.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-N 113.828 -1.533 . . . . 72.540000000000006 110.406 -177.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.9 p -136.91 122.17 26.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 124.287 1.035 . . . . 73.0 108.58 173.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -121.41 114.62 21.54 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.231 0.612 . . . . 74.150000000000006 111.088 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.4 m -148.89 146.78 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.681 1.592 . . . . 74.430000000000007 109.683 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 66.38 27.41 9.97 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.725 1.21 . . . . 62.439999999999998 110.848 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.23 15.64 72.53 Favored Glycine 0 C--N 1.356 1.687 0 CA-C-N 115.787 -0.642 . . . . 72.209999999999994 113.338 -176.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -124.26 129.37 50.64 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.002 0.921 . . . . 71.319999999999993 109.547 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 32.4 ttp180 -110.17 120.35 42.17 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.083 0.553 . . . . 71.530000000000001 110.217 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.1 p -122.34 146.18 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 123.95 0.9 . . . . 64.540000000000006 109.787 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 47.5 t -100.5 113.16 25.72 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.581 -0.896 . . . . 60.030000000000001 108.581 174.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.8 p -102.5 113.72 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 109.215 -0.661 . . . . 75.0 109.215 174.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 55.1 ttt85 -75.75 104.69 6.41 Favored 'General case' 0 C--N 1.35 0.625 0 N-CA-C 108.698 -0.853 . . . . 71.109999999999999 108.698 174.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.623 HG13 ' HA2' ' A' ' 133' ' ' GLY . 12.2 pt -81.52 145.24 54.53 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 124.524 1.129 . . . . 73.109999999999999 109.67 175.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.56 148.95 73.69 Favored 'Trans proline' 0 CA--C 1.565 2.036 0 C-N-CA 122.403 2.069 . . . . 63.119999999999997 112.982 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.59 118.95 5.86 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.87 2.38 . . . . 70.349999999999994 111.628 174.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 88.04 23.44 38.13 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-O 119.724 -0.487 . . . . 65.310000000000002 112.414 -175.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.433 HG11 ' HB ' ' A' ' 149' ' ' ILE . 3.9 p -62.89 120.34 9.2 Favored 'Isoleucine or valine' 0 C--N 1.361 1.105 0 C-N-CA 123.343 0.657 . . . . 62.009999999999998 109.689 176.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.546 ' HA ' HD12 ' A' ' 180' ' ' LEU . 66.0 mtt85 -123.73 159.55 29.19 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.564 0.746 . . . . 75.340000000000003 111.006 -173.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -38.53 127.26 1.46 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.036 2.134 . . . . 65.129999999999995 113.794 -173.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 101.94 -9.66 56.74 Favored Glycine 0 C--N 1.355 1.625 0 CA-C-O 119.017 -0.879 . . . . 74.219999999999999 114.622 174.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.3 t -69.14 120.18 14.58 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 117.799 0.799 . . . . 72.420000000000002 109.45 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 57.3 t -104.72 114.62 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.217 0.607 . . . . 73.340000000000003 109.943 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 51.7 mt -91.86 100.9 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 107.783 -1.191 . . . . 73.409999999999997 107.783 172.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.483 HH11 HD21 ' A' ' 175' ' ' LEU . 57.9 ttt85 -84.0 103.71 13.47 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.954 -0.758 . . . . 72.129999999999995 108.954 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.72 120.31 47.64 Favored Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 123.137 0.575 . . . . 71.239999999999995 110.051 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 92.4 Cg_endo -74.79 149.71 38.15 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.751 2.3 . . . . 72.129999999999995 113.028 -173.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 75.03 -0.3 58.9 Favored Glycine 0 N--CA 1.473 1.149 0 N-CA-C 114.451 0.541 . . . . 70.209999999999994 114.451 174.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 85.8 mmm -98.02 -25.34 14.99 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.935 0.894 . . . . 71.25 110.7 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.401 ' N ' ' HB2' ' A' ' 174' ' ' LEU . . . -79.98 -82.24 0.74 Allowed Glycine 0 C--N 1.348 1.234 0 N-CA-C 111.226 -0.75 . . . . 51.409999999999997 111.226 176.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 117' ' ' ARG . . . -61.26 94.38 0.08 OUTLIER Glycine 0 C--N 1.345 1.062 0 O-C-N 124.171 0.571 . . . . 72.219999999999999 113.221 174.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -88.13 114.65 24.95 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.015 0.926 . . . . 72.099999999999994 109.347 175.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 158.48 -149.84 20.26 Favored Glycine 0 N--CA 1.466 0.666 0 N-CA-C 111.213 -0.755 . . . . 61.049999999999997 111.213 -177.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -72.57 -52.31 6.55 Favored Pre-proline 0 CA--C 1.559 1.299 0 CA-C-O 118.019 -0.991 . . . . 74.109999999999999 111.188 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -83.88 112.42 1.78 Allowed 'Trans proline' 0 C--N 1.391 2.772 0 C-N-CA 121.733 1.622 . . . . 73.230000000000004 111.293 174.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.58 125.61 12.44 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 121.895 1.73 . . . . 44.109999999999999 111.448 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -116.29 156.52 15.58 Favored Glycine 0 C--N 1.342 0.88 0 N-CA-C 111.708 -0.557 . . . . 54.049999999999997 111.708 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 5.8 m-20 -79.61 159.46 26.78 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.339 0.656 . . . . 63.109999999999999 111.4 -175.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.401 ' HB2' ' N ' ' A' ' 165' ' ' GLY . 32.4 tp -127.12 113.16 16.03 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 114.643 -1.162 . . . . 45.32 108.061 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.483 HD21 HH11 ' A' ' 160' ' ' ARG . 86.6 mt -81.86 101.64 10.34 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.472 -0.936 . . . . 64.400000000000006 108.472 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.692 ' HB3' HD23 ' A' ' 123' ' ' LEU . 54.2 mt -90.36 97.11 10.99 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.93 -0.767 . . . . 71.140000000000001 108.93 177.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.48 118.88 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 O-C-N 121.759 -0.588 . . . . 73.450000000000003 109.611 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 14.0 p -67.55 132.52 32.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.815 0 C-N-CA 123.778 0.831 . . . . 60.329999999999998 109.839 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.524 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 17.6 mmm-85 -122.12 104.95 9.84 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.745 0.818 . . . . 73.420000000000002 109.182 -176.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.546 HD12 ' HA ' ' A' ' 154' ' ' ARG . 83.0 mt -109.79 147.82 32.57 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.49 0.716 . . . . 61.140000000000001 111.227 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 89.1 mt . . . . . 0 CA--C 1.557 1.217 0 CA-C-N 114.527 -1.215 . . . . 65.230000000000004 109.496 175.097 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.403 ' N ' ' SD ' ' A' ' 94' ' ' MET . 3.4 mpp? . . . . . 0 N--CA 1.482 1.129 0 N-CA-C 109.164 -0.68 . . . . 75.120000000000005 109.164 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.8 m -66.85 138.24 57.18 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.362 -0.835 . . . . 33.340000000000003 111.835 -177.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 47.3 m -74.81 150.09 39.42 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.576 -0.738 . . . . 74.25 109.073 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.664 HD12 ' HB2' ' A' ' 123' ' ' LEU . 23.5 pt -125.02 171.39 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 123.377 0.671 . . . . 73.340000000000003 110.705 -170.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -133.55 134.33 43.23 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.584 0.753 . . . . 74.400000000000006 110.27 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.579 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.3 tp -84.47 176.2 8.81 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.334 1.053 . . . . 74.430000000000007 109.069 -174.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -101.07 -48.15 4.52 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.41 0.284 . . . . 52.200000000000003 111.75 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.7 mt 57.36 70.45 0.65 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.113 0.965 . . . . 64.099999999999994 110.937 -168.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 20.8 mt -87.4 151.89 51.55 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-N 115.17 -0.923 . . . . 62.32 108.772 174.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo . . . . . 0 CA--C 1.558 1.675 0 C-N-CA 121.924 1.75 . . . . 64.25 111.943 174.516 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.515 ' O ' ' HA3' ' A' ' 172' ' ' GLY . 38.5 ttm180 . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 110.149 -0.315 . . . . 75.209999999999994 110.149 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -77.84 144.94 36.61 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.11 0.481 . . . . 73.349999999999994 109.972 178.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.3 tt -136.72 113.22 10.06 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 105.551 -2.018 . . . . 73.420000000000002 105.551 172.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 34.9 ttt180 -93.8 123.09 36.91 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 108.486 -0.931 . . . . 74.439999999999998 108.486 -177.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.579 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -140.53 131.49 26.11 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 123.534 0.734 . . . . 71.510000000000005 109.342 -172.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -117.63 128.79 55.28 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 110.05 -0.352 . . . . 74.120000000000005 110.05 -169.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.664 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.0 pp -108.16 117.77 54.1 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 123.062 0.545 . . . . 70.25 110.107 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.492 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 68.0 Cg_endo -73.33 113.75 3.86 Favored 'Trans proline' 0 C--N 1.364 1.347 0 C-N-CA 122.451 2.101 . . . . 72.200000000000003 109.088 168.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.587 HD21 HD12 ' A' ' 149' ' ' ILE . 50.6 tp -103.8 147.94 26.69 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 122.794 0.438 . . . . 73.010000000000005 110.015 -166.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.8 t -85.22 149.31 25.59 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 109.018 -0.734 . . . . 63.340000000000003 109.018 -177.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.9 mt -63.06 -30.8 71.88 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.587 0.755 . . . . 65.400000000000006 112.441 -171.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.04 -49.61 76.68 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 109.48 -0.563 . . . . 70.329999999999998 109.48 177.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -72.97 -31.69 64.71 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 114.818 -1.083 . . . . 72.430000000000007 112.164 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.53 -38.08 80.06 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.747 0.654 . . . . 72.439999999999998 110.472 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -73.52 -52.82 12.24 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.027 -0.988 . . . . 74.150000000000006 110.846 174.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -62.52 -49.69 74.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 123.531 0.52 . . . . 75.519999999999996 112.379 -169.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.579 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 67.86 52.16 30.56 Favored Glycine 0 C--N 1.34 0.751 0 O-C-N 123.853 0.721 . . . . 71.120000000000005 112.971 -172.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.438 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -113.05 -163.13 15.54 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 112.077 -0.409 . . . . 54.229999999999997 112.077 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.65 115.42 20.91 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 108.934 -0.765 . . . . 71.349999999999994 108.934 175.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -113.45 124.08 51.57 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.577 0.751 . . . . 73.340000000000003 109.323 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 86.0 t -72.06 127.97 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-N 114.198 -1.365 . . . . 43.299999999999997 109.721 175.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.446 HG22 ' HB2' ' A' ' 99' ' ' LEU . 6.1 p -134.26 111.15 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 124.151 0.981 . . . . 74.409999999999997 108.838 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -103.36 134.73 46.25 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.667 0.787 . . . . 73.310000000000002 109.988 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.9 p -152.35 132.06 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.245 1.018 . . . . 61.039999999999999 109.887 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.37 18.0 8.88 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.348 1.059 . . . . 74.150000000000006 112.506 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.67 -8.83 71.29 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 116.26 -0.427 . . . . 63.439999999999998 113.327 -175.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -92.25 118.39 30.83 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.708 0.803 . . . . 72.019999999999996 110.498 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.5 ttp180 -98.39 120.78 39.4 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.449 1.1 . . . . 75.019999999999996 109.485 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 40.5 t -123.41 125.71 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.054 0.942 . . . . 73.230000000000004 109.346 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.9 t -97.53 112.64 24.41 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.867 -0.79 . . . . 74.25 108.867 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.4 139.14 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.133 0.573 . . . . 75.409999999999997 111.013 -175.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -83.72 110.37 18.25 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.887 -0.783 . . . . 74.099999999999994 108.887 174.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.587 HD12 HD21 ' A' ' 125' ' ' LEU . 9.3 pt -89.55 151.46 46.01 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 124.29 1.036 . . . . 73.129999999999995 110.026 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -67.31 139.57 50.34 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.687 2.258 . . . . 72.340000000000003 112.603 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -65.5 131.85 29.26 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.561 2.174 . . . . 74.329999999999998 111.126 169.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 69.71 29.9 70.95 Favored Glycine 0 C--N 1.343 0.966 0 O-C-N 123.55 0.531 . . . . 65.349999999999994 112.391 -177.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 9.6 p -64.82 148.12 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 124.058 0.943 . . . . 70.140000000000001 110.007 178.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.4 ' HA ' HD12 ' A' ' 180' ' ' LEU . 24.4 mtp180 -134.44 161.75 34.16 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.991 0.516 . . . . 64.340000000000003 110.281 -178.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -44.59 134.71 5.23 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 125.73 1.612 . . . . 55.329999999999998 113.525 -174.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 83.9 3.85 89.01 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 115.746 -0.661 . . . . 51.340000000000003 114.322 176.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.3 t -71.87 121.11 18.45 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 108.412 -0.959 . . . . 45.219999999999999 108.412 174.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.4 t -104.74 114.71 45.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 O-C-N 123.738 0.649 . . . . 74.25 110.603 -175.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 60.8 mt -89.9 102.26 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 107.328 -1.36 . . . . 55.210000000000001 107.328 174.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -87.63 105.45 17.35 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 122.992 0.517 . . . . 73.230000000000004 109.826 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.2 p -111.17 119.64 45.11 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 123.064 0.545 . . . . 63.549999999999997 109.704 175.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.43 153.14 49.98 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 122.247 1.964 . . . . 73.409999999999997 112.044 -177.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.36 -4.12 50.51 Favored Glycine 0 C--N 1.344 0.979 0 N-CA-C 115.208 0.843 . . . . 71.049999999999997 115.208 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 95.9 mmm -102.83 -13.26 17.06 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 117.645 0.723 . . . . 75.219999999999999 110.643 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -86.31 -96.1 0.81 Allowed Glycine 0 C--N 1.355 1.584 0 N-CA-C 111.823 -0.511 . . . . 41.210000000000001 111.823 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -57.28 98.29 0.08 OUTLIER Glycine 0 C--N 1.349 1.255 0 O-C-N 123.972 0.454 . . . . 64.540000000000006 112.319 171.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -88.09 153.89 20.9 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.521 1.128 . . . . 60.119999999999997 109.581 174.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 118.93 -144.17 17.75 Favored Glycine 0 N--CA 1.468 0.794 0 N-CA-C 110.976 -0.85 . . . . 63.25 110.976 -177.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -75.32 -47.36 4.4 Favored Pre-proline 0 CA--C 1.56 1.328 0 CA-C-O 117.97 -1.015 . . . . 72.549999999999997 110.944 168.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -76.47 113.55 3.69 Favored 'Trans proline' 0 C--N 1.395 2.98 0 C-N-CA 121.609 1.539 . . . . 72.340000000000003 112.241 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -82.8 126.77 4.64 Favored 'Trans proline' 0 C--N 1.385 2.461 0 C-N-CA 122.387 2.058 . . . . 74.129999999999995 111.787 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 117' ' ' ARG . . . -130.09 -179.37 15.98 Favored Glycine 0 N--CA 1.463 0.489 0 CA-C-N 116.758 -0.201 . . . . 62.109999999999999 113.181 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -100.92 131.26 46.88 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.817 0.847 . . . . 54.43 110.924 -168.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 29.8 tp -92.51 110.35 21.77 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 108.55 -0.908 . . . . 73.030000000000001 108.55 176.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 60.2 mt -91.19 99.7 12.65 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.49 0.716 . . . . 61.009999999999998 109.367 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.554 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 96.2 mt -88.87 99.85 12.71 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.621 0.369 . . . . 71.310000000000002 111.022 -175.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 38.8 t -87.51 114.56 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 109.261 -0.644 . . . . 74.400000000000006 109.261 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.425 HG22 ' HG ' ' A' ' 180' ' ' LEU . 12.1 p -73.02 132.98 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 CA-C-O 121.188 0.518 . . . . 74.209999999999994 109.843 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.492 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 37.6 mmt180 -115.21 101.42 8.94 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.86 -1.163 . . . . 64.200000000000003 107.86 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.425 ' HG ' HG22 ' A' ' 178' ' ' VAL . 38.8 mt -108.23 141.67 39.65 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.005 0.431 . . . . 72.230000000000004 111.369 -176.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 65.3 mt . . . . . 0 CA--C 1.544 0.729 0 CA-C-N 114.464 -1.244 . . . . 65.340000000000003 107.664 172.84 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.454 ' O ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.582 0 CA-C-O 121.564 0.697 . . . . 62.119999999999997 109.793 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.7 t -77.14 133.41 38.99 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.579 -0.737 . . . . 71.540000000000006 110.726 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 52.3 m -73.67 145.28 45.39 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.152 0.981 . . . . 63.119999999999997 110.308 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.61 HD12 ' HB2' ' A' ' 123' ' ' LEU . 18.2 pt -118.01 162.23 16.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 C-N-CA 123.223 0.609 . . . . 74.439999999999998 110.681 -172.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.408 ' O ' ' HD2' ' A' ' 124' ' ' PRO . . . -104.05 177.63 4.79 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.048 0.939 . . . . 52.530000000000001 108.952 170.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.598 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.4 tp -113.67 -133.77 0.34 Allowed 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 107.147 -1.427 . . . . 62.539999999999999 107.147 177.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.49 -43.47 0.06 Allowed 'General case' 0 C--N 1.345 0.412 0 N-CA-C 109.107 -0.701 . . . . 71.329999999999998 109.107 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 84.3 mt 53.81 64.08 1.96 Allowed 'General case' 0 C--N 1.362 1.129 0 O-C-N 124.438 1.086 . . . . 74.239999999999995 110.117 -172.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 61.0 mt -63.54 159.72 49.14 Favored Pre-proline 0 CA--C 1.55 0.968 0 CA-C-N 113.995 -1.457 . . . . 64.150000000000006 109.717 176.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo . . . . . 0 C--N 1.378 2.093 0 C-N-CA 122.056 1.837 . . . . 71.439999999999998 112.19 173.914 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 . . . . . 0 CA--C 1.541 0.609 0 CA-C-O 121.255 0.55 . . . . 61.340000000000003 111.478 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -83.43 119.7 24.99 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 108.093 -1.077 . . . . 63.140000000000001 108.093 169.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.3 tt -103.81 121.41 42.99 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.158 -1.793 . . . . 62.210000000000001 106.158 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -89.79 133.38 34.74 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.121 -1.066 . . . . 74.430000000000007 108.121 -177.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.598 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -154.56 146.66 23.68 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.252 0.621 . . . . 52.539999999999999 109.579 -175.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -128.19 135.0 49.12 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.502 -0.555 . . . . 73.209999999999994 109.502 -175.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.61 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.4 pp -112.53 116.96 47.78 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 109.88 -0.415 . . . . 73.109999999999999 109.88 178.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.529 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 70.2 Cg_endo -72.87 115.32 4.3 Favored 'Trans proline' 0 C--N 1.36 1.141 0 C-N-CA 122.498 2.132 . . . . 60.130000000000003 108.592 169.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.567 HD21 HD12 ' A' ' 149' ' ' ILE . 43.3 tp -104.26 148.4 26.38 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.933 -0.395 . . . . 74.329999999999998 109.933 -167.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.3 t -88.94 156.5 18.86 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 109.134 -0.691 . . . . 72.209999999999994 109.134 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.3 mt -64.42 -32.95 74.79 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.709 0.804 . . . . 72.120000000000005 112.631 -173.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.52 -46.7 87.23 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 124.168 0.918 . . . . 72.549999999999997 109.752 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -74.68 -34.09 62.6 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.041 -0.981 . . . . 71.0 111.519 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.97 -34.23 73.02 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.169 0.509 . . . . 60.5 110.518 173.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -76.55 -54.07 7.2 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 114.913 -1.04 . . . . 74.430000000000007 110.846 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -62.88 -50.35 71.24 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 122.829 0.452 . . . . 64.439999999999998 111.285 -174.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.571 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 70.04 58.27 6.32 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 114.963 -1.017 . . . . 62.539999999999999 111.369 -169.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.41 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -121.7 -175.18 14.9 Favored Glycine 0 C--N 1.346 1.091 0 N-CA-C 112.463 -0.255 . . . . 64.040000000000006 112.463 -175.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -76.1 113.61 13.82 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.463 -0.94 . . . . 53.420000000000002 108.463 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -111.18 124.61 52.54 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.163 -1.051 . . . . 74.430000000000007 108.163 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.469 HG13 ' HG3' ' A' ' 144' ' ' ARG . 94.9 t -70.34 124.31 26.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 114.466 -1.243 . . . . 65.400000000000006 109.124 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.428 HG11 HD13 ' A' ' 99' ' ' LEU . 34.5 t -117.77 130.14 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 107.83 -1.174 . . . . 75.409999999999997 107.83 177.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -123.71 122.21 37.5 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 118.1 0.409 . . . . 70.049999999999997 110.409 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.417 HG11 ' HB3' ' A' ' 99' ' ' LEU . 0.8 OUTLIER -149.99 128.73 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 124.855 1.262 . . . . 72.030000000000001 109.913 174.478 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.82 20.1 12.05 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.818 1.247 . . . . 74.049999999999997 112.203 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.12 9.14 82.77 Favored Glycine 0 C--N 1.355 1.595 0 CA-C-N 116.416 -0.357 . . . . 75.109999999999999 113.116 -175.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -101.19 120.21 39.9 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.706 1.202 . . . . 71.329999999999998 109.214 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.469 ' HG3' HG13 ' A' ' 137' ' ' VAL . 48.1 ttp180 -99.0 109.59 22.32 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.973 0.909 . . . . 74.540000000000006 109.747 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 53.8 t -107.99 112.38 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.566 -0.901 . . . . 75.530000000000001 108.566 172.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 48.2 t -91.54 104.16 16.69 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.213 -1.032 . . . . 61.0 108.213 174.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.1 p -100.94 119.17 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.521 0.729 . . . . 65.030000000000001 110.441 -175.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -73.74 101.06 3.57 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.334 -0.988 . . . . 73.409999999999997 108.334 167.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.571 HG13 ' HA2' ' A' ' 133' ' ' GLY . 10.0 pt -81.33 151.59 69.47 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 123.97 0.908 . . . . 70.430000000000007 109.675 175.01 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.447 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 64.5 Cg_endo -73.62 144.75 36.15 Favored 'Trans proline' 0 CA--C 1.559 1.763 0 C-N-CA 122.088 1.859 . . . . 61.409999999999997 112.556 177.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 150' ' ' PRO . 37.7 Cg_exo -63.18 124.5 14.0 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.18 2.587 . . . . 63.039999999999999 112.345 177.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 80.18 23.16 61.69 Favored Glycine 0 C--N 1.343 0.947 0 O-C-N 123.448 0.468 . . . . 75.430000000000007 112.906 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.5 p -57.57 145.99 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 124.536 1.135 . . . . 70.409999999999997 110.685 177.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -138.11 162.17 34.88 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.79 0.836 . . . . 65.310000000000002 110.547 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -43.85 129.13 5.71 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 126.366 1.866 . . . . 74.340000000000003 112.694 -174.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.17 -3.11 59.9 Favored Glycine 0 C--N 1.35 1.318 0 O-C-N 123.63 0.581 . . . . 75.219999999999999 113.81 176.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 52.2 m -69.81 119.68 14.4 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 117.724 0.762 . . . . 70.319999999999993 110.148 175.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 45.0 t -103.34 109.09 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.243 0.617 . . . . 72.230000000000004 110.026 -178.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 58.5 mt -91.25 101.92 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.438 1.095 . . . . 74.510000000000005 108.14 172.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -89.62 103.03 15.71 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.918 -0.771 . . . . 74.409999999999997 108.918 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.8 p -103.77 105.49 48.12 Favored Pre-proline 0 CA--C 1.561 1.367 0 C-N-CA 123.228 0.611 . . . . 71.430000000000007 110.316 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -66.44 146.77 81.2 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 123.093 2.528 . . . . 54.109999999999999 113.514 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 81.83 0.13 89.03 Favored Glycine 0 C--N 1.346 1.111 0 CA-C-N 115.603 -0.726 . . . . 71.349999999999994 113.666 176.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.8 mmt -101.66 -24.6 14.08 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 117.598 0.699 . . . . 74.140000000000001 111.529 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -81.84 -87.68 0.67 Allowed Glycine 0 C--N 1.347 1.171 0 CA-C-O 119.822 -0.432 . . . . 70.010000000000005 112.612 -175.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -62.65 93.49 0.1 OUTLIER Glycine 0 C--N 1.352 1.468 0 O-C-N 124.056 0.504 . . . . 61.100000000000001 112.247 174.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -88.86 158.13 18.21 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.152 0.981 . . . . 73.109999999999999 109.417 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 96.85 -142.57 16.25 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-O 119.623 -0.543 . . . . 73.340000000000003 111.879 -176.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -68.84 -53.88 14.09 Favored Pre-proline 0 CA--C 1.567 1.634 0 CA-C-O 118.032 -0.985 . . . . 73.299999999999997 112.389 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -83.92 108.51 1.41 Allowed 'Trans proline' 0 C--N 1.394 2.931 0 C-N-CA 121.709 1.606 . . . . 63.039999999999999 112.149 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.28 127.22 11.02 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.85 2.366 . . . . 63.409999999999997 110.953 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -141.19 176.27 21.78 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-N 116.443 -0.344 . . . . 74.25 112.808 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -100.33 162.21 13.1 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.279 1.032 . . . . 74.25 111.373 -172.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 37.7 tp -117.05 112.7 21.29 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 124.588 1.155 . . . . 74.430000000000007 108.033 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 66.9 mt -84.02 100.3 10.98 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.745 -0.835 . . . . 70.349999999999994 108.745 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.519 HD22 HD11 ' A' ' 99' ' ' LEU . 91.9 mt -96.89 99.7 11.24 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.075 0.55 . . . . 75.329999999999998 110.083 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.6 p -93.55 125.58 46.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 N-CA-C 109.444 -0.576 . . . . 74.120000000000005 109.444 176.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.8 137.63 23.07 Favored 'Isoleucine or valine' 0 C--O 1.249 1.043 0 C-N-CA 123.299 0.639 . . . . 70.209999999999994 109.5 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.529 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 22.3 mmm-85 -115.81 97.84 6.34 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.817 -0.809 . . . . 73.120000000000005 108.817 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 55.1 mt -119.56 131.9 55.62 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.91 0.884 . . . . 74.310000000000002 109.669 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 90.6 mt . . . . . 0 CA--C 1.543 0.686 0 CA-C-N 115.349 -0.841 . . . . 73.439999999999998 110.713 -175.792 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.427 ' SD ' ' N ' ' A' ' 94' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 109.086 -0.709 . . . . 75.150000000000006 109.086 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.3 m -67.84 115.97 7.98 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.449 -0.574 . . . . 65.310000000000002 109.449 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 98.6 m -65.18 144.83 56.94 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.702 0.801 . . . . 71.430000000000007 110.737 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.663 HD12 ' HB2' ' A' ' 123' ' ' LEU . 11.2 pt -117.41 161.07 16.5 Favored 'Isoleucine or valine' 0 C--O 1.245 0.854 0 CA-C-N 115.659 -0.7 . . . . 74.299999999999997 109.23 -174.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -136.69 129.7 31.02 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.725 0.81 . . . . 42.420000000000002 109.159 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.679 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.2 tp -68.78 149.67 48.74 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.956 1.303 . . . . 74.150000000000006 109.935 -174.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.22 -34.58 55.98 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.519 0.328 . . . . 73.209999999999994 110.949 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 70.3 mt 52.1 69.31 0.69 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.064 0.946 . . . . 71.430000000000007 111.059 -175.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 63.2 mt -69.14 161.09 75.45 Favored Pre-proline 0 CA--C 1.558 1.277 0 CA-C-N 115.33 -0.85 . . . . 70.420000000000002 109.913 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo . . . . . 0 C--N 1.377 2.033 0 C-N-CA 122.241 1.961 . . . . 73.430000000000007 112.941 178.769 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.598 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 11.8 tpp180 . . . . . 0 C--O 1.244 0.782 0 CA-C-O 121.132 0.492 . . . . 72.409999999999997 110.103 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -73.8 128.2 34.87 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 114.839 -1.073 . . . . 72.239999999999995 109.102 175.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.4 tt -134.79 114.85 13.04 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.335 -1.728 . . . . 72.319999999999993 106.335 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -90.31 138.05 31.85 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 107.605 -1.257 . . . . 75.430000000000007 107.605 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.679 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -157.25 131.83 8.61 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.253 -0.647 . . . . 72.349999999999994 109.253 -170.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -120.73 126.38 50.03 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 109.068 -0.716 . . . . 74.510000000000005 109.068 -170.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.663 ' HB2' HD12 ' A' ' 97' ' ' ILE . 3.9 pp -100.81 118.78 59.99 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 109.325 -0.62 . . . . 72.049999999999997 109.325 -177.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.559 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 74.1 Cg_endo -73.69 111.63 3.34 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.542 2.162 . . . . 53.450000000000003 109.344 171.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.502 HD21 HD12 ' A' ' 149' ' ' ILE . 28.2 tp -102.47 149.77 24.04 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 109.015 -0.735 . . . . 63.409999999999997 109.015 -168.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.6 t -95.57 158.53 15.41 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-N 115.913 -0.585 . . . . 43.329999999999998 109.479 -177.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 82.1 mt -64.3 -30.45 71.5 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.469 0.708 . . . . 73.129999999999995 112.13 -175.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.07 -48.33 82.18 Favored 'General case' 0 C--O 1.216 -0.701 0 O-C-N 123.904 0.753 . . . . 65.400000000000006 109.507 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.478 ' HG3' ' HD2' ' A' ' 136' ' ' ARG . 8.2 mm-40 -75.54 -30.95 59.9 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.51 0.724 . . . . 74.239999999999995 111.367 -175.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.87 -26.11 64.97 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 122.878 0.471 . . . . 61.310000000000002 111.044 174.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -83.96 -47.99 10.43 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.837 0.855 . . . . 72.0 110.452 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -67.68 -49.55 62.21 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.196 0.598 . . . . 65.299999999999997 110.283 -174.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.503 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 62.86 62.17 5.75 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 114.49 -1.232 . . . . 55.450000000000003 112.318 -173.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.26 -163.69 11.27 Favored Glycine 0 C--N 1.34 0.768 0 N-CA-C 111.769 -0.532 . . . . 42.149999999999999 111.769 -177.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -73.6 118.68 16.83 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.379 -0.971 . . . . 72.420000000000002 108.379 177.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.608 HH21 ' HB ' ' A' ' 137' ' ' VAL . 5.8 tpm_? -111.67 122.76 48.68 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.484 -0.932 . . . . 72.219999999999999 108.484 177.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.608 ' HB ' HH21 ' A' ' 136' ' ' ARG . 71.4 t -71.88 113.71 9.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-N 114.576 -1.193 . . . . 62.340000000000003 110.159 176.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.77 110.2 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 106.889 -1.522 . . . . 74.209999999999994 106.889 174.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -118.19 121.23 39.96 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.62 -0.511 . . . . 73.439999999999998 109.62 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 1.5 m -149.34 142.59 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 125.197 1.399 . . . . 62.509999999999998 109.69 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.35 25.58 15.27 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.696 1.198 . . . . 64.140000000000001 111.559 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 73.07 10.76 78.49 Favored Glycine 0 C--N 1.355 1.615 0 CA-C-N 115.681 -0.691 . . . . 75.209999999999994 113.567 -175.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 58.7 ttt85 -114.03 125.0 53.51 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.937 0.895 . . . . 75.409999999999997 109.066 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -105.42 126.08 51.72 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.754 0.822 . . . . 74.409999999999997 109.738 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 4.4 p -127.98 123.35 60.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 124.269 1.027 . . . . 72.420000000000002 108.803 176.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 30.0 t -99.65 104.29 16.04 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.013 -0.736 . . . . 74.420000000000002 109.013 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.1 p -101.0 123.17 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.188 0.595 . . . . 72.340000000000003 110.545 -176.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -76.44 116.06 16.77 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 109.052 -0.721 . . . . 72.540000000000006 109.052 172.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.503 HG13 ' HA2' ' A' ' 133' ' ' GLY . 10.6 pt -96.87 151.02 37.55 Favored Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 124.319 1.047 . . . . 71.0 109.006 175.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.42 145.96 49.11 Favored 'Trans proline' 0 CA--C 1.565 2.048 0 C-N-CA 122.322 2.015 . . . . 65.409999999999997 112.74 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -64.68 114.4 2.73 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 123.248 2.632 . . . . 73.150000000000006 112.105 175.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 87.82 31.26 15.68 Favored Glycine 0 C--N 1.341 0.83 0 O-C-N 123.333 0.396 . . . . 62.43 112.333 -174.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.89 149.85 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.834 0.853 . . . . 75.510000000000005 110.221 173.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -134.41 154.24 51.48 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.665 0.786 . . . . 72.540000000000006 110.756 -174.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -40.51 131.54 2.23 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.726 2.01 . . . . 71.150000000000006 113.397 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.34 -9.81 69.46 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-O 119.215 -0.769 . . . . 31.309999999999999 114.596 175.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 27.1 t -62.34 122.86 16.73 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.394 0.678 . . . . 74.150000000000006 110.067 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.1 t -102.51 109.28 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.58 0.752 . . . . 72.109999999999999 109.832 -177.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 59.5 mt -92.98 113.5 28.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 108.628 -0.878 . . . . 64.019999999999996 108.628 173.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -86.6 116.95 25.06 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.911 0.484 . . . . 63.539999999999999 110.118 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.493 HG13 ' HB3' ' A' ' 174' ' ' LEU . 7.2 p -125.75 102.72 28.49 Favored Pre-proline 0 CA--C 1.564 1.482 0 C-N-CA 123.253 0.621 . . . . 74.319999999999993 110.486 175.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 51.4 Cg_endo -68.15 154.86 71.41 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 123.049 2.5 . . . . 53.219999999999999 112.873 176.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 84.06 -15.15 40.0 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 116.105 -0.498 . . . . 73.209999999999994 114.178 178.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 24.3 mmt -99.02 -13.9 19.68 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.72 0.808 . . . . 65.340000000000003 111.763 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.41 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -79.54 -113.05 0.24 Allowed Glycine 0 C--N 1.351 1.362 0 O-C-N 123.593 0.558 . . . . 72.0 112.623 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.598 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -66.83 117.59 9.46 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.651 0.225 . . . . 73.230000000000004 113.452 177.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -88.42 131.42 34.87 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.636 0.774 . . . . 52.420000000000002 109.737 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 165.55 -160.68 34.13 Favored Glycine 0 N--CA 1.468 0.775 0 N-CA-C 110.316 -1.114 . . . . 53.140000000000001 110.316 -176.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -70.77 -35.84 4.79 Favored Pre-proline 0 CA--C 1.566 1.589 0 CA-C-O 117.715 -1.136 . . . . 73.310000000000002 112.247 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -91.33 128.9 1.21 Allowed 'Trans proline' 0 C--N 1.402 3.362 0 C-N-CA 122.466 2.111 . . . . 64.450000000000003 110.617 170.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.88 122.21 9.32 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 121.413 1.409 . . . . 74.510000000000005 110.844 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -90.81 146.03 18.2 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.722 -0.672 . . . . 54.420000000000002 112.242 -176.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 16.7 t70 -91.38 146.61 23.67 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.934 0.493 . . . . 74.239999999999995 110.239 -176.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.493 ' HB3' HG13 ' A' ' 161' ' ' VAL . 22.5 tp -123.67 111.17 15.88 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.398 0.679 . . . . 72.219999999999999 109.95 -176.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 75.6 mt -90.36 101.01 13.74 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.995 0.918 . . . . 74.109999999999999 110.069 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 79.8 mt -86.22 101.73 13.29 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.501 0.72 . . . . 73.140000000000001 110.664 -177.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 47.4 t -90.65 115.96 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.386 -0.968 . . . . 74.25 108.386 174.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.3 p -71.66 138.88 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 109.814 -0.439 . . . . 62.219999999999999 109.814 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.559 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 27.0 mmt180 -120.05 94.37 4.37 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.8 0.84 . . . . 64.030000000000001 109.229 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 51.7 mt -106.71 140.82 38.95 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.072 -0.967 . . . . 74.230000000000004 109.738 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 90.0 mt . . . . . 0 CA--C 1.556 1.202 0 CA-C-N 114.922 -1.036 . . . . 54.119999999999997 110.35 178.88 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.591 ' HB2' HH12 ' A' ' 136' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 121.0 0.428 . . . . 64.299999999999997 110.688 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.4 m -80.87 133.33 35.56 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 109.355 -0.609 . . . . 64.329999999999998 109.355 175.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 94.8 m -70.49 145.43 50.93 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 123.482 0.713 . . . . 72.150000000000006 110.746 176.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.602 HD12 ' HB2' ' A' ' 123' ' ' LEU . 23.6 pt -123.15 175.96 5.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 C-N-CA 123.647 0.779 . . . . 72.450000000000003 110.022 -176.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.422 ' O ' ' HD2' ' A' ' 124' ' ' PRO . . . -128.79 167.67 16.98 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.819 0.848 . . . . 35.210000000000001 109.391 176.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.532 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.5 tp -110.41 148.83 31.22 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 108.602 -0.888 . . . . 64.010000000000005 108.602 -177.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.27 -47.21 51.84 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.409 0.284 . . . . 54.450000000000003 110.66 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.6 mt 57.09 75.08 0.38 Allowed 'General case' 0 N--CA 1.478 0.929 0 O-C-N 124.47 1.107 . . . . 72.129999999999995 110.591 -170.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.7 mt -76.74 164.05 61.84 Favored Pre-proline 0 CA--C 1.553 1.076 0 CA-C-N 114.232 -1.349 . . . . 74.450000000000003 109.045 174.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo . . . . . 0 C--N 1.371 1.713 0 C-N-CA 121.858 1.705 . . . . 75.549999999999997 112.812 175.027 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 . . . . . 0 N--CA 1.478 0.939 0 CA-C-O 120.41 0.148 . . . . 54.009999999999998 110.706 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -83.91 133.18 34.72 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.563 -0.903 . . . . 55.200000000000003 108.563 169.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.5 tt -132.69 134.21 44.52 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 107.452 -1.314 . . . . 74.420000000000002 107.452 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -92.05 127.86 37.68 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.808 -0.812 . . . . 72.200000000000003 108.808 -175.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.532 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -149.75 132.56 16.01 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.86 -0.422 . . . . 72.329999999999998 109.86 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -127.91 125.34 39.41 Favored 'General case' 0 C--O 1.245 0.839 0 N-CA-C 109.743 -0.466 . . . . 74.129999999999995 109.743 -172.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.602 ' HB2' HD12 ' A' ' 97' ' ' ILE . 3.7 pp -101.96 119.88 55.52 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 109.299 -0.63 . . . . 64.010000000000005 109.299 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.422 ' HD2' ' O ' ' A' ' 98' ' ' ALA . 62.8 Cg_endo -72.74 115.34 4.31 Favored 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 122.721 2.28 . . . . 73.209999999999994 108.985 167.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.431 HD21 HD12 ' A' ' 149' ' ' ILE . 47.7 tp -102.2 150.26 23.47 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 109.79 -0.448 . . . . 64.349999999999994 109.79 -168.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.7 t -89.12 155.19 19.59 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 123.447 0.699 . . . . 72.299999999999997 109.496 -175.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.8 mt -60.89 -35.24 76.14 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.494 1.117 . . . . 71.400000000000006 112.87 -171.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -61.52 -46.83 88.31 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.388 -0.597 . . . . 73.049999999999997 109.388 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.402 ' HG3' ' HD2' ' A' ' 136' ' ' ARG . 15.8 mm-40 -77.42 -22.39 51.59 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 114.245 -1.343 . . . . 71.099999999999994 112.153 -177.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.0 -51.69 68.59 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 123.586 0.554 . . . . 73.329999999999998 110.401 173.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -81.06 -50.45 9.64 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 115.508 -0.769 . . . . 71.120000000000005 111.887 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -65.93 -45.02 83.39 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.235 0.614 . . . . 72.040000000000006 111.813 -175.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.479 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 73.24 -145.52 36.25 Favored Glycine 0 C--N 1.342 0.899 0 O-C-N 123.441 0.463 . . . . 73.120000000000005 112.092 -175.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.93 -147.09 25.98 Favored Glycine 0 C--N 1.345 1.041 0 O-C-N 123.687 0.286 . . . . 74.129999999999995 112.808 177.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -85.09 121.9 28.52 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.236 0.614 . . . . 74.450000000000003 109.78 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.591 HH12 ' HB2' ' A' ' 94' ' ' MET . 5.0 tpm_? -112.03 123.44 50.27 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.912 -0.774 . . . . 73.109999999999999 108.912 175.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.468 ' HB ' ' NH2' ' A' ' 136' ' ' ARG . 84.8 t -76.11 111.4 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 114.88 -1.055 . . . . 71.120000000000005 109.519 173.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 32.0 t -107.7 129.56 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 107.359 -1.348 . . . . 72.420000000000002 107.359 172.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -115.58 116.48 28.22 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.36 -0.607 . . . . 74.209999999999994 109.36 175.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.8 p -150.02 142.47 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 123.87 0.868 . . . . 54.009999999999998 109.179 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.69 19.16 11.58 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.239 1.016 . . . . 55.409999999999997 112.156 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 82.28 7.41 87.71 Favored Glycine 0 C--N 1.353 1.499 0 CA-C-N 116.214 -0.448 . . . . 53.020000000000003 113.04 -176.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.9 ttm-85 -114.58 143.02 45.66 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.056 0.943 . . . . 74.239999999999995 110.388 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.442 ' HG3' HG13 ' A' ' 137' ' ' VAL . 12.4 ttp180 -96.4 113.72 25.33 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.592 -0.892 . . . . 72.099999999999994 108.592 173.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 25.8 t -105.41 112.09 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 108.243 -1.021 . . . . 73.120000000000005 108.243 172.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 35.8 t -90.29 108.59 19.86 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 107.961 -1.126 . . . . 62.009999999999998 107.961 175.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 34.3 m -104.61 145.69 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.508 0.723 . . . . 65.209999999999994 110.656 -176.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -93.19 96.04 9.77 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.791 -0.818 . . . . 73.239999999999995 108.791 175.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.479 HG13 ' HA2' ' A' ' 133' ' ' GLY . 24.0 pt -85.51 135.53 38.4 Favored Pre-proline 0 CA--C 1.554 1.131 0 CA-C-N 115.596 -0.729 . . . . 53.100000000000001 109.18 172.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.406 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 38.3 Cg_endo -68.07 141.07 51.63 Favored 'Trans proline' 0 CA--C 1.565 2.027 0 C-N-CA 122.338 2.025 . . . . 72.519999999999996 112.438 178.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 150' ' ' PRO . 47.2 Cg_exo -60.2 113.7 1.78 Allowed 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 123.148 2.566 . . . . 72.230000000000004 112.14 173.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 86.61 32.59 15.25 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.359 -0.696 . . . . 63.43 111.359 -173.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.5 p -62.67 144.49 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.608 0.763 . . . . 75.120000000000005 109.682 172.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -132.01 161.36 33.36 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.77 0.428 . . . . 73.120000000000005 110.473 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -43.17 129.04 4.7 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 125.536 1.773 . . . . 72.019999999999996 112.91 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 102.68 -13.06 56.58 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-O 119.259 -0.745 . . . . 74.420000000000002 114.119 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.0 t -62.46 120.6 11.4 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 117.589 0.695 . . . . 74.25 109.698 178.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 176' ' ' LEU . 3.1 p -115.01 112.31 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 121.539 0.685 . . . . 62.25 110.36 -172.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 59.1 mt -90.23 102.92 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 107.965 -1.124 . . . . 55.229999999999997 107.965 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -81.21 99.96 8.86 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.8 -0.815 . . . . 75.230000000000004 108.8 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.2 p -103.73 118.86 56.35 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 122.845 0.458 . . . . 60.43 109.953 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.51 155.71 59.15 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.9 2.4 . . . . 75.420000000000002 112.287 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 81.24 -24.4 4.13 Favored Glycine 0 CA--C 1.535 1.3 0 N-CA-C 114.31 0.484 . . . . 62.240000000000002 114.31 176.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.1 mmt -88.17 -27.26 21.96 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.727 0.811 . . . . 74.150000000000006 112.024 -172.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -70.27 -78.36 0.4 Allowed Glycine 0 C--N 1.345 1.053 0 N-CA-C 111.361 -0.696 . . . . 75.310000000000002 111.361 175.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -71.16 110.84 3.41 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 111.0 -0.84 . . . . 42.520000000000003 111.0 167.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -89.45 151.61 21.92 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.709 0.804 . . . . 43.439999999999998 110.457 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 81.29 -125.77 7.05 Favored Glycine 0 C--N 1.342 0.902 0 CA-C-N 115.831 -0.622 . . . . 60.100000000000001 113.224 174.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.44 ' O ' ' HD3' ' A' ' 171' ' ' PRO . 28.3 t-20 -62.84 -48.64 84.89 Favored Pre-proline 0 CA--C 1.564 1.49 0 C-N-CA 123.972 0.909 . . . . 71.239999999999995 113.01 -174.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -96.84 95.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.392 2.834 0 C-N-CA 122.633 2.222 . . . . 73.430000000000007 113.082 176.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 169' ' ' ASN . 11.3 Cg_exo -70.33 121.96 8.51 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 121.988 1.792 . . . . 75.310000000000002 110.239 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -134.93 179.76 17.32 Favored Glycine 0 C--N 1.343 0.919 0 C-N-CA 121.67 -0.3 . . . . 65.109999999999999 113.108 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -96.11 119.79 35.23 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.51 0.671 . . . . 63.009999999999998 112.124 -167.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.3 tp -89.38 111.66 22.57 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.018 -0.992 . . . . 61.549999999999997 108.529 173.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 60.8 mt -83.95 99.55 10.46 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.562 0.745 . . . . 74.0 109.048 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 158' ' ' VAL . 91.7 mt -91.05 98.67 11.91 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 123.633 0.583 . . . . 72.239999999999995 110.884 -175.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 23.7 t -90.71 123.05 42.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 109.161 -0.681 . . . . 45.340000000000003 109.161 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.6 p -74.94 132.94 32.51 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 109.125 -0.694 . . . . 74.209999999999994 109.125 177.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.418 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 34.6 mmt180 -118.57 92.9 3.93 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.323 -0.991 . . . . 75.519999999999996 108.323 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 26.3 mt -101.02 131.48 46.87 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.616 -0.72 . . . . 63.340000000000003 110.608 -176.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 CA--C 1.549 0.919 0 CA-C-N 114.778 -1.101 . . . . 74.430000000000007 109.889 178.666 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.416 ' HB3' ' NH2' ' A' ' 136' ' ' ARG . 1.1 mpt? . . . . . 0 N--CA 1.484 1.269 0 N-CA-C 109.267 -0.642 . . . . 73.349999999999994 109.267 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.4 t -69.92 140.41 53.08 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-N 115.734 -0.667 . . . . 64.409999999999997 111.058 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.461 ' HA ' HH11 ' A' ' 136' ' ' ARG . 28.6 m -78.39 148.62 33.59 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.775 0.83 . . . . 62.520000000000003 109.596 174.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.743 HD12 ' HB2' ' A' ' 123' ' ' LEU . 26.1 pt -118.03 168.61 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 123.334 0.653 . . . . 55.329999999999998 110.382 -171.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -136.74 127.38 27.05 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.37 0.668 . . . . 54.200000000000003 110.258 -176.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.549 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.5 tp -80.57 157.02 26.18 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 124.07 0.948 . . . . 54.520000000000003 110.866 -168.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.457 ' HB3' ' H ' ' A' ' 122' ' ' GLU . . . -77.18 -54.08 6.95 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.631 0.372 . . . . 64.439999999999998 110.852 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.0 mt 55.46 84.71 0.07 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.187 0.995 . . . . 73.349999999999994 110.796 -168.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.5 mt -100.6 122.43 49.53 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 125.103 1.361 . . . . 44.109999999999999 109.219 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo . . . . . 0 C--N 1.372 1.797 0 C-N-CA 122.678 2.252 . . . . 72.219999999999999 112.869 179.985 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 . . . . . 0 C--O 1.24 0.567 0 CA-C-O 121.238 0.542 . . . . 75.519999999999996 111.132 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -91.7 107.28 19.1 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.71 -1.132 . . . . 72.549999999999997 107.974 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.8 tt -91.95 129.84 37.83 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 106.237 -1.764 . . . . 75.209999999999994 106.237 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 56.8 ttt180 -90.55 120.57 31.75 Favored 'General case' 0 C--O 1.213 -0.854 0 N-CA-C 107.998 -1.112 . . . . 73.120000000000005 107.998 -174.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.549 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -140.37 130.74 25.26 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.331 -0.618 . . . . 72.5 109.331 -174.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.496 ' HG2' ' HB ' ' A' ' 177' ' ' VAL . 84.9 mt-10 -120.63 120.96 37.26 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.316 -0.624 . . . . 64.349999999999994 109.316 -167.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.743 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.4 pp -103.13 118.71 57.34 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 109.522 -0.547 . . . . 74.530000000000001 109.522 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -74.27 113.76 3.87 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 122.819 2.346 . . . . 74.530000000000001 109.37 169.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.573 HD21 HD12 ' A' ' 149' ' ' ILE . 29.4 tp -103.75 143.92 32.17 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 110.151 -0.314 . . . . 73.25 110.151 -166.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.4 t -83.35 155.89 23.31 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.446 -0.797 . . . . 71.140000000000001 109.856 -176.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.2 mt -63.52 -30.98 72.02 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.072 0.949 . . . . 63.229999999999997 112.304 -173.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.55 -43.59 89.42 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.763 0.664 . . . . 74.049999999999997 109.52 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.414 ' HB3' HD11 ' A' ' 149' ' ' ILE . 69.6 mm-40 -77.74 -32.65 52.87 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.014 -0.994 . . . . 64.439999999999998 111.904 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.46 -49.19 74.65 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.489 0.661 . . . . 54.450000000000003 111.152 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -74.21 -59.76 2.58 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.251 -1.341 . . . . 73.420000000000002 110.595 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -72.81 -44.26 61.69 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.662 -0.699 . . . . 74.129999999999995 111.727 -172.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.39 178.12 50.82 Favored Glycine 0 C--N 1.351 1.399 0 O-C-N 123.629 0.581 . . . . 74.120000000000005 113.161 -175.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 127.76 -156.79 20.77 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.934 -0.466 . . . . 53.020000000000003 111.934 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.419 ' HB3' ' OG ' ' A' ' 146' ' ' SER . 3.1 mp0 -88.47 123.07 32.63 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.822 -0.807 . . . . 64.329999999999998 108.822 173.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.461 HH11 ' HA ' ' A' ' 96' ' ' THR . 8.3 tpp180 -116.29 122.42 44.89 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.484 0.714 . . . . 74.219999999999999 109.89 176.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.6 t -70.49 126.64 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 O-C-N 124.105 0.878 . . . . 75.420000000000002 109.783 175.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.74 134.83 64.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 124.699 1.2 . . . . 71.219999999999999 108.667 174.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -124.77 125.11 43.52 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.429 1.092 . . . . 71.150000000000006 109.763 -174.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.3 p -151.63 129.93 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.14 0.576 . . . . 75.019999999999996 110.785 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.82 20.04 11.1 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 123.997 0.919 . . . . 73.129999999999995 112.71 176.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.07 -13.29 67.69 Favored Glycine 0 C--N 1.353 1.498 0 CA-C-N 116.403 -0.362 . . . . 71.219999999999999 112.989 -175.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -90.82 117.97 29.86 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.565 1.146 . . . . 73.040000000000006 109.237 -175.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -114.92 129.61 56.74 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.566 0.746 . . . . 65.239999999999995 110.197 -176.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.14 144.78 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.974 0.909 . . . . 75.540000000000006 109.506 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.419 ' OG ' ' HB3' ' A' ' 135' ' ' GLU . 11.0 t -100.8 120.75 40.58 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.017 -0.734 . . . . 52.030000000000001 109.017 177.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 6.3 p -100.11 129.53 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.446 0.698 . . . . 71.140000000000001 110.332 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -75.92 99.51 4.54 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.206 -0.665 . . . . 73.129999999999995 109.206 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.573 HD12 HD21 ' A' ' 125' ' ' LEU . 10.4 pt -86.32 142.79 35.84 Favored Pre-proline 0 CA--C 1.555 1.162 0 CA-C-N 115.356 -0.838 . . . . 74.420000000000002 110.063 173.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -66.05 135.62 41.39 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.449 2.1 . . . . 72.439999999999998 112.11 172.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -55.57 124.42 16.23 Favored 'Trans proline' 0 C--N 1.367 1.504 0 C-N-CA 122.619 2.213 . . . . 65.040000000000006 111.524 166.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 81.51 24.42 56.47 Favored Glycine 0 CA--C 1.533 1.196 0 O-C-N 123.314 0.384 . . . . 62.109999999999999 112.63 -174.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 6.7 p -62.29 139.19 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.622 0.769 . . . . 74.209999999999994 109.7 173.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -127.34 152.57 47.3 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.339 0.656 . . . . 72.049999999999997 110.419 -174.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -40.67 132.01 2.25 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.475 1.91 . . . . 74.430000000000007 113.144 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.86 -6.94 77.03 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-O 119.658 -0.523 . . . . 63.219999999999999 113.992 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 29.2 m -63.0 130.27 43.97 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.216 0.606 . . . . 55.119999999999997 110.24 172.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 5.8 p -117.91 116.48 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 CA-C-O 121.312 0.577 . . . . 70.5 110.37 -177.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.412 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 58.8 mt -95.3 103.04 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.864 0.866 . . . . 54.549999999999997 108.672 176.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -80.16 109.85 15.01 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.142 0.577 . . . . 72.230000000000004 109.742 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.548 HG13 ' HB3' ' A' ' 174' ' ' LEU . 1.7 p -109.04 111.32 60.55 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 123.489 0.716 . . . . 50.450000000000003 109.266 173.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -67.56 151.7 79.29 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 123.239 2.626 . . . . 75.439999999999998 113.571 -177.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 66.6 24.7 72.63 Favored Glycine 0 C--N 1.356 1.673 0 O-C-N 123.772 0.67 . . . . 61.329999999999998 113.662 175.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.447 ' HB3' ' HB2' ' A' ' 174' ' ' LEU . 8.2 tpt -119.81 -33.79 3.91 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.263 0.625 . . . . 75.019999999999996 110.154 -171.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -91.69 -69.73 1.17 Allowed Glycine 0 C--N 1.35 1.341 0 CA-C-N 116.44 -0.346 . . . . 65.310000000000002 112.31 -177.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -62.77 90.42 0.07 OUTLIER Glycine 0 C--N 1.349 1.274 0 N-CA-C 111.46 -0.656 . . . . 54.340000000000003 111.46 169.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -92.28 170.37 9.85 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.249 1.02 . . . . 74.519999999999996 111.195 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.74 -145.5 18.33 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 115.251 -0.886 . . . . 74.239999999999995 112.179 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -78.99 -36.98 1.21 Allowed Pre-proline 0 CA--C 1.565 1.542 0 CA-C-O 118.288 -0.863 . . . . 50.509999999999998 112.083 177.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -82.68 110.38 1.88 Allowed 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 121.725 1.617 . . . . 74.140000000000001 111.314 166.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -74.62 166.82 28.52 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.619 2.213 . . . . 74.430000000000007 112.583 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 173.34 174.75 40.6 Favored Glycine 0 C--N 1.346 1.109 0 N-CA-C 114.079 0.392 . . . . 63.520000000000003 114.079 170.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -91.04 166.8 12.81 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.639 1.176 . . . . 64.530000000000001 111.088 -167.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.548 ' HB3' HG13 ' A' ' 161' ' ' VAL . 34.8 tp -124.11 118.27 26.54 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.562 -0.903 . . . . 74.109999999999999 108.562 177.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 82.6 mt -92.91 101.88 14.24 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.522 0.729 . . . . 64.109999999999999 109.649 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.412 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 94.9 mt -89.21 99.75 12.67 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.25 0.62 . . . . 72.230000000000004 111.028 -177.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.496 ' HB ' ' HG2' ' A' ' 122' ' ' GLU . 49.5 t -89.23 112.61 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 123.373 0.669 . . . . 75.239999999999995 109.493 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.02 133.56 31.49 Favored 'Isoleucine or valine' 0 C--O 1.249 1.074 0 N-CA-C 109.712 -0.477 . . . . 71.030000000000001 109.712 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -123.43 96.04 4.82 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.353 1.061 . . . . 73.519999999999996 108.471 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 180' ' ' LEU . 35.7 mt -96.84 140.81 30.84 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.642 -0.708 . . . . 74.049999999999997 111.756 -174.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 71.0 mt . . . . . 0 CA--C 1.553 1.058 0 CA-C-N 114.303 -1.317 . . . . 73.340000000000003 110.07 176.388 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 35.2 mtp . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 108.022 -1.103 . . . . 73.439999999999998 108.022 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.477 ' H ' HG21 ' A' ' 126' ' ' THR . 16.3 m -60.28 -22.31 62.96 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.065 1.135 . . . . 64.319999999999993 114.065 -172.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 45.0 m 71.3 145.91 0.07 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.754 1.222 . . . . 43.530000000000001 110.842 -172.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.727 HD12 ' HB2' ' A' ' 123' ' ' LEU . 15.3 pt -128.08 166.19 25.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 123.348 0.659 . . . . 75.049999999999997 110.861 -170.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.407 ' O ' ' HD2' ' A' ' 124' ' ' PRO . . . -126.4 151.33 47.81 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.333 1.053 . . . . 73.400000000000006 109.649 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.617 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.5 tp -100.91 155.14 18.12 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.892 0.477 . . . . 62.340000000000003 109.936 -170.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.44 ' HB3' ' H ' ' A' ' 122' ' ' GLU . . . -84.14 -40.54 18.08 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.249 0.619 . . . . 62.100000000000001 111.929 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.0 mt 48.69 66.18 1.15 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.004 0.922 . . . . 75.209999999999994 111.283 -172.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 76.1 mt -73.43 151.03 89.57 Favored Pre-proline 0 CA--C 1.548 0.89 0 CA-C-N 115.35 -0.841 . . . . 63.140000000000001 110.492 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 C--N 1.373 1.832 0 C-N-CA 122.247 1.965 . . . . 50.329999999999998 112.595 171.975 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.434 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 43.3 ttt180 . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 112.556 0.576 . . . . 71.510000000000005 112.556 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -78.35 139.38 38.82 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.433 -0.803 . . . . 72.129999999999995 109.425 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.9 tt -132.7 126.1 31.78 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.175 -1.417 . . . . 44.210000000000001 107.175 177.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -91.59 136.14 33.35 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.361 0.665 . . . . 65.019999999999996 109.321 -176.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.617 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -154.37 146.87 24.04 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.466 0.706 . . . . 75.310000000000002 110.11 -176.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.44 ' H ' ' HB3' ' A' ' 100' ' ' ALA . 29.4 mt-10 -120.79 124.98 46.4 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 109.179 -0.674 . . . . 73.030000000000001 109.179 -176.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.727 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.5 pp -108.94 115.06 57.72 Favored Pre-proline 0 CA--C 1.551 0.981 0 N-CA-C 108.672 -0.862 . . . . 73.430000000000007 108.672 174.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.475 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 82.4 Cg_endo -78.15 114.74 3.62 Favored 'Trans proline' 0 C--N 1.365 1.437 0 C-N-CA 122.673 2.249 . . . . 73.120000000000005 109.124 170.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.525 HD21 HD12 ' A' ' 149' ' ' ILE . 25.5 tp -103.78 147.18 27.59 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.393 -0.595 . . . . 65.319999999999993 109.393 -166.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.477 HG21 ' H ' ' A' ' 95' ' ' SER . 11.3 t -92.63 162.97 13.96 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 109.718 -0.475 . . . . 63.219999999999999 109.718 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.5 mt -64.65 -37.02 86.15 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.85 0.86 . . . . 54.140000000000001 112.188 -168.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -59.83 -40.18 87.62 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.177 0.923 . . . . 75.420000000000002 109.68 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -76.92 -37.06 56.09 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 114.892 -1.049 . . . . 75.109999999999999 111.567 -173.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.9 -36.15 74.22 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 121.104 0.478 . . . . 64.430000000000007 110.384 172.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -77.16 -34.7 56.39 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 114.751 -1.113 . . . . 73.200000000000003 111.822 177.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 27.4 m80 -74.76 -51.16 14.9 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 117.926 0.33 . . . . 71.310000000000002 110.983 -176.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.429 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 58.62 68.11 1.86 Allowed Glycine 0 C--N 1.344 0.994 0 O-C-N 124.239 0.962 . . . . 44.350000000000001 112.307 -172.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.423 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -155.51 -146.33 4.41 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-O 120.055 -0.303 . . . . 72.5 112.529 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.3 mp0 -75.12 117.08 16.56 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.406 0.682 . . . . 72.230000000000004 109.685 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.667 HH21 ' HB ' ' A' ' 137' ' ' VAL . 4.5 tpm_? -116.56 123.74 48.12 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.113 0.965 . . . . 74.230000000000004 108.674 173.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.667 ' HB ' HH21 ' A' ' 136' ' ' ARG . 87.8 t -72.49 122.8 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.079 0.952 . . . . 64.510000000000005 110.341 174.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.601 ' HB ' HG13 ' A' ' 145' ' ' VAL . 21.4 t -112.6 126.95 70.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.551 -0.907 . . . . 72.140000000000001 108.551 174.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -109.16 110.43 21.66 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.831 0.853 . . . . 61.109999999999999 109.466 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 10.8 p -149.75 133.22 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 123.018 0.527 . . . . 75.409999999999997 110.541 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.64 18.68 10.75 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.513 1.125 . . . . 73.319999999999993 112.645 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.79 5.57 86.27 Favored Glycine 0 C--N 1.348 1.244 0 O-C-N 123.158 0.286 . . . . 40.200000000000003 113.232 -176.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -112.12 131.46 55.44 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.406 1.082 . . . . 72.129999999999995 109.806 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.556 ' HG3' HG13 ' A' ' 137' ' ' VAL . 39.6 ttm180 -90.22 113.98 25.89 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.124 0.97 . . . . 71.329999999999998 109.618 172.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.601 HG13 ' HB ' ' A' ' 138' ' ' VAL . 2.5 p -111.3 115.14 49.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 123.398 0.679 . . . . 54.240000000000002 109.21 169.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.6 t -86.78 115.23 24.07 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 109.19 -0.67 . . . . 74.439999999999998 109.19 175.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.6 p -100.83 124.38 54.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 123.612 0.765 . . . . 71.349999999999994 109.795 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 54.2 ttt85 -80.43 93.93 6.1 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.747 -1.205 . . . . 73.530000000000001 107.747 168.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.525 HD12 HD21 ' A' ' 125' ' ' LEU . 13.8 pt -74.31 143.94 80.64 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 123.824 0.85 . . . . 64.510000000000005 109.753 177.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.429 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 59.9 Cg_endo -72.8 149.07 47.39 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 122.225 1.95 . . . . 73.109999999999999 111.993 177.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 150' ' ' PRO . 31.9 Cg_exo -60.54 134.45 54.75 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 123.137 2.558 . . . . 70.150000000000006 112.122 177.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 65.83 29.31 74.81 Favored Glycine 0 C--N 1.353 1.506 0 O-C-N 123.697 0.623 . . . . 74.010000000000005 112.63 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -58.21 145.65 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 C-N-CA 124.053 0.941 . . . . 74.450000000000003 109.72 176.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -136.64 158.75 43.71 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.53 0.732 . . . . 72.120000000000005 110.415 -173.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -42.69 127.18 3.87 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.895 1.678 . . . . 52.210000000000001 112.838 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.27 -4.82 80.92 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 114.385 0.514 . . . . 64.019999999999996 114.385 177.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.6 t -67.62 122.32 17.8 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.242 -0.651 . . . . 71.200000000000003 109.242 176.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 46.5 t -101.99 117.06 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 109.427 -0.583 . . . . 73.530000000000001 109.427 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.5 mt -91.92 144.1 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.813 1.245 . . . . 71.420000000000002 107.968 173.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.547 HH11 HD21 ' A' ' 175' ' ' LEU . 49.0 ttt85 -118.09 116.75 27.49 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.188 -0.671 . . . . 73.319999999999993 109.188 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 174' ' ' LEU . 5.0 p -124.17 109.62 29.3 Favored Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 123.693 0.797 . . . . 53.140000000000001 110.531 -177.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -70.72 153.62 64.41 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.974 2.449 . . . . 72.439999999999998 112.628 -176.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.77 -13.83 54.67 Favored Glycine 0 C--N 1.339 0.719 0 CA-C-N 115.702 -0.681 . . . . 72.439999999999998 113.954 174.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 84.7 mmm -100.14 -12.42 19.64 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 117.404 0.602 . . . . 65.219999999999999 111.452 -176.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -83.04 -111.5 0.5 Allowed Glycine 0 C--N 1.353 1.485 0 CA-C-O 119.312 -0.716 . . . . 61.119999999999997 111.936 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.434 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -53.85 108.32 0.81 Allowed Glycine 0 C--N 1.353 1.489 0 O-C-N 124.003 0.472 . . . . 53.25 113.128 174.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -91.22 169.54 10.75 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.616 1.167 . . . . 73.400000000000006 110.396 175.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 94.59 -145.41 17.68 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 115.388 -0.824 . . . . 73.019999999999996 112.147 175.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -69.13 -47.66 28.58 Favored Pre-proline 0 CA--C 1.561 1.384 0 CA-C-O 118.13 -0.938 . . . . 73.239999999999995 110.872 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.3 113.59 2.67 Favored 'Trans proline' 0 C--N 1.395 3.011 0 C-N-CA 122.232 1.955 . . . . 62.0 111.087 172.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -72.39 160.17 47.55 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.45 2.1 . . . . 74.340000000000003 111.418 177.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -161.01 -179.13 35.56 Favored Glycine 0 CA--C 1.504 -0.632 0 N-CA-C 114.732 0.653 . . . . 44.149999999999999 114.732 176.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -120.52 150.18 41.25 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.531 1.132 . . . . 75.310000000000002 109.641 -169.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.421 ' HB3' HG13 ' A' ' 161' ' ' VAL . 37.2 tp -117.1 114.1 23.24 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.563 0.745 . . . . 73.340000000000003 110.1 -172.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.547 HD21 HH11 ' A' ' 160' ' ' ARG . 92.8 mt -88.37 103.28 15.69 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.063 0.945 . . . . 74.209999999999994 110.162 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.534 HD22 HD11 ' A' ' 99' ' ' LEU . 77.0 mt -95.41 99.18 11.13 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.085 0.954 . . . . 74.239999999999995 110.615 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 8.5 p -90.37 133.4 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 109.372 -0.603 . . . . 74.140000000000001 109.372 175.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.3 p -87.58 144.81 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 123.238 0.615 . . . . 72.430000000000007 111.165 -171.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.475 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 35.5 mmt180 -119.25 99.74 6.89 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.742 1.217 . . . . 62.329999999999998 108.44 174.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 16.0 mt -118.86 145.86 45.35 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.973 0.909 . . . . 54.109999999999999 111.119 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 65.2 mt . . . . . 0 CA--C 1.551 0.991 0 CA-C-N 114.541 -1.209 . . . . 73.319999999999993 109.423 -178.614 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 49.8 mtt . . . . . 0 N--CA 1.484 1.264 0 N-CA-C 108.927 -0.768 . . . . 74.540000000000006 108.927 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.4 m -71.48 121.68 19.07 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.915 -0.772 . . . . 51.140000000000001 108.915 174.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 86.8 m -68.2 141.56 55.94 Favored 'General case' 0 C--N 1.35 0.63 0 C-N-CA 123.392 0.677 . . . . 72.049999999999997 110.39 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.588 HD12 ' HB2' ' A' ' 123' ' ' LEU . 14.2 pt -114.88 163.41 12.19 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 C-N-CA 123.057 0.543 . . . . 52.409999999999997 110.818 -170.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -123.15 -162.93 1.06 Allowed 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.399 -0.963 . . . . 45.439999999999998 108.399 170.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.488 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.5 tp -136.64 155.93 49.23 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.937 -0.764 . . . . 75.129999999999995 108.937 -175.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.87 -48.92 33.32 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.044 0.538 . . . . 50.100000000000001 110.723 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.585 HD11 ' HB ' ' A' ' 140' ' ' VAL . 60.2 mt 53.68 78.05 0.16 Allowed 'General case' 0 CA--C 1.546 0.809 0 O-C-N 124.469 1.106 . . . . 63.450000000000003 110.348 -171.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 60.9 mt -84.65 143.2 40.61 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 114.984 -1.007 . . . . 75.530000000000001 109.636 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 C--N 1.375 1.953 0 C-N-CA 122.571 2.18 . . . . 72.209999999999994 112.952 179.839 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.706 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 32.8 ttm180 . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 120.685 0.279 . . . . 75.430000000000007 111.01 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -76.11 139.33 41.29 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.519 0.728 . . . . 74.219999999999999 109.539 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.3 tt -141.38 115.5 9.3 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 106.393 -1.706 . . . . 71.329999999999998 106.393 -177.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -90.24 143.08 27.1 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 107.052 -1.462 . . . . 73.420000000000002 107.052 177.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.488 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -149.51 137.16 20.2 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 120.684 0.278 . . . . 62.530000000000001 110.522 -169.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -120.53 112.41 18.91 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.146 -1.057 . . . . 73.450000000000003 108.146 -172.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.588 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.6 pp -99.31 117.79 63.43 Favored Pre-proline 0 C--N 1.354 0.78 0 N-CA-C 108.396 -0.964 . . . . 70.049999999999997 108.396 177.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.417 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 95.6 Cg_endo -75.48 113.68 3.81 Favored 'Trans proline' 0 C--N 1.364 1.36 0 C-N-CA 122.208 1.939 . . . . 71.530000000000001 109.166 170.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.512 HD21 HD12 ' A' ' 149' ' ' ILE . 33.0 tp -102.0 153.08 20.22 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.615 -0.513 . . . . 73.129999999999995 109.615 -172.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.8 t -91.43 155.16 18.65 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 109.224 -0.658 . . . . 74.099999999999994 109.224 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.1 mt -63.12 -34.43 77.59 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.461 0.704 . . . . 72.450000000000003 111.947 -173.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.93 -46.39 90.87 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.834 0.853 . . . . 75.230000000000004 110.022 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -79.09 -26.59 42.96 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.24 -0.891 . . . . 65.310000000000002 112.519 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.38 -40.94 92.65 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.533 0.683 . . . . 71.140000000000001 110.064 171.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -77.62 -48.91 15.71 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 114.224 -1.353 . . . . 73.329999999999998 111.093 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -69.68 -49.43 53.57 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 122.802 0.441 . . . . 54.140000000000001 111.592 -173.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.569 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 75.11 -170.42 54.36 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 115.805 -0.634 . . . . 74.129999999999995 111.702 -163.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.462 ' O ' HG12 ' A' ' 149' ' ' ILE . . . 90.54 -166.29 31.62 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 116.557 0.179 . . . . 55.020000000000003 112.74 -177.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.445 ' HB3' ' OG ' ' A' ' 146' ' ' SER . 3.6 mp0 -71.62 130.69 41.8 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.226 0.61 . . . . 63.020000000000003 110.275 -175.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -131.24 128.58 40.17 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.19 -0.67 . . . . 75.109999999999999 109.19 172.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 38.7 t -72.39 113.08 9.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 O-C-N 124.627 1.205 . . . . 71.519999999999996 110.63 -172.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.5 t -106.44 112.16 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.687 1.195 . . . . 74.319999999999993 107.878 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -94.18 117.35 29.99 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.276 0.63 . . . . 73.409999999999997 109.44 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.585 ' HB ' HD11 ' A' ' 101' ' ' LEU . 19.5 m -135.64 120.84 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 124.502 1.121 . . . . 73.230000000000004 112.048 -169.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 57.88 20.34 6.56 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.55 1.14 . . . . 73.439999999999998 113.603 169.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.67 27.76 18.59 Favored Glycine 0 CA--C 1.535 1.342 0 N-CA-C 112.461 -0.256 . . . . 33.450000000000003 112.461 -175.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -133.64 154.02 51.23 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.405 1.082 . . . . 55.43 109.24 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -112.31 114.79 27.73 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.36 1.064 . . . . 75.310000000000002 109.044 176.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 5.7 p -130.26 124.29 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.536 -0.913 . . . . 74.329999999999998 108.536 174.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.445 ' OG ' ' HB3' ' A' ' 135' ' ' GLU . 12.7 t -103.44 122.8 45.64 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 109.228 -0.656 . . . . 63.549999999999997 109.228 -177.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.1 p -100.94 129.56 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 122.933 0.493 . . . . 71.510000000000005 110.092 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.9 ttp180 -74.73 98.82 3.55 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.573 -0.899 . . . . 61.200000000000003 108.573 170.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.569 HG13 ' HA2' ' A' ' 133' ' ' GLY . 10.7 pt -78.72 145.55 67.03 Favored Pre-proline 0 CA--C 1.563 1.444 0 C-N-CA 124.042 0.937 . . . . 75.340000000000003 109.796 171.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.86 141.34 89.58 Favored 'Trans proline' 0 CA--C 1.564 1.985 0 C-N-CA 122.78 2.32 . . . . 72.439999999999998 113.388 174.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -62.73 114.78 2.55 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.718 2.279 . . . . 70.030000000000001 111.115 168.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 87.59 30.03 19.82 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 111.444 -0.662 . . . . 72.530000000000001 111.444 -174.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -70.21 137.34 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.428 0.691 . . . . 74.409999999999997 109.358 174.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -135.11 157.56 46.61 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.997 0.519 . . . . 64.040000000000006 111.04 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -39.86 122.06 1.38 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.915 2.086 . . . . 41.210000000000001 113.202 -175.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.9 -12.08 38.04 Favored Glycine 0 C--N 1.348 1.213 0 CA-C-O 119.366 -0.685 . . . . 55.0 113.846 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 13.7 t -70.04 122.14 18.8 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 117.382 0.591 . . . . 74.209999999999994 110.138 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 46.5 t -104.41 111.24 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 123.848 0.859 . . . . 74.010000000000005 109.628 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 61.1 mt -89.69 103.63 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.912 -1.144 . . . . 54.299999999999997 107.912 171.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -82.15 119.55 24.2 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.397 -0.594 . . . . 71.239999999999995 109.397 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.542 HG13 ' HB3' ' A' ' 174' ' ' LEU . 6.5 p -124.51 98.2 38.17 Favored Pre-proline 0 CA--C 1.561 1.374 0 C-N-CA 123.68 0.792 . . . . 54.549999999999997 109.476 177.253 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 73.5 Cg_endo -72.35 146.68 45.67 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.954 2.436 . . . . 63.240000000000002 112.503 179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 93.45 -18.51 56.23 Favored Glycine 0 CA--C 1.537 1.43 0 CA-C-O 120.058 -0.301 . . . . 70.120000000000005 113.726 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 69.9 mmm -97.87 -9.87 25.62 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.935 0.894 . . . . 62.009999999999998 112.904 -174.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -79.74 -100.07 0.28 Allowed Glycine 0 C--N 1.342 0.889 0 O-C-N 123.181 0.3 . . . . 73.310000000000002 112.68 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.706 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -67.56 103.04 0.89 Allowed Glycine 0 C--N 1.344 1.022 0 N-CA-C 112.416 -0.273 . . . . 75.530000000000001 112.416 175.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -79.8 131.71 35.97 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.591 0.756 . . . . 65.109999999999999 109.813 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 154.06 -163.73 31.09 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 111.495 -0.642 . . . . 72.319999999999993 111.495 -177.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -58.83 -47.17 99.2 Favored Pre-proline 0 CA--C 1.562 1.422 0 CA-C-O 118.749 -0.643 . . . . 75.329999999999998 111.524 177.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.93 119.28 3.55 Favored 'Trans proline' 0 C--N 1.39 2.733 0 C-N-CA 121.481 1.454 . . . . 54.43 110.967 168.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.6 121.96 9.3 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 121.568 1.512 . . . . 71.519999999999996 109.702 174.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -97.59 149.25 19.19 Favored Glycine 0 C--N 1.339 0.728 0 CA-C-O 119.769 -0.462 . . . . 65.329999999999998 112.539 -173.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 37.6 t70 -83.03 139.78 33.08 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 122.764 0.426 . . . . 63.329999999999998 110.575 -175.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.542 ' HB3' HG13 ' A' ' 161' ' ' VAL . 33.4 tp -122.88 130.67 53.14 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.643 0.777 . . . . 75.319999999999993 109.347 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 80.9 mt -109.34 101.9 10.86 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.602 0.761 . . . . 72.340000000000003 109.307 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 77.3 mt -88.07 101.07 13.43 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 109.583 -0.525 . . . . 72.010000000000005 109.583 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 36.5 t -95.77 124.98 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 109.116 -0.698 . . . . 44.109999999999999 109.116 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.8 p -74.96 127.61 36.66 Favored 'Isoleucine or valine' 0 C--O 1.249 1.064 0 C-N-CA 123.117 0.567 . . . . 65.25 109.966 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.417 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 5.1 mmm180 -114.42 100.61 8.44 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.769 -0.826 . . . . 74.340000000000003 108.769 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 40.3 mt -116.38 139.86 49.96 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.373 1.069 . . . . 65.519999999999996 110.035 -177.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 59.3 mt . . . . . 0 CA--C 1.546 0.803 0 CA-C-N 115.347 -0.842 . . . . 54.310000000000002 108.891 178.633 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.481 ' SD ' ' N ' ' A' ' 94' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 108.108 -1.071 . . . . 52.329999999999998 108.108 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.9 t -62.2 121.56 13.41 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.067 0.547 . . . . 61.340000000000003 111.228 -172.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.521 ' HA ' ' HD2' ' A' ' 136' ' ' ARG . 56.6 m -72.59 149.65 43.78 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.534 0.733 . . . . 72.420000000000002 110.323 177.061 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.725 HD12 ' HB2' ' A' ' 123' ' ' LEU . 14.1 pt -118.09 161.75 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.029 0.532 . . . . 74.329999999999998 111.41 -164.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -113.18 -162.87 0.82 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.954 0.902 . . . . 42.409999999999997 109.186 173.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.762 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.6 tp -150.66 147.42 27.36 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.125 -0.694 . . . . 73.150000000000006 109.125 -172.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.14 -51.91 14.13 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.406 0.283 . . . . 73.340000000000003 111.147 -178.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 89.9 mt 60.59 73.77 0.47 Allowed 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.339 1.025 . . . . 71.530000000000001 110.435 -174.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.9 mt -77.02 109.72 9.86 Favored Pre-proline 0 CA--C 1.555 1.151 0 CA-C-N 114.986 -1.006 . . . . 44.439999999999998 109.18 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo . . . . . 0 C--N 1.383 2.352 0 C-N-CA 123.53 2.82 . . . . 70.299999999999997 114.716 -173.131 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.605 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 17.4 ttm180 . . . . . 0 N--CA 1.479 0.975 0 CA-C-O 120.42 0.152 . . . . 60.420000000000002 111.064 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -71.44 134.29 46.5 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.0 0.52 . . . . 70.430000000000007 110.094 173.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.7 tt -133.93 120.3 20.17 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 106.298 -1.741 . . . . 75.430000000000007 106.298 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -91.83 144.24 25.7 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 108.931 -0.766 . . . . 74.120000000000005 108.931 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.762 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -154.73 133.25 11.98 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.86 0.464 . . . . 53.25 110.037 -172.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -107.02 116.24 31.57 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.493 0.717 . . . . 73.109999999999999 109.365 -168.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.725 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.2 pp -101.36 115.21 65.38 Favored Pre-proline 0 C--N 1.35 0.604 0 N-CA-C 108.694 -0.854 . . . . 70.040000000000006 108.694 177.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -80.26 111.43 2.64 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.533 2.155 . . . . 70.430000000000007 110.984 172.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.605 HD21 HD12 ' A' ' 149' ' ' ILE . 30.0 tp -104.6 152.15 22.78 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 121.899 -0.501 . . . . 64.120000000000005 110.644 -166.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.9 t -90.35 154.11 19.94 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 123.498 0.719 . . . . 75.010000000000005 109.127 178.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.7 mt -68.64 -30.85 69.65 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.499 0.72 . . . . 52.439999999999998 112.251 -170.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -64.49 -48.58 74.65 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.14 0.576 . . . . 73.319999999999993 109.575 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -63.21 -38.45 91.2 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 114.695 -1.139 . . . . 52.25 112.0 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.475 ' HB2' HD21 ' A' ' 180' ' ' LEU . . . -60.02 -38.47 82.8 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 123.616 0.573 . . . . 74.140000000000001 111.505 176.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -76.32 -32.76 58.88 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 115.077 -0.965 . . . . 73.150000000000006 111.077 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -74.5 -49.75 20.91 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.096 0.474 . . . . 73.209999999999994 111.437 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.449 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 66.63 44.54 89.52 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.163 -0.926 . . . . 54.219999999999999 112.036 -164.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -97.09 -161.5 31.8 Favored Glycine 0 C--N 1.351 1.367 0 O-C-N 123.894 0.408 . . . . 75.340000000000003 112.244 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -95.71 116.68 29.23 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.772 -0.825 . . . . 74.120000000000005 108.772 176.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.521 ' HD2' ' HA ' ' A' ' 96' ' ' THR . 10.0 tpp180 -111.0 126.23 54.57 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.159 0.584 . . . . 64.209999999999994 109.527 178.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 91.6 t -73.56 132.89 32.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 114.433 -1.258 . . . . 61.200000000000003 110.333 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 28.2 t -116.59 126.76 74.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 107.302 -1.37 . . . . 65.319999999999993 107.302 174.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -126.06 110.11 13.16 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.994 0.518 . . . . 62.399999999999999 110.27 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -149.25 137.03 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 124.391 1.076 . . . . 72.109999999999999 111.072 -177.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.85 17.33 9.86 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.246 1.419 . . . . 44.039999999999999 112.732 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.33 1.68 74.82 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 116.404 -0.362 . . . . 51.310000000000002 112.987 -176.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -102.38 121.26 41.96 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.385 1.074 . . . . 71.120000000000005 110.109 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -98.48 105.49 17.64 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 109.522 -0.548 . . . . 73.109999999999999 109.522 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.459 HG12 HG13 ' A' ' 147' ' ' VAL . 49.6 t -106.17 111.86 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.778 0.831 . . . . 55.210000000000001 109.062 176.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.6 t -92.39 121.11 33.56 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.191 -1.041 . . . . 65.420000000000002 108.191 176.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.459 HG13 HG12 ' A' ' 145' ' ' VAL . 29.8 m -126.16 144.01 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.142 0.577 . . . . 72.109999999999999 110.785 -176.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 63.5 ttp85 -88.32 124.59 34.06 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.677 -0.86 . . . . 73.519999999999996 108.677 172.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.605 HD12 HD21 ' A' ' 125' ' ' LEU . 4.5 pt -93.47 149.26 36.96 Favored Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 124.295 1.038 . . . . 64.409999999999997 109.752 176.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.412 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 33.7 Cg_exo -61.0 140.37 89.72 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 123.013 2.476 . . . . 55.340000000000003 113.74 174.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 150' ' ' PRO . 22.4 Cg_exo -67.58 113.88 3.1 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.89 2.393 . . . . 53.509999999999998 111.199 170.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 86.07 26.38 34.34 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 116.083 -0.508 . . . . 45.100000000000001 112.107 -173.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.21 137.22 22.92 Favored 'Isoleucine or valine' 0 C--N 1.358 0.958 0 C-N-CA 123.546 0.738 . . . . 71.099999999999994 110.671 176.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 65.3 mtm180 -134.37 164.82 26.58 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.861 0.864 . . . . 72.400000000000006 110.642 -174.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -43.29 122.28 2.5 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.177 1.791 . . . . 75.349999999999994 114.685 -171.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.18 -6.71 72.39 Favored Glycine 0 C--N 1.352 1.431 0 CA-C-O 119.376 -0.68 . . . . 73.409999999999997 114.52 176.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.1 m -60.61 123.33 17.09 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.382 0.673 . . . . 64.299999999999997 111.865 175.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.1 p -101.85 132.88 46.89 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.041 0 C-N-CA 123.172 0.589 . . . . 72.150000000000006 110.744 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.595 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 75.7 mt -106.32 104.74 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 107.465 -1.309 . . . . 62.520000000000003 107.465 176.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -78.94 105.42 10.26 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.723 -0.473 . . . . 63.219999999999999 109.723 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.553 HG13 ' HB3' ' A' ' 174' ' ' LEU . 5.8 p -113.44 100.17 51.16 Favored Pre-proline 0 CA--C 1.558 1.277 0 C-N-CA 122.717 0.407 . . . . 62.140000000000001 110.166 174.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -64.3 150.73 87.74 Favored 'Trans proline' 0 C--N 1.387 2.592 0 C-N-CA 123.713 2.942 . . . . 51.240000000000002 113.168 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 83.35 -25.38 4.99 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 116.223 -0.444 . . . . 73.0 113.988 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.54 -12.84 50.67 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.02 0.928 . . . . 62.409999999999997 111.617 -178.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -84.73 -111.87 0.66 Allowed Glycine 0 C--N 1.349 1.279 0 O-C-N 123.511 0.507 . . . . 44.200000000000003 112.654 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.605 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -61.34 120.59 23.24 Favored Glycine 0 C--N 1.346 1.136 0 O-C-N 123.818 0.364 . . . . 73.420000000000002 112.469 177.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 11.7 mm-40 -88.18 155.42 19.77 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.354 0.662 . . . . 73.420000000000002 111.269 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 129.47 -171.4 20.14 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.069 -0.969 . . . . 61.329999999999998 111.466 -175.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -60.5 -45.27 97.29 Favored Pre-proline 0 CA--C 1.564 1.487 0 CA-C-O 118.451 -0.785 . . . . 62.109999999999999 112.209 175.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -82.73 112.74 2.15 Favored 'Trans proline' 0 C--N 1.395 2.98 0 C-N-CA 121.902 1.735 . . . . 75.430000000000007 111.066 171.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.76 127.43 12.31 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.418 2.079 . . . . 74.349999999999994 112.068 -177.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -105.12 156.13 16.88 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.973 -0.558 . . . . 73.150000000000006 112.785 -175.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -84.91 135.27 34.13 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.709 0.804 . . . . 72.219999999999999 111.241 -176.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.553 ' HB3' HG13 ' A' ' 161' ' ' VAL . 23.4 tp -102.21 107.79 18.97 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.457 -0.942 . . . . 64.120000000000005 108.457 177.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 78.9 mt -86.49 100.22 12.22 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.606 0.762 . . . . 72.510000000000005 109.909 -176.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.649 ' HB3' HD23 ' A' ' 123' ' ' LEU . 75.4 mt -91.42 98.95 12.0 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.059 0.544 . . . . 71.299999999999997 110.927 -175.027 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 47.9 t -91.0 117.34 34.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 109.461 -0.57 . . . . 74.299999999999997 109.461 -178.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.5 p -69.73 135.43 28.28 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 C-N-CA 123.339 0.656 . . . . 62.530000000000001 110.514 -176.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -127.69 85.64 2.38 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.189 -1.041 . . . . 71.340000000000003 108.189 -178.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.475 HD21 ' HB2' ' A' ' 130' ' ' ALA . 43.5 mt -82.36 147.52 28.78 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 114.975 -1.012 . . . . 75.239999999999995 110.27 -178.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 60.4 mt . . . . . 0 CA--C 1.551 1.0 0 N-CA-C 108.644 -0.873 . . . . 60.329999999999998 108.644 176.267 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 3.7 mpp? . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 108.501 -0.926 . . . . 64.140000000000001 108.501 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.5 m -62.82 132.12 51.11 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.555 0.742 . . . . 51.210000000000001 111.741 -171.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.413 ' HA ' ' HD2' ' A' ' 136' ' ' ARG . 39.5 m -77.14 151.75 35.21 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.728 0.811 . . . . 73.519999999999996 110.262 176.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.743 HD12 ' HB2' ' A' ' 123' ' ' LEU . 26.7 pt -112.46 165.09 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 123.173 0.589 . . . . 73.319999999999993 110.985 -174.043 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -135.25 123.64 23.29 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.936 0.895 . . . . 75.420000000000002 109.528 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.544 ' HB2' HG21 ' A' ' 138' ' ' VAL . 13.2 tp -76.69 149.44 36.41 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 124.845 1.258 . . . . 73.310000000000002 110.231 -172.227 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.34 -51.37 20.92 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.951 0.501 . . . . 71.140000000000001 111.115 -175.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.1 mt 57.72 82.36 0.13 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.357 1.063 . . . . 71.400000000000006 111.236 -174.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 45.9 mt -96.6 150.47 37.04 Favored Pre-proline 0 N--CA 1.479 1.008 0 C-N-CA 124.613 1.165 . . . . 71.420000000000002 109.664 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 C--N 1.375 1.966 0 C-N-CA 122.375 2.05 . . . . 70.409999999999997 112.714 176.571 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.501 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 68.4 ttt180 . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 112.459 0.54 . . . . 73.239999999999995 112.459 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -77.21 148.71 35.71 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.263 -0.881 . . . . 63.350000000000001 109.114 174.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.2 tt -140.62 131.14 25.4 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.329 -0.989 . . . . 63.119999999999997 108.329 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -93.32 115.99 28.56 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 108.895 -0.78 . . . . 73.019999999999996 108.895 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.543 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -129.15 144.24 51.14 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.339 -0.615 . . . . 72.319999999999993 109.339 -176.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -126.12 120.12 29.34 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 107.962 -1.125 . . . . 74.549999999999997 107.962 -176.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.743 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.0 pp -100.98 110.62 61.58 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 107.519 -1.289 . . . . 73.409999999999997 107.519 177.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.99 112.8 3.61 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.794 2.329 . . . . 73.409999999999997 108.876 168.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.546 HD21 HD12 ' A' ' 149' ' ' ILE . 22.9 tp -103.21 140.83 36.85 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.149 -0.686 . . . . 72.230000000000004 109.149 -168.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.7 t -78.22 162.69 26.39 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 110.101 -0.333 . . . . 60.5 110.101 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.1 mt -64.01 -36.66 84.72 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.014 0.925 . . . . 73.409999999999997 112.014 -174.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -62.19 -46.48 88.74 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.487 0.715 . . . . 73.150000000000006 109.842 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -71.87 -40.05 69.22 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.398 -1.273 . . . . 70.010000000000005 111.833 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.8 -58.34 8.99 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.57 0.7 . . . . 74.400000000000006 111.187 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -67.44 -56.7 8.54 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.441 -1.254 . . . . 65.400000000000006 111.121 -175.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -77.62 -41.41 38.6 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.246 0.219 . . . . 73.109999999999999 111.314 -170.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.59 165.03 38.96 Favored Glycine 0 C--N 1.351 1.366 0 CA-C-N 116.826 -0.17 . . . . 53.109999999999999 112.986 -176.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.05 -154.69 25.83 Favored Glycine 0 C--N 1.343 0.954 0 N-CA-C 111.796 -0.522 . . . . 51.200000000000003 111.796 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -105.89 121.26 43.72 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.416 -0.957 . . . . 74.120000000000005 108.416 172.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.413 ' HD2' ' HA ' ' A' ' 96' ' ' THR . 10.2 tpp180 -113.2 122.02 46.23 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 109.575 -0.528 . . . . 64.430000000000007 109.575 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 71.7 t -73.32 142.04 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 124.145 0.978 . . . . 64.230000000000004 110.263 175.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.544 HG21 ' HB2' ' A' ' 99' ' ' LEU . 3.1 p -135.07 126.13 45.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.866 1.266 . . . . 44.420000000000002 108.073 175.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -114.02 109.77 18.98 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.129 0.972 . . . . 74.230000000000004 109.461 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.6 m -142.72 141.83 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 124.238 1.015 . . . . 54.240000000000002 110.065 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 65.0 19.37 11.84 Favored 'General case' 0 CA--C 1.554 1.134 0 O-C-N 124.632 1.208 . . . . 72.010000000000005 111.429 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 79.99 11.34 84.6 Favored Glycine 0 C--N 1.359 1.856 0 CA-C-N 116.066 -0.515 . . . . 64.129999999999995 113.1 -174.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -116.31 124.69 50.75 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.402 1.081 . . . . 73.329999999999998 110.555 -172.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -98.21 134.22 41.56 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.894 0.877 . . . . 71.209999999999994 110.125 -179.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.1 p -147.96 141.15 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 123.544 0.738 . . . . 63.229999999999997 109.492 171.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.7 t -107.51 125.3 51.1 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.228 0.611 . . . . 32.140000000000001 109.472 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.7 p -106.96 125.9 63.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 123.381 0.672 . . . . 74.099999999999994 110.769 -177.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -78.33 102.14 7.55 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.52 0.676 . . . . 64.310000000000002 109.68 177.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.546 HD12 HD21 ' A' ' 125' ' ' LEU . 11.2 pt -92.38 144.42 28.87 Favored Pre-proline 0 CA--C 1.556 1.182 0 CA-C-N 114.507 -1.224 . . . . 73.540000000000006 109.611 174.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.2 162.12 34.41 Favored 'Trans proline' 0 CA--C 1.563 1.945 0 C-N-CA 122.636 2.224 . . . . 64.319999999999993 112.18 176.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.87 125.5 12.16 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.704 2.27 . . . . 73.030000000000001 111.803 175.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 81.81 25.81 51.83 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-O 119.892 -0.393 . . . . 71.5 112.127 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.3 p -63.94 119.92 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 C-N-CA 123.452 0.701 . . . . 75.109999999999999 110.212 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -103.63 165.89 10.76 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.126 0.97 . . . . 65.400000000000006 110.291 -171.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -49.14 134.63 17.51 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 125.37 1.669 . . . . 74.030000000000001 111.786 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.51 -11.66 68.4 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-O 119.141 -0.811 . . . . 75.239999999999995 114.35 174.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.9 t -65.54 121.19 14.35 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 117.589 0.695 . . . . 41.409999999999997 109.392 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 55.9 t -100.54 111.46 30.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 108.927 -0.768 . . . . 75.420000000000002 108.927 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 56.5 mt -88.61 103.89 14.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 107.262 -1.384 . . . . 74.340000000000003 107.262 169.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.433 ' HG3' HD23 ' A' ' 175' ' ' LEU . 59.4 ttt180 -90.44 124.7 35.18 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.249 -0.648 . . . . 73.430000000000007 109.249 -176.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.5 p -124.74 107.14 29.04 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 123.447 0.699 . . . . 73.150000000000006 109.469 174.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.2 155.19 61.33 Favored 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 122.485 2.124 . . . . 60.119999999999997 111.534 172.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.553 ' HA2' ' HB2' ' A' ' 171' ' ' PRO . . . 85.21 0.35 88.66 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 114.574 0.59 . . . . 71.109999999999999 114.574 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 55.4 mtp -121.84 -7.26 9.01 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 113.623 0.972 . . . . 73.430000000000007 113.623 -173.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -82.65 -91.12 0.64 Allowed Glycine 0 N--CA 1.471 0.981 0 CA-C-N 118.013 0.369 . . . . 75.420000000000002 112.67 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.501 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -66.09 95.4 0.24 Allowed Glycine 0 C--N 1.345 1.074 0 N-CA-C 111.527 -0.629 . . . . 72.439999999999998 111.527 173.215 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -83.31 110.87 18.48 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.383 0.673 . . . . 75.299999999999997 110.398 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -172.9 -146.21 5.33 Favored Glycine 0 C--O 1.241 0.563 0 N-CA-C 110.526 -1.029 . . . . 61.119999999999997 110.526 -177.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -75.86 -50.97 3.08 Favored Pre-proline 0 CA--C 1.565 1.539 0 CA-C-O 118.844 -0.598 . . . . 75.239999999999995 110.432 175.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.402 ' HA ' ' HD2' ' A' ' 171' ' ' PRO . 93.7 Cg_endo -83.6 116.68 2.29 Favored 'Trans proline' 0 C--N 1.397 3.131 0 C-N-CA 121.508 1.472 . . . . 62.409999999999997 110.751 170.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.553 ' HB2' ' HA2' ' A' ' 163' ' ' GLY . 29.4 Cg_endo -60.94 125.94 18.38 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.35 2.033 . . . . 74.540000000000006 111.368 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -99.2 163.14 20.05 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 113.864 0.306 . . . . 74.209999999999994 113.864 -174.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -86.26 144.46 27.41 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.584 0.754 . . . . 72.299999999999997 110.637 -176.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 30.7 tp -130.63 122.28 27.13 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.22 0.608 . . . . 70.549999999999997 109.525 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.433 HD23 ' HG3' ' A' ' 160' ' ' ARG . 61.6 mt -99.39 114.64 27.67 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.716 -0.846 . . . . 74.349999999999994 108.716 177.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.648 ' HB3' HD23 ' A' ' 123' ' ' LEU . 36.9 mt -102.02 100.41 10.68 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.839 -0.8 . . . . 74.400000000000006 108.839 175.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.3 p -95.53 126.09 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 109.38 -0.6 . . . . 64.129999999999995 109.38 176.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.7 p -73.23 136.05 26.32 Favored 'Isoleucine or valine' 0 C--O 1.247 0.974 0 C-N-CA 123.279 0.632 . . . . 74.129999999999995 110.256 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -123.64 103.82 8.64 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.61 -1.255 . . . . 73.109999999999999 107.61 -176.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 92.7 mt -105.8 148.29 27.68 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.995 0.918 . . . . 64.439999999999998 110.546 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 CA--C 1.549 0.923 0 C-N-CA 124.411 1.084 . . . . 72.219999999999999 111.465 -176.98 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.505 ' HA ' HG21 ' A' ' 126' ' ' THR . 23.7 ptp . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 110.085 -0.339 . . . . 65.049999999999997 110.085 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.8 m -143.3 144.86 32.28 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.394 0.678 . . . . 71.219999999999999 109.885 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.0 p -75.4 148.01 39.52 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.653 -0.703 . . . . 75.200000000000003 110.384 170.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.564 HD12 ' HB2' ' A' ' 123' ' ' LEU . 24.0 pt -128.29 162.65 34.3 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 CA-C-N 114.521 -1.218 . . . . 73.209999999999994 109.729 -167.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -128.12 129.07 45.98 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.277 0.631 . . . . 71.010000000000005 110.122 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.687 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.8 tp -72.84 155.84 39.5 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.137 1.375 . . . . 75.409999999999997 109.331 -175.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -79.25 -38.27 35.92 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.309 0.504 . . . . 32.450000000000003 111.371 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.7 mt 54.04 75.77 0.26 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.438 1.095 . . . . 73.420000000000002 111.485 -175.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 31.5 mt -86.35 136.05 35.91 Favored Pre-proline 0 CA--C 1.553 1.092 0 CA-C-N 115.35 -0.841 . . . . 64.340000000000003 109.277 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo . . . . . 0 C--N 1.377 2.043 0 C-N-CA 122.548 2.165 . . . . 75.200000000000003 112.439 175.608 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.415 ' NH2' HD12 ' A' ' 119' ' ' LEU . 6.9 tmm_? . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 110.195 -0.298 . . . . 62.539999999999999 110.195 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -78.95 128.73 33.66 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 122.981 0.512 . . . . 71.430000000000007 109.636 178.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.415 HD12 ' NH2' ' A' ' 117' ' ' ARG . 2.8 tt -119.44 117.25 27.96 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.555 -1.646 . . . . 63.520000000000003 106.555 178.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -90.4 133.38 35.04 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.272 -1.381 . . . . 75.329999999999998 107.272 176.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.687 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -156.99 140.24 15.58 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.467 -0.568 . . . . 72.040000000000006 109.467 -174.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -127.19 129.24 47.46 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 110.181 -0.303 . . . . 73.409999999999997 110.181 -172.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.564 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.1 pp -102.09 127.17 31.48 Favored Pre-proline 0 C--N 1.352 0.688 0 N-CA-C 109.575 -0.528 . . . . 51.140000000000001 109.575 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.409 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 63.0 Cg_endo -75.05 116.22 4.51 Favored 'Trans proline' 0 C--N 1.362 1.272 0 C-N-CA 122.724 2.282 . . . . 54.130000000000003 109.015 168.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.637 HD21 HD12 ' A' ' 149' ' ' ILE . 37.5 tp -103.37 146.2 28.84 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.63 0.65 . . . . 71.109999999999999 111.168 -168.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.505 HG21 ' HA ' ' A' ' 94' ' ' MET . 92.8 m -75.32 143.69 42.79 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 114.695 -1.139 . . . . 75.109999999999999 109.228 175.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.404 ' HG ' HD12 ' A' ' 181' ' ' LEU . 88.3 mt -68.26 -35.03 77.27 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.721 0.808 . . . . 72.239999999999995 112.306 -172.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -68.28 -34.46 76.2 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.023 0.529 . . . . 74.230000000000004 109.836 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.443 ' HB3' HD11 ' A' ' 149' ' ' ILE . 57.5 mm-40 -68.19 -40.13 82.29 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.342 -0.844 . . . . 74.120000000000005 110.98 176.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.514 ' HB2' HD21 ' A' ' 180' ' ' LEU . . . -68.96 -38.03 79.18 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.811 0.444 . . . . 44.210000000000001 111.96 177.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -70.66 -53.31 16.25 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.089 -0.96 . . . . 75.519999999999996 110.239 -176.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -77.16 -46.02 24.79 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.796 -0.638 . . . . 75.319999999999993 110.828 -176.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.72 94.65 0.16 Allowed Glycine 0 C--N 1.347 1.142 0 O-C-N 123.467 0.479 . . . . 61.450000000000003 112.499 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.495 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -153.17 -160.34 9.63 Favored Glycine 0 C--N 1.341 0.81 0 N-CA-C 111.989 -0.445 . . . . 55.140000000000001 111.989 -178.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -81.3 114.9 20.4 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.556 -0.535 . . . . 63.539999999999999 109.556 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -113.26 124.43 52.5 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.227 1.011 . . . . 63.210000000000001 109.163 177.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 77.3 t -78.93 111.08 15.36 Favored 'Isoleucine or valine' 0 C--O 1.245 0.824 0 CA-C-N 114.673 -1.149 . . . . 74.200000000000003 109.916 176.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.426 HG13 ' HB ' ' A' ' 145' ' ' VAL . 3.7 p -108.78 109.93 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 124.504 1.121 . . . . 64.310000000000002 108.19 170.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -110.64 133.59 53.18 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.886 0.474 . . . . 64.209999999999994 110.531 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.46 141.09 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 125.178 1.391 . . . . 70.040000000000006 110.537 175.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 60.69 25.94 15.71 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.624 1.17 . . . . 61.009999999999998 112.163 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 79.49 8.42 87.77 Favored Glycine 0 C--N 1.355 1.621 0 CA-C-N 116.062 -0.517 . . . . 55.130000000000003 113.075 -178.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.414 HH22 ' HG3' ' A' ' 167' ' ' GLN . 39.9 ttm180 -103.31 117.77 35.25 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.957 0.903 . . . . 74.099999999999994 109.475 178.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -89.53 108.34 19.6 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.908 -0.775 . . . . 74.150000000000006 108.908 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.448 HG12 HG13 ' A' ' 147' ' ' VAL . 19.0 t -104.94 112.88 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 107.9 -1.148 . . . . 63.240000000000002 107.9 178.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.1 t -101.04 107.78 19.32 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.791 -0.818 . . . . 72.109999999999999 108.791 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.448 HG13 HG12 ' A' ' 145' ' ' VAL . 27.1 m -114.27 132.35 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.251 0.62 . . . . 53.140000000000001 111.432 -174.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -88.19 97.6 11.09 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.0 0.92 . . . . 73.329999999999998 109.17 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.637 HD12 HD21 ' A' ' 125' ' ' LEU . 10.7 pt -79.96 139.05 53.27 Favored Pre-proline 0 CA--C 1.562 1.413 0 CA-C-N 115.153 -0.93 . . . . 62.329999999999998 109.652 178.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.32 149.59 63.56 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.458 2.106 . . . . 74.329999999999998 112.657 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.31 112.06 1.8 Allowed 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.525 2.15 . . . . 72.340000000000003 110.91 172.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 96.98 23.34 15.27 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-N 115.824 -0.625 . . . . 41.100000000000001 112.364 -173.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.491 HG11 ' HB ' ' A' ' 149' ' ' ILE . 6.3 p -66.78 120.17 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 108.479 -0.934 . . . . 72.540000000000006 108.479 168.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.408 ' HA ' HD12 ' A' ' 180' ' ' LEU . 24.7 mtp180 -122.45 162.52 21.52 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.235 0.614 . . . . 64.340000000000003 110.948 -173.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -42.37 128.15 3.79 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 126.276 1.83 . . . . 72.5 113.201 -175.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.46 -5.83 74.41 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-N 115.746 -0.661 . . . . 73.140000000000001 114.264 178.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 17.0 m -64.83 124.09 21.07 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.499 0.72 . . . . 70.0 111.08 174.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 176' ' ' LEU . 3.8 p -105.6 110.88 32.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 123.357 0.663 . . . . 53.439999999999998 110.079 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 58.7 mt -90.61 103.5 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 107.951 -1.129 . . . . 73.120000000000005 107.951 173.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -78.2 100.27 6.56 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.146 -0.687 . . . . 54.43 109.146 177.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.508 HG13 ' HB3' ' A' ' 174' ' ' LEU . 7.6 p -99.68 108.19 49.82 Favored Pre-proline 0 CA--C 1.56 1.357 0 N-CA-C 109.221 -0.659 . . . . 65.430000000000007 109.221 176.187 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.03 151.47 61.87 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 123.255 2.636 . . . . 62.329999999999998 113.539 -172.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 69.53 8.52 59.97 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-N 115.84 -0.618 . . . . 45.130000000000003 114.502 172.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 96.8 mmm -104.88 -19.72 13.79 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.127 0.971 . . . . 73.140000000000001 110.167 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -78.43 -94.73 0.27 Allowed Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.667 -0.697 . . . . 64.150000000000006 111.691 176.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -59.29 98.76 0.12 Allowed Glycine 0 C--N 1.352 1.471 0 C-N-CA 123.179 0.418 . . . . 62.009999999999998 113.4 175.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.414 ' HG3' HH22 ' A' ' 143' ' ' ARG . 12.8 mm-40 -89.51 113.55 24.95 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.38 1.072 . . . . 72.109999999999999 110.632 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 157.38 -135.19 4.27 Favored Glycine 0 C--N 1.338 0.64 0 O-C-N 123.121 0.263 . . . . 54.020000000000003 112.49 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -81.91 -43.13 1.05 Allowed Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 123.59 0.756 . . . . 73.200000000000003 111.602 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -91.69 107.24 0.26 Allowed 'Trans proline' 0 C--N 1.396 3.077 0 C-N-CA 122.337 2.025 . . . . 54.310000000000002 112.066 169.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.96 125.33 11.42 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 122.343 2.029 . . . . 70.420000000000002 111.499 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 117' ' ' ARG . . . -114.49 158.67 14.17 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 116.379 -0.373 . . . . 25.129999999999999 112.502 -177.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -83.64 148.83 26.91 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.583 0.753 . . . . 71.129999999999995 110.701 -177.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.508 ' HB3' HG13 ' A' ' 161' ' ' VAL . 39.3 tp -113.72 103.78 11.56 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 107.208 -1.404 . . . . 74.129999999999995 107.208 177.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 81.5 mt -87.04 100.67 12.8 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.786 0.834 . . . . 70.329999999999998 109.595 -173.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 158' ' ' VAL . 63.5 mt -89.34 101.66 14.34 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.874 0.87 . . . . 75.239999999999995 111.517 -172.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 24.8 t -87.3 118.46 33.28 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 108.693 -0.854 . . . . 73.299999999999997 108.693 177.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.6 p -74.59 137.08 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 C-N-CA 122.681 0.393 . . . . 61.229999999999997 110.22 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.409 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 32.0 mmt180 -124.87 89.45 3.07 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.192 0.997 . . . . 73.230000000000004 109.172 -178.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.514 HD21 ' HB2' ' A' ' 130' ' ' ALA . 32.7 mt -85.65 149.88 25.01 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.593 -0.731 . . . . 70.239999999999995 111.711 -178.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.404 HD12 ' HG ' ' A' ' 127' ' ' LEU . 55.9 mt . . . . . 0 CA--C 1.561 1.403 0 CA-C-N 114.095 -1.411 . . . . 70.400000000000006 109.374 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 109.095 -0.706 . . . . 74.099999999999994 109.095 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.479 ' H ' HG21 ' A' ' 126' ' ' THR . 32.5 t -111.57 128.14 55.94 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.103 -0.703 . . . . 63.32 109.103 177.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 26.3 m -76.71 149.23 36.41 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.361 0.664 . . . . 60.229999999999997 110.652 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.718 HD12 ' HB2' ' A' ' 123' ' ' LEU . 25.1 pt -112.77 155.49 13.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 C-N-CA 123.452 0.701 . . . . 75.109999999999999 109.707 -166.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.51 129.58 48.92 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.97 -0.752 . . . . 24.530000000000001 108.97 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.595 ' HB3' HG21 ' A' ' 140' ' ' VAL . 12.4 tp -75.53 162.02 28.67 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.8 1.24 . . . . 75.430000000000007 109.848 -172.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.441 ' HB3' ' H ' ' A' ' 122' ' ' GLU . . . -83.06 -44.49 15.11 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.399 0.28 . . . . 53.149999999999999 111.055 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 41.7 mt 46.68 69.05 0.52 Allowed 'General case' 0 N--CA 1.482 1.159 0 O-C-N 124.313 1.008 . . . . 74.299999999999997 110.214 -169.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.432 HD12 ' HG3' ' A' ' 120' ' ' ARG . 80.8 mt -65.75 119.75 63.17 Favored Pre-proline 0 CA--C 1.549 0.929 0 CA-C-N 115.152 -0.931 . . . . 71.109999999999999 108.867 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo . . . . . 0 C--N 1.38 2.201 0 C-N-CA 123.004 2.47 . . . . 60.149999999999999 112.334 -174.178 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? . . . . . 0 C--O 1.252 1.224 0 N-CA-C 108.746 -0.835 . . . . 73.120000000000005 108.746 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' A' ' 173' ' ' ASP . 8.9 p-10 -84.34 149.23 26.18 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.015 -0.993 . . . . 73.209999999999994 110.81 -171.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.5 tt -130.07 136.95 49.92 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 106.998 -1.482 . . . . 40.549999999999997 106.998 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.432 ' HG3' HD12 ' A' ' 102' ' ' LEU . 10.1 tpt180 -91.43 124.89 35.95 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.766 -0.827 . . . . 61.420000000000002 108.766 -174.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.567 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -145.7 135.58 23.54 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 122.66 0.384 . . . . 51.149999999999999 110.618 -172.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.441 ' H ' ' HB3' ' A' ' 100' ' ' ALA . 9.1 mm-40 -114.13 121.86 45.08 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.544 -0.91 . . . . 64.5 108.544 -172.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.718 ' HB2' HD12 ' A' ' 97' ' ' ILE . 3.1 pp -100.37 113.61 65.48 Favored Pre-proline 0 CA--C 1.546 0.823 0 N-CA-C 107.786 -1.191 . . . . 73.129999999999995 107.786 174.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.486 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 71.9 Cg_endo -75.48 116.28 4.45 Favored 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.601 2.201 . . . . 61.310000000000002 109.391 169.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.44 HD21 HD12 ' A' ' 149' ' ' ILE . 27.1 tp -101.57 145.37 29.13 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 109.459 -0.571 . . . . 72.420000000000002 109.459 -170.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.479 HG21 ' H ' ' A' ' 95' ' ' SER . 4.7 t -91.02 156.09 18.2 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 109.145 -0.687 . . . . 71.439999999999998 109.145 -177.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 93.5 mt -60.8 -34.77 75.01 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.864 0.866 . . . . 73.340000000000003 111.765 -175.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 131' ' ' PHE . 2.1 mp0 -60.41 -48.45 81.69 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.911 0.885 . . . . 54.299999999999997 110.199 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -75.47 -34.33 60.9 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.307 -0.861 . . . . 61.340000000000003 111.891 -175.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.1 -39.8 79.55 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.113 0.483 . . . . 61.310000000000002 110.319 171.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.407 ' HB3' ' O ' ' A' ' 128' ' ' GLU . 68.8 t80 -66.07 -49.17 68.55 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.865 1.266 . . . . 73.200000000000003 111.313 177.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -74.51 -50.72 17.08 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.626 0.37 . . . . 72.420000000000002 111.829 -171.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.531 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 66.32 75.73 0.41 Allowed Glycine 0 CA--C 1.532 1.114 0 CA-C-N 115.768 -0.651 . . . . 75.319999999999993 111.603 -166.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -148.15 -165.44 12.03 Favored Glycine 0 C--N 1.343 0.946 0 N-CA-C 112.08 -0.408 . . . . 54.32 112.08 -176.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -71.92 115.18 10.83 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.513 -0.551 . . . . 74.530000000000001 109.513 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -116.01 121.23 41.62 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.33 -0.989 . . . . 71.420000000000002 108.33 174.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 70.7 t -81.29 141.73 14.76 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 C-N-CA 124.489 1.115 . . . . 75.040000000000006 109.386 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.7 p -141.45 123.6 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 123.944 0.898 . . . . 73.349999999999994 108.964 174.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -124.73 125.47 44.12 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.667 0.787 . . . . 64.109999999999999 110.345 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.595 HG21 ' HB3' ' A' ' 99' ' ' LEU . 1.6 m -151.15 131.81 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.967 1.307 . . . . 72.209999999999994 109.808 -177.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 59.14 24.28 12.62 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.236 1.015 . . . . 75.530000000000001 112.587 176.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 89.6 -7.14 82.49 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-N 116.53 -0.304 . . . . 42.420000000000002 113.499 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -94.63 114.68 26.66 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 109.088 -0.708 . . . . 75.340000000000003 109.088 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -114.57 127.89 56.03 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.179 0.591 . . . . 74.439999999999998 109.616 177.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.28 132.31 45.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 123.76 0.824 . . . . 34.420000000000002 108.826 173.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 40.9 t -94.37 127.8 40.49 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.459 -1.312 . . . . 65.329999999999998 107.459 170.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 19.7 m -120.98 127.89 76.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 109.468 -0.567 . . . . 70.049999999999997 109.468 175.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 56.1 ttt85 -76.59 109.87 10.7 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.981 -1.118 . . . . 74.329999999999998 107.981 173.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.531 HG13 ' HA2' ' A' ' 133' ' ' GLY . 12.2 pt -84.01 148.44 53.72 Favored Pre-proline 0 CA--C 1.557 1.243 0 CA-C-N 115.135 -0.939 . . . . 73.129999999999995 109.371 177.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -67.58 150.36 79.87 Favored 'Trans proline' 0 C--N 1.369 1.654 0 C-N-CA 122.485 2.123 . . . . 62.340000000000003 112.941 172.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -63.4 121.11 8.79 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.652 2.235 . . . . 50.009999999999998 111.341 171.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 76.72 30.69 55.79 Favored Glycine 0 N--CA 1.465 0.614 0 CA-C-N 116.288 -0.415 . . . . 65.430000000000007 112.115 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.9 p -61.87 125.24 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 108.967 -0.753 . . . . 72.019999999999996 108.967 170.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.476 ' HA ' HD12 ' A' ' 180' ' ' LEU . 95.6 mtt180 -116.66 153.87 31.56 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.589 0.756 . . . . 71.299999999999997 110.055 -169.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -37.56 123.28 0.99 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 126.446 1.899 . . . . 73.230000000000004 113.013 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.63 -20.07 35.06 Favored Glycine 0 N--CA 1.473 1.161 0 CA-C-O 119.207 -0.774 . . . . 71.439999999999998 113.726 178.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.1 t -61.95 121.42 12.92 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 117.491 0.645 . . . . 74.010000000000005 110.423 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.441 HG22 HG22 ' A' ' 177' ' ' VAL . 55.1 t -101.11 115.3 42.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 109.703 -0.48 . . . . 45.329999999999998 109.703 -178.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 57.7 mt -90.02 105.13 15.86 Favored 'Isoleucine or valine' 0 C--N 1.343 0.306 0 N-CA-C 107.391 -1.337 . . . . 63.140000000000001 107.391 173.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -84.52 119.44 25.18 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.037 -0.727 . . . . 71.420000000000002 109.037 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.493 HG13 ' HB3' ' A' ' 174' ' ' LEU . 6.3 p -124.48 98.16 38.31 Favored Pre-proline 0 CA--C 1.558 1.269 0 C-N-CA 123.394 0.678 . . . . 73.519999999999996 109.691 177.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 32.4 Cg_exo -61.92 150.07 87.66 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.99 2.46 . . . . 61.0 112.679 172.178 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.47 -16.94 51.66 Favored Glycine 0 N--CA 1.474 1.208 0 CA-C-O 119.963 -0.354 . . . . 73.329999999999998 113.807 178.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -102.14 -4.4 25.92 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.94 0.896 . . . . 52.340000000000003 111.979 -176.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.491 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -88.19 -111.59 1.09 Allowed Glycine 0 C--N 1.35 1.347 0 CA-C-O 119.397 -0.668 . . . . 73.209999999999994 113.064 -175.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -61.62 102.39 0.44 Allowed Glycine 0 C--N 1.359 1.852 0 CA-C-N 117.01 0.405 . . . . 54.439999999999998 112.739 173.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -80.69 135.29 35.99 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.953 0.501 . . . . 64.150000000000006 109.95 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 152.26 -155.75 26.31 Favored Glycine 0 C--N 1.343 0.956 0 N-CA-C 111.566 -0.613 . . . . 42.049999999999997 111.566 -178.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -66.78 -49.7 47.82 Favored Pre-proline 0 CA--C 1.559 1.297 0 CA-C-O 118.309 -0.853 . . . . 65.109999999999999 110.76 178.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.56 114.34 2.98 Favored 'Trans proline' 0 C--N 1.397 3.119 0 C-N-CA 121.392 1.395 . . . . 74.329999999999998 110.375 168.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -69.75 123.93 10.59 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 121.962 1.775 . . . . 74.430000000000007 110.036 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -100.01 159.24 19.53 Favored Glycine 0 CA--C 1.507 -0.44 0 CA-C-N 116.091 -0.504 . . . . 65.150000000000006 113.391 -171.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.491 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 34.6 t70 -91.46 151.54 20.75 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.967 0.907 . . . . 64.099999999999994 110.017 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.493 ' HB3' HG13 ' A' ' 161' ' ' VAL . 19.5 tp -127.71 119.19 25.28 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 118.104 0.411 . . . . 54.329999999999998 110.197 -179.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 97.6 mt -93.53 101.19 13.37 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.639 0.776 . . . . 75.329999999999998 109.347 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.661 ' HB3' HD23 ' A' ' 123' ' ' LEU . 48.0 mt -88.68 101.38 13.93 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.276 0.631 . . . . 74.319999999999993 109.843 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.441 HG22 HG22 ' A' ' 158' ' ' VAL . 60.7 t -86.1 115.45 27.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 109.406 -0.59 . . . . 74.310000000000002 109.406 176.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.6 p -67.64 136.69 26.11 Favored 'Isoleucine or valine' 0 C--O 1.245 0.85 0 N-CA-C 109.346 -0.612 . . . . 62.219999999999999 109.346 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.486 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 34.4 mmt180 -125.16 91.23 3.38 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.593 0.757 . . . . 65.5 109.406 -175.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 154' ' ' ARG . 26.2 mt -97.0 132.87 42.38 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 114.759 -1.11 . . . . 72.450000000000003 109.333 173.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 75.1 mt . . . . . 0 CA--C 1.555 1.154 0 CA-C-N 115.14 -0.937 . . . . 64.340000000000003 109.914 -178.898 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 109.263 -0.643 . . . . 61.520000000000003 109.263 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.4 m -59.9 124.12 19.18 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.051 0.941 . . . . 23.34 111.666 -171.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.516 ' HA ' ' NH1' ' A' ' 136' ' ' ARG . 81.3 m -70.76 127.9 34.23 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 123.197 0.599 . . . . 74.200000000000003 110.345 179.007 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.613 HD12 ' HB2' ' A' ' 123' ' ' LEU . 26.2 pt -102.87 153.62 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.588 -0.733 . . . . 70.319999999999993 110.798 -169.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -101.79 157.97 16.45 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.299 -1.0 . . . . 64.409999999999997 108.299 170.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.548 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.7 tp -90.08 -103.81 0.09 Allowed 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 109.71 -0.478 . . . . 62.439999999999998 109.71 -177.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 177.48 -56.26 0.01 OUTLIER 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.036 0.934 . . . . 63.030000000000001 108.946 -172.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.536 HD11 ' HB ' ' A' ' 140' ' ' VAL . 75.3 mt 53.21 78.55 0.14 Allowed 'General case' 0 C--N 1.361 1.099 0 C-N-CA 124.658 1.183 . . . . 64.409999999999997 110.449 -171.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 61.7 mt -83.99 139.14 39.79 Favored Pre-proline 0 C--O 1.243 0.711 0 CA-C-N 114.705 -1.134 . . . . 74.420000000000002 109.665 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo . . . . . 0 C--N 1.37 1.665 0 C-N-CA 122.987 2.458 . . . . 75.439999999999998 113.604 173.946 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.468 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 14.9 tpp85 . . . . . 0 N--CA 1.472 0.628 0 N-CA-C 109.5 -0.555 . . . . 73.049999999999997 109.5 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -83.46 145.9 28.7 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.955 -1.128 . . . . 73.140000000000001 107.955 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.2 tt -127.62 125.93 41.11 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.789 -1.56 . . . . 72.409999999999997 106.789 173.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 -91.01 131.79 36.39 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 108.042 -1.095 . . . . 75.310000000000002 108.042 -172.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.548 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -158.53 141.86 14.99 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 109.413 -0.588 . . . . 74.030000000000001 109.413 -176.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -128.87 131.45 47.65 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.725 -0.472 . . . . 73.549999999999997 109.725 -174.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.613 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.1 pp -104.2 113.79 64.91 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 120.643 0.259 . . . . 50.299999999999997 110.309 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 36.2 Cg_endo -68.44 115.73 4.03 Favored 'Trans proline' 0 C--N 1.364 1.35 0 C-N-CA 122.411 2.074 . . . . 75.25 108.962 163.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.572 HD21 HD12 ' A' ' 149' ' ' ILE . 56.6 tp -102.83 146.11 28.76 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 109.692 -0.484 . . . . 71.140000000000001 109.692 -166.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.7 t -80.99 149.9 29.12 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 123.732 0.645 . . . . 70.150000000000006 109.612 -175.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.41 -33.92 71.82 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.187 0.995 . . . . 75.439999999999998 112.373 -170.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -61.32 -51.8 67.32 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.139 0.899 . . . . 75.109999999999999 110.004 178.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.449 ' HB3' HD11 ' A' ' 149' ' ' ILE . 21.4 mm-40 -73.19 -29.87 63.14 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.838 -1.074 . . . . 71.420000000000002 112.428 -174.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.23 -48.71 74.79 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-O 121.639 0.733 . . . . 43.229999999999997 110.52 174.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -67.74 -53.94 23.34 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 113.967 -1.469 . . . . 75.329999999999998 111.089 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -86.66 -46.72 9.8 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.696 -0.684 . . . . 63.340000000000003 111.258 -171.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.71 144.42 0.99 Allowed Glycine 0 C--N 1.353 1.517 0 N-CA-C 113.996 0.358 . . . . 42.039999999999999 113.996 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.409 ' O ' HG12 ' A' ' 149' ' ' ILE . . . 158.76 -152.23 23.3 Favored Glycine 0 C--N 1.341 0.815 0 N-CA-C 111.586 -0.606 . . . . 74.319999999999993 111.586 -178.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -76.46 116.69 17.38 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.297 -0.631 . . . . 70.109999999999999 109.297 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.516 ' NH1' ' HA ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -112.06 133.41 54.24 Favored 'General case' 0 C--N 1.346 0.452 0 C-N-CA 123.173 0.589 . . . . 70.510000000000005 110.428 179.525 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 85.8 t -90.91 124.97 43.69 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 C-N-CA 124.487 1.115 . . . . 73.299999999999997 110.088 177.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 97' ' ' ILE . 5.8 p -134.24 126.23 49.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 124.606 1.162 . . . . 75.409999999999997 108.796 177.056 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -99.33 140.04 34.09 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.222 0.609 . . . . 74.439999999999998 110.726 -174.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.536 ' HB ' HD11 ' A' ' 101' ' ' LEU . 15.4 m -138.75 101.11 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 124.672 1.189 . . . . 75.5 110.303 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.0 26.63 16.09 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.924 0.89 . . . . 55.310000000000002 111.679 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.0 -6.12 58.21 Favored Glycine 0 C--N 1.352 1.462 0 CA-C-N 116.014 -0.539 . . . . 64.219999999999999 113.741 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.478 ' HB3' HG23 ' A' ' 140' ' ' VAL . 18.0 tpp85 -93.31 119.81 32.88 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.54 0.736 . . . . 75.299999999999997 109.853 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -84.08 114.31 21.66 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.25 0.62 . . . . 73.549999999999997 109.764 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.415 ' HB ' HG13 ' A' ' 138' ' ' VAL . 36.3 t -107.35 117.57 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.26 1.024 . . . . 73.109999999999999 108.698 177.048 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.5 t -103.5 119.08 38.19 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 108.442 -0.948 . . . . 62.020000000000003 108.442 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.6 m -125.72 135.84 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.79 0.836 . . . . 71.439999999999998 109.678 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 45.4 ttt85 -81.43 103.48 11.21 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.437 -0.579 . . . . 74.450000000000003 109.437 177.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.572 HD12 HD21 ' A' ' 125' ' ' LEU . 13.4 pt -79.93 142.05 55.7 Favored Pre-proline 0 CA--C 1.557 1.23 0 CA-C-N 115.032 -0.986 . . . . 74.299999999999997 109.218 172.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.61 138.79 42.67 Favored 'Trans proline' 0 CA--C 1.562 1.906 0 C-N-CA 121.979 1.786 . . . . 65.530000000000001 112.146 176.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -55.45 123.98 15.15 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 123.169 2.58 . . . . 73.310000000000002 112.88 171.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 76.56 32.17 51.77 Favored Glycine 0 C--N 1.351 1.413 0 N-CA-C 112.23 -0.348 . . . . 40.32 112.23 -177.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.87 140.28 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 123.659 0.784 . . . . 64.420000000000002 109.707 174.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 21.0 mtp180 -118.14 152.67 35.17 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.816 0.846 . . . . 73.219999999999999 109.75 -175.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -45.4 129.24 8.33 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 124.966 1.416 . . . . 64.310000000000002 111.952 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 104.75 -16.81 46.89 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-O 119.261 -0.744 . . . . 65.420000000000002 113.742 177.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.7 m -60.48 119.72 8.57 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 117.652 0.726 . . . . 71.319999999999993 111.036 177.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.431 HG22 HG22 ' A' ' 177' ' ' VAL . 49.2 t -101.24 112.34 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 109.383 -0.599 . . . . 74.319999999999993 109.383 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 63.7 mt -91.82 106.99 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 108.176 -1.046 . . . . 73.329999999999998 108.176 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 -87.46 107.24 18.47 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.173 0.589 . . . . 75.239999999999995 109.452 -177.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.59 HG13 ' HB3' ' A' ' 174' ' ' LEU . 3.3 p -104.39 100.66 23.12 Favored Pre-proline 0 CA--C 1.56 1.341 0 N-CA-C 109.706 -0.479 . . . . 60.310000000000002 109.706 175.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 58.2 Cg_endo -68.52 156.34 65.91 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.0 2.467 . . . . 64.129999999999995 112.709 -178.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 81.91 -8.33 60.32 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 114.37 0.508 . . . . 50.25 114.37 176.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 39.3 mtp -106.29 -13.0 15.51 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.387 0.675 . . . . 51.350000000000001 112.555 -175.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -84.04 -86.1 0.88 Allowed Glycine 0 C--N 1.344 1.005 0 N-CA-C 111.539 -0.625 . . . . 30.539999999999999 111.539 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.468 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -73.32 106.15 1.93 Allowed Glycine 0 C--N 1.342 0.876 0 O-C-N 123.906 0.415 . . . . 41.210000000000001 112.58 175.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -88.25 158.92 18.34 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 123.509 0.724 . . . . 60.420000000000002 109.055 175.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 132.67 -117.29 1.95 Allowed Glycine 0 C--N 1.34 0.803 0 N-CA-C 111.181 -0.768 . . . . 75.349999999999994 111.181 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.56 ' H ' ' HD2' ' A' ' 170' ' ' PRO . 95.4 m-20 -118.87 -46.16 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 CA-C-O 118.019 -0.991 . . . . 52.240000000000002 111.565 175.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.56 ' HD2' ' H ' ' A' ' 169' ' ' ASN . 74.1 Cg_endo -75.53 111.13 3.23 Favored 'Trans proline' 0 C--N 1.392 2.864 0 CA-C-N 121.083 1.422 . . . . 74.140000000000001 110.7 168.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.85 127.92 15.21 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.336 2.024 . . . . 74.409999999999997 112.051 -175.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -115.13 159.26 13.85 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 115.876 -0.602 . . . . 45.210000000000001 112.297 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.519 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 9.2 p-10 -96.12 153.18 17.93 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.876 0.87 . . . . 53.119999999999997 111.341 -171.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.59 ' HB3' HG13 ' A' ' 161' ' ' VAL . 48.1 tp -115.02 106.97 14.76 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 107.723 -1.214 . . . . 74.129999999999995 107.723 178.094 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 85.5 mt -84.85 104.87 15.19 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.749 0.82 . . . . 65.329999999999998 109.834 -175.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.42 HD22 HD11 ' A' ' 99' ' ' LEU . 58.4 mt -96.42 102.07 13.8 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.449 0.699 . . . . 71.549999999999997 110.528 -177.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.431 HG22 HG22 ' A' ' 158' ' ' VAL . 25.3 t -86.42 119.22 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 108.977 -0.749 . . . . 72.5 108.977 176.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 5.4 p -71.06 138.12 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 N-CA-C 108.971 -0.752 . . . . 73.450000000000003 108.971 178.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 22.0 mmm180 -127.84 100.77 6.06 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.955 0.902 . . . . 75.400000000000006 109.015 -173.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 91.8 mt -109.24 130.23 55.49 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.629 -0.714 . . . . 71.209999999999994 109.545 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 75.3 mt . . . . . 0 CA--C 1.548 0.871 0 O-C-N 124.449 1.093 . . . . 72.510000000000005 110.926 -176.9 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 69.8 mtm . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 108.749 -0.834 . . . . 73.040000000000006 108.749 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.1 p -75.87 146.24 39.94 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.763 0.825 . . . . 75.150000000000006 111.654 -173.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 42.9 m -81.28 145.99 30.63 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.068 0.947 . . . . 74.450000000000003 110.396 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.6 pt -128.75 172.19 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.971 0.908 . . . . 72.319999999999993 110.344 -176.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -134.15 147.98 50.87 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.234 1.013 . . . . 74.430000000000007 110.044 -176.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.555 ' HB3' HG11 ' A' ' 140' ' ' VAL . 11.5 tp -85.2 173.91 10.05 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.69 -0.856 . . . . 73.239999999999995 108.69 -177.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -97.19 -33.47 11.47 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.974 -0.454 . . . . 74.109999999999999 111.855 175.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.2 mt 49.98 61.96 2.91 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.706 0.803 . . . . 74.450000000000003 110.668 -171.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 71.6 mt -64.46 111.0 4.67 Favored Pre-proline 0 CA--C 1.556 1.203 0 CA-C-N 115.616 -0.72 . . . . 54.119999999999997 109.289 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo . . . . . 0 C--N 1.377 2.039 0 C-N-CA 122.205 1.937 . . . . 62.439999999999998 112.085 -173.778 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.483 ' O ' ' HA3' ' A' ' 172' ' ' GLY . 28.6 ttm180 . . . . . 0 N--CA 1.48 1.048 0 N-CA-C 111.132 0.049 . . . . 73.109999999999999 111.132 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -84.65 135.76 34.04 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.191 -1.04 . . . . 71.109999999999999 108.191 174.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.8 tt -110.33 125.58 53.33 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 105.688 -1.967 . . . . 73.430000000000007 105.688 174.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.463 ' HG2' HD12 ' A' ' 175' ' ' LEU . 27.5 mtp180 -91.96 144.54 25.36 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.361 -0.977 . . . . 64.430000000000007 108.361 -175.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.545 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -158.75 156.44 29.83 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.625 -0.509 . . . . 64.409999999999997 109.625 -174.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -129.37 138.85 51.76 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.994 -0.743 . . . . 73.040000000000006 108.994 176.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 55.7 tp -110.43 101.7 49.3 Favored Pre-proline 0 CA--C 1.538 0.482 0 O-C-N 123.815 0.697 . . . . 71.209999999999994 109.842 -175.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.9 112.47 3.11 Favored 'Trans proline' 0 C--N 1.372 1.81 0 N-CA-C 108.253 -1.479 . . . . 53.329999999999998 108.253 169.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.499 HD21 HD12 ' A' ' 149' ' ' ILE . 35.1 tp -104.87 138.02 41.75 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.47 -0.567 . . . . 73.319999999999993 109.47 -168.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.0 t -81.76 153.94 26.24 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 109.124 -0.695 . . . . 71.439999999999998 109.124 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 74.2 mt -61.67 -33.61 74.28 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.525 0.73 . . . . 74.329999999999998 112.195 -169.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.0 -44.16 97.82 Favored 'General case' 0 C--O 1.22 -0.488 0 O-C-N 124.311 1.007 . . . . 63.100000000000001 109.477 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -79.15 -29.22 42.95 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.369 -0.832 . . . . 74.530000000000001 112.101 -175.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.52 -39.8 89.16 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.342 0.591 . . . . 62.539999999999999 110.21 172.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -74.07 -57.22 4.11 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 114.715 -1.13 . . . . 72.310000000000002 110.748 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -61.32 -50.61 72.26 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.122 0.569 . . . . 72.030000000000001 110.923 -173.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.609 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 63.71 67.7 1.95 Allowed Glycine 0 C--N 1.337 0.616 0 CA-C-N 114.763 -1.108 . . . . 65.120000000000005 112.128 -172.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -134.15 -160.0 9.09 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 112.508 -0.237 . . . . 63.450000000000003 112.508 -177.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -82.42 116.75 22.02 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.081 -0.711 . . . . 62.140000000000001 109.081 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -114.13 126.68 55.35 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.277 0.631 . . . . 74.099999999999994 109.338 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 83.0 t -70.52 110.61 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 124.305 1.003 . . . . 74.439999999999998 108.85 173.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.9 t -113.87 109.75 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 108.286 -1.005 . . . . 62.240000000000002 108.286 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -117.15 124.52 49.36 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.351 -0.611 . . . . 73.299999999999997 109.351 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.555 HG11 ' HB3' ' A' ' 99' ' ' LEU . 5.8 p -149.63 136.09 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.71 1.204 . . . . 74.310000000000002 108.601 -175.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.89 18.76 10.09 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.086 0.954 . . . . 75.010000000000005 112.322 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 88.01 -5.93 84.19 Favored Glycine 0 C--N 1.35 1.344 0 CA-C-N 116.075 -0.511 . . . . 61.0 113.183 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -94.99 121.87 37.06 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.265 1.026 . . . . 75.510000000000005 109.525 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -108.14 115.28 29.84 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.031 0.933 . . . . 75.430000000000007 110.31 -174.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.8 p -126.04 119.37 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.239 1.015 . . . . 74.230000000000004 109.601 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 39.5 t -88.32 108.71 19.47 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 109.205 -0.665 . . . . 73.349999999999994 109.205 176.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.2 p -100.76 127.61 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 123.014 0.526 . . . . 71.439999999999998 110.802 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -85.01 103.04 13.69 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.792 -0.818 . . . . 71.549999999999997 108.792 172.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.609 HG13 ' HA2' ' A' ' 133' ' ' GLY . 11.6 pt -86.64 151.79 53.4 Favored Pre-proline 0 CA--C 1.562 1.424 0 C-N-CA 124.518 1.127 . . . . 71.430000000000007 109.507 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.442 ' HG2' ' HB ' ' A' ' 153' ' ' VAL . 55.2 Cg_endo -71.37 146.32 50.22 Favored 'Trans proline' 0 CA--C 1.565 2.049 0 C-N-CA 122.108 1.872 . . . . 53.350000000000001 112.514 174.469 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.407 ' HA ' ' HA3' ' A' ' 133' ' ' GLY . 23.6 Cg_exo -67.11 124.92 12.79 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.991 2.461 . . . . 62.399999999999999 112.036 174.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 81.18 24.52 57.14 Favored Glycine 0 C--N 1.35 1.318 0 O-C-N 123.478 0.486 . . . . 30.120000000000001 112.101 -175.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.442 ' HB ' ' HG2' ' A' ' 150' ' ' PRO . 4.4 p -60.65 128.83 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 123.959 0.903 . . . . 72.340000000000003 109.413 173.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.468 ' HA ' HD12 ' A' ' 180' ' ' LEU . 76.9 mtp180 -123.56 166.43 15.46 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.118 0.567 . . . . 62.030000000000001 110.047 -175.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -45.31 129.62 8.16 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 125.709 1.604 . . . . 75.439999999999998 113.357 -172.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.92 -2.66 66.6 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-O 119.404 -0.664 . . . . 65.019999999999996 114.623 175.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.6 t -69.56 122.34 18.87 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 117.651 0.725 . . . . 61.439999999999998 109.57 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 45.6 t -101.2 113.18 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.186 0.594 . . . . 75.5 109.886 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 51.6 mt -91.52 117.63 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 107.886 -1.153 . . . . 72.310000000000002 107.886 170.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -104.97 101.11 10.7 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.924 -0.769 . . . . 73.030000000000001 108.924 -173.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.4 p -107.76 107.72 60.64 Favored Pre-proline 0 CA--C 1.556 1.199 0 C-N-CA 123.148 0.579 . . . . 70.519999999999996 110.722 -176.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.553 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 59.8 Cg_endo -69.37 147.34 65.19 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.561 2.174 . . . . 44.439999999999998 112.709 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.41 -3.14 87.64 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 115.794 -0.639 . . . . 64.530000000000001 113.527 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 24.7 mmt -103.42 -16.94 15.45 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.304 0.641 . . . . 73.299999999999997 110.772 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -91.58 -108.17 1.56 Allowed Glycine 0 C--N 1.349 1.302 0 CA-C-O 119.541 -0.589 . . . . 53.439999999999998 113.173 -175.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -60.43 100.39 0.22 Allowed Glycine 0 C--N 1.349 1.28 0 O-C-N 123.861 0.389 . . . . 65.140000000000001 112.661 177.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -88.34 116.26 26.43 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 124.04 0.936 . . . . 54.039999999999999 109.169 177.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 160.15 -149.21 18.5 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.5 -0.64 . . . . 54.219999999999999 111.5 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -70.97 -48.96 13.68 Favored Pre-proline 0 CA--C 1.561 1.369 0 CA-C-O 117.9 -1.047 . . . . 75.340000000000003 111.822 177.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.425 ' HA ' ' HD3' ' A' ' 171' ' ' PRO . 87.0 Cg_endo -81.81 110.62 2.14 Favored 'Trans proline' 0 C--N 1.391 2.801 0 C-N-CA 121.572 1.514 . . . . 74.0 110.749 174.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 170' ' ' PRO . 14.4 Cg_exo -67.79 123.6 10.91 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.358 2.039 . . . . 75.519999999999996 110.807 -174.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 117' ' ' ARG . . . -115.67 152.09 18.16 Favored Glycine 0 C--N 1.335 0.477 0 N-CA-C 114.004 0.361 . . . . 43.219999999999999 114.004 -172.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.553 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 6.8 p-10 -91.66 155.64 18.17 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.516 1.126 . . . . 71.019999999999996 110.53 178.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 41.3 tp -112.97 115.52 28.52 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.947 -0.76 . . . . 51.409999999999997 108.947 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.463 HD12 ' HG2' ' A' ' 120' ' ' ARG . 73.5 mt -84.53 106.93 16.48 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.102 0.961 . . . . 70.430000000000007 109.513 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 27.2 mt -99.54 98.75 9.6 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.843 -0.799 . . . . 72.420000000000002 108.843 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 8.5 p -95.75 110.69 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 109.092 -0.706 . . . . 74.230000000000004 109.092 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.0 p -66.67 143.77 15.28 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 123.299 0.64 . . . . 53.109999999999999 111.275 -172.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -126.14 103.11 7.52 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 125.042 1.337 . . . . 75.439999999999998 108.192 -174.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 154' ' ' ARG . 91.8 mt -113.45 131.42 56.03 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.53 0.732 . . . . 55.340000000000003 109.984 177.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 81.4 mt . . . . . 0 CA--C 1.548 0.896 0 N-CA-C 108.374 -0.972 . . . . 72.310000000000002 108.374 173.401 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.509 ' HB3' ' NH2' ' A' ' 136' ' ' ARG . 59.1 mtt . . . . . 0 N--CA 1.477 0.886 0 N-CA-C 109.299 -0.63 . . . . 52.509999999999998 109.299 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.1 m -70.66 134.17 47.3 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.454 0.702 . . . . 73.120000000000005 111.062 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.6 m -73.55 138.35 44.93 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.938 0.495 . . . . 71.129999999999995 109.73 174.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.64 HD12 ' HB2' ' A' ' 123' ' ' LEU . 21.3 pt -109.53 175.42 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 122.992 0.517 . . . . 64.109999999999999 111.547 -166.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -122.81 -167.62 1.61 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.388 1.075 . . . . 72.019999999999996 109.617 173.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.689 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.9 tp -142.06 156.26 45.4 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 108.655 -0.868 . . . . 72.239999999999995 108.655 -175.046 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.415 ' HB3' ' H ' ' A' ' 122' ' ' GLU . . . -78.44 -56.99 4.01 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.269 0.228 . . . . 43.020000000000003 110.468 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 95.9 mt 60.19 73.49 0.48 Allowed 'General case' 0 CA--C 1.553 1.078 0 O-C-N 124.366 1.041 . . . . 74.319999999999993 109.902 -170.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 79.5 mt -70.89 155.94 92.69 Favored Pre-proline 0 CA--C 1.561 1.382 0 C-N-CA 125.251 1.421 . . . . 75.519999999999996 111.766 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo . . . . . 0 C--N 1.386 2.532 0 C-N-CA 123.307 2.671 . . . . 73.030000000000001 113.646 178.593 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? . . . . . 0 N--CA 1.473 0.676 0 CA-C-O 120.446 0.165 . . . . 74.120000000000005 111.293 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -74.63 116.23 15.09 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 108.736 -0.838 . . . . 62.340000000000003 108.736 172.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.7 tt -94.9 118.89 32.53 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 106.735 -1.58 . . . . 64.209999999999994 106.735 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -90.98 141.66 28.61 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 108.726 -0.842 . . . . 71.409999999999997 108.726 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.689 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -153.25 142.77 21.77 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.821 -0.627 . . . . 64.030000000000001 109.545 -171.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.459 ' HB3' ' HG3' ' A' ' 179' ' ' ARG . 35.3 mt-10 -119.69 118.3 30.56 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.181 -1.044 . . . . 62.030000000000001 108.181 -174.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.64 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.6 pp -100.74 113.91 65.71 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 108.914 -0.772 . . . . 74.329999999999998 108.914 176.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.13 113.95 3.91 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 121.864 1.709 . . . . 41.039999999999999 109.335 170.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.571 HD21 HD12 ' A' ' 149' ' ' ILE . 36.1 tp -103.12 151.05 23.03 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 122.004 -0.435 . . . . 70.430000000000007 110.601 -167.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 13.4 t -85.61 154.61 21.59 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.955 -0.757 . . . . 72.049999999999997 108.955 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 39.3 mt -70.78 -26.68 63.45 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.215 0.606 . . . . 72.230000000000004 111.805 -167.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -73.49 -41.82 62.63 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.397 -0.82 . . . . 62.219999999999999 110.08 -178.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.471 ' HB3' HD11 ' A' ' 149' ' ' ILE . 34.1 mm-40 -74.4 -31.26 62.27 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.185 -0.916 . . . . 72.129999999999995 111.158 177.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.71 -50.83 70.87 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.425 0.69 . . . . 73.530000000000001 110.5 176.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -66.67 -62.89 1.22 Allowed 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 114.223 -1.353 . . . . 72.099999999999994 110.641 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -70.32 -43.75 69.65 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.929 0.491 . . . . 71.239999999999995 111.89 -171.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.43 97.56 0.05 OUTLIER Glycine 0 C--N 1.346 1.103 0 O-C-N 123.816 0.697 . . . . 61.340000000000003 113.063 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.4 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -144.06 -143.64 4.09 Favored Glycine 0 C--N 1.342 0.883 0 N-CA-C 111.097 -0.801 . . . . 70.010000000000005 111.097 178.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -96.26 119.07 34.09 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.845 -0.798 . . . . 72.140000000000001 108.845 176.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.509 ' NH2' ' HB3' ' A' ' 94' ' ' MET . 11.0 tpp180 -116.98 123.79 47.78 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.412 0.685 . . . . 71.120000000000005 109.386 176.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 146' ' ' SER . 76.2 t -74.47 136.9 24.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 C-N-CA 123.621 0.768 . . . . 72.310000000000002 110.683 177.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.455 ' HB ' HG13 ' A' ' 145' ' ' VAL . 39.1 t -115.59 126.17 73.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.29 1.436 . . . . 61.509999999999998 107.615 174.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -115.23 101.51 9.02 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.632 -0.507 . . . . 72.140000000000001 109.632 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.66 144.16 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 123.719 0.808 . . . . 74.319999999999993 110.907 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 65.32 18.69 11.45 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.283 1.433 . . . . 64.540000000000006 111.746 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.19 21.76 69.71 Favored Glycine 0 C--N 1.351 1.37 0 CA-C-N 116.016 -0.538 . . . . 72.439999999999998 112.257 -175.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -122.45 140.06 53.15 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.923 0.889 . . . . 63.009999999999998 110.204 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -102.69 125.32 49.38 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.206 1.002 . . . . 71.420000000000002 108.719 177.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.455 HG13 ' HB ' ' A' ' 138' ' ' VAL . 3.5 p -137.78 112.26 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 CA-C-O 121.54 0.686 . . . . 73.0 110.2 176.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 137' ' ' VAL . 46.4 t -90.43 106.0 18.2 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.189 -0.671 . . . . 53.310000000000002 109.189 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 28.7 m -100.62 141.15 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.232 0.613 . . . . 72.150000000000006 110.13 -178.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.1 ttp180 -90.84 117.47 29.48 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.284 -0.635 . . . . 73.319999999999993 109.284 177.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.571 HD12 HD21 ' A' ' 125' ' ' LEU . 9.1 pt -100.49 139.77 20.89 Favored Pre-proline 0 CA--C 1.561 1.378 0 C-N-CA 124.871 1.268 . . . . 73.239999999999995 109.307 176.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -63.14 152.46 79.52 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 123.083 2.522 . . . . 74.109999999999999 113.695 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.47 121.3 9.04 Favored 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 122.272 1.981 . . . . 62.509999999999998 111.228 171.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 85.21 23.64 47.51 Favored Glycine 0 C--N 1.346 1.084 0 N-CA-C 112.13 -0.388 . . . . 45.509999999999998 112.13 -176.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.493 HG11 ' HB ' ' A' ' 149' ' ' ILE . 4.1 p -63.53 117.45 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 123.784 0.833 . . . . 61.109999999999999 109.853 177.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.528 ' HA ' HD12 ' A' ' 180' ' ' LEU . 82.0 mtm180 -132.89 161.93 32.93 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 115.923 -0.58 . . . . 74.310000000000002 110.847 -172.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -35.29 119.77 0.51 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.881 2.072 . . . . 55.240000000000002 113.838 -169.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.24 -12.14 48.13 Favored Glycine 0 N--CA 1.473 1.145 0 CA-C-O 119.297 -0.724 . . . . 71.430000000000007 114.552 177.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 33.5 t -66.22 122.3 17.15 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 117.832 0.816 . . . . 51.049999999999997 109.243 176.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.0 t -110.0 114.55 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.347 0.659 . . . . 74.140000000000001 110.402 -176.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 56.0 mt -92.48 120.6 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 108.355 -0.98 . . . . 72.329999999999998 108.355 172.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -104.67 116.63 32.38 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.305 0.642 . . . . 74.319999999999993 110.143 -176.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.489 HG13 ' HB3' ' A' ' 174' ' ' LEU . 3.3 p -120.45 108.58 37.52 Favored Pre-proline 0 CA--C 1.559 1.316 0 C-N-CA 123.031 0.532 . . . . 70.510000000000005 110.725 176.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.418 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 16.7 Cg_exo -67.59 153.46 76.23 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.886 2.391 . . . . 65.400000000000006 112.267 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.01 -24.19 8.3 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-O 119.864 -0.409 . . . . 72.239999999999995 113.909 177.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 92.9 mmm -92.44 -4.92 52.96 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.66 0.784 . . . . 60.229999999999997 111.224 -177.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -91.21 -103.02 1.3 Allowed Glycine 0 C--N 1.344 1.007 0 CA-C-O 119.719 -0.49 . . . . 64.519999999999996 112.409 -177.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.52 103.8 0.88 Allowed Glycine 0 C--N 1.352 1.418 0 N-CA-C 111.467 -0.653 . . . . 72.109999999999999 111.467 175.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.544 ' HA ' HE21 ' A' ' 167' ' ' GLN . 0.0 OUTLIER -87.76 121.47 30.22 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.484 0.714 . . . . 71.340000000000003 110.72 -174.923 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 169.88 -146.21 9.82 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 110.633 -0.987 . . . . 75.439999999999998 110.633 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -76.79 -49.15 2.68 Favored Pre-proline 0 CA--C 1.56 1.331 0 CA-C-O 118.075 -0.964 . . . . 72.319999999999993 109.332 172.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -81.61 112.62 2.46 Favored 'Trans proline' 0 C--N 1.4 3.243 0 C-N-CA 122.173 1.915 . . . . 61.43 111.316 170.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.43 127.75 11.36 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 122.502 2.135 . . . . 52.340000000000003 112.239 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -104.88 165.88 14.62 Favored Glycine 0 C--N 1.344 1.022 0 CA-C-N 116.365 -0.38 . . . . 73.340000000000003 112.256 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 15.2 m-20 -86.25 142.71 28.37 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.855 0.862 . . . . 51.240000000000002 110.773 -177.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.489 ' HB3' HG13 ' A' ' 161' ' ' VAL . 34.5 tp -105.35 104.62 14.39 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 107.934 -1.136 . . . . 75.040000000000006 107.934 175.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 51.1 mt -88.46 101.17 13.66 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.197 -0.91 . . . . 73.209999999999994 109.282 -175.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 48.0 mt -97.1 101.11 12.61 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.896 0.878 . . . . 71.200000000000003 110.455 -174.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.3 p -92.48 130.33 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 109.893 -0.41 . . . . 63.149999999999999 109.893 175.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 14.1 p -77.54 133.81 29.83 Favored 'Isoleucine or valine' 0 C--O 1.248 0.999 0 C-N-CA 123.338 0.655 . . . . 72.319999999999993 110.053 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.459 ' HG3' ' HB3' ' A' ' 122' ' ' GLU . 9.1 mmm180 -122.6 96.38 5.01 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.167 0.987 . . . . 74.450000000000003 108.795 -174.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.528 HD12 ' HA ' ' A' ' 154' ' ' ARG . 64.5 mt -101.23 147.65 26.03 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.657 -0.701 . . . . 71.519999999999996 110.588 177.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 61.4 mt . . . . . 0 CA--C 1.556 1.186 0 CA-C-N 114.998 -1.001 . . . . 74.439999999999998 108.717 171.848 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 CA--C 1.545 0.766 0 N-CA-C 109.719 -0.474 . . . . 52.299999999999997 109.719 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.431 ' H ' HG21 ' A' ' 126' ' ' THR . 23.0 t -82.01 132.65 35.26 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.397 0.679 . . . . 72.329999999999998 110.251 178.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.425 ' HA ' HH11 ' A' ' 136' ' ' ARG . 63.9 m -76.05 143.04 41.61 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.607 0.763 . . . . 71.239999999999995 110.052 174.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.624 HD12 ' HB2' ' A' ' 123' ' ' LEU . 15.6 pt -121.4 173.02 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 123.012 0.525 . . . . 75.239999999999995 111.651 -165.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -124.86 -172.39 2.56 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.321 1.048 . . . . 42.520000000000003 109.541 174.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.649 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.6 tp -131.65 148.91 52.63 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 107.677 -1.231 . . . . 75.329999999999998 107.677 -177.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.48 -43.16 67.1 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 117.983 0.356 . . . . 65.319999999999993 110.949 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 41.8 mt 53.01 79.62 0.12 Allowed 'General case' 0 N--CA 1.477 0.916 0 O-C-N 124.473 1.108 . . . . 75.129999999999995 110.907 -173.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 35.0 mt -86.37 121.26 72.47 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 108.29 -1.004 . . . . 74.010000000000005 108.29 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo . . . . . 0 C--N 1.378 2.126 0 C-N-CA 122.512 2.141 . . . . 73.519999999999996 112.497 -177.148 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 . . . . . 0 CA--C 1.549 0.922 0 CA-C-O 120.83 0.348 . . . . 74.519999999999996 111.327 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -91.38 111.19 22.58 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.627 0.771 . . . . 73.329999999999998 109.984 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.0 tt -95.18 127.32 41.14 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 106.885 -1.524 . . . . 61.009999999999998 106.885 173.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -90.04 124.03 34.42 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 107.831 -1.174 . . . . 64.430000000000007 107.831 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.649 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -146.15 144.85 30.23 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.156 0.582 . . . . 73.299999999999997 110.121 -173.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -128.75 131.11 47.84 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.655 0.382 . . . . 75.510000000000005 110.144 -177.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.624 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.2 pp -107.61 119.71 49.66 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 109.223 -0.658 . . . . 74.329999999999998 109.223 177.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.562 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 66.9 Cg_endo -74.14 113.94 3.91 Favored 'Trans proline' 0 C--N 1.364 1.385 0 C-N-CA 122.512 2.142 . . . . 45.530000000000001 109.404 169.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 42.1 tp -102.66 154.17 19.41 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 109.326 -0.62 . . . . 74.200000000000003 109.326 -168.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.431 HG21 ' H ' ' A' ' 95' ' ' SER . 1.5 t -91.27 148.02 22.64 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 108.154 -1.054 . . . . 74.450000000000003 108.154 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.401 HD23 HD22 ' A' ' 180' ' ' LEU . 89.4 mt -64.41 -27.47 69.02 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.106 0.562 . . . . 65.439999999999998 111.883 -172.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.24 -41.76 85.1 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.799 0.839 . . . . 74.510000000000005 110.035 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.417 ' HG3' ' HE ' ' A' ' 136' ' ' ARG . 21.5 mm-40 -75.07 -34.78 61.84 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.384 0.674 . . . . 73.209999999999994 111.345 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.72 -34.62 73.16 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.287 0.635 . . . . 62.130000000000003 110.817 171.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -76.34 -46.81 25.85 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 114.773 -1.103 . . . . 74.409999999999997 111.437 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 34.3 m80 -73.54 -49.97 23.75 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 120.804 0.335 . . . . 74.25 111.457 -173.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.444 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 70.44 66.22 2.26 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-N 115.422 -0.808 . . . . 52.509999999999998 112.226 -173.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -134.44 -158.76 8.58 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 112.45 -0.26 . . . . 54.530000000000001 112.45 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -74.98 115.1 14.21 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.594 0.758 . . . . 62.210000000000001 109.058 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.425 HH11 ' HA ' ' A' ' 96' ' ' THR . 5.0 tpp180 -114.34 120.61 40.96 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.233 0.54 . . . . 62.299999999999997 109.72 178.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 88.1 t -77.17 111.73 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.712 0 CA-C-N 114.825 -1.08 . . . . 50.32 110.124 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 43.6 t -102.89 112.07 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.97 1.308 . . . . 73.019999999999996 107.905 172.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -115.13 115.2 26.37 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.008 -0.738 . . . . 74.510000000000005 109.008 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.547 HG11 ' HB3' ' A' ' 99' ' ' LEU . 7.6 p -151.61 138.29 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 124.209 1.004 . . . . 63.450000000000003 110.035 -178.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.88 18.59 10.92 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.529 1.132 . . . . 64.299999999999997 113.472 171.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.63 -2.63 80.62 Favored Glycine 0 C--N 1.351 1.369 0 C-N-CA 122.831 0.253 . . . . 73.140000000000001 112.891 -176.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -99.01 117.51 33.68 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.279 1.031 . . . . 73.140000000000001 108.766 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -106.56 105.62 15.74 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.393 -0.966 . . . . 71.319999999999993 108.393 172.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.4 p -114.16 137.1 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.845 0.858 . . . . 72.219999999999999 109.225 178.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.8 t -97.89 114.89 27.09 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.51 -0.922 . . . . 73.530000000000001 108.51 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 33.7 t -100.45 111.6 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.479 1.112 . . . . 71.510000000000005 109.131 -178.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -79.88 96.66 6.42 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.589 -0.893 . . . . 72.420000000000002 108.589 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.449 ' HB ' HG11 ' A' ' 153' ' ' VAL . 10.1 pt -81.04 147.6 61.83 Favored Pre-proline 0 CA--C 1.56 1.348 0 CA-C-N 114.755 -1.111 . . . . 75.299999999999997 110.442 -179.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.43 145.15 42.18 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.41 2.073 . . . . 61.409999999999997 112.389 176.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.26 113.29 2.37 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 122.508 2.139 . . . . 61.109999999999999 111.879 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 105.14 13.65 24.46 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-N 115.514 -0.766 . . . . 35.229999999999997 112.601 -176.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.449 HG11 ' HB ' ' A' ' 149' ' ' ILE . 7.3 p -63.33 127.97 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.529 0.731 . . . . 63.420000000000002 110.546 177.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.648 ' HA ' HD12 ' A' ' 180' ' ' LEU . 28.7 mtm180 -134.78 164.26 27.95 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.312 0.645 . . . . 65.120000000000005 111.581 -172.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -38.86 125.14 1.46 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 126.314 1.846 . . . . 75.519999999999996 113.641 -174.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.25 -11.22 60.09 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-O 119.293 -0.726 . . . . 70.019999999999996 114.241 176.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.6 t -67.4 121.79 16.53 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 117.432 0.616 . . . . 71.120000000000005 110.191 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 40.6 t -104.23 111.14 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.55 0.74 . . . . 75.430000000000007 110.435 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 75.7 mt -93.6 106.45 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 125.236 1.414 . . . . 63.420000000000002 109.521 175.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 30.8 ttt-85 -79.67 106.29 11.59 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.26 0.624 . . . . 73.430000000000007 109.777 175.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.437 HG13 ' HB3' ' A' ' 174' ' ' LEU . 7.6 p -106.05 104.89 51.64 Favored Pre-proline 0 CA--C 1.562 1.432 0 N-CA-C 109.175 -0.676 . . . . 71.120000000000005 109.175 171.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 59.6 Cg_endo -69.29 154.18 69.98 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 123.04 2.494 . . . . 72.25 113.615 -175.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 75.82 2.88 72.03 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 115.47 -0.787 . . . . 72.239999999999995 113.881 177.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 92.7 mmm -110.37 -25.95 9.81 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.553 0.741 . . . . 54.530000000000001 111.916 -172.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -83.18 -73.17 1.25 Allowed Glycine 0 C--N 1.345 1.06 0 N-CA-C 111.313 -0.715 . . . . 60.439999999999998 111.313 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -62.47 96.29 0.14 Allowed Glycine 0 C--N 1.345 1.035 0 N-CA-C 111.8 -0.52 . . . . 53.210000000000001 111.8 165.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -88.79 170.58 10.63 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.458 1.103 . . . . 72.150000000000006 110.288 176.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 97.49 -147.88 18.78 Favored Glycine 0 C--N 1.341 0.807 0 CA-C-N 116.14 -0.482 . . . . 53.119999999999997 112.166 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -64.64 -49.16 71.68 Favored Pre-proline 0 CA--C 1.57 1.723 0 CA-C-O 118.458 -0.782 . . . . 72.239999999999995 111.907 177.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -84.13 129.58 4.58 Favored 'Trans proline' 0 C--N 1.392 2.832 0 C-N-CA 122.046 1.831 . . . . 74.129999999999995 111.409 175.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.33 145.52 34.39 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 121.959 1.773 . . . . 64.329999999999998 111.168 170.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -152.55 164.4 30.65 Favored Glycine 0 N--CA 1.47 0.925 0 CA-C-O 120.195 -0.225 . . . . 60.299999999999997 112.636 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 29.8 m-20 -84.23 146.33 27.86 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.143 0.577 . . . . 75.140000000000001 111.498 -167.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.437 ' HB3' HG13 ' A' ' 161' ' ' VAL . 33.7 tp -114.87 104.24 11.74 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.458 -1.312 . . . . 52.32 107.458 176.4 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 68.5 mt -85.82 100.36 12.0 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.613 0.765 . . . . 74.019999999999996 109.392 -174.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 67.1 mt -92.79 99.25 11.96 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.817 0.847 . . . . 74.5 110.786 -174.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.8 p -89.22 123.5 41.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 N-CA-C 109.037 -0.727 . . . . 62.439999999999998 109.037 173.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.5 p -77.7 143.76 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 123.437 0.695 . . . . 61.539999999999999 110.59 -176.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.562 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 30.0 mmt180 -123.99 96.94 5.13 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.066 0.947 . . . . 64.409999999999997 109.656 -177.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.648 HD12 ' HA ' ' A' ' 154' ' ' ARG . 49.1 mt -100.53 114.84 28.81 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.261 -0.644 . . . . 74.209999999999994 109.261 173.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 69.0 mt . . . . . 0 CA--C 1.548 0.9 0 O-C-N 123.917 0.761 . . . . 72.239999999999995 109.282 176.031 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.418 ' HB3' ' NH2' ' A' ' 136' ' ' ARG . 65.8 mtt . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 109.082 -0.71 . . . . 72.430000000000007 109.082 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.2 m -66.82 120.37 13.44 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 116.192 -0.458 . . . . 55.310000000000002 109.956 176.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.2 m -85.8 137.03 33.08 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 109.305 -0.628 . . . . 74.219999999999999 109.305 177.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.517 HD12 ' HB2' ' A' ' 123' ' ' LEU . 9.1 pt -123.73 166.29 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 112.359 0.503 . . . . 71.319999999999993 112.359 -155.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -112.37 176.63 4.94 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.783 1.233 . . . . 64.140000000000001 109.269 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.657 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.3 tp -126.52 150.81 48.55 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.745 -0.835 . . . . 70.140000000000001 108.745 -174.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.7 -34.33 71.83 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.881 0.472 . . . . 75.420000000000002 112.134 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.661 HD11 ' HB ' ' A' ' 140' ' ' VAL . 21.7 mt 47.35 56.35 7.06 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.146 0.978 . . . . 74.310000000000002 112.065 -176.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.6 mt -71.25 117.28 55.31 Favored Pre-proline 0 CA--C 1.553 1.064 0 N-CA-C 108.926 -0.768 . . . . 54.420000000000002 108.926 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo . . . . . 0 C--N 1.375 1.956 0 C-N-CA 122.149 1.899 . . . . 62.100000000000001 112.447 179.426 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 . . . . . 0 CA--C 1.541 0.631 0 N-CA-C 108.055 -1.091 . . . . 73.409999999999997 108.055 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -91.59 121.6 33.41 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 107.542 -1.281 . . . . 53.399999999999999 107.542 168.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.4 tt -108.37 121.6 45.27 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 106.943 -1.503 . . . . 53.219999999999999 106.943 -177.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -92.48 135.02 34.4 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.871 -0.789 . . . . 72.129999999999995 108.871 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.657 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -156.28 138.1 14.32 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 122.921 0.488 . . . . 71.519999999999996 109.8 -174.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -126.77 128.63 46.91 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 110.166 -0.309 . . . . 75.219999999999999 110.166 -170.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.517 ' HB2' HD12 ' A' ' 97' ' ' ILE . 3.5 pp -103.13 133.36 20.38 Favored Pre-proline 0 C--N 1.349 0.583 0 C-N-CA 123.342 0.657 . . . . 63.229999999999997 109.816 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PRO . . . . . 0.497 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 71.9 Cg_endo -78.13 115.93 3.84 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 122.418 2.079 . . . . 64.510000000000005 109.172 166.316 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.537 HD21 HD12 ' A' ' 149' ' ' ILE . 39.3 tp -102.72 147.38 26.91 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.554 -0.536 . . . . 54.100000000000001 109.554 -169.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.7 t -86.59 145.22 26.83 Favored 'General case' 0 C--O 1.245 0.839 0 N-CA-C 107.833 -1.173 . . . . 62.399999999999999 107.833 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.39 -20.75 65.59 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 112.766 0.654 . . . . 73.299999999999997 112.766 -170.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -67.61 -48.15 67.61 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.424 -0.584 . . . . 75.099999999999994 109.424 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -64.32 -38.41 90.93 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.081 -0.963 . . . . 54.43 111.149 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.434 ' HB2' HD21 ' A' ' 180' ' ' LEU . . . -59.97 -48.02 83.43 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.849 0.718 . . . . 73.439999999999998 111.569 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -67.86 -60.0 2.85 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.931 -1.031 . . . . 71.319999999999993 111.078 -178.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -67.14 -36.9 82.85 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.218 0.607 . . . . 74.540000000000006 111.437 -173.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.0 79.11 0.34 Allowed Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.568 -0.742 . . . . 73.209999999999994 111.572 -173.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.444 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -118.05 -172.16 15.62 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 112.731 -0.148 . . . . 73.450000000000003 112.731 -177.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -91.82 120.08 32.2 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.564 -1.273 . . . . 54.409999999999997 107.564 171.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.418 ' NH2' ' HB3' ' A' ' 94' ' ' MET . 8.5 tpp180 -113.1 122.11 46.59 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.377 -0.601 . . . . 70.420000000000002 109.377 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.508 HG13 ' HG3' ' A' ' 144' ' ' ARG . 99.5 t -72.55 132.1 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.179 0.992 . . . . 51.229999999999997 109.985 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.477 ' HB ' HG13 ' A' ' 145' ' ' VAL . 28.8 t -127.64 128.2 69.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 107.018 -1.475 . . . . 72.329999999999998 107.018 175.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.65 99.61 9.2 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.662 0.744 . . . . 70.319999999999993 111.069 -175.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.661 ' HB ' HD11 ' A' ' 101' ' ' LEU . 14.4 m -132.79 134.56 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 112.415 0.524 . . . . 70.450000000000003 112.415 -173.437 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 59.84 25.44 14.53 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.929 1.291 . . . . 73.400000000000006 112.298 173.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 80.32 22.39 62.88 Favored Glycine 0 C--N 1.355 1.626 0 CA-C-N 115.813 -0.631 . . . . 41.240000000000002 112.964 -178.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 24.5 tpp180 -133.8 126.54 30.79 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.309 1.044 . . . . 60.149999999999999 109.692 -175.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.508 ' HG3' HG13 ' A' ' 137' ' ' VAL . 13.6 ttm180 -73.21 120.46 18.86 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 109.234 -0.654 . . . . 75.230000000000004 109.234 167.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.477 HG13 ' HB ' ' A' ' 138' ' ' VAL . 3.5 p -118.7 112.14 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.244 -1.021 . . . . 55.43 108.244 169.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.2 t -94.42 109.65 21.5 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.167 -1.049 . . . . 62.229999999999997 108.167 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.5 p -97.56 118.44 44.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 CA-C-O 121.572 0.701 . . . . 74.25 109.946 -177.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -82.83 114.76 21.37 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.585 -0.894 . . . . 71.0 108.585 173.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.537 HD12 HD21 ' A' ' 125' ' ' LEU . 6.6 pt -99.47 149.9 36.28 Favored Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 124.506 1.123 . . . . 63.329999999999998 109.542 179.297 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.99 149.84 77.52 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.246 1.964 . . . . 75.340000000000003 112.029 176.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -66.23 113.71 2.75 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 122.406 2.071 . . . . 62.240000000000002 110.845 175.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 89.44 31.34 11.72 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-N 115.836 -0.62 . . . . 72.420000000000002 113.023 -175.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.26 138.09 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.333 0.653 . . . . 75.129999999999995 109.767 173.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -127.05 162.36 26.22 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.38 0.672 . . . . 75.420000000000002 111.063 -174.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -46.78 131.84 11.56 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 126.343 1.857 . . . . 64.439999999999998 113.344 -172.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.93 -2.55 84.24 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-O 119.554 -0.581 . . . . 72.129999999999995 114.434 177.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.1 t -66.87 122.51 17.86 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 117.474 0.637 . . . . 72.420000000000002 109.443 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.7 p -101.94 135.94 36.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 123.491 0.717 . . . . 64.010000000000005 109.991 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 45.4 mt -120.55 103.67 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.362 1.065 . . . . 73.450000000000003 108.734 -176.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -80.25 110.88 16.1 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.352 0.661 . . . . 74.0 109.702 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.5 p -115.21 110.15 45.84 Favored Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 122.904 0.482 . . . . 73.109999999999999 110.101 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.84 145.08 49.97 Favored 'Trans proline' 0 C--N 1.383 2.347 0 C-N-CA 122.885 2.39 . . . . 63.409999999999997 113.392 -175.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.08 15.51 78.67 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-N 115.557 -0.747 . . . . 71.230000000000004 113.565 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 87.3 mmm -113.18 -18.19 12.18 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.462 0.705 . . . . 63.130000000000003 111.026 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -96.84 -89.58 1.84 Allowed Glycine 0 C--N 1.349 1.295 0 N-CA-C 112.155 -0.378 . . . . 74.140000000000001 112.155 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -76.03 98.48 1.21 Allowed Glycine 0 C--N 1.345 1.033 0 C-N-CA 122.848 0.261 . . . . 75.299999999999997 112.527 176.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -88.56 113.53 24.24 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.444 0.698 . . . . 75.5 110.065 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 166.83 -154.53 25.03 Favored Glycine 0 C--O 1.241 0.551 0 N-CA-C 111.821 -0.512 . . . . 52.219999999999999 111.821 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -73.37 -50.92 5.98 Favored Pre-proline 0 CA--C 1.563 1.454 0 CA-C-O 117.97 -1.014 . . . . 73.049999999999997 110.992 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.14 111.6 3.31 Favored 'Trans proline' 0 C--N 1.393 2.878 0 CA-C-N 121.572 1.597 . . . . 73.109999999999999 110.315 168.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -67.11 125.36 13.46 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.526 2.151 . . . . 64.439999999999998 111.901 -173.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -120.25 146.34 17.76 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 111.908 -0.477 . . . . 72.329999999999998 111.908 -176.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -105.29 170.77 7.69 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.057 0.943 . . . . 42.240000000000002 112.024 -172.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 45.4 tp -121.99 113.8 20.09 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.792 1.237 . . . . 64.230000000000004 108.758 -177.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 69.4 mt -85.25 99.99 11.48 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.7 0.8 . . . . 63.530000000000001 110.032 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' LEU . . . . . 0.577 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 87.9 mt -88.93 100.43 13.18 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.244 0.618 . . . . 74.340000000000003 111.274 -175.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 71.4 t -89.2 124.83 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 109.198 -0.668 . . . . 74.420000000000002 109.198 177.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.4 p -80.53 137.82 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 122.727 0.411 . . . . 74.129999999999995 110.524 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.497 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 33.7 mmt180 -122.09 91.6 3.54 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.201 1.0 . . . . 64.340000000000003 109.255 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.434 HD21 ' HB2' ' A' ' 130' ' ' ALA . 43.2 mt -93.74 140.33 29.78 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.334 0.654 . . . . 61.439999999999998 111.355 -178.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 70.7 mt . . . . . 0 CA--C 1.548 0.893 0 CA-C-N 114.869 -1.059 . . . . 75.109999999999999 109.182 177.694 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.506 ' HB3' ' NH2' ' A' ' 136' ' ' ARG . 49.9 mtm . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 109.064 -0.717 . . . . 70.239999999999995 109.064 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.1 m -62.79 137.25 58.22 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.676 0.39 . . . . 62.310000000000002 111.093 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.3 m -70.93 148.62 47.53 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.705 0.802 . . . . 64.219999999999999 110.27 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.677 HD12 ' HB2' ' A' ' 123' ' ' LEU . 13.2 pt -117.28 163.02 14.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 123.104 0.562 . . . . 74.340000000000003 110.327 -177.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -139.12 124.12 18.85 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.714 0.806 . . . . 53.009999999999998 108.938 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.706 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.2 tp -72.17 160.44 32.43 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.46 1.104 . . . . 75.340000000000003 109.81 -173.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.527 ' HB3' ' H ' ' A' ' 122' ' ' GLU . . . -84.11 -43.92 14.56 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.489 0.316 . . . . 71.120000000000005 110.977 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.408 HD23 ' HB2' ' A' ' 121' ' ' ALA . 43.6 mt 49.35 71.97 0.34 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.063 0.945 . . . . 72.439999999999998 111.018 -168.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.623 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 86.2 mt -76.38 133.09 71.7 Favored Pre-proline 0 C--O 1.239 0.536 0 CA-C-N 115.34 -0.846 . . . . 73.409999999999997 109.718 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.94 154.82 30.73 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 121.992 1.795 . . . . 64.400000000000006 110.15 164.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.46 118.63 7.8 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.643 0.735 . . . . 74.150000000000006 112.271 -171.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 143.93 -141.34 10.19 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 114.316 -1.311 . . . . 73.420000000000002 109.909 -174.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 61.1 m 59.03 19.85 7.67 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 124.174 0.99 . . . . 75.219999999999999 112.578 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.63 36.45 29.5 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 112.382 -0.287 . . . . 61.219999999999999 112.382 -173.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.439 ' HA3' ' HD2' ' A' ' 120' ' ' ARG . . . -147.59 114.82 0.72 Allowed Glycine 0 C--N 1.348 1.22 0 N-CA-C 110.718 -0.953 . . . . 64.400000000000006 110.718 -178.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.7 t -158.28 111.95 2.46 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.646 0.778 . . . . 73.400000000000006 109.816 -175.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.1 -64.29 2.96 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 110.103 -1.199 . . . . 71.129999999999995 110.103 167.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 77.36 -68.6 2.65 Favored Glycine 0 C--N 1.347 1.181 0 C-N-CA 123.522 0.582 . . . . 64.439999999999998 112.631 176.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 59.5 p -53.37 120.18 5.73 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.618 1.167 . . . . 70.099999999999994 111.476 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 150.86 -42.78 0.73 Allowed Glycine 0 C--N 1.336 0.564 0 N-CA-C 110.944 -0.862 . . . . 64.129999999999995 110.944 -177.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 70.8 -84.25 0.38 Allowed Glycine 0 C--N 1.353 1.49 0 N-CA-C 111.305 -0.718 . . . . 71.219999999999999 111.305 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 32.3 m -78.67 86.66 4.63 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 108.734 -0.839 . . . . 74.109999999999999 108.734 169.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 151.85 73.03 0.01 OUTLIER Glycine 0 C--N 1.339 0.698 0 N-CA-C 109.985 -1.246 . . . . 34.32 109.985 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -65.14 116.65 6.74 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.401 0.681 . . . . 75.099999999999994 110.062 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -82.9 149.37 27.12 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.556 0.742 . . . . 73.409999999999997 109.653 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.5 tt -141.63 138.28 32.43 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 106.249 -1.76 . . . . 64.329999999999998 106.249 176.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.623 ' HG3' ' HB2' ' A' ' 102' ' ' LEU . 13.2 ptm180 -103.75 149.58 24.87 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.228 0.537 . . . . 71.109999999999999 110.504 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.706 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -159.63 135.89 8.92 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.765 -0.652 . . . . 53.43 109.76 -172.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.527 ' H ' ' HB3' ' A' ' 100' ' ' ALA . 7.0 mm-40 -108.5 120.93 43.85 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 107.583 -1.265 . . . . 64.400000000000006 107.583 -171.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.768 HD23 ' HB3' ' A' ' 176' ' ' LEU . 3.6 pp -101.08 110.47 61.3 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 108.085 -1.08 . . . . 74.120000000000005 108.085 176.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.61 112.29 3.5 Favored 'Trans proline' 0 C--N 1.367 1.536 0 C-N-CA 121.785 1.657 . . . . 75.530000000000001 108.994 169.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.54 HD21 HD12 ' A' ' 149' ' ' ILE . 32.1 tp -103.54 153.06 20.98 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.32 -0.622 . . . . 63.109999999999999 109.32 -169.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.7 t -92.51 146.07 23.96 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 108.024 -1.102 . . . . 71.510000000000005 108.024 178.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.514 HD23 HD22 ' A' ' 180' ' ' LEU . 87.6 mt -66.18 -24.5 66.64 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.919 0.711 . . . . 75.340000000000003 112.919 -173.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.08 -45.43 94.75 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.456 -0.572 . . . . 75.510000000000005 109.456 174.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.436 ' HB3' HD11 ' A' ' 149' ' ' ILE . 18.3 mm-40 -76.15 -31.6 58.65 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.128 -0.942 . . . . 75.109999999999999 111.83 -178.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.58 -36.36 78.34 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.936 0.494 . . . . 62.340000000000003 110.241 173.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -74.2 -57.99 3.59 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.755 -1.112 . . . . 63.340000000000003 110.945 176.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -60.95 -50.14 74.62 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.122 0.569 . . . . 73.329999999999998 111.184 -172.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.533 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 64.34 61.59 5.87 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 114.759 -1.11 . . . . 63.32 112.626 -173.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.445 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -123.92 -157.63 9.86 Favored Glycine 0 N--CA 1.467 0.749 0 N-CA-C 111.179 -0.768 . . . . 73.319999999999993 111.179 177.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -78.18 126.11 30.33 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.12 -0.696 . . . . 74.239999999999995 109.12 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.506 ' NH2' ' HB3' ' A' ' 94' ' ' MET . 8.6 tpp180 -120.05 123.06 42.51 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.727 -0.842 . . . . 72.409999999999997 108.727 175.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 72.7 t -71.58 113.7 8.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-N 114.306 -1.315 . . . . 44.140000000000001 109.677 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.522 HG22 HD11 ' A' ' 97' ' ' ILE . 35.9 t -100.88 112.17 32.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 108.394 -0.965 . . . . 73.430000000000007 108.394 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -99.8 113.72 26.42 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.102 -1.073 . . . . 70.299999999999997 108.102 174.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.0 p -152.66 132.14 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 122.92 0.488 . . . . 54.450000000000003 110.986 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 60.88 20.92 11.15 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.213 1.005 . . . . 75.319999999999993 112.792 173.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.62 -6.19 80.08 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-O 119.847 -0.418 . . . . 63.420000000000002 113.291 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.419 ' NH1' ' SD ' ' A' ' 164' ' ' MET . 35.1 ttm180 -101.71 122.77 44.54 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.908 0.883 . . . . 70.540000000000006 109.947 -178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -97.42 108.31 21.01 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.253 1.021 . . . . 50.039999999999999 108.641 174.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 3.2 p -123.26 113.66 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.392 0.677 . . . . 54.109999999999999 109.551 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.2 t -91.27 113.92 26.32 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.789 -0.819 . . . . 61.109999999999999 108.789 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 23.3 m -108.34 133.68 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.364 0.666 . . . . 72.0 110.584 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -81.99 96.05 7.6 Favored 'General case' 0 C--N 1.349 0.548 0 N-CA-C 108.886 -0.783 . . . . 71.239999999999995 108.886 176.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.54 HD12 HD21 ' A' ' 125' ' ' LEU . 12.3 pt -73.4 147.24 87.32 Favored Pre-proline 0 CA--C 1.559 1.301 0 CA-C-N 114.636 -1.165 . . . . 75.530000000000001 109.609 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.6 142.01 75.62 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.915 2.41 . . . . 72.049999999999997 113.508 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.29 117.21 3.99 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.332 2.021 . . . . 64.319999999999993 110.996 170.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 93.0 17.82 42.3 Favored Glycine 0 C--N 1.34 0.786 0 O-C-N 123.645 0.59 . . . . 41.149999999999999 112.901 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.7 p -62.93 123.79 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 C-N-CA 123.424 0.69 . . . . 72.299999999999997 110.255 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -127.44 164.31 22.16 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.278 0.631 . . . . 70.030000000000001 110.982 -172.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -40.84 127.05 2.56 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.28 1.832 . . . . 64.409999999999997 113.767 -171.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.32 -11.77 66.95 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-O 119.486 -0.619 . . . . 72.340000000000003 114.246 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.4 m -60.64 121.1 11.37 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 117.553 0.676 . . . . 62.439999999999998 110.281 173.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.423 HG22 HG22 ' A' ' 177' ' ' VAL . 61.4 t -105.52 110.97 32.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.334 0.653 . . . . 71.109999999999999 109.524 -178.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.416 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 67.0 mt -90.33 103.73 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 107.985 -1.117 . . . . 74.019999999999996 107.985 177.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -83.01 101.33 11.03 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.752 -0.658 . . . . 72.230000000000004 109.451 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.438 HG13 ' HB3' ' A' ' 174' ' ' LEU . 3.8 p -101.93 109.05 58.78 Favored Pre-proline 0 CA--C 1.558 1.251 0 C-N-CA 123.24 0.616 . . . . 75.310000000000002 110.205 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.461 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 16.5 Cg_exo -69.13 145.56 61.2 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.859 2.373 . . . . 65.030000000000001 112.799 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 87.42 0.27 84.74 Favored Glycine 0 C--N 1.344 1.02 0 CA-C-N 115.643 -0.708 . . . . 73.329999999999998 113.722 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.419 ' SD ' ' NH1' ' A' ' 143' ' ' ARG . 24.5 mmt -107.7 -12.09 15.3 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.454 0.701 . . . . 75.120000000000005 111.485 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -98.87 -87.17 1.9 Allowed Glycine 0 C--N 1.351 1.37 0 N-CA-C 112.102 -0.399 . . . . 63.109999999999999 112.102 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.26 97.02 0.22 Allowed Glycine 0 C--N 1.349 1.29 0 C-N-CA 123.249 0.452 . . . . 62.439999999999998 112.872 176.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -90.44 170.94 9.8 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.705 1.202 . . . . 70.329999999999998 110.575 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 110.96 -66.13 0.24 Allowed Glycine 0 N--CA 1.47 0.947 0 C-N-CA 123.364 0.507 . . . . 63.119999999999997 112.189 173.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -154.79 -53.96 0.02 OUTLIER Pre-proline 0 CA--C 1.558 1.287 0 CA-C-O 117.739 -1.124 . . . . 73.219999999999999 111.155 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -81.32 109.35 2.1 Favored 'Trans proline' 0 C--N 1.398 3.182 0 C-N-CA 121.929 1.752 . . . . 61.520000000000003 110.247 177.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.63 124.12 12.35 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 121.777 1.652 . . . . 55.329999999999998 110.251 -176.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -123.51 164.21 16.72 Favored Glycine 0 C--O 1.238 0.383 0 CA-C-N 115.859 -0.609 . . . . 62.299999999999997 111.684 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 6.7 p-10 -91.13 162.07 14.82 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.725 0.81 . . . . 73.519999999999996 111.055 -170.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.438 ' HB3' HG13 ' A' ' 161' ' ' VAL . 34.7 tp -126.29 116.14 20.79 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 114.727 -1.124 . . . . 71.319999999999993 108.819 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 88.6 mt -85.2 100.84 12.03 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.206 1.003 . . . . 72.430000000000007 110.026 -175.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.768 ' HB3' HD23 ' A' ' 123' ' ' LEU . 46.8 mt -90.05 99.23 12.28 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.82 0.448 . . . . 74.439999999999998 110.167 -177.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.423 HG22 HG22 ' A' ' 158' ' ' VAL . 41.5 t -86.4 113.29 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 109.333 -0.617 . . . . 74.140000000000001 109.333 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.6 p -68.68 133.3 32.02 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.981 0 O-C-N 123.462 0.476 . . . . 74.439999999999998 109.945 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -127.47 94.19 3.92 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.109 0.964 . . . . 75.200000000000003 109.042 -174.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.514 HD22 HD23 ' A' ' 127' ' ' LEU . 97.1 mt -98.57 147.98 24.25 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.185 -0.916 . . . . 65.439999999999998 110.505 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 79.2 mt -71.05 135.53 85.05 Favored Pre-proline 0 CA--C 1.553 1.084 0 N-CA-C 109.471 -0.566 . . . . 73.129999999999995 109.471 175.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.63 -30.84 76.84 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 123.086 2.524 . . . . 70.219999999999999 113.6 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 . . . . . 0 CA--C 1.551 0.987 0 N-CA-C 109.128 -0.693 . . . . 74.140000000000001 109.128 171.528 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.46 ' N ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 121.659 0.743 . . . . 72.299999999999997 109.967 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.3 m -63.38 125.14 23.2 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.132 -0.94 . . . . 54.219999999999999 110.649 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.546 ' HA ' HH11 ' A' ' 136' ' ' ARG . 92.4 m -68.21 131.97 46.32 Favored 'General case' 0 C--O 1.24 0.593 0 O-C-N 123.424 0.453 . . . . 43.409999999999997 110.164 176.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.688 HD12 ' HB2' ' A' ' 123' ' ' LEU . 23.1 pt -104.45 167.6 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 115.448 -0.796 . . . . 74.140000000000001 110.759 -171.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -112.45 -171.44 1.86 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.517 0.727 . . . . 74.409999999999997 109.707 172.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.562 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.1 tp -133.7 158.0 44.39 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 108.268 -1.012 . . . . 71.409999999999997 108.268 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.481 ' HB3' ' H ' ' A' ' 122' ' ' GLU . . . -75.8 -47.53 25.37 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 110.129 -0.323 . . . . 74.299999999999997 110.129 176.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 54.5 mt 50.8 86.58 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.238 0 O-C-N 124.453 1.095 . . . . 73.109999999999999 111.034 -171.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.0 mt -99.31 157.77 33.43 Favored Pre-proline 0 CA--C 1.549 0.918 0 CA-C-N 115.15 -0.932 . . . . 73.409999999999997 109.491 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -67.92 -170.35 0.28 Allowed 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 122.88 2.387 . . . . 75.450000000000003 113.859 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.611 HD11 ' HG3' ' A' ' 117' ' ' ARG . 4.6 mm? -55.86 130.58 44.13 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.076 0.95 . . . . 74.430000000000007 111.019 175.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 131.06 75.22 0.13 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 111.146 -0.781 . . . . 73.239999999999995 111.146 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 51.5 p -82.58 1.34 38.59 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.86 0.864 . . . . 73.209999999999994 112.481 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.8 22.39 21.01 Favored Glycine 0 N--CA 1.474 1.211 0 N-CA-C 112.066 -0.414 . . . . 72.219999999999999 112.066 -175.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 174.72 -30.89 0.09 OUTLIER Glycine 0 C--N 1.338 0.669 0 N-CA-C 111.326 -0.71 . . . . 63.420000000000002 111.326 -177.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.2 t 68.17 -172.79 0.19 Allowed 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 124.238 1.015 . . . . 74.430000000000007 111.54 174.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -66.3 81.9 0.1 Allowed Glycine 0 C--N 1.349 1.289 0 N-CA-C 112.399 -0.28 . . . . 63.439999999999998 112.399 173.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.99 -10.2 58.44 Favored Glycine 0 C--N 1.354 1.566 0 N-CA-C 114.857 0.703 . . . . 35.229999999999997 114.857 -172.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.2 t -77.14 -5.63 49.8 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 123.565 0.746 . . . . 64.409999999999997 111.235 175.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.06 35.55 38.3 Favored Glycine 0 C--N 1.354 1.54 0 N-CA-C 112.135 -0.386 . . . . 74.340000000000003 112.135 -176.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 123.62 -176.61 16.75 Favored Glycine 0 C--N 1.347 1.141 0 C-N-CA 122.987 0.327 . . . . 75.129999999999995 112.375 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 24.8 t 63.61 70.09 0.53 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.985 1.314 . . . . 62.450000000000003 110.794 -177.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 127.07 111.92 1.73 Allowed Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.244 -0.889 . . . . 53.420000000000002 112.115 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.611 ' HG3' HD11 ' A' ' 104' ' ' LEU . 51.2 ttp180 -84.58 125.67 32.65 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.066 0.46 . . . . 71.349999999999994 109.902 173.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -82.56 144.79 30.12 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.407 0.683 . . . . 75.319999999999993 109.808 176.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.9 tt -143.8 118.26 9.7 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 107.905 -1.146 . . . . 63.219999999999999 107.905 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -91.14 127.77 36.7 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 107.835 -1.172 . . . . 54.049999999999997 107.835 176.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.562 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -146.07 130.66 17.87 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.269 -0.641 . . . . 74.120000000000005 109.269 -176.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.481 ' H ' ' HB3' ' A' ' 100' ' ' ALA . 52.9 mt-10 -117.51 120.57 38.48 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 110.037 -0.357 . . . . 75.430000000000007 110.037 -169.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.688 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.4 pp -100.82 122.89 47.49 Favored Pre-proline 0 C--N 1.349 0.564 0 N-CA-C 109.961 -0.385 . . . . 62.420000000000002 109.961 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -76.78 113.58 3.67 Favored 'Trans proline' 0 C--N 1.365 1.433 0 C-N-CA 122.309 2.006 . . . . 73.129999999999995 108.27 167.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.549 HD21 HD12 ' A' ' 149' ' ' ILE . 51.2 tp -101.73 147.09 26.88 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.6 -0.518 . . . . 75.140000000000001 109.6 -168.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.5 t -89.57 148.92 23.09 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 108.587 -0.894 . . . . 75.319999999999993 108.587 -176.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.46 -31.2 71.88 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.776 0.83 . . . . 72.230000000000004 112.629 -169.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.45 -47.59 85.45 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.855 0.722 . . . . 70.129999999999995 109.35 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -76.31 -28.84 57.1 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 114.619 -1.173 . . . . 63.210000000000001 112.055 -174.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.0 -43.12 99.5 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.331 0.586 . . . . 72.230000000000004 110.266 172.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -65.21 -54.16 33.69 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 114.421 -1.263 . . . . 74.420000000000002 110.976 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -63.58 -48.86 75.65 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.076 0.55 . . . . 74.510000000000005 111.486 -175.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.59 ' HA3' ' HA ' ' A' ' 151' ' ' PRO . . . 61.04 72.53 0.62 Allowed Glycine 0 C--N 1.341 0.832 0 CA-C-N 114.788 -1.096 . . . . 71.129999999999995 112.147 -171.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.464 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -144.37 -157.63 7.28 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 111.696 -0.561 . . . . 61.219999999999999 111.696 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -72.35 112.56 8.53 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.412 -0.588 . . . . 52.119999999999997 109.412 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.546 HH11 ' HA ' ' A' ' 96' ' ' THR . 5.9 tpp180 -113.0 122.71 48.45 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.253 -1.017 . . . . 73.209999999999994 108.253 173.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 96.8 t -77.69 125.97 37.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 CA-C-N 114.472 -1.24 . . . . 63.439999999999998 109.918 -178.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 45.1 t -103.45 121.55 54.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.423 1.089 . . . . 75.230000000000004 108.35 176.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -112.93 106.47 14.76 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.136 -1.061 . . . . 74.340000000000003 108.136 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.3 p -151.14 122.4 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 123.175 0.59 . . . . 73.409999999999997 110.639 -175.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 64.24 19.96 11.99 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.131 0.972 . . . . 73.430000000000007 112.359 174.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.53 -9.68 76.85 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 116.368 -0.378 . . . . 52.109999999999999 112.787 -174.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 18.6 ttm180 -89.47 120.9 31.19 Favored 'General case' 0 C--N 1.347 0.493 0 N-CA-C 108.507 -0.923 . . . . 73.310000000000002 108.507 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.425 ' HA ' ' O ' ' A' ' 138' ' ' VAL . 40.7 ttm180 -112.53 114.95 27.86 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.217 -0.901 . . . . 73.010000000000005 108.708 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 6.4 p -129.9 117.55 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.424 0.63 . . . . 62.439999999999998 110.529 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 43.0 t -81.48 110.1 16.57 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.563 -0.902 . . . . 73.310000000000002 108.563 174.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.6 p -107.73 123.47 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.181 0.592 . . . . 72.200000000000003 109.741 177.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 51.1 ttt85 -76.96 94.81 4.01 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 108.734 -0.839 . . . . 74.049999999999997 108.734 172.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.549 HD12 HD21 ' A' ' 125' ' ' LEU . 8.0 pt -69.9 142.83 91.2 Favored Pre-proline 0 CA--C 1.561 1.372 0 CA-C-N 114.533 -1.212 . . . . 70.140000000000001 109.146 175.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.4 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 24.6 Cg_endo -63.01 148.72 93.17 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.396 2.064 . . . . 71.010000000000005 112.702 178.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.59 ' HA ' ' HA3' ' A' ' 133' ' ' GLY . 34.9 Cg_exo -62.36 124.84 15.02 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.689 2.259 . . . . 74.019999999999996 111.441 177.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 74.44 30.66 60.01 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 112.23 -0.348 . . . . 51.130000000000003 112.23 -177.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.0 p -62.27 116.95 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 123.576 0.751 . . . . 61.32 109.78 175.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.526 ' HA ' HD12 ' A' ' 180' ' ' LEU . 96.1 mtt180 -113.57 166.33 11.62 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.423 0.689 . . . . 65.109999999999999 110.886 -177.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -40.21 128.47 2.29 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 126.628 1.971 . . . . 75.340000000000003 113.692 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.69 -10.24 72.76 Favored Glycine 0 C--N 1.352 1.433 0 CA-C-O 119.442 -0.643 . . . . 64.340000000000003 114.124 175.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 25.3 t -64.77 120.57 12.72 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 117.521 0.66 . . . . 72.319999999999993 109.885 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.428 HG22 HG22 ' A' ' 177' ' ' VAL . 53.4 t -99.26 125.02 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.588 0.755 . . . . 65.430000000000007 109.224 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 54.8 mt -101.63 105.22 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 108.553 -0.906 . . . . 75.040000000000006 108.553 176.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -80.85 101.86 9.67 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.879 0.472 . . . . 72.409999999999997 109.782 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.551 HG13 ' HB3' ' A' ' 174' ' ' LEU . 5.4 p -110.63 98.12 35.73 Favored Pre-proline 0 CA--C 1.561 1.389 0 N-CA-C 109.802 -0.444 . . . . 74.219999999999999 109.802 173.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 44.4 Cg_endo -65.69 156.53 63.44 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.521 2.814 . . . . 75.219999999999999 113.291 -178.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 68.89 11.66 63.54 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.122 -0.944 . . . . 61.200000000000003 114.458 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 97.4 mmm -113.82 -26.94 7.96 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.857 0.863 . . . . 61.140000000000001 109.422 174.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -76.67 -84.87 0.44 Allowed Glycine 0 C--N 1.35 1.328 0 N-CA-C 110.705 -0.958 . . . . 4.0999999999999996 110.705 172.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.412 ' HA2' ' HB3' ' A' ' 117' ' ' ARG . . . -66.22 101.29 0.6 Allowed Glycine 0 C--N 1.342 0.906 0 O-C-N 123.958 0.446 . . . . 73.510000000000005 113.791 171.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.64 HE21 ' HA ' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -90.83 169.97 10.49 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.05 0.94 . . . . 75.400000000000006 110.559 174.596 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 83.0 -143.63 22.26 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-O 119.648 -0.529 . . . . 74.150000000000006 112.405 -176.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -63.07 -57.18 22.31 Favored Pre-proline 0 CA--C 1.56 1.358 0 CA-C-O 118.404 -0.807 . . . . 64.219999999999999 112.084 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -80.29 111.83 2.69 Favored 'Trans proline' 0 C--N 1.393 2.918 0 CA-C-N 121.179 1.457 . . . . 74.409999999999997 112.22 -176.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -76.07 123.9 7.59 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 122.024 1.816 . . . . 65.319999999999993 110.704 -178.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 117' ' ' ARG . . . -137.04 162.92 25.33 Favored Glycine 0 C--N 1.34 0.751 0 C-N-CA 121.406 -0.426 . . . . 53.520000000000003 113.42 -172.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.517 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 8.8 m-20 -91.23 132.23 36.25 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 123.892 0.877 . . . . 74.129999999999995 111.87 -164.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.551 ' HB3' HG13 ' A' ' 161' ' ' VAL . 33.7 tp -96.13 102.95 14.81 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.021 -1.474 . . . . 64.219999999999999 107.021 171.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 88.4 mt -87.9 100.25 12.74 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.182 0.593 . . . . 61.530000000000001 109.441 -175.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.565 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 74.3 mt -87.25 99.45 11.97 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 123.262 0.625 . . . . 73.409999999999997 110.253 -175.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.428 HG22 HG22 ' A' ' 158' ' ' VAL . 33.2 t -87.97 116.09 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 108.949 -0.76 . . . . 74.209999999999994 108.949 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 13.0 p -73.64 140.39 17.83 Favored 'Isoleucine or valine' 0 C--O 1.246 0.878 0 C-N-CA 123.003 0.521 . . . . 72.109999999999999 110.888 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -124.75 113.58 18.15 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 107.946 -1.131 . . . . 75.109999999999999 107.946 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.526 HD12 ' HA ' ' A' ' 154' ' ' ARG . 47.8 mt -111.35 134.34 53.01 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.947 0.499 . . . . 64.439999999999998 110.772 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 96.0 mt -58.53 142.18 82.95 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 123.818 0.847 . . . . 55.43 110.362 174.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -69.21 -10.09 28.06 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 122.946 2.431 . . . . 73.209999999999994 112.907 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 42.9 m80 . . . . . 0 C--O 1.252 1.193 0 N-CA-C 107.163 -1.421 . . . . 72.219999999999999 107.163 174.06 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 73.3 mtp . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 109.333 -0.617 . . . . 74.230000000000004 109.333 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 43.5 m -71.0 125.1 25.94 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.953 -0.567 . . . . 65.319999999999993 110.575 -177.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 56.8 m -67.92 147.37 52.56 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.921 0.888 . . . . 51.420000000000002 111.153 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.689 HD12 ' HB2' ' A' ' 123' ' ' LEU . 26.8 pt -116.93 168.18 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 123.496 0.718 . . . . 75.409999999999997 110.577 -172.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -141.65 127.69 19.54 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.756 0.822 . . . . 64.439999999999998 109.41 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.724 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.1 tp -73.96 140.15 45.35 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.628 1.571 . . . . 71.109999999999999 110.417 -169.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.58 -33.82 76.81 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.557 0.743 . . . . 75.450000000000003 111.713 -176.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.8 mt 48.7 62.78 2.39 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.417 1.087 . . . . 61.450000000000003 111.697 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.0 mt -69.89 147.14 95.94 Favored Pre-proline 0 CA--C 1.554 1.134 0 N-CA-C 108.719 -0.845 . . . . 64.040000000000006 108.719 176.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.76 172.17 9.89 Favored 'Trans proline' 0 C--N 1.367 1.505 0 C-N-CA 122.071 1.847 . . . . 54.530000000000001 112.45 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.1 pp -75.68 155.81 35.37 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 116.598 -0.274 . . . . 72.230000000000004 111.109 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 144.66 -75.9 0.29 Allowed Glycine 0 C--N 1.339 0.747 0 N-CA-C 110.884 -0.886 . . . . 61.340000000000003 110.884 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 53.4 p -101.99 89.23 3.57 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.567 0.747 . . . . 74.519999999999996 109.517 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.417 ' HA2' ' HD3' ' A' ' 120' ' ' ARG . . . -106.94 -82.41 1.5 Allowed Glycine 0 C--N 1.339 0.699 0 CA-C-N 115.908 -0.587 . . . . 72.319999999999993 111.909 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.28 162.16 32.39 Favored Glycine 0 CA--C 1.534 1.245 0 O-C-N 123.843 0.378 . . . . 75.540000000000006 113.142 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.0 m 72.45 -68.47 0.22 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 125.113 1.365 . . . . 74.109999999999999 111.901 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -94.03 -174.79 39.4 Favored Glycine 0 C--N 1.346 1.095 0 CA-C-O 120.137 -0.257 . . . . 51.210000000000001 112.551 178.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.537 ' HA3' ' HB3' ' A' ' 118' ' ' ASP . . . 68.33 57.84 7.91 Favored Glycine 0 C--N 1.345 1.075 0 N-CA-C 111.846 -0.501 . . . . 72.420000000000002 111.846 -178.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.7 m -66.42 156.13 35.52 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.671 0.788 . . . . 74.409999999999997 111.676 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -75.83 71.75 1.87 Allowed Glycine 0 C--N 1.353 1.481 0 O-C-N 123.544 0.528 . . . . 43.439999999999998 113.486 -176.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -167.34 43.88 0.25 Allowed Glycine 0 C--N 1.342 0.891 0 N-CA-C 111.102 -0.799 . . . . 33.43 111.102 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 54.0 m 67.07 93.81 0.07 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.322 1.449 . . . . 62.240000000000002 111.841 -177.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 177.65 98.25 0.11 Allowed Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.199 -0.909 . . . . 61.140000000000001 111.032 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.696 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 18.4 ttm180 -73.69 119.28 17.7 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.862 0.865 . . . . 73.329999999999998 110.468 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.537 ' HB3' ' HA3' ' A' ' 111' ' ' GLY . 10.4 p-10 -85.28 116.74 23.8 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.43 0.634 . . . . 74.519999999999996 109.958 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.7 tt -94.34 124.19 38.21 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.399 -1.704 . . . . 74.400000000000006 106.399 175.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.417 ' HD3' ' HA2' ' A' ' 107' ' ' GLY . 23.5 tpt85 -90.98 117.73 29.8 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 107.879 -1.156 . . . . 73.219999999999999 107.879 -175.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.724 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -140.04 151.04 45.11 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 110.032 -0.359 . . . . 63.219999999999999 110.032 -173.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.536 ' HG2' ' HB ' ' A' ' 177' ' ' VAL . 89.1 mt-10 -129.69 120.5 25.25 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.242 -0.651 . . . . 64.519999999999996 109.242 -177.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.689 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.4 pp -97.83 113.61 63.9 Favored Pre-proline 0 C--N 1.353 0.727 0 N-CA-C 107.684 -1.228 . . . . 63.43 107.684 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.15 113.45 3.78 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 122.477 2.118 . . . . 72.049999999999997 108.549 171.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.453 HD21 HD12 ' A' ' 149' ' ' ILE . 34.0 tp -102.29 146.68 27.67 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 109.429 -0.582 . . . . 74.030000000000001 109.429 -168.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.9 t -90.47 154.06 19.92 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 108.324 -0.991 . . . . 63.310000000000002 108.324 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.82 -36.37 82.95 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.146 0.579 . . . . 41.130000000000003 111.803 -173.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -55.19 -47.74 74.82 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.233 0.613 . . . . 71.230000000000004 110.425 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.475 ' HG3' ' HE ' ' A' ' 136' ' ' ARG . 14.3 mm-40 -76.57 -31.7 57.69 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.933 -1.03 . . . . 71.040000000000006 111.829 -174.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.7 -31.94 72.94 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.779 0.431 . . . . 72.430000000000007 110.704 174.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -78.25 -49.98 12.71 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.433 -0.803 . . . . 70.329999999999998 110.895 173.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -62.72 -50.06 72.6 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.745 0.418 . . . . 75.120000000000005 111.413 -172.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.585 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 60.85 75.05 0.31 Allowed Glycine 0 C--N 1.342 0.862 0 CA-C-N 115.129 -0.942 . . . . 54.030000000000001 112.921 -177.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -162.3 -144.16 3.92 Favored Glycine 0 C--O 1.24 0.492 0 N-CA-C 110.967 -0.853 . . . . 64.430000000000007 110.967 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -72.05 113.36 9.0 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 122.787 0.435 . . . . 63.350000000000001 110.15 -175.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.475 ' HE ' ' HG3' ' A' ' 129' ' ' GLU . 6.8 tpp180 -120.21 120.83 37.29 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.24 -1.022 . . . . 73.5 108.24 170.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 146' ' ' SER . 63.8 t -77.07 131.71 34.26 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-N 115.417 -0.81 . . . . 74.150000000000006 110.416 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.4 p -125.18 119.64 56.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 124.361 1.065 . . . . 64.209999999999994 108.597 171.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -115.61 115.24 26.09 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.946 0.498 . . . . 73.329999999999998 110.259 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.461 HG21 ' HB3' ' A' ' 99' ' ' LEU . 2.5 m -149.22 144.01 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 125.017 1.327 . . . . 73.420000000000002 110.384 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.6 26.5 14.68 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.729 1.211 . . . . 63.32 111.611 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 81.37 -0.74 87.32 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 115.706 -0.679 . . . . 73.239999999999995 112.961 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -101.13 117.92 35.96 Favored 'General case' 0 C--N 1.346 0.451 0 C-N-CA 123.718 0.807 . . . . 70.310000000000002 110.036 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 37.1 ttp180 -97.78 105.79 17.99 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.351 -0.981 . . . . 65.430000000000007 108.351 174.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 5.6 p -125.96 125.97 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.298 0.639 . . . . 70.120000000000005 109.53 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 137' ' ' VAL . 38.3 t -89.95 134.5 34.19 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 109.371 -0.603 . . . . 70.25 109.371 175.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.6 p -113.79 130.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.277 0.631 . . . . 50.140000000000001 109.611 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -85.81 104.11 15.18 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.772 0.796 . . . . 75.0 109.778 173.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.585 HG13 ' HA2' ' A' ' 133' ' ' GLY . 8.2 pt -83.42 150.74 60.93 Favored Pre-proline 0 CA--C 1.558 1.269 0 CA-C-N 114.42 -1.264 . . . . 61.020000000000003 109.756 173.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -73.91 145.93 36.77 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.263 1.976 . . . . 75.109999999999999 112.191 173.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.48 120.1 7.31 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 122.391 2.06 . . . . 75.200000000000003 111.176 173.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 89.74 27.65 21.24 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 111.626 -0.59 . . . . 53.420000000000002 111.626 -170.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 4.3 p -66.6 129.95 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 109.272 -0.64 . . . . 73.439999999999998 109.272 172.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 29.3 mtm180 -127.02 157.87 38.45 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.442 0.697 . . . . 63.25 110.856 -168.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -42.17 125.49 3.07 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 126.716 2.006 . . . . 63.539999999999999 114.107 -175.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.79 2.75 69.17 Favored Glycine 0 C--N 1.351 1.392 0 N-CA-C 114.652 0.621 . . . . 53.399999999999999 114.652 176.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 33.1 t -68.29 122.42 18.32 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 117.556 0.678 . . . . 54.240000000000002 109.257 173.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.476 HG22 HG22 ' A' ' 177' ' ' VAL . 52.1 t -110.08 109.55 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.465 0.706 . . . . 72.25 109.592 -176.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.434 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 54.5 mt -90.78 111.57 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 108.551 -0.907 . . . . 54.229999999999997 108.551 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -86.41 104.29 15.77 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.732 0.813 . . . . 70.129999999999995 110.079 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.625 HG13 ' HB3' ' A' ' 174' ' ' LEU . 2.7 p -115.0 101.14 54.46 Favored Pre-proline 0 CA--C 1.564 1.494 0 C-N-CA 123.221 0.608 . . . . 63.030000000000001 110.352 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 49.1 Cg_endo -67.14 150.57 82.13 Favored 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 123.21 2.607 . . . . 72.239999999999995 113.231 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 74.0 11.05 81.44 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.785 -0.643 . . . . 74.230000000000004 114.331 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 23.1 mmt -114.92 -11.78 12.14 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.571 0.749 . . . . 55.020000000000003 110.353 173.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -97.24 -102.94 2.16 Favored Glycine 0 C--N 1.354 1.567 0 CA-C-N 116.059 -0.519 . . . . 63.43 112.246 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.696 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -70.48 90.63 0.38 Allowed Glycine 0 C--N 1.35 1.349 0 O-C-N 123.616 0.245 . . . . 74.040000000000006 113.621 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.728 HE21 ' HA ' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -81.6 158.17 24.46 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.524 0.678 . . . . 75.430000000000007 112.155 179.208 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 139.02 -145.72 17.11 Favored Glycine 0 C--N 1.342 0.885 0 CA-C-N 114.27 -1.332 . . . . 70.230000000000004 110.55 -172.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -75.94 -44.14 3.84 Favored Pre-proline 0 CA--C 1.562 1.409 0 CA-C-O 118.919 -0.563 . . . . 70.25 111.708 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -88.55 132.52 2.55 Favored 'Trans proline' 0 C--N 1.386 2.519 0 C-N-CA 121.653 1.569 . . . . 71.0 110.995 165.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.13 126.63 6.42 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 122.096 1.864 . . . . 55.340000000000003 111.484 176.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -109.25 154.01 16.65 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 116.071 -0.513 . . . . 73.150000000000006 112.74 -173.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.541 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 28.5 m-20 -77.35 144.44 38.01 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.62 0.768 . . . . 52.420000000000002 111.989 -175.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.625 ' HB3' HG13 ' A' ' 161' ' ' VAL . 45.6 tp -111.26 114.73 28.13 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.115 -1.069 . . . . 71.019999999999996 108.115 174.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 43.4 mt -87.04 112.38 21.81 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.302 1.041 . . . . 65.219999999999999 108.846 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.523 ' HB3' HD23 ' A' ' 123' ' ' LEU . 69.9 mt -101.75 99.0 9.19 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 123.576 0.547 . . . . 62.119999999999997 109.565 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.536 ' HB ' ' HG2' ' A' ' 122' ' ' GLU . 35.5 t -94.69 108.18 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 108.75 -0.833 . . . . 62.119999999999997 108.75 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 13.8 p -68.03 132.03 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 122.877 0.471 . . . . 74.409999999999997 110.904 -177.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -123.34 91.23 3.44 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.081 0.952 . . . . 73.209999999999994 109.071 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 85.8 mt -85.2 149.09 25.75 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.173 -0.921 . . . . 72.319999999999993 109.825 175.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 81.9 mt -67.4 130.15 93.49 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 109.48 -0.563 . . . . 65.540000000000006 109.48 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -67.33 -16.89 49.14 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.567 2.178 . . . . 73.129999999999995 112.895 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 10.8 t60 . . . . . 0 C--O 1.249 1.072 0 N-CA-C 108.139 -1.06 . . . . 63.0 108.139 172.022 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 20.1 ptt? . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 109.799 -0.445 . . . . 75.430000000000007 109.799 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.479 ' H ' HG21 ' A' ' 126' ' ' THR . 19.9 m -77.66 140.68 39.63 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.358 0.663 . . . . 44.149999999999999 111.619 -178.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.522 ' HA ' HH11 ' A' ' 136' ' ' ARG . 90.1 m -71.41 151.52 43.97 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.315 1.046 . . . . 63.409999999999997 110.199 170.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.736 HD12 ' HB2' ' A' ' 123' ' ' LEU . 27.1 pt -118.15 159.35 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 123.105 0.562 . . . . 70.230000000000004 110.107 -173.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -127.12 129.23 47.53 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.619 -0.882 . . . . 72.209999999999994 108.619 172.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.628 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.5 tp -69.51 151.23 46.28 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.256 1.022 . . . . 72.120000000000005 108.737 -177.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.88 -48.58 24.15 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 122.79 0.436 . . . . 70.340000000000003 109.846 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 93.1 mt 57.43 80.51 0.16 Allowed 'General case' 0 C--N 1.359 1.012 0 O-C-N 124.566 1.166 . . . . 73.340000000000003 109.524 -170.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.3 mt -74.28 151.92 87.92 Favored Pre-proline 0 N--CA 1.471 0.592 0 CA-C-N 115.218 -0.901 . . . . 70.510000000000005 110.671 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.23 146.01 95.94 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.471 2.114 . . . . 72.299999999999997 110.554 171.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -65.59 118.85 10.1 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.3 0.852 . . . . 72.409999999999997 113.3 -168.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -165.67 35.08 0.25 Allowed Glycine 0 C--N 1.336 0.561 0 CA-C-N 114.74 -1.118 . . . . 61.240000000000002 110.403 169.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.8 m -78.07 86.64 4.23 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.982 0.913 . . . . 53.240000000000002 110.161 -174.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.02 30.69 7.74 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 116.499 -0.319 . . . . 60.530000000000001 112.597 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.03 94.11 0.6 Allowed Glycine 0 C--N 1.353 1.517 0 N-CA-C 112.067 -0.413 . . . . 64.420000000000002 112.067 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.2 t -69.22 94.37 0.68 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.233 1.013 . . . . 55.200000000000003 111.334 -173.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 164.56 18.2 0.02 OUTLIER Glycine 0 N--CA 1.471 0.989 0 CA-C-N 115.504 -0.771 . . . . 53.340000000000003 112.353 175.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -103.44 19.03 46.55 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-O 119.286 -0.73 . . . . 72.239999999999995 114.616 -171.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 26.1 p -61.77 110.62 1.57 Allowed 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.588 0.755 . . . . 74.010000000000005 111.303 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -172.15 28.44 0.1 Allowed Glycine 0 C--N 1.344 1.021 0 CA-C-N 116.389 -0.369 . . . . 63.310000000000002 113.062 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 131.8 -165.4 23.4 Favored Glycine 0 C--N 1.343 0.941 0 N-CA-C 111.74 -0.544 . . . . 54.450000000000003 111.74 -177.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 56.6 m -122.99 132.37 54.11 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.464 0.706 . . . . 63.109999999999999 109.879 175.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 172.7 175.57 40.73 Favored Glycine 0 C--O 1.243 0.673 0 N-CA-C 110.105 -1.198 . . . . 72.230000000000004 110.105 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.529 ' HB3' ' HA2' ' A' ' 166' ' ' GLY . 59.4 ttp180 -79.26 123.48 27.48 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 117.13 0.465 . . . . 75.120000000000005 110.13 179.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -91.55 106.87 18.8 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 106.443 -1.688 . . . . 75.209999999999994 106.443 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.6 tt -104.08 123.17 46.77 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.173 -1.047 . . . . 55.409999999999997 108.173 -172.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -90.5 128.18 36.46 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.233 -1.025 . . . . 72.420000000000002 108.233 175.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.628 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -140.88 149.76 42.36 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 123.788 0.835 . . . . 73.420000000000002 109.314 -172.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -119.93 122.3 40.92 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.667 -0.864 . . . . 62.43 108.667 -175.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.736 ' HB2' HD12 ' A' ' 97' ' ' ILE . 3.9 pp -99.63 108.03 48.83 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 106.912 -1.514 . . . . 74.209999999999994 106.912 173.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.524 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 63.1 Cg_endo -71.59 112.18 3.3 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 121.838 1.692 . . . . 74.400000000000006 108.373 169.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.466 HD21 HD12 ' A' ' 149' ' ' ILE . 32.8 tp -100.55 142.84 31.46 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.216 -1.031 . . . . 71.129999999999995 108.216 -170.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.479 HG21 ' H ' ' A' ' 95' ' ' SER . 1.9 t -79.47 145.1 33.44 Favored 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 107.941 -1.133 . . . . 51.219999999999999 107.941 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.84 -28.73 69.69 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.389 0.676 . . . . 74.340000000000003 112.479 -170.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.84 -41.16 97.88 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.601 -0.727 . . . . 72.239999999999995 109.794 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -75.99 -31.29 58.9 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.879 0.872 . . . . 71.319999999999993 112.461 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.32 -40.35 77.73 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.415 0.626 . . . . 53.439999999999998 110.272 169.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -73.93 -48.22 32.25 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-N 114.432 -1.258 . . . . 70.430000000000007 111.876 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -76.13 -51.33 12.4 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 120.722 0.296 . . . . 74.340000000000003 111.137 -171.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.623 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 67.33 69.1 1.45 Allowed Glycine 0 C--N 1.348 1.24 0 CA-C-N 115.25 -0.887 . . . . 71.510000000000005 113.478 -178.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -131.84 -154.65 7.8 Favored Glycine 0 N--CA 1.477 1.367 0 N-CA-C 111.684 -0.566 . . . . 71.230000000000004 111.684 178.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -70.96 114.31 8.88 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.101 -0.703 . . . . 64.200000000000003 109.101 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.522 HH11 ' HA ' ' A' ' 96' ' ' THR . 8.0 tpp180 -112.07 122.19 47.07 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.326 -0.99 . . . . 54.149999999999999 108.326 175.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 78.1 t -78.82 131.46 34.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-N 113.828 -1.533 . . . . 72.540000000000006 110.406 -177.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.9 p -136.91 122.17 26.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 124.287 1.035 . . . . 73.0 108.58 173.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -121.41 114.62 21.54 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.231 0.612 . . . . 74.150000000000006 111.088 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.4 m -148.89 146.78 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.681 1.592 . . . . 74.430000000000007 109.683 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 66.38 27.41 9.97 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.725 1.21 . . . . 62.439999999999998 110.848 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.23 15.64 72.53 Favored Glycine 0 C--N 1.356 1.687 0 CA-C-N 115.787 -0.642 . . . . 72.209999999999994 113.338 -176.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -124.26 129.37 50.64 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.002 0.921 . . . . 71.319999999999993 109.547 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 32.4 ttp180 -110.17 120.35 42.17 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.083 0.553 . . . . 71.530000000000001 110.217 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.1 p -122.34 146.18 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 123.95 0.9 . . . . 64.540000000000006 109.787 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 47.5 t -100.5 113.16 25.72 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.581 -0.896 . . . . 60.030000000000001 108.581 174.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.8 p -102.5 113.72 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 109.215 -0.661 . . . . 75.0 109.215 174.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 55.1 ttt85 -75.75 104.69 6.41 Favored 'General case' 0 C--N 1.35 0.625 0 N-CA-C 108.698 -0.853 . . . . 71.109999999999999 108.698 174.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.623 HG13 ' HA2' ' A' ' 133' ' ' GLY . 12.2 pt -81.52 145.24 54.53 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 124.524 1.129 . . . . 73.109999999999999 109.67 175.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.56 148.95 73.69 Favored 'Trans proline' 0 CA--C 1.565 2.036 0 C-N-CA 122.403 2.069 . . . . 63.119999999999997 112.982 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.59 118.95 5.86 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.87 2.38 . . . . 70.349999999999994 111.628 174.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 88.04 23.44 38.13 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-O 119.724 -0.487 . . . . 65.310000000000002 112.414 -175.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.433 HG11 ' HB ' ' A' ' 149' ' ' ILE . 3.9 p -62.89 120.34 9.2 Favored 'Isoleucine or valine' 0 C--N 1.361 1.105 0 C-N-CA 123.343 0.657 . . . . 62.009999999999998 109.689 176.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.546 ' HA ' HD12 ' A' ' 180' ' ' LEU . 66.0 mtt85 -123.73 159.55 29.19 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.564 0.746 . . . . 75.340000000000003 111.006 -173.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -38.53 127.26 1.46 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.036 2.134 . . . . 65.129999999999995 113.794 -173.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 101.94 -9.66 56.74 Favored Glycine 0 C--N 1.355 1.625 0 CA-C-O 119.017 -0.879 . . . . 74.219999999999999 114.622 174.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.3 t -69.14 120.18 14.58 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 117.799 0.799 . . . . 72.420000000000002 109.45 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 57.3 t -104.72 114.62 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.217 0.607 . . . . 73.340000000000003 109.943 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 51.7 mt -91.86 100.9 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 107.783 -1.191 . . . . 73.409999999999997 107.783 172.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.483 HH11 HD21 ' A' ' 175' ' ' LEU . 57.9 ttt85 -84.0 103.71 13.47 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.954 -0.758 . . . . 72.129999999999995 108.954 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.72 120.31 47.64 Favored Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 123.137 0.575 . . . . 71.239999999999995 110.051 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 92.4 Cg_endo -74.79 149.71 38.15 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.751 2.3 . . . . 72.129999999999995 113.028 -173.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 75.03 -0.3 58.9 Favored Glycine 0 N--CA 1.473 1.149 0 N-CA-C 114.451 0.541 . . . . 70.209999999999994 114.451 174.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 85.8 mmm -98.02 -25.34 14.99 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.935 0.894 . . . . 71.25 110.7 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.401 ' N ' ' HB2' ' A' ' 174' ' ' LEU . . . -79.98 -82.24 0.74 Allowed Glycine 0 C--N 1.348 1.234 0 N-CA-C 111.226 -0.75 . . . . 51.409999999999997 111.226 176.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 117' ' ' ARG . . . -61.26 94.38 0.08 OUTLIER Glycine 0 C--N 1.345 1.062 0 O-C-N 124.171 0.571 . . . . 72.219999999999999 113.221 174.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -88.13 114.65 24.95 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.015 0.926 . . . . 72.099999999999994 109.347 175.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 158.48 -149.84 20.26 Favored Glycine 0 N--CA 1.466 0.666 0 N-CA-C 111.213 -0.755 . . . . 61.049999999999997 111.213 -177.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -72.57 -52.31 6.55 Favored Pre-proline 0 CA--C 1.559 1.299 0 CA-C-O 118.019 -0.991 . . . . 74.109999999999999 111.188 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -83.88 112.42 1.78 Allowed 'Trans proline' 0 C--N 1.391 2.772 0 C-N-CA 121.733 1.622 . . . . 73.230000000000004 111.293 174.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.58 125.61 12.44 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 121.895 1.73 . . . . 44.109999999999999 111.448 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -116.29 156.52 15.58 Favored Glycine 0 C--N 1.342 0.88 0 N-CA-C 111.708 -0.557 . . . . 54.049999999999997 111.708 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 5.8 m-20 -79.61 159.46 26.78 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.339 0.656 . . . . 63.109999999999999 111.4 -175.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.401 ' HB2' ' N ' ' A' ' 165' ' ' GLY . 32.4 tp -127.12 113.16 16.03 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 114.643 -1.162 . . . . 45.32 108.061 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.483 HD21 HH11 ' A' ' 160' ' ' ARG . 86.6 mt -81.86 101.64 10.34 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.472 -0.936 . . . . 64.400000000000006 108.472 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.692 ' HB3' HD23 ' A' ' 123' ' ' LEU . 54.2 mt -90.36 97.11 10.99 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.93 -0.767 . . . . 71.140000000000001 108.93 177.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.48 118.88 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 O-C-N 121.759 -0.588 . . . . 73.450000000000003 109.611 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 14.0 p -67.55 132.52 32.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.815 0 C-N-CA 123.778 0.831 . . . . 60.329999999999998 109.839 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.524 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 17.6 mmm-85 -122.12 104.95 9.84 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.745 0.818 . . . . 73.420000000000002 109.182 -176.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.546 HD12 ' HA ' ' A' ' 154' ' ' ARG . 83.0 mt -109.79 147.82 32.57 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.49 0.716 . . . . 61.140000000000001 111.227 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 89.1 mt -74.21 155.44 88.07 Favored Pre-proline 0 CA--C 1.557 1.217 0 CA-C-N 114.527 -1.215 . . . . 65.230000000000004 109.496 175.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -74.95 19.39 0.49 Allowed 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 123.19 2.593 . . . . 61.5 114.549 -175.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 . . . . . 0 CA--C 1.556 1.192 0 C-N-CA 124.392 1.077 . . . . 70.439999999999998 109.537 177.061 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.403 ' N ' ' SD ' ' A' ' 94' ' ' MET . 3.4 mpp? . . . . . 0 N--CA 1.482 1.129 0 N-CA-C 109.164 -0.68 . . . . 75.120000000000005 109.164 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.8 m -66.85 138.24 57.18 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.362 -0.835 . . . . 33.340000000000003 111.835 -177.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 47.3 m -74.81 150.09 39.42 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.576 -0.738 . . . . 74.25 109.073 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.664 HD12 ' HB2' ' A' ' 123' ' ' LEU . 23.5 pt -125.02 171.39 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 123.377 0.671 . . . . 73.340000000000003 110.705 -170.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -133.55 134.33 43.23 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.584 0.753 . . . . 74.400000000000006 110.27 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.579 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.3 tp -84.47 176.2 8.81 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.334 1.053 . . . . 74.430000000000007 109.069 -174.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -101.07 -48.15 4.52 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.41 0.284 . . . . 52.200000000000003 111.75 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.7 mt 57.36 70.45 0.65 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.113 0.965 . . . . 64.099999999999994 110.937 -168.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 20.8 mt -87.4 151.89 51.55 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-N 115.17 -0.923 . . . . 62.32 108.772 174.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -64.86 169.32 11.89 Favored 'Trans proline' 0 CA--C 1.558 1.675 0 C-N-CA 121.924 1.75 . . . . 64.25 111.943 174.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.409 HD23 ' H ' ' A' ' 104' ' ' LEU . 2.3 pt? -59.43 -31.81 69.62 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.109 0.564 . . . . 72.409999999999997 111.048 175.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -97.71 71.41 0.68 Allowed Glycine 0 C--N 1.345 1.034 0 N-CA-C 110.893 -0.883 . . . . 74.200000000000003 110.893 168.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 33.1 m -57.91 -50.32 73.73 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.719 0.808 . . . . 73.040000000000006 111.772 -175.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -101.82 37.97 3.39 Favored Glycine 0 C--N 1.344 1.02 0 CA-C-N 116.199 -0.455 . . . . 73.540000000000006 112.488 177.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.35 12.54 83.53 Favored Glycine 0 C--N 1.345 1.064 0 CA-C-O 119.969 -0.351 . . . . 70.109999999999999 113.918 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.7 p -71.09 145.66 49.72 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.584 0.753 . . . . 71.430000000000007 110.985 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -82.65 80.97 1.75 Allowed Glycine 0 C--N 1.35 1.33 0 N-CA-C 111.922 -0.471 . . . . 72.030000000000001 111.922 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.67 157.55 47.86 Favored Glycine 0 C--N 1.349 1.275 0 O-C-N 123.82 0.365 . . . . 65.140000000000001 113.813 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 74.9 p -131.29 127.37 37.61 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.399 0.68 . . . . 71.319999999999993 110.757 -173.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 179.12 122.81 0.78 Allowed Glycine 0 C--N 1.345 1.043 0 CA-C-O 119.605 -0.553 . . . . 55.299999999999997 111.955 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -75.63 -88.87 0.25 Allowed Glycine 0 C--N 1.355 1.605 0 CA-C-N 116.903 0.352 . . . . 44.32 112.473 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 60.3 p -82.58 -26.93 31.9 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.19 0.596 . . . . 74.409999999999997 110.203 175.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -91.38 93.6 1.85 Allowed Glycine 0 C--N 1.343 0.958 0 N-CA-C 111.015 -0.834 . . . . 62.009999999999998 111.015 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.515 ' O ' ' HA3' ' A' ' 172' ' ' GLY . 38.5 ttm180 -90.54 120.9 32.02 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.047 0.539 . . . . 75.209999999999994 110.149 176.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -77.84 144.94 36.61 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.11 0.481 . . . . 73.349999999999994 109.972 178.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.3 tt -136.72 113.22 10.06 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 105.551 -2.018 . . . . 73.420000000000002 105.551 172.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 34.9 ttt180 -93.8 123.09 36.91 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 108.486 -0.931 . . . . 74.439999999999998 108.486 -177.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.579 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -140.53 131.49 26.11 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 123.534 0.734 . . . . 71.510000000000005 109.342 -172.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -117.63 128.79 55.28 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 110.05 -0.352 . . . . 74.120000000000005 110.05 -169.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.664 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.0 pp -108.16 117.77 54.1 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 123.062 0.545 . . . . 70.25 110.107 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.492 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 68.0 Cg_endo -73.33 113.75 3.86 Favored 'Trans proline' 0 C--N 1.364 1.347 0 C-N-CA 122.451 2.101 . . . . 72.200000000000003 109.088 168.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.587 HD21 HD12 ' A' ' 149' ' ' ILE . 50.6 tp -103.8 147.94 26.69 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 122.794 0.438 . . . . 73.010000000000005 110.015 -166.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.8 t -85.22 149.31 25.59 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 109.018 -0.734 . . . . 63.340000000000003 109.018 -177.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.9 mt -63.06 -30.8 71.88 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.587 0.755 . . . . 65.400000000000006 112.441 -171.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.04 -49.61 76.68 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 109.48 -0.563 . . . . 70.329999999999998 109.48 177.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -72.97 -31.69 64.71 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 114.818 -1.083 . . . . 72.430000000000007 112.164 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.53 -38.08 80.06 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.747 0.654 . . . . 72.439999999999998 110.472 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -73.52 -52.82 12.24 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.027 -0.988 . . . . 74.150000000000006 110.846 174.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -62.52 -49.69 74.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 123.531 0.52 . . . . 75.519999999999996 112.379 -169.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.579 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 67.86 52.16 30.56 Favored Glycine 0 C--N 1.34 0.751 0 O-C-N 123.853 0.721 . . . . 71.120000000000005 112.971 -172.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.438 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -113.05 -163.13 15.54 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 112.077 -0.409 . . . . 54.229999999999997 112.077 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.65 115.42 20.91 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 108.934 -0.765 . . . . 71.349999999999994 108.934 175.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -113.45 124.08 51.57 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.577 0.751 . . . . 73.340000000000003 109.323 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 86.0 t -72.06 127.97 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-N 114.198 -1.365 . . . . 43.299999999999997 109.721 175.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.446 HG22 ' HB2' ' A' ' 99' ' ' LEU . 6.1 p -134.26 111.15 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 124.151 0.981 . . . . 74.409999999999997 108.838 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -103.36 134.73 46.25 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.667 0.787 . . . . 73.310000000000002 109.988 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.9 p -152.35 132.06 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.245 1.018 . . . . 61.039999999999999 109.887 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.37 18.0 8.88 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.348 1.059 . . . . 74.150000000000006 112.506 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.67 -8.83 71.29 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 116.26 -0.427 . . . . 63.439999999999998 113.327 -175.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -92.25 118.39 30.83 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.708 0.803 . . . . 72.019999999999996 110.498 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.5 ttp180 -98.39 120.78 39.4 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.449 1.1 . . . . 75.019999999999996 109.485 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 40.5 t -123.41 125.71 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.054 0.942 . . . . 73.230000000000004 109.346 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.9 t -97.53 112.64 24.41 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.867 -0.79 . . . . 74.25 108.867 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.4 139.14 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.133 0.573 . . . . 75.409999999999997 111.013 -175.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -83.72 110.37 18.25 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.887 -0.783 . . . . 74.099999999999994 108.887 174.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.587 HD12 HD21 ' A' ' 125' ' ' LEU . 9.3 pt -89.55 151.46 46.01 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 124.29 1.036 . . . . 73.129999999999995 110.026 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -67.31 139.57 50.34 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.687 2.258 . . . . 72.340000000000003 112.603 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -65.5 131.85 29.26 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.561 2.174 . . . . 74.329999999999998 111.126 169.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 69.71 29.9 70.95 Favored Glycine 0 C--N 1.343 0.966 0 O-C-N 123.55 0.531 . . . . 65.349999999999994 112.391 -177.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 9.6 p -64.82 148.12 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 124.058 0.943 . . . . 70.140000000000001 110.007 178.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.4 ' HA ' HD12 ' A' ' 180' ' ' LEU . 24.4 mtp180 -134.44 161.75 34.16 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.991 0.516 . . . . 64.340000000000003 110.281 -178.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -44.59 134.71 5.23 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 125.73 1.612 . . . . 55.329999999999998 113.525 -174.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 83.9 3.85 89.01 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 115.746 -0.661 . . . . 51.340000000000003 114.322 176.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.3 t -71.87 121.11 18.45 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 108.412 -0.959 . . . . 45.219999999999999 108.412 174.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.4 t -104.74 114.71 45.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 O-C-N 123.738 0.649 . . . . 74.25 110.603 -175.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 60.8 mt -89.9 102.26 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 107.328 -1.36 . . . . 55.210000000000001 107.328 174.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -87.63 105.45 17.35 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 122.992 0.517 . . . . 73.230000000000004 109.826 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.2 p -111.17 119.64 45.11 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 123.064 0.545 . . . . 63.549999999999997 109.704 175.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.43 153.14 49.98 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 122.247 1.964 . . . . 73.409999999999997 112.044 -177.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.36 -4.12 50.51 Favored Glycine 0 C--N 1.344 0.979 0 N-CA-C 115.208 0.843 . . . . 71.049999999999997 115.208 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 95.9 mmm -102.83 -13.26 17.06 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 117.645 0.723 . . . . 75.219999999999999 110.643 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -86.31 -96.1 0.81 Allowed Glycine 0 C--N 1.355 1.584 0 N-CA-C 111.823 -0.511 . . . . 41.210000000000001 111.823 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -57.28 98.29 0.08 OUTLIER Glycine 0 C--N 1.349 1.255 0 O-C-N 123.972 0.454 . . . . 64.540000000000006 112.319 171.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -88.09 153.89 20.9 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.521 1.128 . . . . 60.119999999999997 109.581 174.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 118.93 -144.17 17.75 Favored Glycine 0 N--CA 1.468 0.794 0 N-CA-C 110.976 -0.85 . . . . 63.25 110.976 -177.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -75.32 -47.36 4.4 Favored Pre-proline 0 CA--C 1.56 1.328 0 CA-C-O 117.97 -1.015 . . . . 72.549999999999997 110.944 168.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -76.47 113.55 3.69 Favored 'Trans proline' 0 C--N 1.395 2.98 0 C-N-CA 121.609 1.539 . . . . 72.340000000000003 112.241 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -82.8 126.77 4.64 Favored 'Trans proline' 0 C--N 1.385 2.461 0 C-N-CA 122.387 2.058 . . . . 74.129999999999995 111.787 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 117' ' ' ARG . . . -130.09 -179.37 15.98 Favored Glycine 0 N--CA 1.463 0.489 0 CA-C-N 116.758 -0.201 . . . . 62.109999999999999 113.181 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -100.92 131.26 46.88 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.817 0.847 . . . . 54.43 110.924 -168.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 29.8 tp -92.51 110.35 21.77 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 108.55 -0.908 . . . . 73.030000000000001 108.55 176.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 60.2 mt -91.19 99.7 12.65 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.49 0.716 . . . . 61.009999999999998 109.367 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.554 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 96.2 mt -88.87 99.85 12.71 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.621 0.369 . . . . 71.310000000000002 111.022 -175.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 38.8 t -87.51 114.56 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 109.261 -0.644 . . . . 74.400000000000006 109.261 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.425 HG22 ' HG ' ' A' ' 180' ' ' LEU . 12.1 p -73.02 132.98 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 CA-C-O 121.188 0.518 . . . . 74.209999999999994 109.843 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.492 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 37.6 mmt180 -115.21 101.42 8.94 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.86 -1.163 . . . . 64.200000000000003 107.86 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.425 ' HG ' HG22 ' A' ' 178' ' ' VAL . 38.8 mt -108.23 141.67 39.65 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.005 0.431 . . . . 72.230000000000004 111.369 -176.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 65.3 mt -73.81 110.98 10.38 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 114.464 -1.244 . . . . 65.340000000000003 107.664 172.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -61.83 -23.97 76.71 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.951 2.434 . . . . 62.409999999999997 113.554 -171.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 47.2 m80 . . . . . 0 CA--C 1.546 0.809 0 N-CA-C 107.61 -1.256 . . . . 74.409999999999997 107.61 177.666 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.454 ' O ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.582 0 CA-C-O 121.564 0.697 . . . . 62.119999999999997 109.793 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.7 t -77.14 133.41 38.99 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.579 -0.737 . . . . 71.540000000000006 110.726 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 52.3 m -73.67 145.28 45.39 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.152 0.981 . . . . 63.119999999999997 110.308 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.61 HD12 ' HB2' ' A' ' 123' ' ' LEU . 18.2 pt -118.01 162.23 16.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 C-N-CA 123.223 0.609 . . . . 74.439999999999998 110.681 -172.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.408 ' O ' ' HD2' ' A' ' 124' ' ' PRO . . . -104.05 177.63 4.79 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.048 0.939 . . . . 52.530000000000001 108.952 170.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.598 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.4 tp -113.67 -133.77 0.34 Allowed 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 107.147 -1.427 . . . . 62.539999999999999 107.147 177.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.49 -43.47 0.06 Allowed 'General case' 0 C--N 1.345 0.412 0 N-CA-C 109.107 -0.701 . . . . 71.329999999999998 109.107 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 84.3 mt 53.81 64.08 1.96 Allowed 'General case' 0 C--N 1.362 1.129 0 O-C-N 124.438 1.086 . . . . 74.239999999999995 110.117 -172.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 61.0 mt -63.54 159.72 49.14 Favored Pre-proline 0 CA--C 1.55 0.968 0 CA-C-N 113.995 -1.457 . . . . 64.150000000000006 109.717 176.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -55.53 158.7 12.39 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.056 1.837 . . . . 71.439999999999998 112.19 173.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.5 pp -57.57 134.76 56.41 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.697 0.799 . . . . 71.400000000000006 110.163 -177.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -97.93 -153.01 28.68 Favored Glycine 0 C--N 1.334 0.421 0 N-CA-C 112.416 -0.274 . . . . 74.340000000000003 112.416 -174.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 53.6 p -110.36 27.53 9.54 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.058 0.943 . . . . 71.200000000000003 110.113 175.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.36 -35.15 75.67 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 115.858 -0.61 . . . . 74.430000000000007 112.682 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -82.12 62.47 4.55 Favored Glycine 0 C--N 1.351 1.381 0 C-N-CA 123.137 0.399 . . . . 33.140000000000001 112.628 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 52.8 m -109.2 28.65 8.29 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.374 1.07 . . . . 72.049999999999997 110.434 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -81.61 64.34 4.21 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 116.133 -0.485 . . . . 63.200000000000003 112.454 176.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 66.63 -87.63 0.13 Allowed Glycine 0 C--N 1.35 1.31 0 C-N-CA 123.514 0.578 . . . . 24.010000000000002 112.009 -177.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.8 p -169.41 61.02 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.699 1.2 . . . . 65.239999999999995 108.948 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -58.51 -31.83 67.58 Favored Glycine 0 C--N 1.355 1.631 0 CA-C-N 115.733 -0.667 . . . . 54.520000000000003 113.719 -176.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 155.02 -84.14 0.15 Allowed Glycine 0 C--N 1.348 1.248 0 N-CA-C 110.664 -0.974 . . . . 64.519999999999996 110.664 176.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 36.1 p -158.65 24.93 0.23 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.832 0.853 . . . . 71.219999999999999 110.293 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.76 95.96 0.09 OUTLIER Glycine 0 C--N 1.357 1.714 0 N-CA-C 111.208 -0.757 . . . . 74.409999999999997 111.208 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 -74.61 116.65 15.55 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.647 0.779 . . . . 61.340000000000003 111.478 -170.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -83.43 119.7 24.99 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 108.093 -1.077 . . . . 63.140000000000001 108.093 169.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.3 tt -103.81 121.41 42.99 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.158 -1.793 . . . . 62.210000000000001 106.158 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -89.79 133.38 34.74 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.121 -1.066 . . . . 74.430000000000007 108.121 -177.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.598 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -154.56 146.66 23.68 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.252 0.621 . . . . 52.539999999999999 109.579 -175.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -128.19 135.0 49.12 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.502 -0.555 . . . . 73.209999999999994 109.502 -175.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.61 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.4 pp -112.53 116.96 47.78 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 109.88 -0.415 . . . . 73.109999999999999 109.88 178.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.529 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 70.2 Cg_endo -72.87 115.32 4.3 Favored 'Trans proline' 0 C--N 1.36 1.141 0 C-N-CA 122.498 2.132 . . . . 60.130000000000003 108.592 169.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.567 HD21 HD12 ' A' ' 149' ' ' ILE . 43.3 tp -104.26 148.4 26.38 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.933 -0.395 . . . . 74.329999999999998 109.933 -167.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.3 t -88.94 156.5 18.86 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 109.134 -0.691 . . . . 72.209999999999994 109.134 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.3 mt -64.42 -32.95 74.79 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.709 0.804 . . . . 72.120000000000005 112.631 -173.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.52 -46.7 87.23 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 124.168 0.918 . . . . 72.549999999999997 109.752 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -74.68 -34.09 62.6 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.041 -0.981 . . . . 71.0 111.519 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.97 -34.23 73.02 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.169 0.509 . . . . 60.5 110.518 173.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -76.55 -54.07 7.2 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 114.913 -1.04 . . . . 74.430000000000007 110.846 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -62.88 -50.35 71.24 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 122.829 0.452 . . . . 64.439999999999998 111.285 -174.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.571 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 70.04 58.27 6.32 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 114.963 -1.017 . . . . 62.539999999999999 111.369 -169.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.41 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -121.7 -175.18 14.9 Favored Glycine 0 C--N 1.346 1.091 0 N-CA-C 112.463 -0.255 . . . . 64.040000000000006 112.463 -175.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -76.1 113.61 13.82 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.463 -0.94 . . . . 53.420000000000002 108.463 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -111.18 124.61 52.54 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.163 -1.051 . . . . 74.430000000000007 108.163 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.469 HG13 ' HG3' ' A' ' 144' ' ' ARG . 94.9 t -70.34 124.31 26.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 114.466 -1.243 . . . . 65.400000000000006 109.124 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.428 HG11 HD13 ' A' ' 99' ' ' LEU . 34.5 t -117.77 130.14 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 107.83 -1.174 . . . . 75.409999999999997 107.83 177.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -123.71 122.21 37.5 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 118.1 0.409 . . . . 70.049999999999997 110.409 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.417 HG11 ' HB3' ' A' ' 99' ' ' LEU . 0.8 OUTLIER -149.99 128.73 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 124.855 1.262 . . . . 72.030000000000001 109.913 174.478 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.82 20.1 12.05 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.818 1.247 . . . . 74.049999999999997 112.203 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.12 9.14 82.77 Favored Glycine 0 C--N 1.355 1.595 0 CA-C-N 116.416 -0.357 . . . . 75.109999999999999 113.116 -175.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -101.19 120.21 39.9 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.706 1.202 . . . . 71.329999999999998 109.214 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.469 ' HG3' HG13 ' A' ' 137' ' ' VAL . 48.1 ttp180 -99.0 109.59 22.32 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.973 0.909 . . . . 74.540000000000006 109.747 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 53.8 t -107.99 112.38 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.566 -0.901 . . . . 75.530000000000001 108.566 172.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 48.2 t -91.54 104.16 16.69 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.213 -1.032 . . . . 61.0 108.213 174.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.1 p -100.94 119.17 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.521 0.729 . . . . 65.030000000000001 110.441 -175.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -73.74 101.06 3.57 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.334 -0.988 . . . . 73.409999999999997 108.334 167.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.571 HG13 ' HA2' ' A' ' 133' ' ' GLY . 10.0 pt -81.33 151.59 69.47 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 123.97 0.908 . . . . 70.430000000000007 109.675 175.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.447 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 64.5 Cg_endo -73.62 144.75 36.15 Favored 'Trans proline' 0 CA--C 1.559 1.763 0 C-N-CA 122.088 1.859 . . . . 61.409999999999997 112.556 177.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 150' ' ' PRO . 37.7 Cg_exo -63.18 124.5 14.0 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.18 2.587 . . . . 63.039999999999999 112.345 177.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 80.18 23.16 61.69 Favored Glycine 0 C--N 1.343 0.947 0 O-C-N 123.448 0.468 . . . . 75.430000000000007 112.906 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.5 p -57.57 145.99 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 124.536 1.135 . . . . 70.409999999999997 110.685 177.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -138.11 162.17 34.88 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.79 0.836 . . . . 65.310000000000002 110.547 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -43.85 129.13 5.71 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 126.366 1.866 . . . . 74.340000000000003 112.694 -174.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.17 -3.11 59.9 Favored Glycine 0 C--N 1.35 1.318 0 O-C-N 123.63 0.581 . . . . 75.219999999999999 113.81 176.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 52.2 m -69.81 119.68 14.4 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 117.724 0.762 . . . . 70.319999999999993 110.148 175.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 45.0 t -103.34 109.09 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.243 0.617 . . . . 72.230000000000004 110.026 -178.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 58.5 mt -91.25 101.92 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.438 1.095 . . . . 74.510000000000005 108.14 172.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -89.62 103.03 15.71 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.918 -0.771 . . . . 74.409999999999997 108.918 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.8 p -103.77 105.49 48.12 Favored Pre-proline 0 CA--C 1.561 1.367 0 C-N-CA 123.228 0.611 . . . . 71.430000000000007 110.316 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -66.44 146.77 81.2 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 123.093 2.528 . . . . 54.109999999999999 113.514 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 81.83 0.13 89.03 Favored Glycine 0 C--N 1.346 1.111 0 CA-C-N 115.603 -0.726 . . . . 71.349999999999994 113.666 176.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.8 mmt -101.66 -24.6 14.08 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 117.598 0.699 . . . . 74.140000000000001 111.529 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -81.84 -87.68 0.67 Allowed Glycine 0 C--N 1.347 1.171 0 CA-C-O 119.822 -0.432 . . . . 70.010000000000005 112.612 -175.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -62.65 93.49 0.1 OUTLIER Glycine 0 C--N 1.352 1.468 0 O-C-N 124.056 0.504 . . . . 61.100000000000001 112.247 174.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -88.86 158.13 18.21 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.152 0.981 . . . . 73.109999999999999 109.417 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 96.85 -142.57 16.25 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-O 119.623 -0.543 . . . . 73.340000000000003 111.879 -176.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -68.84 -53.88 14.09 Favored Pre-proline 0 CA--C 1.567 1.634 0 CA-C-O 118.032 -0.985 . . . . 73.299999999999997 112.389 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -83.92 108.51 1.41 Allowed 'Trans proline' 0 C--N 1.394 2.931 0 C-N-CA 121.709 1.606 . . . . 63.039999999999999 112.149 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.28 127.22 11.02 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.85 2.366 . . . . 63.409999999999997 110.953 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -141.19 176.27 21.78 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-N 116.443 -0.344 . . . . 74.25 112.808 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -100.33 162.21 13.1 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.279 1.032 . . . . 74.25 111.373 -172.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 37.7 tp -117.05 112.7 21.29 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 124.588 1.155 . . . . 74.430000000000007 108.033 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 66.9 mt -84.02 100.3 10.98 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.745 -0.835 . . . . 70.349999999999994 108.745 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.519 HD22 HD11 ' A' ' 99' ' ' LEU . 91.9 mt -96.89 99.7 11.24 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.075 0.55 . . . . 75.329999999999998 110.083 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.6 p -93.55 125.58 46.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 N-CA-C 109.444 -0.576 . . . . 74.120000000000005 109.444 176.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.8 137.63 23.07 Favored 'Isoleucine or valine' 0 C--O 1.249 1.043 0 C-N-CA 123.299 0.639 . . . . 70.209999999999994 109.5 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.529 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 22.3 mmm-85 -115.81 97.84 6.34 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.817 -0.809 . . . . 73.120000000000005 108.817 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 55.1 mt -119.56 131.9 55.62 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.91 0.884 . . . . 74.310000000000002 109.669 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 90.6 mt -62.01 138.81 95.83 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 115.349 -0.841 . . . . 73.439999999999998 110.713 -175.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -50.92 -35.21 48.76 Favored 'Trans proline' 0 C--N 1.385 2.456 0 C-N-CA 123.762 2.975 . . . . 74.400000000000006 113.332 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 . . . . . 0 C--O 1.253 1.275 0 N-CA-C 107.785 -1.191 . . . . 65.010000000000005 107.785 168.831 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.427 ' SD ' ' N ' ' A' ' 94' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 109.086 -0.709 . . . . 75.150000000000006 109.086 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.3 m -67.84 115.97 7.98 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.449 -0.574 . . . . 65.310000000000002 109.449 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 98.6 m -65.18 144.83 56.94 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.702 0.801 . . . . 71.430000000000007 110.737 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.663 HD12 ' HB2' ' A' ' 123' ' ' LEU . 11.2 pt -117.41 161.07 16.5 Favored 'Isoleucine or valine' 0 C--O 1.245 0.854 0 CA-C-N 115.659 -0.7 . . . . 74.299999999999997 109.23 -174.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -136.69 129.7 31.02 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.725 0.81 . . . . 42.420000000000002 109.159 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.679 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.2 tp -68.78 149.67 48.74 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.956 1.303 . . . . 74.150000000000006 109.935 -174.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.22 -34.58 55.98 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.519 0.328 . . . . 73.209999999999994 110.949 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 70.3 mt 52.1 69.31 0.69 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.064 0.946 . . . . 71.430000000000007 111.059 -175.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 63.2 mt -69.14 161.09 75.45 Favored Pre-proline 0 CA--C 1.558 1.277 0 CA-C-N 115.33 -0.85 . . . . 70.420000000000002 109.913 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -62.28 164.18 18.23 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.241 1.961 . . . . 73.430000000000007 112.941 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.416 ' HB3' ' HD2' ' A' ' 117' ' ' ARG . 3.6 pp -64.1 126.65 28.41 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.953 -0.758 . . . . 55.43 108.953 175.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -145.32 -115.77 0.99 Allowed Glycine 0 C--N 1.338 0.691 0 N-CA-C 111.582 -0.607 . . . . 74.430000000000007 111.582 -170.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.5 t -98.68 115.19 28.16 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 108.615 -0.883 . . . . 73.230000000000004 108.615 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -171.5 -173.31 38.34 Favored Glycine 0 C--N 1.343 0.948 0 O-C-N 123.717 0.636 . . . . 74.230000000000004 111.835 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.15 21.85 77.37 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-O 120.008 -0.329 . . . . 53.020000000000003 113.426 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 70.2 p -80.6 110.39 16.03 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 109.773 -0.454 . . . . 73.129999999999995 109.773 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 167.94 132.13 1.38 Allowed Glycine 0 C--N 1.334 0.432 0 N-CA-C 110.56 -1.016 . . . . 73.120000000000005 110.56 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -79.56 66.54 3.5 Favored Glycine 0 C--N 1.346 1.095 0 C-N-CA 122.847 0.26 . . . . 42.340000000000003 112.508 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.5 t -158.77 35.26 0.22 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.297 1.039 . . . . 74.519999999999996 108.731 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 83.05 166.66 39.94 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.509 -0.769 . . . . 73.019999999999996 113.593 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -147.95 35.77 1.16 Allowed Glycine 0 C--N 1.354 1.552 0 C-N-CA 122.881 0.277 . . . . 50.329999999999998 112.505 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 73.6 m -81.72 71.41 8.74 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.482 0.658 . . . . 75.439999999999998 109.794 174.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -177.55 137.33 3.39 Favored Glycine 0 C--O 1.24 0.515 0 N-CA-C 110.362 -1.095 . . . . 44.109999999999999 110.362 -177.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.598 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 11.8 tpp180 -70.38 116.14 10.37 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 123.297 0.639 . . . . 72.409999999999997 110.103 -177.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -73.8 128.2 34.87 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 114.839 -1.073 . . . . 72.239999999999995 109.102 175.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.4 tt -134.79 114.85 13.04 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.335 -1.728 . . . . 72.319999999999993 106.335 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -90.31 138.05 31.85 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 107.605 -1.257 . . . . 75.430000000000007 107.605 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.679 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -157.25 131.83 8.61 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.253 -0.647 . . . . 72.349999999999994 109.253 -170.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -120.73 126.38 50.03 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 109.068 -0.716 . . . . 74.510000000000005 109.068 -170.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.663 ' HB2' HD12 ' A' ' 97' ' ' ILE . 3.9 pp -100.81 118.78 59.99 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 109.325 -0.62 . . . . 72.049999999999997 109.325 -177.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.559 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 74.1 Cg_endo -73.69 111.63 3.34 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.542 2.162 . . . . 53.450000000000003 109.344 171.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.502 HD21 HD12 ' A' ' 149' ' ' ILE . 28.2 tp -102.47 149.77 24.04 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 109.015 -0.735 . . . . 63.409999999999997 109.015 -168.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.6 t -95.57 158.53 15.41 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-N 115.913 -0.585 . . . . 43.329999999999998 109.479 -177.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 82.1 mt -64.3 -30.45 71.5 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.469 0.708 . . . . 73.129999999999995 112.13 -175.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.07 -48.33 82.18 Favored 'General case' 0 C--O 1.216 -0.701 0 O-C-N 123.904 0.753 . . . . 65.400000000000006 109.507 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.478 ' HG3' ' HD2' ' A' ' 136' ' ' ARG . 8.2 mm-40 -75.54 -30.95 59.9 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.51 0.724 . . . . 74.239999999999995 111.367 -175.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.87 -26.11 64.97 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 122.878 0.471 . . . . 61.310000000000002 111.044 174.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -83.96 -47.99 10.43 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.837 0.855 . . . . 72.0 110.452 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -67.68 -49.55 62.21 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.196 0.598 . . . . 65.299999999999997 110.283 -174.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.503 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 62.86 62.17 5.75 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 114.49 -1.232 . . . . 55.450000000000003 112.318 -173.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.26 -163.69 11.27 Favored Glycine 0 C--N 1.34 0.768 0 N-CA-C 111.769 -0.532 . . . . 42.149999999999999 111.769 -177.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -73.6 118.68 16.83 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.379 -0.971 . . . . 72.420000000000002 108.379 177.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.608 HH21 ' HB ' ' A' ' 137' ' ' VAL . 5.8 tpm_? -111.67 122.76 48.68 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.484 -0.932 . . . . 72.219999999999999 108.484 177.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.608 ' HB ' HH21 ' A' ' 136' ' ' ARG . 71.4 t -71.88 113.71 9.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-N 114.576 -1.193 . . . . 62.340000000000003 110.159 176.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.77 110.2 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 106.889 -1.522 . . . . 74.209999999999994 106.889 174.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -118.19 121.23 39.96 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.62 -0.511 . . . . 73.439999999999998 109.62 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 1.5 m -149.34 142.59 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 125.197 1.399 . . . . 62.509999999999998 109.69 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.35 25.58 15.27 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.696 1.198 . . . . 64.140000000000001 111.559 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 73.07 10.76 78.49 Favored Glycine 0 C--N 1.355 1.615 0 CA-C-N 115.681 -0.691 . . . . 75.209999999999994 113.567 -175.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 58.7 ttt85 -114.03 125.0 53.51 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.937 0.895 . . . . 75.409999999999997 109.066 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -105.42 126.08 51.72 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.754 0.822 . . . . 74.409999999999997 109.738 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 4.4 p -127.98 123.35 60.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 124.269 1.027 . . . . 72.420000000000002 108.803 176.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 30.0 t -99.65 104.29 16.04 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.013 -0.736 . . . . 74.420000000000002 109.013 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.1 p -101.0 123.17 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.188 0.595 . . . . 72.340000000000003 110.545 -176.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -76.44 116.06 16.77 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 109.052 -0.721 . . . . 72.540000000000006 109.052 172.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.503 HG13 ' HA2' ' A' ' 133' ' ' GLY . 10.6 pt -96.87 151.02 37.55 Favored Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 124.319 1.047 . . . . 71.0 109.006 175.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.42 145.96 49.11 Favored 'Trans proline' 0 CA--C 1.565 2.048 0 C-N-CA 122.322 2.015 . . . . 65.409999999999997 112.74 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -64.68 114.4 2.73 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 123.248 2.632 . . . . 73.150000000000006 112.105 175.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 87.82 31.26 15.68 Favored Glycine 0 C--N 1.341 0.83 0 O-C-N 123.333 0.396 . . . . 62.43 112.333 -174.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.89 149.85 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.834 0.853 . . . . 75.510000000000005 110.221 173.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -134.41 154.24 51.48 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.665 0.786 . . . . 72.540000000000006 110.756 -174.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -40.51 131.54 2.23 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.726 2.01 . . . . 71.150000000000006 113.397 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.34 -9.81 69.46 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-O 119.215 -0.769 . . . . 31.309999999999999 114.596 175.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 27.1 t -62.34 122.86 16.73 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.394 0.678 . . . . 74.150000000000006 110.067 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.1 t -102.51 109.28 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.58 0.752 . . . . 72.109999999999999 109.832 -177.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 59.5 mt -92.98 113.5 28.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 108.628 -0.878 . . . . 64.019999999999996 108.628 173.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -86.6 116.95 25.06 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.911 0.484 . . . . 63.539999999999999 110.118 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.493 HG13 ' HB3' ' A' ' 174' ' ' LEU . 7.2 p -125.75 102.72 28.49 Favored Pre-proline 0 CA--C 1.564 1.482 0 C-N-CA 123.253 0.621 . . . . 74.319999999999993 110.486 175.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 51.4 Cg_endo -68.15 154.86 71.41 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 123.049 2.5 . . . . 53.219999999999999 112.873 176.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 84.06 -15.15 40.0 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 116.105 -0.498 . . . . 73.209999999999994 114.178 178.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 24.3 mmt -99.02 -13.9 19.68 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.72 0.808 . . . . 65.340000000000003 111.763 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.41 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -79.54 -113.05 0.24 Allowed Glycine 0 C--N 1.351 1.362 0 O-C-N 123.593 0.558 . . . . 72.0 112.623 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.598 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -66.83 117.59 9.46 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.651 0.225 . . . . 73.230000000000004 113.452 177.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -88.42 131.42 34.87 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.636 0.774 . . . . 52.420000000000002 109.737 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 165.55 -160.68 34.13 Favored Glycine 0 N--CA 1.468 0.775 0 N-CA-C 110.316 -1.114 . . . . 53.140000000000001 110.316 -176.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -70.77 -35.84 4.79 Favored Pre-proline 0 CA--C 1.566 1.589 0 CA-C-O 117.715 -1.136 . . . . 73.310000000000002 112.247 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -91.33 128.9 1.21 Allowed 'Trans proline' 0 C--N 1.402 3.362 0 C-N-CA 122.466 2.111 . . . . 64.450000000000003 110.617 170.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.88 122.21 9.32 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 121.413 1.409 . . . . 74.510000000000005 110.844 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -90.81 146.03 18.2 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.722 -0.672 . . . . 54.420000000000002 112.242 -176.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 16.7 t70 -91.38 146.61 23.67 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.934 0.493 . . . . 74.239999999999995 110.239 -176.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.493 ' HB3' HG13 ' A' ' 161' ' ' VAL . 22.5 tp -123.67 111.17 15.88 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.398 0.679 . . . . 72.219999999999999 109.95 -176.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 75.6 mt -90.36 101.01 13.74 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.995 0.918 . . . . 74.109999999999999 110.069 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 79.8 mt -86.22 101.73 13.29 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.501 0.72 . . . . 73.140000000000001 110.664 -177.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 47.4 t -90.65 115.96 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.386 -0.968 . . . . 74.25 108.386 174.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.3 p -71.66 138.88 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 109.814 -0.439 . . . . 62.219999999999999 109.814 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.559 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 27.0 mmt180 -120.05 94.37 4.37 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.8 0.84 . . . . 64.030000000000001 109.229 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 51.7 mt -106.71 140.82 38.95 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.072 -0.967 . . . . 74.230000000000004 109.738 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 90.0 mt -68.67 155.28 93.36 Favored Pre-proline 0 CA--C 1.556 1.202 0 CA-C-N 114.922 -1.036 . . . . 54.119999999999997 110.35 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -76.41 35.66 0.47 Allowed 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 123.178 2.585 . . . . 64.200000000000003 113.574 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 59.2 m80 . . . . . 0 C--O 1.252 1.221 0 N-CA-C 107.683 -1.229 . . . . 73.439999999999998 107.683 176.386 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.591 ' HB2' HH12 ' A' ' 136' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 121.0 0.428 . . . . 64.299999999999997 110.688 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.4 m -80.87 133.33 35.56 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 109.355 -0.609 . . . . 64.329999999999998 109.355 175.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 94.8 m -70.49 145.43 50.93 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 123.482 0.713 . . . . 72.150000000000006 110.746 176.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.602 HD12 ' HB2' ' A' ' 123' ' ' LEU . 23.6 pt -123.15 175.96 5.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 C-N-CA 123.647 0.779 . . . . 72.450000000000003 110.022 -176.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.422 ' O ' ' HD2' ' A' ' 124' ' ' PRO . . . -128.79 167.67 16.98 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.819 0.848 . . . . 35.210000000000001 109.391 176.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.532 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.5 tp -110.41 148.83 31.22 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 108.602 -0.888 . . . . 64.010000000000005 108.602 -177.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.27 -47.21 51.84 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.409 0.284 . . . . 54.450000000000003 110.66 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.6 mt 57.09 75.08 0.38 Allowed 'General case' 0 N--CA 1.478 0.929 0 O-C-N 124.47 1.107 . . . . 72.129999999999995 110.591 -170.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.7 mt -76.74 164.05 61.84 Favored Pre-proline 0 CA--C 1.553 1.076 0 CA-C-N 114.232 -1.349 . . . . 74.450000000000003 109.045 174.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -61.2 168.69 7.29 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 121.858 1.705 . . . . 75.549999999999997 112.812 175.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -58.2 -28.88 65.22 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.232 1.013 . . . . 62.130000000000003 111.12 176.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 62.65 -89.84 0.06 OUTLIER Glycine 0 C--N 1.361 1.947 0 O-C-N 123.937 0.773 . . . . 54.149999999999999 112.223 178.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 33.7 t -141.39 -27.89 0.67 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.105 0.962 . . . . 73.420000000000002 109.716 173.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.41 -82.12 1.29 Allowed Glycine 0 C--N 1.346 1.126 0 CA-C-N 115.815 -0.63 . . . . 73.519999999999996 112.032 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.52 -1.87 41.76 Favored Glycine 0 CA--C 1.534 1.281 0 N-CA-C 114.483 0.553 . . . . 54.219999999999999 114.483 174.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.2 m -90.14 -28.18 19.11 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.413 0.685 . . . . 74.439999999999998 110.569 -174.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -117.11 102.9 1.05 Allowed Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.32 -0.854 . . . . 74.299999999999997 111.105 174.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -60.78 -35.58 90.21 Favored Glycine 0 C--N 1.353 1.52 0 C-N-CA 122.845 0.259 . . . . 45.229999999999997 112.859 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.2 m -93.51 53.05 1.81 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.778 0.831 . . . . 72.310000000000002 109.555 173.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -75.07 81.43 0.91 Allowed Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.204 -0.907 . . . . 63.229999999999997 112.468 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.74 -47.16 0.05 OUTLIER Glycine 0 C--N 1.341 0.807 0 N-CA-C 110.936 -0.866 . . . . 65.420000000000002 110.936 176.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 29.5 m -84.44 5.39 27.5 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.234 0.614 . . . . 71.439999999999998 111.239 176.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -168.68 130.41 2.07 Favored Glycine 0 C--N 1.351 1.399 0 N-CA-C 112.063 -0.415 . . . . 71.519999999999996 112.063 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -94.58 133.87 37.75 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.112 0.565 . . . . 54.009999999999998 110.706 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -83.91 133.18 34.72 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.563 -0.903 . . . . 55.200000000000003 108.563 169.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.5 tt -132.69 134.21 44.52 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 107.452 -1.314 . . . . 74.420000000000002 107.452 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -92.05 127.86 37.68 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.808 -0.812 . . . . 72.200000000000003 108.808 -175.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.532 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -149.75 132.56 16.01 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.86 -0.422 . . . . 72.329999999999998 109.86 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -127.91 125.34 39.41 Favored 'General case' 0 C--O 1.245 0.839 0 N-CA-C 109.743 -0.466 . . . . 74.129999999999995 109.743 -172.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.602 ' HB2' HD12 ' A' ' 97' ' ' ILE . 3.7 pp -101.96 119.88 55.52 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 109.299 -0.63 . . . . 64.010000000000005 109.299 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.422 ' HD2' ' O ' ' A' ' 98' ' ' ALA . 62.8 Cg_endo -72.74 115.34 4.31 Favored 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 122.721 2.28 . . . . 73.209999999999994 108.985 167.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.431 HD21 HD12 ' A' ' 149' ' ' ILE . 47.7 tp -102.2 150.26 23.47 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 109.79 -0.448 . . . . 64.349999999999994 109.79 -168.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.7 t -89.12 155.19 19.59 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 123.447 0.699 . . . . 72.299999999999997 109.496 -175.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.8 mt -60.89 -35.24 76.14 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.494 1.117 . . . . 71.400000000000006 112.87 -171.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -61.52 -46.83 88.31 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.388 -0.597 . . . . 73.049999999999997 109.388 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.402 ' HG3' ' HD2' ' A' ' 136' ' ' ARG . 15.8 mm-40 -77.42 -22.39 51.59 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 114.245 -1.343 . . . . 71.099999999999994 112.153 -177.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.0 -51.69 68.59 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 123.586 0.554 . . . . 73.329999999999998 110.401 173.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -81.06 -50.45 9.64 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 115.508 -0.769 . . . . 71.120000000000005 111.887 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -65.93 -45.02 83.39 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.235 0.614 . . . . 72.040000000000006 111.813 -175.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.479 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 73.24 -145.52 36.25 Favored Glycine 0 C--N 1.342 0.899 0 O-C-N 123.441 0.463 . . . . 73.120000000000005 112.092 -175.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.93 -147.09 25.98 Favored Glycine 0 C--N 1.345 1.041 0 O-C-N 123.687 0.286 . . . . 74.129999999999995 112.808 177.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -85.09 121.9 28.52 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.236 0.614 . . . . 74.450000000000003 109.78 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.591 HH12 ' HB2' ' A' ' 94' ' ' MET . 5.0 tpm_? -112.03 123.44 50.27 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.912 -0.774 . . . . 73.109999999999999 108.912 175.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.468 ' HB ' ' NH2' ' A' ' 136' ' ' ARG . 84.8 t -76.11 111.4 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 114.88 -1.055 . . . . 71.120000000000005 109.519 173.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 32.0 t -107.7 129.56 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 107.359 -1.348 . . . . 72.420000000000002 107.359 172.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -115.58 116.48 28.22 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.36 -0.607 . . . . 74.209999999999994 109.36 175.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.8 p -150.02 142.47 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 123.87 0.868 . . . . 54.009999999999998 109.179 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.69 19.16 11.58 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.239 1.016 . . . . 55.409999999999997 112.156 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 82.28 7.41 87.71 Favored Glycine 0 C--N 1.353 1.499 0 CA-C-N 116.214 -0.448 . . . . 53.020000000000003 113.04 -176.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.9 ttm-85 -114.58 143.02 45.66 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.056 0.943 . . . . 74.239999999999995 110.388 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.442 ' HG3' HG13 ' A' ' 137' ' ' VAL . 12.4 ttp180 -96.4 113.72 25.33 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.592 -0.892 . . . . 72.099999999999994 108.592 173.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 25.8 t -105.41 112.09 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 108.243 -1.021 . . . . 73.120000000000005 108.243 172.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 35.8 t -90.29 108.59 19.86 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 107.961 -1.126 . . . . 62.009999999999998 107.961 175.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 34.3 m -104.61 145.69 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.508 0.723 . . . . 65.209999999999994 110.656 -176.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -93.19 96.04 9.77 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.791 -0.818 . . . . 73.239999999999995 108.791 175.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.479 HG13 ' HA2' ' A' ' 133' ' ' GLY . 24.0 pt -85.51 135.53 38.4 Favored Pre-proline 0 CA--C 1.554 1.131 0 CA-C-N 115.596 -0.729 . . . . 53.100000000000001 109.18 172.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.406 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 38.3 Cg_endo -68.07 141.07 51.63 Favored 'Trans proline' 0 CA--C 1.565 2.027 0 C-N-CA 122.338 2.025 . . . . 72.519999999999996 112.438 178.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 150' ' ' PRO . 47.2 Cg_exo -60.2 113.7 1.78 Allowed 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 123.148 2.566 . . . . 72.230000000000004 112.14 173.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 86.61 32.59 15.25 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.359 -0.696 . . . . 63.43 111.359 -173.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.5 p -62.67 144.49 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.608 0.763 . . . . 75.120000000000005 109.682 172.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -132.01 161.36 33.36 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.77 0.428 . . . . 73.120000000000005 110.473 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -43.17 129.04 4.7 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 125.536 1.773 . . . . 72.019999999999996 112.91 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 102.68 -13.06 56.58 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-O 119.259 -0.745 . . . . 74.420000000000002 114.119 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.0 t -62.46 120.6 11.4 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 117.589 0.695 . . . . 74.25 109.698 178.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 176' ' ' LEU . 3.1 p -115.01 112.31 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 121.539 0.685 . . . . 62.25 110.36 -172.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 59.1 mt -90.23 102.92 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 107.965 -1.124 . . . . 55.229999999999997 107.965 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -81.21 99.96 8.86 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.8 -0.815 . . . . 75.230000000000004 108.8 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.2 p -103.73 118.86 56.35 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 122.845 0.458 . . . . 60.43 109.953 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.51 155.71 59.15 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.9 2.4 . . . . 75.420000000000002 112.287 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 81.24 -24.4 4.13 Favored Glycine 0 CA--C 1.535 1.3 0 N-CA-C 114.31 0.484 . . . . 62.240000000000002 114.31 176.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.1 mmt -88.17 -27.26 21.96 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.727 0.811 . . . . 74.150000000000006 112.024 -172.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -70.27 -78.36 0.4 Allowed Glycine 0 C--N 1.345 1.053 0 N-CA-C 111.361 -0.696 . . . . 75.310000000000002 111.361 175.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -71.16 110.84 3.41 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 111.0 -0.84 . . . . 42.520000000000003 111.0 167.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -89.45 151.61 21.92 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.709 0.804 . . . . 43.439999999999998 110.457 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 81.29 -125.77 7.05 Favored Glycine 0 C--N 1.342 0.902 0 CA-C-N 115.831 -0.622 . . . . 60.100000000000001 113.224 174.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.44 ' O ' ' HD3' ' A' ' 171' ' ' PRO . 28.3 t-20 -62.84 -48.64 84.89 Favored Pre-proline 0 CA--C 1.564 1.49 0 C-N-CA 123.972 0.909 . . . . 71.239999999999995 113.01 -174.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -96.84 95.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.392 2.834 0 C-N-CA 122.633 2.222 . . . . 73.430000000000007 113.082 176.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 169' ' ' ASN . 11.3 Cg_exo -70.33 121.96 8.51 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 121.988 1.792 . . . . 75.310000000000002 110.239 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -134.93 179.76 17.32 Favored Glycine 0 C--N 1.343 0.919 0 C-N-CA 121.67 -0.3 . . . . 65.109999999999999 113.108 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -96.11 119.79 35.23 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.51 0.671 . . . . 63.009999999999998 112.124 -167.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.3 tp -89.38 111.66 22.57 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.018 -0.992 . . . . 61.549999999999997 108.529 173.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 60.8 mt -83.95 99.55 10.46 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.562 0.745 . . . . 74.0 109.048 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 158' ' ' VAL . 91.7 mt -91.05 98.67 11.91 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 123.633 0.583 . . . . 72.239999999999995 110.884 -175.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 23.7 t -90.71 123.05 42.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 109.161 -0.681 . . . . 45.340000000000003 109.161 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.6 p -74.94 132.94 32.51 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 109.125 -0.694 . . . . 74.209999999999994 109.125 177.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.418 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 34.6 mmt180 -118.57 92.9 3.93 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.323 -0.991 . . . . 75.519999999999996 108.323 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 26.3 mt -101.02 131.48 46.87 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.616 -0.72 . . . . 63.340000000000003 110.608 -176.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.47 136.25 96.62 Favored Pre-proline 0 CA--C 1.549 0.919 0 CA-C-N 114.778 -1.101 . . . . 74.430000000000007 109.889 178.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.4 5.4 1.57 Allowed 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 122.759 2.306 . . . . 74.120000000000005 113.683 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 . . . . . 0 C--O 1.25 1.113 0 C-N-CA 123.897 0.879 . . . . 74.200000000000003 108.77 170.796 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.416 ' HB3' ' NH2' ' A' ' 136' ' ' ARG . 1.1 mpt? . . . . . 0 N--CA 1.484 1.269 0 N-CA-C 109.267 -0.642 . . . . 73.349999999999994 109.267 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.4 t -69.92 140.41 53.08 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-N 115.734 -0.667 . . . . 64.409999999999997 111.058 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.461 ' HA ' HH11 ' A' ' 136' ' ' ARG . 28.6 m -78.39 148.62 33.59 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.775 0.83 . . . . 62.520000000000003 109.596 174.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.743 HD12 ' HB2' ' A' ' 123' ' ' LEU . 26.1 pt -118.03 168.61 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 123.334 0.653 . . . . 55.329999999999998 110.382 -171.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -136.74 127.38 27.05 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.37 0.668 . . . . 54.200000000000003 110.258 -176.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.549 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.5 tp -80.57 157.02 26.18 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 124.07 0.948 . . . . 54.520000000000003 110.866 -168.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.457 ' HB3' ' H ' ' A' ' 122' ' ' GLU . . . -77.18 -54.08 6.95 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.631 0.372 . . . . 64.439999999999998 110.852 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.0 mt 55.46 84.71 0.07 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.187 0.995 . . . . 73.349999999999994 110.796 -168.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.5 mt -100.6 122.43 49.53 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 125.103 1.361 . . . . 44.109999999999999 109.219 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -69.41 161.67 44.96 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.678 2.252 . . . . 72.219999999999999 112.869 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -74.62 110.16 8.69 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.895 0.878 . . . . 72.239999999999995 111.447 -175.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.6 55.41 11.92 Favored Glycine 0 C--N 1.343 0.944 0 O-C-N 123.945 0.778 . . . . 63.310000000000002 113.138 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.7 m -71.9 -32.83 67.8 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.028 0.531 . . . . 71.349999999999994 109.885 174.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.83 40.49 0.3 Allowed Glycine 0 C--N 1.342 0.885 0 N-CA-C 109.553 -1.419 . . . . 52.43 109.553 171.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.31 -167.29 12.34 Favored Glycine 0 C--N 1.35 1.344 0 N-CA-C 111.224 -0.751 . . . . 73.129999999999995 111.224 -169.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.41 ' HB3' HH11 ' A' ' 120' ' ' ARG . 51.0 m 59.26 29.45 19.02 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.915 0.886 . . . . 51.399999999999999 112.598 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -140.38 96.06 0.21 Allowed Glycine 0 C--N 1.347 1.154 0 N-CA-C 110.231 -1.148 . . . . 75.530000000000001 110.231 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -70.08 -76.34 0.52 Allowed Glycine 0 C--N 1.349 1.292 0 N-CA-C 111.911 -0.476 . . . . 61.109999999999999 111.911 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.7 m -154.09 166.17 33.89 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.783 0.833 . . . . 65.319999999999993 109.894 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 170.23 74.79 0.04 OUTLIER Glycine 0 C--N 1.348 1.245 0 C-N-CA 121.726 -0.273 . . . . 70.140000000000001 112.882 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -92.77 -71.79 1.18 Allowed Glycine 0 C--N 1.349 1.257 0 N-CA-C 111.872 -0.491 . . . . 72.209999999999994 111.872 177.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 31.6 p -77.73 -27.59 50.55 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.583 0.753 . . . . 74.319999999999993 111.905 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -135.46 79.81 0.32 Allowed Glycine 0 C--N 1.336 0.561 0 N-CA-C 109.847 -1.301 . . . . 74.540000000000006 109.847 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -72.19 117.49 13.89 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.238 0.542 . . . . 75.519999999999996 111.132 -177.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -91.7 107.28 19.1 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.71 -1.132 . . . . 72.549999999999997 107.974 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.8 tt -91.95 129.84 37.83 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 106.237 -1.764 . . . . 75.209999999999994 106.237 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.41 HH11 ' HB3' ' A' ' 109' ' ' SER . 56.8 ttt180 -90.55 120.57 31.75 Favored 'General case' 0 C--O 1.213 -0.854 0 N-CA-C 107.998 -1.112 . . . . 73.120000000000005 107.998 -174.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.549 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -140.37 130.74 25.26 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.331 -0.618 . . . . 72.5 109.331 -174.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.496 ' HG2' ' HB ' ' A' ' 177' ' ' VAL . 84.9 mt-10 -120.63 120.96 37.26 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.316 -0.624 . . . . 64.349999999999994 109.316 -167.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.743 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.4 pp -103.13 118.71 57.34 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 109.522 -0.547 . . . . 74.530000000000001 109.522 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -74.27 113.76 3.87 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 122.819 2.346 . . . . 74.530000000000001 109.37 169.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.573 HD21 HD12 ' A' ' 149' ' ' ILE . 29.4 tp -103.75 143.92 32.17 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 110.151 -0.314 . . . . 73.25 110.151 -166.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.4 t -83.35 155.89 23.31 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.446 -0.797 . . . . 71.140000000000001 109.856 -176.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.2 mt -63.52 -30.98 72.02 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.072 0.949 . . . . 63.229999999999997 112.304 -173.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.55 -43.59 89.42 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.763 0.664 . . . . 74.049999999999997 109.52 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.414 ' HB3' HD11 ' A' ' 149' ' ' ILE . 69.6 mm-40 -77.74 -32.65 52.87 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.014 -0.994 . . . . 64.439999999999998 111.904 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.46 -49.19 74.65 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.489 0.661 . . . . 54.450000000000003 111.152 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -74.21 -59.76 2.58 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.251 -1.341 . . . . 73.420000000000002 110.595 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -72.81 -44.26 61.69 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.662 -0.699 . . . . 74.129999999999995 111.727 -172.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.39 178.12 50.82 Favored Glycine 0 C--N 1.351 1.399 0 O-C-N 123.629 0.581 . . . . 74.120000000000005 113.161 -175.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 127.76 -156.79 20.77 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.934 -0.466 . . . . 53.020000000000003 111.934 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.419 ' HB3' ' OG ' ' A' ' 146' ' ' SER . 3.1 mp0 -88.47 123.07 32.63 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.822 -0.807 . . . . 64.329999999999998 108.822 173.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.461 HH11 ' HA ' ' A' ' 96' ' ' THR . 8.3 tpp180 -116.29 122.42 44.89 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.484 0.714 . . . . 74.219999999999999 109.89 176.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.6 t -70.49 126.64 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 O-C-N 124.105 0.878 . . . . 75.420000000000002 109.783 175.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.74 134.83 64.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 124.699 1.2 . . . . 71.219999999999999 108.667 174.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -124.77 125.11 43.52 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.429 1.092 . . . . 71.150000000000006 109.763 -174.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.3 p -151.63 129.93 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.14 0.576 . . . . 75.019999999999996 110.785 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.82 20.04 11.1 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 123.997 0.919 . . . . 73.129999999999995 112.71 176.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.07 -13.29 67.69 Favored Glycine 0 C--N 1.353 1.498 0 CA-C-N 116.403 -0.362 . . . . 71.219999999999999 112.989 -175.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -90.82 117.97 29.86 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.565 1.146 . . . . 73.040000000000006 109.237 -175.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -114.92 129.61 56.74 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.566 0.746 . . . . 65.239999999999995 110.197 -176.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.14 144.78 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.974 0.909 . . . . 75.540000000000006 109.506 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.419 ' OG ' ' HB3' ' A' ' 135' ' ' GLU . 11.0 t -100.8 120.75 40.58 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.017 -0.734 . . . . 52.030000000000001 109.017 177.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 6.3 p -100.11 129.53 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.446 0.698 . . . . 71.140000000000001 110.332 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -75.92 99.51 4.54 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.206 -0.665 . . . . 73.129999999999995 109.206 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.573 HD12 HD21 ' A' ' 125' ' ' LEU . 10.4 pt -86.32 142.79 35.84 Favored Pre-proline 0 CA--C 1.555 1.162 0 CA-C-N 115.356 -0.838 . . . . 74.420000000000002 110.063 173.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -66.05 135.62 41.39 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.449 2.1 . . . . 72.439999999999998 112.11 172.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -55.57 124.42 16.23 Favored 'Trans proline' 0 C--N 1.367 1.504 0 C-N-CA 122.619 2.213 . . . . 65.040000000000006 111.524 166.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 81.51 24.42 56.47 Favored Glycine 0 CA--C 1.533 1.196 0 O-C-N 123.314 0.384 . . . . 62.109999999999999 112.63 -174.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 6.7 p -62.29 139.19 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.622 0.769 . . . . 74.209999999999994 109.7 173.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -127.34 152.57 47.3 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.339 0.656 . . . . 72.049999999999997 110.419 -174.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -40.67 132.01 2.25 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.475 1.91 . . . . 74.430000000000007 113.144 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.86 -6.94 77.03 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-O 119.658 -0.523 . . . . 63.219999999999999 113.992 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 29.2 m -63.0 130.27 43.97 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.216 0.606 . . . . 55.119999999999997 110.24 172.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 5.8 p -117.91 116.48 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 CA-C-O 121.312 0.577 . . . . 70.5 110.37 -177.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.412 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 58.8 mt -95.3 103.04 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.864 0.866 . . . . 54.549999999999997 108.672 176.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -80.16 109.85 15.01 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.142 0.577 . . . . 72.230000000000004 109.742 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.548 HG13 ' HB3' ' A' ' 174' ' ' LEU . 1.7 p -109.04 111.32 60.55 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 123.489 0.716 . . . . 50.450000000000003 109.266 173.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -67.56 151.7 79.29 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 123.239 2.626 . . . . 75.439999999999998 113.571 -177.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 66.6 24.7 72.63 Favored Glycine 0 C--N 1.356 1.673 0 O-C-N 123.772 0.67 . . . . 61.329999999999998 113.662 175.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.447 ' HB3' ' HB2' ' A' ' 174' ' ' LEU . 8.2 tpt -119.81 -33.79 3.91 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.263 0.625 . . . . 75.019999999999996 110.154 -171.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -91.69 -69.73 1.17 Allowed Glycine 0 C--N 1.35 1.341 0 CA-C-N 116.44 -0.346 . . . . 65.310000000000002 112.31 -177.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -62.77 90.42 0.07 OUTLIER Glycine 0 C--N 1.349 1.274 0 N-CA-C 111.46 -0.656 . . . . 54.340000000000003 111.46 169.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -92.28 170.37 9.85 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.249 1.02 . . . . 74.519999999999996 111.195 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.74 -145.5 18.33 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 115.251 -0.886 . . . . 74.239999999999995 112.179 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -78.99 -36.98 1.21 Allowed Pre-proline 0 CA--C 1.565 1.542 0 CA-C-O 118.288 -0.863 . . . . 50.509999999999998 112.083 177.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -82.68 110.38 1.88 Allowed 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 121.725 1.617 . . . . 74.140000000000001 111.314 166.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -74.62 166.82 28.52 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.619 2.213 . . . . 74.430000000000007 112.583 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 173.34 174.75 40.6 Favored Glycine 0 C--N 1.346 1.109 0 N-CA-C 114.079 0.392 . . . . 63.520000000000003 114.079 170.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -91.04 166.8 12.81 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.639 1.176 . . . . 64.530000000000001 111.088 -167.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.548 ' HB3' HG13 ' A' ' 161' ' ' VAL . 34.8 tp -124.11 118.27 26.54 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.562 -0.903 . . . . 74.109999999999999 108.562 177.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 82.6 mt -92.91 101.88 14.24 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.522 0.729 . . . . 64.109999999999999 109.649 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.412 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 94.9 mt -89.21 99.75 12.67 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.25 0.62 . . . . 72.230000000000004 111.028 -177.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.496 ' HB ' ' HG2' ' A' ' 122' ' ' GLU . 49.5 t -89.23 112.61 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 123.373 0.669 . . . . 75.239999999999995 109.493 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.02 133.56 31.49 Favored 'Isoleucine or valine' 0 C--O 1.249 1.074 0 N-CA-C 109.712 -0.477 . . . . 71.030000000000001 109.712 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -123.43 96.04 4.82 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.353 1.061 . . . . 73.519999999999996 108.471 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 180' ' ' LEU . 35.7 mt -96.84 140.81 30.84 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.642 -0.708 . . . . 74.049999999999997 111.756 -174.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 71.0 mt -61.93 146.79 90.92 Favored Pre-proline 0 CA--C 1.553 1.058 0 CA-C-N 114.303 -1.317 . . . . 73.340000000000003 110.07 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -77.16 31.56 0.42 Allowed 'Trans proline' 0 CA--C 1.559 1.726 0 C-N-CA 122.849 2.366 . . . . 74.420000000000002 113.859 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 . . . . . 0 C--O 1.251 1.154 0 C-N-CA 123.812 0.845 . . . . 71.120000000000005 109.756 173.373 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 35.2 mtp . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 108.022 -1.103 . . . . 73.439999999999998 108.022 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.477 ' H ' HG21 ' A' ' 126' ' ' THR . 16.3 m -60.28 -22.31 62.96 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.065 1.135 . . . . 64.319999999999993 114.065 -172.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 45.0 m 71.3 145.91 0.07 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.754 1.222 . . . . 43.530000000000001 110.842 -172.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.727 HD12 ' HB2' ' A' ' 123' ' ' LEU . 15.3 pt -128.08 166.19 25.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 123.348 0.659 . . . . 75.049999999999997 110.861 -170.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.407 ' O ' ' HD2' ' A' ' 124' ' ' PRO . . . -126.4 151.33 47.81 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.333 1.053 . . . . 73.400000000000006 109.649 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.617 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.5 tp -100.91 155.14 18.12 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.892 0.477 . . . . 62.340000000000003 109.936 -170.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.44 ' HB3' ' H ' ' A' ' 122' ' ' GLU . . . -84.14 -40.54 18.08 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.249 0.619 . . . . 62.100000000000001 111.929 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.0 mt 48.69 66.18 1.15 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.004 0.922 . . . . 75.209999999999994 111.283 -172.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 76.1 mt -73.43 151.03 89.57 Favored Pre-proline 0 CA--C 1.548 0.89 0 CA-C-N 115.35 -0.841 . . . . 63.140000000000001 110.492 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.12 179.65 1.08 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.247 1.965 . . . . 50.329999999999998 112.595 171.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.8 pp -122.88 -169.72 1.97 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.963 0.905 . . . . 64.230000000000004 110.313 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 140.33 -41.18 1.31 Allowed Glycine 0 C--N 1.337 0.616 0 N-CA-C 110.13 -1.188 . . . . 62.43 110.13 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.6 t -145.99 -172.52 3.94 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.281 1.032 . . . . 73.140000000000001 108.475 175.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 112.21 -0.22 26.75 Favored Glycine 0 N--CA 1.47 0.961 0 N-CA-C 111.657 -0.577 . . . . 62.240000000000002 111.657 -174.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 148.89 165.49 12.27 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 111.398 -0.681 . . . . 74.299999999999997 111.398 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.3 t -76.94 -8.86 58.14 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.31 0.644 . . . . 71.140000000000001 110.942 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 71.77 -149.25 44.53 Favored Glycine 0 C--N 1.356 1.654 0 N-CA-C 110.995 -0.842 . . . . 71.319999999999993 110.995 -174.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -106.34 9.95 42.51 Favored Glycine 0 N--CA 1.466 0.673 0 N-CA-C 111.47 -0.652 . . . . 61.25 111.47 173.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.2 m 64.25 178.98 0.17 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.91 1.284 . . . . 74.040000000000006 111.963 -177.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.93 -83.0 0.83 Allowed Glycine 0 C--N 1.349 1.271 0 CA-C-N 116.003 -0.544 . . . . 70.319999999999993 112.578 178.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 168.4 -45.96 0.23 Allowed Glycine 0 C--N 1.341 0.815 0 N-CA-C 111.78 -0.528 . . . . 64.510000000000005 111.78 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 28.3 p -64.55 136.88 57.48 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.801 0.84 . . . . 71.120000000000005 110.835 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.56 40.17 6.07 Favored Glycine 0 C--N 1.345 1.067 0 O-C-N 123.802 0.689 . . . . 55.130000000000003 111.679 -176.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.434 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 43.3 ttt180 -56.43 119.58 6.27 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.537 1.135 . . . . 71.510000000000005 112.556 -174.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -78.35 139.38 38.82 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.433 -0.803 . . . . 72.129999999999995 109.425 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.9 tt -132.7 126.1 31.78 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.175 -1.417 . . . . 44.210000000000001 107.175 177.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -91.59 136.14 33.35 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.361 0.665 . . . . 65.019999999999996 109.321 -176.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.617 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -154.37 146.87 24.04 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.466 0.706 . . . . 75.310000000000002 110.11 -176.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.44 ' H ' ' HB3' ' A' ' 100' ' ' ALA . 29.4 mt-10 -120.79 124.98 46.4 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 109.179 -0.674 . . . . 73.030000000000001 109.179 -176.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.727 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.5 pp -108.94 115.06 57.72 Favored Pre-proline 0 CA--C 1.551 0.981 0 N-CA-C 108.672 -0.862 . . . . 73.430000000000007 108.672 174.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.475 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 82.4 Cg_endo -78.15 114.74 3.62 Favored 'Trans proline' 0 C--N 1.365 1.437 0 C-N-CA 122.673 2.249 . . . . 73.120000000000005 109.124 170.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.525 HD21 HD12 ' A' ' 149' ' ' ILE . 25.5 tp -103.78 147.18 27.59 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.393 -0.595 . . . . 65.319999999999993 109.393 -166.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.477 HG21 ' H ' ' A' ' 95' ' ' SER . 11.3 t -92.63 162.97 13.96 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 109.718 -0.475 . . . . 63.219999999999999 109.718 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.5 mt -64.65 -37.02 86.15 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.85 0.86 . . . . 54.140000000000001 112.188 -168.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -59.83 -40.18 87.62 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.177 0.923 . . . . 75.420000000000002 109.68 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -76.92 -37.06 56.09 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 114.892 -1.049 . . . . 75.109999999999999 111.567 -173.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.9 -36.15 74.22 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 121.104 0.478 . . . . 64.430000000000007 110.384 172.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -77.16 -34.7 56.39 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 114.751 -1.113 . . . . 73.200000000000003 111.822 177.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 27.4 m80 -74.76 -51.16 14.9 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 117.926 0.33 . . . . 71.310000000000002 110.983 -176.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.429 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 58.62 68.11 1.86 Allowed Glycine 0 C--N 1.344 0.994 0 O-C-N 124.239 0.962 . . . . 44.350000000000001 112.307 -172.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.423 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -155.51 -146.33 4.41 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-O 120.055 -0.303 . . . . 72.5 112.529 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.3 mp0 -75.12 117.08 16.56 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.406 0.682 . . . . 72.230000000000004 109.685 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.667 HH21 ' HB ' ' A' ' 137' ' ' VAL . 4.5 tpm_? -116.56 123.74 48.12 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.113 0.965 . . . . 74.230000000000004 108.674 173.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.667 ' HB ' HH21 ' A' ' 136' ' ' ARG . 87.8 t -72.49 122.8 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.079 0.952 . . . . 64.510000000000005 110.341 174.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.601 ' HB ' HG13 ' A' ' 145' ' ' VAL . 21.4 t -112.6 126.95 70.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.551 -0.907 . . . . 72.140000000000001 108.551 174.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -109.16 110.43 21.66 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.831 0.853 . . . . 61.109999999999999 109.466 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 10.8 p -149.75 133.22 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 123.018 0.527 . . . . 75.409999999999997 110.541 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.64 18.68 10.75 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.513 1.125 . . . . 73.319999999999993 112.645 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.79 5.57 86.27 Favored Glycine 0 C--N 1.348 1.244 0 O-C-N 123.158 0.286 . . . . 40.200000000000003 113.232 -176.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -112.12 131.46 55.44 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.406 1.082 . . . . 72.129999999999995 109.806 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.556 ' HG3' HG13 ' A' ' 137' ' ' VAL . 39.6 ttm180 -90.22 113.98 25.89 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.124 0.97 . . . . 71.329999999999998 109.618 172.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.601 HG13 ' HB ' ' A' ' 138' ' ' VAL . 2.5 p -111.3 115.14 49.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 123.398 0.679 . . . . 54.240000000000002 109.21 169.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.6 t -86.78 115.23 24.07 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 109.19 -0.67 . . . . 74.439999999999998 109.19 175.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.6 p -100.83 124.38 54.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 123.612 0.765 . . . . 71.349999999999994 109.795 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 54.2 ttt85 -80.43 93.93 6.1 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.747 -1.205 . . . . 73.530000000000001 107.747 168.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.525 HD12 HD21 ' A' ' 125' ' ' LEU . 13.8 pt -74.31 143.94 80.64 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 123.824 0.85 . . . . 64.510000000000005 109.753 177.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.429 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 59.9 Cg_endo -72.8 149.07 47.39 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 122.225 1.95 . . . . 73.109999999999999 111.993 177.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 150' ' ' PRO . 31.9 Cg_exo -60.54 134.45 54.75 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 123.137 2.558 . . . . 70.150000000000006 112.122 177.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 65.83 29.31 74.81 Favored Glycine 0 C--N 1.353 1.506 0 O-C-N 123.697 0.623 . . . . 74.010000000000005 112.63 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -58.21 145.65 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 C-N-CA 124.053 0.941 . . . . 74.450000000000003 109.72 176.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -136.64 158.75 43.71 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.53 0.732 . . . . 72.120000000000005 110.415 -173.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -42.69 127.18 3.87 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.895 1.678 . . . . 52.210000000000001 112.838 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.27 -4.82 80.92 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 114.385 0.514 . . . . 64.019999999999996 114.385 177.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.6 t -67.62 122.32 17.8 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.242 -0.651 . . . . 71.200000000000003 109.242 176.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 46.5 t -101.99 117.06 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 109.427 -0.583 . . . . 73.530000000000001 109.427 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.5 mt -91.92 144.1 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.813 1.245 . . . . 71.420000000000002 107.968 173.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.547 HH11 HD21 ' A' ' 175' ' ' LEU . 49.0 ttt85 -118.09 116.75 27.49 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.188 -0.671 . . . . 73.319999999999993 109.188 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 174' ' ' LEU . 5.0 p -124.17 109.62 29.3 Favored Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 123.693 0.797 . . . . 53.140000000000001 110.531 -177.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -70.72 153.62 64.41 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.974 2.449 . . . . 72.439999999999998 112.628 -176.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.77 -13.83 54.67 Favored Glycine 0 C--N 1.339 0.719 0 CA-C-N 115.702 -0.681 . . . . 72.439999999999998 113.954 174.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 84.7 mmm -100.14 -12.42 19.64 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 117.404 0.602 . . . . 65.219999999999999 111.452 -176.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -83.04 -111.5 0.5 Allowed Glycine 0 C--N 1.353 1.485 0 CA-C-O 119.312 -0.716 . . . . 61.119999999999997 111.936 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.434 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -53.85 108.32 0.81 Allowed Glycine 0 C--N 1.353 1.489 0 O-C-N 124.003 0.472 . . . . 53.25 113.128 174.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -91.22 169.54 10.75 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.616 1.167 . . . . 73.400000000000006 110.396 175.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 94.59 -145.41 17.68 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 115.388 -0.824 . . . . 73.019999999999996 112.147 175.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -69.13 -47.66 28.58 Favored Pre-proline 0 CA--C 1.561 1.384 0 CA-C-O 118.13 -0.938 . . . . 73.239999999999995 110.872 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.3 113.59 2.67 Favored 'Trans proline' 0 C--N 1.395 3.011 0 C-N-CA 122.232 1.955 . . . . 62.0 111.087 172.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -72.39 160.17 47.55 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.45 2.1 . . . . 74.340000000000003 111.418 177.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -161.01 -179.13 35.56 Favored Glycine 0 CA--C 1.504 -0.632 0 N-CA-C 114.732 0.653 . . . . 44.149999999999999 114.732 176.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -120.52 150.18 41.25 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.531 1.132 . . . . 75.310000000000002 109.641 -169.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.421 ' HB3' HG13 ' A' ' 161' ' ' VAL . 37.2 tp -117.1 114.1 23.24 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.563 0.745 . . . . 73.340000000000003 110.1 -172.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.547 HD21 HH11 ' A' ' 160' ' ' ARG . 92.8 mt -88.37 103.28 15.69 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.063 0.945 . . . . 74.209999999999994 110.162 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.534 HD22 HD11 ' A' ' 99' ' ' LEU . 77.0 mt -95.41 99.18 11.13 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.085 0.954 . . . . 74.239999999999995 110.615 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 8.5 p -90.37 133.4 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 109.372 -0.603 . . . . 74.140000000000001 109.372 175.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.3 p -87.58 144.81 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 123.238 0.615 . . . . 72.430000000000007 111.165 -171.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.475 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 35.5 mmt180 -119.25 99.74 6.89 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.742 1.217 . . . . 62.329999999999998 108.44 174.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 16.0 mt -118.86 145.86 45.35 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.973 0.909 . . . . 54.109999999999999 111.119 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 65.2 mt -70.25 132.07 88.23 Favored Pre-proline 0 CA--C 1.551 0.991 0 CA-C-N 114.541 -1.209 . . . . 73.319999999999993 109.423 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.15 -19.01 67.77 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.7 2.267 . . . . 51.200000000000003 113.118 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 . . . . . 0 C--O 1.252 1.215 0 C-N-CA 124.89 1.276 . . . . 71.430000000000007 108.24 177.699 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 49.8 mtt . . . . . 0 N--CA 1.484 1.264 0 N-CA-C 108.927 -0.768 . . . . 74.540000000000006 108.927 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.4 m -71.48 121.68 19.07 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.915 -0.772 . . . . 51.140000000000001 108.915 174.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 86.8 m -68.2 141.56 55.94 Favored 'General case' 0 C--N 1.35 0.63 0 C-N-CA 123.392 0.677 . . . . 72.049999999999997 110.39 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.588 HD12 ' HB2' ' A' ' 123' ' ' LEU . 14.2 pt -114.88 163.41 12.19 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 C-N-CA 123.057 0.543 . . . . 52.409999999999997 110.818 -170.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -123.15 -162.93 1.06 Allowed 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.399 -0.963 . . . . 45.439999999999998 108.399 170.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.488 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.5 tp -136.64 155.93 49.23 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.937 -0.764 . . . . 75.129999999999995 108.937 -175.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.87 -48.92 33.32 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.044 0.538 . . . . 50.100000000000001 110.723 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.585 HD11 ' HB ' ' A' ' 140' ' ' VAL . 60.2 mt 53.68 78.05 0.16 Allowed 'General case' 0 CA--C 1.546 0.809 0 O-C-N 124.469 1.106 . . . . 63.450000000000003 110.348 -171.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 60.9 mt -84.65 143.2 40.61 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 114.984 -1.007 . . . . 75.530000000000001 109.636 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.47 -173.48 0.56 Allowed 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.571 2.18 . . . . 72.209999999999994 112.952 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -53.76 133.21 42.23 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.944 0.898 . . . . 73.329999999999998 111.712 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -172.3 -110.68 0.25 Allowed Glycine 0 C--N 1.347 1.144 0 N-CA-C 111.94 -0.464 . . . . 51.32 111.94 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.3 m -74.4 96.53 2.89 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.148 0.579 . . . . 74.120000000000005 110.06 177.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -160.67 -112.08 0.29 Allowed Glycine 0 C--N 1.35 1.359 0 CA-C-N 115.849 -0.614 . . . . 54.539999999999999 111.734 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.12 27.63 73.52 Favored Glycine 0 C--N 1.356 1.647 0 N-CA-C 112.21 -0.356 . . . . 44.5 112.21 -174.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.2 m -100.93 151.29 21.93 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.18 0.992 . . . . 74.340000000000003 112.156 -167.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -151.03 -161.07 9.78 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 115.674 -0.694 . . . . 53.240000000000002 111.847 178.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 165.41 -144.52 9.33 Favored Glycine 0 C--N 1.343 0.944 0 N-CA-C 112.099 -0.4 . . . . 62.25 112.099 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 60.3 p -78.71 -51.02 10.41 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.649 0.779 . . . . 74.329999999999998 110.91 -178.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -143.16 98.53 0.21 Allowed Glycine 0 C--N 1.352 1.431 0 N-CA-C 111.202 -0.759 . . . . 50.329999999999998 111.202 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.605 ' HA3' ' HB2' ' A' ' 162' ' ' PRO . . . 146.91 20.53 0.11 Allowed Glycine 0 N--CA 1.473 1.165 0 C-N-CA 123.03 0.348 . . . . 32.439999999999998 112.26 178.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 36.5 m -79.51 103.26 9.31 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.29 0.636 . . . . 74.340000000000003 109.499 176.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -169.88 -159.54 15.96 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 110.936 -0.866 . . . . 42.210000000000001 110.936 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.706 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 32.8 ttm180 -58.81 119.66 7.56 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 117.191 0.496 . . . . 75.430000000000007 111.01 -178.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -76.11 139.33 41.29 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.519 0.728 . . . . 74.219999999999999 109.539 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.3 tt -141.38 115.5 9.3 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 106.393 -1.706 . . . . 71.329999999999998 106.393 -177.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -90.24 143.08 27.1 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 107.052 -1.462 . . . . 73.420000000000002 107.052 177.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.488 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -149.51 137.16 20.2 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 120.684 0.278 . . . . 62.530000000000001 110.522 -169.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -120.53 112.41 18.91 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.146 -1.057 . . . . 73.450000000000003 108.146 -172.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.588 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.6 pp -99.31 117.79 63.43 Favored Pre-proline 0 C--N 1.354 0.78 0 N-CA-C 108.396 -0.964 . . . . 70.049999999999997 108.396 177.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.417 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 95.6 Cg_endo -75.48 113.68 3.81 Favored 'Trans proline' 0 C--N 1.364 1.36 0 C-N-CA 122.208 1.939 . . . . 71.530000000000001 109.166 170.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.512 HD21 HD12 ' A' ' 149' ' ' ILE . 33.0 tp -102.0 153.08 20.22 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.615 -0.513 . . . . 73.129999999999995 109.615 -172.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.8 t -91.43 155.16 18.65 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 109.224 -0.658 . . . . 74.099999999999994 109.224 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.1 mt -63.12 -34.43 77.59 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.461 0.704 . . . . 72.450000000000003 111.947 -173.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.93 -46.39 90.87 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.834 0.853 . . . . 75.230000000000004 110.022 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -79.09 -26.59 42.96 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.24 -0.891 . . . . 65.310000000000002 112.519 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.38 -40.94 92.65 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.533 0.683 . . . . 71.140000000000001 110.064 171.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -77.62 -48.91 15.71 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 114.224 -1.353 . . . . 73.329999999999998 111.093 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -69.68 -49.43 53.57 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 122.802 0.441 . . . . 54.140000000000001 111.592 -173.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.569 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 75.11 -170.42 54.36 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 115.805 -0.634 . . . . 74.129999999999995 111.702 -163.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.462 ' O ' HG12 ' A' ' 149' ' ' ILE . . . 90.54 -166.29 31.62 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 116.557 0.179 . . . . 55.020000000000003 112.74 -177.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.445 ' HB3' ' OG ' ' A' ' 146' ' ' SER . 3.6 mp0 -71.62 130.69 41.8 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.226 0.61 . . . . 63.020000000000003 110.275 -175.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -131.24 128.58 40.17 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.19 -0.67 . . . . 75.109999999999999 109.19 172.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 38.7 t -72.39 113.08 9.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 O-C-N 124.627 1.205 . . . . 71.519999999999996 110.63 -172.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.5 t -106.44 112.16 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.687 1.195 . . . . 74.319999999999993 107.878 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -94.18 117.35 29.99 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.276 0.63 . . . . 73.409999999999997 109.44 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.585 ' HB ' HD11 ' A' ' 101' ' ' LEU . 19.5 m -135.64 120.84 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 124.502 1.121 . . . . 73.230000000000004 112.048 -169.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 57.88 20.34 6.56 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.55 1.14 . . . . 73.439999999999998 113.603 169.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.67 27.76 18.59 Favored Glycine 0 CA--C 1.535 1.342 0 N-CA-C 112.461 -0.256 . . . . 33.450000000000003 112.461 -175.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -133.64 154.02 51.23 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.405 1.082 . . . . 55.43 109.24 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -112.31 114.79 27.73 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.36 1.064 . . . . 75.310000000000002 109.044 176.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 5.7 p -130.26 124.29 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.536 -0.913 . . . . 74.329999999999998 108.536 174.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.445 ' OG ' ' HB3' ' A' ' 135' ' ' GLU . 12.7 t -103.44 122.8 45.64 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 109.228 -0.656 . . . . 63.549999999999997 109.228 -177.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.1 p -100.94 129.56 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 122.933 0.493 . . . . 71.510000000000005 110.092 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.9 ttp180 -74.73 98.82 3.55 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.573 -0.899 . . . . 61.200000000000003 108.573 170.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.569 HG13 ' HA2' ' A' ' 133' ' ' GLY . 10.7 pt -78.72 145.55 67.03 Favored Pre-proline 0 CA--C 1.563 1.444 0 C-N-CA 124.042 0.937 . . . . 75.340000000000003 109.796 171.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.86 141.34 89.58 Favored 'Trans proline' 0 CA--C 1.564 1.985 0 C-N-CA 122.78 2.32 . . . . 72.439999999999998 113.388 174.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -62.73 114.78 2.55 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.718 2.279 . . . . 70.030000000000001 111.115 168.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 87.59 30.03 19.82 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 111.444 -0.662 . . . . 72.530000000000001 111.444 -174.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -70.21 137.34 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.428 0.691 . . . . 74.409999999999997 109.358 174.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -135.11 157.56 46.61 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.997 0.519 . . . . 64.040000000000006 111.04 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -39.86 122.06 1.38 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.915 2.086 . . . . 41.210000000000001 113.202 -175.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.9 -12.08 38.04 Favored Glycine 0 C--N 1.348 1.213 0 CA-C-O 119.366 -0.685 . . . . 55.0 113.846 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 13.7 t -70.04 122.14 18.8 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 117.382 0.591 . . . . 74.209999999999994 110.138 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 46.5 t -104.41 111.24 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 123.848 0.859 . . . . 74.010000000000005 109.628 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 61.1 mt -89.69 103.63 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.912 -1.144 . . . . 54.299999999999997 107.912 171.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -82.15 119.55 24.2 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.397 -0.594 . . . . 71.239999999999995 109.397 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.542 HG13 ' HB3' ' A' ' 174' ' ' LEU . 6.5 p -124.51 98.2 38.17 Favored Pre-proline 0 CA--C 1.561 1.374 0 C-N-CA 123.68 0.792 . . . . 54.549999999999997 109.476 177.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.605 ' HB2' ' HA3' ' A' ' 114' ' ' GLY . 73.5 Cg_endo -72.35 146.68 45.67 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.954 2.436 . . . . 63.240000000000002 112.503 179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 93.45 -18.51 56.23 Favored Glycine 0 CA--C 1.537 1.43 0 CA-C-O 120.058 -0.301 . . . . 70.120000000000005 113.726 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 69.9 mmm -97.87 -9.87 25.62 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.935 0.894 . . . . 62.009999999999998 112.904 -174.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -79.74 -100.07 0.28 Allowed Glycine 0 C--N 1.342 0.889 0 O-C-N 123.181 0.3 . . . . 73.310000000000002 112.68 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.706 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -67.56 103.04 0.89 Allowed Glycine 0 C--N 1.344 1.022 0 N-CA-C 112.416 -0.273 . . . . 75.530000000000001 112.416 175.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -79.8 131.71 35.97 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.591 0.756 . . . . 65.109999999999999 109.813 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 154.06 -163.73 31.09 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 111.495 -0.642 . . . . 72.319999999999993 111.495 -177.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -58.83 -47.17 99.2 Favored Pre-proline 0 CA--C 1.562 1.422 0 CA-C-O 118.749 -0.643 . . . . 75.329999999999998 111.524 177.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.93 119.28 3.55 Favored 'Trans proline' 0 C--N 1.39 2.733 0 C-N-CA 121.481 1.454 . . . . 54.43 110.967 168.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.6 121.96 9.3 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 121.568 1.512 . . . . 71.519999999999996 109.702 174.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -97.59 149.25 19.19 Favored Glycine 0 C--N 1.339 0.728 0 CA-C-O 119.769 -0.462 . . . . 65.329999999999998 112.539 -173.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 37.6 t70 -83.03 139.78 33.08 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 122.764 0.426 . . . . 63.329999999999998 110.575 -175.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.542 ' HB3' HG13 ' A' ' 161' ' ' VAL . 33.4 tp -122.88 130.67 53.14 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.643 0.777 . . . . 75.319999999999993 109.347 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 80.9 mt -109.34 101.9 10.86 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.602 0.761 . . . . 72.340000000000003 109.307 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 77.3 mt -88.07 101.07 13.43 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 109.583 -0.525 . . . . 72.010000000000005 109.583 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 36.5 t -95.77 124.98 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 109.116 -0.698 . . . . 44.109999999999999 109.116 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.8 p -74.96 127.61 36.66 Favored 'Isoleucine or valine' 0 C--O 1.249 1.064 0 C-N-CA 123.117 0.567 . . . . 65.25 109.966 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.417 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 5.1 mmm180 -114.42 100.61 8.44 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.769 -0.826 . . . . 74.340000000000003 108.769 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 40.3 mt -116.38 139.86 49.96 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.373 1.069 . . . . 65.519999999999996 110.035 -177.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 59.3 mt -91.35 131.76 35.63 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-N 115.347 -0.842 . . . . 54.310000000000002 108.891 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.84 -30.33 91.64 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 123.485 2.79 . . . . 64.120000000000005 112.951 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 . . . . . 0 C--O 1.256 1.401 0 N-CA-C 108.093 -1.077 . . . . 72.540000000000006 108.093 169.776 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.481 ' SD ' ' N ' ' A' ' 94' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 108.108 -1.071 . . . . 52.329999999999998 108.108 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.9 t -62.2 121.56 13.41 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.067 0.547 . . . . 61.340000000000003 111.228 -172.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.521 ' HA ' ' HD2' ' A' ' 136' ' ' ARG . 56.6 m -72.59 149.65 43.78 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.534 0.733 . . . . 72.420000000000002 110.323 177.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.725 HD12 ' HB2' ' A' ' 123' ' ' LEU . 14.1 pt -118.09 161.75 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.029 0.532 . . . . 74.329999999999998 111.41 -164.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -113.18 -162.87 0.82 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.954 0.902 . . . . 42.409999999999997 109.186 173.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.762 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.6 tp -150.66 147.42 27.36 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.125 -0.694 . . . . 73.150000000000006 109.125 -172.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.14 -51.91 14.13 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.406 0.283 . . . . 73.340000000000003 111.147 -178.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 89.9 mt 60.59 73.77 0.47 Allowed 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.339 1.025 . . . . 71.530000000000001 110.435 -174.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.9 mt -77.02 109.72 9.86 Favored Pre-proline 0 CA--C 1.555 1.151 0 CA-C-N 114.986 -1.006 . . . . 44.439999999999998 109.18 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -55.28 -32.35 80.58 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 123.53 2.82 . . . . 70.299999999999997 114.716 -173.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -154.18 19.93 0.5 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.634 0.774 . . . . 70.340000000000003 111.078 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -78.28 85.5 1.13 Allowed Glycine 0 C--N 1.347 1.162 0 CA-C-O 119.933 -0.37 . . . . 74.049999999999997 112.668 -177.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.7 m 62.45 84.69 0.14 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.87 1.268 . . . . 75.129999999999995 110.969 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -169.92 103.13 0.19 Allowed Glycine 0 C--N 1.346 1.092 0 CA-C-N 115.906 -0.588 . . . . 65.200000000000003 111.76 -177.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -174.75 106.55 0.22 Allowed Glycine 0 C--N 1.348 1.208 0 N-CA-C 111.169 -0.772 . . . . 42.43 111.169 176.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.8 t -141.07 177.44 8.06 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.261 1.025 . . . . 72.329999999999998 109.14 178.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 169.8 -79.87 0.1 OUTLIER Glycine 0 C--N 1.341 0.851 0 N-CA-C 110.985 -0.846 . . . . 41.25 110.985 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 63.27 -113.8 6.25 Favored Glycine 0 C--N 1.352 1.429 0 C-N-CA 123.318 0.485 . . . . 71.319999999999993 113.233 177.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 25.3 p -90.07 90.29 8.06 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.536 0.734 . . . . 65.200000000000003 110.668 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.83 78.22 0.74 Allowed Glycine 0 C--N 1.353 1.505 0 CA-C-N 115.754 -0.657 . . . . 62.340000000000003 113.658 175.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -123.47 -87.13 0.79 Allowed Glycine 0 C--N 1.348 1.197 0 N-CA-C 111.839 -0.504 . . . . 63.409999999999997 111.839 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 39.9 m 72.21 -10.81 0.86 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.547 1.539 . . . . 73.329999999999998 114.198 176.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -96.78 143.45 16.74 Favored Glycine 0 C--N 1.35 1.357 0 N-CA-C 112.139 -0.384 . . . . 64.430000000000007 112.139 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.605 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 17.4 ttm180 -79.06 120.05 23.07 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.98 0.512 . . . . 60.420000000000002 111.064 -177.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -71.44 134.29 46.5 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.0 0.52 . . . . 70.430000000000007 110.094 173.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.7 tt -133.93 120.3 20.17 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 106.298 -1.741 . . . . 75.430000000000007 106.298 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -91.83 144.24 25.7 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 108.931 -0.766 . . . . 74.120000000000005 108.931 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.762 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -154.73 133.25 11.98 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.86 0.464 . . . . 53.25 110.037 -172.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -107.02 116.24 31.57 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.493 0.717 . . . . 73.109999999999999 109.365 -168.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.725 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.2 pp -101.36 115.21 65.38 Favored Pre-proline 0 C--N 1.35 0.604 0 N-CA-C 108.694 -0.854 . . . . 70.040000000000006 108.694 177.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -80.26 111.43 2.64 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.533 2.155 . . . . 70.430000000000007 110.984 172.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.605 HD21 HD12 ' A' ' 149' ' ' ILE . 30.0 tp -104.6 152.15 22.78 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 121.899 -0.501 . . . . 64.120000000000005 110.644 -166.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.9 t -90.35 154.11 19.94 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 123.498 0.719 . . . . 75.010000000000005 109.127 178.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.7 mt -68.64 -30.85 69.65 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.499 0.72 . . . . 52.439999999999998 112.251 -170.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -64.49 -48.58 74.65 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.14 0.576 . . . . 73.319999999999993 109.575 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -63.21 -38.45 91.2 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 114.695 -1.139 . . . . 52.25 112.0 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.475 ' HB2' HD21 ' A' ' 180' ' ' LEU . . . -60.02 -38.47 82.8 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 123.616 0.573 . . . . 74.140000000000001 111.505 176.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -76.32 -32.76 58.88 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 115.077 -0.965 . . . . 73.150000000000006 111.077 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -74.5 -49.75 20.91 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.096 0.474 . . . . 73.209999999999994 111.437 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.449 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 66.63 44.54 89.52 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.163 -0.926 . . . . 54.219999999999999 112.036 -164.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -97.09 -161.5 31.8 Favored Glycine 0 C--N 1.351 1.367 0 O-C-N 123.894 0.408 . . . . 75.340000000000003 112.244 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -95.71 116.68 29.23 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.772 -0.825 . . . . 74.120000000000005 108.772 176.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.521 ' HD2' ' HA ' ' A' ' 96' ' ' THR . 10.0 tpp180 -111.0 126.23 54.57 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.159 0.584 . . . . 64.209999999999994 109.527 178.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 91.6 t -73.56 132.89 32.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 114.433 -1.258 . . . . 61.200000000000003 110.333 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 28.2 t -116.59 126.76 74.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 107.302 -1.37 . . . . 65.319999999999993 107.302 174.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -126.06 110.11 13.16 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.994 0.518 . . . . 62.399999999999999 110.27 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -149.25 137.03 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 124.391 1.076 . . . . 72.109999999999999 111.072 -177.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.85 17.33 9.86 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.246 1.419 . . . . 44.039999999999999 112.732 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.33 1.68 74.82 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 116.404 -0.362 . . . . 51.310000000000002 112.987 -176.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -102.38 121.26 41.96 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.385 1.074 . . . . 71.120000000000005 110.109 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -98.48 105.49 17.64 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 109.522 -0.548 . . . . 73.109999999999999 109.522 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.459 HG12 HG13 ' A' ' 147' ' ' VAL . 49.6 t -106.17 111.86 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.778 0.831 . . . . 55.210000000000001 109.062 176.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.6 t -92.39 121.11 33.56 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.191 -1.041 . . . . 65.420000000000002 108.191 176.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.459 HG13 HG12 ' A' ' 145' ' ' VAL . 29.8 m -126.16 144.01 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.142 0.577 . . . . 72.109999999999999 110.785 -176.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 63.5 ttp85 -88.32 124.59 34.06 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.677 -0.86 . . . . 73.519999999999996 108.677 172.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.605 HD12 HD21 ' A' ' 125' ' ' LEU . 4.5 pt -93.47 149.26 36.96 Favored Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 124.295 1.038 . . . . 64.409999999999997 109.752 176.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.412 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 33.7 Cg_exo -61.0 140.37 89.72 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 123.013 2.476 . . . . 55.340000000000003 113.74 174.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 150' ' ' PRO . 22.4 Cg_exo -67.58 113.88 3.1 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.89 2.393 . . . . 53.509999999999998 111.199 170.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 86.07 26.38 34.34 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 116.083 -0.508 . . . . 45.100000000000001 112.107 -173.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.21 137.22 22.92 Favored 'Isoleucine or valine' 0 C--N 1.358 0.958 0 C-N-CA 123.546 0.738 . . . . 71.099999999999994 110.671 176.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 65.3 mtm180 -134.37 164.82 26.58 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.861 0.864 . . . . 72.400000000000006 110.642 -174.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -43.29 122.28 2.5 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.177 1.791 . . . . 75.349999999999994 114.685 -171.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.18 -6.71 72.39 Favored Glycine 0 C--N 1.352 1.431 0 CA-C-O 119.376 -0.68 . . . . 73.409999999999997 114.52 176.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.1 m -60.61 123.33 17.09 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.382 0.673 . . . . 64.299999999999997 111.865 175.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.1 p -101.85 132.88 46.89 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.041 0 C-N-CA 123.172 0.589 . . . . 72.150000000000006 110.744 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.595 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 75.7 mt -106.32 104.74 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 107.465 -1.309 . . . . 62.520000000000003 107.465 176.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -78.94 105.42 10.26 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.723 -0.473 . . . . 63.219999999999999 109.723 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.553 HG13 ' HB3' ' A' ' 174' ' ' LEU . 5.8 p -113.44 100.17 51.16 Favored Pre-proline 0 CA--C 1.558 1.277 0 C-N-CA 122.717 0.407 . . . . 62.140000000000001 110.166 174.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -64.3 150.73 87.74 Favored 'Trans proline' 0 C--N 1.387 2.592 0 C-N-CA 123.713 2.942 . . . . 51.240000000000002 113.168 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 83.35 -25.38 4.99 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 116.223 -0.444 . . . . 73.0 113.988 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.54 -12.84 50.67 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.02 0.928 . . . . 62.409999999999997 111.617 -178.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -84.73 -111.87 0.66 Allowed Glycine 0 C--N 1.349 1.279 0 O-C-N 123.511 0.507 . . . . 44.200000000000003 112.654 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.605 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -61.34 120.59 23.24 Favored Glycine 0 C--N 1.346 1.136 0 O-C-N 123.818 0.364 . . . . 73.420000000000002 112.469 177.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 11.7 mm-40 -88.18 155.42 19.77 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.354 0.662 . . . . 73.420000000000002 111.269 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 129.47 -171.4 20.14 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.069 -0.969 . . . . 61.329999999999998 111.466 -175.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -60.5 -45.27 97.29 Favored Pre-proline 0 CA--C 1.564 1.487 0 CA-C-O 118.451 -0.785 . . . . 62.109999999999999 112.209 175.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -82.73 112.74 2.15 Favored 'Trans proline' 0 C--N 1.395 2.98 0 C-N-CA 121.902 1.735 . . . . 75.430000000000007 111.066 171.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.76 127.43 12.31 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.418 2.079 . . . . 74.349999999999994 112.068 -177.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -105.12 156.13 16.88 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.973 -0.558 . . . . 73.150000000000006 112.785 -175.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -84.91 135.27 34.13 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.709 0.804 . . . . 72.219999999999999 111.241 -176.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.553 ' HB3' HG13 ' A' ' 161' ' ' VAL . 23.4 tp -102.21 107.79 18.97 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.457 -0.942 . . . . 64.120000000000005 108.457 177.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 78.9 mt -86.49 100.22 12.22 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.606 0.762 . . . . 72.510000000000005 109.909 -176.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.649 ' HB3' HD23 ' A' ' 123' ' ' LEU . 75.4 mt -91.42 98.95 12.0 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.059 0.544 . . . . 71.299999999999997 110.927 -175.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 47.9 t -91.0 117.34 34.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 109.461 -0.57 . . . . 74.299999999999997 109.461 -178.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.5 p -69.73 135.43 28.28 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 C-N-CA 123.339 0.656 . . . . 62.530000000000001 110.514 -176.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -127.69 85.64 2.38 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.189 -1.041 . . . . 71.340000000000003 108.189 -178.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.475 HD21 ' HB2' ' A' ' 130' ' ' ALA . 43.5 mt -82.36 147.52 28.78 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 114.975 -1.012 . . . . 75.239999999999995 110.27 -178.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 60.4 mt -67.01 116.0 31.17 Favored Pre-proline 0 CA--C 1.551 1.0 0 N-CA-C 108.644 -0.873 . . . . 60.329999999999998 108.644 176.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -65.05 -24.73 59.43 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.552 2.168 . . . . 72.010000000000005 112.359 176.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 . . . . . 0 CA--C 1.549 0.913 0 C-N-CA 124.806 1.242 . . . . 62.409999999999997 107.688 171.355 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 3.7 mpp? . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 108.501 -0.926 . . . . 64.140000000000001 108.501 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.5 m -62.82 132.12 51.11 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.555 0.742 . . . . 51.210000000000001 111.741 -171.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.413 ' HA ' ' HD2' ' A' ' 136' ' ' ARG . 39.5 m -77.14 151.75 35.21 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.728 0.811 . . . . 73.519999999999996 110.262 176.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.743 HD12 ' HB2' ' A' ' 123' ' ' LEU . 26.7 pt -112.46 165.09 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 123.173 0.589 . . . . 73.319999999999993 110.985 -174.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -135.25 123.64 23.29 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.936 0.895 . . . . 75.420000000000002 109.528 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.544 ' HB2' HG21 ' A' ' 138' ' ' VAL . 13.2 tp -76.69 149.44 36.41 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 124.845 1.258 . . . . 73.310000000000002 110.231 -172.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.34 -51.37 20.92 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.951 0.501 . . . . 71.140000000000001 111.115 -175.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.1 mt 57.72 82.36 0.13 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.357 1.063 . . . . 71.400000000000006 111.236 -174.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 45.9 mt -96.6 150.47 37.04 Favored Pre-proline 0 N--CA 1.479 1.008 0 C-N-CA 124.613 1.165 . . . . 71.420000000000002 109.664 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -83.49 -176.34 2.71 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.375 2.05 . . . . 70.409999999999997 112.714 176.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 74.0 mt -74.22 125.66 28.89 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.138 -0.937 . . . . 74.200000000000003 111.889 -176.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 60.49 40.96 98.44 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 124.45 1.094 . . . . 71.010000000000005 113.39 173.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 25.6 p -77.38 -43.22 33.5 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.923 0.889 . . . . 54.229999999999997 110.661 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 167.84 128.89 1.02 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 110.685 -0.966 . . . . 72.530000000000001 110.685 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.62 -132.55 11.0 Favored Glycine 0 C--N 1.349 1.252 0 N-CA-C 111.711 -0.556 . . . . 74.230000000000004 111.711 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.1 m -143.76 149.6 37.33 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.284 0.634 . . . . 73.099999999999994 111.018 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -141.39 -146.6 4.75 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 114.806 -1.088 . . . . 64.019999999999996 110.995 172.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -92.91 -161.53 36.3 Favored Glycine 0 C--N 1.342 0.883 0 N-CA-C 111.998 -0.441 . . . . 74.230000000000004 111.998 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 57.8 m -148.34 113.13 5.41 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.625 -0.88 . . . . 74.420000000000002 108.625 174.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -127.25 138.5 10.56 Favored Glycine 0 C--N 1.347 1.148 0 N-CA-C 111.968 -0.453 . . . . 53.43 111.968 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -103.45 -65.93 0.72 Allowed Glycine 0 C--N 1.353 1.491 0 N-CA-C 111.452 -0.659 . . . . 53.43 111.452 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.2 m -98.94 60.73 1.24 Allowed 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.624 0.726 . . . . 74.450000000000003 109.087 173.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 151.48 90.66 0.08 OUTLIER Glycine 0 C--N 1.339 0.734 0 N-CA-C 109.641 -1.383 . . . . 72.239999999999995 109.641 -175.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.501 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 68.4 ttt180 -64.12 127.5 31.73 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.216 1.006 . . . . 73.239999999999995 112.459 -171.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -77.21 148.71 35.71 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.263 -0.881 . . . . 63.350000000000001 109.114 174.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.2 tt -140.62 131.14 25.4 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.329 -0.989 . . . . 63.119999999999997 108.329 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -93.32 115.99 28.56 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 108.895 -0.78 . . . . 73.019999999999996 108.895 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.543 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -129.15 144.24 51.14 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.339 -0.615 . . . . 72.319999999999993 109.339 -176.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -126.12 120.12 29.34 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 107.962 -1.125 . . . . 74.549999999999997 107.962 -176.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.743 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.0 pp -100.98 110.62 61.58 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 107.519 -1.289 . . . . 73.409999999999997 107.519 177.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.99 112.8 3.61 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.794 2.329 . . . . 73.409999999999997 108.876 168.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.546 HD21 HD12 ' A' ' 149' ' ' ILE . 22.9 tp -103.21 140.83 36.85 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.149 -0.686 . . . . 72.230000000000004 109.149 -168.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.7 t -78.22 162.69 26.39 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 110.101 -0.333 . . . . 60.5 110.101 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.1 mt -64.01 -36.66 84.72 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.014 0.925 . . . . 73.409999999999997 112.014 -174.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -62.19 -46.48 88.74 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.487 0.715 . . . . 73.150000000000006 109.842 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -71.87 -40.05 69.22 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.398 -1.273 . . . . 70.010000000000005 111.833 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.8 -58.34 8.99 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.57 0.7 . . . . 74.400000000000006 111.187 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -67.44 -56.7 8.54 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.441 -1.254 . . . . 65.400000000000006 111.121 -175.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -77.62 -41.41 38.6 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.246 0.219 . . . . 73.109999999999999 111.314 -170.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.59 165.03 38.96 Favored Glycine 0 C--N 1.351 1.366 0 CA-C-N 116.826 -0.17 . . . . 53.109999999999999 112.986 -176.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.05 -154.69 25.83 Favored Glycine 0 C--N 1.343 0.954 0 N-CA-C 111.796 -0.522 . . . . 51.200000000000003 111.796 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -105.89 121.26 43.72 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.416 -0.957 . . . . 74.120000000000005 108.416 172.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.413 ' HD2' ' HA ' ' A' ' 96' ' ' THR . 10.2 tpp180 -113.2 122.02 46.23 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 109.575 -0.528 . . . . 64.430000000000007 109.575 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 71.7 t -73.32 142.04 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 124.145 0.978 . . . . 64.230000000000004 110.263 175.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.544 HG21 ' HB2' ' A' ' 99' ' ' LEU . 3.1 p -135.07 126.13 45.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.866 1.266 . . . . 44.420000000000002 108.073 175.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -114.02 109.77 18.98 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.129 0.972 . . . . 74.230000000000004 109.461 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.6 m -142.72 141.83 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 124.238 1.015 . . . . 54.240000000000002 110.065 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 65.0 19.37 11.84 Favored 'General case' 0 CA--C 1.554 1.134 0 O-C-N 124.632 1.208 . . . . 72.010000000000005 111.429 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 79.99 11.34 84.6 Favored Glycine 0 C--N 1.359 1.856 0 CA-C-N 116.066 -0.515 . . . . 64.129999999999995 113.1 -174.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -116.31 124.69 50.75 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.402 1.081 . . . . 73.329999999999998 110.555 -172.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -98.21 134.22 41.56 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.894 0.877 . . . . 71.209999999999994 110.125 -179.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.1 p -147.96 141.15 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 123.544 0.738 . . . . 63.229999999999997 109.492 171.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.7 t -107.51 125.3 51.1 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.228 0.611 . . . . 32.140000000000001 109.472 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.7 p -106.96 125.9 63.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 123.381 0.672 . . . . 74.099999999999994 110.769 -177.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -78.33 102.14 7.55 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.52 0.676 . . . . 64.310000000000002 109.68 177.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.546 HD12 HD21 ' A' ' 125' ' ' LEU . 11.2 pt -92.38 144.42 28.87 Favored Pre-proline 0 CA--C 1.556 1.182 0 CA-C-N 114.507 -1.224 . . . . 73.540000000000006 109.611 174.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.2 162.12 34.41 Favored 'Trans proline' 0 CA--C 1.563 1.945 0 C-N-CA 122.636 2.224 . . . . 64.319999999999993 112.18 176.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.87 125.5 12.16 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.704 2.27 . . . . 73.030000000000001 111.803 175.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 81.81 25.81 51.83 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-O 119.892 -0.393 . . . . 71.5 112.127 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.3 p -63.94 119.92 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 C-N-CA 123.452 0.701 . . . . 75.109999999999999 110.212 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -103.63 165.89 10.76 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.126 0.97 . . . . 65.400000000000006 110.291 -171.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -49.14 134.63 17.51 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 125.37 1.669 . . . . 74.030000000000001 111.786 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.51 -11.66 68.4 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-O 119.141 -0.811 . . . . 75.239999999999995 114.35 174.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.9 t -65.54 121.19 14.35 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 117.589 0.695 . . . . 41.409999999999997 109.392 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 55.9 t -100.54 111.46 30.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 108.927 -0.768 . . . . 75.420000000000002 108.927 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 56.5 mt -88.61 103.89 14.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 107.262 -1.384 . . . . 74.340000000000003 107.262 169.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.433 ' HG3' HD23 ' A' ' 175' ' ' LEU . 59.4 ttt180 -90.44 124.7 35.18 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.249 -0.648 . . . . 73.430000000000007 109.249 -176.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.5 p -124.74 107.14 29.04 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 123.447 0.699 . . . . 73.150000000000006 109.469 174.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.2 155.19 61.33 Favored 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 122.485 2.124 . . . . 60.119999999999997 111.534 172.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.553 ' HA2' ' HB2' ' A' ' 171' ' ' PRO . . . 85.21 0.35 88.66 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 114.574 0.59 . . . . 71.109999999999999 114.574 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 55.4 mtp -121.84 -7.26 9.01 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 113.623 0.972 . . . . 73.430000000000007 113.623 -173.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -82.65 -91.12 0.64 Allowed Glycine 0 N--CA 1.471 0.981 0 CA-C-N 118.013 0.369 . . . . 75.420000000000002 112.67 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.501 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -66.09 95.4 0.24 Allowed Glycine 0 C--N 1.345 1.074 0 N-CA-C 111.527 -0.629 . . . . 72.439999999999998 111.527 173.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -83.31 110.87 18.48 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.383 0.673 . . . . 75.299999999999997 110.398 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -172.9 -146.21 5.33 Favored Glycine 0 C--O 1.241 0.563 0 N-CA-C 110.526 -1.029 . . . . 61.119999999999997 110.526 -177.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -75.86 -50.97 3.08 Favored Pre-proline 0 CA--C 1.565 1.539 0 CA-C-O 118.844 -0.598 . . . . 75.239999999999995 110.432 175.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.402 ' HA ' ' HD2' ' A' ' 171' ' ' PRO . 93.7 Cg_endo -83.6 116.68 2.29 Favored 'Trans proline' 0 C--N 1.397 3.131 0 C-N-CA 121.508 1.472 . . . . 62.409999999999997 110.751 170.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.553 ' HB2' ' HA2' ' A' ' 163' ' ' GLY . 29.4 Cg_endo -60.94 125.94 18.38 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.35 2.033 . . . . 74.540000000000006 111.368 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -99.2 163.14 20.05 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 113.864 0.306 . . . . 74.209999999999994 113.864 -174.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -86.26 144.46 27.41 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.584 0.754 . . . . 72.299999999999997 110.637 -176.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 30.7 tp -130.63 122.28 27.13 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.22 0.608 . . . . 70.549999999999997 109.525 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.433 HD23 ' HG3' ' A' ' 160' ' ' ARG . 61.6 mt -99.39 114.64 27.67 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.716 -0.846 . . . . 74.349999999999994 108.716 177.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.648 ' HB3' HD23 ' A' ' 123' ' ' LEU . 36.9 mt -102.02 100.41 10.68 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.839 -0.8 . . . . 74.400000000000006 108.839 175.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.3 p -95.53 126.09 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 109.38 -0.6 . . . . 64.129999999999995 109.38 176.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.7 p -73.23 136.05 26.32 Favored 'Isoleucine or valine' 0 C--O 1.247 0.974 0 C-N-CA 123.279 0.632 . . . . 74.129999999999995 110.256 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -123.64 103.82 8.64 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.61 -1.255 . . . . 73.109999999999999 107.61 -176.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 92.7 mt -105.8 148.29 27.68 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.995 0.918 . . . . 64.439999999999998 110.546 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 96.4 mt -54.3 142.04 50.29 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.411 1.084 . . . . 72.219999999999999 111.465 -176.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -56.38 -31.04 83.85 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.045 2.496 . . . . 53.43 112.678 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 . . . . . 0 N--CA 1.478 0.932 0 N-CA-C 109.359 -0.608 . . . . 64.230000000000004 109.359 171.172 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.505 ' HA ' HG21 ' A' ' 126' ' ' THR . 23.7 ptp . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 110.085 -0.339 . . . . 65.049999999999997 110.085 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.8 m -143.3 144.86 32.28 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.394 0.678 . . . . 71.219999999999999 109.885 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.0 p -75.4 148.01 39.52 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.653 -0.703 . . . . 75.200000000000003 110.384 170.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.564 HD12 ' HB2' ' A' ' 123' ' ' LEU . 24.0 pt -128.29 162.65 34.3 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 CA-C-N 114.521 -1.218 . . . . 73.209999999999994 109.729 -167.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -128.12 129.07 45.98 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.277 0.631 . . . . 71.010000000000005 110.122 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.687 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.8 tp -72.84 155.84 39.5 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.137 1.375 . . . . 75.409999999999997 109.331 -175.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -79.25 -38.27 35.92 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.309 0.504 . . . . 32.450000000000003 111.371 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.7 mt 54.04 75.77 0.26 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.438 1.095 . . . . 73.420000000000002 111.485 -175.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 31.5 mt -86.35 136.05 35.91 Favored Pre-proline 0 CA--C 1.553 1.092 0 CA-C-N 115.35 -0.841 . . . . 64.340000000000003 109.277 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.43 167.04 13.78 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.548 2.165 . . . . 75.200000000000003 112.439 175.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 pp -73.8 175.8 6.92 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.916 0.486 . . . . 74.409999999999997 112.282 -175.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 170.54 -54.25 0.19 Allowed Glycine 0 C--N 1.339 0.712 0 N-CA-C 110.145 -1.182 . . . . 72.030000000000001 110.145 176.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 27.0 t -168.04 121.2 0.89 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.541 -1.281 . . . . 70.0 107.541 177.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -175.17 -48.75 0.05 OUTLIER Glycine 0 C--N 1.345 1.039 0 N-CA-C 112.036 -0.426 . . . . 34.350000000000001 112.036 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -87.52 57.42 4.46 Favored Glycine 0 C--N 1.343 0.924 0 N-CA-C 112.45 -0.26 . . . . 54.399999999999999 112.45 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.7 m -68.49 147.91 51.34 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.61 0.764 . . . . 52.140000000000001 109.894 177.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 95.58 -63.74 1.33 Allowed Glycine 0 C--N 1.335 0.501 0 N-CA-C 110.637 -0.985 . . . . 44.399999999999999 110.637 -170.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 71.94 31.58 64.36 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 123.891 0.406 . . . . 55.030000000000001 112.884 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.6 m -70.81 109.36 4.95 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.595 0.758 . . . . 70.340000000000003 109.975 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.87 -13.6 4.43 Favored Glycine 0 C--N 1.342 0.864 0 CA-C-N 114.689 -1.141 . . . . 63.039999999999999 110.884 -168.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.0 -127.56 8.24 Favored Glycine 0 C--N 1.351 1.378 0 N-CA-C 111.542 -0.623 . . . . 71.420000000000002 111.542 -177.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 29.5 m -76.81 125.99 30.22 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.217 0.607 . . . . 51.299999999999997 110.254 179.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 179.49 105.63 0.2 Allowed Glycine 0 C--N 1.342 0.898 0 N-CA-C 110.989 -0.845 . . . . 72.530000000000001 110.989 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.415 ' NH2' HD12 ' A' ' 119' ' ' LEU . 6.9 tmm_? -62.79 117.48 6.39 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.805 0.842 . . . . 62.539999999999999 110.195 -175.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -78.95 128.73 33.66 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 122.981 0.512 . . . . 71.430000000000007 109.636 178.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.415 HD12 ' NH2' ' A' ' 117' ' ' ARG . 2.8 tt -119.44 117.25 27.96 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.555 -1.646 . . . . 63.520000000000003 106.555 178.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -90.4 133.38 35.04 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.272 -1.381 . . . . 75.329999999999998 107.272 176.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.687 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -156.99 140.24 15.58 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.467 -0.568 . . . . 72.040000000000006 109.467 -174.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -127.19 129.24 47.46 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 110.181 -0.303 . . . . 73.409999999999997 110.181 -172.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.564 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.1 pp -102.09 127.17 31.48 Favored Pre-proline 0 C--N 1.352 0.688 0 N-CA-C 109.575 -0.528 . . . . 51.140000000000001 109.575 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.409 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 63.0 Cg_endo -75.05 116.22 4.51 Favored 'Trans proline' 0 C--N 1.362 1.272 0 C-N-CA 122.724 2.282 . . . . 54.130000000000003 109.015 168.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.637 HD21 HD12 ' A' ' 149' ' ' ILE . 37.5 tp -103.37 146.2 28.84 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.63 0.65 . . . . 71.109999999999999 111.168 -168.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.505 HG21 ' HA ' ' A' ' 94' ' ' MET . 92.8 m -75.32 143.69 42.79 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 114.695 -1.139 . . . . 75.109999999999999 109.228 175.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.404 ' HG ' HD12 ' A' ' 181' ' ' LEU . 88.3 mt -68.26 -35.03 77.27 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.721 0.808 . . . . 72.239999999999995 112.306 -172.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -68.28 -34.46 76.2 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.023 0.529 . . . . 74.230000000000004 109.836 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.443 ' HB3' HD11 ' A' ' 149' ' ' ILE . 57.5 mm-40 -68.19 -40.13 82.29 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.342 -0.844 . . . . 74.120000000000005 110.98 176.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.514 ' HB2' HD21 ' A' ' 180' ' ' LEU . . . -68.96 -38.03 79.18 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.811 0.444 . . . . 44.210000000000001 111.96 177.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -70.66 -53.31 16.25 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.089 -0.96 . . . . 75.519999999999996 110.239 -176.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -77.16 -46.02 24.79 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.796 -0.638 . . . . 75.319999999999993 110.828 -176.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.72 94.65 0.16 Allowed Glycine 0 C--N 1.347 1.142 0 O-C-N 123.467 0.479 . . . . 61.450000000000003 112.499 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.495 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -153.17 -160.34 9.63 Favored Glycine 0 C--N 1.341 0.81 0 N-CA-C 111.989 -0.445 . . . . 55.140000000000001 111.989 -178.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -81.3 114.9 20.4 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.556 -0.535 . . . . 63.539999999999999 109.556 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -113.26 124.43 52.5 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.227 1.011 . . . . 63.210000000000001 109.163 177.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 77.3 t -78.93 111.08 15.36 Favored 'Isoleucine or valine' 0 C--O 1.245 0.824 0 CA-C-N 114.673 -1.149 . . . . 74.200000000000003 109.916 176.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.426 HG13 ' HB ' ' A' ' 145' ' ' VAL . 3.7 p -108.78 109.93 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 124.504 1.121 . . . . 64.310000000000002 108.19 170.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -110.64 133.59 53.18 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.886 0.474 . . . . 64.209999999999994 110.531 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.46 141.09 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 125.178 1.391 . . . . 70.040000000000006 110.537 175.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 60.69 25.94 15.71 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.624 1.17 . . . . 61.009999999999998 112.163 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 79.49 8.42 87.77 Favored Glycine 0 C--N 1.355 1.621 0 CA-C-N 116.062 -0.517 . . . . 55.130000000000003 113.075 -178.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.414 HH22 ' HG3' ' A' ' 167' ' ' GLN . 39.9 ttm180 -103.31 117.77 35.25 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.957 0.903 . . . . 74.099999999999994 109.475 178.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -89.53 108.34 19.6 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.908 -0.775 . . . . 74.150000000000006 108.908 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.448 HG12 HG13 ' A' ' 147' ' ' VAL . 19.0 t -104.94 112.88 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 107.9 -1.148 . . . . 63.240000000000002 107.9 178.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.1 t -101.04 107.78 19.32 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.791 -0.818 . . . . 72.109999999999999 108.791 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.448 HG13 HG12 ' A' ' 145' ' ' VAL . 27.1 m -114.27 132.35 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.251 0.62 . . . . 53.140000000000001 111.432 -174.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -88.19 97.6 11.09 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.0 0.92 . . . . 73.329999999999998 109.17 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.637 HD12 HD21 ' A' ' 125' ' ' LEU . 10.7 pt -79.96 139.05 53.27 Favored Pre-proline 0 CA--C 1.562 1.413 0 CA-C-N 115.153 -0.93 . . . . 62.329999999999998 109.652 178.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.32 149.59 63.56 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.458 2.106 . . . . 74.329999999999998 112.657 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.31 112.06 1.8 Allowed 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.525 2.15 . . . . 72.340000000000003 110.91 172.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 96.98 23.34 15.27 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-N 115.824 -0.625 . . . . 41.100000000000001 112.364 -173.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.491 HG11 ' HB ' ' A' ' 149' ' ' ILE . 6.3 p -66.78 120.17 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 108.479 -0.934 . . . . 72.540000000000006 108.479 168.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.408 ' HA ' HD12 ' A' ' 180' ' ' LEU . 24.7 mtp180 -122.45 162.52 21.52 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.235 0.614 . . . . 64.340000000000003 110.948 -173.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -42.37 128.15 3.79 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 126.276 1.83 . . . . 72.5 113.201 -175.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.46 -5.83 74.41 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-N 115.746 -0.661 . . . . 73.140000000000001 114.264 178.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 17.0 m -64.83 124.09 21.07 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.499 0.72 . . . . 70.0 111.08 174.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 176' ' ' LEU . 3.8 p -105.6 110.88 32.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 123.357 0.663 . . . . 53.439999999999998 110.079 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 58.7 mt -90.61 103.5 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 107.951 -1.129 . . . . 73.120000000000005 107.951 173.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -78.2 100.27 6.56 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.146 -0.687 . . . . 54.43 109.146 177.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.508 HG13 ' HB3' ' A' ' 174' ' ' LEU . 7.6 p -99.68 108.19 49.82 Favored Pre-proline 0 CA--C 1.56 1.357 0 N-CA-C 109.221 -0.659 . . . . 65.430000000000007 109.221 176.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.03 151.47 61.87 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 123.255 2.636 . . . . 62.329999999999998 113.539 -172.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 69.53 8.52 59.97 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-N 115.84 -0.618 . . . . 45.130000000000003 114.502 172.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 96.8 mmm -104.88 -19.72 13.79 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.127 0.971 . . . . 73.140000000000001 110.167 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -78.43 -94.73 0.27 Allowed Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.667 -0.697 . . . . 64.150000000000006 111.691 176.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -59.29 98.76 0.12 Allowed Glycine 0 C--N 1.352 1.471 0 C-N-CA 123.179 0.418 . . . . 62.009999999999998 113.4 175.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.414 ' HG3' HH22 ' A' ' 143' ' ' ARG . 12.8 mm-40 -89.51 113.55 24.95 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.38 1.072 . . . . 72.109999999999999 110.632 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 157.38 -135.19 4.27 Favored Glycine 0 C--N 1.338 0.64 0 O-C-N 123.121 0.263 . . . . 54.020000000000003 112.49 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -81.91 -43.13 1.05 Allowed Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 123.59 0.756 . . . . 73.200000000000003 111.602 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -91.69 107.24 0.26 Allowed 'Trans proline' 0 C--N 1.396 3.077 0 C-N-CA 122.337 2.025 . . . . 54.310000000000002 112.066 169.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.96 125.33 11.42 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 122.343 2.029 . . . . 70.420000000000002 111.499 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 117' ' ' ARG . . . -114.49 158.67 14.17 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 116.379 -0.373 . . . . 25.129999999999999 112.502 -177.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -83.64 148.83 26.91 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.583 0.753 . . . . 71.129999999999995 110.701 -177.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.508 ' HB3' HG13 ' A' ' 161' ' ' VAL . 39.3 tp -113.72 103.78 11.56 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 107.208 -1.404 . . . . 74.129999999999995 107.208 177.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 81.5 mt -87.04 100.67 12.8 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.786 0.834 . . . . 70.329999999999998 109.595 -173.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 158' ' ' VAL . 63.5 mt -89.34 101.66 14.34 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.874 0.87 . . . . 75.239999999999995 111.517 -172.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 24.8 t -87.3 118.46 33.28 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 108.693 -0.854 . . . . 73.299999999999997 108.693 177.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.6 p -74.59 137.08 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 C-N-CA 122.681 0.393 . . . . 61.229999999999997 110.22 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.409 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 32.0 mmt180 -124.87 89.45 3.07 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.192 0.997 . . . . 73.230000000000004 109.172 -178.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.514 HD21 ' HB2' ' A' ' 130' ' ' ALA . 32.7 mt -85.65 149.88 25.01 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.593 -0.731 . . . . 70.239999999999995 111.711 -178.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.404 HD12 ' HG ' ' A' ' 127' ' ' LEU . 55.9 mt -64.41 139.69 97.78 Favored Pre-proline 0 CA--C 1.561 1.403 0 CA-C-N 114.095 -1.411 . . . . 70.400000000000006 109.374 178.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -63.34 -5.87 9.03 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 123.726 2.95 . . . . 72.109999999999999 115.006 -171.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 62.7 t-80 . . . . . 0 C--O 1.252 1.218 0 N-CA-C 107.795 -1.187 . . . . 71.409999999999997 107.795 171.101 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 109.095 -0.706 . . . . 74.099999999999994 109.095 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.479 ' H ' HG21 ' A' ' 126' ' ' THR . 32.5 t -111.57 128.14 55.94 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.103 -0.703 . . . . 63.32 109.103 177.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 26.3 m -76.71 149.23 36.41 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.361 0.664 . . . . 60.229999999999997 110.652 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.718 HD12 ' HB2' ' A' ' 123' ' ' LEU . 25.1 pt -112.77 155.49 13.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 C-N-CA 123.452 0.701 . . . . 75.109999999999999 109.707 -166.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.51 129.58 48.92 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.97 -0.752 . . . . 24.530000000000001 108.97 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.595 ' HB3' HG21 ' A' ' 140' ' ' VAL . 12.4 tp -75.53 162.02 28.67 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.8 1.24 . . . . 75.430000000000007 109.848 -172.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.441 ' HB3' ' H ' ' A' ' 122' ' ' GLU . . . -83.06 -44.49 15.11 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.399 0.28 . . . . 53.149999999999999 111.055 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 41.7 mt 46.68 69.05 0.52 Allowed 'General case' 0 N--CA 1.482 1.159 0 O-C-N 124.313 1.008 . . . . 74.299999999999997 110.214 -169.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.432 HD12 ' HG3' ' A' ' 120' ' ' ARG . 80.8 mt -65.75 119.75 63.17 Favored Pre-proline 0 CA--C 1.549 0.929 0 CA-C-N 115.152 -0.931 . . . . 71.109999999999999 108.867 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -54.95 125.16 18.22 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.004 2.47 . . . . 60.149999999999999 112.334 -174.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.455 ' HG ' ' H ' ' A' ' 105' ' ' GLY 0.288 1.0 OUTLIER 50.94 -73.13 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 127.167 2.187 . . . . 63.530000000000001 114.644 -175.275 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.455 ' H ' ' HG ' ' A' ' 104' ' ' LEU . . . 102.31 -2.18 50.45 Favored Glycine 0 N--CA 1.482 1.722 0 CA-C-O 119.864 -0.409 . . . . 55.140000000000001 112.351 -174.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 46.6 m 58.7 51.03 8.11 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.51 1.524 . . . . 63.450000000000003 111.735 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.22 -53.81 3.55 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 114.915 -1.039 . . . . 41.219999999999999 112.704 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 63.83 23.29 67.25 Favored Glycine 0 C--N 1.352 1.457 0 O-C-N 123.862 0.389 . . . . 62.329999999999998 112.539 -173.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.7 m -125.49 128.14 47.55 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.619 1.168 . . . . 74.140000000000001 109.868 -172.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -179.21 56.27 0.09 OUTLIER Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.35 -1.1 . . . . 64.040000000000006 110.35 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 176.46 33.84 0.05 OUTLIER Glycine 0 C--N 1.341 0.854 0 CA-C-N 115.228 -0.486 . . . . 34.530000000000001 111.94 -177.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.0 p -117.21 110.51 18.23 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.383 1.073 . . . . 64.310000000000002 108.171 174.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.38 -6.61 56.88 Favored Glycine 0 C--N 1.351 1.409 0 O-C-N 123.541 0.526 . . . . 35.329999999999998 113.945 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 149.66 178.87 25.02 Favored Glycine 0 C--N 1.354 1.531 0 CA-C-N 116.915 0.358 . . . . 54.130000000000003 112.619 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 35.6 m -78.1 115.42 17.82 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.365 1.066 . . . . 71.150000000000006 110.443 178.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 177.42 73.17 0.06 OUTLIER Glycine 0 C--N 1.34 0.775 0 N-CA-C 111.622 -0.591 . . . . 71.030000000000001 111.622 -178.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -70.35 116.43 10.68 Favored 'General case' 0 C--O 1.252 1.224 0 N-CA-C 108.746 -0.835 . . . . 73.120000000000005 108.746 175.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' A' ' 173' ' ' ASP . 8.9 p-10 -84.34 149.23 26.18 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.015 -0.993 . . . . 73.209999999999994 110.81 -171.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.5 tt -130.07 136.95 49.92 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 106.998 -1.482 . . . . 40.549999999999997 106.998 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.432 ' HG3' HD12 ' A' ' 102' ' ' LEU . 10.1 tpt180 -91.43 124.89 35.95 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.766 -0.827 . . . . 61.420000000000002 108.766 -174.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.567 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -145.7 135.58 23.54 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 122.66 0.384 . . . . 51.149999999999999 110.618 -172.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.441 ' H ' ' HB3' ' A' ' 100' ' ' ALA . 9.1 mm-40 -114.13 121.86 45.08 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.544 -0.91 . . . . 64.5 108.544 -172.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.718 ' HB2' HD12 ' A' ' 97' ' ' ILE . 3.1 pp -100.37 113.61 65.48 Favored Pre-proline 0 CA--C 1.546 0.823 0 N-CA-C 107.786 -1.191 . . . . 73.129999999999995 107.786 174.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.486 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 71.9 Cg_endo -75.48 116.28 4.45 Favored 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.601 2.201 . . . . 61.310000000000002 109.391 169.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.44 HD21 HD12 ' A' ' 149' ' ' ILE . 27.1 tp -101.57 145.37 29.13 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 109.459 -0.571 . . . . 72.420000000000002 109.459 -170.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.479 HG21 ' H ' ' A' ' 95' ' ' SER . 4.7 t -91.02 156.09 18.2 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 109.145 -0.687 . . . . 71.439999999999998 109.145 -177.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 93.5 mt -60.8 -34.77 75.01 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.864 0.866 . . . . 73.340000000000003 111.765 -175.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 131' ' ' PHE . 2.1 mp0 -60.41 -48.45 81.69 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.911 0.885 . . . . 54.299999999999997 110.199 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -75.47 -34.33 60.9 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.307 -0.861 . . . . 61.340000000000003 111.891 -175.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.1 -39.8 79.55 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.113 0.483 . . . . 61.310000000000002 110.319 171.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.407 ' HB3' ' O ' ' A' ' 128' ' ' GLU . 68.8 t80 -66.07 -49.17 68.55 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.865 1.266 . . . . 73.200000000000003 111.313 177.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -74.51 -50.72 17.08 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.626 0.37 . . . . 72.420000000000002 111.829 -171.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.531 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 66.32 75.73 0.41 Allowed Glycine 0 CA--C 1.532 1.114 0 CA-C-N 115.768 -0.651 . . . . 75.319999999999993 111.603 -166.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -148.15 -165.44 12.03 Favored Glycine 0 C--N 1.343 0.946 0 N-CA-C 112.08 -0.408 . . . . 54.32 112.08 -176.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -71.92 115.18 10.83 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.513 -0.551 . . . . 74.530000000000001 109.513 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -116.01 121.23 41.62 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.33 -0.989 . . . . 71.420000000000002 108.33 174.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 70.7 t -81.29 141.73 14.76 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 C-N-CA 124.489 1.115 . . . . 75.040000000000006 109.386 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.7 p -141.45 123.6 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 123.944 0.898 . . . . 73.349999999999994 108.964 174.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -124.73 125.47 44.12 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.667 0.787 . . . . 64.109999999999999 110.345 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.595 HG21 ' HB3' ' A' ' 99' ' ' LEU . 1.6 m -151.15 131.81 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.967 1.307 . . . . 72.209999999999994 109.808 -177.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 59.14 24.28 12.62 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.236 1.015 . . . . 75.530000000000001 112.587 176.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 89.6 -7.14 82.49 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-N 116.53 -0.304 . . . . 42.420000000000002 113.499 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -94.63 114.68 26.66 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 109.088 -0.708 . . . . 75.340000000000003 109.088 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -114.57 127.89 56.03 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.179 0.591 . . . . 74.439999999999998 109.616 177.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.28 132.31 45.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 123.76 0.824 . . . . 34.420000000000002 108.826 173.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 40.9 t -94.37 127.8 40.49 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.459 -1.312 . . . . 65.329999999999998 107.459 170.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 19.7 m -120.98 127.89 76.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 109.468 -0.567 . . . . 70.049999999999997 109.468 175.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 56.1 ttt85 -76.59 109.87 10.7 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.981 -1.118 . . . . 74.329999999999998 107.981 173.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.531 HG13 ' HA2' ' A' ' 133' ' ' GLY . 12.2 pt -84.01 148.44 53.72 Favored Pre-proline 0 CA--C 1.557 1.243 0 CA-C-N 115.135 -0.939 . . . . 73.129999999999995 109.371 177.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -67.58 150.36 79.87 Favored 'Trans proline' 0 C--N 1.369 1.654 0 C-N-CA 122.485 2.123 . . . . 62.340000000000003 112.941 172.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -63.4 121.11 8.79 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.652 2.235 . . . . 50.009999999999998 111.341 171.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 76.72 30.69 55.79 Favored Glycine 0 N--CA 1.465 0.614 0 CA-C-N 116.288 -0.415 . . . . 65.430000000000007 112.115 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.9 p -61.87 125.24 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 108.967 -0.753 . . . . 72.019999999999996 108.967 170.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.476 ' HA ' HD12 ' A' ' 180' ' ' LEU . 95.6 mtt180 -116.66 153.87 31.56 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.589 0.756 . . . . 71.299999999999997 110.055 -169.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -37.56 123.28 0.99 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 126.446 1.899 . . . . 73.230000000000004 113.013 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.63 -20.07 35.06 Favored Glycine 0 N--CA 1.473 1.161 0 CA-C-O 119.207 -0.774 . . . . 71.439999999999998 113.726 178.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.1 t -61.95 121.42 12.92 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 117.491 0.645 . . . . 74.010000000000005 110.423 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.441 HG22 HG22 ' A' ' 177' ' ' VAL . 55.1 t -101.11 115.3 42.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 109.703 -0.48 . . . . 45.329999999999998 109.703 -178.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 57.7 mt -90.02 105.13 15.86 Favored 'Isoleucine or valine' 0 C--N 1.343 0.306 0 N-CA-C 107.391 -1.337 . . . . 63.140000000000001 107.391 173.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -84.52 119.44 25.18 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.037 -0.727 . . . . 71.420000000000002 109.037 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.493 HG13 ' HB3' ' A' ' 174' ' ' LEU . 6.3 p -124.48 98.16 38.31 Favored Pre-proline 0 CA--C 1.558 1.269 0 C-N-CA 123.394 0.678 . . . . 73.519999999999996 109.691 177.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 32.4 Cg_exo -61.92 150.07 87.66 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.99 2.46 . . . . 61.0 112.679 172.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.47 -16.94 51.66 Favored Glycine 0 N--CA 1.474 1.208 0 CA-C-O 119.963 -0.354 . . . . 73.329999999999998 113.807 178.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -102.14 -4.4 25.92 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.94 0.896 . . . . 52.340000000000003 111.979 -176.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.491 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -88.19 -111.59 1.09 Allowed Glycine 0 C--N 1.35 1.347 0 CA-C-O 119.397 -0.668 . . . . 73.209999999999994 113.064 -175.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -61.62 102.39 0.44 Allowed Glycine 0 C--N 1.359 1.852 0 CA-C-N 117.01 0.405 . . . . 54.439999999999998 112.739 173.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -80.69 135.29 35.99 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.953 0.501 . . . . 64.150000000000006 109.95 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 152.26 -155.75 26.31 Favored Glycine 0 C--N 1.343 0.956 0 N-CA-C 111.566 -0.613 . . . . 42.049999999999997 111.566 -178.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -66.78 -49.7 47.82 Favored Pre-proline 0 CA--C 1.559 1.297 0 CA-C-O 118.309 -0.853 . . . . 65.109999999999999 110.76 178.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.56 114.34 2.98 Favored 'Trans proline' 0 C--N 1.397 3.119 0 C-N-CA 121.392 1.395 . . . . 74.329999999999998 110.375 168.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -69.75 123.93 10.59 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 121.962 1.775 . . . . 74.430000000000007 110.036 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -100.01 159.24 19.53 Favored Glycine 0 CA--C 1.507 -0.44 0 CA-C-N 116.091 -0.504 . . . . 65.150000000000006 113.391 -171.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.491 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 34.6 t70 -91.46 151.54 20.75 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.967 0.907 . . . . 64.099999999999994 110.017 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.493 ' HB3' HG13 ' A' ' 161' ' ' VAL . 19.5 tp -127.71 119.19 25.28 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 118.104 0.411 . . . . 54.329999999999998 110.197 -179.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 97.6 mt -93.53 101.19 13.37 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.639 0.776 . . . . 75.329999999999998 109.347 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.661 ' HB3' HD23 ' A' ' 123' ' ' LEU . 48.0 mt -88.68 101.38 13.93 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.276 0.631 . . . . 74.319999999999993 109.843 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.441 HG22 HG22 ' A' ' 158' ' ' VAL . 60.7 t -86.1 115.45 27.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 109.406 -0.59 . . . . 74.310000000000002 109.406 176.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.6 p -67.64 136.69 26.11 Favored 'Isoleucine or valine' 0 C--O 1.245 0.85 0 N-CA-C 109.346 -0.612 . . . . 62.219999999999999 109.346 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.486 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 34.4 mmt180 -125.16 91.23 3.38 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.593 0.757 . . . . 65.5 109.406 -175.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 154' ' ' ARG . 26.2 mt -97.0 132.87 42.38 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 114.759 -1.11 . . . . 72.450000000000003 109.333 173.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 75.1 mt -64.46 115.71 22.36 Favored Pre-proline 0 CA--C 1.555 1.154 0 CA-C-N 115.14 -0.937 . . . . 64.340000000000003 109.914 -178.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -85.9 44.43 1.31 Allowed 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 123.582 2.854 . . . . 65.409999999999997 114.286 -165.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 27.5 p-80 . . . . . 0 CA--C 1.56 1.338 0 N-CA-C 109.576 -0.528 . . . . 75.140000000000001 109.576 174.271 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 109.263 -0.643 . . . . 61.520000000000003 109.263 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.4 m -59.9 124.12 19.18 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.051 0.941 . . . . 23.34 111.666 -171.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.516 ' HA ' ' NH1' ' A' ' 136' ' ' ARG . 81.3 m -70.76 127.9 34.23 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 123.197 0.599 . . . . 74.200000000000003 110.345 179.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.613 HD12 ' HB2' ' A' ' 123' ' ' LEU . 26.2 pt -102.87 153.62 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.588 -0.733 . . . . 70.319999999999993 110.798 -169.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -101.79 157.97 16.45 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.299 -1.0 . . . . 64.409999999999997 108.299 170.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.548 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.7 tp -90.08 -103.81 0.09 Allowed 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 109.71 -0.478 . . . . 62.439999999999998 109.71 -177.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 177.48 -56.26 0.01 OUTLIER 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.036 0.934 . . . . 63.030000000000001 108.946 -172.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.536 HD11 ' HB ' ' A' ' 140' ' ' VAL . 75.3 mt 53.21 78.55 0.14 Allowed 'General case' 0 C--N 1.361 1.099 0 C-N-CA 124.658 1.183 . . . . 64.409999999999997 110.449 -171.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 61.7 mt -83.99 139.14 39.79 Favored Pre-proline 0 C--O 1.243 0.711 0 CA-C-N 114.705 -1.134 . . . . 74.420000000000002 109.665 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -59.04 172.36 1.73 Allowed 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 122.987 2.458 . . . . 75.439999999999998 113.604 173.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.58 157.42 36.11 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.71 -1.132 . . . . 74.049999999999997 111.511 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.86 -51.25 3.51 Favored Glycine 0 C--N 1.341 0.835 0 CA-C-N 115.697 -0.683 . . . . 73.530000000000001 112.433 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.0 p -73.02 93.88 1.82 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.443 0.697 . . . . 73.340000000000003 110.614 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 158.46 108.63 0.26 Allowed Glycine 0 C--N 1.341 0.808 0 N-CA-C 109.628 -1.389 . . . . 61.530000000000001 109.628 -178.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -69.08 79.71 0.27 Allowed Glycine 0 C--N 1.357 1.712 0 C-N-CA 123.327 0.489 . . . . 54.210000000000001 114.16 -172.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.572 ' HB2' HH22 ' A' ' 120' ' ' ARG . 43.7 m -152.3 -25.67 0.17 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.278 1.031 . . . . 52.43 110.588 179.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.55 -144.4 16.72 Favored Glycine 0 C--N 1.35 1.356 0 N-CA-C 110.908 -0.877 . . . . 74.430000000000007 110.908 -171.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 171.45 50.35 0.04 OUTLIER Glycine 0 C--N 1.344 0.977 0 CA-C-N 117.113 0.457 . . . . 51.009999999999998 112.617 178.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 34.8 p -150.17 109.6 3.99 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.845 -0.798 . . . . 73.510000000000005 108.845 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 170.65 59.47 0.04 OUTLIER Glycine 0 C--N 1.342 0.888 0 N-CA-C 111.269 -0.733 . . . . 73.329999999999998 111.269 -178.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.1 171.58 28.59 Favored Glycine 0 C--N 1.345 1.057 0 O-C-N 123.951 0.442 . . . . 73.030000000000001 112.342 177.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.5 m -83.28 65.61 8.36 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.918 0.887 . . . . 63.130000000000003 110.142 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -140.41 89.25 0.19 Allowed Glycine 0 CA--C 1.508 -0.367 0 N-CA-C 109.646 -1.382 . . . . 72.120000000000005 109.646 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.468 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 14.9 tpp85 -63.97 114.32 4.03 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.5 -0.555 . . . . 73.049999999999997 109.5 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -83.46 145.9 28.7 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.955 -1.128 . . . . 73.140000000000001 107.955 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.2 tt -127.62 125.93 41.11 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.789 -1.56 . . . . 72.409999999999997 106.789 173.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.572 HH22 ' HB2' ' A' ' 109' ' ' SER . 2.0 tpp180 -91.01 131.79 36.39 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 108.042 -1.095 . . . . 75.310000000000002 108.042 -172.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.548 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -158.53 141.86 14.99 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 109.413 -0.588 . . . . 74.030000000000001 109.413 -176.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -128.87 131.45 47.65 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.725 -0.472 . . . . 73.549999999999997 109.725 -174.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.613 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.1 pp -104.2 113.79 64.91 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 120.643 0.259 . . . . 50.299999999999997 110.309 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 36.2 Cg_endo -68.44 115.73 4.03 Favored 'Trans proline' 0 C--N 1.364 1.35 0 C-N-CA 122.411 2.074 . . . . 75.25 108.962 163.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.572 HD21 HD12 ' A' ' 149' ' ' ILE . 56.6 tp -102.83 146.11 28.76 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 109.692 -0.484 . . . . 71.140000000000001 109.692 -166.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.7 t -80.99 149.9 29.12 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 123.732 0.645 . . . . 70.150000000000006 109.612 -175.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.41 -33.92 71.82 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.187 0.995 . . . . 75.439999999999998 112.373 -170.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -61.32 -51.8 67.32 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.139 0.899 . . . . 75.109999999999999 110.004 178.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.449 ' HB3' HD11 ' A' ' 149' ' ' ILE . 21.4 mm-40 -73.19 -29.87 63.14 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.838 -1.074 . . . . 71.420000000000002 112.428 -174.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.23 -48.71 74.79 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-O 121.639 0.733 . . . . 43.229999999999997 110.52 174.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -67.74 -53.94 23.34 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 113.967 -1.469 . . . . 75.329999999999998 111.089 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -86.66 -46.72 9.8 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.696 -0.684 . . . . 63.340000000000003 111.258 -171.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.71 144.42 0.99 Allowed Glycine 0 C--N 1.353 1.517 0 N-CA-C 113.996 0.358 . . . . 42.039999999999999 113.996 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.409 ' O ' HG12 ' A' ' 149' ' ' ILE . . . 158.76 -152.23 23.3 Favored Glycine 0 C--N 1.341 0.815 0 N-CA-C 111.586 -0.606 . . . . 74.319999999999993 111.586 -178.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -76.46 116.69 17.38 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.297 -0.631 . . . . 70.109999999999999 109.297 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.516 ' NH1' ' HA ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -112.06 133.41 54.24 Favored 'General case' 0 C--N 1.346 0.452 0 C-N-CA 123.173 0.589 . . . . 70.510000000000005 110.428 179.525 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 85.8 t -90.91 124.97 43.69 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 C-N-CA 124.487 1.115 . . . . 73.299999999999997 110.088 177.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 97' ' ' ILE . 5.8 p -134.24 126.23 49.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 124.606 1.162 . . . . 75.409999999999997 108.796 177.056 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -99.33 140.04 34.09 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.222 0.609 . . . . 74.439999999999998 110.726 -174.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.536 ' HB ' HD11 ' A' ' 101' ' ' LEU . 15.4 m -138.75 101.11 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 124.672 1.189 . . . . 75.5 110.303 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.0 26.63 16.09 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.924 0.89 . . . . 55.310000000000002 111.679 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.0 -6.12 58.21 Favored Glycine 0 C--N 1.352 1.462 0 CA-C-N 116.014 -0.539 . . . . 64.219999999999999 113.741 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.478 ' HB3' HG23 ' A' ' 140' ' ' VAL . 18.0 tpp85 -93.31 119.81 32.88 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.54 0.736 . . . . 75.299999999999997 109.853 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -84.08 114.31 21.66 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.25 0.62 . . . . 73.549999999999997 109.764 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.415 ' HB ' HG13 ' A' ' 138' ' ' VAL . 36.3 t -107.35 117.57 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.26 1.024 . . . . 73.109999999999999 108.698 177.048 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.5 t -103.5 119.08 38.19 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 108.442 -0.948 . . . . 62.020000000000003 108.442 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.6 m -125.72 135.84 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.79 0.836 . . . . 71.439999999999998 109.678 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 45.4 ttt85 -81.43 103.48 11.21 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.437 -0.579 . . . . 74.450000000000003 109.437 177.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.572 HD12 HD21 ' A' ' 125' ' ' LEU . 13.4 pt -79.93 142.05 55.7 Favored Pre-proline 0 CA--C 1.557 1.23 0 CA-C-N 115.032 -0.986 . . . . 74.299999999999997 109.218 172.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.61 138.79 42.67 Favored 'Trans proline' 0 CA--C 1.562 1.906 0 C-N-CA 121.979 1.786 . . . . 65.530000000000001 112.146 176.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -55.45 123.98 15.15 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 123.169 2.58 . . . . 73.310000000000002 112.88 171.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 76.56 32.17 51.77 Favored Glycine 0 C--N 1.351 1.413 0 N-CA-C 112.23 -0.348 . . . . 40.32 112.23 -177.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.87 140.28 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 123.659 0.784 . . . . 64.420000000000002 109.707 174.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 21.0 mtp180 -118.14 152.67 35.17 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.816 0.846 . . . . 73.219999999999999 109.75 -175.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -45.4 129.24 8.33 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 124.966 1.416 . . . . 64.310000000000002 111.952 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 104.75 -16.81 46.89 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-O 119.261 -0.744 . . . . 65.420000000000002 113.742 177.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.7 m -60.48 119.72 8.57 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 117.652 0.726 . . . . 71.319999999999993 111.036 177.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.431 HG22 HG22 ' A' ' 177' ' ' VAL . 49.2 t -101.24 112.34 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 109.383 -0.599 . . . . 74.319999999999993 109.383 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 63.7 mt -91.82 106.99 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 108.176 -1.046 . . . . 73.329999999999998 108.176 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 -87.46 107.24 18.47 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.173 0.589 . . . . 75.239999999999995 109.452 -177.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.59 HG13 ' HB3' ' A' ' 174' ' ' LEU . 3.3 p -104.39 100.66 23.12 Favored Pre-proline 0 CA--C 1.56 1.341 0 N-CA-C 109.706 -0.479 . . . . 60.310000000000002 109.706 175.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 58.2 Cg_endo -68.52 156.34 65.91 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.0 2.467 . . . . 64.129999999999995 112.709 -178.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 81.91 -8.33 60.32 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 114.37 0.508 . . . . 50.25 114.37 176.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 39.3 mtp -106.29 -13.0 15.51 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.387 0.675 . . . . 51.350000000000001 112.555 -175.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -84.04 -86.1 0.88 Allowed Glycine 0 C--N 1.344 1.005 0 N-CA-C 111.539 -0.625 . . . . 30.539999999999999 111.539 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.468 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -73.32 106.15 1.93 Allowed Glycine 0 C--N 1.342 0.876 0 O-C-N 123.906 0.415 . . . . 41.210000000000001 112.58 175.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -88.25 158.92 18.34 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 123.509 0.724 . . . . 60.420000000000002 109.055 175.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 132.67 -117.29 1.95 Allowed Glycine 0 C--N 1.34 0.803 0 N-CA-C 111.181 -0.768 . . . . 75.349999999999994 111.181 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.56 ' H ' ' HD2' ' A' ' 170' ' ' PRO . 95.4 m-20 -118.87 -46.16 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 CA-C-O 118.019 -0.991 . . . . 52.240000000000002 111.565 175.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.56 ' HD2' ' H ' ' A' ' 169' ' ' ASN . 74.1 Cg_endo -75.53 111.13 3.23 Favored 'Trans proline' 0 C--N 1.392 2.864 0 CA-C-N 121.083 1.422 . . . . 74.140000000000001 110.7 168.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.85 127.92 15.21 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.336 2.024 . . . . 74.409999999999997 112.051 -175.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -115.13 159.26 13.85 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 115.876 -0.602 . . . . 45.210000000000001 112.297 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.519 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 9.2 p-10 -96.12 153.18 17.93 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.876 0.87 . . . . 53.119999999999997 111.341 -171.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.59 ' HB3' HG13 ' A' ' 161' ' ' VAL . 48.1 tp -115.02 106.97 14.76 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 107.723 -1.214 . . . . 74.129999999999995 107.723 178.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 85.5 mt -84.85 104.87 15.19 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.749 0.82 . . . . 65.329999999999998 109.834 -175.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.42 HD22 HD11 ' A' ' 99' ' ' LEU . 58.4 mt -96.42 102.07 13.8 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.449 0.699 . . . . 71.549999999999997 110.528 -177.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.431 HG22 HG22 ' A' ' 158' ' ' VAL . 25.3 t -86.42 119.22 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 108.977 -0.749 . . . . 72.5 108.977 176.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 5.4 p -71.06 138.12 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 N-CA-C 108.971 -0.752 . . . . 73.450000000000003 108.971 178.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 22.0 mmm180 -127.84 100.77 6.06 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.955 0.902 . . . . 75.400000000000006 109.015 -173.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 91.8 mt -109.24 130.23 55.49 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.629 -0.714 . . . . 71.209999999999994 109.545 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 75.3 mt -60.3 145.28 86.42 Favored Pre-proline 0 CA--C 1.548 0.871 0 O-C-N 124.449 1.093 . . . . 72.510000000000005 110.926 -176.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.73 -29.86 27.28 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 123.671 2.914 . . . . 73.310000000000002 113.672 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 . . . . . 0 C--O 1.249 1.07 0 N-CA-C 108.674 -0.862 . . . . 74.200000000000003 108.674 170.807 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 69.8 mtm . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 108.749 -0.834 . . . . 73.040000000000006 108.749 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.1 p -75.87 146.24 39.94 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.763 0.825 . . . . 75.150000000000006 111.654 -173.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 42.9 m -81.28 145.99 30.63 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.068 0.947 . . . . 74.450000000000003 110.396 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.6 pt -128.75 172.19 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.971 0.908 . . . . 72.319999999999993 110.344 -176.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -134.15 147.98 50.87 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.234 1.013 . . . . 74.430000000000007 110.044 -176.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.555 ' HB3' HG11 ' A' ' 140' ' ' VAL . 11.5 tp -85.2 173.91 10.05 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.69 -0.856 . . . . 73.239999999999995 108.69 -177.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -97.19 -33.47 11.47 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.974 -0.454 . . . . 74.109999999999999 111.855 175.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.2 mt 49.98 61.96 2.91 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.706 0.803 . . . . 74.450000000000003 110.668 -171.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 71.6 mt -64.46 111.0 4.67 Favored Pre-proline 0 CA--C 1.556 1.203 0 CA-C-N 115.616 -0.72 . . . . 54.119999999999997 109.289 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.25 166.22 17.58 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.205 1.937 . . . . 62.439999999999998 112.085 -173.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.53 83.64 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.194 0 CA-C-O 121.782 0.801 . . . . 62.340000000000003 111.827 177.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.72 -30.16 45.04 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 114.955 -1.02 . . . . 64.530000000000001 111.286 174.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.1 t -120.21 166.35 13.58 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.421 1.088 . . . . 75.230000000000004 108.696 173.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.7 150.09 34.08 Favored Glycine 0 C--N 1.342 0.902 0 CA-C-N 116.251 -0.431 . . . . 75.310000000000002 112.56 178.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -85.99 -168.5 44.84 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-O 121.164 0.313 . . . . 73.150000000000006 112.978 175.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.8 m -106.0 150.69 25.48 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.89 0.876 . . . . 73.299999999999997 109.981 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -156.15 -157.74 8.47 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.851 -0.5 . . . . 61.310000000000002 111.851 178.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 164.78 -155.13 26.35 Favored Glycine 0 C--N 1.349 1.288 0 CA-C-N 117.113 0.457 . . . . 70.099999999999994 112.873 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.0 t -64.03 -42.43 97.1 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.271 1.028 . . . . 73.019999999999996 110.965 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -119.58 14.85 10.68 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.494 -0.642 . . . . 73.430000000000007 111.494 172.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -91.53 91.88 1.67 Allowed Glycine 0 C--N 1.346 1.107 0 N-CA-C 111.331 -0.707 . . . . 71.340000000000003 111.331 178.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 54.6 m -132.65 104.3 6.57 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.947 0.899 . . . . 64.530000000000001 109.368 177.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 171.81 108.83 0.22 Allowed Glycine 0 C--N 1.344 0.986 0 N-CA-C 110.801 -0.92 . . . . 32.530000000000001 110.801 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.483 ' O ' ' HA3' ' A' ' 172' ' ' GLY . 28.6 ttm180 -72.79 122.81 22.16 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.536 0.735 . . . . 73.109999999999999 111.132 -178.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -84.65 135.76 34.04 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.191 -1.04 . . . . 71.109999999999999 108.191 174.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.8 tt -110.33 125.58 53.33 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 105.688 -1.967 . . . . 73.430000000000007 105.688 174.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.463 ' HG2' HD12 ' A' ' 175' ' ' LEU . 27.5 mtp180 -91.96 144.54 25.36 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.361 -0.977 . . . . 64.430000000000007 108.361 -175.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.545 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -158.75 156.44 29.83 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.625 -0.509 . . . . 64.409999999999997 109.625 -174.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -129.37 138.85 51.76 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.994 -0.743 . . . . 73.040000000000006 108.994 176.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 55.7 tp -110.43 101.7 49.3 Favored Pre-proline 0 CA--C 1.538 0.482 0 O-C-N 123.815 0.697 . . . . 71.209999999999994 109.842 -175.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.9 112.47 3.11 Favored 'Trans proline' 0 C--N 1.372 1.81 0 N-CA-C 108.253 -1.479 . . . . 53.329999999999998 108.253 169.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.499 HD21 HD12 ' A' ' 149' ' ' ILE . 35.1 tp -104.87 138.02 41.75 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.47 -0.567 . . . . 73.319999999999993 109.47 -168.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.0 t -81.76 153.94 26.24 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 109.124 -0.695 . . . . 71.439999999999998 109.124 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 74.2 mt -61.67 -33.61 74.28 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.525 0.73 . . . . 74.329999999999998 112.195 -169.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.0 -44.16 97.82 Favored 'General case' 0 C--O 1.22 -0.488 0 O-C-N 124.311 1.007 . . . . 63.100000000000001 109.477 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -79.15 -29.22 42.95 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.369 -0.832 . . . . 74.530000000000001 112.101 -175.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.52 -39.8 89.16 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.342 0.591 . . . . 62.539999999999999 110.21 172.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -74.07 -57.22 4.11 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 114.715 -1.13 . . . . 72.310000000000002 110.748 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -61.32 -50.61 72.26 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.122 0.569 . . . . 72.030000000000001 110.923 -173.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.609 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 63.71 67.7 1.95 Allowed Glycine 0 C--N 1.337 0.616 0 CA-C-N 114.763 -1.108 . . . . 65.120000000000005 112.128 -172.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -134.15 -160.0 9.09 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 112.508 -0.237 . . . . 63.450000000000003 112.508 -177.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -82.42 116.75 22.02 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.081 -0.711 . . . . 62.140000000000001 109.081 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -114.13 126.68 55.35 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.277 0.631 . . . . 74.099999999999994 109.338 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 83.0 t -70.52 110.61 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 124.305 1.003 . . . . 74.439999999999998 108.85 173.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.9 t -113.87 109.75 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 108.286 -1.005 . . . . 62.240000000000002 108.286 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -117.15 124.52 49.36 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.351 -0.611 . . . . 73.299999999999997 109.351 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.555 HG11 ' HB3' ' A' ' 99' ' ' LEU . 5.8 p -149.63 136.09 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.71 1.204 . . . . 74.310000000000002 108.601 -175.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.89 18.76 10.09 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.086 0.954 . . . . 75.010000000000005 112.322 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 88.01 -5.93 84.19 Favored Glycine 0 C--N 1.35 1.344 0 CA-C-N 116.075 -0.511 . . . . 61.0 113.183 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -94.99 121.87 37.06 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.265 1.026 . . . . 75.510000000000005 109.525 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -108.14 115.28 29.84 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.031 0.933 . . . . 75.430000000000007 110.31 -174.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.8 p -126.04 119.37 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.239 1.015 . . . . 74.230000000000004 109.601 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 39.5 t -88.32 108.71 19.47 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 109.205 -0.665 . . . . 73.349999999999994 109.205 176.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.2 p -100.76 127.61 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 123.014 0.526 . . . . 71.439999999999998 110.802 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -85.01 103.04 13.69 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.792 -0.818 . . . . 71.549999999999997 108.792 172.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.609 HG13 ' HA2' ' A' ' 133' ' ' GLY . 11.6 pt -86.64 151.79 53.4 Favored Pre-proline 0 CA--C 1.562 1.424 0 C-N-CA 124.518 1.127 . . . . 71.430000000000007 109.507 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.442 ' HG2' ' HB ' ' A' ' 153' ' ' VAL . 55.2 Cg_endo -71.37 146.32 50.22 Favored 'Trans proline' 0 CA--C 1.565 2.049 0 C-N-CA 122.108 1.872 . . . . 53.350000000000001 112.514 174.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.407 ' HA ' ' HA3' ' A' ' 133' ' ' GLY . 23.6 Cg_exo -67.11 124.92 12.79 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.991 2.461 . . . . 62.399999999999999 112.036 174.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 81.18 24.52 57.14 Favored Glycine 0 C--N 1.35 1.318 0 O-C-N 123.478 0.486 . . . . 30.120000000000001 112.101 -175.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.442 ' HB ' ' HG2' ' A' ' 150' ' ' PRO . 4.4 p -60.65 128.83 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 123.959 0.903 . . . . 72.340000000000003 109.413 173.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.468 ' HA ' HD12 ' A' ' 180' ' ' LEU . 76.9 mtp180 -123.56 166.43 15.46 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.118 0.567 . . . . 62.030000000000001 110.047 -175.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -45.31 129.62 8.16 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 125.709 1.604 . . . . 75.439999999999998 113.357 -172.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.92 -2.66 66.6 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-O 119.404 -0.664 . . . . 65.019999999999996 114.623 175.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.6 t -69.56 122.34 18.87 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 117.651 0.725 . . . . 61.439999999999998 109.57 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 45.6 t -101.2 113.18 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.186 0.594 . . . . 75.5 109.886 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 51.6 mt -91.52 117.63 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 107.886 -1.153 . . . . 72.310000000000002 107.886 170.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -104.97 101.11 10.7 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.924 -0.769 . . . . 73.030000000000001 108.924 -173.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.4 p -107.76 107.72 60.64 Favored Pre-proline 0 CA--C 1.556 1.199 0 C-N-CA 123.148 0.579 . . . . 70.519999999999996 110.722 -176.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.553 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 59.8 Cg_endo -69.37 147.34 65.19 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.561 2.174 . . . . 44.439999999999998 112.709 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.41 -3.14 87.64 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 115.794 -0.639 . . . . 64.530000000000001 113.527 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 24.7 mmt -103.42 -16.94 15.45 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.304 0.641 . . . . 73.299999999999997 110.772 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -91.58 -108.17 1.56 Allowed Glycine 0 C--N 1.349 1.302 0 CA-C-O 119.541 -0.589 . . . . 53.439999999999998 113.173 -175.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -60.43 100.39 0.22 Allowed Glycine 0 C--N 1.349 1.28 0 O-C-N 123.861 0.389 . . . . 65.140000000000001 112.661 177.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -88.34 116.26 26.43 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 124.04 0.936 . . . . 54.039999999999999 109.169 177.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 160.15 -149.21 18.5 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.5 -0.64 . . . . 54.219999999999999 111.5 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -70.97 -48.96 13.68 Favored Pre-proline 0 CA--C 1.561 1.369 0 CA-C-O 117.9 -1.047 . . . . 75.340000000000003 111.822 177.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.425 ' HA ' ' HD3' ' A' ' 171' ' ' PRO . 87.0 Cg_endo -81.81 110.62 2.14 Favored 'Trans proline' 0 C--N 1.391 2.801 0 C-N-CA 121.572 1.514 . . . . 74.0 110.749 174.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 170' ' ' PRO . 14.4 Cg_exo -67.79 123.6 10.91 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.358 2.039 . . . . 75.519999999999996 110.807 -174.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 117' ' ' ARG . . . -115.67 152.09 18.16 Favored Glycine 0 C--N 1.335 0.477 0 N-CA-C 114.004 0.361 . . . . 43.219999999999999 114.004 -172.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.553 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 6.8 p-10 -91.66 155.64 18.17 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.516 1.126 . . . . 71.019999999999996 110.53 178.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 41.3 tp -112.97 115.52 28.52 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.947 -0.76 . . . . 51.409999999999997 108.947 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.463 HD12 ' HG2' ' A' ' 120' ' ' ARG . 73.5 mt -84.53 106.93 16.48 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.102 0.961 . . . . 70.430000000000007 109.513 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 27.2 mt -99.54 98.75 9.6 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.843 -0.799 . . . . 72.420000000000002 108.843 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 8.5 p -95.75 110.69 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 109.092 -0.706 . . . . 74.230000000000004 109.092 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.0 p -66.67 143.77 15.28 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 123.299 0.64 . . . . 53.109999999999999 111.275 -172.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -126.14 103.11 7.52 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 125.042 1.337 . . . . 75.439999999999998 108.192 -174.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 154' ' ' ARG . 91.8 mt -113.45 131.42 56.03 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.53 0.732 . . . . 55.340000000000003 109.984 177.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 81.4 mt -71.04 125.81 92.02 Favored Pre-proline 0 CA--C 1.548 0.896 0 N-CA-C 108.374 -0.972 . . . . 72.310000000000002 108.374 173.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.37 -28.7 73.82 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.842 2.361 . . . . 62.25 113.107 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 . . . . . 0 C--O 1.246 0.897 0 C-N-CA 124.734 1.214 . . . . 62.539999999999999 107.961 174.998 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.509 ' HB3' ' NH2' ' A' ' 136' ' ' ARG . 59.1 mtt . . . . . 0 N--CA 1.477 0.886 0 N-CA-C 109.299 -0.63 . . . . 52.509999999999998 109.299 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.1 m -70.66 134.17 47.3 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.454 0.702 . . . . 73.120000000000005 111.062 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.6 m -73.55 138.35 44.93 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.938 0.495 . . . . 71.129999999999995 109.73 174.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.64 HD12 ' HB2' ' A' ' 123' ' ' LEU . 21.3 pt -109.53 175.42 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 122.992 0.517 . . . . 64.109999999999999 111.547 -166.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -122.81 -167.62 1.61 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.388 1.075 . . . . 72.019999999999996 109.617 173.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.689 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.9 tp -142.06 156.26 45.4 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 108.655 -0.868 . . . . 72.239999999999995 108.655 -175.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.415 ' HB3' ' H ' ' A' ' 122' ' ' GLU . . . -78.44 -56.99 4.01 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.269 0.228 . . . . 43.020000000000003 110.468 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 95.9 mt 60.19 73.49 0.48 Allowed 'General case' 0 CA--C 1.553 1.078 0 O-C-N 124.366 1.041 . . . . 74.319999999999993 109.902 -170.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 79.5 mt -70.89 155.94 92.69 Favored Pre-proline 0 CA--C 1.561 1.382 0 C-N-CA 125.251 1.421 . . . . 75.519999999999996 111.766 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.16 -170.64 0.43 Allowed 'Trans proline' 0 C--N 1.386 2.532 0 C-N-CA 123.307 2.671 . . . . 73.030000000000001 113.646 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 pp -72.12 2.4 5.89 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 114.393 1.257 . . . . 74.230000000000004 114.393 -169.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -73.59 81.75 0.72 Allowed Glycine 0 C--N 1.352 1.465 0 CA-C-N 118.192 0.451 . . . . 64.120000000000005 112.606 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 73.1 p -157.19 127.55 6.44 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.774 0.83 . . . . 72.430000000000007 110.822 -178.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.44 77.56 1.68 Allowed Glycine 0 C--N 1.341 0.844 0 N-CA-C 110.7 -0.96 . . . . 62.100000000000001 110.7 172.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.54 89.17 0.04 OUTLIER Glycine 0 C--N 1.355 1.629 0 C-N-CA 123.874 0.749 . . . . 64.310000000000002 112.539 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.3 m -96.13 119.89 35.43 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.252 1.021 . . . . 44.310000000000002 110.572 -176.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -141.53 159.7 26.82 Favored Glycine 0 C--N 1.343 0.931 0 N-CA-C 111.541 -0.624 . . . . 33.240000000000002 111.541 176.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.64 -50.53 53.73 Favored Glycine 0 C--N 1.35 1.339 0 O-C-N 123.766 0.333 . . . . 73.030000000000001 112.525 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 65.1 p -89.27 141.48 28.49 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.425 0.69 . . . . 53.350000000000001 109.844 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -98.43 136.71 12.86 Favored Glycine 0 C--N 1.345 1.047 0 O-C-N 123.265 0.353 . . . . 43.329999999999998 112.397 -177.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -171.69 163.86 36.51 Favored Glycine 0 C--N 1.344 1.017 0 N-CA-C 112.244 -0.342 . . . . 74.200000000000003 112.244 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.0 t -84.27 143.26 29.67 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.285 0.634 . . . . 73.219999999999999 110.274 177.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 144.33 96.45 0.22 Allowed Glycine 0 C--N 1.34 0.769 0 N-CA-C 109.894 -1.282 . . . . 55.119999999999997 109.894 -176.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -61.2 123.69 18.41 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.584 0.753 . . . . 74.120000000000005 111.293 -175.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -74.63 116.23 15.09 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 108.736 -0.838 . . . . 62.340000000000003 108.736 172.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.7 tt -94.9 118.89 32.53 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 106.735 -1.58 . . . . 64.209999999999994 106.735 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -90.98 141.66 28.61 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 108.726 -0.842 . . . . 71.409999999999997 108.726 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.689 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -153.25 142.77 21.77 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.821 -0.627 . . . . 64.030000000000001 109.545 -171.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.459 ' HB3' ' HG3' ' A' ' 179' ' ' ARG . 35.3 mt-10 -119.69 118.3 30.56 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.181 -1.044 . . . . 62.030000000000001 108.181 -174.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.64 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.6 pp -100.74 113.91 65.71 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 108.914 -0.772 . . . . 74.329999999999998 108.914 176.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.13 113.95 3.91 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 121.864 1.709 . . . . 41.039999999999999 109.335 170.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.571 HD21 HD12 ' A' ' 149' ' ' ILE . 36.1 tp -103.12 151.05 23.03 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 122.004 -0.435 . . . . 70.430000000000007 110.601 -167.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 13.4 t -85.61 154.61 21.59 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.955 -0.757 . . . . 72.049999999999997 108.955 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 39.3 mt -70.78 -26.68 63.45 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.215 0.606 . . . . 72.230000000000004 111.805 -167.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -73.49 -41.82 62.63 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.397 -0.82 . . . . 62.219999999999999 110.08 -178.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.471 ' HB3' HD11 ' A' ' 149' ' ' ILE . 34.1 mm-40 -74.4 -31.26 62.27 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.185 -0.916 . . . . 72.129999999999995 111.158 177.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.71 -50.83 70.87 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.425 0.69 . . . . 73.530000000000001 110.5 176.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -66.67 -62.89 1.22 Allowed 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 114.223 -1.353 . . . . 72.099999999999994 110.641 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -70.32 -43.75 69.65 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.929 0.491 . . . . 71.239999999999995 111.89 -171.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.43 97.56 0.05 OUTLIER Glycine 0 C--N 1.346 1.103 0 O-C-N 123.816 0.697 . . . . 61.340000000000003 113.063 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.4 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -144.06 -143.64 4.09 Favored Glycine 0 C--N 1.342 0.883 0 N-CA-C 111.097 -0.801 . . . . 70.010000000000005 111.097 178.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -96.26 119.07 34.09 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.845 -0.798 . . . . 72.140000000000001 108.845 176.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.509 ' NH2' ' HB3' ' A' ' 94' ' ' MET . 11.0 tpp180 -116.98 123.79 47.78 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.412 0.685 . . . . 71.120000000000005 109.386 176.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 146' ' ' SER . 76.2 t -74.47 136.9 24.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 C-N-CA 123.621 0.768 . . . . 72.310000000000002 110.683 177.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.455 ' HB ' HG13 ' A' ' 145' ' ' VAL . 39.1 t -115.59 126.17 73.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.29 1.436 . . . . 61.509999999999998 107.615 174.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -115.23 101.51 9.02 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.632 -0.507 . . . . 72.140000000000001 109.632 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.66 144.16 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 123.719 0.808 . . . . 74.319999999999993 110.907 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 65.32 18.69 11.45 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.283 1.433 . . . . 64.540000000000006 111.746 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.19 21.76 69.71 Favored Glycine 0 C--N 1.351 1.37 0 CA-C-N 116.016 -0.538 . . . . 72.439999999999998 112.257 -175.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -122.45 140.06 53.15 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.923 0.889 . . . . 63.009999999999998 110.204 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -102.69 125.32 49.38 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.206 1.002 . . . . 71.420000000000002 108.719 177.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.455 HG13 ' HB ' ' A' ' 138' ' ' VAL . 3.5 p -137.78 112.26 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 CA-C-O 121.54 0.686 . . . . 73.0 110.2 176.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 137' ' ' VAL . 46.4 t -90.43 106.0 18.2 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.189 -0.671 . . . . 53.310000000000002 109.189 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 28.7 m -100.62 141.15 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.232 0.613 . . . . 72.150000000000006 110.13 -178.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.1 ttp180 -90.84 117.47 29.48 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.284 -0.635 . . . . 73.319999999999993 109.284 177.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.571 HD12 HD21 ' A' ' 125' ' ' LEU . 9.1 pt -100.49 139.77 20.89 Favored Pre-proline 0 CA--C 1.561 1.378 0 C-N-CA 124.871 1.268 . . . . 73.239999999999995 109.307 176.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -63.14 152.46 79.52 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 123.083 2.522 . . . . 74.109999999999999 113.695 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.47 121.3 9.04 Favored 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 122.272 1.981 . . . . 62.509999999999998 111.228 171.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 85.21 23.64 47.51 Favored Glycine 0 C--N 1.346 1.084 0 N-CA-C 112.13 -0.388 . . . . 45.509999999999998 112.13 -176.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.493 HG11 ' HB ' ' A' ' 149' ' ' ILE . 4.1 p -63.53 117.45 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 123.784 0.833 . . . . 61.109999999999999 109.853 177.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.528 ' HA ' HD12 ' A' ' 180' ' ' LEU . 82.0 mtm180 -132.89 161.93 32.93 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 115.923 -0.58 . . . . 74.310000000000002 110.847 -172.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -35.29 119.77 0.51 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.881 2.072 . . . . 55.240000000000002 113.838 -169.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.24 -12.14 48.13 Favored Glycine 0 N--CA 1.473 1.145 0 CA-C-O 119.297 -0.724 . . . . 71.430000000000007 114.552 177.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 33.5 t -66.22 122.3 17.15 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 117.832 0.816 . . . . 51.049999999999997 109.243 176.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.0 t -110.0 114.55 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.347 0.659 . . . . 74.140000000000001 110.402 -176.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 56.0 mt -92.48 120.6 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 108.355 -0.98 . . . . 72.329999999999998 108.355 172.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -104.67 116.63 32.38 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.305 0.642 . . . . 74.319999999999993 110.143 -176.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.489 HG13 ' HB3' ' A' ' 174' ' ' LEU . 3.3 p -120.45 108.58 37.52 Favored Pre-proline 0 CA--C 1.559 1.316 0 C-N-CA 123.031 0.532 . . . . 70.510000000000005 110.725 176.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.418 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 16.7 Cg_exo -67.59 153.46 76.23 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.886 2.391 . . . . 65.400000000000006 112.267 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.01 -24.19 8.3 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-O 119.864 -0.409 . . . . 72.239999999999995 113.909 177.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 92.9 mmm -92.44 -4.92 52.96 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.66 0.784 . . . . 60.229999999999997 111.224 -177.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -91.21 -103.02 1.3 Allowed Glycine 0 C--N 1.344 1.007 0 CA-C-O 119.719 -0.49 . . . . 64.519999999999996 112.409 -177.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.52 103.8 0.88 Allowed Glycine 0 C--N 1.352 1.418 0 N-CA-C 111.467 -0.653 . . . . 72.109999999999999 111.467 175.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.544 ' HA ' HE21 ' A' ' 167' ' ' GLN . 0.0 OUTLIER -87.76 121.47 30.22 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.484 0.714 . . . . 71.340000000000003 110.72 -174.923 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 169.88 -146.21 9.82 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 110.633 -0.987 . . . . 75.439999999999998 110.633 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -76.79 -49.15 2.68 Favored Pre-proline 0 CA--C 1.56 1.331 0 CA-C-O 118.075 -0.964 . . . . 72.319999999999993 109.332 172.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -81.61 112.62 2.46 Favored 'Trans proline' 0 C--N 1.4 3.243 0 C-N-CA 122.173 1.915 . . . . 61.43 111.316 170.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.43 127.75 11.36 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 122.502 2.135 . . . . 52.340000000000003 112.239 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -104.88 165.88 14.62 Favored Glycine 0 C--N 1.344 1.022 0 CA-C-N 116.365 -0.38 . . . . 73.340000000000003 112.256 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 15.2 m-20 -86.25 142.71 28.37 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.855 0.862 . . . . 51.240000000000002 110.773 -177.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.489 ' HB3' HG13 ' A' ' 161' ' ' VAL . 34.5 tp -105.35 104.62 14.39 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 107.934 -1.136 . . . . 75.040000000000006 107.934 175.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 51.1 mt -88.46 101.17 13.66 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.197 -0.91 . . . . 73.209999999999994 109.282 -175.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 48.0 mt -97.1 101.11 12.61 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.896 0.878 . . . . 71.200000000000003 110.455 -174.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.3 p -92.48 130.33 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 109.893 -0.41 . . . . 63.149999999999999 109.893 175.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 14.1 p -77.54 133.81 29.83 Favored 'Isoleucine or valine' 0 C--O 1.248 0.999 0 C-N-CA 123.338 0.655 . . . . 72.319999999999993 110.053 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.459 ' HG3' ' HB3' ' A' ' 122' ' ' GLU . 9.1 mmm180 -122.6 96.38 5.01 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.167 0.987 . . . . 74.450000000000003 108.795 -174.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.528 HD12 ' HA ' ' A' ' 154' ' ' ARG . 64.5 mt -101.23 147.65 26.03 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.657 -0.701 . . . . 71.519999999999996 110.588 177.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 61.4 mt -74.83 157.09 86.08 Favored Pre-proline 0 CA--C 1.556 1.186 0 CA-C-N 114.998 -1.001 . . . . 74.439999999999998 108.717 171.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.13 2.26 5.11 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.267 1.978 . . . . 73.349999999999994 112.991 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 . . . . . 0 CA--C 1.554 1.117 0 C-N-CA 124.672 1.189 . . . . 73.310000000000002 108.968 174.01 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 CA--C 1.545 0.766 0 N-CA-C 109.719 -0.474 . . . . 52.299999999999997 109.719 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.431 ' H ' HG21 ' A' ' 126' ' ' THR . 23.0 t -82.01 132.65 35.26 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.397 0.679 . . . . 72.329999999999998 110.251 178.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.425 ' HA ' HH11 ' A' ' 136' ' ' ARG . 63.9 m -76.05 143.04 41.61 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.607 0.763 . . . . 71.239999999999995 110.052 174.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.624 HD12 ' HB2' ' A' ' 123' ' ' LEU . 15.6 pt -121.4 173.02 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 123.012 0.525 . . . . 75.239999999999995 111.651 -165.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -124.86 -172.39 2.56 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.321 1.048 . . . . 42.520000000000003 109.541 174.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.649 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.6 tp -131.65 148.91 52.63 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 107.677 -1.231 . . . . 75.329999999999998 107.677 -177.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.48 -43.16 67.1 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 117.983 0.356 . . . . 65.319999999999993 110.949 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 41.8 mt 53.01 79.62 0.12 Allowed 'General case' 0 N--CA 1.477 0.916 0 O-C-N 124.473 1.108 . . . . 75.129999999999995 110.907 -173.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 35.0 mt -86.37 121.26 72.47 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 108.29 -1.004 . . . . 74.010000000000005 108.29 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.46 87.35 0.27 Allowed 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 122.512 2.141 . . . . 73.519999999999996 112.497 -177.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.466 ' HG ' ' HA2' ' A' ' 110' ' ' GLY . 2.9 mm? 64.84 -81.33 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.403 1.481 . . . . 73.540000000000006 112.212 174.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -145.55 -175.62 18.8 Favored Glycine 0 C--N 1.34 0.792 0 O-C-N 123.473 0.483 . . . . 64.219999999999999 112.125 -176.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 23.2 t -65.46 130.62 43.97 Favored 'General case' 0 CA--C 1.546 0.788 0 C-N-CA 123.55 0.74 . . . . 73.340000000000003 111.189 -176.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 82.0 7.96 87.21 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 115.904 -0.589 . . . . 41.420000000000002 112.792 -177.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.38 32.76 59.56 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-N 116.76 0.28 . . . . 70.230000000000004 112.575 -176.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 35.3 p -73.78 96.55 2.57 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.071 0.548 . . . . 72.420000000000002 110.251 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.466 ' HA2' ' HG ' ' A' ' 104' ' ' LEU . . . -77.37 69.2 2.58 Favored Glycine 0 C--N 1.35 1.351 0 CA-C-N 115.872 -0.604 . . . . 24.350000000000001 112.305 177.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -92.44 49.36 2.64 Favored Glycine 0 C--N 1.343 0.971 0 C-N-CA 123.031 0.348 . . . . 71.430000000000007 113.089 -173.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 27.5 p -98.28 137.43 37.03 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 109.278 -0.638 . . . . 53.399999999999999 109.278 175.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -73.54 -81.3 0.41 Allowed Glycine 0 C--N 1.351 1.388 0 O-C-N 123.638 0.586 . . . . 73.400000000000006 113.481 -173.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -115.34 -150.82 9.84 Favored Glycine 0 C--N 1.346 1.132 0 N-CA-C 111.935 -0.466 . . . . 54.340000000000003 111.935 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 47.6 p -65.47 91.94 0.13 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.302 1.041 . . . . 55.119999999999997 111.071 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 153.93 55.94 0.01 OUTLIER Glycine 0 C--N 1.344 1.012 0 CA-C-N 115.849 -0.614 . . . . 73.439999999999998 112.132 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.457 ' HD2' HD21 ' A' ' 104' ' ' LEU . 21.4 ttp180 -68.49 124.08 22.58 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.67 0.788 . . . . 74.519999999999996 111.327 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -91.38 111.19 22.58 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.627 0.771 . . . . 73.329999999999998 109.984 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.0 tt -95.18 127.32 41.14 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 106.885 -1.524 . . . . 61.009999999999998 106.885 173.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -90.04 124.03 34.42 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 107.831 -1.174 . . . . 64.430000000000007 107.831 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.649 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -146.15 144.85 30.23 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.156 0.582 . . . . 73.299999999999997 110.121 -173.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -128.75 131.11 47.84 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.655 0.382 . . . . 75.510000000000005 110.144 -177.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.624 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.2 pp -107.61 119.71 49.66 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 109.223 -0.658 . . . . 74.329999999999998 109.223 177.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.562 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 66.9 Cg_endo -74.14 113.94 3.91 Favored 'Trans proline' 0 C--N 1.364 1.385 0 C-N-CA 122.512 2.142 . . . . 45.530000000000001 109.404 169.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 42.1 tp -102.66 154.17 19.41 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 109.326 -0.62 . . . . 74.200000000000003 109.326 -168.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.431 HG21 ' H ' ' A' ' 95' ' ' SER . 1.5 t -91.27 148.02 22.64 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 108.154 -1.054 . . . . 74.450000000000003 108.154 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.401 HD23 HD22 ' A' ' 180' ' ' LEU . 89.4 mt -64.41 -27.47 69.02 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.106 0.562 . . . . 65.439999999999998 111.883 -172.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.24 -41.76 85.1 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.799 0.839 . . . . 74.510000000000005 110.035 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.417 ' HG3' ' HE ' ' A' ' 136' ' ' ARG . 21.5 mm-40 -75.07 -34.78 61.84 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.384 0.674 . . . . 73.209999999999994 111.345 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.72 -34.62 73.16 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.287 0.635 . . . . 62.130000000000003 110.817 171.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -76.34 -46.81 25.85 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 114.773 -1.103 . . . . 74.409999999999997 111.437 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 34.3 m80 -73.54 -49.97 23.75 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 120.804 0.335 . . . . 74.25 111.457 -173.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.444 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 70.44 66.22 2.26 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-N 115.422 -0.808 . . . . 52.509999999999998 112.226 -173.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -134.44 -158.76 8.58 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 112.45 -0.26 . . . . 54.530000000000001 112.45 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -74.98 115.1 14.21 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.594 0.758 . . . . 62.210000000000001 109.058 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.425 HH11 ' HA ' ' A' ' 96' ' ' THR . 5.0 tpp180 -114.34 120.61 40.96 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.233 0.54 . . . . 62.299999999999997 109.72 178.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 88.1 t -77.17 111.73 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.712 0 CA-C-N 114.825 -1.08 . . . . 50.32 110.124 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 43.6 t -102.89 112.07 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.97 1.308 . . . . 73.019999999999996 107.905 172.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -115.13 115.2 26.37 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.008 -0.738 . . . . 74.510000000000005 109.008 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.547 HG11 ' HB3' ' A' ' 99' ' ' LEU . 7.6 p -151.61 138.29 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 124.209 1.004 . . . . 63.450000000000003 110.035 -178.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.88 18.59 10.92 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.529 1.132 . . . . 64.299999999999997 113.472 171.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.63 -2.63 80.62 Favored Glycine 0 C--N 1.351 1.369 0 C-N-CA 122.831 0.253 . . . . 73.140000000000001 112.891 -176.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -99.01 117.51 33.68 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.279 1.031 . . . . 73.140000000000001 108.766 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -106.56 105.62 15.74 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.393 -0.966 . . . . 71.319999999999993 108.393 172.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.4 p -114.16 137.1 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.845 0.858 . . . . 72.219999999999999 109.225 178.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.8 t -97.89 114.89 27.09 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.51 -0.922 . . . . 73.530000000000001 108.51 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 33.7 t -100.45 111.6 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.479 1.112 . . . . 71.510000000000005 109.131 -178.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -79.88 96.66 6.42 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.589 -0.893 . . . . 72.420000000000002 108.589 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.449 ' HB ' HG11 ' A' ' 153' ' ' VAL . 10.1 pt -81.04 147.6 61.83 Favored Pre-proline 0 CA--C 1.56 1.348 0 CA-C-N 114.755 -1.111 . . . . 75.299999999999997 110.442 -179.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.43 145.15 42.18 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.41 2.073 . . . . 61.409999999999997 112.389 176.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.26 113.29 2.37 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 122.508 2.139 . . . . 61.109999999999999 111.879 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 105.14 13.65 24.46 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-N 115.514 -0.766 . . . . 35.229999999999997 112.601 -176.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.449 HG11 ' HB ' ' A' ' 149' ' ' ILE . 7.3 p -63.33 127.97 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.529 0.731 . . . . 63.420000000000002 110.546 177.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.648 ' HA ' HD12 ' A' ' 180' ' ' LEU . 28.7 mtm180 -134.78 164.26 27.95 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.312 0.645 . . . . 65.120000000000005 111.581 -172.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -38.86 125.14 1.46 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 126.314 1.846 . . . . 75.519999999999996 113.641 -174.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.25 -11.22 60.09 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-O 119.293 -0.726 . . . . 70.019999999999996 114.241 176.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.6 t -67.4 121.79 16.53 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 117.432 0.616 . . . . 71.120000000000005 110.191 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 40.6 t -104.23 111.14 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.55 0.74 . . . . 75.430000000000007 110.435 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 75.7 mt -93.6 106.45 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 125.236 1.414 . . . . 63.420000000000002 109.521 175.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 30.8 ttt-85 -79.67 106.29 11.59 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.26 0.624 . . . . 73.430000000000007 109.777 175.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.437 HG13 ' HB3' ' A' ' 174' ' ' LEU . 7.6 p -106.05 104.89 51.64 Favored Pre-proline 0 CA--C 1.562 1.432 0 N-CA-C 109.175 -0.676 . . . . 71.120000000000005 109.175 171.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 59.6 Cg_endo -69.29 154.18 69.98 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 123.04 2.494 . . . . 72.25 113.615 -175.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 75.82 2.88 72.03 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 115.47 -0.787 . . . . 72.239999999999995 113.881 177.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 92.7 mmm -110.37 -25.95 9.81 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.553 0.741 . . . . 54.530000000000001 111.916 -172.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -83.18 -73.17 1.25 Allowed Glycine 0 C--N 1.345 1.06 0 N-CA-C 111.313 -0.715 . . . . 60.439999999999998 111.313 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -62.47 96.29 0.14 Allowed Glycine 0 C--N 1.345 1.035 0 N-CA-C 111.8 -0.52 . . . . 53.210000000000001 111.8 165.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -88.79 170.58 10.63 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.458 1.103 . . . . 72.150000000000006 110.288 176.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 97.49 -147.88 18.78 Favored Glycine 0 C--N 1.341 0.807 0 CA-C-N 116.14 -0.482 . . . . 53.119999999999997 112.166 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -64.64 -49.16 71.68 Favored Pre-proline 0 CA--C 1.57 1.723 0 CA-C-O 118.458 -0.782 . . . . 72.239999999999995 111.907 177.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -84.13 129.58 4.58 Favored 'Trans proline' 0 C--N 1.392 2.832 0 C-N-CA 122.046 1.831 . . . . 74.129999999999995 111.409 175.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.33 145.52 34.39 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 121.959 1.773 . . . . 64.329999999999998 111.168 170.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -152.55 164.4 30.65 Favored Glycine 0 N--CA 1.47 0.925 0 CA-C-O 120.195 -0.225 . . . . 60.299999999999997 112.636 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 29.8 m-20 -84.23 146.33 27.86 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.143 0.577 . . . . 75.140000000000001 111.498 -167.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.437 ' HB3' HG13 ' A' ' 161' ' ' VAL . 33.7 tp -114.87 104.24 11.74 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.458 -1.312 . . . . 52.32 107.458 176.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 68.5 mt -85.82 100.36 12.0 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.613 0.765 . . . . 74.019999999999996 109.392 -174.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 67.1 mt -92.79 99.25 11.96 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.817 0.847 . . . . 74.5 110.786 -174.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.8 p -89.22 123.5 41.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 N-CA-C 109.037 -0.727 . . . . 62.439999999999998 109.037 173.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.5 p -77.7 143.76 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 123.437 0.695 . . . . 61.539999999999999 110.59 -176.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.562 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 30.0 mmt180 -123.99 96.94 5.13 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.066 0.947 . . . . 64.409999999999997 109.656 -177.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.648 HD12 ' HA ' ' A' ' 154' ' ' ARG . 49.1 mt -100.53 114.84 28.81 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.261 -0.644 . . . . 74.209999999999994 109.261 173.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 69.0 mt -64.59 130.15 94.59 Favored Pre-proline 0 CA--C 1.548 0.9 0 O-C-N 123.917 0.761 . . . . 72.239999999999995 109.282 176.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -58.36 -48.46 15.51 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.938 2.426 . . . . 62.530000000000001 111.604 -176.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 . . . . . 0 C--O 1.251 1.179 0 C-N-CA 125.058 1.343 . . . . 63.219999999999999 107.448 171.811 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.418 ' HB3' ' NH2' ' A' ' 136' ' ' ARG . 65.8 mtt . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 109.082 -0.71 . . . . 72.430000000000007 109.082 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.2 m -66.82 120.37 13.44 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 116.192 -0.458 . . . . 55.310000000000002 109.956 176.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.2 m -85.8 137.03 33.08 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 109.305 -0.628 . . . . 74.219999999999999 109.305 177.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.517 HD12 ' HB2' ' A' ' 123' ' ' LEU . 9.1 pt -123.73 166.29 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 112.359 0.503 . . . . 71.319999999999993 112.359 -155.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -112.37 176.63 4.94 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.783 1.233 . . . . 64.140000000000001 109.269 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.657 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.3 tp -126.52 150.81 48.55 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.745 -0.835 . . . . 70.140000000000001 108.745 -174.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.7 -34.33 71.83 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.881 0.472 . . . . 75.420000000000002 112.134 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.661 HD11 ' HB ' ' A' ' 140' ' ' VAL . 21.7 mt 47.35 56.35 7.06 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.146 0.978 . . . . 74.310000000000002 112.065 -176.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.6 mt -71.25 117.28 55.31 Favored Pre-proline 0 CA--C 1.553 1.064 0 N-CA-C 108.926 -0.768 . . . . 54.420000000000002 108.926 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.74 177.25 1.01 Allowed 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.149 1.899 . . . . 62.100000000000001 112.447 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.588 HD23 ' HG3' ' A' ' 117' ' ' ARG . 1.4 pp -66.19 -15.14 62.9 Favored 'General case' 0 CA--C 1.554 1.114 0 O-C-N 122.184 -0.323 . . . . 75.109999999999999 111.581 176.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.07 -90.18 0.59 Allowed Glycine 0 C--N 1.363 2.07 0 N-CA-C 110.813 -0.915 . . . . 71.329999999999998 110.813 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.8 m -128.89 87.66 2.61 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.652 -1.24 . . . . 72.319999999999993 107.652 172.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -126.44 156.86 20.07 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-N 116.086 -0.506 . . . . 75.219999999999999 111.977 -177.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -71.35 104.53 1.45 Allowed Glycine 0 C--N 1.349 1.263 0 N-CA-C 111.316 -0.714 . . . . 75.340000000000003 111.316 176.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.1 t -68.65 98.34 0.88 Allowed 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.634 0.774 . . . . 33.399999999999999 109.916 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -171.95 -107.98 0.21 Allowed Glycine 0 C--N 1.342 0.883 0 CA-C-N 115.695 -0.684 . . . . 33.039999999999999 111.96 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.491 ' HA3' ' HA2' ' A' ' 116' ' ' GLY . . . 86.73 167.24 43.46 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 111.846 -0.501 . . . . 62.100000000000001 111.846 -171.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.2 t -149.98 -52.59 0.15 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.627 0.771 . . . . 64.0 109.234 -175.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -155.9 152.15 23.61 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.543 -0.753 . . . . 75.030000000000001 111.263 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.13 -63.51 4.47 Favored Glycine 0 C--N 1.343 0.965 0 N-CA-C 111.59 -0.604 . . . . 53.310000000000002 111.59 -176.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.3 m -135.08 116.0 14.08 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 123.916 0.887 . . . . 75.530000000000001 109.273 176.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.491 ' HA2' ' HA3' ' A' ' 111' ' ' GLY . . . -72.66 -89.62 0.14 Allowed Glycine 0 C--N 1.343 0.946 0 N-CA-C 109.456 -1.458 . . . . 53.210000000000001 109.456 166.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.588 ' HG3' HD23 ' A' ' 104' ' ' LEU . 23.7 ttm180 -97.87 125.48 42.77 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.055 -1.091 . . . . 73.409999999999997 108.055 158.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -91.59 121.6 33.41 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 107.542 -1.281 . . . . 53.399999999999999 107.542 168.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.4 tt -108.37 121.6 45.27 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 106.943 -1.503 . . . . 53.219999999999999 106.943 -177.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -92.48 135.02 34.4 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.871 -0.789 . . . . 72.129999999999995 108.871 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.657 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -156.28 138.1 14.32 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 122.921 0.488 . . . . 71.519999999999996 109.8 -174.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -126.77 128.63 46.91 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 110.166 -0.309 . . . . 75.219999999999999 110.166 -170.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.517 ' HB2' HD12 ' A' ' 97' ' ' ILE . 3.5 pp -103.13 133.36 20.38 Favored Pre-proline 0 C--N 1.349 0.583 0 C-N-CA 123.342 0.657 . . . . 63.229999999999997 109.816 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.497 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 71.9 Cg_endo -78.13 115.93 3.84 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 122.418 2.079 . . . . 64.510000000000005 109.172 166.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.537 HD21 HD12 ' A' ' 149' ' ' ILE . 39.3 tp -102.72 147.38 26.91 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.554 -0.536 . . . . 54.100000000000001 109.554 -169.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.7 t -86.59 145.22 26.83 Favored 'General case' 0 C--O 1.245 0.839 0 N-CA-C 107.833 -1.173 . . . . 62.399999999999999 107.833 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.39 -20.75 65.59 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 112.766 0.654 . . . . 73.299999999999997 112.766 -170.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -67.61 -48.15 67.61 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.424 -0.584 . . . . 75.099999999999994 109.424 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -64.32 -38.41 90.93 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.081 -0.963 . . . . 54.43 111.149 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.434 ' HB2' HD21 ' A' ' 180' ' ' LEU . . . -59.97 -48.02 83.43 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.849 0.718 . . . . 73.439999999999998 111.569 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -67.86 -60.0 2.85 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.931 -1.031 . . . . 71.319999999999993 111.078 -178.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -67.14 -36.9 82.85 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.218 0.607 . . . . 74.540000000000006 111.437 -173.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.0 79.11 0.34 Allowed Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.568 -0.742 . . . . 73.209999999999994 111.572 -173.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.444 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -118.05 -172.16 15.62 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 112.731 -0.148 . . . . 73.450000000000003 112.731 -177.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -91.82 120.08 32.2 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.564 -1.273 . . . . 54.409999999999997 107.564 171.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.418 ' NH2' ' HB3' ' A' ' 94' ' ' MET . 8.5 tpp180 -113.1 122.11 46.59 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.377 -0.601 . . . . 70.420000000000002 109.377 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.508 HG13 ' HG3' ' A' ' 144' ' ' ARG . 99.5 t -72.55 132.1 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.179 0.992 . . . . 51.229999999999997 109.985 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.477 ' HB ' HG13 ' A' ' 145' ' ' VAL . 28.8 t -127.64 128.2 69.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 107.018 -1.475 . . . . 72.329999999999998 107.018 175.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.65 99.61 9.2 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.662 0.744 . . . . 70.319999999999993 111.069 -175.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.661 ' HB ' HD11 ' A' ' 101' ' ' LEU . 14.4 m -132.79 134.56 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 112.415 0.524 . . . . 70.450000000000003 112.415 -173.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 59.84 25.44 14.53 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.929 1.291 . . . . 73.400000000000006 112.298 173.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 80.32 22.39 62.88 Favored Glycine 0 C--N 1.355 1.626 0 CA-C-N 115.813 -0.631 . . . . 41.240000000000002 112.964 -178.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 24.5 tpp180 -133.8 126.54 30.79 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.309 1.044 . . . . 60.149999999999999 109.692 -175.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.508 ' HG3' HG13 ' A' ' 137' ' ' VAL . 13.6 ttm180 -73.21 120.46 18.86 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 109.234 -0.654 . . . . 75.230000000000004 109.234 167.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.477 HG13 ' HB ' ' A' ' 138' ' ' VAL . 3.5 p -118.7 112.14 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.244 -1.021 . . . . 55.43 108.244 169.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.2 t -94.42 109.65 21.5 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.167 -1.049 . . . . 62.229999999999997 108.167 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.5 p -97.56 118.44 44.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 CA-C-O 121.572 0.701 . . . . 74.25 109.946 -177.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -82.83 114.76 21.37 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.585 -0.894 . . . . 71.0 108.585 173.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.537 HD12 HD21 ' A' ' 125' ' ' LEU . 6.6 pt -99.47 149.9 36.28 Favored Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 124.506 1.123 . . . . 63.329999999999998 109.542 179.297 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.99 149.84 77.52 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.246 1.964 . . . . 75.340000000000003 112.029 176.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -66.23 113.71 2.75 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 122.406 2.071 . . . . 62.240000000000002 110.845 175.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 89.44 31.34 11.72 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-N 115.836 -0.62 . . . . 72.420000000000002 113.023 -175.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.26 138.09 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.333 0.653 . . . . 75.129999999999995 109.767 173.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -127.05 162.36 26.22 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.38 0.672 . . . . 75.420000000000002 111.063 -174.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -46.78 131.84 11.56 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 126.343 1.857 . . . . 64.439999999999998 113.344 -172.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.93 -2.55 84.24 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-O 119.554 -0.581 . . . . 72.129999999999995 114.434 177.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.1 t -66.87 122.51 17.86 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 117.474 0.637 . . . . 72.420000000000002 109.443 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.7 p -101.94 135.94 36.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 123.491 0.717 . . . . 64.010000000000005 109.991 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 45.4 mt -120.55 103.67 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.362 1.065 . . . . 73.450000000000003 108.734 -176.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -80.25 110.88 16.1 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.352 0.661 . . . . 74.0 109.702 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.5 p -115.21 110.15 45.84 Favored Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 122.904 0.482 . . . . 73.109999999999999 110.101 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.84 145.08 49.97 Favored 'Trans proline' 0 C--N 1.383 2.347 0 C-N-CA 122.885 2.39 . . . . 63.409999999999997 113.392 -175.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.08 15.51 78.67 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-N 115.557 -0.747 . . . . 71.230000000000004 113.565 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 87.3 mmm -113.18 -18.19 12.18 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.462 0.705 . . . . 63.130000000000003 111.026 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -96.84 -89.58 1.84 Allowed Glycine 0 C--N 1.349 1.295 0 N-CA-C 112.155 -0.378 . . . . 74.140000000000001 112.155 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -76.03 98.48 1.21 Allowed Glycine 0 C--N 1.345 1.033 0 C-N-CA 122.848 0.261 . . . . 75.299999999999997 112.527 176.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -88.56 113.53 24.24 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.444 0.698 . . . . 75.5 110.065 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 166.83 -154.53 25.03 Favored Glycine 0 C--O 1.241 0.551 0 N-CA-C 111.821 -0.512 . . . . 52.219999999999999 111.821 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -73.37 -50.92 5.98 Favored Pre-proline 0 CA--C 1.563 1.454 0 CA-C-O 117.97 -1.014 . . . . 73.049999999999997 110.992 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.14 111.6 3.31 Favored 'Trans proline' 0 C--N 1.393 2.878 0 CA-C-N 121.572 1.597 . . . . 73.109999999999999 110.315 168.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -67.11 125.36 13.46 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.526 2.151 . . . . 64.439999999999998 111.901 -173.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -120.25 146.34 17.76 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 111.908 -0.477 . . . . 72.329999999999998 111.908 -176.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -105.29 170.77 7.69 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.057 0.943 . . . . 42.240000000000002 112.024 -172.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 45.4 tp -121.99 113.8 20.09 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.792 1.237 . . . . 64.230000000000004 108.758 -177.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 69.4 mt -85.25 99.99 11.48 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.7 0.8 . . . . 63.530000000000001 110.032 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' LEU . . . . . 0.577 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 87.9 mt -88.93 100.43 13.18 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.244 0.618 . . . . 74.340000000000003 111.274 -175.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 71.4 t -89.2 124.83 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 109.198 -0.668 . . . . 74.420000000000002 109.198 177.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.4 p -80.53 137.82 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 122.727 0.411 . . . . 74.129999999999995 110.524 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.497 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 33.7 mmt180 -122.09 91.6 3.54 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.201 1.0 . . . . 64.340000000000003 109.255 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.434 HD21 ' HB2' ' A' ' 130' ' ' ALA . 43.2 mt -93.74 140.33 29.78 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.334 0.654 . . . . 61.439999999999998 111.355 -178.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 70.7 mt -75.4 119.11 75.5 Favored Pre-proline 0 CA--C 1.548 0.893 0 CA-C-N 114.869 -1.059 . . . . 75.109999999999999 109.182 177.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.35 -31.85 17.16 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.634 2.223 . . . . 74.439999999999998 111.977 -176.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 85.6 t60 . . . . . 0 CA--C 1.544 0.736 0 C-N-CA 125.034 1.333 . . . . 71.230000000000004 108.189 168.653 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.506 ' HB3' ' NH2' ' A' ' 136' ' ' ARG . 49.9 mtm . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 109.064 -0.717 . . . . 70.24 109.064 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.1 m -62.79 137.25 58.22 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.676 0.39 . . . . 62.31 111.093 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.3 m -70.93 148.62 47.53 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.705 0.802 . . . . 64.22 110.27 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.677 HD12 ' HB2' ' A' ' 123' ' ' LEU . 13.2 pt -117.28 163.02 14.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 123.104 0.562 . . . . 74.34 110.327 -177.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -139.12 124.12 18.85 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.714 0.806 . . . . 53.01 108.938 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.706 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.2 tp -72.17 160.44 32.43 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.46 1.104 . . . . 75.34 109.81 -173.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.527 ' HB3' ' H ' ' A' ' 122' ' ' GLU . . . -84.11 -43.92 14.56 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.489 0.316 . . . . 71.12 110.977 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.408 HD23 ' HB2' ' A' ' 121' ' ' ALA . 43.6 mt 49.35 71.97 0.34 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.063 0.945 . . . . 72.44 111.018 -168.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.623 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 86.2 mt -76.38 133.09 71.7 Favored Pre-proline 0 C--O 1.239 0.536 0 CA-C-N 115.34 -0.846 . . . . 73.41 109.718 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo . . . . . 0 C--N 1.374 1.895 0 C-N-CA 121.992 1.795 . . . . 64.4 110.15 164.621 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? . . . . . 0 CA--C 1.543 0.71 0 CA-C-O 121.166 0.508 . . . . 75.1 110.062 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -82.9 149.37 27.12 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.556 0.742 . . . . 73.41 109.653 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.5 tt -141.63 138.28 32.43 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 106.249 -1.76 . . . . 64.33 106.249 176.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.623 ' HG3' ' HB2' ' A' ' 102' ' ' LEU . 13.2 ptm180 -103.75 149.58 24.87 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.228 0.537 . . . . 71.11 110.504 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.706 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -159.63 135.89 8.92 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.765 -0.652 . . . . 53.43 109.76 -172.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.527 ' H ' ' HB3' ' A' ' 100' ' ' ALA . 7.0 mm-40 -108.5 120.93 43.85 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 107.583 -1.265 . . . . 64.4 107.583 -171.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.768 HD23 ' HB3' ' A' ' 176' ' ' LEU . 3.6 pp -101.08 110.47 61.3 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 108.085 -1.08 . . . . 74.12 108.085 176.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.61 112.29 3.5 Favored 'Trans proline' 0 C--N 1.367 1.536 0 C-N-CA 121.785 1.657 . . . . 75.53 108.994 169.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.54 HD21 HD12 ' A' ' 149' ' ' ILE . 32.1 tp -103.54 153.06 20.98 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.32 -0.622 . . . . 63.11 109.32 -169.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.7 t -92.51 146.07 23.96 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 108.024 -1.102 . . . . 71.51 108.024 178.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.514 HD23 HD22 ' A' ' 180' ' ' LEU . 87.6 mt -66.18 -24.5 66.64 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.919 0.711 . . . . 75.34 112.919 -173.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.08 -45.43 94.75 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.456 -0.572 . . . . 75.51 109.456 174.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.436 ' HB3' HD11 ' A' ' 149' ' ' ILE . 18.3 mm-40 -76.15 -31.6 58.65 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.128 -0.942 . . . . 75.11 111.83 -178.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.58 -36.36 78.34 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.936 0.494 . . . . 62.34 110.241 173.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -74.2 -57.99 3.59 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.755 -1.112 . . . . 63.34 110.945 176.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -60.95 -50.14 74.62 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.122 0.569 . . . . 73.33 111.184 -172.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.533 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 64.34 61.59 5.87 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 114.759 -1.11 . . . . 63.32 112.626 -173.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.445 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -123.92 -157.63 9.86 Favored Glycine 0 N--CA 1.467 0.749 0 N-CA-C 111.179 -0.768 . . . . 73.32 111.179 177.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -78.18 126.11 30.33 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.12 -0.696 . . . . 74.24 109.12 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.506 ' NH2' ' HB3' ' A' ' 94' ' ' MET . 8.6 tpp180 -120.05 123.06 42.51 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.727 -0.842 . . . . 72.41 108.727 175.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 72.7 t -71.58 113.7 8.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-N 114.306 -1.315 . . . . 44.14 109.677 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.522 HG22 HD11 ' A' ' 97' ' ' ILE . 35.9 t -100.88 112.17 32.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 108.394 -0.965 . . . . 73.43 108.394 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -99.8 113.72 26.42 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.102 -1.073 . . . . 70.3 108.102 174.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.0 p -152.66 132.14 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 122.92 0.488 . . . . 54.45 110.986 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 60.88 20.92 11.15 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.213 1.005 . . . . 75.32 112.792 173.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.62 -6.19 80.08 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-O 119.847 -0.418 . . . . 63.42 113.291 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.419 ' NH1' ' SD ' ' A' ' 164' ' ' MET . 35.1 ttm180 -101.71 122.77 44.54 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.908 0.883 . . . . 70.54 109.947 -178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -97.42 108.31 21.01 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.253 1.021 . . . . 50.04 108.641 174.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 3.2 p -123.26 113.66 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.392 0.677 . . . . 54.11 109.551 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.2 t -91.27 113.92 26.32 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.789 -0.819 . . . . 61.11 108.789 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 23.3 m -108.34 133.68 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.364 0.666 . . . . 72.0 110.584 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -81.99 96.05 7.6 Favored 'General case' 0 C--N 1.349 0.548 0 N-CA-C 108.886 -0.783 . . . . 71.24 108.886 176.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.54 HD12 HD21 ' A' ' 125' ' ' LEU . 12.3 pt -73.4 147.24 87.32 Favored Pre-proline 0 CA--C 1.559 1.301 0 CA-C-N 114.636 -1.165 . . . . 75.53 109.609 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.6 142.01 75.62 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.915 2.41 . . . . 72.05 113.508 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.29 117.21 3.99 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.332 2.021 . . . . 64.32 110.996 170.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 93.0 17.82 42.3 Favored Glycine 0 C--N 1.34 0.786 0 O-C-N 123.645 0.59 . . . . 41.15 112.901 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.7 p -62.93 123.79 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 C-N-CA 123.424 0.69 . . . . 72.3 110.255 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -127.44 164.31 22.16 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.278 0.631 . . . . 70.03 110.982 -172.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -40.84 127.05 2.56 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.28 1.832 . . . . 64.41 113.767 -171.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.32 -11.77 66.95 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-O 119.486 -0.619 . . . . 72.34 114.246 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.4 m -60.64 121.1 11.37 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 117.553 0.676 . . . . 62.44 110.281 173.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.423 HG22 HG22 ' A' ' 177' ' ' VAL . 61.4 t -105.52 110.97 32.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.334 0.653 . . . . 71.11 109.524 -178.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.416 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 67.0 mt -90.33 103.73 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 107.985 -1.117 . . . . 74.02 107.985 177.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -83.01 101.33 11.03 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.752 -0.658 . . . . 72.23 109.451 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.438 HG13 ' HB3' ' A' ' 174' ' ' LEU . 3.8 p -101.93 109.05 58.78 Favored Pre-proline 0 CA--C 1.558 1.251 0 C-N-CA 123.24 0.616 . . . . 75.31 110.205 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.461 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 16.5 Cg_exo -69.13 145.56 61.2 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.859 2.373 . . . . 65.03 112.799 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 87.42 0.27 84.74 Favored Glycine 0 C--N 1.344 1.02 0 CA-C-N 115.643 -0.708 . . . . 73.33 113.722 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.419 ' SD ' ' NH1' ' A' ' 143' ' ' ARG . 24.5 mmt -107.7 -12.09 15.3 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.454 0.701 . . . . 75.12 111.485 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -98.87 -87.17 1.9 Allowed Glycine 0 C--N 1.351 1.37 0 N-CA-C 112.102 -0.399 . . . . 63.11 112.102 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.26 97.02 0.22 Allowed Glycine 0 C--N 1.349 1.29 0 C-N-CA 123.249 0.452 . . . . 62.44 112.872 176.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -90.44 170.94 9.8 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.705 1.202 . . . . 70.33 110.575 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 110.96 -66.13 0.24 Allowed Glycine 0 N--CA 1.47 0.947 0 C-N-CA 123.364 0.507 . . . . 63.12 112.189 173.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -154.79 -53.96 0.02 OUTLIER Pre-proline 0 CA--C 1.558 1.287 0 CA-C-O 117.739 -1.124 . . . . 73.22 111.155 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -81.32 109.35 2.1 Favored 'Trans proline' 0 C--N 1.398 3.182 0 C-N-CA 121.929 1.752 . . . . 61.52 110.247 177.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.63 124.12 12.35 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 121.777 1.652 . . . . 55.33 110.251 -176.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -123.51 164.21 16.72 Favored Glycine 0 C--O 1.238 0.383 0 CA-C-N 115.859 -0.609 . . . . 62.3 111.684 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 6.7 p-10 -91.13 162.07 14.82 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.725 0.81 . . . . 73.52 111.055 -170.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.438 ' HB3' HG13 ' A' ' 161' ' ' VAL . 34.7 tp -126.29 116.14 20.79 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 114.727 -1.124 . . . . 71.32 108.819 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 88.6 mt -85.2 100.84 12.03 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.206 1.003 . . . . 72.43 110.026 -175.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.768 ' HB3' HD23 ' A' ' 123' ' ' LEU . 46.8 mt -90.05 99.23 12.28 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.82 0.448 . . . . 74.44 110.167 -177.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.423 HG22 HG22 ' A' ' 158' ' ' VAL . 41.5 t -86.4 113.29 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 109.333 -0.617 . . . . 74.14 109.333 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.6 p -68.68 133.3 32.02 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.981 0 O-C-N 123.462 0.476 . . . . 74.44 109.945 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -127.47 94.19 3.92 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.109 0.964 . . . . 75.2 109.042 -174.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.514 HD22 HD23 ' A' ' 127' ' ' LEU . 97.1 mt -98.57 147.98 24.25 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.185 -0.916 . . . . 65.44 110.505 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 79.2 mt . . . . . 0 CA--C 1.553 1.084 0 N-CA-C 109.471 -0.566 . . . . 73.13 109.471 175.226 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.46 ' N ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 121.659 0.743 . . . . 72.3 109.967 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.3 m -63.38 125.14 23.2 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.132 -0.94 . . . . 54.22 110.649 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.546 ' HA ' HH11 ' A' ' 136' ' ' ARG . 92.4 m -68.21 131.97 46.32 Favored 'General case' 0 C--O 1.24 0.593 0 O-C-N 123.424 0.453 . . . . 43.41 110.164 176.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.688 HD12 ' HB2' ' A' ' 123' ' ' LEU . 23.1 pt -104.45 167.6 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 115.448 -0.796 . . . . 74.14 110.759 -171.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -112.45 -171.44 1.86 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.517 0.727 . . . . 74.41 109.707 172.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.562 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.1 tp -133.7 158.0 44.39 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 108.268 -1.012 . . . . 71.41 108.268 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.481 ' HB3' ' H ' ' A' ' 122' ' ' GLU . . . -75.8 -47.53 25.37 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 110.129 -0.323 . . . . 74.3 110.129 176.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 54.5 mt 50.8 86.58 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.238 0 O-C-N 124.453 1.095 . . . . 73.11 111.034 -171.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.0 mt -99.31 157.77 33.43 Favored Pre-proline 0 CA--C 1.549 0.918 0 CA-C-N 115.15 -0.932 . . . . 73.41 109.491 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 C--N 1.373 1.849 0 C-N-CA 122.88 2.387 . . . . 75.45 113.859 178.846 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.424 ' O ' ' HA3' ' A' ' 172' ' ' GLY . 51.2 ttp180 . . . . . 0 N--CA 1.48 1.055 0 CA-C-O 121.066 0.46 . . . . 71.35 109.902 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -82.56 144.79 30.12 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.407 0.683 . . . . 75.32 109.808 176.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.9 tt -143.8 118.26 9.7 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 107.905 -1.146 . . . . 63.22 107.905 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -91.14 127.77 36.7 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 107.835 -1.172 . . . . 54.05 107.835 176.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.562 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -146.07 130.66 17.87 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.269 -0.641 . . . . 74.12 109.269 -176.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.481 ' H ' ' HB3' ' A' ' 100' ' ' ALA . 52.9 mt-10 -117.51 120.57 38.48 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 110.037 -0.357 . . . . 75.43 110.037 -169.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.688 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.4 pp -100.82 122.89 47.49 Favored Pre-proline 0 C--N 1.349 0.564 0 N-CA-C 109.961 -0.385 . . . . 62.42 109.961 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -76.78 113.58 3.67 Favored 'Trans proline' 0 C--N 1.365 1.433 0 C-N-CA 122.309 2.006 . . . . 73.13 108.27 167.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.549 HD21 HD12 ' A' ' 149' ' ' ILE . 51.2 tp -101.73 147.09 26.88 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.6 -0.518 . . . . 75.14 109.6 -168.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.5 t -89.57 148.92 23.09 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 108.587 -0.894 . . . . 75.32 108.587 -176.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.46 -31.2 71.88 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.776 0.83 . . . . 72.23 112.629 -169.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.45 -47.59 85.45 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.855 0.722 . . . . 70.13 109.35 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -76.31 -28.84 57.1 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 114.619 -1.173 . . . . 63.21 112.055 -174.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.0 -43.12 99.5 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.331 0.586 . . . . 72.23 110.266 172.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -65.21 -54.16 33.69 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 114.421 -1.263 . . . . 74.42 110.976 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -63.58 -48.86 75.65 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.076 0.55 . . . . 74.51 111.486 -175.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.59 ' HA3' ' HA ' ' A' ' 151' ' ' PRO . . . 61.04 72.53 0.62 Allowed Glycine 0 C--N 1.341 0.832 0 CA-C-N 114.788 -1.096 . . . . 71.13 112.147 -171.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.464 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -144.37 -157.63 7.28 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 111.696 -0.561 . . . . 61.22 111.696 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -72.35 112.56 8.53 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.412 -0.588 . . . . 52.12 109.412 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.546 HH11 ' HA ' ' A' ' 96' ' ' THR . 5.9 tpp180 -113.0 122.71 48.45 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.253 -1.017 . . . . 73.21 108.253 173.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 96.8 t -77.69 125.97 37.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 CA-C-N 114.472 -1.24 . . . . 63.44 109.918 -178.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 45.1 t -103.45 121.55 54.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.423 1.089 . . . . 75.23 108.35 176.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -112.93 106.47 14.76 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.136 -1.061 . . . . 74.34 108.136 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.3 p -151.14 122.4 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 123.175 0.59 . . . . 73.41 110.639 -175.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 64.24 19.96 11.99 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.131 0.972 . . . . 73.43 112.359 174.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.53 -9.68 76.85 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 116.368 -0.378 . . . . 52.11 112.787 -174.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 18.6 ttm180 -89.47 120.9 31.19 Favored 'General case' 0 C--N 1.347 0.493 0 N-CA-C 108.507 -0.923 . . . . 73.31 108.507 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.425 ' HA ' ' O ' ' A' ' 138' ' ' VAL . 40.7 ttm180 -112.53 114.95 27.86 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.217 -0.901 . . . . 73.01 108.708 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 6.4 p -129.9 117.55 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.424 0.63 . . . . 62.44 110.529 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 43.0 t -81.48 110.1 16.57 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.563 -0.902 . . . . 73.31 108.563 174.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.6 p -107.73 123.47 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.181 0.592 . . . . 72.2 109.741 177.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 51.1 ttt85 -76.96 94.81 4.01 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 108.734 -0.839 . . . . 74.05 108.734 172.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.549 HD12 HD21 ' A' ' 125' ' ' LEU . 8.0 pt -69.9 142.83 91.2 Favored Pre-proline 0 CA--C 1.561 1.372 0 CA-C-N 114.533 -1.212 . . . . 70.14 109.146 175.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.4 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 24.6 Cg_endo -63.01 148.72 93.17 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.396 2.064 . . . . 71.01 112.702 178.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.59 ' HA ' ' HA3' ' A' ' 133' ' ' GLY . 34.9 Cg_exo -62.36 124.84 15.02 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.689 2.259 . . . . 74.02 111.441 177.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 74.44 30.66 60.01 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 112.23 -0.348 . . . . 51.13 112.23 -177.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.0 p -62.27 116.95 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 123.576 0.751 . . . . 61.32 109.78 175.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.526 ' HA ' HD12 ' A' ' 180' ' ' LEU . 96.1 mtt180 -113.57 166.33 11.62 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.423 0.689 . . . . 65.11 110.886 -177.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -40.21 128.47 2.29 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 126.628 1.971 . . . . 75.34 113.692 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.69 -10.24 72.76 Favored Glycine 0 C--N 1.352 1.433 0 CA-C-O 119.442 -0.643 . . . . 64.34 114.124 175.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 25.3 t -64.77 120.57 12.72 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 117.521 0.66 . . . . 72.32 109.885 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.428 HG22 HG22 ' A' ' 177' ' ' VAL . 53.4 t -99.26 125.02 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.588 0.755 . . . . 65.43 109.224 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 54.8 mt -101.63 105.22 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 108.553 -0.906 . . . . 75.04 108.553 176.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -80.85 101.86 9.67 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.879 0.472 . . . . 72.41 109.782 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.551 HG13 ' HB3' ' A' ' 174' ' ' LEU . 5.4 p -110.63 98.12 35.73 Favored Pre-proline 0 CA--C 1.561 1.389 0 N-CA-C 109.802 -0.444 . . . . 74.22 109.802 173.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 44.4 Cg_endo -65.69 156.53 63.44 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.521 2.814 . . . . 75.22 113.291 -178.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 68.89 11.66 63.54 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.122 -0.944 . . . . 61.2 114.458 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 97.4 mmm -113.82 -26.94 7.96 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.857 0.863 . . . . 61.14 109.422 174.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -76.67 -84.87 0.44 Allowed Glycine 0 C--N 1.35 1.328 0 N-CA-C 110.705 -0.958 . . . . 4.1 110.705 172.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.412 ' HA2' ' HB3' ' A' ' 117' ' ' ARG . . . -66.22 101.29 0.6 Allowed Glycine 0 C--N 1.342 0.906 0 O-C-N 123.958 0.446 . . . . 73.51 113.791 171.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.64 ' HA ' HE21 ' A' ' 167' ' ' GLN . 0.0 OUTLIER -90.83 169.97 10.49 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.05 0.94 . . . . 75.4 110.559 174.596 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 83.0 -143.63 22.26 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-O 119.648 -0.529 . . . . 74.15 112.405 -176.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -63.07 -57.18 22.31 Favored Pre-proline 0 CA--C 1.56 1.358 0 CA-C-O 118.404 -0.807 . . . . 64.22 112.084 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -80.29 111.83 2.69 Favored 'Trans proline' 0 C--N 1.393 2.918 0 CA-C-N 121.179 1.457 . . . . 74.41 112.22 -176.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -76.07 123.9 7.59 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 122.024 1.816 . . . . 65.32 110.704 -178.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 117' ' ' ARG . . . -137.04 162.92 25.33 Favored Glycine 0 C--N 1.34 0.751 0 C-N-CA 121.406 -0.426 . . . . 53.52 113.42 -172.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.517 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 8.8 m-20 -91.23 132.23 36.25 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 123.892 0.877 . . . . 74.13 111.87 -164.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.551 ' HB3' HG13 ' A' ' 161' ' ' VAL . 33.7 tp -96.13 102.95 14.81 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.021 -1.474 . . . . 64.22 107.021 171.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 88.4 mt -87.9 100.25 12.74 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.182 0.593 . . . . 61.53 109.441 -175.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.565 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 74.3 mt -87.25 99.45 11.97 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 123.262 0.625 . . . . 73.41 110.253 -175.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.428 HG22 HG22 ' A' ' 158' ' ' VAL . 33.2 t -87.97 116.09 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 108.949 -0.76 . . . . 74.21 108.949 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 13.0 p -73.64 140.39 17.83 Favored 'Isoleucine or valine' 0 C--O 1.246 0.878 0 C-N-CA 123.003 0.521 . . . . 72.11 110.888 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -124.75 113.58 18.15 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 107.946 -1.131 . . . . 75.11 107.946 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.526 HD12 ' HA ' ' A' ' 154' ' ' ARG . 47.8 mt -111.35 134.34 53.01 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.947 0.499 . . . . 64.44 110.772 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 CA--C 1.55 0.972 0 C-N-CA 123.818 0.847 . . . . 55.43 110.362 174.846 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 73.3 mtp . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 109.333 -0.617 . . . . 74.23 109.333 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 43.5 m -71.0 125.1 25.94 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.953 -0.567 . . . . 65.32 110.575 -177.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 56.8 m -67.92 147.37 52.56 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.921 0.888 . . . . 51.42 111.153 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.689 HD12 ' HB2' ' A' ' 123' ' ' LEU . 26.8 pt -116.93 168.18 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 123.496 0.718 . . . . 75.41 110.577 -172.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -141.65 127.69 19.54 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.756 0.822 . . . . 64.44 109.41 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.724 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.1 tp -73.96 140.15 45.35 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.628 1.571 . . . . 71.11 110.417 -169.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.58 -33.82 76.81 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.557 0.743 . . . . 75.45 111.713 -176.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.8 mt 48.7 62.78 2.39 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.417 1.087 . . . . 61.45 111.697 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.0 mt -69.89 147.14 95.94 Favored Pre-proline 0 CA--C 1.554 1.134 0 N-CA-C 108.719 -0.845 . . . . 64.04 108.719 176.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 C--N 1.367 1.505 0 C-N-CA 122.071 1.847 . . . . 54.53 112.45 179.378 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.696 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 18.4 ttm180 . . . . . 0 N--CA 1.48 1.028 0 N-CA-C 110.468 -0.197 . . . . 73.33 110.468 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -85.28 116.74 23.8 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.43 0.634 . . . . 74.52 109.958 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.7 tt -94.34 124.19 38.21 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.399 -1.704 . . . . 74.4 106.399 175.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 23.5 tpt85 -90.98 117.73 29.8 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 107.879 -1.156 . . . . 73.22 107.879 -175.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.724 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -140.04 151.04 45.11 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 110.032 -0.359 . . . . 63.22 110.032 -173.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.536 ' HG2' ' HB ' ' A' ' 177' ' ' VAL . 89.1 mt-10 -129.69 120.5 25.25 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.242 -0.651 . . . . 64.52 109.242 -177.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.689 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.4 pp -97.83 113.61 63.9 Favored Pre-proline 0 C--N 1.353 0.727 0 N-CA-C 107.684 -1.228 . . . . 63.43 107.684 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.15 113.45 3.78 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 122.477 2.118 . . . . 72.05 108.549 171.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.453 HD21 HD12 ' A' ' 149' ' ' ILE . 34.0 tp -102.29 146.68 27.67 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 109.429 -0.582 . . . . 74.03 109.429 -168.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.9 t -90.47 154.06 19.92 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 108.324 -0.991 . . . . 63.31 108.324 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.82 -36.37 82.95 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.146 0.579 . . . . 41.13 111.803 -173.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -55.19 -47.74 74.82 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.233 0.613 . . . . 71.23 110.425 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.475 ' HG3' ' HE ' ' A' ' 136' ' ' ARG . 14.3 mm-40 -76.57 -31.7 57.69 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.933 -1.03 . . . . 71.04 111.829 -174.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.7 -31.94 72.94 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.779 0.431 . . . . 72.43 110.704 174.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -78.25 -49.98 12.71 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.433 -0.803 . . . . 70.33 110.895 173.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -62.72 -50.06 72.6 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.745 0.418 . . . . 75.12 111.413 -172.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.585 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 60.85 75.05 0.31 Allowed Glycine 0 C--N 1.342 0.862 0 CA-C-N 115.129 -0.942 . . . . 54.03 112.921 -177.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -162.3 -144.16 3.92 Favored Glycine 0 C--O 1.24 0.492 0 N-CA-C 110.967 -0.853 . . . . 64.43 110.967 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -72.05 113.36 9.0 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 122.787 0.435 . . . . 63.35 110.15 -175.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.475 ' HE ' ' HG3' ' A' ' 129' ' ' GLU . 6.8 tpp180 -120.21 120.83 37.29 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.24 -1.022 . . . . 73.5 108.24 170.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 146' ' ' SER . 63.8 t -77.07 131.71 34.26 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-N 115.417 -0.81 . . . . 74.15 110.416 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.4 p -125.18 119.64 56.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 124.361 1.065 . . . . 64.21 108.597 171.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -115.61 115.24 26.09 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.946 0.498 . . . . 73.33 110.259 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.461 HG21 ' HB3' ' A' ' 99' ' ' LEU . 2.5 m -149.22 144.01 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 125.017 1.327 . . . . 73.42 110.384 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.6 26.5 14.68 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.729 1.211 . . . . 63.32 111.611 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 81.37 -0.74 87.32 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 115.706 -0.679 . . . . 73.24 112.961 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -101.13 117.92 35.96 Favored 'General case' 0 C--N 1.346 0.451 0 C-N-CA 123.718 0.807 . . . . 70.31 110.036 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 37.1 ttp180 -97.78 105.79 17.99 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.351 -0.981 . . . . 65.43 108.351 174.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 5.6 p -125.96 125.97 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.298 0.639 . . . . 70.12 109.53 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 137' ' ' VAL . 38.3 t -89.95 134.5 34.19 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 109.371 -0.603 . . . . 70.25 109.371 175.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.6 p -113.79 130.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.277 0.631 . . . . 50.14 109.611 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -85.81 104.11 15.18 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.772 0.796 . . . . 75.0 109.778 173.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.585 HG13 ' HA2' ' A' ' 133' ' ' GLY . 8.2 pt -83.42 150.74 60.93 Favored Pre-proline 0 CA--C 1.558 1.269 0 CA-C-N 114.42 -1.264 . . . . 61.02 109.756 173.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -73.91 145.93 36.77 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.263 1.976 . . . . 75.11 112.191 173.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.48 120.1 7.31 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 122.391 2.06 . . . . 75.2 111.176 173.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 89.74 27.65 21.24 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 111.626 -0.59 . . . . 53.42 111.626 -170.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 4.3 p -66.6 129.95 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 109.272 -0.64 . . . . 73.44 109.272 172.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 29.3 mtm180 -127.02 157.87 38.45 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.442 0.697 . . . . 63.25 110.856 -168.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -42.17 125.49 3.07 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 126.716 2.006 . . . . 63.54 114.107 -175.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.79 2.75 69.17 Favored Glycine 0 C--N 1.351 1.392 0 N-CA-C 114.652 0.621 . . . . 53.4 114.652 176.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 33.1 t -68.29 122.42 18.32 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 117.556 0.678 . . . . 54.24 109.257 173.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.476 HG22 HG22 ' A' ' 177' ' ' VAL . 52.1 t -110.08 109.55 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.465 0.706 . . . . 72.25 109.592 -176.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.434 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 54.5 mt -90.78 111.57 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 108.551 -0.907 . . . . 54.23 108.551 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -86.41 104.29 15.77 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.732 0.813 . . . . 70.13 110.079 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.625 HG13 ' HB3' ' A' ' 174' ' ' LEU . 2.7 p -115.0 101.14 54.46 Favored Pre-proline 0 CA--C 1.564 1.494 0 C-N-CA 123.221 0.608 . . . . 63.03 110.352 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 49.1 Cg_endo -67.14 150.57 82.13 Favored 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 123.21 2.607 . . . . 72.24 113.231 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 74.0 11.05 81.44 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.785 -0.643 . . . . 74.23 114.331 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 23.1 mmt -114.92 -11.78 12.14 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.571 0.749 . . . . 55.02 110.353 173.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -97.24 -102.94 2.16 Favored Glycine 0 C--N 1.354 1.567 0 CA-C-N 116.059 -0.519 . . . . 63.43 112.246 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.696 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -70.48 90.63 0.38 Allowed Glycine 0 C--N 1.35 1.349 0 O-C-N 123.616 0.245 . . . . 74.04 113.621 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.728 HE21 ' HA ' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -81.6 158.17 24.46 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.524 0.678 . . . . 75.43 112.155 179.208 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 139.02 -145.72 17.11 Favored Glycine 0 C--N 1.342 0.885 0 CA-C-N 114.27 -1.332 . . . . 70.23 110.55 -172.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -75.94 -44.14 3.84 Favored Pre-proline 0 CA--C 1.562 1.409 0 CA-C-O 118.919 -0.563 . . . . 70.25 111.708 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -88.55 132.52 2.55 Favored 'Trans proline' 0 C--N 1.386 2.519 0 C-N-CA 121.653 1.569 . . . . 71.0 110.995 165.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.13 126.63 6.42 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 122.096 1.864 . . . . 55.34 111.484 176.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -109.25 154.01 16.65 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 116.071 -0.513 . . . . 73.15 112.74 -173.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.541 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 28.5 m-20 -77.35 144.44 38.01 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.62 0.768 . . . . 52.42 111.989 -175.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.625 ' HB3' HG13 ' A' ' 161' ' ' VAL . 45.6 tp -111.26 114.73 28.13 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.115 -1.069 . . . . 71.02 108.115 174.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 43.4 mt -87.04 112.38 21.81 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.302 1.041 . . . . 65.22 108.846 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.523 ' HB3' HD23 ' A' ' 123' ' ' LEU . 69.9 mt -101.75 99.0 9.19 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 123.576 0.547 . . . . 62.12 109.565 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.536 ' HB ' ' HG2' ' A' ' 122' ' ' GLU . 35.5 t -94.69 108.18 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 108.75 -0.833 . . . . 62.12 108.75 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 13.8 p -68.03 132.03 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 122.877 0.471 . . . . 74.41 110.904 -177.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -123.34 91.23 3.44 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.081 0.952 . . . . 73.21 109.071 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 85.8 mt -85.2 149.09 25.75 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.173 -0.921 . . . . 72.32 109.825 175.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 81.9 mt . . . . . 0 CA--C 1.549 0.935 0 N-CA-C 109.48 -0.563 . . . . 65.54 109.48 175.759 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 20.1 ptt? . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 109.799 -0.445 . . . . 75.43 109.799 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.479 ' H ' HG21 ' A' ' 126' ' ' THR . 19.9 m -77.66 140.68 39.63 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.358 0.663 . . . . 44.15 111.619 -178.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.522 ' HA ' HH11 ' A' ' 136' ' ' ARG . 90.1 m -71.41 151.52 43.97 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.315 1.046 . . . . 63.41 110.199 170.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.736 HD12 ' HB2' ' A' ' 123' ' ' LEU . 27.1 pt -118.15 159.35 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 123.105 0.562 . . . . 70.23 110.107 -173.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -127.12 129.23 47.53 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.619 -0.882 . . . . 72.21 108.619 172.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.628 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.5 tp -69.51 151.23 46.28 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.256 1.022 . . . . 72.12 108.737 -177.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.88 -48.58 24.15 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 122.79 0.436 . . . . 70.34 109.846 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 93.1 mt 57.43 80.51 0.16 Allowed 'General case' 0 C--N 1.359 1.012 0 O-C-N 124.566 1.166 . . . . 73.34 109.524 -170.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.3 mt -74.28 151.92 87.92 Favored Pre-proline 0 N--CA 1.471 0.592 0 CA-C-N 115.218 -0.901 . . . . 70.51 110.671 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo . . . . . 0 C--N 1.376 2.002 0 C-N-CA 122.471 2.114 . . . . 72.3 110.554 171.683 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.529 ' HB3' ' HA2' ' A' ' 166' ' ' GLY . 59.4 ttp180 . . . . . 0 CA--C 1.546 0.798 0 N-CA-C 110.13 -0.322 . . . . 75.12 110.13 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -91.55 106.87 18.8 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 106.443 -1.688 . . . . 75.21 106.443 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.6 tt -104.08 123.17 46.77 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.173 -1.047 . . . . 55.41 108.173 -172.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -90.5 128.18 36.46 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.233 -1.025 . . . . 72.42 108.233 175.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.628 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -140.88 149.76 42.36 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 123.788 0.835 . . . . 73.42 109.314 -172.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -119.93 122.3 40.92 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.667 -0.864 . . . . 62.43 108.667 -175.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.736 ' HB2' HD12 ' A' ' 97' ' ' ILE . 3.9 pp -99.63 108.03 48.83 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 106.912 -1.514 . . . . 74.21 106.912 173.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.524 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 63.1 Cg_endo -71.59 112.18 3.3 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 121.838 1.692 . . . . 74.4 108.373 169.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.466 HD21 HD12 ' A' ' 149' ' ' ILE . 32.8 tp -100.55 142.84 31.46 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.216 -1.031 . . . . 71.13 108.216 -170.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.479 HG21 ' H ' ' A' ' 95' ' ' SER . 1.9 t -79.47 145.1 33.44 Favored 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 107.941 -1.133 . . . . 51.22 107.941 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.84 -28.73 69.69 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.389 0.676 . . . . 74.34 112.479 -170.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.84 -41.16 97.88 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.601 -0.727 . . . . 72.24 109.794 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -75.99 -31.29 58.9 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.879 0.872 . . . . 71.32 112.461 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.32 -40.35 77.73 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.415 0.626 . . . . 53.44 110.272 169.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -73.93 -48.22 32.25 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-N 114.432 -1.258 . . . . 70.43 111.876 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -76.13 -51.33 12.4 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 120.722 0.296 . . . . 74.34 111.137 -171.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.623 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 67.33 69.1 1.45 Allowed Glycine 0 C--N 1.348 1.24 0 CA-C-N 115.25 -0.887 . . . . 71.51 113.478 -178.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -131.84 -154.65 7.8 Favored Glycine 0 N--CA 1.477 1.367 0 N-CA-C 111.684 -0.566 . . . . 71.23 111.684 178.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -70.96 114.31 8.88 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.101 -0.703 . . . . 64.2 109.101 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.522 HH11 ' HA ' ' A' ' 96' ' ' THR . 8.0 tpp180 -112.07 122.19 47.07 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.326 -0.99 . . . . 54.15 108.326 175.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 78.1 t -78.82 131.46 34.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-N 113.828 -1.533 . . . . 72.54 110.406 -177.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.9 p -136.91 122.17 26.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 124.287 1.035 . . . . 73.0 108.58 173.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -121.41 114.62 21.54 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.231 0.612 . . . . 74.15 111.088 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.4 m -148.89 146.78 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.681 1.592 . . . . 74.43 109.683 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 66.38 27.41 9.97 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.725 1.21 . . . . 62.44 110.848 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.23 15.64 72.53 Favored Glycine 0 C--N 1.356 1.687 0 CA-C-N 115.787 -0.642 . . . . 72.21 113.338 -176.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -124.26 129.37 50.64 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.002 0.921 . . . . 71.32 109.547 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 32.4 ttp180 -110.17 120.35 42.17 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.083 0.553 . . . . 71.53 110.217 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.1 p -122.34 146.18 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 123.95 0.9 . . . . 64.54 109.787 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 47.5 t -100.5 113.16 25.72 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.581 -0.896 . . . . 60.03 108.581 174.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.8 p -102.5 113.72 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 109.215 -0.661 . . . . 75.0 109.215 174.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 55.1 ttt85 -75.75 104.69 6.41 Favored 'General case' 0 C--N 1.35 0.625 0 N-CA-C 108.698 -0.853 . . . . 71.11 108.698 174.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.623 HG13 ' HA2' ' A' ' 133' ' ' GLY . 12.2 pt -81.52 145.24 54.53 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 124.524 1.129 . . . . 73.11 109.67 175.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.56 148.95 73.69 Favored 'Trans proline' 0 CA--C 1.565 2.036 0 C-N-CA 122.403 2.069 . . . . 63.12 112.982 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.59 118.95 5.86 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.87 2.38 . . . . 70.35 111.628 174.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 88.04 23.44 38.13 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-O 119.724 -0.487 . . . . 65.31 112.414 -175.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.433 HG11 ' HB ' ' A' ' 149' ' ' ILE . 3.9 p -62.89 120.34 9.2 Favored 'Isoleucine or valine' 0 C--N 1.361 1.105 0 C-N-CA 123.343 0.657 . . . . 62.01 109.689 176.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.546 ' HA ' HD12 ' A' ' 180' ' ' LEU . 66.0 mtt85 -123.73 159.55 29.19 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.564 0.746 . . . . 75.34 111.006 -173.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -38.53 127.26 1.46 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.036 2.134 . . . . 65.13 113.794 -173.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 101.94 -9.66 56.74 Favored Glycine 0 C--N 1.355 1.625 0 CA-C-O 119.017 -0.879 . . . . 74.22 114.622 174.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.3 t -69.14 120.18 14.58 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 117.799 0.799 . . . . 72.42 109.45 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 57.3 t -104.72 114.62 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.217 0.607 . . . . 73.34 109.943 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 51.7 mt -91.86 100.9 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 107.783 -1.191 . . . . 73.41 107.783 172.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.483 HH11 HD21 ' A' ' 175' ' ' LEU . 57.9 ttt85 -84.0 103.71 13.47 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.954 -0.758 . . . . 72.13 108.954 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.72 120.31 47.64 Favored Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 123.137 0.575 . . . . 71.24 110.051 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 92.4 Cg_endo -74.79 149.71 38.15 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.751 2.3 . . . . 72.13 113.028 -173.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 75.03 -0.3 58.9 Favored Glycine 0 N--CA 1.473 1.149 0 N-CA-C 114.451 0.541 . . . . 70.21 114.451 174.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 85.8 mmm -98.02 -25.34 14.99 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.935 0.894 . . . . 71.25 110.7 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.401 ' N ' ' HB2' ' A' ' 174' ' ' LEU . . . -79.98 -82.24 0.74 Allowed Glycine 0 C--N 1.348 1.234 0 N-CA-C 111.226 -0.75 . . . . 51.41 111.226 176.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 117' ' ' ARG . . . -61.26 94.38 0.08 OUTLIER Glycine 0 C--N 1.345 1.062 0 O-C-N 124.171 0.571 . . . . 72.22 113.221 174.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -88.13 114.65 24.95 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.015 0.926 . . . . 72.1 109.347 175.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 158.48 -149.84 20.26 Favored Glycine 0 N--CA 1.466 0.666 0 N-CA-C 111.213 -0.755 . . . . 61.05 111.213 -177.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -72.57 -52.31 6.55 Favored Pre-proline 0 CA--C 1.559 1.299 0 CA-C-O 118.019 -0.991 . . . . 74.11 111.188 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -83.88 112.42 1.78 Allowed 'Trans proline' 0 C--N 1.391 2.772 0 C-N-CA 121.733 1.622 . . . . 73.23 111.293 174.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.58 125.61 12.44 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 121.895 1.73 . . . . 44.11 111.448 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -116.29 156.52 15.58 Favored Glycine 0 C--N 1.342 0.88 0 N-CA-C 111.708 -0.557 . . . . 54.05 111.708 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 5.8 m-20 -79.61 159.46 26.78 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.339 0.656 . . . . 63.11 111.4 -175.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.401 ' HB2' ' N ' ' A' ' 165' ' ' GLY . 32.4 tp -127.12 113.16 16.03 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 114.643 -1.162 . . . . 45.32 108.061 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.483 HD21 HH11 ' A' ' 160' ' ' ARG . 86.6 mt -81.86 101.64 10.34 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.472 -0.936 . . . . 64.4 108.472 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.692 ' HB3' HD23 ' A' ' 123' ' ' LEU . 54.2 mt -90.36 97.11 10.99 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.93 -0.767 . . . . 71.14 108.93 177.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.48 118.88 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 O-C-N 121.759 -0.588 . . . . 73.45 109.611 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 14.0 p -67.55 132.52 32.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.815 0 C-N-CA 123.778 0.831 . . . . 60.33 109.839 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.524 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 17.6 mmm-85 -122.12 104.95 9.84 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.745 0.818 . . . . 73.42 109.182 -176.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.546 HD12 ' HA ' ' A' ' 154' ' ' ARG . 83.0 mt -109.79 147.82 32.57 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.49 0.716 . . . . 61.14 111.227 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 89.1 mt . . . . . 0 CA--C 1.557 1.217 0 CA-C-N 114.527 -1.215 . . . . 65.23 109.496 175.097 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.403 ' N ' ' SD ' ' A' ' 94' ' ' MET . 3.4 mpp? . . . . . 0 N--CA 1.482 1.129 0 N-CA-C 109.164 -0.68 . . . . 75.12 109.164 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.8 m -66.85 138.24 57.18 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.362 -0.835 . . . . 33.34 111.835 -177.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 47.3 m -74.81 150.09 39.42 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.576 -0.738 . . . . 74.25 109.073 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.664 HD12 ' HB2' ' A' ' 123' ' ' LEU . 23.5 pt -125.02 171.39 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 123.377 0.671 . . . . 73.34 110.705 -170.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -133.55 134.33 43.23 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.584 0.753 . . . . 74.4 110.27 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.579 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.3 tp -84.47 176.2 8.81 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.334 1.053 . . . . 74.43 109.069 -174.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -101.07 -48.15 4.52 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.41 0.284 . . . . 52.2 111.75 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.7 mt 57.36 70.45 0.65 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.113 0.965 . . . . 64.1 110.937 -168.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 20.8 mt -87.4 151.89 51.55 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-N 115.17 -0.923 . . . . 62.32 108.772 174.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo . . . . . 0 CA--C 1.558 1.675 0 C-N-CA 121.924 1.75 . . . . 64.25 111.943 174.516 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.515 ' O ' ' HA3' ' A' ' 172' ' ' GLY . 38.5 ttm180 . . . . . 0 N--CA 1.473 0.707 0 N-CA-C 110.149 -0.315 . . . . 75.21 110.149 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -77.84 144.94 36.61 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.11 0.481 . . . . 73.35 109.972 178.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.3 tt -136.72 113.22 10.06 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 105.551 -2.018 . . . . 73.42 105.551 172.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 34.9 ttt180 -93.8 123.09 36.91 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 108.486 -0.931 . . . . 74.44 108.486 -177.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.579 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -140.53 131.49 26.11 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 123.534 0.734 . . . . 71.51 109.342 -172.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -117.63 128.79 55.28 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 110.05 -0.352 . . . . 74.12 110.05 -169.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.664 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.0 pp -108.16 117.77 54.1 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 123.062 0.545 . . . . 70.25 110.107 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.492 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 68.0 Cg_endo -73.33 113.75 3.86 Favored 'Trans proline' 0 C--N 1.364 1.347 0 C-N-CA 122.451 2.101 . . . . 72.2 109.088 168.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.587 HD21 HD12 ' A' ' 149' ' ' ILE . 50.6 tp -103.8 147.94 26.69 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 122.794 0.438 . . . . 73.01 110.015 -166.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.8 t -85.22 149.31 25.59 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 109.018 -0.734 . . . . 63.34 109.018 -177.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.9 mt -63.06 -30.8 71.88 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.587 0.755 . . . . 65.4 112.441 -171.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.04 -49.61 76.68 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 109.48 -0.563 . . . . 70.33 109.48 177.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -72.97 -31.69 64.71 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 114.818 -1.083 . . . . 72.43 112.164 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.53 -38.08 80.06 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.747 0.654 . . . . 72.44 110.472 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -73.52 -52.82 12.24 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.027 -0.988 . . . . 74.15 110.846 174.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -62.52 -49.69 74.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 123.531 0.52 . . . . 75.52 112.379 -169.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.579 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 67.86 52.16 30.56 Favored Glycine 0 C--N 1.34 0.751 0 O-C-N 123.853 0.721 . . . . 71.12 112.971 -172.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.438 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -113.05 -163.13 15.54 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 112.077 -0.409 . . . . 54.23 112.077 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.65 115.42 20.91 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 108.934 -0.765 . . . . 71.35 108.934 175.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -113.45 124.08 51.57 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.577 0.751 . . . . 73.34 109.323 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 86.0 t -72.06 127.97 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-N 114.198 -1.365 . . . . 43.3 109.721 175.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.446 HG22 ' HB2' ' A' ' 99' ' ' LEU . 6.1 p -134.26 111.15 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 124.151 0.981 . . . . 74.41 108.838 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -103.36 134.73 46.25 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.667 0.787 . . . . 73.31 109.988 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.9 p -152.35 132.06 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.245 1.018 . . . . 61.04 109.887 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.37 18.0 8.88 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.348 1.059 . . . . 74.15 112.506 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.67 -8.83 71.29 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 116.26 -0.427 . . . . 63.44 113.327 -175.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -92.25 118.39 30.83 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.708 0.803 . . . . 72.02 110.498 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.5 ttp180 -98.39 120.78 39.4 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.449 1.1 . . . . 75.02 109.485 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 40.5 t -123.41 125.71 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.054 0.942 . . . . 73.23 109.346 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.9 t -97.53 112.64 24.41 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.867 -0.79 . . . . 74.25 108.867 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.4 139.14 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.133 0.573 . . . . 75.41 111.013 -175.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -83.72 110.37 18.25 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.887 -0.783 . . . . 74.1 108.887 174.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.587 HD12 HD21 ' A' ' 125' ' ' LEU . 9.3 pt -89.55 151.46 46.01 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 124.29 1.036 . . . . 73.13 110.026 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -67.31 139.57 50.34 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.687 2.258 . . . . 72.34 112.603 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -65.5 131.85 29.26 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.561 2.174 . . . . 74.33 111.126 169.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 69.71 29.9 70.95 Favored Glycine 0 C--N 1.343 0.966 0 O-C-N 123.55 0.531 . . . . 65.35 112.391 -177.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 9.6 p -64.82 148.12 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 124.058 0.943 . . . . 70.14 110.007 178.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.4 ' HA ' HD12 ' A' ' 180' ' ' LEU . 24.4 mtp180 -134.44 161.75 34.16 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.991 0.516 . . . . 64.34 110.281 -178.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -44.59 134.71 5.23 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 125.73 1.612 . . . . 55.33 113.525 -174.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 83.9 3.85 89.01 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 115.746 -0.661 . . . . 51.34 114.322 176.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.3 t -71.87 121.11 18.45 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 108.412 -0.959 . . . . 45.22 108.412 174.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.4 t -104.74 114.71 45.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 O-C-N 123.738 0.649 . . . . 74.25 110.603 -175.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 60.8 mt -89.9 102.26 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 107.328 -1.36 . . . . 55.21 107.328 174.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -87.63 105.45 17.35 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 122.992 0.517 . . . . 73.23 109.826 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.2 p -111.17 119.64 45.11 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 123.064 0.545 . . . . 63.55 109.704 175.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.43 153.14 49.98 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 122.247 1.964 . . . . 73.41 112.044 -177.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.36 -4.12 50.51 Favored Glycine 0 C--N 1.344 0.979 0 N-CA-C 115.208 0.843 . . . . 71.05 115.208 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 95.9 mmm -102.83 -13.26 17.06 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 117.645 0.723 . . . . 75.22 110.643 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -86.31 -96.1 0.81 Allowed Glycine 0 C--N 1.355 1.584 0 N-CA-C 111.823 -0.511 . . . . 41.21 111.823 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -57.28 98.29 0.08 OUTLIER Glycine 0 C--N 1.349 1.255 0 O-C-N 123.972 0.454 . . . . 64.54 112.319 171.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -88.09 153.89 20.9 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.521 1.128 . . . . 60.12 109.581 174.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 118.93 -144.17 17.75 Favored Glycine 0 N--CA 1.468 0.794 0 N-CA-C 110.976 -0.85 . . . . 63.25 110.976 -177.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -75.32 -47.36 4.4 Favored Pre-proline 0 CA--C 1.56 1.328 0 CA-C-O 117.97 -1.015 . . . . 72.55 110.944 168.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -76.47 113.55 3.69 Favored 'Trans proline' 0 C--N 1.395 2.98 0 C-N-CA 121.609 1.539 . . . . 72.34 112.241 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -82.8 126.77 4.64 Favored 'Trans proline' 0 C--N 1.385 2.461 0 C-N-CA 122.387 2.058 . . . . 74.13 111.787 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 117' ' ' ARG . . . -130.09 -179.37 15.98 Favored Glycine 0 N--CA 1.463 0.489 0 CA-C-N 116.758 -0.201 . . . . 62.11 113.181 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -100.92 131.26 46.88 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.817 0.847 . . . . 54.43 110.924 -168.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 29.8 tp -92.51 110.35 21.77 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 108.55 -0.908 . . . . 73.03 108.55 176.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 60.2 mt -91.19 99.7 12.65 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.49 0.716 . . . . 61.01 109.367 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.554 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 96.2 mt -88.87 99.85 12.71 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.621 0.369 . . . . 71.31 111.022 -175.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 38.8 t -87.51 114.56 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 109.261 -0.644 . . . . 74.4 109.261 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.425 HG22 ' HG ' ' A' ' 180' ' ' LEU . 12.1 p -73.02 132.98 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 CA-C-O 121.188 0.518 . . . . 74.21 109.843 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.492 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 37.6 mmt180 -115.21 101.42 8.94 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.86 -1.163 . . . . 64.2 107.86 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.425 ' HG ' HG22 ' A' ' 178' ' ' VAL . 38.8 mt -108.23 141.67 39.65 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.005 0.431 . . . . 72.23 111.369 -176.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 65.3 mt . . . . . 0 CA--C 1.544 0.729 0 CA-C-N 114.464 -1.244 . . . . 65.34 107.664 172.84 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.454 ' SD ' ' O ' ' A' ' 94' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.582 0 CA-C-O 121.564 0.697 . . . . 62.12 109.793 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.7 t -77.14 133.41 38.99 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.579 -0.737 . . . . 71.54 110.726 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 52.3 m -73.67 145.28 45.39 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.152 0.981 . . . . 63.12 110.308 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.61 HD12 ' HB2' ' A' ' 123' ' ' LEU . 18.2 pt -118.01 162.23 16.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 C-N-CA 123.223 0.609 . . . . 74.44 110.681 -172.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.408 ' O ' ' HD2' ' A' ' 124' ' ' PRO . . . -104.05 177.63 4.79 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.048 0.939 . . . . 52.53 108.952 170.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.598 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.4 tp -113.67 -133.77 0.34 Allowed 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 107.147 -1.427 . . . . 62.54 107.147 177.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.49 -43.47 0.06 Allowed 'General case' 0 C--N 1.345 0.412 0 N-CA-C 109.107 -0.701 . . . . 71.33 109.107 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 84.3 mt 53.81 64.08 1.96 Allowed 'General case' 0 C--N 1.362 1.129 0 O-C-N 124.438 1.086 . . . . 74.24 110.117 -172.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 61.0 mt -63.54 159.72 49.14 Favored Pre-proline 0 CA--C 1.55 0.968 0 CA-C-N 113.995 -1.457 . . . . 64.15 109.717 176.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo . . . . . 0 C--N 1.378 2.093 0 C-N-CA 122.056 1.837 . . . . 71.44 112.19 173.914 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 . . . . . 0 CA--C 1.541 0.609 0 CA-C-O 121.255 0.55 . . . . 61.34 111.478 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -83.43 119.7 24.99 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 108.093 -1.077 . . . . 63.14 108.093 169.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.3 tt -103.81 121.41 42.99 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.158 -1.793 . . . . 62.21 106.158 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -89.79 133.38 34.74 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.121 -1.066 . . . . 74.43 108.121 -177.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.598 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -154.56 146.66 23.68 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.252 0.621 . . . . 52.54 109.579 -175.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -128.19 135.0 49.12 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.502 -0.555 . . . . 73.21 109.502 -175.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.61 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.4 pp -112.53 116.96 47.78 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 109.88 -0.415 . . . . 73.11 109.88 178.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.529 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 70.2 Cg_endo -72.87 115.32 4.3 Favored 'Trans proline' 0 C--N 1.36 1.141 0 C-N-CA 122.498 2.132 . . . . 60.13 108.592 169.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.567 HD21 HD12 ' A' ' 149' ' ' ILE . 43.3 tp -104.26 148.4 26.38 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.933 -0.395 . . . . 74.33 109.933 -167.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.3 t -88.94 156.5 18.86 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 109.134 -0.691 . . . . 72.21 109.134 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.3 mt -64.42 -32.95 74.79 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.709 0.804 . . . . 72.12 112.631 -173.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.52 -46.7 87.23 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 124.168 0.918 . . . . 72.55 109.752 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -74.68 -34.09 62.6 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.041 -0.981 . . . . 71.0 111.519 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.97 -34.23 73.02 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.169 0.509 . . . . 60.5 110.518 173.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -76.55 -54.07 7.2 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 114.913 -1.04 . . . . 74.43 110.846 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -62.88 -50.35 71.24 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 122.829 0.452 . . . . 64.44 111.285 -174.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.571 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 70.04 58.27 6.32 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 114.963 -1.017 . . . . 62.54 111.369 -169.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.41 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -121.7 -175.18 14.9 Favored Glycine 0 C--N 1.346 1.091 0 N-CA-C 112.463 -0.255 . . . . 64.04 112.463 -175.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -76.1 113.61 13.82 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.463 -0.94 . . . . 53.42 108.463 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -111.18 124.61 52.54 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.163 -1.051 . . . . 74.43 108.163 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.469 HG13 ' HG3' ' A' ' 144' ' ' ARG . 94.9 t -70.34 124.31 26.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 114.466 -1.243 . . . . 65.4 109.124 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.428 HG11 HD13 ' A' ' 99' ' ' LEU . 34.5 t -117.77 130.14 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 107.83 -1.174 . . . . 75.41 107.83 177.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -123.71 122.21 37.5 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 118.1 0.409 . . . . 70.05 110.409 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.417 HG11 ' HB3' ' A' ' 99' ' ' LEU . 0.8 OUTLIER -149.99 128.73 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 124.855 1.262 . . . . 72.03 109.913 174.478 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.82 20.1 12.05 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.818 1.247 . . . . 74.05 112.203 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.12 9.14 82.77 Favored Glycine 0 C--N 1.355 1.595 0 CA-C-N 116.416 -0.357 . . . . 75.11 113.116 -175.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -101.19 120.21 39.9 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.706 1.202 . . . . 71.33 109.214 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.469 ' HG3' HG13 ' A' ' 137' ' ' VAL . 48.1 ttp180 -99.0 109.59 22.32 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.973 0.909 . . . . 74.54 109.747 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 53.8 t -107.99 112.38 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.566 -0.901 . . . . 75.53 108.566 172.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 48.2 t -91.54 104.16 16.69 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.213 -1.032 . . . . 61.0 108.213 174.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.1 p -100.94 119.17 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.521 0.729 . . . . 65.03 110.441 -175.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -73.74 101.06 3.57 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.334 -0.988 . . . . 73.41 108.334 167.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.571 HG13 ' HA2' ' A' ' 133' ' ' GLY . 10.0 pt -81.33 151.59 69.47 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 123.97 0.908 . . . . 70.43 109.675 175.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.447 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 64.5 Cg_endo -73.62 144.75 36.15 Favored 'Trans proline' 0 CA--C 1.559 1.763 0 C-N-CA 122.088 1.859 . . . . 61.41 112.556 177.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 150' ' ' PRO . 37.7 Cg_exo -63.18 124.5 14.0 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.18 2.587 . . . . 63.04 112.345 177.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 80.18 23.16 61.69 Favored Glycine 0 C--N 1.343 0.947 0 O-C-N 123.448 0.468 . . . . 75.43 112.906 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.5 p -57.57 145.99 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 124.536 1.135 . . . . 70.41 110.685 177.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -138.11 162.17 34.88 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.79 0.836 . . . . 65.31 110.547 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -43.85 129.13 5.71 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 126.366 1.866 . . . . 74.34 112.694 -174.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.17 -3.11 59.9 Favored Glycine 0 C--N 1.35 1.318 0 O-C-N 123.63 0.581 . . . . 75.22 113.81 176.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 52.2 m -69.81 119.68 14.4 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 117.724 0.762 . . . . 70.32 110.148 175.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 45.0 t -103.34 109.09 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.243 0.617 . . . . 72.23 110.026 -178.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 58.5 mt -91.25 101.92 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.438 1.095 . . . . 74.51 108.14 172.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -89.62 103.03 15.71 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.918 -0.771 . . . . 74.41 108.918 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.8 p -103.77 105.49 48.12 Favored Pre-proline 0 CA--C 1.561 1.367 0 C-N-CA 123.228 0.611 . . . . 71.43 110.316 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -66.44 146.77 81.2 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 123.093 2.528 . . . . 54.11 113.514 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 81.83 0.13 89.03 Favored Glycine 0 C--N 1.346 1.111 0 CA-C-N 115.603 -0.726 . . . . 71.35 113.666 176.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.8 mmt -101.66 -24.6 14.08 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 117.598 0.699 . . . . 74.14 111.529 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -81.84 -87.68 0.67 Allowed Glycine 0 C--N 1.347 1.171 0 CA-C-O 119.822 -0.432 . . . . 70.01 112.612 -175.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -62.65 93.49 0.1 OUTLIER Glycine 0 C--N 1.352 1.468 0 O-C-N 124.056 0.504 . . . . 61.1 112.247 174.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -88.86 158.13 18.21 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.152 0.981 . . . . 73.11 109.417 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 96.85 -142.57 16.25 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-O 119.623 -0.543 . . . . 73.34 111.879 -176.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -68.84 -53.88 14.09 Favored Pre-proline 0 CA--C 1.567 1.634 0 CA-C-O 118.032 -0.985 . . . . 73.3 112.389 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -83.92 108.51 1.41 Allowed 'Trans proline' 0 C--N 1.394 2.931 0 C-N-CA 121.709 1.606 . . . . 63.04 112.149 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.28 127.22 11.02 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.85 2.366 . . . . 63.41 110.953 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -141.19 176.27 21.78 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-N 116.443 -0.344 . . . . 74.25 112.808 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -100.33 162.21 13.1 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.279 1.032 . . . . 74.25 111.373 -172.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 37.7 tp -117.05 112.7 21.29 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 124.588 1.155 . . . . 74.43 108.033 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 66.9 mt -84.02 100.3 10.98 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.745 -0.835 . . . . 70.35 108.745 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.519 HD22 HD11 ' A' ' 99' ' ' LEU . 91.9 mt -96.89 99.7 11.24 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.075 0.55 . . . . 75.33 110.083 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.6 p -93.55 125.58 46.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 N-CA-C 109.444 -0.576 . . . . 74.12 109.444 176.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.8 137.63 23.07 Favored 'Isoleucine or valine' 0 C--O 1.249 1.043 0 C-N-CA 123.299 0.639 . . . . 70.21 109.5 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.529 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 22.3 mmm-85 -115.81 97.84 6.34 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.817 -0.809 . . . . 73.12 108.817 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 55.1 mt -119.56 131.9 55.62 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.91 0.884 . . . . 74.31 109.669 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 90.6 mt . . . . . 0 CA--C 1.543 0.686 0 CA-C-N 115.349 -0.841 . . . . 73.44 110.713 -175.792 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.427 ' SD ' ' N ' ' A' ' 94' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 109.086 -0.709 . . . . 75.15 109.086 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.3 m -67.84 115.97 7.98 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.449 -0.574 . . . . 65.31 109.449 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 98.6 m -65.18 144.83 56.94 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.702 0.801 . . . . 71.43 110.737 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.663 HD12 ' HB2' ' A' ' 123' ' ' LEU . 11.2 pt -117.41 161.07 16.5 Favored 'Isoleucine or valine' 0 C--O 1.245 0.854 0 CA-C-N 115.659 -0.7 . . . . 74.3 109.23 -174.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -136.69 129.7 31.02 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.725 0.81 . . . . 42.42 109.159 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.679 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.2 tp -68.78 149.67 48.74 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.956 1.303 . . . . 74.15 109.935 -174.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.22 -34.58 55.98 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.519 0.328 . . . . 73.21 110.949 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 70.3 mt 52.1 69.31 0.69 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.064 0.946 . . . . 71.43 111.059 -175.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 63.2 mt -69.14 161.09 75.45 Favored Pre-proline 0 CA--C 1.558 1.277 0 CA-C-N 115.33 -0.85 . . . . 70.42 109.913 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo . . . . . 0 C--N 1.377 2.033 0 C-N-CA 122.241 1.961 . . . . 73.43 112.941 178.769 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.598 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 11.8 tpp180 . . . . . 0 C--O 1.244 0.782 0 CA-C-O 121.132 0.492 . . . . 72.41 110.103 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -73.8 128.2 34.87 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 114.839 -1.073 . . . . 72.24 109.102 175.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.4 tt -134.79 114.85 13.04 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.335 -1.728 . . . . 72.32 106.335 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -90.31 138.05 31.85 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 107.605 -1.257 . . . . 75.43 107.605 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.679 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -157.25 131.83 8.61 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.253 -0.647 . . . . 72.35 109.253 -170.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -120.73 126.38 50.03 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 109.068 -0.716 . . . . 74.51 109.068 -170.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.663 ' HB2' HD12 ' A' ' 97' ' ' ILE . 3.9 pp -100.81 118.78 59.99 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 109.325 -0.62 . . . . 72.05 109.325 -177.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.559 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 74.1 Cg_endo -73.69 111.63 3.34 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.542 2.162 . . . . 53.45 109.344 171.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.502 HD21 HD12 ' A' ' 149' ' ' ILE . 28.2 tp -102.47 149.77 24.04 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 109.015 -0.735 . . . . 63.41 109.015 -168.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.6 t -95.57 158.53 15.41 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-N 115.913 -0.585 . . . . 43.33 109.479 -177.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 82.1 mt -64.3 -30.45 71.5 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.469 0.708 . . . . 73.13 112.13 -175.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.07 -48.33 82.18 Favored 'General case' 0 C--O 1.216 -0.701 0 O-C-N 123.904 0.753 . . . . 65.4 109.507 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.478 ' HG3' ' HD2' ' A' ' 136' ' ' ARG . 8.2 mm-40 -75.54 -30.95 59.9 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.51 0.724 . . . . 74.24 111.367 -175.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.87 -26.11 64.97 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 122.878 0.471 . . . . 61.31 111.044 174.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -83.96 -47.99 10.43 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.837 0.855 . . . . 72.0 110.452 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -67.68 -49.55 62.21 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.196 0.598 . . . . 65.3 110.283 -174.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.503 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 62.86 62.17 5.75 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 114.49 -1.232 . . . . 55.45 112.318 -173.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.26 -163.69 11.27 Favored Glycine 0 C--N 1.34 0.768 0 N-CA-C 111.769 -0.532 . . . . 42.15 111.769 -177.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -73.6 118.68 16.83 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.379 -0.971 . . . . 72.42 108.379 177.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.608 HH21 ' HB ' ' A' ' 137' ' ' VAL . 5.8 tpm_? -111.67 122.76 48.68 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.484 -0.932 . . . . 72.22 108.484 177.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.608 ' HB ' HH21 ' A' ' 136' ' ' ARG . 71.4 t -71.88 113.71 9.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-N 114.576 -1.193 . . . . 62.34 110.159 176.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.77 110.2 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 106.889 -1.522 . . . . 74.21 106.889 174.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -118.19 121.23 39.96 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.62 -0.511 . . . . 73.44 109.62 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 1.5 m -149.34 142.59 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 125.197 1.399 . . . . 62.51 109.69 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.35 25.58 15.27 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.696 1.198 . . . . 64.14 111.559 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 73.07 10.76 78.49 Favored Glycine 0 C--N 1.355 1.615 0 CA-C-N 115.681 -0.691 . . . . 75.21 113.567 -175.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 58.7 ttt85 -114.03 125.0 53.51 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.937 0.895 . . . . 75.41 109.066 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -105.42 126.08 51.72 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.754 0.822 . . . . 74.41 109.738 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 4.4 p -127.98 123.35 60.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 124.269 1.027 . . . . 72.42 108.803 176.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 30.0 t -99.65 104.29 16.04 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.013 -0.736 . . . . 74.42 109.013 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.1 p -101.0 123.17 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.188 0.595 . . . . 72.34 110.545 -176.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -76.44 116.06 16.77 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 109.052 -0.721 . . . . 72.54 109.052 172.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.503 HG13 ' HA2' ' A' ' 133' ' ' GLY . 10.6 pt -96.87 151.02 37.55 Favored Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 124.319 1.047 . . . . 71.0 109.006 175.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.42 145.96 49.11 Favored 'Trans proline' 0 CA--C 1.565 2.048 0 C-N-CA 122.322 2.015 . . . . 65.41 112.74 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -64.68 114.4 2.73 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 123.248 2.632 . . . . 73.15 112.105 175.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 87.82 31.26 15.68 Favored Glycine 0 C--N 1.341 0.83 0 O-C-N 123.333 0.396 . . . . 62.43 112.333 -174.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.89 149.85 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.834 0.853 . . . . 75.51 110.221 173.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -134.41 154.24 51.48 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.665 0.786 . . . . 72.54 110.756 -174.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -40.51 131.54 2.23 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.726 2.01 . . . . 71.15 113.397 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.34 -9.81 69.46 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-O 119.215 -0.769 . . . . 31.31 114.596 175.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 27.1 t -62.34 122.86 16.73 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.394 0.678 . . . . 74.15 110.067 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.1 t -102.51 109.28 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.58 0.752 . . . . 72.11 109.832 -177.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 59.5 mt -92.98 113.5 28.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 108.628 -0.878 . . . . 64.02 108.628 173.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -86.6 116.95 25.06 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.911 0.484 . . . . 63.54 110.118 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.493 HG13 ' HB3' ' A' ' 174' ' ' LEU . 7.2 p -125.75 102.72 28.49 Favored Pre-proline 0 CA--C 1.564 1.482 0 C-N-CA 123.253 0.621 . . . . 74.32 110.486 175.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 51.4 Cg_endo -68.15 154.86 71.41 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 123.049 2.5 . . . . 53.22 112.873 176.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 84.06 -15.15 40.0 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 116.105 -0.498 . . . . 73.21 114.178 178.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 24.3 mmt -99.02 -13.9 19.68 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.72 0.808 . . . . 65.34 111.763 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.41 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -79.54 -113.05 0.24 Allowed Glycine 0 C--N 1.351 1.362 0 O-C-N 123.593 0.558 . . . . 72.0 112.623 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.598 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -66.83 117.59 9.46 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.651 0.225 . . . . 73.23 113.452 177.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -88.42 131.42 34.87 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.636 0.774 . . . . 52.42 109.737 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 165.55 -160.68 34.13 Favored Glycine 0 N--CA 1.468 0.775 0 N-CA-C 110.316 -1.114 . . . . 53.14 110.316 -176.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -70.77 -35.84 4.79 Favored Pre-proline 0 CA--C 1.566 1.589 0 CA-C-O 117.715 -1.136 . . . . 73.31 112.247 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -91.33 128.9 1.21 Allowed 'Trans proline' 0 C--N 1.402 3.362 0 C-N-CA 122.466 2.111 . . . . 64.45 110.617 170.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.88 122.21 9.32 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 121.413 1.409 . . . . 74.51 110.844 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -90.81 146.03 18.2 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.722 -0.672 . . . . 54.42 112.242 -176.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 16.7 t70 -91.38 146.61 23.67 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.934 0.493 . . . . 74.24 110.239 -176.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.493 ' HB3' HG13 ' A' ' 161' ' ' VAL . 22.5 tp -123.67 111.17 15.88 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.398 0.679 . . . . 72.22 109.95 -176.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 75.6 mt -90.36 101.01 13.74 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.995 0.918 . . . . 74.11 110.069 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 79.8 mt -86.22 101.73 13.29 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.501 0.72 . . . . 73.14 110.664 -177.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 47.4 t -90.65 115.96 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.386 -0.968 . . . . 74.25 108.386 174.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.3 p -71.66 138.88 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 109.814 -0.439 . . . . 62.22 109.814 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.559 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 27.0 mmt180 -120.05 94.37 4.37 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.8 0.84 . . . . 64.03 109.229 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 51.7 mt -106.71 140.82 38.95 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.072 -0.967 . . . . 74.23 109.738 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 90.0 mt . . . . . 0 CA--C 1.556 1.202 0 CA-C-N 114.922 -1.036 . . . . 54.12 110.35 178.88 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.591 ' HB2' HH12 ' A' ' 136' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 121.0 0.428 . . . . 64.3 110.688 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.4 m -80.87 133.33 35.56 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 109.355 -0.609 . . . . 64.33 109.355 175.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 94.8 m -70.49 145.43 50.93 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 123.482 0.713 . . . . 72.15 110.746 176.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.602 HD12 ' HB2' ' A' ' 123' ' ' LEU . 23.6 pt -123.15 175.96 5.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 C-N-CA 123.647 0.779 . . . . 72.45 110.022 -176.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.422 ' O ' ' HD2' ' A' ' 124' ' ' PRO . . . -128.79 167.67 16.98 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.819 0.848 . . . . 35.21 109.391 176.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.532 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.5 tp -110.41 148.83 31.22 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 108.602 -0.888 . . . . 64.01 108.602 -177.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.27 -47.21 51.84 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.409 0.284 . . . . 54.45 110.66 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.6 mt 57.09 75.08 0.38 Allowed 'General case' 0 N--CA 1.478 0.929 0 O-C-N 124.47 1.107 . . . . 72.13 110.591 -170.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.7 mt -76.74 164.05 61.84 Favored Pre-proline 0 CA--C 1.553 1.076 0 CA-C-N 114.232 -1.349 . . . . 74.45 109.045 174.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo . . . . . 0 C--N 1.371 1.713 0 C-N-CA 121.858 1.705 . . . . 75.55 112.812 175.027 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 . . . . . 0 N--CA 1.478 0.939 0 CA-C-O 120.41 0.148 . . . . 54.01 110.706 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -83.91 133.18 34.72 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.563 -0.903 . . . . 55.2 108.563 169.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.5 tt -132.69 134.21 44.52 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 107.452 -1.314 . . . . 74.42 107.452 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -92.05 127.86 37.68 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.808 -0.812 . . . . 72.2 108.808 -175.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.532 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -149.75 132.56 16.01 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.86 -0.422 . . . . 72.33 109.86 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -127.91 125.34 39.41 Favored 'General case' 0 C--O 1.245 0.839 0 N-CA-C 109.743 -0.466 . . . . 74.13 109.743 -172.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.602 ' HB2' HD12 ' A' ' 97' ' ' ILE . 3.7 pp -101.96 119.88 55.52 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 109.299 -0.63 . . . . 64.01 109.299 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.422 ' HD2' ' O ' ' A' ' 98' ' ' ALA . 62.8 Cg_endo -72.74 115.34 4.31 Favored 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 122.721 2.28 . . . . 73.21 108.985 167.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.431 HD21 HD12 ' A' ' 149' ' ' ILE . 47.7 tp -102.2 150.26 23.47 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 109.79 -0.448 . . . . 64.35 109.79 -168.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.7 t -89.12 155.19 19.59 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 123.447 0.699 . . . . 72.3 109.496 -175.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.8 mt -60.89 -35.24 76.14 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.494 1.117 . . . . 71.4 112.87 -171.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -61.52 -46.83 88.31 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.388 -0.597 . . . . 73.05 109.388 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.402 ' HG3' ' HD2' ' A' ' 136' ' ' ARG . 15.8 mm-40 -77.42 -22.39 51.59 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 114.245 -1.343 . . . . 71.1 112.153 -177.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.0 -51.69 68.59 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 123.586 0.554 . . . . 73.33 110.401 173.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -81.06 -50.45 9.64 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 115.508 -0.769 . . . . 71.12 111.887 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -65.93 -45.02 83.39 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.235 0.614 . . . . 72.04 111.813 -175.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.479 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 73.24 -145.52 36.25 Favored Glycine 0 C--N 1.342 0.899 0 O-C-N 123.441 0.463 . . . . 73.12 112.092 -175.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.93 -147.09 25.98 Favored Glycine 0 C--N 1.345 1.041 0 O-C-N 123.687 0.286 . . . . 74.13 112.808 177.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -85.09 121.9 28.52 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.236 0.614 . . . . 74.45 109.78 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.591 HH12 ' HB2' ' A' ' 94' ' ' MET . 5.0 tpm_? -112.03 123.44 50.27 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.912 -0.774 . . . . 73.11 108.912 175.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.468 ' HB ' ' NH2' ' A' ' 136' ' ' ARG . 84.8 t -76.11 111.4 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 114.88 -1.055 . . . . 71.12 109.519 173.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 32.0 t -107.7 129.56 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 107.359 -1.348 . . . . 72.42 107.359 172.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -115.58 116.48 28.22 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.36 -0.607 . . . . 74.21 109.36 175.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.8 p -150.02 142.47 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 123.87 0.868 . . . . 54.01 109.179 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.69 19.16 11.58 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.239 1.016 . . . . 55.41 112.156 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 82.28 7.41 87.71 Favored Glycine 0 C--N 1.353 1.499 0 CA-C-N 116.214 -0.448 . . . . 53.02 113.04 -176.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.9 ttm-85 -114.58 143.02 45.66 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.056 0.943 . . . . 74.24 110.388 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.442 ' HG3' HG13 ' A' ' 137' ' ' VAL . 12.4 ttp180 -96.4 113.72 25.33 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.592 -0.892 . . . . 72.1 108.592 173.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 25.8 t -105.41 112.09 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 108.243 -1.021 . . . . 73.12 108.243 172.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 35.8 t -90.29 108.59 19.86 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 107.961 -1.126 . . . . 62.01 107.961 175.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 34.3 m -104.61 145.69 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.508 0.723 . . . . 65.21 110.656 -176.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -93.19 96.04 9.77 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.791 -0.818 . . . . 73.24 108.791 175.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.479 HG13 ' HA2' ' A' ' 133' ' ' GLY . 24.0 pt -85.51 135.53 38.4 Favored Pre-proline 0 CA--C 1.554 1.131 0 CA-C-N 115.596 -0.729 . . . . 53.1 109.18 172.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.406 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 38.3 Cg_endo -68.07 141.07 51.63 Favored 'Trans proline' 0 CA--C 1.565 2.027 0 C-N-CA 122.338 2.025 . . . . 72.52 112.438 178.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 150' ' ' PRO . 47.2 Cg_exo -60.2 113.7 1.78 Allowed 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 123.148 2.566 . . . . 72.23 112.14 173.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 86.61 32.59 15.25 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.359 -0.696 . . . . 63.43 111.359 -173.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.5 p -62.67 144.49 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.608 0.763 . . . . 75.12 109.682 172.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -132.01 161.36 33.36 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.77 0.428 . . . . 73.12 110.473 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -43.17 129.04 4.7 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 125.536 1.773 . . . . 72.02 112.91 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 102.68 -13.06 56.58 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-O 119.259 -0.745 . . . . 74.42 114.119 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.0 t -62.46 120.6 11.4 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 117.589 0.695 . . . . 74.25 109.698 178.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 176' ' ' LEU . 3.1 p -115.01 112.31 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 121.539 0.685 . . . . 62.25 110.36 -172.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 59.1 mt -90.23 102.92 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 107.965 -1.124 . . . . 55.23 107.965 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -81.21 99.96 8.86 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.8 -0.815 . . . . 75.23 108.8 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.2 p -103.73 118.86 56.35 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 122.845 0.458 . . . . 60.43 109.953 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.51 155.71 59.15 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.9 2.4 . . . . 75.42 112.287 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 81.24 -24.4 4.13 Favored Glycine 0 CA--C 1.535 1.3 0 N-CA-C 114.31 0.484 . . . . 62.24 114.31 176.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.1 mmt -88.17 -27.26 21.96 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.727 0.811 . . . . 74.15 112.024 -172.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -70.27 -78.36 0.4 Allowed Glycine 0 C--N 1.345 1.053 0 N-CA-C 111.361 -0.696 . . . . 75.31 111.361 175.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -71.16 110.84 3.41 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 111.0 -0.84 . . . . 42.52 111.0 167.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -89.45 151.61 21.92 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.709 0.804 . . . . 43.44 110.457 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 81.29 -125.77 7.05 Favored Glycine 0 C--N 1.342 0.902 0 CA-C-N 115.831 -0.622 . . . . 60.1 113.224 174.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.44 ' O ' ' HD3' ' A' ' 171' ' ' PRO . 28.3 t-20 -62.84 -48.64 84.89 Favored Pre-proline 0 CA--C 1.564 1.49 0 C-N-CA 123.972 0.909 . . . . 71.24 113.01 -174.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -96.84 95.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.392 2.834 0 C-N-CA 122.633 2.222 . . . . 73.43 113.082 176.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 169' ' ' ASN . 11.3 Cg_exo -70.33 121.96 8.51 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 121.988 1.792 . . . . 75.31 110.239 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -134.93 179.76 17.32 Favored Glycine 0 C--N 1.343 0.919 0 C-N-CA 121.67 -0.3 . . . . 65.11 113.108 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -96.11 119.79 35.23 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.51 0.671 . . . . 63.01 112.124 -167.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.3 tp -89.38 111.66 22.57 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.018 -0.992 . . . . 61.55 108.529 173.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 60.8 mt -83.95 99.55 10.46 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.562 0.745 . . . . 74.0 109.048 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 158' ' ' VAL . 91.7 mt -91.05 98.67 11.91 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 123.633 0.583 . . . . 72.24 110.884 -175.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 23.7 t -90.71 123.05 42.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 109.161 -0.681 . . . . 45.34 109.161 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.6 p -74.94 132.94 32.51 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 109.125 -0.694 . . . . 74.21 109.125 177.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.418 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 34.6 mmt180 -118.57 92.9 3.93 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.323 -0.991 . . . . 75.52 108.323 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 26.3 mt -101.02 131.48 46.87 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.616 -0.72 . . . . 63.34 110.608 -176.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 CA--C 1.549 0.919 0 CA-C-N 114.778 -1.101 . . . . 74.43 109.889 178.666 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.416 ' HB3' ' NH2' ' A' ' 136' ' ' ARG . 1.1 mpt? . . . . . 0 N--CA 1.484 1.269 0 N-CA-C 109.267 -0.642 . . . . 73.35 109.267 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.4 t -69.92 140.41 53.08 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-N 115.734 -0.667 . . . . 64.41 111.058 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.461 ' HA ' HH11 ' A' ' 136' ' ' ARG . 28.6 m -78.39 148.62 33.59 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.775 0.83 . . . . 62.52 109.596 174.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.743 HD12 ' HB2' ' A' ' 123' ' ' LEU . 26.1 pt -118.03 168.61 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 123.334 0.653 . . . . 55.33 110.382 -171.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -136.74 127.38 27.05 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.37 0.668 . . . . 54.2 110.258 -176.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.549 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.5 tp -80.57 157.02 26.18 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 124.07 0.948 . . . . 54.52 110.866 -168.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.457 ' HB3' ' H ' ' A' ' 122' ' ' GLU . . . -77.18 -54.08 6.95 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.631 0.372 . . . . 64.44 110.852 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.0 mt 55.46 84.71 0.07 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.187 0.995 . . . . 73.35 110.796 -168.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.5 mt -100.6 122.43 49.53 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 125.103 1.361 . . . . 44.11 109.219 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo . . . . . 0 C--N 1.372 1.797 0 C-N-CA 122.678 2.252 . . . . 72.22 112.869 179.985 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 . . . . . 0 C--O 1.24 0.567 0 CA-C-O 121.238 0.542 . . . . 75.52 111.132 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -91.7 107.28 19.1 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.71 -1.132 . . . . 72.55 107.974 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.8 tt -91.95 129.84 37.83 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 106.237 -1.764 . . . . 75.21 106.237 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 56.8 ttt180 -90.55 120.57 31.75 Favored 'General case' 0 C--O 1.213 -0.854 0 N-CA-C 107.998 -1.112 . . . . 73.12 107.998 -174.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.549 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -140.37 130.74 25.26 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.331 -0.618 . . . . 72.5 109.331 -174.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.496 ' HG2' ' HB ' ' A' ' 177' ' ' VAL . 84.9 mt-10 -120.63 120.96 37.26 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.316 -0.624 . . . . 64.35 109.316 -167.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.743 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.4 pp -103.13 118.71 57.34 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 109.522 -0.547 . . . . 74.53 109.522 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -74.27 113.76 3.87 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 122.819 2.346 . . . . 74.53 109.37 169.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.573 HD21 HD12 ' A' ' 149' ' ' ILE . 29.4 tp -103.75 143.92 32.17 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 110.151 -0.314 . . . . 73.25 110.151 -166.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.4 t -83.35 155.89 23.31 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.446 -0.797 . . . . 71.14 109.856 -176.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.2 mt -63.52 -30.98 72.02 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.072 0.949 . . . . 63.23 112.304 -173.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.55 -43.59 89.42 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.763 0.664 . . . . 74.05 109.52 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.414 ' HB3' HD11 ' A' ' 149' ' ' ILE . 69.6 mm-40 -77.74 -32.65 52.87 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.014 -0.994 . . . . 64.44 111.904 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.46 -49.19 74.65 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.489 0.661 . . . . 54.45 111.152 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -74.21 -59.76 2.58 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.251 -1.341 . . . . 73.42 110.595 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -72.81 -44.26 61.69 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.662 -0.699 . . . . 74.13 111.727 -172.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.39 178.12 50.82 Favored Glycine 0 C--N 1.351 1.399 0 O-C-N 123.629 0.581 . . . . 74.12 113.161 -175.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 127.76 -156.79 20.77 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.934 -0.466 . . . . 53.02 111.934 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.419 ' HB3' ' OG ' ' A' ' 146' ' ' SER . 3.1 mp0 -88.47 123.07 32.63 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.822 -0.807 . . . . 64.33 108.822 173.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.461 HH11 ' HA ' ' A' ' 96' ' ' THR . 8.3 tpp180 -116.29 122.42 44.89 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.484 0.714 . . . . 74.22 109.89 176.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.6 t -70.49 126.64 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 O-C-N 124.105 0.878 . . . . 75.42 109.783 175.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.74 134.83 64.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 124.699 1.2 . . . . 71.22 108.667 174.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -124.77 125.11 43.52 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.429 1.092 . . . . 71.15 109.763 -174.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.3 p -151.63 129.93 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.14 0.576 . . . . 75.02 110.785 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.82 20.04 11.1 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 123.997 0.919 . . . . 73.13 112.71 176.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.07 -13.29 67.69 Favored Glycine 0 C--N 1.353 1.498 0 CA-C-N 116.403 -0.362 . . . . 71.22 112.989 -175.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -90.82 117.97 29.86 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.565 1.146 . . . . 73.04 109.237 -175.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -114.92 129.61 56.74 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.566 0.746 . . . . 65.24 110.197 -176.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.14 144.78 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.974 0.909 . . . . 75.54 109.506 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.419 ' OG ' ' HB3' ' A' ' 135' ' ' GLU . 11.0 t -100.8 120.75 40.58 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.017 -0.734 . . . . 52.03 109.017 177.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 6.3 p -100.11 129.53 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.446 0.698 . . . . 71.14 110.332 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -75.92 99.51 4.54 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.206 -0.665 . . . . 73.13 109.206 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.573 HD12 HD21 ' A' ' 125' ' ' LEU . 10.4 pt -86.32 142.79 35.84 Favored Pre-proline 0 CA--C 1.555 1.162 0 CA-C-N 115.356 -0.838 . . . . 74.42 110.063 173.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -66.05 135.62 41.39 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.449 2.1 . . . . 72.44 112.11 172.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -55.57 124.42 16.23 Favored 'Trans proline' 0 C--N 1.367 1.504 0 C-N-CA 122.619 2.213 . . . . 65.04 111.524 166.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 81.51 24.42 56.47 Favored Glycine 0 CA--C 1.533 1.196 0 O-C-N 123.314 0.384 . . . . 62.11 112.63 -174.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 6.7 p -62.29 139.19 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.622 0.769 . . . . 74.21 109.7 173.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -127.34 152.57 47.3 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.339 0.656 . . . . 72.05 110.419 -174.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -40.67 132.01 2.25 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.475 1.91 . . . . 74.43 113.144 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.86 -6.94 77.03 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-O 119.658 -0.523 . . . . 63.22 113.992 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 29.2 m -63.0 130.27 43.97 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.216 0.606 . . . . 55.12 110.24 172.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 5.8 p -117.91 116.48 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 CA-C-O 121.312 0.577 . . . . 70.5 110.37 -177.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.412 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 58.8 mt -95.3 103.04 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.864 0.866 . . . . 54.55 108.672 176.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -80.16 109.85 15.01 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.142 0.577 . . . . 72.23 109.742 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.548 HG13 ' HB3' ' A' ' 174' ' ' LEU . 1.7 p -109.04 111.32 60.55 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 123.489 0.716 . . . . 50.45 109.266 173.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -67.56 151.7 79.29 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 123.239 2.626 . . . . 75.44 113.571 -177.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 66.6 24.7 72.63 Favored Glycine 0 C--N 1.356 1.673 0 O-C-N 123.772 0.67 . . . . 61.33 113.662 175.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.447 ' HB3' ' HB2' ' A' ' 174' ' ' LEU . 8.2 tpt -119.81 -33.79 3.91 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.263 0.625 . . . . 75.02 110.154 -171.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -91.69 -69.73 1.17 Allowed Glycine 0 C--N 1.35 1.341 0 CA-C-N 116.44 -0.346 . . . . 65.31 112.31 -177.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -62.77 90.42 0.07 OUTLIER Glycine 0 C--N 1.349 1.274 0 N-CA-C 111.46 -0.656 . . . . 54.34 111.46 169.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -92.28 170.37 9.85 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.249 1.02 . . . . 74.52 111.195 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.74 -145.5 18.33 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 115.251 -0.886 . . . . 74.24 112.179 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -78.99 -36.98 1.21 Allowed Pre-proline 0 CA--C 1.565 1.542 0 CA-C-O 118.288 -0.863 . . . . 50.51 112.083 177.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -82.68 110.38 1.88 Allowed 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 121.725 1.617 . . . . 74.14 111.314 166.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -74.62 166.82 28.52 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.619 2.213 . . . . 74.43 112.583 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 173.34 174.75 40.6 Favored Glycine 0 C--N 1.346 1.109 0 N-CA-C 114.079 0.392 . . . . 63.52 114.079 170.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -91.04 166.8 12.81 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.639 1.176 . . . . 64.53 111.088 -167.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.548 ' HB3' HG13 ' A' ' 161' ' ' VAL . 34.8 tp -124.11 118.27 26.54 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.562 -0.903 . . . . 74.11 108.562 177.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 82.6 mt -92.91 101.88 14.24 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.522 0.729 . . . . 64.11 109.649 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.412 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 94.9 mt -89.21 99.75 12.67 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.25 0.62 . . . . 72.23 111.028 -177.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.496 ' HB ' ' HG2' ' A' ' 122' ' ' GLU . 49.5 t -89.23 112.61 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 123.373 0.669 . . . . 75.24 109.493 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.02 133.56 31.49 Favored 'Isoleucine or valine' 0 C--O 1.249 1.074 0 N-CA-C 109.712 -0.477 . . . . 71.03 109.712 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -123.43 96.04 4.82 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.353 1.061 . . . . 73.52 108.471 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 180' ' ' LEU . 35.7 mt -96.84 140.81 30.84 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.642 -0.708 . . . . 74.05 111.756 -174.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 71.0 mt . . . . . 0 CA--C 1.553 1.058 0 CA-C-N 114.303 -1.317 . . . . 73.34 110.07 176.388 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 35.2 mtp . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 108.022 -1.103 . . . . 73.44 108.022 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.477 ' H ' HG21 ' A' ' 126' ' ' THR . 16.3 m -60.28 -22.31 62.96 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.065 1.135 . . . . 64.32 114.065 -172.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 45.0 m 71.3 145.91 0.07 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.754 1.222 . . . . 43.53 110.842 -172.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.727 HD12 ' HB2' ' A' ' 123' ' ' LEU . 15.3 pt -128.08 166.19 25.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 123.348 0.659 . . . . 75.05 110.861 -170.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.407 ' O ' ' HD2' ' A' ' 124' ' ' PRO . . . -126.4 151.33 47.81 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.333 1.053 . . . . 73.4 109.649 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.617 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.5 tp -100.91 155.14 18.12 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.892 0.477 . . . . 62.34 109.936 -170.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.44 ' HB3' ' H ' ' A' ' 122' ' ' GLU . . . -84.14 -40.54 18.08 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.249 0.619 . . . . 62.1 111.929 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.0 mt 48.69 66.18 1.15 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.004 0.922 . . . . 75.21 111.283 -172.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 76.1 mt -73.43 151.03 89.57 Favored Pre-proline 0 CA--C 1.548 0.89 0 CA-C-N 115.35 -0.841 . . . . 63.14 110.492 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 C--N 1.373 1.832 0 C-N-CA 122.247 1.965 . . . . 50.33 112.595 171.975 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.434 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 43.3 ttt180 . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 112.556 0.576 . . . . 71.51 112.556 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -78.35 139.38 38.82 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.433 -0.803 . . . . 72.13 109.425 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.9 tt -132.7 126.1 31.78 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.175 -1.417 . . . . 44.21 107.175 177.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -91.59 136.14 33.35 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.361 0.665 . . . . 65.02 109.321 -176.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.617 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -154.37 146.87 24.04 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.466 0.706 . . . . 75.31 110.11 -176.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.44 ' H ' ' HB3' ' A' ' 100' ' ' ALA . 29.4 mt-10 -120.79 124.98 46.4 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 109.179 -0.674 . . . . 73.03 109.179 -176.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.727 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.5 pp -108.94 115.06 57.72 Favored Pre-proline 0 CA--C 1.551 0.981 0 N-CA-C 108.672 -0.862 . . . . 73.43 108.672 174.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.475 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 82.4 Cg_endo -78.15 114.74 3.62 Favored 'Trans proline' 0 C--N 1.365 1.437 0 C-N-CA 122.673 2.249 . . . . 73.12 109.124 170.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.525 HD21 HD12 ' A' ' 149' ' ' ILE . 25.5 tp -103.78 147.18 27.59 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.393 -0.595 . . . . 65.32 109.393 -166.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.477 HG21 ' H ' ' A' ' 95' ' ' SER . 11.3 t -92.63 162.97 13.96 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 109.718 -0.475 . . . . 63.22 109.718 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.5 mt -64.65 -37.02 86.15 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.85 0.86 . . . . 54.14 112.188 -168.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -59.83 -40.18 87.62 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.177 0.923 . . . . 75.42 109.68 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -76.92 -37.06 56.09 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 114.892 -1.049 . . . . 75.11 111.567 -173.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.9 -36.15 74.22 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 121.104 0.478 . . . . 64.43 110.384 172.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -77.16 -34.7 56.39 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 114.751 -1.113 . . . . 73.2 111.822 177.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 27.4 m80 -74.76 -51.16 14.9 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 117.926 0.33 . . . . 71.31 110.983 -176.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.429 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 58.62 68.11 1.86 Allowed Glycine 0 C--N 1.344 0.994 0 O-C-N 124.239 0.962 . . . . 44.35 112.307 -172.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.423 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -155.51 -146.33 4.41 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-O 120.055 -0.303 . . . . 72.5 112.529 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.3 mp0 -75.12 117.08 16.56 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.406 0.682 . . . . 72.23 109.685 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.667 HH21 ' HB ' ' A' ' 137' ' ' VAL . 4.5 tpm_? -116.56 123.74 48.12 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.113 0.965 . . . . 74.23 108.674 173.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.667 ' HB ' HH21 ' A' ' 136' ' ' ARG . 87.8 t -72.49 122.8 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.079 0.952 . . . . 64.51 110.341 174.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.601 ' HB ' HG13 ' A' ' 145' ' ' VAL . 21.4 t -112.6 126.95 70.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.551 -0.907 . . . . 72.14 108.551 174.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -109.16 110.43 21.66 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.831 0.853 . . . . 61.11 109.466 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 10.8 p -149.75 133.22 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 123.018 0.527 . . . . 75.41 110.541 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.64 18.68 10.75 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.513 1.125 . . . . 73.32 112.645 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.79 5.57 86.27 Favored Glycine 0 C--N 1.348 1.244 0 O-C-N 123.158 0.286 . . . . 40.2 113.232 -176.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -112.12 131.46 55.44 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.406 1.082 . . . . 72.13 109.806 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.556 ' HG3' HG13 ' A' ' 137' ' ' VAL . 39.6 ttm180 -90.22 113.98 25.89 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.124 0.97 . . . . 71.33 109.618 172.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.601 HG13 ' HB ' ' A' ' 138' ' ' VAL . 2.5 p -111.3 115.14 49.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 123.398 0.679 . . . . 54.24 109.21 169.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.6 t -86.78 115.23 24.07 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 109.19 -0.67 . . . . 74.44 109.19 175.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.6 p -100.83 124.38 54.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 123.612 0.765 . . . . 71.35 109.795 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 54.2 ttt85 -80.43 93.93 6.1 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.747 -1.205 . . . . 73.53 107.747 168.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.525 HD12 HD21 ' A' ' 125' ' ' LEU . 13.8 pt -74.31 143.94 80.64 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 123.824 0.85 . . . . 64.51 109.753 177.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.429 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 59.9 Cg_endo -72.8 149.07 47.39 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 122.225 1.95 . . . . 73.11 111.993 177.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 150' ' ' PRO . 31.9 Cg_exo -60.54 134.45 54.75 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 123.137 2.558 . . . . 70.15 112.122 177.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 65.83 29.31 74.81 Favored Glycine 0 C--N 1.353 1.506 0 O-C-N 123.697 0.623 . . . . 74.01 112.63 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -58.21 145.65 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 C-N-CA 124.053 0.941 . . . . 74.45 109.72 176.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -136.64 158.75 43.71 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.53 0.732 . . . . 72.12 110.415 -173.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -42.69 127.18 3.87 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.895 1.678 . . . . 52.21 112.838 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.27 -4.82 80.92 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 114.385 0.514 . . . . 64.02 114.385 177.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.6 t -67.62 122.32 17.8 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.242 -0.651 . . . . 71.2 109.242 176.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 46.5 t -101.99 117.06 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 109.427 -0.583 . . . . 73.53 109.427 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.5 mt -91.92 144.1 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.813 1.245 . . . . 71.42 107.968 173.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.547 HH11 HD21 ' A' ' 175' ' ' LEU . 49.0 ttt85 -118.09 116.75 27.49 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.188 -0.671 . . . . 73.32 109.188 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 174' ' ' LEU . 5.0 p -124.17 109.62 29.3 Favored Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 123.693 0.797 . . . . 53.14 110.531 -177.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -70.72 153.62 64.41 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.974 2.449 . . . . 72.44 112.628 -176.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.77 -13.83 54.67 Favored Glycine 0 C--N 1.339 0.719 0 CA-C-N 115.702 -0.681 . . . . 72.44 113.954 174.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 84.7 mmm -100.14 -12.42 19.64 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 117.404 0.602 . . . . 65.22 111.452 -176.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -83.04 -111.5 0.5 Allowed Glycine 0 C--N 1.353 1.485 0 CA-C-O 119.312 -0.716 . . . . 61.12 111.936 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.434 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -53.85 108.32 0.81 Allowed Glycine 0 C--N 1.353 1.489 0 O-C-N 124.003 0.472 . . . . 53.25 113.128 174.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -91.22 169.54 10.75 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.616 1.167 . . . . 73.4 110.396 175.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 94.59 -145.41 17.68 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 115.388 -0.824 . . . . 73.02 112.147 175.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -69.13 -47.66 28.58 Favored Pre-proline 0 CA--C 1.561 1.384 0 CA-C-O 118.13 -0.938 . . . . 73.24 110.872 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.3 113.59 2.67 Favored 'Trans proline' 0 C--N 1.395 3.011 0 C-N-CA 122.232 1.955 . . . . 62.0 111.087 172.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -72.39 160.17 47.55 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.45 2.1 . . . . 74.34 111.418 177.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -161.01 -179.13 35.56 Favored Glycine 0 CA--C 1.504 -0.632 0 N-CA-C 114.732 0.653 . . . . 44.15 114.732 176.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -120.52 150.18 41.25 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.531 1.132 . . . . 75.31 109.641 -169.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.421 ' HB3' HG13 ' A' ' 161' ' ' VAL . 37.2 tp -117.1 114.1 23.24 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.563 0.745 . . . . 73.34 110.1 -172.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.547 HD21 HH11 ' A' ' 160' ' ' ARG . 92.8 mt -88.37 103.28 15.69 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.063 0.945 . . . . 74.21 110.162 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.534 HD22 HD11 ' A' ' 99' ' ' LEU . 77.0 mt -95.41 99.18 11.13 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.085 0.954 . . . . 74.24 110.615 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 8.5 p -90.37 133.4 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 109.372 -0.603 . . . . 74.14 109.372 175.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.3 p -87.58 144.81 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 123.238 0.615 . . . . 72.43 111.165 -171.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.475 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 35.5 mmt180 -119.25 99.74 6.89 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.742 1.217 . . . . 62.33 108.44 174.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 16.0 mt -118.86 145.86 45.35 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.973 0.909 . . . . 54.11 111.119 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 65.2 mt . . . . . 0 CA--C 1.551 0.991 0 CA-C-N 114.541 -1.209 . . . . 73.32 109.423 -178.614 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 49.8 mtt . . . . . 0 N--CA 1.484 1.264 0 N-CA-C 108.927 -0.768 . . . . 74.54 108.927 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.4 m -71.48 121.68 19.07 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.915 -0.772 . . . . 51.14 108.915 174.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 86.8 m -68.2 141.56 55.94 Favored 'General case' 0 C--N 1.35 0.63 0 C-N-CA 123.392 0.677 . . . . 72.05 110.39 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.588 HD12 ' HB2' ' A' ' 123' ' ' LEU . 14.2 pt -114.88 163.41 12.19 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 C-N-CA 123.057 0.543 . . . . 52.41 110.818 -170.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -123.15 -162.93 1.06 Allowed 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.399 -0.963 . . . . 45.44 108.399 170.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.488 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.5 tp -136.64 155.93 49.23 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.937 -0.764 . . . . 75.13 108.937 -175.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.87 -48.92 33.32 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.044 0.538 . . . . 50.1 110.723 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.585 HD11 ' HB ' ' A' ' 140' ' ' VAL . 60.2 mt 53.68 78.05 0.16 Allowed 'General case' 0 CA--C 1.546 0.809 0 O-C-N 124.469 1.106 . . . . 63.45 110.348 -171.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 60.9 mt -84.65 143.2 40.61 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 114.984 -1.007 . . . . 75.53 109.636 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 C--N 1.375 1.953 0 C-N-CA 122.571 2.18 . . . . 72.21 112.952 179.839 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.706 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 32.8 ttm180 . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 120.685 0.279 . . . . 75.43 111.01 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -76.11 139.33 41.29 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.519 0.728 . . . . 74.22 109.539 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.3 tt -141.38 115.5 9.3 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 106.393 -1.706 . . . . 71.33 106.393 -177.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -90.24 143.08 27.1 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 107.052 -1.462 . . . . 73.42 107.052 177.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.488 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -149.51 137.16 20.2 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 120.684 0.278 . . . . 62.53 110.522 -169.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -120.53 112.41 18.91 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.146 -1.057 . . . . 73.45 108.146 -172.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.588 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.6 pp -99.31 117.79 63.43 Favored Pre-proline 0 C--N 1.354 0.78 0 N-CA-C 108.396 -0.964 . . . . 70.05 108.396 177.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.417 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 95.6 Cg_endo -75.48 113.68 3.81 Favored 'Trans proline' 0 C--N 1.364 1.36 0 C-N-CA 122.208 1.939 . . . . 71.53 109.166 170.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.512 HD21 HD12 ' A' ' 149' ' ' ILE . 33.0 tp -102.0 153.08 20.22 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.615 -0.513 . . . . 73.13 109.615 -172.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.8 t -91.43 155.16 18.65 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 109.224 -0.658 . . . . 74.1 109.224 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.1 mt -63.12 -34.43 77.59 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.461 0.704 . . . . 72.45 111.947 -173.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.93 -46.39 90.87 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.834 0.853 . . . . 75.23 110.022 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -79.09 -26.59 42.96 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.24 -0.891 . . . . 65.31 112.519 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.38 -40.94 92.65 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.533 0.683 . . . . 71.14 110.064 171.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -77.62 -48.91 15.71 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 114.224 -1.353 . . . . 73.33 111.093 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -69.68 -49.43 53.57 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 122.802 0.441 . . . . 54.14 111.592 -173.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.569 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 75.11 -170.42 54.36 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 115.805 -0.634 . . . . 74.13 111.702 -163.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.462 ' O ' HG12 ' A' ' 149' ' ' ILE . . . 90.54 -166.29 31.62 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 116.557 0.179 . . . . 55.02 112.74 -177.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.445 ' HB3' ' OG ' ' A' ' 146' ' ' SER . 3.6 mp0 -71.62 130.69 41.8 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.226 0.61 . . . . 63.02 110.275 -175.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -131.24 128.58 40.17 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.19 -0.67 . . . . 75.11 109.19 172.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 38.7 t -72.39 113.08 9.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 O-C-N 124.627 1.205 . . . . 71.52 110.63 -172.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.5 t -106.44 112.16 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.687 1.195 . . . . 74.32 107.878 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -94.18 117.35 29.99 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.276 0.63 . . . . 73.41 109.44 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.585 ' HB ' HD11 ' A' ' 101' ' ' LEU . 19.5 m -135.64 120.84 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 124.502 1.121 . . . . 73.23 112.048 -169.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 57.88 20.34 6.56 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.55 1.14 . . . . 73.44 113.603 169.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.67 27.76 18.59 Favored Glycine 0 CA--C 1.535 1.342 0 N-CA-C 112.461 -0.256 . . . . 33.45 112.461 -175.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -133.64 154.02 51.23 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.405 1.082 . . . . 55.43 109.24 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -112.31 114.79 27.73 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.36 1.064 . . . . 75.31 109.044 176.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 5.7 p -130.26 124.29 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.536 -0.913 . . . . 74.33 108.536 174.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.445 ' OG ' ' HB3' ' A' ' 135' ' ' GLU . 12.7 t -103.44 122.8 45.64 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 109.228 -0.656 . . . . 63.55 109.228 -177.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.1 p -100.94 129.56 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 122.933 0.493 . . . . 71.51 110.092 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.9 ttp180 -74.73 98.82 3.55 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.573 -0.899 . . . . 61.2 108.573 170.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.569 HG13 ' HA2' ' A' ' 133' ' ' GLY . 10.7 pt -78.72 145.55 67.03 Favored Pre-proline 0 CA--C 1.563 1.444 0 C-N-CA 124.042 0.937 . . . . 75.34 109.796 171.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.86 141.34 89.58 Favored 'Trans proline' 0 CA--C 1.564 1.985 0 C-N-CA 122.78 2.32 . . . . 72.44 113.388 174.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -62.73 114.78 2.55 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.718 2.279 . . . . 70.03 111.115 168.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 87.59 30.03 19.82 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 111.444 -0.662 . . . . 72.53 111.444 -174.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -70.21 137.34 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.428 0.691 . . . . 74.41 109.358 174.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -135.11 157.56 46.61 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.997 0.519 . . . . 64.04 111.04 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -39.86 122.06 1.38 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.915 2.086 . . . . 41.21 113.202 -175.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.9 -12.08 38.04 Favored Glycine 0 C--N 1.348 1.213 0 CA-C-O 119.366 -0.685 . . . . 55.0 113.846 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 13.7 t -70.04 122.14 18.8 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 117.382 0.591 . . . . 74.21 110.138 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 46.5 t -104.41 111.24 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 123.848 0.859 . . . . 74.01 109.628 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 61.1 mt -89.69 103.63 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.912 -1.144 . . . . 54.3 107.912 171.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -82.15 119.55 24.2 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.397 -0.594 . . . . 71.24 109.397 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.542 HG13 ' HB3' ' A' ' 174' ' ' LEU . 6.5 p -124.51 98.2 38.17 Favored Pre-proline 0 CA--C 1.561 1.374 0 C-N-CA 123.68 0.792 . . . . 54.55 109.476 177.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 73.5 Cg_endo -72.35 146.68 45.67 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.954 2.436 . . . . 63.24 112.503 179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 93.45 -18.51 56.23 Favored Glycine 0 CA--C 1.537 1.43 0 CA-C-O 120.058 -0.301 . . . . 70.12 113.726 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 69.9 mmm -97.87 -9.87 25.62 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.935 0.894 . . . . 62.01 112.904 -174.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -79.74 -100.07 0.28 Allowed Glycine 0 C--N 1.342 0.889 0 O-C-N 123.181 0.3 . . . . 73.31 112.68 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.706 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -67.56 103.04 0.89 Allowed Glycine 0 C--N 1.344 1.022 0 N-CA-C 112.416 -0.273 . . . . 75.53 112.416 175.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -79.8 131.71 35.97 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.591 0.756 . . . . 65.11 109.813 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 154.06 -163.73 31.09 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 111.495 -0.642 . . . . 72.32 111.495 -177.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -58.83 -47.17 99.2 Favored Pre-proline 0 CA--C 1.562 1.422 0 CA-C-O 118.749 -0.643 . . . . 75.33 111.524 177.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.93 119.28 3.55 Favored 'Trans proline' 0 C--N 1.39 2.733 0 C-N-CA 121.481 1.454 . . . . 54.43 110.967 168.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.6 121.96 9.3 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 121.568 1.512 . . . . 71.52 109.702 174.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -97.59 149.25 19.19 Favored Glycine 0 C--N 1.339 0.728 0 CA-C-O 119.769 -0.462 . . . . 65.33 112.539 -173.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 37.6 t70 -83.03 139.78 33.08 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 122.764 0.426 . . . . 63.33 110.575 -175.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.542 ' HB3' HG13 ' A' ' 161' ' ' VAL . 33.4 tp -122.88 130.67 53.14 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.643 0.777 . . . . 75.32 109.347 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 80.9 mt -109.34 101.9 10.86 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.602 0.761 . . . . 72.34 109.307 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 77.3 mt -88.07 101.07 13.43 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 109.583 -0.525 . . . . 72.01 109.583 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 36.5 t -95.77 124.98 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 109.116 -0.698 . . . . 44.11 109.116 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.8 p -74.96 127.61 36.66 Favored 'Isoleucine or valine' 0 C--O 1.249 1.064 0 C-N-CA 123.117 0.567 . . . . 65.25 109.966 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.417 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 5.1 mmm180 -114.42 100.61 8.44 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.769 -0.826 . . . . 74.34 108.769 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 40.3 mt -116.38 139.86 49.96 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.373 1.069 . . . . 65.52 110.035 -177.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 59.3 mt . . . . . 0 CA--C 1.546 0.803 0 CA-C-N 115.347 -0.842 . . . . 54.31 108.891 178.633 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.481 ' SD ' ' N ' ' A' ' 94' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 108.108 -1.071 . . . . 52.33 108.108 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.9 t -62.2 121.56 13.41 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.067 0.547 . . . . 61.34 111.228 -172.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.521 ' HA ' ' HD2' ' A' ' 136' ' ' ARG . 56.6 m -72.59 149.65 43.78 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.534 0.733 . . . . 72.42 110.323 177.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.725 HD12 ' HB2' ' A' ' 123' ' ' LEU . 14.1 pt -118.09 161.75 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.029 0.532 . . . . 74.33 111.41 -164.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -113.18 -162.87 0.82 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.954 0.902 . . . . 42.41 109.186 173.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.762 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.6 tp -150.66 147.42 27.36 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.125 -0.694 . . . . 73.15 109.125 -172.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.14 -51.91 14.13 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.406 0.283 . . . . 73.34 111.147 -178.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 89.9 mt 60.59 73.77 0.47 Allowed 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.339 1.025 . . . . 71.53 110.435 -174.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.9 mt -77.02 109.72 9.86 Favored Pre-proline 0 CA--C 1.555 1.151 0 CA-C-N 114.986 -1.006 . . . . 44.44 109.18 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo . . . . . 0 C--N 1.383 2.352 0 C-N-CA 123.53 2.82 . . . . 70.3 114.716 -173.131 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.605 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 17.4 ttm180 . . . . . 0 N--CA 1.479 0.975 0 CA-C-O 120.42 0.152 . . . . 60.42 111.064 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -71.44 134.29 46.5 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.0 0.52 . . . . 70.43 110.094 173.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.7 tt -133.93 120.3 20.17 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 106.298 -1.741 . . . . 75.43 106.298 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -91.83 144.24 25.7 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 108.931 -0.766 . . . . 74.12 108.931 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.762 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -154.73 133.25 11.98 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.86 0.464 . . . . 53.25 110.037 -172.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -107.02 116.24 31.57 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.493 0.717 . . . . 73.11 109.365 -168.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.725 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.2 pp -101.36 115.21 65.38 Favored Pre-proline 0 C--N 1.35 0.604 0 N-CA-C 108.694 -0.854 . . . . 70.04 108.694 177.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -80.26 111.43 2.64 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.533 2.155 . . . . 70.43 110.984 172.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.605 HD21 HD12 ' A' ' 149' ' ' ILE . 30.0 tp -104.6 152.15 22.78 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 121.899 -0.501 . . . . 64.12 110.644 -166.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.9 t -90.35 154.11 19.94 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 123.498 0.719 . . . . 75.01 109.127 178.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.7 mt -68.64 -30.85 69.65 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.499 0.72 . . . . 52.44 112.251 -170.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -64.49 -48.58 74.65 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.14 0.576 . . . . 73.32 109.575 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -63.21 -38.45 91.2 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 114.695 -1.139 . . . . 52.25 112.0 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.475 ' HB2' HD21 ' A' ' 180' ' ' LEU . . . -60.02 -38.47 82.8 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 123.616 0.573 . . . . 74.14 111.505 176.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -76.32 -32.76 58.88 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 115.077 -0.965 . . . . 73.15 111.077 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -74.5 -49.75 20.91 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.096 0.474 . . . . 73.21 111.437 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.449 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 66.63 44.54 89.52 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.163 -0.926 . . . . 54.22 112.036 -164.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -97.09 -161.5 31.8 Favored Glycine 0 C--N 1.351 1.367 0 O-C-N 123.894 0.408 . . . . 75.34 112.244 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -95.71 116.68 29.23 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.772 -0.825 . . . . 74.12 108.772 176.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.521 ' HD2' ' HA ' ' A' ' 96' ' ' THR . 10.0 tpp180 -111.0 126.23 54.57 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.159 0.584 . . . . 64.21 109.527 178.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 91.6 t -73.56 132.89 32.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 114.433 -1.258 . . . . 61.2 110.333 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 28.2 t -116.59 126.76 74.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 107.302 -1.37 . . . . 65.32 107.302 174.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -126.06 110.11 13.16 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.994 0.518 . . . . 62.4 110.27 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -149.25 137.03 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 124.391 1.076 . . . . 72.11 111.072 -177.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.85 17.33 9.86 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.246 1.419 . . . . 44.04 112.732 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.33 1.68 74.82 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 116.404 -0.362 . . . . 51.31 112.987 -176.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -102.38 121.26 41.96 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.385 1.074 . . . . 71.12 110.109 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -98.48 105.49 17.64 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 109.522 -0.548 . . . . 73.11 109.522 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.459 HG12 HG13 ' A' ' 147' ' ' VAL . 49.6 t -106.17 111.86 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.778 0.831 . . . . 55.21 109.062 176.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.6 t -92.39 121.11 33.56 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.191 -1.041 . . . . 65.42 108.191 176.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.459 HG13 HG12 ' A' ' 145' ' ' VAL . 29.8 m -126.16 144.01 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.142 0.577 . . . . 72.11 110.785 -176.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 63.5 ttp85 -88.32 124.59 34.06 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.677 -0.86 . . . . 73.52 108.677 172.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.605 HD12 HD21 ' A' ' 125' ' ' LEU . 4.5 pt -93.47 149.26 36.96 Favored Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 124.295 1.038 . . . . 64.41 109.752 176.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.412 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 33.7 Cg_exo -61.0 140.37 89.72 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 123.013 2.476 . . . . 55.34 113.74 174.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 150' ' ' PRO . 22.4 Cg_exo -67.58 113.88 3.1 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.89 2.393 . . . . 53.51 111.199 170.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 86.07 26.38 34.34 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 116.083 -0.508 . . . . 45.1 112.107 -173.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.21 137.22 22.92 Favored 'Isoleucine or valine' 0 C--N 1.358 0.958 0 C-N-CA 123.546 0.738 . . . . 71.1 110.671 176.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 65.3 mtm180 -134.37 164.82 26.58 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.861 0.864 . . . . 72.4 110.642 -174.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -43.29 122.28 2.5 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.177 1.791 . . . . 75.35 114.685 -171.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.18 -6.71 72.39 Favored Glycine 0 C--N 1.352 1.431 0 CA-C-O 119.376 -0.68 . . . . 73.41 114.52 176.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.1 m -60.61 123.33 17.09 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.382 0.673 . . . . 64.3 111.865 175.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.1 p -101.85 132.88 46.89 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.041 0 C-N-CA 123.172 0.589 . . . . 72.15 110.744 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.595 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 75.7 mt -106.32 104.74 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 107.465 -1.309 . . . . 62.52 107.465 176.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -78.94 105.42 10.26 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.723 -0.473 . . . . 63.22 109.723 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.553 HG13 ' HB3' ' A' ' 174' ' ' LEU . 5.8 p -113.44 100.17 51.16 Favored Pre-proline 0 CA--C 1.558 1.277 0 C-N-CA 122.717 0.407 . . . . 62.14 110.166 174.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -64.3 150.73 87.74 Favored 'Trans proline' 0 C--N 1.387 2.592 0 C-N-CA 123.713 2.942 . . . . 51.24 113.168 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 83.35 -25.38 4.99 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 116.223 -0.444 . . . . 73.0 113.988 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.54 -12.84 50.67 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.02 0.928 . . . . 62.41 111.617 -178.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -84.73 -111.87 0.66 Allowed Glycine 0 C--N 1.349 1.279 0 O-C-N 123.511 0.507 . . . . 44.2 112.654 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.605 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -61.34 120.59 23.24 Favored Glycine 0 C--N 1.346 1.136 0 O-C-N 123.818 0.364 . . . . 73.42 112.469 177.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 11.7 mm-40 -88.18 155.42 19.77 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.354 0.662 . . . . 73.42 111.269 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 129.47 -171.4 20.14 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.069 -0.969 . . . . 61.33 111.466 -175.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -60.5 -45.27 97.29 Favored Pre-proline 0 CA--C 1.564 1.487 0 CA-C-O 118.451 -0.785 . . . . 62.11 112.209 175.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -82.73 112.74 2.15 Favored 'Trans proline' 0 C--N 1.395 2.98 0 C-N-CA 121.902 1.735 . . . . 75.43 111.066 171.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.76 127.43 12.31 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.418 2.079 . . . . 74.35 112.068 -177.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -105.12 156.13 16.88 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.973 -0.558 . . . . 73.15 112.785 -175.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -84.91 135.27 34.13 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.709 0.804 . . . . 72.22 111.241 -176.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.553 ' HB3' HG13 ' A' ' 161' ' ' VAL . 23.4 tp -102.21 107.79 18.97 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.457 -0.942 . . . . 64.12 108.457 177.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 78.9 mt -86.49 100.22 12.22 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.606 0.762 . . . . 72.51 109.909 -176.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.649 ' HB3' HD23 ' A' ' 123' ' ' LEU . 75.4 mt -91.42 98.95 12.0 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.059 0.544 . . . . 71.3 110.927 -175.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 47.9 t -91.0 117.34 34.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 109.461 -0.57 . . . . 74.3 109.461 -178.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.5 p -69.73 135.43 28.28 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 C-N-CA 123.339 0.656 . . . . 62.53 110.514 -176.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -127.69 85.64 2.38 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.189 -1.041 . . . . 71.34 108.189 -178.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.475 HD21 ' HB2' ' A' ' 130' ' ' ALA . 43.5 mt -82.36 147.52 28.78 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 114.975 -1.012 . . . . 75.24 110.27 -178.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 60.4 mt . . . . . 0 CA--C 1.551 1.0 0 N-CA-C 108.644 -0.873 . . . . 60.33 108.644 176.267 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 3.7 mpp? . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 108.501 -0.926 . . . . 64.14 108.501 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.5 m -62.82 132.12 51.11 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.555 0.742 . . . . 51.21 111.741 -171.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.413 ' HA ' ' HD2' ' A' ' 136' ' ' ARG . 39.5 m -77.14 151.75 35.21 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.728 0.811 . . . . 73.52 110.262 176.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.743 HD12 ' HB2' ' A' ' 123' ' ' LEU . 26.7 pt -112.46 165.09 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 123.173 0.589 . . . . 73.32 110.985 -174.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -135.25 123.64 23.29 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.936 0.895 . . . . 75.42 109.528 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.544 ' HB2' HG21 ' A' ' 138' ' ' VAL . 13.2 tp -76.69 149.44 36.41 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 124.845 1.258 . . . . 73.31 110.231 -172.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.34 -51.37 20.92 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.951 0.501 . . . . 71.14 111.115 -175.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.1 mt 57.72 82.36 0.13 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.357 1.063 . . . . 71.4 111.236 -174.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 45.9 mt -96.6 150.47 37.04 Favored Pre-proline 0 N--CA 1.479 1.008 0 C-N-CA 124.613 1.165 . . . . 71.42 109.664 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 C--N 1.375 1.966 0 C-N-CA 122.375 2.05 . . . . 70.41 112.714 176.571 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.501 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 68.4 ttt180 . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 112.459 0.54 . . . . 73.24 112.459 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -77.21 148.71 35.71 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.263 -0.881 . . . . 63.35 109.114 174.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.2 tt -140.62 131.14 25.4 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.329 -0.989 . . . . 63.12 108.329 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -93.32 115.99 28.56 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 108.895 -0.78 . . . . 73.02 108.895 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.543 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -129.15 144.24 51.14 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.339 -0.615 . . . . 72.32 109.339 -176.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -126.12 120.12 29.34 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 107.962 -1.125 . . . . 74.55 107.962 -176.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.743 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.0 pp -100.98 110.62 61.58 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 107.519 -1.289 . . . . 73.41 107.519 177.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.99 112.8 3.61 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.794 2.329 . . . . 73.41 108.876 168.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.546 HD21 HD12 ' A' ' 149' ' ' ILE . 22.9 tp -103.21 140.83 36.85 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.149 -0.686 . . . . 72.23 109.149 -168.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.7 t -78.22 162.69 26.39 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 110.101 -0.333 . . . . 60.5 110.101 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.1 mt -64.01 -36.66 84.72 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.014 0.925 . . . . 73.41 112.014 -174.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -62.19 -46.48 88.74 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.487 0.715 . . . . 73.15 109.842 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -71.87 -40.05 69.22 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.398 -1.273 . . . . 70.01 111.833 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.8 -58.34 8.99 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.57 0.7 . . . . 74.4 111.187 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -67.44 -56.7 8.54 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.441 -1.254 . . . . 65.4 111.121 -175.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -77.62 -41.41 38.6 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.246 0.219 . . . . 73.11 111.314 -170.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.59 165.03 38.96 Favored Glycine 0 C--N 1.351 1.366 0 CA-C-N 116.826 -0.17 . . . . 53.11 112.986 -176.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.05 -154.69 25.83 Favored Glycine 0 C--N 1.343 0.954 0 N-CA-C 111.796 -0.522 . . . . 51.2 111.796 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -105.89 121.26 43.72 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.416 -0.957 . . . . 74.12 108.416 172.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.413 ' HD2' ' HA ' ' A' ' 96' ' ' THR . 10.2 tpp180 -113.2 122.02 46.23 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 109.575 -0.528 . . . . 64.43 109.575 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 71.7 t -73.32 142.04 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 124.145 0.978 . . . . 64.23 110.263 175.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.544 HG21 ' HB2' ' A' ' 99' ' ' LEU . 3.1 p -135.07 126.13 45.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.866 1.266 . . . . 44.42 108.073 175.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -114.02 109.77 18.98 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.129 0.972 . . . . 74.23 109.461 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.6 m -142.72 141.83 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 124.238 1.015 . . . . 54.24 110.065 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 65.0 19.37 11.84 Favored 'General case' 0 CA--C 1.554 1.134 0 O-C-N 124.632 1.208 . . . . 72.01 111.429 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 79.99 11.34 84.6 Favored Glycine 0 C--N 1.359 1.856 0 CA-C-N 116.066 -0.515 . . . . 64.13 113.1 -174.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -116.31 124.69 50.75 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.402 1.081 . . . . 73.33 110.555 -172.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -98.21 134.22 41.56 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.894 0.877 . . . . 71.21 110.125 -179.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.1 p -147.96 141.15 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 123.544 0.738 . . . . 63.23 109.492 171.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.7 t -107.51 125.3 51.1 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.228 0.611 . . . . 32.14 109.472 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.7 p -106.96 125.9 63.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 123.381 0.672 . . . . 74.1 110.769 -177.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -78.33 102.14 7.55 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.52 0.676 . . . . 64.31 109.68 177.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.546 HD12 HD21 ' A' ' 125' ' ' LEU . 11.2 pt -92.38 144.42 28.87 Favored Pre-proline 0 CA--C 1.556 1.182 0 CA-C-N 114.507 -1.224 . . . . 73.54 109.611 174.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.2 162.12 34.41 Favored 'Trans proline' 0 CA--C 1.563 1.945 0 C-N-CA 122.636 2.224 . . . . 64.32 112.18 176.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.87 125.5 12.16 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.704 2.27 . . . . 73.03 111.803 175.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 81.81 25.81 51.83 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-O 119.892 -0.393 . . . . 71.5 112.127 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.3 p -63.94 119.92 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 C-N-CA 123.452 0.701 . . . . 75.11 110.212 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -103.63 165.89 10.76 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.126 0.97 . . . . 65.4 110.291 -171.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -49.14 134.63 17.51 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 125.37 1.669 . . . . 74.03 111.786 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.51 -11.66 68.4 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-O 119.141 -0.811 . . . . 75.24 114.35 174.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.9 t -65.54 121.19 14.35 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 117.589 0.695 . . . . 41.41 109.392 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 55.9 t -100.54 111.46 30.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 108.927 -0.768 . . . . 75.42 108.927 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 56.5 mt -88.61 103.89 14.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 107.262 -1.384 . . . . 74.34 107.262 169.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.433 ' HG3' HD23 ' A' ' 175' ' ' LEU . 59.4 ttt180 -90.44 124.7 35.18 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.249 -0.648 . . . . 73.43 109.249 -176.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.5 p -124.74 107.14 29.04 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 123.447 0.699 . . . . 73.15 109.469 174.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.2 155.19 61.33 Favored 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 122.485 2.124 . . . . 60.12 111.534 172.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.553 ' HA2' ' HB2' ' A' ' 171' ' ' PRO . . . 85.21 0.35 88.66 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 114.574 0.59 . . . . 71.11 114.574 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 55.4 mtp -121.84 -7.26 9.01 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 113.623 0.972 . . . . 73.43 113.623 -173.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -82.65 -91.12 0.64 Allowed Glycine 0 N--CA 1.471 0.981 0 CA-C-N 118.013 0.369 . . . . 75.42 112.67 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.501 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -66.09 95.4 0.24 Allowed Glycine 0 C--N 1.345 1.074 0 N-CA-C 111.527 -0.629 . . . . 72.44 111.527 173.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -83.31 110.87 18.48 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.383 0.673 . . . . 75.3 110.398 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -172.9 -146.21 5.33 Favored Glycine 0 C--O 1.241 0.563 0 N-CA-C 110.526 -1.029 . . . . 61.12 110.526 -177.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -75.86 -50.97 3.08 Favored Pre-proline 0 CA--C 1.565 1.539 0 CA-C-O 118.844 -0.598 . . . . 75.24 110.432 175.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.402 ' HA ' ' HD2' ' A' ' 171' ' ' PRO . 93.7 Cg_endo -83.6 116.68 2.29 Favored 'Trans proline' 0 C--N 1.397 3.131 0 C-N-CA 121.508 1.472 . . . . 62.41 110.751 170.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.553 ' HB2' ' HA2' ' A' ' 163' ' ' GLY . 29.4 Cg_endo -60.94 125.94 18.38 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.35 2.033 . . . . 74.54 111.368 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -99.2 163.14 20.05 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 113.864 0.306 . . . . 74.21 113.864 -174.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -86.26 144.46 27.41 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.584 0.754 . . . . 72.3 110.637 -176.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 30.7 tp -130.63 122.28 27.13 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.22 0.608 . . . . 70.55 109.525 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.433 HD23 ' HG3' ' A' ' 160' ' ' ARG . 61.6 mt -99.39 114.64 27.67 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.716 -0.846 . . . . 74.35 108.716 177.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.648 ' HB3' HD23 ' A' ' 123' ' ' LEU . 36.9 mt -102.02 100.41 10.68 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.839 -0.8 . . . . 74.4 108.839 175.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.3 p -95.53 126.09 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 109.38 -0.6 . . . . 64.13 109.38 176.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.7 p -73.23 136.05 26.32 Favored 'Isoleucine or valine' 0 C--O 1.247 0.974 0 C-N-CA 123.279 0.632 . . . . 74.13 110.256 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -123.64 103.82 8.64 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.61 -1.255 . . . . 73.11 107.61 -176.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 92.7 mt -105.8 148.29 27.68 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.995 0.918 . . . . 64.44 110.546 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 CA--C 1.549 0.923 0 C-N-CA 124.411 1.084 . . . . 72.22 111.465 -176.98 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.505 ' HA ' HG21 ' A' ' 126' ' ' THR . 23.7 ptp . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 110.085 -0.339 . . . . 65.05 110.085 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.8 m -143.3 144.86 32.28 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.394 0.678 . . . . 71.22 109.885 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.0 p -75.4 148.01 39.52 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.653 -0.703 . . . . 75.2 110.384 170.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.564 HD12 ' HB2' ' A' ' 123' ' ' LEU . 24.0 pt -128.29 162.65 34.3 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 CA-C-N 114.521 -1.218 . . . . 73.21 109.729 -167.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -128.12 129.07 45.98 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.277 0.631 . . . . 71.01 110.122 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.687 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.8 tp -72.84 155.84 39.5 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.137 1.375 . . . . 75.41 109.331 -175.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -79.25 -38.27 35.92 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.309 0.504 . . . . 32.45 111.371 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.7 mt 54.04 75.77 0.26 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.438 1.095 . . . . 73.42 111.485 -175.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 31.5 mt -86.35 136.05 35.91 Favored Pre-proline 0 CA--C 1.553 1.092 0 CA-C-N 115.35 -0.841 . . . . 64.34 109.277 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo . . . . . 0 C--N 1.377 2.043 0 C-N-CA 122.548 2.165 . . . . 75.2 112.439 175.608 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.415 ' NH2' HD12 ' A' ' 119' ' ' LEU . 6.9 tmm_? . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 110.195 -0.298 . . . . 62.54 110.195 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -78.95 128.73 33.66 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 122.981 0.512 . . . . 71.43 109.636 178.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.415 HD12 ' NH2' ' A' ' 117' ' ' ARG . 2.8 tt -119.44 117.25 27.96 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.555 -1.646 . . . . 63.52 106.555 178.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -90.4 133.38 35.04 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.272 -1.381 . . . . 75.33 107.272 176.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.687 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -156.99 140.24 15.58 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.467 -0.568 . . . . 72.04 109.467 -174.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -127.19 129.24 47.46 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 110.181 -0.303 . . . . 73.41 110.181 -172.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.564 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.1 pp -102.09 127.17 31.48 Favored Pre-proline 0 C--N 1.352 0.688 0 N-CA-C 109.575 -0.528 . . . . 51.14 109.575 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.409 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 63.0 Cg_endo -75.05 116.22 4.51 Favored 'Trans proline' 0 C--N 1.362 1.272 0 C-N-CA 122.724 2.282 . . . . 54.13 109.015 168.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.637 HD21 HD12 ' A' ' 149' ' ' ILE . 37.5 tp -103.37 146.2 28.84 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.63 0.65 . . . . 71.11 111.168 -168.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.505 HG21 ' HA ' ' A' ' 94' ' ' MET . 92.8 m -75.32 143.69 42.79 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 114.695 -1.139 . . . . 75.11 109.228 175.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.404 ' HG ' HD12 ' A' ' 181' ' ' LEU . 88.3 mt -68.26 -35.03 77.27 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.721 0.808 . . . . 72.24 112.306 -172.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -68.28 -34.46 76.2 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.023 0.529 . . . . 74.23 109.836 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.443 ' HB3' HD11 ' A' ' 149' ' ' ILE . 57.5 mm-40 -68.19 -40.13 82.29 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.342 -0.844 . . . . 74.12 110.98 176.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.514 ' HB2' HD21 ' A' ' 180' ' ' LEU . . . -68.96 -38.03 79.18 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.811 0.444 . . . . 44.21 111.96 177.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -70.66 -53.31 16.25 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.089 -0.96 . . . . 75.52 110.239 -176.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -77.16 -46.02 24.79 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.796 -0.638 . . . . 75.32 110.828 -176.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.72 94.65 0.16 Allowed Glycine 0 C--N 1.347 1.142 0 O-C-N 123.467 0.479 . . . . 61.45 112.499 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.495 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -153.17 -160.34 9.63 Favored Glycine 0 C--N 1.341 0.81 0 N-CA-C 111.989 -0.445 . . . . 55.14 111.989 -178.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -81.3 114.9 20.4 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.556 -0.535 . . . . 63.54 109.556 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -113.26 124.43 52.5 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.227 1.011 . . . . 63.21 109.163 177.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 77.3 t -78.93 111.08 15.36 Favored 'Isoleucine or valine' 0 C--O 1.245 0.824 0 CA-C-N 114.673 -1.149 . . . . 74.2 109.916 176.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.426 HG13 ' HB ' ' A' ' 145' ' ' VAL . 3.7 p -108.78 109.93 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 124.504 1.121 . . . . 64.31 108.19 170.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -110.64 133.59 53.18 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.886 0.474 . . . . 64.21 110.531 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.46 141.09 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 125.178 1.391 . . . . 70.04 110.537 175.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 60.69 25.94 15.71 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.624 1.17 . . . . 61.01 112.163 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 79.49 8.42 87.77 Favored Glycine 0 C--N 1.355 1.621 0 CA-C-N 116.062 -0.517 . . . . 55.13 113.075 -178.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.414 HH22 ' HG3' ' A' ' 167' ' ' GLN . 39.9 ttm180 -103.31 117.77 35.25 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.957 0.903 . . . . 74.1 109.475 178.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -89.53 108.34 19.6 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.908 -0.775 . . . . 74.15 108.908 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.448 HG12 HG13 ' A' ' 147' ' ' VAL . 19.0 t -104.94 112.88 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 107.9 -1.148 . . . . 63.24 107.9 178.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.1 t -101.04 107.78 19.32 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.791 -0.818 . . . . 72.11 108.791 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.448 HG13 HG12 ' A' ' 145' ' ' VAL . 27.1 m -114.27 132.35 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.251 0.62 . . . . 53.14 111.432 -174.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -88.19 97.6 11.09 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.0 0.92 . . . . 73.33 109.17 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.637 HD12 HD21 ' A' ' 125' ' ' LEU . 10.7 pt -79.96 139.05 53.27 Favored Pre-proline 0 CA--C 1.562 1.413 0 CA-C-N 115.153 -0.93 . . . . 62.33 109.652 178.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.32 149.59 63.56 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.458 2.106 . . . . 74.33 112.657 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.31 112.06 1.8 Allowed 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.525 2.15 . . . . 72.34 110.91 172.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 96.98 23.34 15.27 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-N 115.824 -0.625 . . . . 41.1 112.364 -173.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.491 HG11 ' HB ' ' A' ' 149' ' ' ILE . 6.3 p -66.78 120.17 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 108.479 -0.934 . . . . 72.54 108.479 168.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.408 ' HA ' HD12 ' A' ' 180' ' ' LEU . 24.7 mtp180 -122.45 162.52 21.52 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.235 0.614 . . . . 64.34 110.948 -173.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -42.37 128.15 3.79 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 126.276 1.83 . . . . 72.5 113.201 -175.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.46 -5.83 74.41 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-N 115.746 -0.661 . . . . 73.14 114.264 178.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 17.0 m -64.83 124.09 21.07 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.499 0.72 . . . . 70.0 111.08 174.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 176' ' ' LEU . 3.8 p -105.6 110.88 32.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 123.357 0.663 . . . . 53.44 110.079 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 58.7 mt -90.61 103.5 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 107.951 -1.129 . . . . 73.12 107.951 173.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -78.2 100.27 6.56 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.146 -0.687 . . . . 54.43 109.146 177.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.508 HG13 ' HB3' ' A' ' 174' ' ' LEU . 7.6 p -99.68 108.19 49.82 Favored Pre-proline 0 CA--C 1.56 1.357 0 N-CA-C 109.221 -0.659 . . . . 65.43 109.221 176.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.03 151.47 61.87 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 123.255 2.636 . . . . 62.33 113.539 -172.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 69.53 8.52 59.97 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-N 115.84 -0.618 . . . . 45.13 114.502 172.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 96.8 mmm -104.88 -19.72 13.79 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.127 0.971 . . . . 73.14 110.167 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -78.43 -94.73 0.27 Allowed Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.667 -0.697 . . . . 64.15 111.691 176.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -59.29 98.76 0.12 Allowed Glycine 0 C--N 1.352 1.471 0 C-N-CA 123.179 0.418 . . . . 62.01 113.4 175.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.414 ' HG3' HH22 ' A' ' 143' ' ' ARG . 12.8 mm-40 -89.51 113.55 24.95 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.38 1.072 . . . . 72.11 110.632 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 157.38 -135.19 4.27 Favored Glycine 0 C--N 1.338 0.64 0 O-C-N 123.121 0.263 . . . . 54.02 112.49 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -81.91 -43.13 1.05 Allowed Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 123.59 0.756 . . . . 73.2 111.602 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -91.69 107.24 0.26 Allowed 'Trans proline' 0 C--N 1.396 3.077 0 C-N-CA 122.337 2.025 . . . . 54.31 112.066 169.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.96 125.33 11.42 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 122.343 2.029 . . . . 70.42 111.499 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 117' ' ' ARG . . . -114.49 158.67 14.17 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 116.379 -0.373 . . . . 25.13 112.502 -177.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -83.64 148.83 26.91 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.583 0.753 . . . . 71.13 110.701 -177.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.508 ' HB3' HG13 ' A' ' 161' ' ' VAL . 39.3 tp -113.72 103.78 11.56 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 107.208 -1.404 . . . . 74.13 107.208 177.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 81.5 mt -87.04 100.67 12.8 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.786 0.834 . . . . 70.33 109.595 -173.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 158' ' ' VAL . 63.5 mt -89.34 101.66 14.34 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.874 0.87 . . . . 75.24 111.517 -172.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 24.8 t -87.3 118.46 33.28 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 108.693 -0.854 . . . . 73.3 108.693 177.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.6 p -74.59 137.08 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 C-N-CA 122.681 0.393 . . . . 61.23 110.22 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.409 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 32.0 mmt180 -124.87 89.45 3.07 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.192 0.997 . . . . 73.23 109.172 -178.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.514 HD21 ' HB2' ' A' ' 130' ' ' ALA . 32.7 mt -85.65 149.88 25.01 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.593 -0.731 . . . . 70.24 111.711 -178.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.404 HD12 ' HG ' ' A' ' 127' ' ' LEU . 55.9 mt . . . . . 0 CA--C 1.561 1.403 0 CA-C-N 114.095 -1.411 . . . . 70.4 109.374 178.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 109.095 -0.706 . . . . 74.1 109.095 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.479 ' H ' HG21 ' A' ' 126' ' ' THR . 32.5 t -111.57 128.14 55.94 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.103 -0.703 . . . . 63.32 109.103 177.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 26.3 m -76.71 149.23 36.41 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.361 0.664 . . . . 60.23 110.652 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.718 HD12 ' HB2' ' A' ' 123' ' ' LEU . 25.1 pt -112.77 155.49 13.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 C-N-CA 123.452 0.701 . . . . 75.11 109.707 -166.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.51 129.58 48.92 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.97 -0.752 . . . . 24.53 108.97 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.595 ' HB3' HG21 ' A' ' 140' ' ' VAL . 12.4 tp -75.53 162.02 28.67 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.8 1.24 . . . . 75.43 109.848 -172.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.441 ' HB3' ' H ' ' A' ' 122' ' ' GLU . . . -83.06 -44.49 15.11 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.399 0.28 . . . . 53.15 111.055 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 41.7 mt 46.68 69.05 0.52 Allowed 'General case' 0 N--CA 1.482 1.159 0 O-C-N 124.313 1.008 . . . . 74.3 110.214 -169.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.432 HD12 ' HG3' ' A' ' 120' ' ' ARG . 80.8 mt -65.75 119.75 63.17 Favored Pre-proline 0 CA--C 1.549 0.929 0 CA-C-N 115.152 -0.931 . . . . 71.11 108.867 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo . . . . . 0 C--N 1.38 2.201 0 C-N-CA 123.004 2.47 . . . . 60.15 112.334 -174.178 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? . . . . . 0 C--O 1.252 1.224 0 N-CA-C 108.746 -0.835 . . . . 73.12 108.746 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' A' ' 173' ' ' ASP . 8.9 p-10 -84.34 149.23 26.18 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.015 -0.993 . . . . 73.21 110.81 -171.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.5 tt -130.07 136.95 49.92 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 106.998 -1.482 . . . . 40.55 106.998 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.432 ' HG3' HD12 ' A' ' 102' ' ' LEU . 10.1 tpt180 -91.43 124.89 35.95 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.766 -0.827 . . . . 61.42 108.766 -174.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.567 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -145.7 135.58 23.54 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 122.66 0.384 . . . . 51.15 110.618 -172.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.441 ' H ' ' HB3' ' A' ' 100' ' ' ALA . 9.1 mm-40 -114.13 121.86 45.08 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.544 -0.91 . . . . 64.5 108.544 -172.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.718 ' HB2' HD12 ' A' ' 97' ' ' ILE . 3.1 pp -100.37 113.61 65.48 Favored Pre-proline 0 CA--C 1.546 0.823 0 N-CA-C 107.786 -1.191 . . . . 73.13 107.786 174.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.486 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 71.9 Cg_endo -75.48 116.28 4.45 Favored 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.601 2.201 . . . . 61.31 109.391 169.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.44 HD21 HD12 ' A' ' 149' ' ' ILE . 27.1 tp -101.57 145.37 29.13 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 109.459 -0.571 . . . . 72.42 109.459 -170.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.479 HG21 ' H ' ' A' ' 95' ' ' SER . 4.7 t -91.02 156.09 18.2 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 109.145 -0.687 . . . . 71.44 109.145 -177.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 93.5 mt -60.8 -34.77 75.01 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.864 0.866 . . . . 73.34 111.765 -175.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 131' ' ' PHE . 2.1 mp0 -60.41 -48.45 81.69 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.911 0.885 . . . . 54.3 110.199 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -75.47 -34.33 60.9 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.307 -0.861 . . . . 61.34 111.891 -175.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.1 -39.8 79.55 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.113 0.483 . . . . 61.31 110.319 171.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.407 ' HB3' ' O ' ' A' ' 128' ' ' GLU . 68.8 t80 -66.07 -49.17 68.55 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.865 1.266 . . . . 73.2 111.313 177.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -74.51 -50.72 17.08 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.626 0.37 . . . . 72.42 111.829 -171.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.531 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 66.32 75.73 0.41 Allowed Glycine 0 CA--C 1.532 1.114 0 CA-C-N 115.768 -0.651 . . . . 75.32 111.603 -166.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -148.15 -165.44 12.03 Favored Glycine 0 C--N 1.343 0.946 0 N-CA-C 112.08 -0.408 . . . . 54.32 112.08 -176.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -71.92 115.18 10.83 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.513 -0.551 . . . . 74.53 109.513 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -116.01 121.23 41.62 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.33 -0.989 . . . . 71.42 108.33 174.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 70.7 t -81.29 141.73 14.76 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 C-N-CA 124.489 1.115 . . . . 75.04 109.386 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.7 p -141.45 123.6 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 123.944 0.898 . . . . 73.35 108.964 174.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -124.73 125.47 44.12 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.667 0.787 . . . . 64.11 110.345 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.595 HG21 ' HB3' ' A' ' 99' ' ' LEU . 1.6 m -151.15 131.81 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.967 1.307 . . . . 72.21 109.808 -177.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 59.14 24.28 12.62 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.236 1.015 . . . . 75.53 112.587 176.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 89.6 -7.14 82.49 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-N 116.53 -0.304 . . . . 42.42 113.499 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -94.63 114.68 26.66 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 109.088 -0.708 . . . . 75.34 109.088 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -114.57 127.89 56.03 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.179 0.591 . . . . 74.44 109.616 177.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.28 132.31 45.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 123.76 0.824 . . . . 34.42 108.826 173.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 40.9 t -94.37 127.8 40.49 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.459 -1.312 . . . . 65.33 107.459 170.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 19.7 m -120.98 127.89 76.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 109.468 -0.567 . . . . 70.05 109.468 175.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 56.1 ttt85 -76.59 109.87 10.7 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.981 -1.118 . . . . 74.33 107.981 173.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.531 HG13 ' HA2' ' A' ' 133' ' ' GLY . 12.2 pt -84.01 148.44 53.72 Favored Pre-proline 0 CA--C 1.557 1.243 0 CA-C-N 115.135 -0.939 . . . . 73.13 109.371 177.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -67.58 150.36 79.87 Favored 'Trans proline' 0 C--N 1.369 1.654 0 C-N-CA 122.485 2.123 . . . . 62.34 112.941 172.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -63.4 121.11 8.79 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.652 2.235 . . . . 50.01 111.341 171.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 76.72 30.69 55.79 Favored Glycine 0 N--CA 1.465 0.614 0 CA-C-N 116.288 -0.415 . . . . 65.43 112.115 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.9 p -61.87 125.24 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 108.967 -0.753 . . . . 72.02 108.967 170.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.476 ' HA ' HD12 ' A' ' 180' ' ' LEU . 95.6 mtt180 -116.66 153.87 31.56 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.589 0.756 . . . . 71.3 110.055 -169.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -37.56 123.28 0.99 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 126.446 1.899 . . . . 73.23 113.013 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.63 -20.07 35.06 Favored Glycine 0 N--CA 1.473 1.161 0 CA-C-O 119.207 -0.774 . . . . 71.44 113.726 178.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.1 t -61.95 121.42 12.92 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 117.491 0.645 . . . . 74.01 110.423 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.441 HG22 HG22 ' A' ' 177' ' ' VAL . 55.1 t -101.11 115.3 42.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 109.703 -0.48 . . . . 45.33 109.703 -178.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 57.7 mt -90.02 105.13 15.86 Favored 'Isoleucine or valine' 0 C--N 1.343 0.306 0 N-CA-C 107.391 -1.337 . . . . 63.14 107.391 173.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -84.52 119.44 25.18 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.037 -0.727 . . . . 71.42 109.037 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.493 HG13 ' HB3' ' A' ' 174' ' ' LEU . 6.3 p -124.48 98.16 38.31 Favored Pre-proline 0 CA--C 1.558 1.269 0 C-N-CA 123.394 0.678 . . . . 73.52 109.691 177.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 32.4 Cg_exo -61.92 150.07 87.66 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.99 2.46 . . . . 61.0 112.679 172.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.47 -16.94 51.66 Favored Glycine 0 N--CA 1.474 1.208 0 CA-C-O 119.963 -0.354 . . . . 73.33 113.807 178.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -102.14 -4.4 25.92 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.94 0.896 . . . . 52.34 111.979 -176.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.491 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -88.19 -111.59 1.09 Allowed Glycine 0 C--N 1.35 1.347 0 CA-C-O 119.397 -0.668 . . . . 73.21 113.064 -175.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -61.62 102.39 0.44 Allowed Glycine 0 C--N 1.359 1.852 0 CA-C-N 117.01 0.405 . . . . 54.44 112.739 173.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -80.69 135.29 35.99 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.953 0.501 . . . . 64.15 109.95 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 152.26 -155.75 26.31 Favored Glycine 0 C--N 1.343 0.956 0 N-CA-C 111.566 -0.613 . . . . 42.05 111.566 -178.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -66.78 -49.7 47.82 Favored Pre-proline 0 CA--C 1.559 1.297 0 CA-C-O 118.309 -0.853 . . . . 65.11 110.76 178.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.56 114.34 2.98 Favored 'Trans proline' 0 C--N 1.397 3.119 0 C-N-CA 121.392 1.395 . . . . 74.33 110.375 168.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -69.75 123.93 10.59 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 121.962 1.775 . . . . 74.43 110.036 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -100.01 159.24 19.53 Favored Glycine 0 CA--C 1.507 -0.44 0 CA-C-N 116.091 -0.504 . . . . 65.15 113.391 -171.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.491 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 34.6 t70 -91.46 151.54 20.75 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.967 0.907 . . . . 64.1 110.017 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.493 ' HB3' HG13 ' A' ' 161' ' ' VAL . 19.5 tp -127.71 119.19 25.28 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 118.104 0.411 . . . . 54.33 110.197 -179.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 97.6 mt -93.53 101.19 13.37 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.639 0.776 . . . . 75.33 109.347 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.661 ' HB3' HD23 ' A' ' 123' ' ' LEU . 48.0 mt -88.68 101.38 13.93 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.276 0.631 . . . . 74.32 109.843 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.441 HG22 HG22 ' A' ' 158' ' ' VAL . 60.7 t -86.1 115.45 27.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 109.406 -0.59 . . . . 74.31 109.406 176.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.6 p -67.64 136.69 26.11 Favored 'Isoleucine or valine' 0 C--O 1.245 0.85 0 N-CA-C 109.346 -0.612 . . . . 62.22 109.346 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.486 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 34.4 mmt180 -125.16 91.23 3.38 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.593 0.757 . . . . 65.5 109.406 -175.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 154' ' ' ARG . 26.2 mt -97.0 132.87 42.38 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 114.759 -1.11 . . . . 72.45 109.333 173.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 75.1 mt . . . . . 0 CA--C 1.555 1.154 0 CA-C-N 115.14 -0.937 . . . . 64.34 109.914 -178.898 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 109.263 -0.643 . . . . 61.52 109.263 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.4 m -59.9 124.12 19.18 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.051 0.941 . . . . 23.34 111.666 -171.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.516 ' HA ' ' NH1' ' A' ' 136' ' ' ARG . 81.3 m -70.76 127.9 34.23 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 123.197 0.599 . . . . 74.2 110.345 179.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.613 HD12 ' HB2' ' A' ' 123' ' ' LEU . 26.2 pt -102.87 153.62 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.588 -0.733 . . . . 70.32 110.798 -169.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -101.79 157.97 16.45 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.299 -1.0 . . . . 64.41 108.299 170.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.548 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.7 tp -90.08 -103.81 0.09 Allowed 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 109.71 -0.478 . . . . 62.44 109.71 -177.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 177.48 -56.26 0.01 OUTLIER 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.036 0.934 . . . . 63.03 108.946 -172.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.536 HD11 ' HB ' ' A' ' 140' ' ' VAL . 75.3 mt 53.21 78.55 0.14 Allowed 'General case' 0 C--N 1.361 1.099 0 C-N-CA 124.658 1.183 . . . . 64.41 110.449 -171.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 61.7 mt -83.99 139.14 39.79 Favored Pre-proline 0 C--O 1.243 0.711 0 CA-C-N 114.705 -1.134 . . . . 74.42 109.665 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo . . . . . 0 C--N 1.37 1.665 0 C-N-CA 122.987 2.458 . . . . 75.44 113.604 173.946 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.468 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 14.9 tpp85 . . . . . 0 N--CA 1.472 0.628 0 N-CA-C 109.5 -0.555 . . . . 73.05 109.5 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -83.46 145.9 28.7 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.955 -1.128 . . . . 73.14 107.955 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.2 tt -127.62 125.93 41.11 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.789 -1.56 . . . . 72.41 106.789 173.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 -91.01 131.79 36.39 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 108.042 -1.095 . . . . 75.31 108.042 -172.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.548 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -158.53 141.86 14.99 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 109.413 -0.588 . . . . 74.03 109.413 -176.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -128.87 131.45 47.65 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.725 -0.472 . . . . 73.55 109.725 -174.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.613 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.1 pp -104.2 113.79 64.91 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 120.643 0.259 . . . . 50.3 110.309 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 36.2 Cg_endo -68.44 115.73 4.03 Favored 'Trans proline' 0 C--N 1.364 1.35 0 C-N-CA 122.411 2.074 . . . . 75.25 108.962 163.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.572 HD21 HD12 ' A' ' 149' ' ' ILE . 56.6 tp -102.83 146.11 28.76 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 109.692 -0.484 . . . . 71.14 109.692 -166.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.7 t -80.99 149.9 29.12 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 123.732 0.645 . . . . 70.15 109.612 -175.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.41 -33.92 71.82 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.187 0.995 . . . . 75.44 112.373 -170.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -61.32 -51.8 67.32 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.139 0.899 . . . . 75.11 110.004 178.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.449 ' HB3' HD11 ' A' ' 149' ' ' ILE . 21.4 mm-40 -73.19 -29.87 63.14 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.838 -1.074 . . . . 71.42 112.428 -174.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.23 -48.71 74.79 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-O 121.639 0.733 . . . . 43.23 110.52 174.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -67.74 -53.94 23.34 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 113.967 -1.469 . . . . 75.33 111.089 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -86.66 -46.72 9.8 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.696 -0.684 . . . . 63.34 111.258 -171.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.71 144.42 0.99 Allowed Glycine 0 C--N 1.353 1.517 0 N-CA-C 113.996 0.358 . . . . 42.04 113.996 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.409 ' O ' HG12 ' A' ' 149' ' ' ILE . . . 158.76 -152.23 23.3 Favored Glycine 0 C--N 1.341 0.815 0 N-CA-C 111.586 -0.606 . . . . 74.32 111.586 -178.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -76.46 116.69 17.38 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.297 -0.631 . . . . 70.11 109.297 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.516 ' NH1' ' HA ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -112.06 133.41 54.24 Favored 'General case' 0 C--N 1.346 0.452 0 C-N-CA 123.173 0.589 . . . . 70.51 110.428 179.525 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 85.8 t -90.91 124.97 43.69 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 C-N-CA 124.487 1.115 . . . . 73.3 110.088 177.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 97' ' ' ILE . 5.8 p -134.24 126.23 49.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 124.606 1.162 . . . . 75.41 108.796 177.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -99.33 140.04 34.09 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.222 0.609 . . . . 74.44 110.726 -174.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.536 ' HB ' HD11 ' A' ' 101' ' ' LEU . 15.4 m -138.75 101.11 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 124.672 1.189 . . . . 75.5 110.303 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.0 26.63 16.09 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.924 0.89 . . . . 55.31 111.679 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.0 -6.12 58.21 Favored Glycine 0 C--N 1.352 1.462 0 CA-C-N 116.014 -0.539 . . . . 64.22 113.741 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.478 ' HB3' HG23 ' A' ' 140' ' ' VAL . 18.0 tpp85 -93.31 119.81 32.88 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.54 0.736 . . . . 75.3 109.853 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -84.08 114.31 21.66 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.25 0.62 . . . . 73.55 109.764 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.415 ' HB ' HG13 ' A' ' 138' ' ' VAL . 36.3 t -107.35 117.57 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.26 1.024 . . . . 73.11 108.698 177.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.5 t -103.5 119.08 38.19 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 108.442 -0.948 . . . . 62.02 108.442 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.6 m -125.72 135.84 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.79 0.836 . . . . 71.44 109.678 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 45.4 ttt85 -81.43 103.48 11.21 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.437 -0.579 . . . . 74.45 109.437 177.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.572 HD12 HD21 ' A' ' 125' ' ' LEU . 13.4 pt -79.93 142.05 55.7 Favored Pre-proline 0 CA--C 1.557 1.23 0 CA-C-N 115.032 -0.986 . . . . 74.3 109.218 172.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.61 138.79 42.67 Favored 'Trans proline' 0 CA--C 1.562 1.906 0 C-N-CA 121.979 1.786 . . . . 65.53 112.146 176.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -55.45 123.98 15.15 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 123.169 2.58 . . . . 73.31 112.88 171.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 76.56 32.17 51.77 Favored Glycine 0 C--N 1.351 1.413 0 N-CA-C 112.23 -0.348 . . . . 40.32 112.23 -177.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.87 140.28 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 123.659 0.784 . . . . 64.42 109.707 174.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 21.0 mtp180 -118.14 152.67 35.17 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.816 0.846 . . . . 73.22 109.75 -175.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -45.4 129.24 8.33 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 124.966 1.416 . . . . 64.31 111.952 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 104.75 -16.81 46.89 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-O 119.261 -0.744 . . . . 65.42 113.742 177.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.7 m -60.48 119.72 8.57 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 117.652 0.726 . . . . 71.32 111.036 177.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.431 HG22 HG22 ' A' ' 177' ' ' VAL . 49.2 t -101.24 112.34 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 109.383 -0.599 . . . . 74.32 109.383 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 63.7 mt -91.82 106.99 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 108.176 -1.046 . . . . 73.33 108.176 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 -87.46 107.24 18.47 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.173 0.589 . . . . 75.24 109.452 -177.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.59 HG13 ' HB3' ' A' ' 174' ' ' LEU . 3.3 p -104.39 100.66 23.12 Favored Pre-proline 0 CA--C 1.56 1.341 0 N-CA-C 109.706 -0.479 . . . . 60.31 109.706 175.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 58.2 Cg_endo -68.52 156.34 65.91 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.0 2.467 . . . . 64.13 112.709 -178.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 81.91 -8.33 60.32 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 114.37 0.508 . . . . 50.25 114.37 176.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 39.3 mtp -106.29 -13.0 15.51 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.387 0.675 . . . . 51.35 112.555 -175.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -84.04 -86.1 0.88 Allowed Glycine 0 C--N 1.344 1.005 0 N-CA-C 111.539 -0.625 . . . . 30.54 111.539 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.468 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -73.32 106.15 1.93 Allowed Glycine 0 C--N 1.342 0.876 0 O-C-N 123.906 0.415 . . . . 41.21 112.58 175.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -88.25 158.92 18.34 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 123.509 0.724 . . . . 60.42 109.055 175.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 132.67 -117.29 1.95 Allowed Glycine 0 C--N 1.34 0.803 0 N-CA-C 111.181 -0.768 . . . . 75.35 111.181 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.56 ' H ' ' HD2' ' A' ' 170' ' ' PRO . 95.4 m-20 -118.87 -46.16 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 CA-C-O 118.019 -0.991 . . . . 52.24 111.565 175.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.56 ' HD2' ' H ' ' A' ' 169' ' ' ASN . 74.1 Cg_endo -75.53 111.13 3.23 Favored 'Trans proline' 0 C--N 1.392 2.864 0 CA-C-N 121.083 1.422 . . . . 74.14 110.7 168.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.85 127.92 15.21 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.336 2.024 . . . . 74.41 112.051 -175.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -115.13 159.26 13.85 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 115.876 -0.602 . . . . 45.21 112.297 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.519 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 9.2 p-10 -96.12 153.18 17.93 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.876 0.87 . . . . 53.12 111.341 -171.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.59 ' HB3' HG13 ' A' ' 161' ' ' VAL . 48.1 tp -115.02 106.97 14.76 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 107.723 -1.214 . . . . 74.13 107.723 178.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 85.5 mt -84.85 104.87 15.19 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.749 0.82 . . . . 65.33 109.834 -175.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.42 HD22 HD11 ' A' ' 99' ' ' LEU . 58.4 mt -96.42 102.07 13.8 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.449 0.699 . . . . 71.55 110.528 -177.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.431 HG22 HG22 ' A' ' 158' ' ' VAL . 25.3 t -86.42 119.22 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 108.977 -0.749 . . . . 72.5 108.977 176.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 5.4 p -71.06 138.12 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 N-CA-C 108.971 -0.752 . . . . 73.45 108.971 178.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 22.0 mmm180 -127.84 100.77 6.06 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.955 0.902 . . . . 75.4 109.015 -173.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 91.8 mt -109.24 130.23 55.49 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.629 -0.714 . . . . 71.21 109.545 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 75.3 mt . . . . . 0 CA--C 1.548 0.871 0 O-C-N 124.449 1.093 . . . . 72.51 110.926 -176.9 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 69.8 mtm . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 108.749 -0.834 . . . . 73.04 108.749 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.1 p -75.87 146.24 39.94 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.763 0.825 . . . . 75.15 111.654 -173.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 42.9 m -81.28 145.99 30.63 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.068 0.947 . . . . 74.45 110.396 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.6 pt -128.75 172.19 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.971 0.908 . . . . 72.32 110.344 -176.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -134.15 147.98 50.87 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.234 1.013 . . . . 74.43 110.044 -176.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.555 ' HB3' HG11 ' A' ' 140' ' ' VAL . 11.5 tp -85.2 173.91 10.05 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.69 -0.856 . . . . 73.24 108.69 -177.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -97.19 -33.47 11.47 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.974 -0.454 . . . . 74.11 111.855 175.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.2 mt 49.98 61.96 2.91 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.706 0.803 . . . . 74.45 110.668 -171.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 71.6 mt -64.46 111.0 4.67 Favored Pre-proline 0 CA--C 1.556 1.203 0 CA-C-N 115.616 -0.72 . . . . 54.12 109.289 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo . . . . . 0 C--N 1.377 2.039 0 C-N-CA 122.205 1.937 . . . . 62.44 112.085 -173.778 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.483 ' O ' ' HA3' ' A' ' 172' ' ' GLY . 28.6 ttm180 . . . . . 0 N--CA 1.48 1.048 0 N-CA-C 111.132 0.049 . . . . 73.11 111.132 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -84.65 135.76 34.04 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.191 -1.04 . . . . 71.11 108.191 174.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.8 tt -110.33 125.58 53.33 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 105.688 -1.967 . . . . 73.43 105.688 174.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.463 ' HG2' HD12 ' A' ' 175' ' ' LEU . 27.5 mtp180 -91.96 144.54 25.36 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.361 -0.977 . . . . 64.43 108.361 -175.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.545 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -158.75 156.44 29.83 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.625 -0.509 . . . . 64.41 109.625 -174.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -129.37 138.85 51.76 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.994 -0.743 . . . . 73.04 108.994 176.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 55.7 tp -110.43 101.7 49.3 Favored Pre-proline 0 CA--C 1.538 0.482 0 O-C-N 123.815 0.697 . . . . 71.21 109.842 -175.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.9 112.47 3.11 Favored 'Trans proline' 0 C--N 1.372 1.81 0 N-CA-C 108.253 -1.479 . . . . 53.33 108.253 169.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.499 HD21 HD12 ' A' ' 149' ' ' ILE . 35.1 tp -104.87 138.02 41.75 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.47 -0.567 . . . . 73.32 109.47 -168.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.0 t -81.76 153.94 26.24 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 109.124 -0.695 . . . . 71.44 109.124 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 74.2 mt -61.67 -33.61 74.28 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.525 0.73 . . . . 74.33 112.195 -169.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.0 -44.16 97.82 Favored 'General case' 0 C--O 1.22 -0.488 0 O-C-N 124.311 1.007 . . . . 63.1 109.477 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -79.15 -29.22 42.95 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.369 -0.832 . . . . 74.53 112.101 -175.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.52 -39.8 89.16 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.342 0.591 . . . . 62.54 110.21 172.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -74.07 -57.22 4.11 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 114.715 -1.13 . . . . 72.31 110.748 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -61.32 -50.61 72.26 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.122 0.569 . . . . 72.03 110.923 -173.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.609 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 63.71 67.7 1.95 Allowed Glycine 0 C--N 1.337 0.616 0 CA-C-N 114.763 -1.108 . . . . 65.12 112.128 -172.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -134.15 -160.0 9.09 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 112.508 -0.237 . . . . 63.45 112.508 -177.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -82.42 116.75 22.02 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.081 -0.711 . . . . 62.14 109.081 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -114.13 126.68 55.35 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.277 0.631 . . . . 74.1 109.338 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 83.0 t -70.52 110.61 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 124.305 1.003 . . . . 74.44 108.85 173.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.9 t -113.87 109.75 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 108.286 -1.005 . . . . 62.24 108.286 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -117.15 124.52 49.36 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.351 -0.611 . . . . 73.3 109.351 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.555 HG11 ' HB3' ' A' ' 99' ' ' LEU . 5.8 p -149.63 136.09 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.71 1.204 . . . . 74.31 108.601 -175.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.89 18.76 10.09 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.086 0.954 . . . . 75.01 112.322 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 88.01 -5.93 84.19 Favored Glycine 0 C--N 1.35 1.344 0 CA-C-N 116.075 -0.511 . . . . 61.0 113.183 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -94.99 121.87 37.06 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.265 1.026 . . . . 75.51 109.525 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -108.14 115.28 29.84 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.031 0.933 . . . . 75.43 110.31 -174.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.8 p -126.04 119.37 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.239 1.015 . . . . 74.23 109.601 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 39.5 t -88.32 108.71 19.47 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 109.205 -0.665 . . . . 73.35 109.205 176.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.2 p -100.76 127.61 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 123.014 0.526 . . . . 71.44 110.802 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -85.01 103.04 13.69 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.792 -0.818 . . . . 71.55 108.792 172.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.609 HG13 ' HA2' ' A' ' 133' ' ' GLY . 11.6 pt -86.64 151.79 53.4 Favored Pre-proline 0 CA--C 1.562 1.424 0 C-N-CA 124.518 1.127 . . . . 71.43 109.507 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.442 ' HG2' ' HB ' ' A' ' 153' ' ' VAL . 55.2 Cg_endo -71.37 146.32 50.22 Favored 'Trans proline' 0 CA--C 1.565 2.049 0 C-N-CA 122.108 1.872 . . . . 53.35 112.514 174.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.407 ' HA ' ' HA3' ' A' ' 133' ' ' GLY . 23.6 Cg_exo -67.11 124.92 12.79 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.991 2.461 . . . . 62.4 112.036 174.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 81.18 24.52 57.14 Favored Glycine 0 C--N 1.35 1.318 0 O-C-N 123.478 0.486 . . . . 30.12 112.101 -175.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.442 ' HB ' ' HG2' ' A' ' 150' ' ' PRO . 4.4 p -60.65 128.83 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 123.959 0.903 . . . . 72.34 109.413 173.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.468 ' HA ' HD12 ' A' ' 180' ' ' LEU . 76.9 mtp180 -123.56 166.43 15.46 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.118 0.567 . . . . 62.03 110.047 -175.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -45.31 129.62 8.16 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 125.709 1.604 . . . . 75.44 113.357 -172.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.92 -2.66 66.6 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-O 119.404 -0.664 . . . . 65.02 114.623 175.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.6 t -69.56 122.34 18.87 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 117.651 0.725 . . . . 61.44 109.57 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 45.6 t -101.2 113.18 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.186 0.594 . . . . 75.5 109.886 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 51.6 mt -91.52 117.63 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 107.886 -1.153 . . . . 72.31 107.886 170.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -104.97 101.11 10.7 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.924 -0.769 . . . . 73.03 108.924 -173.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.4 p -107.76 107.72 60.64 Favored Pre-proline 0 CA--C 1.556 1.199 0 C-N-CA 123.148 0.579 . . . . 70.52 110.722 -176.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.553 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 59.8 Cg_endo -69.37 147.34 65.19 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.561 2.174 . . . . 44.44 112.709 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.41 -3.14 87.64 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 115.794 -0.639 . . . . 64.53 113.527 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 24.7 mmt -103.42 -16.94 15.45 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.304 0.641 . . . . 73.3 110.772 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -91.58 -108.17 1.56 Allowed Glycine 0 C--N 1.349 1.302 0 CA-C-O 119.541 -0.589 . . . . 53.44 113.173 -175.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -60.43 100.39 0.22 Allowed Glycine 0 C--N 1.349 1.28 0 O-C-N 123.861 0.389 . . . . 65.14 112.661 177.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -88.34 116.26 26.43 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 124.04 0.936 . . . . 54.04 109.169 177.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 160.15 -149.21 18.5 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.5 -0.64 . . . . 54.22 111.5 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -70.97 -48.96 13.68 Favored Pre-proline 0 CA--C 1.561 1.369 0 CA-C-O 117.9 -1.047 . . . . 75.34 111.822 177.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.425 ' HA ' ' HD3' ' A' ' 171' ' ' PRO . 87.0 Cg_endo -81.81 110.62 2.14 Favored 'Trans proline' 0 C--N 1.391 2.801 0 C-N-CA 121.572 1.514 . . . . 74.0 110.749 174.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 170' ' ' PRO . 14.4 Cg_exo -67.79 123.6 10.91 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.358 2.039 . . . . 75.52 110.807 -174.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 117' ' ' ARG . . . -115.67 152.09 18.16 Favored Glycine 0 C--N 1.335 0.477 0 N-CA-C 114.004 0.361 . . . . 43.22 114.004 -172.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.553 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 6.8 p-10 -91.66 155.64 18.17 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.516 1.126 . . . . 71.02 110.53 178.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 41.3 tp -112.97 115.52 28.52 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.947 -0.76 . . . . 51.41 108.947 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.463 HD12 ' HG2' ' A' ' 120' ' ' ARG . 73.5 mt -84.53 106.93 16.48 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.102 0.961 . . . . 70.43 109.513 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 27.2 mt -99.54 98.75 9.6 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.843 -0.799 . . . . 72.42 108.843 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 8.5 p -95.75 110.69 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 109.092 -0.706 . . . . 74.23 109.092 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.0 p -66.67 143.77 15.28 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 123.299 0.64 . . . . 53.11 111.275 -172.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -126.14 103.11 7.52 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 125.042 1.337 . . . . 75.44 108.192 -174.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 154' ' ' ARG . 91.8 mt -113.45 131.42 56.03 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.53 0.732 . . . . 55.34 109.984 177.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 81.4 mt . . . . . 0 CA--C 1.548 0.896 0 N-CA-C 108.374 -0.972 . . . . 72.31 108.374 173.401 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.509 ' HB3' ' NH2' ' A' ' 136' ' ' ARG . 59.1 mtt . . . . . 0 N--CA 1.477 0.886 0 N-CA-C 109.299 -0.63 . . . . 52.51 109.299 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.1 m -70.66 134.17 47.3 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.454 0.702 . . . . 73.12 111.062 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.6 m -73.55 138.35 44.93 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.938 0.495 . . . . 71.13 109.73 174.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.64 HD12 ' HB2' ' A' ' 123' ' ' LEU . 21.3 pt -109.53 175.42 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 122.992 0.517 . . . . 64.11 111.547 -166.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -122.81 -167.62 1.61 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.388 1.075 . . . . 72.02 109.617 173.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.689 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.9 tp -142.06 156.26 45.4 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 108.655 -0.868 . . . . 72.24 108.655 -175.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.415 ' HB3' ' H ' ' A' ' 122' ' ' GLU . . . -78.44 -56.99 4.01 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.269 0.228 . . . . 43.02 110.468 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 95.9 mt 60.19 73.49 0.48 Allowed 'General case' 0 CA--C 1.553 1.078 0 O-C-N 124.366 1.041 . . . . 74.32 109.902 -170.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 79.5 mt -70.89 155.94 92.69 Favored Pre-proline 0 CA--C 1.561 1.382 0 C-N-CA 125.251 1.421 . . . . 75.52 111.766 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo . . . . . 0 C--N 1.386 2.532 0 C-N-CA 123.307 2.671 . . . . 73.03 113.646 178.593 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? . . . . . 0 N--CA 1.473 0.676 0 CA-C-O 120.446 0.165 . . . . 74.12 111.293 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -74.63 116.23 15.09 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 108.736 -0.838 . . . . 62.34 108.736 172.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.7 tt -94.9 118.89 32.53 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 106.735 -1.58 . . . . 64.21 106.735 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -90.98 141.66 28.61 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 108.726 -0.842 . . . . 71.41 108.726 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.689 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -153.25 142.77 21.77 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.821 -0.627 . . . . 64.03 109.545 -171.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.459 ' HB3' ' HG3' ' A' ' 179' ' ' ARG . 35.3 mt-10 -119.69 118.3 30.56 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.181 -1.044 . . . . 62.03 108.181 -174.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.64 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.6 pp -100.74 113.91 65.71 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 108.914 -0.772 . . . . 74.33 108.914 176.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.13 113.95 3.91 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 121.864 1.709 . . . . 41.04 109.335 170.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.571 HD21 HD12 ' A' ' 149' ' ' ILE . 36.1 tp -103.12 151.05 23.03 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 122.004 -0.435 . . . . 70.43 110.601 -167.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 13.4 t -85.61 154.61 21.59 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.955 -0.757 . . . . 72.05 108.955 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 39.3 mt -70.78 -26.68 63.45 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.215 0.606 . . . . 72.23 111.805 -167.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -73.49 -41.82 62.63 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.397 -0.82 . . . . 62.22 110.08 -178.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.471 ' HB3' HD11 ' A' ' 149' ' ' ILE . 34.1 mm-40 -74.4 -31.26 62.27 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.185 -0.916 . . . . 72.13 111.158 177.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.71 -50.83 70.87 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.425 0.69 . . . . 73.53 110.5 176.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -66.67 -62.89 1.22 Allowed 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 114.223 -1.353 . . . . 72.1 110.641 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -70.32 -43.75 69.65 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.929 0.491 . . . . 71.24 111.89 -171.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.43 97.56 0.05 OUTLIER Glycine 0 C--N 1.346 1.103 0 O-C-N 123.816 0.697 . . . . 61.34 113.063 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.4 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -144.06 -143.64 4.09 Favored Glycine 0 C--N 1.342 0.883 0 N-CA-C 111.097 -0.801 . . . . 70.01 111.097 178.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -96.26 119.07 34.09 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.845 -0.798 . . . . 72.14 108.845 176.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.509 ' NH2' ' HB3' ' A' ' 94' ' ' MET . 11.0 tpp180 -116.98 123.79 47.78 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.412 0.685 . . . . 71.12 109.386 176.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 146' ' ' SER . 76.2 t -74.47 136.9 24.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 C-N-CA 123.621 0.768 . . . . 72.31 110.683 177.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.455 ' HB ' HG13 ' A' ' 145' ' ' VAL . 39.1 t -115.59 126.17 73.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.29 1.436 . . . . 61.51 107.615 174.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -115.23 101.51 9.02 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.632 -0.507 . . . . 72.14 109.632 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.66 144.16 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 123.719 0.808 . . . . 74.32 110.907 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 65.32 18.69 11.45 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.283 1.433 . . . . 64.54 111.746 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.19 21.76 69.71 Favored Glycine 0 C--N 1.351 1.37 0 CA-C-N 116.016 -0.538 . . . . 72.44 112.257 -175.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -122.45 140.06 53.15 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.923 0.889 . . . . 63.01 110.204 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -102.69 125.32 49.38 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.206 1.002 . . . . 71.42 108.719 177.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.455 HG13 ' HB ' ' A' ' 138' ' ' VAL . 3.5 p -137.78 112.26 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 CA-C-O 121.54 0.686 . . . . 73.0 110.2 176.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 137' ' ' VAL . 46.4 t -90.43 106.0 18.2 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.189 -0.671 . . . . 53.31 109.189 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 28.7 m -100.62 141.15 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.232 0.613 . . . . 72.15 110.13 -178.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.1 ttp180 -90.84 117.47 29.48 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.284 -0.635 . . . . 73.32 109.284 177.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.571 HD12 HD21 ' A' ' 125' ' ' LEU . 9.1 pt -100.49 139.77 20.89 Favored Pre-proline 0 CA--C 1.561 1.378 0 C-N-CA 124.871 1.268 . . . . 73.24 109.307 176.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -63.14 152.46 79.52 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 123.083 2.522 . . . . 74.11 113.695 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.47 121.3 9.04 Favored 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 122.272 1.981 . . . . 62.51 111.228 171.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 85.21 23.64 47.51 Favored Glycine 0 C--N 1.346 1.084 0 N-CA-C 112.13 -0.388 . . . . 45.51 112.13 -176.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.493 HG11 ' HB ' ' A' ' 149' ' ' ILE . 4.1 p -63.53 117.45 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 123.784 0.833 . . . . 61.11 109.853 177.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.528 ' HA ' HD12 ' A' ' 180' ' ' LEU . 82.0 mtm180 -132.89 161.93 32.93 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 115.923 -0.58 . . . . 74.31 110.847 -172.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -35.29 119.77 0.51 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.881 2.072 . . . . 55.24 113.838 -169.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.24 -12.14 48.13 Favored Glycine 0 N--CA 1.473 1.145 0 CA-C-O 119.297 -0.724 . . . . 71.43 114.552 177.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 33.5 t -66.22 122.3 17.15 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 117.832 0.816 . . . . 51.05 109.243 176.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.0 t -110.0 114.55 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.347 0.659 . . . . 74.14 110.402 -176.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 56.0 mt -92.48 120.6 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 108.355 -0.98 . . . . 72.33 108.355 172.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -104.67 116.63 32.38 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.305 0.642 . . . . 74.32 110.143 -176.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.489 HG13 ' HB3' ' A' ' 174' ' ' LEU . 3.3 p -120.45 108.58 37.52 Favored Pre-proline 0 CA--C 1.559 1.316 0 C-N-CA 123.031 0.532 . . . . 70.51 110.725 176.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.418 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 16.7 Cg_exo -67.59 153.46 76.23 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.886 2.391 . . . . 65.4 112.267 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.01 -24.19 8.3 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-O 119.864 -0.409 . . . . 72.24 113.909 177.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 92.9 mmm -92.44 -4.92 52.96 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.66 0.784 . . . . 60.23 111.224 -177.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -91.21 -103.02 1.3 Allowed Glycine 0 C--N 1.344 1.007 0 CA-C-O 119.719 -0.49 . . . . 64.52 112.409 -177.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.52 103.8 0.88 Allowed Glycine 0 C--N 1.352 1.418 0 N-CA-C 111.467 -0.653 . . . . 72.11 111.467 175.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.544 HE21 ' HA ' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -87.76 121.47 30.22 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.484 0.714 . . . . 71.34 110.72 -174.923 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 169.88 -146.21 9.82 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 110.633 -0.987 . . . . 75.44 110.633 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -76.79 -49.15 2.68 Favored Pre-proline 0 CA--C 1.56 1.331 0 CA-C-O 118.075 -0.964 . . . . 72.32 109.332 172.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -81.61 112.62 2.46 Favored 'Trans proline' 0 C--N 1.4 3.243 0 C-N-CA 122.173 1.915 . . . . 61.43 111.316 170.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.43 127.75 11.36 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 122.502 2.135 . . . . 52.34 112.239 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -104.88 165.88 14.62 Favored Glycine 0 C--N 1.344 1.022 0 CA-C-N 116.365 -0.38 . . . . 73.34 112.256 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 15.2 m-20 -86.25 142.71 28.37 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.855 0.862 . . . . 51.24 110.773 -177.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.489 ' HB3' HG13 ' A' ' 161' ' ' VAL . 34.5 tp -105.35 104.62 14.39 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 107.934 -1.136 . . . . 75.04 107.934 175.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 51.1 mt -88.46 101.17 13.66 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.197 -0.91 . . . . 73.21 109.282 -175.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 48.0 mt -97.1 101.11 12.61 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.896 0.878 . . . . 71.2 110.455 -174.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.3 p -92.48 130.33 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 109.893 -0.41 . . . . 63.15 109.893 175.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 14.1 p -77.54 133.81 29.83 Favored 'Isoleucine or valine' 0 C--O 1.248 0.999 0 C-N-CA 123.338 0.655 . . . . 72.32 110.053 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.459 ' HG3' ' HB3' ' A' ' 122' ' ' GLU . 9.1 mmm180 -122.6 96.38 5.01 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.167 0.987 . . . . 74.45 108.795 -174.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.528 HD12 ' HA ' ' A' ' 154' ' ' ARG . 64.5 mt -101.23 147.65 26.03 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.657 -0.701 . . . . 71.52 110.588 177.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 61.4 mt . . . . . 0 CA--C 1.556 1.186 0 CA-C-N 114.998 -1.001 . . . . 74.44 108.717 171.848 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 CA--C 1.545 0.766 0 N-CA-C 109.719 -0.474 . . . . 52.3 109.719 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.431 ' H ' HG21 ' A' ' 126' ' ' THR . 23.0 t -82.01 132.65 35.26 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.397 0.679 . . . . 72.33 110.251 178.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.425 ' HA ' HH11 ' A' ' 136' ' ' ARG . 63.9 m -76.05 143.04 41.61 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.607 0.763 . . . . 71.24 110.052 174.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.624 HD12 ' HB2' ' A' ' 123' ' ' LEU . 15.6 pt -121.4 173.02 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 123.012 0.525 . . . . 75.24 111.651 -165.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -124.86 -172.39 2.56 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.321 1.048 . . . . 42.52 109.541 174.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.649 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.6 tp -131.65 148.91 52.63 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 107.677 -1.231 . . . . 75.33 107.677 -177.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.48 -43.16 67.1 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 117.983 0.356 . . . . 65.32 110.949 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 41.8 mt 53.01 79.62 0.12 Allowed 'General case' 0 N--CA 1.477 0.916 0 O-C-N 124.473 1.108 . . . . 75.13 110.907 -173.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 35.0 mt -86.37 121.26 72.47 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 108.29 -1.004 . . . . 74.01 108.29 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo . . . . . 0 C--N 1.378 2.126 0 C-N-CA 122.512 2.141 . . . . 73.52 112.497 -177.148 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 . . . . . 0 CA--C 1.549 0.922 0 CA-C-O 120.83 0.348 . . . . 74.52 111.327 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -91.38 111.19 22.58 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.627 0.771 . . . . 73.33 109.984 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.0 tt -95.18 127.32 41.14 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 106.885 -1.524 . . . . 61.01 106.885 173.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -90.04 124.03 34.42 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 107.831 -1.174 . . . . 64.43 107.831 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.649 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -146.15 144.85 30.23 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.156 0.582 . . . . 73.3 110.121 -173.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -128.75 131.11 47.84 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.655 0.382 . . . . 75.51 110.144 -177.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.624 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.2 pp -107.61 119.71 49.66 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 109.223 -0.658 . . . . 74.33 109.223 177.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.562 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 66.9 Cg_endo -74.14 113.94 3.91 Favored 'Trans proline' 0 C--N 1.364 1.385 0 C-N-CA 122.512 2.142 . . . . 45.53 109.404 169.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 42.1 tp -102.66 154.17 19.41 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 109.326 -0.62 . . . . 74.2 109.326 -168.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.431 HG21 ' H ' ' A' ' 95' ' ' SER . 1.5 t -91.27 148.02 22.64 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 108.154 -1.054 . . . . 74.45 108.154 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.401 HD23 HD22 ' A' ' 180' ' ' LEU . 89.4 mt -64.41 -27.47 69.02 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.106 0.562 . . . . 65.44 111.883 -172.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.24 -41.76 85.1 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.799 0.839 . . . . 74.51 110.035 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.417 ' HG3' ' HE ' ' A' ' 136' ' ' ARG . 21.5 mm-40 -75.07 -34.78 61.84 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.384 0.674 . . . . 73.21 111.345 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.72 -34.62 73.16 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.287 0.635 . . . . 62.13 110.817 171.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -76.34 -46.81 25.85 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 114.773 -1.103 . . . . 74.41 111.437 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 34.3 m80 -73.54 -49.97 23.75 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 120.804 0.335 . . . . 74.25 111.457 -173.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.444 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 70.44 66.22 2.26 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-N 115.422 -0.808 . . . . 52.51 112.226 -173.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -134.44 -158.76 8.58 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 112.45 -0.26 . . . . 54.53 112.45 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -74.98 115.1 14.21 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.594 0.758 . . . . 62.21 109.058 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.425 HH11 ' HA ' ' A' ' 96' ' ' THR . 5.0 tpp180 -114.34 120.61 40.96 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.233 0.54 . . . . 62.3 109.72 178.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 88.1 t -77.17 111.73 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.712 0 CA-C-N 114.825 -1.08 . . . . 50.32 110.124 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 43.6 t -102.89 112.07 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.97 1.308 . . . . 73.02 107.905 172.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -115.13 115.2 26.37 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.008 -0.738 . . . . 74.51 109.008 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.547 HG11 ' HB3' ' A' ' 99' ' ' LEU . 7.6 p -151.61 138.29 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 124.209 1.004 . . . . 63.45 110.035 -178.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.88 18.59 10.92 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.529 1.132 . . . . 64.3 113.472 171.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.63 -2.63 80.62 Favored Glycine 0 C--N 1.351 1.369 0 C-N-CA 122.831 0.253 . . . . 73.14 112.891 -176.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -99.01 117.51 33.68 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.279 1.031 . . . . 73.14 108.766 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -106.56 105.62 15.74 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.393 -0.966 . . . . 71.32 108.393 172.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.4 p -114.16 137.1 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.845 0.858 . . . . 72.22 109.225 178.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.8 t -97.89 114.89 27.09 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.51 -0.922 . . . . 73.53 108.51 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 33.7 t -100.45 111.6 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.479 1.112 . . . . 71.51 109.131 -178.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -79.88 96.66 6.42 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.589 -0.893 . . . . 72.42 108.589 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.449 ' HB ' HG11 ' A' ' 153' ' ' VAL . 10.1 pt -81.04 147.6 61.83 Favored Pre-proline 0 CA--C 1.56 1.348 0 CA-C-N 114.755 -1.111 . . . . 75.3 110.442 -179.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.43 145.15 42.18 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.41 2.073 . . . . 61.41 112.389 176.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.26 113.29 2.37 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 122.508 2.139 . . . . 61.11 111.879 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 105.14 13.65 24.46 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-N 115.514 -0.766 . . . . 35.23 112.601 -176.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.449 HG11 ' HB ' ' A' ' 149' ' ' ILE . 7.3 p -63.33 127.97 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.529 0.731 . . . . 63.42 110.546 177.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.648 ' HA ' HD12 ' A' ' 180' ' ' LEU . 28.7 mtm180 -134.78 164.26 27.95 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.312 0.645 . . . . 65.12 111.581 -172.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -38.86 125.14 1.46 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 126.314 1.846 . . . . 75.52 113.641 -174.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.25 -11.22 60.09 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-O 119.293 -0.726 . . . . 70.02 114.241 176.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.6 t -67.4 121.79 16.53 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 117.432 0.616 . . . . 71.12 110.191 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 40.6 t -104.23 111.14 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.55 0.74 . . . . 75.43 110.435 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 75.7 mt -93.6 106.45 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 125.236 1.414 . . . . 63.42 109.521 175.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 30.8 ttt-85 -79.67 106.29 11.59 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.26 0.624 . . . . 73.43 109.777 175.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.437 HG13 ' HB3' ' A' ' 174' ' ' LEU . 7.6 p -106.05 104.89 51.64 Favored Pre-proline 0 CA--C 1.562 1.432 0 N-CA-C 109.175 -0.676 . . . . 71.12 109.175 171.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 59.6 Cg_endo -69.29 154.18 69.98 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 123.04 2.494 . . . . 72.25 113.615 -175.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 75.82 2.88 72.03 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 115.47 -0.787 . . . . 72.24 113.881 177.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 92.7 mmm -110.37 -25.95 9.81 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.553 0.741 . . . . 54.53 111.916 -172.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -83.18 -73.17 1.25 Allowed Glycine 0 C--N 1.345 1.06 0 N-CA-C 111.313 -0.715 . . . . 60.44 111.313 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -62.47 96.29 0.14 Allowed Glycine 0 C--N 1.345 1.035 0 N-CA-C 111.8 -0.52 . . . . 53.21 111.8 165.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -88.79 170.58 10.63 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.458 1.103 . . . . 72.15 110.288 176.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 97.49 -147.88 18.78 Favored Glycine 0 C--N 1.341 0.807 0 CA-C-N 116.14 -0.482 . . . . 53.12 112.166 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -64.64 -49.16 71.68 Favored Pre-proline 0 CA--C 1.57 1.723 0 CA-C-O 118.458 -0.782 . . . . 72.24 111.907 177.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -84.13 129.58 4.58 Favored 'Trans proline' 0 C--N 1.392 2.832 0 C-N-CA 122.046 1.831 . . . . 74.13 111.409 175.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.33 145.52 34.39 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 121.959 1.773 . . . . 64.33 111.168 170.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -152.55 164.4 30.65 Favored Glycine 0 N--CA 1.47 0.925 0 CA-C-O 120.195 -0.225 . . . . 60.3 112.636 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 29.8 m-20 -84.23 146.33 27.86 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.143 0.577 . . . . 75.14 111.498 -167.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.437 ' HB3' HG13 ' A' ' 161' ' ' VAL . 33.7 tp -114.87 104.24 11.74 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.458 -1.312 . . . . 52.32 107.458 176.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 68.5 mt -85.82 100.36 12.0 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.613 0.765 . . . . 74.02 109.392 -174.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 67.1 mt -92.79 99.25 11.96 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.817 0.847 . . . . 74.5 110.786 -174.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.8 p -89.22 123.5 41.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 N-CA-C 109.037 -0.727 . . . . 62.44 109.037 173.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.5 p -77.7 143.76 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 123.437 0.695 . . . . 61.54 110.59 -176.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.562 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 30.0 mmt180 -123.99 96.94 5.13 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.066 0.947 . . . . 64.41 109.656 -177.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.648 HD12 ' HA ' ' A' ' 154' ' ' ARG . 49.1 mt -100.53 114.84 28.81 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.261 -0.644 . . . . 74.21 109.261 173.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 69.0 mt . . . . . 0 CA--C 1.548 0.9 0 O-C-N 123.917 0.761 . . . . 72.24 109.282 176.031 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.418 ' HB3' ' NH2' ' A' ' 136' ' ' ARG . 65.8 mtt . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 109.082 -0.71 . . . . 72.43 109.082 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.2 m -66.82 120.37 13.44 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 116.192 -0.458 . . . . 55.31 109.956 176.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.2 m -85.8 137.03 33.08 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 109.305 -0.628 . . . . 74.22 109.305 177.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.517 HD12 ' HB2' ' A' ' 123' ' ' LEU . 9.1 pt -123.73 166.29 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 112.359 0.503 . . . . 71.32 112.359 -155.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -112.37 176.63 4.94 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.783 1.233 . . . . 64.14 109.269 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.657 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.3 tp -126.52 150.81 48.55 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.745 -0.835 . . . . 70.14 108.745 -174.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.7 -34.33 71.83 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.881 0.472 . . . . 75.42 112.134 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.661 HD11 ' HB ' ' A' ' 140' ' ' VAL . 21.7 mt 47.35 56.35 7.06 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.146 0.978 . . . . 74.31 112.065 -176.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.6 mt -71.25 117.28 55.31 Favored Pre-proline 0 CA--C 1.553 1.064 0 N-CA-C 108.926 -0.768 . . . . 54.42 108.926 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo . . . . . 0 C--N 1.375 1.956 0 C-N-CA 122.149 1.899 . . . . 62.1 112.447 179.426 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 . . . . . 0 CA--C 1.541 0.631 0 N-CA-C 108.055 -1.091 . . . . 73.41 108.055 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -91.59 121.6 33.41 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 107.542 -1.281 . . . . 53.4 107.542 168.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.4 tt -108.37 121.6 45.27 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 106.943 -1.503 . . . . 53.22 106.943 -177.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -92.48 135.02 34.4 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.871 -0.789 . . . . 72.13 108.871 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.657 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -156.28 138.1 14.32 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 122.921 0.488 . . . . 71.52 109.8 -174.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -126.77 128.63 46.91 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 110.166 -0.309 . . . . 75.22 110.166 -170.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.517 ' HB2' HD12 ' A' ' 97' ' ' ILE . 3.5 pp -103.13 133.36 20.38 Favored Pre-proline 0 C--N 1.349 0.583 0 C-N-CA 123.342 0.657 . . . . 63.23 109.816 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . 0.497 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 71.9 Cg_endo -78.13 115.93 3.84 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 122.418 2.079 . . . . 64.51 109.172 166.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.537 HD21 HD12 ' A' ' 149' ' ' ILE . 39.3 tp -102.72 147.38 26.91 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.554 -0.536 . . . . 54.1 109.554 -169.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.7 t -86.59 145.22 26.83 Favored 'General case' 0 C--O 1.245 0.839 0 N-CA-C 107.833 -1.173 . . . . 62.4 107.833 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.39 -20.75 65.59 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 112.766 0.654 . . . . 73.3 112.766 -170.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -67.61 -48.15 67.61 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.424 -0.584 . . . . 75.1 109.424 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -64.32 -38.41 90.93 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.081 -0.963 . . . . 54.43 111.149 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.434 ' HB2' HD21 ' A' ' 180' ' ' LEU . . . -59.97 -48.02 83.43 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.849 0.718 . . . . 73.44 111.569 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -67.86 -60.0 2.85 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.931 -1.031 . . . . 71.32 111.078 -178.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -67.14 -36.9 82.85 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.218 0.607 . . . . 74.54 111.437 -173.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.0 79.11 0.34 Allowed Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.568 -0.742 . . . . 73.21 111.572 -173.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.444 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -118.05 -172.16 15.62 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 112.731 -0.148 . . . . 73.45 112.731 -177.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -91.82 120.08 32.2 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.564 -1.273 . . . . 54.41 107.564 171.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.418 ' NH2' ' HB3' ' A' ' 94' ' ' MET . 8.5 tpp180 -113.1 122.11 46.59 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.377 -0.601 . . . . 70.42 109.377 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.508 HG13 ' HG3' ' A' ' 144' ' ' ARG . 99.5 t -72.55 132.1 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.179 0.992 . . . . 51.23 109.985 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.477 ' HB ' HG13 ' A' ' 145' ' ' VAL . 28.8 t -127.64 128.2 69.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 107.018 -1.475 . . . . 72.33 107.018 175.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.65 99.61 9.2 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.662 0.744 . . . . 70.32 111.069 -175.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.661 ' HB ' HD11 ' A' ' 101' ' ' LEU . 14.4 m -132.79 134.56 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 112.415 0.524 . . . . 70.45 112.415 -173.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 59.84 25.44 14.53 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.929 1.291 . . . . 73.4 112.298 173.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 80.32 22.39 62.88 Favored Glycine 0 C--N 1.355 1.626 0 CA-C-N 115.813 -0.631 . . . . 41.24 112.964 -178.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 24.5 tpp180 -133.8 126.54 30.79 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.309 1.044 . . . . 60.15 109.692 -175.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.508 ' HG3' HG13 ' A' ' 137' ' ' VAL . 13.6 ttm180 -73.21 120.46 18.86 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 109.234 -0.654 . . . . 75.23 109.234 167.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.477 HG13 ' HB ' ' A' ' 138' ' ' VAL . 3.5 p -118.7 112.14 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.244 -1.021 . . . . 55.43 108.244 169.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.2 t -94.42 109.65 21.5 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.167 -1.049 . . . . 62.23 108.167 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.5 p -97.56 118.44 44.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 CA-C-O 121.572 0.701 . . . . 74.25 109.946 -177.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -82.83 114.76 21.37 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.585 -0.894 . . . . 71.0 108.585 173.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.537 HD12 HD21 ' A' ' 125' ' ' LEU . 6.6 pt -99.47 149.9 36.28 Favored Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 124.506 1.123 . . . . 63.33 109.542 179.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.99 149.84 77.52 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.246 1.964 . . . . 75.34 112.029 176.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -66.23 113.71 2.75 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 122.406 2.071 . . . . 62.24 110.845 175.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 89.44 31.34 11.72 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-N 115.836 -0.62 . . . . 72.42 113.023 -175.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.26 138.09 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.333 0.653 . . . . 75.13 109.767 173.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -127.05 162.36 26.22 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.38 0.672 . . . . 75.42 111.063 -174.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -46.78 131.84 11.56 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 126.343 1.857 . . . . 64.44 113.344 -172.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.93 -2.55 84.24 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-O 119.554 -0.581 . . . . 72.13 114.434 177.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.1 t -66.87 122.51 17.86 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 117.474 0.637 . . . . 72.42 109.443 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.7 p -101.94 135.94 36.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 123.491 0.717 . . . . 64.01 109.991 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 45.4 mt -120.55 103.67 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.362 1.065 . . . . 73.45 108.734 -176.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -80.25 110.88 16.1 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.352 0.661 . . . . 74.0 109.702 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.5 p -115.21 110.15 45.84 Favored Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 122.904 0.482 . . . . 73.11 110.101 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.84 145.08 49.97 Favored 'Trans proline' 0 C--N 1.383 2.347 0 C-N-CA 122.885 2.39 . . . . 63.41 113.392 -175.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.08 15.51 78.67 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-N 115.557 -0.747 . . . . 71.23 113.565 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 87.3 mmm -113.18 -18.19 12.18 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.462 0.705 . . . . 63.13 111.026 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -96.84 -89.58 1.84 Allowed Glycine 0 C--N 1.349 1.295 0 N-CA-C 112.155 -0.378 . . . . 74.14 112.155 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -76.03 98.48 1.21 Allowed Glycine 0 C--N 1.345 1.033 0 C-N-CA 122.848 0.261 . . . . 75.3 112.527 176.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.585 HE21 ' HA ' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -88.56 113.53 24.24 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.444 0.698 . . . . 75.5 110.065 177.759 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 166.83 -154.53 25.03 Favored Glycine 0 C--O 1.241 0.551 0 N-CA-C 111.821 -0.512 . . . . 52.22 111.821 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -73.37 -50.92 5.98 Favored Pre-proline 0 CA--C 1.563 1.454 0 CA-C-O 117.97 -1.014 . . . . 73.05 110.992 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.14 111.6 3.31 Favored 'Trans proline' 0 C--N 1.393 2.878 0 CA-C-N 121.572 1.597 . . . . 73.11 110.315 168.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -67.11 125.36 13.46 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.526 2.151 . . . . 64.44 111.901 -173.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -120.25 146.34 17.76 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 111.908 -0.477 . . . . 72.33 111.908 -176.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -105.29 170.77 7.69 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.057 0.943 . . . . 42.24 112.024 -172.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 45.4 tp -121.99 113.8 20.09 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.792 1.237 . . . . 64.23 108.758 -177.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 69.4 mt -85.25 99.99 11.48 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.7 0.8 . . . . 63.53 110.032 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . 0.577 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 87.9 mt -88.93 100.43 13.18 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.244 0.618 . . . . 74.34 111.274 -175.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 71.4 t -89.2 124.83 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 109.198 -0.668 . . . . 74.42 109.198 177.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.4 p -80.53 137.82 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 122.727 0.411 . . . . 74.13 110.524 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.497 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 33.7 mmt180 -122.09 91.6 3.54 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.201 1.0 . . . . 64.34 109.255 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.434 HD21 ' HB2' ' A' ' 130' ' ' ALA . 43.2 mt -93.74 140.33 29.78 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.334 0.654 . . . . 61.44 111.355 -178.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 70.7 mt . . . . . 0 CA--C 1.548 0.893 0 CA-C-N 114.869 -1.059 . . . . 75.11 109.182 177.694 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.506 ' HB3' ' NH2' ' A' ' 136' ' ' ARG . 49.9 mtm . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 109.064 -0.717 . . . . 70.24 109.064 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.1 m -62.79 137.25 58.22 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.676 0.39 . . . . 62.31 111.093 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.3 m -70.93 148.62 47.53 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.705 0.802 . . . . 64.22 110.27 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.677 HD12 ' HB2' ' A' ' 123' ' ' LEU . 13.2 pt -117.28 163.02 14.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 123.104 0.562 . . . . 74.34 110.327 -177.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -139.12 124.12 18.85 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.714 0.806 . . . . 53.01 108.938 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.706 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.2 tp -72.17 160.44 32.43 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.46 1.104 . . . . 75.34 109.81 -173.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.527 ' HB3' ' H ' ' A' ' 122' ' ' GLU . . . -84.11 -43.92 14.56 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.489 0.316 . . . . 71.12 110.977 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.408 HD23 ' HB2' ' A' ' 121' ' ' ALA . 43.6 mt 49.35 71.97 0.34 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.063 0.945 . . . . 72.44 111.018 -168.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.623 ' HB2' ' HG3' ' A' ' 120' ' ' ARG . 86.2 mt -76.38 133.09 71.7 Favored Pre-proline 0 C--O 1.239 0.536 0 CA-C-N 115.34 -0.846 . . . . 73.41 109.718 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.94 154.82 30.73 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 121.992 1.795 . . . . 64.4 110.15 164.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.46 118.63 7.8 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.643 0.735 . . . . 74.15 112.271 -171.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 143.93 -141.34 10.19 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 114.316 -1.311 . . . . 73.42 109.909 -174.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 61.1 m 59.03 19.85 7.67 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 124.174 0.99 . . . . 75.22 112.578 178.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.63 36.45 29.5 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 112.382 -0.287 . . . . 61.22 112.382 -173.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.439 ' HA3' ' HD2' ' A' ' 120' ' ' ARG . . . -147.59 114.82 0.72 Allowed Glycine 0 C--N 1.348 1.22 0 N-CA-C 110.718 -0.953 . . . . 64.4 110.718 -178.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.7 t -158.28 111.95 2.46 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.646 0.778 . . . . 73.4 109.816 -175.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.1 -64.29 2.96 Favored Glycine 0 CA--C 1.53 0.993 0 N-CA-C 110.103 -1.199 . . . . 71.13 110.103 167.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 77.36 -68.6 2.65 Favored Glycine 0 C--N 1.347 1.181 0 C-N-CA 123.522 0.582 . . . . 64.44 112.631 176.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 59.5 p -53.37 120.18 5.73 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.618 1.167 . . . . 70.1 111.476 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 150.86 -42.78 0.73 Allowed Glycine 0 C--N 1.336 0.564 0 N-CA-C 110.944 -0.862 . . . . 64.13 110.944 -177.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 70.8 -84.25 0.38 Allowed Glycine 0 C--N 1.353 1.49 0 N-CA-C 111.305 -0.718 . . . . 71.22 111.305 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 32.3 m -78.67 86.66 4.63 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 108.734 -0.839 . . . . 74.11 108.734 169.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 151.85 73.03 0.01 OUTLIER Glycine 0 C--N 1.339 0.698 0 N-CA-C 109.985 -1.246 . . . . 34.32 109.985 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -65.14 116.65 6.74 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.401 0.681 . . . . 75.1 110.062 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -82.9 149.37 27.12 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.556 0.742 . . . . 73.41 109.653 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.5 tt -141.63 138.28 32.43 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 106.249 -1.76 . . . . 64.33 106.249 176.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.623 ' HG3' ' HB2' ' A' ' 102' ' ' LEU . 13.2 ptm180 -103.75 149.58 24.87 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.228 0.537 . . . . 71.11 110.504 -178.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.706 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -159.63 135.89 8.92 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.765 -0.652 . . . . 53.43 109.76 -172.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.527 ' H ' ' HB3' ' A' ' 100' ' ' ALA . 7.0 mm-40 -108.5 120.93 43.85 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 107.583 -1.265 . . . . 64.4 107.583 -171.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.768 HD23 ' HB3' ' A' ' 176' ' ' LEU . 3.6 pp -101.08 110.47 61.3 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 108.085 -1.08 . . . . 74.12 108.085 176.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.61 112.29 3.5 Favored 'Trans proline' 0 C--N 1.367 1.536 0 C-N-CA 121.785 1.657 . . . . 75.53 108.994 169.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.54 HD21 HD12 ' A' ' 149' ' ' ILE . 32.1 tp -103.54 153.06 20.98 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.32 -0.622 . . . . 63.11 109.32 -169.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.7 t -92.51 146.07 23.96 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 108.024 -1.102 . . . . 71.51 108.024 178.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.514 HD23 HD22 ' A' ' 180' ' ' LEU . 87.6 mt -66.18 -24.5 66.64 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 112.919 0.711 . . . . 75.34 112.919 -173.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.08 -45.43 94.75 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.456 -0.572 . . . . 75.51 109.456 174.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.436 ' HB3' HD11 ' A' ' 149' ' ' ILE . 18.3 mm-40 -76.15 -31.6 58.65 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.128 -0.942 . . . . 75.11 111.83 -178.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.58 -36.36 78.34 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.936 0.494 . . . . 62.34 110.241 173.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -74.2 -57.99 3.59 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.755 -1.112 . . . . 63.34 110.945 176.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -60.95 -50.14 74.62 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.122 0.569 . . . . 73.33 111.184 -172.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.533 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 64.34 61.59 5.87 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 114.759 -1.11 . . . . 63.32 112.626 -173.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.445 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -123.92 -157.63 9.86 Favored Glycine 0 N--CA 1.467 0.749 0 N-CA-C 111.179 -0.768 . . . . 73.32 111.179 177.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -78.18 126.11 30.33 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.12 -0.696 . . . . 74.24 109.12 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.506 ' NH2' ' HB3' ' A' ' 94' ' ' MET . 8.6 tpp180 -120.05 123.06 42.51 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.727 -0.842 . . . . 72.41 108.727 175.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 72.7 t -71.58 113.7 8.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-N 114.306 -1.315 . . . . 44.14 109.677 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.522 HG22 HD11 ' A' ' 97' ' ' ILE . 35.9 t -100.88 112.17 32.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 108.394 -0.965 . . . . 73.43 108.394 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -99.8 113.72 26.42 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.102 -1.073 . . . . 70.3 108.102 174.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 12.0 p -152.66 132.14 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 122.92 0.488 . . . . 54.45 110.986 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 60.88 20.92 11.15 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.213 1.005 . . . . 75.32 112.792 173.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.62 -6.19 80.08 Favored Glycine 0 C--N 1.349 1.284 0 CA-C-O 119.847 -0.418 . . . . 63.42 113.291 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.419 ' NH1' ' SD ' ' A' ' 164' ' ' MET . 35.1 ttm180 -101.71 122.77 44.54 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.908 0.883 . . . . 70.54 109.947 -178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -97.42 108.31 21.01 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.253 1.021 . . . . 50.04 108.641 174.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 3.2 p -123.26 113.66 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.392 0.677 . . . . 54.11 109.551 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.2 t -91.27 113.92 26.32 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 108.789 -0.819 . . . . 61.11 108.789 178.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 23.3 m -108.34 133.68 52.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.364 0.666 . . . . 72.0 110.584 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -81.99 96.05 7.6 Favored 'General case' 0 C--N 1.349 0.548 0 N-CA-C 108.886 -0.783 . . . . 71.24 108.886 176.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.54 HD12 HD21 ' A' ' 125' ' ' LEU . 12.3 pt -73.4 147.24 87.32 Favored Pre-proline 0 CA--C 1.559 1.301 0 CA-C-N 114.636 -1.165 . . . . 75.53 109.609 176.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.6 142.01 75.62 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.915 2.41 . . . . 72.05 113.508 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -61.29 117.21 3.99 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.332 2.021 . . . . 64.32 110.996 170.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 93.0 17.82 42.3 Favored Glycine 0 C--N 1.34 0.786 0 O-C-N 123.645 0.59 . . . . 41.15 112.901 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.7 p -62.93 123.79 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 C-N-CA 123.424 0.69 . . . . 72.3 110.255 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -127.44 164.31 22.16 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.278 0.631 . . . . 70.03 110.982 -172.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -40.84 127.05 2.56 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 126.28 1.832 . . . . 64.41 113.767 -171.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.32 -11.77 66.95 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-O 119.486 -0.619 . . . . 72.34 114.246 176.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.4 m -60.64 121.1 11.37 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 117.553 0.676 . . . . 62.44 110.281 173.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.423 HG22 HG22 ' A' ' 177' ' ' VAL . 61.4 t -105.52 110.97 32.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 123.334 0.653 . . . . 71.11 109.524 -178.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.416 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 67.0 mt -90.33 103.73 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 107.985 -1.117 . . . . 74.02 107.985 177.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -83.01 101.33 11.03 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.752 -0.658 . . . . 72.23 109.451 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.438 HG13 ' HB3' ' A' ' 174' ' ' LEU . 3.8 p -101.93 109.05 58.78 Favored Pre-proline 0 CA--C 1.558 1.251 0 C-N-CA 123.24 0.616 . . . . 75.31 110.205 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.461 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 16.5 Cg_exo -69.13 145.56 61.2 Favored 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 122.859 2.373 . . . . 65.03 112.799 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 87.42 0.27 84.74 Favored Glycine 0 C--N 1.344 1.02 0 CA-C-N 115.643 -0.708 . . . . 73.33 113.722 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.419 ' SD ' ' NH1' ' A' ' 143' ' ' ARG . 24.5 mmt -107.7 -12.09 15.3 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.454 0.701 . . . . 75.12 111.485 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -98.87 -87.17 1.9 Allowed Glycine 0 C--N 1.351 1.37 0 N-CA-C 112.102 -0.399 . . . . 63.11 112.102 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -64.26 97.02 0.22 Allowed Glycine 0 C--N 1.349 1.29 0 C-N-CA 123.249 0.452 . . . . 62.44 112.872 176.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -90.44 170.94 9.8 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.705 1.202 . . . . 70.33 110.575 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 110.96 -66.13 0.24 Allowed Glycine 0 N--CA 1.47 0.947 0 C-N-CA 123.364 0.507 . . . . 63.12 112.189 173.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -154.79 -53.96 0.02 OUTLIER Pre-proline 0 CA--C 1.558 1.287 0 CA-C-O 117.739 -1.124 . . . . 73.22 111.155 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -81.32 109.35 2.1 Favored 'Trans proline' 0 C--N 1.398 3.182 0 C-N-CA 121.929 1.752 . . . . 61.52 110.247 177.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.63 124.12 12.35 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 121.777 1.652 . . . . 55.33 110.251 -176.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -123.51 164.21 16.72 Favored Glycine 0 C--O 1.238 0.383 0 CA-C-N 115.859 -0.609 . . . . 62.3 111.684 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 6.7 p-10 -91.13 162.07 14.82 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.725 0.81 . . . . 73.52 111.055 -170.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.438 ' HB3' HG13 ' A' ' 161' ' ' VAL . 34.7 tp -126.29 116.14 20.79 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 114.727 -1.124 . . . . 71.32 108.819 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 88.6 mt -85.2 100.84 12.03 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.206 1.003 . . . . 72.43 110.026 -175.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.768 ' HB3' HD23 ' A' ' 123' ' ' LEU . 46.8 mt -90.05 99.23 12.28 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.82 0.448 . . . . 74.44 110.167 -177.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.423 HG22 HG22 ' A' ' 158' ' ' VAL . 41.5 t -86.4 113.29 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 109.333 -0.617 . . . . 74.14 109.333 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 8.6 p -68.68 133.3 32.02 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.981 0 O-C-N 123.462 0.476 . . . . 74.44 109.945 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 30.4 mmm180 -127.47 94.19 3.92 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.109 0.964 . . . . 75.2 109.042 -174.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.514 HD22 HD23 ' A' ' 127' ' ' LEU . 97.1 mt -98.57 147.98 24.25 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.185 -0.916 . . . . 65.44 110.505 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 79.2 mt -71.05 135.53 85.05 Favored Pre-proline 0 CA--C 1.553 1.084 0 N-CA-C 109.471 -0.566 . . . . 73.13 109.471 175.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.63 -30.84 76.84 Favored 'Trans proline' 0 C--N 1.382 2.329 0 C-N-CA 123.086 2.524 . . . . 70.22 113.6 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 . . . . . 0 CA--C 1.551 0.987 0 N-CA-C 109.128 -0.693 . . . . 74.14 109.128 171.528 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.46 ' N ' ' SD ' ' A' ' 94' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 121.659 0.743 . . . . 72.3 109.967 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.3 m -63.38 125.14 23.2 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.132 -0.94 . . . . 54.22 110.649 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.546 ' HA ' HH11 ' A' ' 136' ' ' ARG . 92.4 m -68.21 131.97 46.32 Favored 'General case' 0 C--O 1.24 0.593 0 O-C-N 123.424 0.453 . . . . 43.41 110.164 176.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.688 HD12 ' HB2' ' A' ' 123' ' ' LEU . 23.1 pt -104.45 167.6 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 115.448 -0.796 . . . . 74.14 110.759 -171.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -112.45 -171.44 1.86 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.517 0.727 . . . . 74.41 109.707 172.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.562 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.1 tp -133.7 158.0 44.39 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 108.268 -1.012 . . . . 71.41 108.268 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.481 ' HB3' ' H ' ' A' ' 122' ' ' GLU . . . -75.8 -47.53 25.37 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 110.129 -0.323 . . . . 74.3 110.129 176.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 54.5 mt 50.8 86.58 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.238 0 O-C-N 124.453 1.095 . . . . 73.11 111.034 -171.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.0 mt -99.31 157.77 33.43 Favored Pre-proline 0 CA--C 1.549 0.918 0 CA-C-N 115.15 -0.932 . . . . 73.41 109.491 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -67.92 -170.35 0.28 Allowed 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 122.88 2.387 . . . . 75.45 113.859 178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.611 HD11 ' HG3' ' A' ' 117' ' ' ARG . 4.6 mm? -55.86 130.58 44.13 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.076 0.95 . . . . 74.43 111.019 175.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 131.06 75.22 0.13 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 111.146 -0.781 . . . . 73.24 111.146 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 51.5 p -82.58 1.34 38.59 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.86 0.864 . . . . 73.21 112.481 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.8 22.39 21.01 Favored Glycine 0 N--CA 1.474 1.211 0 N-CA-C 112.066 -0.414 . . . . 72.22 112.066 -175.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 174.72 -30.89 0.09 OUTLIER Glycine 0 C--N 1.338 0.669 0 N-CA-C 111.326 -0.71 . . . . 63.42 111.326 -177.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.2 t 68.17 -172.79 0.19 Allowed 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 124.238 1.015 . . . . 74.43 111.54 174.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -66.3 81.9 0.1 Allowed Glycine 0 C--N 1.349 1.289 0 N-CA-C 112.399 -0.28 . . . . 63.44 112.399 173.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -67.99 -10.2 58.44 Favored Glycine 0 C--N 1.354 1.566 0 N-CA-C 114.857 0.703 . . . . 35.23 114.857 -172.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.2 t -77.14 -5.63 49.8 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 123.565 0.746 . . . . 64.41 111.235 175.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.06 35.55 38.3 Favored Glycine 0 C--N 1.354 1.54 0 N-CA-C 112.135 -0.386 . . . . 74.34 112.135 -176.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 123.62 -176.61 16.75 Favored Glycine 0 C--N 1.347 1.141 0 C-N-CA 122.987 0.327 . . . . 75.13 112.375 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 24.8 t 63.61 70.09 0.53 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.985 1.314 . . . . 62.45 110.794 -177.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 127.07 111.92 1.73 Allowed Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.244 -0.889 . . . . 53.42 112.115 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.611 ' HG3' HD11 ' A' ' 104' ' ' LEU . 51.2 ttp180 -84.58 125.67 32.65 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.066 0.46 . . . . 71.35 109.902 173.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -82.56 144.79 30.12 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.407 0.683 . . . . 75.32 109.808 176.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.9 tt -143.8 118.26 9.7 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 107.905 -1.146 . . . . 63.22 107.905 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -91.14 127.77 36.7 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 107.835 -1.172 . . . . 54.05 107.835 176.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.562 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -146.07 130.66 17.87 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.269 -0.641 . . . . 74.12 109.269 -176.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.481 ' H ' ' HB3' ' A' ' 100' ' ' ALA . 52.9 mt-10 -117.51 120.57 38.48 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 110.037 -0.357 . . . . 75.43 110.037 -169.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.688 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.4 pp -100.82 122.89 47.49 Favored Pre-proline 0 C--N 1.349 0.564 0 N-CA-C 109.961 -0.385 . . . . 62.42 109.961 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -76.78 113.58 3.67 Favored 'Trans proline' 0 C--N 1.365 1.433 0 C-N-CA 122.309 2.006 . . . . 73.13 108.27 167.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.549 HD21 HD12 ' A' ' 149' ' ' ILE . 51.2 tp -101.73 147.09 26.88 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.6 -0.518 . . . . 75.14 109.6 -168.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.5 t -89.57 148.92 23.09 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 108.587 -0.894 . . . . 75.32 108.587 -176.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.46 -31.2 71.88 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.776 0.83 . . . . 72.23 112.629 -169.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.45 -47.59 85.45 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.855 0.722 . . . . 70.13 109.35 178.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -76.31 -28.84 57.1 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 114.619 -1.173 . . . . 63.21 112.055 -174.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.0 -43.12 99.5 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.331 0.586 . . . . 72.23 110.266 172.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -65.21 -54.16 33.69 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 114.421 -1.263 . . . . 74.42 110.976 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -63.58 -48.86 75.65 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.076 0.55 . . . . 74.51 111.486 -175.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.59 ' HA3' ' HA ' ' A' ' 151' ' ' PRO . . . 61.04 72.53 0.62 Allowed Glycine 0 C--N 1.341 0.832 0 CA-C-N 114.788 -1.096 . . . . 71.13 112.147 -171.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.464 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -144.37 -157.63 7.28 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 111.696 -0.561 . . . . 61.22 111.696 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -72.35 112.56 8.53 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.412 -0.588 . . . . 52.12 109.412 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.546 HH11 ' HA ' ' A' ' 96' ' ' THR . 5.9 tpp180 -113.0 122.71 48.45 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 108.253 -1.017 . . . . 73.21 108.253 173.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 96.8 t -77.69 125.97 37.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 CA-C-N 114.472 -1.24 . . . . 63.44 109.918 -178.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 144' ' ' ARG . 45.1 t -103.45 121.55 54.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.423 1.089 . . . . 75.23 108.35 176.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -112.93 106.47 14.76 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.136 -1.061 . . . . 74.34 108.136 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 7.3 p -151.14 122.4 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 123.175 0.59 . . . . 73.41 110.639 -175.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 64.24 19.96 11.99 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.131 0.972 . . . . 73.43 112.359 174.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.53 -9.68 76.85 Favored Glycine 0 C--N 1.351 1.416 0 CA-C-N 116.368 -0.378 . . . . 52.11 112.787 -174.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 18.6 ttm180 -89.47 120.9 31.19 Favored 'General case' 0 C--N 1.347 0.493 0 N-CA-C 108.507 -0.923 . . . . 73.31 108.507 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.425 ' HA ' ' O ' ' A' ' 138' ' ' VAL . 40.7 ttm180 -112.53 114.95 27.86 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.217 -0.901 . . . . 73.01 108.708 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 6.4 p -129.9 117.55 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 121.424 0.63 . . . . 62.44 110.529 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 43.0 t -81.48 110.1 16.57 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.563 -0.902 . . . . 73.31 108.563 174.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.6 p -107.73 123.47 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.181 0.592 . . . . 72.2 109.741 177.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 51.1 ttt85 -76.96 94.81 4.01 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 108.734 -0.839 . . . . 74.05 108.734 172.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.549 HD12 HD21 ' A' ' 125' ' ' LEU . 8.0 pt -69.9 142.83 91.2 Favored Pre-proline 0 CA--C 1.561 1.372 0 CA-C-N 114.533 -1.212 . . . . 70.14 109.146 175.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.4 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 24.6 Cg_endo -63.01 148.72 93.17 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.396 2.064 . . . . 71.01 112.702 178.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.59 ' HA ' ' HA3' ' A' ' 133' ' ' GLY . 34.9 Cg_exo -62.36 124.84 15.02 Favored 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.689 2.259 . . . . 74.02 111.441 177.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 74.44 30.66 60.01 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 112.23 -0.348 . . . . 51.13 112.23 -177.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.0 p -62.27 116.95 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 123.576 0.751 . . . . 61.32 109.78 175.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.526 ' HA ' HD12 ' A' ' 180' ' ' LEU . 96.1 mtt180 -113.57 166.33 11.62 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.423 0.689 . . . . 65.11 110.886 -177.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -40.21 128.47 2.29 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 126.628 1.971 . . . . 75.34 113.692 -176.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.69 -10.24 72.76 Favored Glycine 0 C--N 1.352 1.433 0 CA-C-O 119.442 -0.643 . . . . 64.34 114.124 175.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 25.3 t -64.77 120.57 12.72 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 117.521 0.66 . . . . 72.32 109.885 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.428 HG22 HG22 ' A' ' 177' ' ' VAL . 53.4 t -99.26 125.02 52.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.588 0.755 . . . . 65.43 109.224 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 54.8 mt -101.63 105.22 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 108.553 -0.906 . . . . 75.04 108.553 176.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -80.85 101.86 9.67 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.879 0.472 . . . . 72.41 109.782 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.551 HG13 ' HB3' ' A' ' 174' ' ' LEU . 5.4 p -110.63 98.12 35.73 Favored Pre-proline 0 CA--C 1.561 1.389 0 N-CA-C 109.802 -0.444 . . . . 74.22 109.802 173.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 44.4 Cg_endo -65.69 156.53 63.44 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.521 2.814 . . . . 75.22 113.291 -178.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 68.89 11.66 63.54 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.122 -0.944 . . . . 61.2 114.458 177.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 97.4 mmm -113.82 -26.94 7.96 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.857 0.863 . . . . 61.14 109.422 174.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -76.67 -84.87 0.44 Allowed Glycine 0 C--N 1.35 1.328 0 N-CA-C 110.705 -0.958 . . . . 4.1 110.705 172.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.412 ' HA2' ' HB3' ' A' ' 117' ' ' ARG . . . -66.22 101.29 0.6 Allowed Glycine 0 C--N 1.342 0.906 0 O-C-N 123.958 0.446 . . . . 73.51 113.791 171.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.64 ' HA ' HE21 ' A' ' 167' ' ' GLN . 0.0 OUTLIER -90.83 169.97 10.49 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.05 0.94 . . . . 75.4 110.559 174.596 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 83.0 -143.63 22.26 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-O 119.648 -0.529 . . . . 74.15 112.405 -176.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -63.07 -57.18 22.31 Favored Pre-proline 0 CA--C 1.56 1.358 0 CA-C-O 118.404 -0.807 . . . . 64.22 112.084 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -80.29 111.83 2.69 Favored 'Trans proline' 0 C--N 1.393 2.918 0 CA-C-N 121.179 1.457 . . . . 74.41 112.22 -176.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -76.07 123.9 7.59 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 122.024 1.816 . . . . 65.32 110.704 -178.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 117' ' ' ARG . . . -137.04 162.92 25.33 Favored Glycine 0 C--N 1.34 0.751 0 C-N-CA 121.406 -0.426 . . . . 53.52 113.42 -172.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.517 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 8.8 m-20 -91.23 132.23 36.25 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 123.892 0.877 . . . . 74.13 111.87 -164.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.551 ' HB3' HG13 ' A' ' 161' ' ' VAL . 33.7 tp -96.13 102.95 14.81 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.021 -1.474 . . . . 64.22 107.021 171.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 88.4 mt -87.9 100.25 12.74 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.182 0.593 . . . . 61.53 109.441 -175.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.565 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 74.3 mt -87.25 99.45 11.97 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 123.262 0.625 . . . . 73.41 110.253 -175.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.428 HG22 HG22 ' A' ' 158' ' ' VAL . 33.2 t -87.97 116.09 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 N-CA-C 108.949 -0.76 . . . . 74.21 108.949 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 13.0 p -73.64 140.39 17.83 Favored 'Isoleucine or valine' 0 C--O 1.246 0.878 0 C-N-CA 123.003 0.521 . . . . 72.11 110.888 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -124.75 113.58 18.15 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 107.946 -1.131 . . . . 75.11 107.946 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.526 HD12 ' HA ' ' A' ' 154' ' ' ARG . 47.8 mt -111.35 134.34 53.01 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.947 0.499 . . . . 64.44 110.772 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 96.0 mt -58.53 142.18 82.95 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 123.818 0.847 . . . . 55.43 110.362 174.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -69.21 -10.09 28.06 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 122.946 2.431 . . . . 73.21 112.907 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 42.9 m80 . . . . . 0 C--O 1.252 1.193 0 N-CA-C 107.163 -1.421 . . . . 72.22 107.163 174.06 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 73.3 mtp . . . . . 0 N--CA 1.483 1.221 0 N-CA-C 109.333 -0.617 . . . . 74.23 109.333 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 43.5 m -71.0 125.1 25.94 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.953 -0.567 . . . . 65.32 110.575 -177.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 56.8 m -67.92 147.37 52.56 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.921 0.888 . . . . 51.42 111.153 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.689 HD12 ' HB2' ' A' ' 123' ' ' LEU . 26.8 pt -116.93 168.18 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 123.496 0.718 . . . . 75.41 110.577 -172.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -141.65 127.69 19.54 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.756 0.822 . . . . 64.44 109.41 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.724 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.1 tp -73.96 140.15 45.35 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.628 1.571 . . . . 71.11 110.417 -169.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.58 -33.82 76.81 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.557 0.743 . . . . 75.45 111.713 -176.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.8 mt 48.7 62.78 2.39 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.417 1.087 . . . . 61.45 111.697 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 36.0 mt -69.89 147.14 95.94 Favored Pre-proline 0 CA--C 1.554 1.134 0 N-CA-C 108.719 -0.845 . . . . 64.04 108.719 176.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -66.76 172.17 9.89 Favored 'Trans proline' 0 C--N 1.367 1.505 0 C-N-CA 122.071 1.847 . . . . 54.53 112.45 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.1 pp -75.68 155.81 35.37 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 116.598 -0.274 . . . . 72.23 111.109 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 144.66 -75.9 0.29 Allowed Glycine 0 C--N 1.339 0.747 0 N-CA-C 110.884 -0.886 . . . . 61.34 110.884 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 53.4 p -101.99 89.23 3.57 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.567 0.747 . . . . 74.52 109.517 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.417 ' HA2' ' HD3' ' A' ' 120' ' ' ARG . . . -106.94 -82.41 1.5 Allowed Glycine 0 C--N 1.339 0.699 0 CA-C-N 115.908 -0.587 . . . . 72.32 111.909 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 83.28 162.16 32.39 Favored Glycine 0 CA--C 1.534 1.245 0 O-C-N 123.843 0.378 . . . . 75.54 113.142 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.0 m 72.45 -68.47 0.22 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 125.113 1.365 . . . . 74.11 111.901 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -94.03 -174.79 39.4 Favored Glycine 0 C--N 1.346 1.095 0 CA-C-O 120.137 -0.257 . . . . 51.21 112.551 178.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.537 ' HA3' ' HB3' ' A' ' 118' ' ' ASP . . . 68.33 57.84 7.91 Favored Glycine 0 C--N 1.345 1.075 0 N-CA-C 111.846 -0.501 . . . . 72.42 111.846 -178.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.7 m -66.42 156.13 35.52 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.671 0.788 . . . . 74.41 111.676 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -75.83 71.75 1.87 Allowed Glycine 0 C--N 1.353 1.481 0 O-C-N 123.544 0.528 . . . . 43.44 113.486 -176.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -167.34 43.88 0.25 Allowed Glycine 0 C--N 1.342 0.891 0 N-CA-C 111.102 -0.799 . . . . 33.43 111.102 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 54.0 m 67.07 93.81 0.07 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.322 1.449 . . . . 62.24 111.841 -177.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 177.65 98.25 0.11 Allowed Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.199 -0.909 . . . . 61.14 111.032 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.696 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 18.4 ttm180 -73.69 119.28 17.7 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.862 0.865 . . . . 73.33 110.468 -179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.537 ' HB3' ' HA3' ' A' ' 111' ' ' GLY . 10.4 p-10 -85.28 116.74 23.8 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.43 0.634 . . . . 74.52 109.958 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.7 tt -94.34 124.19 38.21 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 106.399 -1.704 . . . . 74.4 106.399 175.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.417 ' HD3' ' HA2' ' A' ' 107' ' ' GLY . 23.5 tpt85 -90.98 117.73 29.8 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 107.879 -1.156 . . . . 73.22 107.879 -175.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.724 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -140.04 151.04 45.11 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 110.032 -0.359 . . . . 63.22 110.032 -173.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.536 ' HG2' ' HB ' ' A' ' 177' ' ' VAL . 89.1 mt-10 -129.69 120.5 25.25 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.242 -0.651 . . . . 64.52 109.242 -177.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.689 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.4 pp -97.83 113.61 63.9 Favored Pre-proline 0 C--N 1.353 0.727 0 N-CA-C 107.684 -1.228 . . . . 63.43 107.684 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.15 113.45 3.78 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 122.477 2.118 . . . . 72.05 108.549 171.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.453 HD21 HD12 ' A' ' 149' ' ' ILE . 34.0 tp -102.29 146.68 27.67 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 109.429 -0.582 . . . . 74.03 109.429 -168.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.9 t -90.47 154.06 19.92 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 108.324 -0.991 . . . . 63.31 108.324 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.82 -36.37 82.95 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.146 0.579 . . . . 41.13 111.803 -173.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -55.19 -47.74 74.82 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.233 0.613 . . . . 71.23 110.425 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.475 ' HG3' ' HE ' ' A' ' 136' ' ' ARG . 14.3 mm-40 -76.57 -31.7 57.69 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.933 -1.03 . . . . 71.04 111.829 -174.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.7 -31.94 72.94 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.779 0.431 . . . . 72.43 110.704 174.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -78.25 -49.98 12.71 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.433 -0.803 . . . . 70.33 110.895 173.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -62.72 -50.06 72.6 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 122.745 0.418 . . . . 75.12 111.413 -172.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.585 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 60.85 75.05 0.31 Allowed Glycine 0 C--N 1.342 0.862 0 CA-C-N 115.129 -0.942 . . . . 54.03 112.921 -177.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -162.3 -144.16 3.92 Favored Glycine 0 C--O 1.24 0.492 0 N-CA-C 110.967 -0.853 . . . . 64.43 110.967 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -72.05 113.36 9.0 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 122.787 0.435 . . . . 63.35 110.15 -175.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.475 ' HE ' ' HG3' ' A' ' 129' ' ' GLU . 6.8 tpp180 -120.21 120.83 37.29 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 108.24 -1.022 . . . . 73.5 108.24 170.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 146' ' ' SER . 63.8 t -77.07 131.71 34.26 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-N 115.417 -0.81 . . . . 74.15 110.416 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.4 p -125.18 119.64 56.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 C-N-CA 124.361 1.065 . . . . 64.21 108.597 171.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -115.61 115.24 26.09 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.946 0.498 . . . . 73.33 110.259 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.461 HG21 ' HB3' ' A' ' 99' ' ' LEU . 2.5 m -149.22 144.01 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 125.017 1.327 . . . . 73.42 110.384 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.6 26.5 14.68 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.729 1.211 . . . . 63.32 111.611 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 81.37 -0.74 87.32 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 115.706 -0.679 . . . . 73.24 112.961 -177.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -101.13 117.92 35.96 Favored 'General case' 0 C--N 1.346 0.451 0 C-N-CA 123.718 0.807 . . . . 70.31 110.036 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 37.1 ttp180 -97.78 105.79 17.99 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.351 -0.981 . . . . 65.43 108.351 174.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 5.6 p -125.96 125.97 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.298 0.639 . . . . 70.12 109.53 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 137' ' ' VAL . 38.3 t -89.95 134.5 34.19 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 109.371 -0.603 . . . . 70.25 109.371 175.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 5.6 p -113.79 130.34 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.277 0.631 . . . . 50.14 109.611 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -85.81 104.11 15.18 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.772 0.796 . . . . 75.0 109.778 173.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.585 HG13 ' HA2' ' A' ' 133' ' ' GLY . 8.2 pt -83.42 150.74 60.93 Favored Pre-proline 0 CA--C 1.558 1.269 0 CA-C-N 114.42 -1.264 . . . . 61.02 109.756 173.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -73.91 145.93 36.77 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.263 1.976 . . . . 75.11 112.191 173.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -64.48 120.1 7.31 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 122.391 2.06 . . . . 75.2 111.176 173.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 89.74 27.65 21.24 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 111.626 -0.59 . . . . 53.42 111.626 -170.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 4.3 p -66.6 129.95 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 109.272 -0.64 . . . . 73.44 109.272 172.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 29.3 mtm180 -127.02 157.87 38.45 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.442 0.697 . . . . 63.25 110.856 -168.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -42.17 125.49 3.07 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 126.716 2.006 . . . . 63.54 114.107 -175.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.79 2.75 69.17 Favored Glycine 0 C--N 1.351 1.392 0 N-CA-C 114.652 0.621 . . . . 53.4 114.652 176.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 33.1 t -68.29 122.42 18.32 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 117.556 0.678 . . . . 54.24 109.257 173.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.476 HG22 HG22 ' A' ' 177' ' ' VAL . 52.1 t -110.08 109.55 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.465 0.706 . . . . 72.25 109.592 -176.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.434 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 54.5 mt -90.78 111.57 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 108.551 -0.907 . . . . 54.23 108.551 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -86.41 104.29 15.77 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.732 0.813 . . . . 70.13 110.079 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.625 HG13 ' HB3' ' A' ' 174' ' ' LEU . 2.7 p -115.0 101.14 54.46 Favored Pre-proline 0 CA--C 1.564 1.494 0 C-N-CA 123.221 0.608 . . . . 63.03 110.352 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 49.1 Cg_endo -67.14 150.57 82.13 Favored 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 123.21 2.607 . . . . 72.24 113.231 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 74.0 11.05 81.44 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 115.785 -0.643 . . . . 74.23 114.331 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 23.1 mmt -114.92 -11.78 12.14 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.571 0.749 . . . . 55.02 110.353 173.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -97.24 -102.94 2.16 Favored Glycine 0 C--N 1.354 1.567 0 CA-C-N 116.059 -0.519 . . . . 63.43 112.246 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.696 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -70.48 90.63 0.38 Allowed Glycine 0 C--N 1.35 1.349 0 O-C-N 123.616 0.245 . . . . 74.04 113.621 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.728 ' HA ' HE21 ' A' ' 167' ' ' GLN . 0.0 OUTLIER -81.6 158.17 24.46 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.524 0.678 . . . . 75.43 112.155 179.208 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 139.02 -145.72 17.11 Favored Glycine 0 C--N 1.342 0.885 0 CA-C-N 114.27 -1.332 . . . . 70.23 110.55 -172.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -75.94 -44.14 3.84 Favored Pre-proline 0 CA--C 1.562 1.409 0 CA-C-O 118.919 -0.563 . . . . 70.25 111.708 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -88.55 132.52 2.55 Favored 'Trans proline' 0 C--N 1.386 2.519 0 C-N-CA 121.653 1.569 . . . . 71.0 110.995 165.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.13 126.63 6.42 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 122.096 1.864 . . . . 55.34 111.484 176.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -109.25 154.01 16.65 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 116.071 -0.513 . . . . 73.15 112.74 -173.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.541 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 28.5 m-20 -77.35 144.44 38.01 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.62 0.768 . . . . 52.42 111.989 -175.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.625 ' HB3' HG13 ' A' ' 161' ' ' VAL . 45.6 tp -111.26 114.73 28.13 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.115 -1.069 . . . . 71.02 108.115 174.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 43.4 mt -87.04 112.38 21.81 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.302 1.041 . . . . 65.22 108.846 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.523 ' HB3' HD23 ' A' ' 123' ' ' LEU . 69.9 mt -101.75 99.0 9.19 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 123.576 0.547 . . . . 62.12 109.565 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.536 ' HB ' ' HG2' ' A' ' 122' ' ' GLU . 35.5 t -94.69 108.18 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 108.75 -0.833 . . . . 62.12 108.75 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 13.8 p -68.03 132.03 32.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 122.877 0.471 . . . . 74.41 110.904 -177.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -123.34 91.23 3.44 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.081 0.952 . . . . 73.21 109.071 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 85.8 mt -85.2 149.09 25.75 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.173 -0.921 . . . . 72.32 109.825 175.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 81.9 mt -67.4 130.15 93.49 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 109.48 -0.563 . . . . 65.54 109.48 175.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -67.33 -16.89 49.14 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.567 2.178 . . . . 73.13 112.895 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 10.8 t60 . . . . . 0 C--O 1.249 1.072 0 N-CA-C 108.139 -1.06 . . . . 63.0 108.139 172.022 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 20.1 ptt? . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 109.799 -0.445 . . . . 75.43 109.799 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.479 ' H ' HG21 ' A' ' 126' ' ' THR . 19.9 m -77.66 140.68 39.63 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.358 0.663 . . . . 44.15 111.619 -178.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.522 ' HA ' HH11 ' A' ' 136' ' ' ARG . 90.1 m -71.41 151.52 43.97 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.315 1.046 . . . . 63.41 110.199 170.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.736 HD12 ' HB2' ' A' ' 123' ' ' LEU . 27.1 pt -118.15 159.35 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 C-N-CA 123.105 0.562 . . . . 70.23 110.107 -173.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -127.12 129.23 47.53 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.619 -0.882 . . . . 72.21 108.619 172.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.628 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.5 tp -69.51 151.23 46.28 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.256 1.022 . . . . 72.12 108.737 -177.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.88 -48.58 24.15 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 122.79 0.436 . . . . 70.34 109.846 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 93.1 mt 57.43 80.51 0.16 Allowed 'General case' 0 C--N 1.359 1.012 0 O-C-N 124.566 1.166 . . . . 73.34 109.524 -170.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.3 mt -74.28 151.92 87.92 Favored Pre-proline 0 N--CA 1.471 0.592 0 CA-C-N 115.218 -0.901 . . . . 70.51 110.671 -176.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.23 146.01 95.94 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.471 2.114 . . . . 72.3 110.554 171.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -65.59 118.85 10.1 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.3 0.852 . . . . 72.41 113.3 -168.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -165.67 35.08 0.25 Allowed Glycine 0 C--N 1.336 0.561 0 CA-C-N 114.74 -1.118 . . . . 61.24 110.403 169.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 4.8 m -78.07 86.64 4.23 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.982 0.913 . . . . 53.24 110.161 -174.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -95.02 30.69 7.74 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 116.499 -0.319 . . . . 60.53 112.597 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.03 94.11 0.6 Allowed Glycine 0 C--N 1.353 1.517 0 N-CA-C 112.067 -0.413 . . . . 64.42 112.067 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.2 t -69.22 94.37 0.68 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.233 1.013 . . . . 55.2 111.334 -173.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 164.56 18.2 0.02 OUTLIER Glycine 0 N--CA 1.471 0.989 0 CA-C-N 115.504 -0.771 . . . . 53.34 112.353 175.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -103.44 19.03 46.55 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-O 119.286 -0.73 . . . . 72.24 114.616 -171.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 26.1 p -61.77 110.62 1.57 Allowed 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.588 0.755 . . . . 74.01 111.303 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -172.15 28.44 0.1 Allowed Glycine 0 C--N 1.344 1.021 0 CA-C-N 116.389 -0.369 . . . . 63.31 113.062 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 131.8 -165.4 23.4 Favored Glycine 0 C--N 1.343 0.941 0 N-CA-C 111.74 -0.544 . . . . 54.45 111.74 -177.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 56.6 m -122.99 132.37 54.11 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.464 0.706 . . . . 63.11 109.879 175.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 172.7 175.57 40.73 Favored Glycine 0 C--O 1.243 0.673 0 N-CA-C 110.105 -1.198 . . . . 72.23 110.105 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.529 ' HB3' ' HA2' ' A' ' 166' ' ' GLY . 59.4 ttp180 -79.26 123.48 27.48 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 117.13 0.465 . . . . 75.12 110.13 179.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -91.55 106.87 18.8 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 106.443 -1.688 . . . . 75.21 106.443 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.6 tt -104.08 123.17 46.77 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.173 -1.047 . . . . 55.41 108.173 -172.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -90.5 128.18 36.46 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.233 -1.025 . . . . 72.42 108.233 175.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.628 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -140.88 149.76 42.36 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 123.788 0.835 . . . . 73.42 109.314 -172.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -119.93 122.3 40.92 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.667 -0.864 . . . . 62.43 108.667 -175.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.736 ' HB2' HD12 ' A' ' 97' ' ' ILE . 3.9 pp -99.63 108.03 48.83 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 106.912 -1.514 . . . . 74.21 106.912 173.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.524 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 63.1 Cg_endo -71.59 112.18 3.3 Favored 'Trans proline' 0 C--N 1.369 1.628 0 C-N-CA 121.838 1.692 . . . . 74.4 108.373 169.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.466 HD21 HD12 ' A' ' 149' ' ' ILE . 32.8 tp -100.55 142.84 31.46 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 108.216 -1.031 . . . . 71.13 108.216 -170.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.479 HG21 ' H ' ' A' ' 95' ' ' SER . 1.9 t -79.47 145.1 33.44 Favored 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 107.941 -1.133 . . . . 51.22 107.941 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.2 mt -61.84 -28.73 69.69 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.389 0.676 . . . . 74.34 112.479 -170.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -63.84 -41.16 97.88 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 115.601 -0.727 . . . . 72.24 109.794 178.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -75.99 -31.29 58.9 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.879 0.872 . . . . 71.32 112.461 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.32 -40.35 77.73 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.415 0.626 . . . . 53.44 110.272 169.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -73.93 -48.22 32.25 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-N 114.432 -1.258 . . . . 70.43 111.876 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 32.8 m80 -76.13 -51.33 12.4 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 120.722 0.296 . . . . 74.34 111.137 -171.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.623 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 67.33 69.1 1.45 Allowed Glycine 0 C--N 1.348 1.24 0 CA-C-N 115.25 -0.887 . . . . 71.51 113.478 -178.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -131.84 -154.65 7.8 Favored Glycine 0 N--CA 1.477 1.367 0 N-CA-C 111.684 -0.566 . . . . 71.23 111.684 178.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -70.96 114.31 8.88 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.101 -0.703 . . . . 64.2 109.101 175.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.522 HH11 ' HA ' ' A' ' 96' ' ' THR . 8.0 tpp180 -112.07 122.19 47.07 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.326 -0.99 . . . . 54.15 108.326 175.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 78.1 t -78.82 131.46 34.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 CA-C-N 113.828 -1.533 . . . . 72.54 110.406 -177.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.9 p -136.91 122.17 26.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 C-N-CA 124.287 1.035 . . . . 73.0 108.58 173.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -121.41 114.62 21.54 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.231 0.612 . . . . 74.15 111.088 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.4 m -148.89 146.78 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.681 1.592 . . . . 74.43 109.683 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 66.38 27.41 9.97 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.725 1.21 . . . . 62.44 110.848 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.23 15.64 72.53 Favored Glycine 0 C--N 1.356 1.687 0 CA-C-N 115.787 -0.642 . . . . 72.21 113.338 -176.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -124.26 129.37 50.64 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.002 0.921 . . . . 71.32 109.547 -178.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 32.4 ttp180 -110.17 120.35 42.17 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.083 0.553 . . . . 71.53 110.217 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.1 p -122.34 146.18 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 123.95 0.9 . . . . 64.54 109.787 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 47.5 t -100.5 113.16 25.72 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.581 -0.896 . . . . 60.03 108.581 174.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.8 p -102.5 113.72 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 109.215 -0.661 . . . . 75.0 109.215 174.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 55.1 ttt85 -75.75 104.69 6.41 Favored 'General case' 0 C--N 1.35 0.625 0 N-CA-C 108.698 -0.853 . . . . 71.11 108.698 174.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.623 HG13 ' HA2' ' A' ' 133' ' ' GLY . 12.2 pt -81.52 145.24 54.53 Favored Pre-proline 0 CA--C 1.56 1.357 0 C-N-CA 124.524 1.129 . . . . 73.11 109.67 175.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.56 148.95 73.69 Favored 'Trans proline' 0 CA--C 1.565 2.036 0 C-N-CA 122.403 2.069 . . . . 63.12 112.982 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.59 118.95 5.86 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.87 2.38 . . . . 70.35 111.628 174.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 88.04 23.44 38.13 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-O 119.724 -0.487 . . . . 65.31 112.414 -175.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.433 HG11 ' HB ' ' A' ' 149' ' ' ILE . 3.9 p -62.89 120.34 9.2 Favored 'Isoleucine or valine' 0 C--N 1.361 1.105 0 C-N-CA 123.343 0.657 . . . . 62.01 109.689 176.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.546 ' HA ' HD12 ' A' ' 180' ' ' LEU . 66.0 mtt85 -123.73 159.55 29.19 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.564 0.746 . . . . 75.34 111.006 -173.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -38.53 127.26 1.46 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.036 2.134 . . . . 65.13 113.794 -173.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 101.94 -9.66 56.74 Favored Glycine 0 C--N 1.355 1.625 0 CA-C-O 119.017 -0.879 . . . . 74.22 114.622 174.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.3 t -69.14 120.18 14.58 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 117.799 0.799 . . . . 72.42 109.45 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 57.3 t -104.72 114.62 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.217 0.607 . . . . 73.34 109.943 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 51.7 mt -91.86 100.9 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 107.783 -1.191 . . . . 73.41 107.783 172.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.483 HH11 HD21 ' A' ' 175' ' ' LEU . 57.9 ttt85 -84.0 103.71 13.47 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 108.954 -0.758 . . . . 72.13 108.954 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.72 120.31 47.64 Favored Pre-proline 0 CA--C 1.558 1.256 0 C-N-CA 123.137 0.575 . . . . 71.24 110.051 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 92.4 Cg_endo -74.79 149.71 38.15 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.751 2.3 . . . . 72.13 113.028 -173.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 75.03 -0.3 58.9 Favored Glycine 0 N--CA 1.473 1.149 0 N-CA-C 114.451 0.541 . . . . 70.21 114.451 174.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 85.8 mmm -98.02 -25.34 14.99 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.935 0.894 . . . . 71.25 110.7 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.401 ' N ' ' HB2' ' A' ' 174' ' ' LEU . . . -79.98 -82.24 0.74 Allowed Glycine 0 C--N 1.348 1.234 0 N-CA-C 111.226 -0.75 . . . . 51.41 111.226 176.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 117' ' ' ARG . . . -61.26 94.38 0.08 OUTLIER Glycine 0 C--N 1.345 1.062 0 O-C-N 124.171 0.571 . . . . 72.22 113.221 174.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -88.13 114.65 24.95 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.015 0.926 . . . . 72.1 109.347 175.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 158.48 -149.84 20.26 Favored Glycine 0 N--CA 1.466 0.666 0 N-CA-C 111.213 -0.755 . . . . 61.05 111.213 -177.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -72.57 -52.31 6.55 Favored Pre-proline 0 CA--C 1.559 1.299 0 CA-C-O 118.019 -0.991 . . . . 74.11 111.188 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -83.88 112.42 1.78 Allowed 'Trans proline' 0 C--N 1.391 2.772 0 C-N-CA 121.733 1.622 . . . . 73.23 111.293 174.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.58 125.61 12.44 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 121.895 1.73 . . . . 44.11 111.448 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -116.29 156.52 15.58 Favored Glycine 0 C--N 1.342 0.88 0 N-CA-C 111.708 -0.557 . . . . 54.05 111.708 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 5.8 m-20 -79.61 159.46 26.78 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.339 0.656 . . . . 63.11 111.4 -175.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.401 ' HB2' ' N ' ' A' ' 165' ' ' GLY . 32.4 tp -127.12 113.16 16.03 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 114.643 -1.162 . . . . 45.32 108.061 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.483 HD21 HH11 ' A' ' 160' ' ' ARG . 86.6 mt -81.86 101.64 10.34 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.472 -0.936 . . . . 64.4 108.472 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.692 ' HB3' HD23 ' A' ' 123' ' ' LEU . 54.2 mt -90.36 97.11 10.99 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.93 -0.767 . . . . 71.14 108.93 177.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.7 p -94.48 118.88 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 O-C-N 121.759 -0.588 . . . . 73.45 109.611 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 14.0 p -67.55 132.52 32.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.815 0 C-N-CA 123.778 0.831 . . . . 60.33 109.839 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.524 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 17.6 mmm-85 -122.12 104.95 9.84 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.745 0.818 . . . . 73.42 109.182 -176.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.546 HD12 ' HA ' ' A' ' 154' ' ' ARG . 83.0 mt -109.79 147.82 32.57 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.49 0.716 . . . . 61.14 111.227 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 89.1 mt -74.21 155.44 88.07 Favored Pre-proline 0 CA--C 1.557 1.217 0 CA-C-N 114.527 -1.215 . . . . 65.23 109.496 175.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -74.95 19.39 0.49 Allowed 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 123.19 2.593 . . . . 61.5 114.549 -175.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 . . . . . 0 CA--C 1.556 1.192 0 C-N-CA 124.392 1.077 . . . . 70.44 109.537 177.061 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.403 ' N ' ' SD ' ' A' ' 94' ' ' MET . 3.4 mpp? . . . . . 0 N--CA 1.482 1.129 0 N-CA-C 109.164 -0.68 . . . . 75.12 109.164 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.8 m -66.85 138.24 57.18 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.362 -0.835 . . . . 33.34 111.835 -177.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 47.3 m -74.81 150.09 39.42 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.576 -0.738 . . . . 74.25 109.073 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.664 HD12 ' HB2' ' A' ' 123' ' ' LEU . 23.5 pt -125.02 171.39 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 123.377 0.671 . . . . 73.34 110.705 -170.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -133.55 134.33 43.23 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.584 0.753 . . . . 74.4 110.27 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.579 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.3 tp -84.47 176.2 8.81 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.334 1.053 . . . . 74.43 109.069 -174.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -101.07 -48.15 4.52 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.41 0.284 . . . . 52.2 111.75 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.7 mt 57.36 70.45 0.65 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.113 0.965 . . . . 64.1 110.937 -168.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 20.8 mt -87.4 151.89 51.55 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-N 115.17 -0.923 . . . . 62.32 108.772 174.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -64.86 169.32 11.89 Favored 'Trans proline' 0 CA--C 1.558 1.675 0 C-N-CA 121.924 1.75 . . . . 64.25 111.943 174.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.409 HD23 ' H ' ' A' ' 104' ' ' LEU . 2.3 pt? -59.43 -31.81 69.62 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.109 0.564 . . . . 72.41 111.048 175.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -97.71 71.41 0.68 Allowed Glycine 0 C--N 1.345 1.034 0 N-CA-C 110.893 -0.883 . . . . 74.2 110.893 168.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 33.1 m -57.91 -50.32 73.73 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.719 0.808 . . . . 73.04 111.772 -175.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -101.82 37.97 3.39 Favored Glycine 0 C--N 1.344 1.02 0 CA-C-N 116.199 -0.455 . . . . 73.54 112.488 177.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.35 12.54 83.53 Favored Glycine 0 C--N 1.345 1.064 0 CA-C-O 119.969 -0.351 . . . . 70.11 113.918 177.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.7 p -71.09 145.66 49.72 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.584 0.753 . . . . 71.43 110.985 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -82.65 80.97 1.75 Allowed Glycine 0 C--N 1.35 1.33 0 N-CA-C 111.922 -0.471 . . . . 72.03 111.922 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.67 157.55 47.86 Favored Glycine 0 C--N 1.349 1.275 0 O-C-N 123.82 0.365 . . . . 65.14 113.813 -178.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 74.9 p -131.29 127.37 37.61 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.399 0.68 . . . . 71.32 110.757 -173.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 179.12 122.81 0.78 Allowed Glycine 0 C--N 1.345 1.043 0 CA-C-O 119.605 -0.553 . . . . 55.3 111.955 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -75.63 -88.87 0.25 Allowed Glycine 0 C--N 1.355 1.605 0 CA-C-N 116.903 0.352 . . . . 44.32 112.473 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 60.3 p -82.58 -26.93 31.9 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.19 0.596 . . . . 74.41 110.203 175.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -91.38 93.6 1.85 Allowed Glycine 0 C--N 1.343 0.958 0 N-CA-C 111.015 -0.834 . . . . 62.01 111.015 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.515 ' O ' ' HA3' ' A' ' 172' ' ' GLY . 38.5 ttm180 -90.54 120.9 32.02 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.047 0.539 . . . . 75.21 110.149 176.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -77.84 144.94 36.61 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.11 0.481 . . . . 73.35 109.972 178.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.3 tt -136.72 113.22 10.06 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 105.551 -2.018 . . . . 73.42 105.551 172.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 34.9 ttt180 -93.8 123.09 36.91 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 108.486 -0.931 . . . . 74.44 108.486 -177.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.579 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -140.53 131.49 26.11 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 123.534 0.734 . . . . 71.51 109.342 -172.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -117.63 128.79 55.28 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 110.05 -0.352 . . . . 74.12 110.05 -169.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.664 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.0 pp -108.16 117.77 54.1 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 123.062 0.545 . . . . 70.25 110.107 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.492 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 68.0 Cg_endo -73.33 113.75 3.86 Favored 'Trans proline' 0 C--N 1.364 1.347 0 C-N-CA 122.451 2.101 . . . . 72.2 109.088 168.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.587 HD21 HD12 ' A' ' 149' ' ' ILE . 50.6 tp -103.8 147.94 26.69 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 122.794 0.438 . . . . 73.01 110.015 -166.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.8 t -85.22 149.31 25.59 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 109.018 -0.734 . . . . 63.34 109.018 -177.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.9 mt -63.06 -30.8 71.88 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.587 0.755 . . . . 65.4 112.441 -171.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.04 -49.61 76.68 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 109.48 -0.563 . . . . 70.33 109.48 177.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -72.97 -31.69 64.71 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 114.818 -1.083 . . . . 72.43 112.164 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.53 -38.08 80.06 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.747 0.654 . . . . 72.44 110.472 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -73.52 -52.82 12.24 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.027 -0.988 . . . . 74.15 110.846 174.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -62.52 -49.69 74.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 123.531 0.52 . . . . 75.52 112.379 -169.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.579 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 67.86 52.16 30.56 Favored Glycine 0 C--N 1.34 0.751 0 O-C-N 123.853 0.721 . . . . 71.12 112.971 -172.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.438 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -113.05 -163.13 15.54 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 112.077 -0.409 . . . . 54.23 112.077 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.65 115.42 20.91 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 108.934 -0.765 . . . . 71.35 108.934 175.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.0 tpp180 -113.45 124.08 51.57 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.577 0.751 . . . . 73.34 109.323 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 86.0 t -72.06 127.97 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-N 114.198 -1.365 . . . . 43.3 109.721 175.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.446 HG22 ' HB2' ' A' ' 99' ' ' LEU . 6.1 p -134.26 111.15 14.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 124.151 0.981 . . . . 74.41 108.838 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -103.36 134.73 46.25 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.667 0.787 . . . . 73.31 109.988 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 5.9 p -152.35 132.06 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.245 1.018 . . . . 61.04 109.887 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.37 18.0 8.88 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.348 1.059 . . . . 74.15 112.506 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.67 -8.83 71.29 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 116.26 -0.427 . . . . 63.44 113.327 -175.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 39.6 ttm180 -92.25 118.39 30.83 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.708 0.803 . . . . 72.02 110.498 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.5 ttp180 -98.39 120.78 39.4 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.449 1.1 . . . . 75.02 109.485 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 40.5 t -123.41 125.71 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.054 0.942 . . . . 73.23 109.346 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.9 t -97.53 112.64 24.41 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.867 -0.79 . . . . 74.25 108.867 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.4 139.14 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.133 0.573 . . . . 75.41 111.013 -175.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -83.72 110.37 18.25 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.887 -0.783 . . . . 74.1 108.887 174.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.587 HD12 HD21 ' A' ' 125' ' ' LEU . 9.3 pt -89.55 151.46 46.01 Favored Pre-proline 0 CA--C 1.556 1.177 0 C-N-CA 124.29 1.036 . . . . 73.13 110.026 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -67.31 139.57 50.34 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 122.687 2.258 . . . . 72.34 112.603 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -65.5 131.85 29.26 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.561 2.174 . . . . 74.33 111.126 169.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 69.71 29.9 70.95 Favored Glycine 0 C--N 1.343 0.966 0 O-C-N 123.55 0.531 . . . . 65.35 112.391 -177.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 9.6 p -64.82 148.12 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 124.058 0.943 . . . . 70.14 110.007 178.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.4 ' HA ' HD12 ' A' ' 180' ' ' LEU . 24.4 mtp180 -134.44 161.75 34.16 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.991 0.516 . . . . 64.34 110.281 -178.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -44.59 134.71 5.23 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 125.73 1.612 . . . . 55.33 113.525 -174.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 83.9 3.85 89.01 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-N 115.746 -0.661 . . . . 51.34 114.322 176.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.3 t -71.87 121.11 18.45 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 108.412 -0.959 . . . . 45.22 108.412 174.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 61.4 t -104.74 114.71 45.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 O-C-N 123.738 0.649 . . . . 74.25 110.603 -175.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 60.8 mt -89.9 102.26 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 107.328 -1.36 . . . . 55.21 107.328 174.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -87.63 105.45 17.35 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 122.992 0.517 . . . . 73.23 109.826 -178.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.2 p -111.17 119.64 45.11 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 123.064 0.545 . . . . 63.55 109.704 175.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.43 153.14 49.98 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 122.247 1.964 . . . . 73.41 112.044 -177.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 76.36 -4.12 50.51 Favored Glycine 0 C--N 1.344 0.979 0 N-CA-C 115.208 0.843 . . . . 71.05 115.208 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 95.9 mmm -102.83 -13.26 17.06 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 117.645 0.723 . . . . 75.22 110.643 177.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -86.31 -96.1 0.81 Allowed Glycine 0 C--N 1.355 1.584 0 N-CA-C 111.823 -0.511 . . . . 41.21 111.823 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -57.28 98.29 0.08 OUTLIER Glycine 0 C--N 1.349 1.255 0 O-C-N 123.972 0.454 . . . . 64.54 112.319 171.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.2 mm-40 -88.09 153.89 20.9 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.521 1.128 . . . . 60.12 109.581 174.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 118.93 -144.17 17.75 Favored Glycine 0 N--CA 1.468 0.794 0 N-CA-C 110.976 -0.85 . . . . 63.25 110.976 -177.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -75.32 -47.36 4.4 Favored Pre-proline 0 CA--C 1.56 1.328 0 CA-C-O 117.97 -1.015 . . . . 72.55 110.944 168.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -76.47 113.55 3.69 Favored 'Trans proline' 0 C--N 1.395 2.98 0 C-N-CA 121.609 1.539 . . . . 72.34 112.241 177.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -82.8 126.77 4.64 Favored 'Trans proline' 0 C--N 1.385 2.461 0 C-N-CA 122.387 2.058 . . . . 74.13 111.787 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.515 ' HA3' ' O ' ' A' ' 117' ' ' ARG . . . -130.09 -179.37 15.98 Favored Glycine 0 N--CA 1.463 0.489 0 CA-C-N 116.758 -0.201 . . . . 62.11 113.181 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -100.92 131.26 46.88 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.817 0.847 . . . . 54.43 110.924 -168.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 29.8 tp -92.51 110.35 21.77 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 108.55 -0.908 . . . . 73.03 108.55 176.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 60.2 mt -91.19 99.7 12.65 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.49 0.716 . . . . 61.01 109.367 -177.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.554 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 96.2 mt -88.87 99.85 12.71 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.621 0.369 . . . . 71.31 111.022 -175.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 38.8 t -87.51 114.56 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 109.261 -0.644 . . . . 74.4 109.261 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.425 HG22 ' HG ' ' A' ' 180' ' ' LEU . 12.1 p -73.02 132.98 32.64 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 CA-C-O 121.188 0.518 . . . . 74.21 109.843 177.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.492 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 37.6 mmt180 -115.21 101.42 8.94 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.86 -1.163 . . . . 64.2 107.86 178.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.425 ' HG ' HG22 ' A' ' 178' ' ' VAL . 38.8 mt -108.23 141.67 39.65 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.005 0.431 . . . . 72.23 111.369 -176.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 65.3 mt -73.81 110.98 10.38 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-N 114.464 -1.244 . . . . 65.34 107.664 172.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -61.83 -23.97 76.71 Favored 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.951 2.434 . . . . 62.41 113.554 -171.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 47.2 m80 . . . . . 0 CA--C 1.546 0.809 0 N-CA-C 107.61 -1.256 . . . . 74.41 107.61 177.666 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.454 ' SD ' ' O ' ' A' ' 94' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.582 0 CA-C-O 121.564 0.697 . . . . 62.12 109.793 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.7 t -77.14 133.41 38.99 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.579 -0.737 . . . . 71.54 110.726 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 52.3 m -73.67 145.28 45.39 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.152 0.981 . . . . 63.12 110.308 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.61 HD12 ' HB2' ' A' ' 123' ' ' LEU . 18.2 pt -118.01 162.23 16.24 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 C-N-CA 123.223 0.609 . . . . 74.44 110.681 -172.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.408 ' O ' ' HD2' ' A' ' 124' ' ' PRO . . . -104.05 177.63 4.79 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.048 0.939 . . . . 52.53 108.952 170.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.598 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.4 tp -113.67 -133.77 0.34 Allowed 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 107.147 -1.427 . . . . 62.54 107.147 177.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.49 -43.47 0.06 Allowed 'General case' 0 C--N 1.345 0.412 0 N-CA-C 109.107 -0.701 . . . . 71.33 109.107 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 84.3 mt 53.81 64.08 1.96 Allowed 'General case' 0 C--N 1.362 1.129 0 O-C-N 124.438 1.086 . . . . 74.24 110.117 -172.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 61.0 mt -63.54 159.72 49.14 Favored Pre-proline 0 CA--C 1.55 0.968 0 CA-C-N 113.995 -1.457 . . . . 64.15 109.717 176.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -55.53 158.7 12.39 Favored 'Trans proline' 0 C--N 1.378 2.093 0 C-N-CA 122.056 1.837 . . . . 71.44 112.19 173.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.5 pp -57.57 134.76 56.41 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.697 0.799 . . . . 71.4 110.163 -177.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -97.93 -153.01 28.68 Favored Glycine 0 C--N 1.334 0.421 0 N-CA-C 112.416 -0.274 . . . . 74.34 112.416 -174.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 53.6 p -110.36 27.53 9.54 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.058 0.943 . . . . 71.2 110.113 175.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -69.36 -35.15 75.67 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 115.858 -0.61 . . . . 74.43 112.682 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -82.12 62.47 4.55 Favored Glycine 0 C--N 1.351 1.381 0 C-N-CA 123.137 0.399 . . . . 33.14 112.628 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 52.8 m -109.2 28.65 8.29 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.374 1.07 . . . . 72.05 110.434 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -81.61 64.34 4.21 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 116.133 -0.485 . . . . 63.2 112.454 176.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 66.63 -87.63 0.13 Allowed Glycine 0 C--N 1.35 1.31 0 C-N-CA 123.514 0.578 . . . . 24.01 112.009 -177.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.8 p -169.41 61.02 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.699 1.2 . . . . 65.24 108.948 -178.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -58.51 -31.83 67.58 Favored Glycine 0 C--N 1.355 1.631 0 CA-C-N 115.733 -0.667 . . . . 54.52 113.719 -176.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 155.02 -84.14 0.15 Allowed Glycine 0 C--N 1.348 1.248 0 N-CA-C 110.664 -0.974 . . . . 64.52 110.664 176.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 36.1 p -158.65 24.93 0.23 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.832 0.853 . . . . 71.22 110.293 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -60.76 95.96 0.09 OUTLIER Glycine 0 C--N 1.357 1.714 0 N-CA-C 111.208 -0.757 . . . . 74.41 111.208 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.5 tpp180 -74.61 116.65 15.55 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.647 0.779 . . . . 61.34 111.478 -170.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -83.43 119.7 24.99 Favored 'General case' 0 C--O 1.245 0.83 0 N-CA-C 108.093 -1.077 . . . . 63.14 108.093 169.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.3 tt -103.81 121.41 42.99 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.158 -1.793 . . . . 62.21 106.158 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -89.79 133.38 34.74 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.121 -1.066 . . . . 74.43 108.121 -177.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.598 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -154.56 146.66 23.68 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.252 0.621 . . . . 52.54 109.579 -175.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -128.19 135.0 49.12 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.502 -0.555 . . . . 73.21 109.502 -175.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.61 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.4 pp -112.53 116.96 47.78 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 109.88 -0.415 . . . . 73.11 109.88 178.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.529 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 70.2 Cg_endo -72.87 115.32 4.3 Favored 'Trans proline' 0 C--N 1.36 1.141 0 C-N-CA 122.498 2.132 . . . . 60.13 108.592 169.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.567 HD21 HD12 ' A' ' 149' ' ' ILE . 43.3 tp -104.26 148.4 26.38 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 109.933 -0.395 . . . . 74.33 109.933 -167.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.3 t -88.94 156.5 18.86 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 109.134 -0.691 . . . . 72.21 109.134 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.3 mt -64.42 -32.95 74.79 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.709 0.804 . . . . 72.12 112.631 -173.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -62.52 -46.7 87.23 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 124.168 0.918 . . . . 72.55 109.752 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -74.68 -34.09 62.6 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.041 -0.981 . . . . 71.0 111.519 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.97 -34.23 73.02 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.169 0.509 . . . . 60.5 110.518 173.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -76.55 -54.07 7.2 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 114.913 -1.04 . . . . 74.43 110.846 178.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.8 m80 -62.88 -50.35 71.24 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 122.829 0.452 . . . . 64.44 111.285 -174.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.571 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 70.04 58.27 6.32 Favored Glycine 0 C--N 1.339 0.745 0 CA-C-N 114.963 -1.017 . . . . 62.54 111.369 -169.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.41 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -121.7 -175.18 14.9 Favored Glycine 0 C--N 1.346 1.091 0 N-CA-C 112.463 -0.255 . . . . 64.04 112.463 -175.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -76.1 113.61 13.82 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.463 -0.94 . . . . 53.42 108.463 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -111.18 124.61 52.54 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.163 -1.051 . . . . 74.43 108.163 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.469 HG13 ' HG3' ' A' ' 144' ' ' ARG . 94.9 t -70.34 124.31 26.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 CA-C-N 114.466 -1.243 . . . . 65.4 109.124 178.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.428 HG11 HD13 ' A' ' 99' ' ' LEU . 34.5 t -117.77 130.14 73.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 107.83 -1.174 . . . . 75.41 107.83 177.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -123.71 122.21 37.5 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 118.1 0.409 . . . . 70.05 110.409 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.417 HG11 ' HB3' ' A' ' 99' ' ' LEU . 0.8 OUTLIER -149.99 128.73 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 124.855 1.262 . . . . 72.03 109.913 174.478 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.82 20.1 12.05 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.818 1.247 . . . . 74.05 112.203 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.12 9.14 82.77 Favored Glycine 0 C--N 1.355 1.595 0 CA-C-N 116.416 -0.357 . . . . 75.11 113.116 -175.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -101.19 120.21 39.9 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.706 1.202 . . . . 71.33 109.214 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.469 ' HG3' HG13 ' A' ' 137' ' ' VAL . 48.1 ttp180 -99.0 109.59 22.32 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.973 0.909 . . . . 74.54 109.747 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 53.8 t -107.99 112.38 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.566 -0.901 . . . . 75.53 108.566 172.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 48.2 t -91.54 104.16 16.69 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.213 -1.032 . . . . 61.0 108.213 174.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.1 p -100.94 119.17 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.521 0.729 . . . . 65.03 110.441 -175.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -73.74 101.06 3.57 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.334 -0.988 . . . . 73.41 108.334 167.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.571 HG13 ' HA2' ' A' ' 133' ' ' GLY . 10.0 pt -81.33 151.59 69.47 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 123.97 0.908 . . . . 70.43 109.675 175.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.447 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 64.5 Cg_endo -73.62 144.75 36.15 Favored 'Trans proline' 0 CA--C 1.559 1.763 0 C-N-CA 122.088 1.859 . . . . 61.41 112.556 177.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 150' ' ' PRO . 37.7 Cg_exo -63.18 124.5 14.0 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.18 2.587 . . . . 63.04 112.345 177.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 80.18 23.16 61.69 Favored Glycine 0 C--N 1.343 0.947 0 O-C-N 123.448 0.468 . . . . 75.43 112.906 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.5 p -57.57 145.99 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 124.536 1.135 . . . . 70.41 110.685 177.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 68.2 mtp180 -138.11 162.17 34.88 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.79 0.836 . . . . 65.31 110.547 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -43.85 129.13 5.71 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 126.366 1.866 . . . . 74.34 112.694 -174.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.17 -3.11 59.9 Favored Glycine 0 C--N 1.35 1.318 0 O-C-N 123.63 0.581 . . . . 75.22 113.81 176.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 52.2 m -69.81 119.68 14.4 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 117.724 0.762 . . . . 70.32 110.148 175.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 45.0 t -103.34 109.09 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.243 0.617 . . . . 72.23 110.026 -178.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 58.5 mt -91.25 101.92 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.438 1.095 . . . . 74.51 108.14 172.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -89.62 103.03 15.71 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 108.918 -0.771 . . . . 74.41 108.918 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.8 p -103.77 105.49 48.12 Favored Pre-proline 0 CA--C 1.561 1.367 0 C-N-CA 123.228 0.611 . . . . 71.43 110.316 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -66.44 146.77 81.2 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 123.093 2.528 . . . . 54.11 113.514 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 81.83 0.13 89.03 Favored Glycine 0 C--N 1.346 1.111 0 CA-C-N 115.603 -0.726 . . . . 71.35 113.666 176.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.8 mmt -101.66 -24.6 14.08 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 117.598 0.699 . . . . 74.14 111.529 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -81.84 -87.68 0.67 Allowed Glycine 0 C--N 1.347 1.171 0 CA-C-O 119.822 -0.432 . . . . 70.01 112.612 -175.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -62.65 93.49 0.1 OUTLIER Glycine 0 C--N 1.352 1.468 0 O-C-N 124.056 0.504 . . . . 61.1 112.247 174.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -88.86 158.13 18.21 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.152 0.981 . . . . 73.11 109.417 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 96.85 -142.57 16.25 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-O 119.623 -0.543 . . . . 73.34 111.879 -176.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -68.84 -53.88 14.09 Favored Pre-proline 0 CA--C 1.567 1.634 0 CA-C-O 118.032 -0.985 . . . . 73.3 112.389 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -83.92 108.51 1.41 Allowed 'Trans proline' 0 C--N 1.394 2.931 0 C-N-CA 121.709 1.606 . . . . 63.04 112.149 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.28 127.22 11.02 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.85 2.366 . . . . 63.41 110.953 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -141.19 176.27 21.78 Favored Glycine 0 C--N 1.335 0.514 0 CA-C-N 116.443 -0.344 . . . . 74.25 112.808 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -100.33 162.21 13.1 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.279 1.032 . . . . 74.25 111.373 -172.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 37.7 tp -117.05 112.7 21.29 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 124.588 1.155 . . . . 74.43 108.033 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 66.9 mt -84.02 100.3 10.98 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.745 -0.835 . . . . 70.35 108.745 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.519 HD22 HD11 ' A' ' 99' ' ' LEU . 91.9 mt -96.89 99.7 11.24 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.075 0.55 . . . . 75.33 110.083 -179.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 7.6 p -93.55 125.58 46.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 N-CA-C 109.444 -0.576 . . . . 74.12 109.444 176.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.8 137.63 23.07 Favored 'Isoleucine or valine' 0 C--O 1.249 1.043 0 C-N-CA 123.299 0.639 . . . . 70.21 109.5 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.529 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 22.3 mmm-85 -115.81 97.84 6.34 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.817 -0.809 . . . . 73.12 108.817 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 55.1 mt -119.56 131.9 55.62 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.91 0.884 . . . . 74.31 109.669 179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 90.6 mt -62.01 138.81 95.83 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 115.349 -0.841 . . . . 73.44 110.713 -175.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -50.92 -35.21 48.76 Favored 'Trans proline' 0 C--N 1.385 2.456 0 C-N-CA 123.762 2.975 . . . . 74.4 113.332 178.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 . . . . . 0 C--O 1.253 1.275 0 N-CA-C 107.785 -1.191 . . . . 65.01 107.785 168.831 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.427 ' SD ' ' N ' ' A' ' 94' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 109.086 -0.709 . . . . 75.15 109.086 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.3 m -67.84 115.97 7.98 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 109.449 -0.574 . . . . 65.31 109.449 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 98.6 m -65.18 144.83 56.94 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.702 0.801 . . . . 71.43 110.737 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.663 HD12 ' HB2' ' A' ' 123' ' ' LEU . 11.2 pt -117.41 161.07 16.5 Favored 'Isoleucine or valine' 0 C--O 1.245 0.854 0 CA-C-N 115.659 -0.7 . . . . 74.3 109.23 -174.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -136.69 129.7 31.02 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.725 0.81 . . . . 42.42 109.159 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.679 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.2 tp -68.78 149.67 48.74 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.956 1.303 . . . . 74.15 109.935 -174.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.22 -34.58 55.98 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.519 0.328 . . . . 73.21 110.949 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 70.3 mt 52.1 69.31 0.69 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.064 0.946 . . . . 71.43 111.059 -175.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 63.2 mt -69.14 161.09 75.45 Favored Pre-proline 0 CA--C 1.558 1.277 0 CA-C-N 115.33 -0.85 . . . . 70.42 109.913 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -62.28 164.18 18.23 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.241 1.961 . . . . 73.43 112.941 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.416 ' HB3' ' HD2' ' A' ' 117' ' ' ARG . 3.6 pp -64.1 126.65 28.41 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.953 -0.758 . . . . 55.43 108.953 175.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -145.32 -115.77 0.99 Allowed Glycine 0 C--N 1.338 0.691 0 N-CA-C 111.582 -0.607 . . . . 74.43 111.582 -170.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 17.5 t -98.68 115.19 28.16 Favored 'General case' 0 C--O 1.244 0.809 0 N-CA-C 108.615 -0.883 . . . . 73.23 108.615 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -171.5 -173.31 38.34 Favored Glycine 0 C--N 1.343 0.948 0 O-C-N 123.717 0.636 . . . . 74.23 111.835 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.15 21.85 77.37 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-O 120.008 -0.329 . . . . 53.02 113.426 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 70.2 p -80.6 110.39 16.03 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 109.773 -0.454 . . . . 73.13 109.773 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 167.94 132.13 1.38 Allowed Glycine 0 C--N 1.334 0.432 0 N-CA-C 110.56 -1.016 . . . . 73.12 110.56 178.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -79.56 66.54 3.5 Favored Glycine 0 C--N 1.346 1.095 0 C-N-CA 122.847 0.26 . . . . 42.34 112.508 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.5 t -158.77 35.26 0.22 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.297 1.039 . . . . 74.52 108.731 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 83.05 166.66 39.94 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.509 -0.769 . . . . 73.02 113.593 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -147.95 35.77 1.16 Allowed Glycine 0 C--N 1.354 1.552 0 C-N-CA 122.881 0.277 . . . . 50.33 112.505 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 73.6 m -81.72 71.41 8.74 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.482 0.658 . . . . 75.44 109.794 174.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -177.55 137.33 3.39 Favored Glycine 0 C--O 1.24 0.515 0 N-CA-C 110.362 -1.095 . . . . 44.11 110.362 -177.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.598 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 11.8 tpp180 -70.38 116.14 10.37 Favored 'General case' 0 C--O 1.244 0.782 0 C-N-CA 123.297 0.639 . . . . 72.41 110.103 -177.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -73.8 128.2 34.87 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 114.839 -1.073 . . . . 72.24 109.102 175.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.4 tt -134.79 114.85 13.04 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 106.335 -1.728 . . . . 72.32 106.335 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -90.31 138.05 31.85 Favored 'General case' 0 CA--C 1.52 -0.175 0 N-CA-C 107.605 -1.257 . . . . 75.43 107.605 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.679 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -157.25 131.83 8.61 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.253 -0.647 . . . . 72.35 109.253 -170.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -120.73 126.38 50.03 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 109.068 -0.716 . . . . 74.51 109.068 -170.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.663 ' HB2' HD12 ' A' ' 97' ' ' ILE . 3.9 pp -100.81 118.78 59.99 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 109.325 -0.62 . . . . 72.05 109.325 -177.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.559 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 74.1 Cg_endo -73.69 111.63 3.34 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.542 2.162 . . . . 53.45 109.344 171.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.502 HD21 HD12 ' A' ' 149' ' ' ILE . 28.2 tp -102.47 149.77 24.04 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 109.015 -0.735 . . . . 63.41 109.015 -168.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.6 t -95.57 158.53 15.41 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-N 115.913 -0.585 . . . . 43.33 109.479 -177.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 82.1 mt -64.3 -30.45 71.5 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.469 0.708 . . . . 73.13 112.13 -175.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.07 -48.33 82.18 Favored 'General case' 0 C--O 1.216 -0.701 0 O-C-N 123.904 0.753 . . . . 65.4 109.507 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.478 ' HG3' ' HD2' ' A' ' 136' ' ' ARG . 8.2 mm-40 -75.54 -30.95 59.9 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.51 0.724 . . . . 74.24 111.367 -175.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.87 -26.11 64.97 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 122.878 0.471 . . . . 61.31 111.044 174.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -83.96 -47.99 10.43 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.837 0.855 . . . . 72.0 110.452 176.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -67.68 -49.55 62.21 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.196 0.598 . . . . 65.3 110.283 -174.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.503 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 62.86 62.17 5.75 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-N 114.49 -1.232 . . . . 55.45 112.318 -173.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -129.26 -163.69 11.27 Favored Glycine 0 C--N 1.34 0.768 0 N-CA-C 111.769 -0.532 . . . . 42.15 111.769 -177.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -73.6 118.68 16.83 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.379 -0.971 . . . . 72.42 108.379 177.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.608 HH21 ' HB ' ' A' ' 137' ' ' VAL . 5.8 tpm_? -111.67 122.76 48.68 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.484 -0.932 . . . . 72.22 108.484 177.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.608 ' HB ' HH21 ' A' ' 136' ' ' ARG . 71.4 t -71.88 113.71 9.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-N 114.576 -1.193 . . . . 62.34 110.159 176.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.77 110.2 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 106.889 -1.522 . . . . 74.21 106.889 174.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -118.19 121.23 39.96 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 109.62 -0.511 . . . . 73.44 109.62 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 1.5 m -149.34 142.59 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 125.197 1.399 . . . . 62.51 109.69 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.35 25.58 15.27 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 124.696 1.198 . . . . 64.14 111.559 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 73.07 10.76 78.49 Favored Glycine 0 C--N 1.355 1.615 0 CA-C-N 115.681 -0.691 . . . . 75.21 113.567 -175.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 58.7 ttt85 -114.03 125.0 53.51 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.937 0.895 . . . . 75.41 109.066 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 25.4 ttm180 -105.42 126.08 51.72 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.754 0.822 . . . . 74.41 109.738 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 4.4 p -127.98 123.35 60.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 124.269 1.027 . . . . 72.42 108.803 176.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 30.0 t -99.65 104.29 16.04 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.013 -0.736 . . . . 74.42 109.013 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.1 p -101.0 123.17 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.188 0.595 . . . . 72.34 110.545 -176.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -76.44 116.06 16.77 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 109.052 -0.721 . . . . 72.54 109.052 172.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.503 HG13 ' HA2' ' A' ' 133' ' ' GLY . 10.6 pt -96.87 151.02 37.55 Favored Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 124.319 1.047 . . . . 71.0 109.006 175.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.42 145.96 49.11 Favored 'Trans proline' 0 CA--C 1.565 2.048 0 C-N-CA 122.322 2.015 . . . . 65.41 112.74 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -64.68 114.4 2.73 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 123.248 2.632 . . . . 73.15 112.105 175.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 87.82 31.26 15.68 Favored Glycine 0 C--N 1.341 0.83 0 O-C-N 123.333 0.396 . . . . 62.43 112.333 -174.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -61.89 149.85 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 123.834 0.853 . . . . 75.51 110.221 173.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -134.41 154.24 51.48 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.665 0.786 . . . . 72.54 110.756 -174.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -40.51 131.54 2.23 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 126.726 2.01 . . . . 71.15 113.397 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.34 -9.81 69.46 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-O 119.215 -0.769 . . . . 31.31 114.596 175.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 27.1 t -62.34 122.86 16.73 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.394 0.678 . . . . 74.15 110.067 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.1 t -102.51 109.28 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.58 0.752 . . . . 72.11 109.832 -177.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 59.5 mt -92.98 113.5 28.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 108.628 -0.878 . . . . 64.02 108.628 173.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -86.6 116.95 25.06 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 122.911 0.484 . . . . 63.54 110.118 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.493 HG13 ' HB3' ' A' ' 174' ' ' LEU . 7.2 p -125.75 102.72 28.49 Favored Pre-proline 0 CA--C 1.564 1.482 0 C-N-CA 123.253 0.621 . . . . 74.32 110.486 175.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 51.4 Cg_endo -68.15 154.86 71.41 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 123.049 2.5 . . . . 53.22 112.873 176.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 84.06 -15.15 40.0 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 116.105 -0.498 . . . . 73.21 114.178 178.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 24.3 mmt -99.02 -13.9 19.68 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.72 0.808 . . . . 65.34 111.763 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.41 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -79.54 -113.05 0.24 Allowed Glycine 0 C--N 1.351 1.362 0 O-C-N 123.593 0.558 . . . . 72.0 112.623 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.598 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -66.83 117.59 9.46 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 116.651 0.225 . . . . 73.23 113.452 177.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -88.42 131.42 34.87 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.636 0.774 . . . . 52.42 109.737 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 165.55 -160.68 34.13 Favored Glycine 0 N--CA 1.468 0.775 0 N-CA-C 110.316 -1.114 . . . . 53.14 110.316 -176.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -70.77 -35.84 4.79 Favored Pre-proline 0 CA--C 1.566 1.589 0 CA-C-O 117.715 -1.136 . . . . 73.31 112.247 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -91.33 128.9 1.21 Allowed 'Trans proline' 0 C--N 1.402 3.362 0 C-N-CA 122.466 2.111 . . . . 64.45 110.617 170.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.88 122.21 9.32 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 121.413 1.409 . . . . 74.51 110.844 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -90.81 146.03 18.2 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.722 -0.672 . . . . 54.42 112.242 -176.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 16.7 t70 -91.38 146.61 23.67 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.934 0.493 . . . . 74.24 110.239 -176.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.493 ' HB3' HG13 ' A' ' 161' ' ' VAL . 22.5 tp -123.67 111.17 15.88 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.398 0.679 . . . . 72.22 109.95 -176.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 75.6 mt -90.36 101.01 13.74 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.995 0.918 . . . . 74.11 110.069 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 79.8 mt -86.22 101.73 13.29 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.501 0.72 . . . . 73.14 110.664 -177.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 47.4 t -90.65 115.96 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.386 -0.968 . . . . 74.25 108.386 174.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.3 p -71.66 138.88 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 109.814 -0.439 . . . . 62.22 109.814 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.559 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 27.0 mmt180 -120.05 94.37 4.37 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.8 0.84 . . . . 64.03 109.229 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 51.7 mt -106.71 140.82 38.95 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.072 -0.967 . . . . 74.23 109.738 177.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 90.0 mt -68.67 155.28 93.36 Favored Pre-proline 0 CA--C 1.556 1.202 0 CA-C-N 114.922 -1.036 . . . . 54.12 110.35 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -76.41 35.66 0.47 Allowed 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 123.178 2.585 . . . . 64.2 113.574 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 59.2 m80 . . . . . 0 C--O 1.252 1.221 0 N-CA-C 107.683 -1.229 . . . . 73.44 107.683 176.386 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.591 ' HB2' HH12 ' A' ' 136' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 121.0 0.428 . . . . 64.3 110.688 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.4 m -80.87 133.33 35.56 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 109.355 -0.609 . . . . 64.33 109.355 175.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 94.8 m -70.49 145.43 50.93 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 123.482 0.713 . . . . 72.15 110.746 176.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.602 HD12 ' HB2' ' A' ' 123' ' ' LEU . 23.6 pt -123.15 175.96 5.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 C-N-CA 123.647 0.779 . . . . 72.45 110.022 -176.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.422 ' O ' ' HD2' ' A' ' 124' ' ' PRO . . . -128.79 167.67 16.98 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.819 0.848 . . . . 35.21 109.391 176.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.532 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.5 tp -110.41 148.83 31.22 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 108.602 -0.888 . . . . 64.01 108.602 -177.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.27 -47.21 51.84 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.409 0.284 . . . . 54.45 110.66 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.6 mt 57.09 75.08 0.38 Allowed 'General case' 0 N--CA 1.478 0.929 0 O-C-N 124.47 1.107 . . . . 72.13 110.591 -170.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.7 mt -76.74 164.05 61.84 Favored Pre-proline 0 CA--C 1.553 1.076 0 CA-C-N 114.232 -1.349 . . . . 74.45 109.045 174.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -61.2 168.69 7.29 Favored 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 121.858 1.705 . . . . 75.55 112.812 175.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -58.2 -28.88 65.22 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.232 1.013 . . . . 62.13 111.12 176.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 62.65 -89.84 0.06 OUTLIER Glycine 0 C--N 1.361 1.947 0 O-C-N 123.937 0.773 . . . . 54.15 112.223 178.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 33.7 t -141.39 -27.89 0.67 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.105 0.962 . . . . 73.42 109.716 173.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.41 -82.12 1.29 Allowed Glycine 0 C--N 1.346 1.126 0 CA-C-N 115.815 -0.63 . . . . 73.52 112.032 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.52 -1.87 41.76 Favored Glycine 0 CA--C 1.534 1.281 0 N-CA-C 114.483 0.553 . . . . 54.22 114.483 174.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.2 m -90.14 -28.18 19.11 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.413 0.685 . . . . 74.44 110.569 -174.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -117.11 102.9 1.05 Allowed Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.32 -0.854 . . . . 74.3 111.105 174.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -60.78 -35.58 90.21 Favored Glycine 0 C--N 1.353 1.52 0 C-N-CA 122.845 0.259 . . . . 45.23 112.859 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.2 m -93.51 53.05 1.81 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.778 0.831 . . . . 72.31 109.555 173.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -75.07 81.43 0.91 Allowed Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.204 -0.907 . . . . 63.23 112.468 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.74 -47.16 0.05 OUTLIER Glycine 0 C--N 1.341 0.807 0 N-CA-C 110.936 -0.866 . . . . 65.42 110.936 176.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 29.5 m -84.44 5.39 27.5 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.234 0.614 . . . . 71.44 111.239 176.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -168.68 130.41 2.07 Favored Glycine 0 C--N 1.351 1.399 0 N-CA-C 112.063 -0.415 . . . . 71.52 112.063 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -94.58 133.87 37.75 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.112 0.565 . . . . 54.01 110.706 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -83.91 133.18 34.72 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.563 -0.903 . . . . 55.2 108.563 169.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.5 tt -132.69 134.21 44.52 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 107.452 -1.314 . . . . 74.42 107.452 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -92.05 127.86 37.68 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.808 -0.812 . . . . 72.2 108.808 -175.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.532 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -149.75 132.56 16.01 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.86 -0.422 . . . . 72.33 109.86 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -127.91 125.34 39.41 Favored 'General case' 0 C--O 1.245 0.839 0 N-CA-C 109.743 -0.466 . . . . 74.13 109.743 -172.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.602 ' HB2' HD12 ' A' ' 97' ' ' ILE . 3.7 pp -101.96 119.88 55.52 Favored Pre-proline 0 CA--C 1.542 0.653 0 N-CA-C 109.299 -0.63 . . . . 64.01 109.299 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.422 ' HD2' ' O ' ' A' ' 98' ' ' ALA . 62.8 Cg_endo -72.74 115.34 4.31 Favored 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 122.721 2.28 . . . . 73.21 108.985 167.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.431 HD21 HD12 ' A' ' 149' ' ' ILE . 47.7 tp -102.2 150.26 23.47 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 109.79 -0.448 . . . . 64.35 109.79 -168.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.7 t -89.12 155.19 19.59 Favored 'General case' 0 CA--C 1.559 1.309 0 C-N-CA 123.447 0.699 . . . . 72.3 109.496 -175.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.8 mt -60.89 -35.24 76.14 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.494 1.117 . . . . 71.4 112.87 -171.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -61.52 -46.83 88.31 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.388 -0.597 . . . . 73.05 109.388 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.402 ' HG3' ' HD2' ' A' ' 136' ' ' ARG . 15.8 mm-40 -77.42 -22.39 51.59 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 114.245 -1.343 . . . . 71.1 112.153 -177.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.0 -51.69 68.59 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 123.586 0.554 . . . . 73.33 110.401 173.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -81.06 -50.45 9.64 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 115.508 -0.769 . . . . 71.12 111.887 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -65.93 -45.02 83.39 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.235 0.614 . . . . 72.04 111.813 -175.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.479 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 73.24 -145.52 36.25 Favored Glycine 0 C--N 1.342 0.899 0 O-C-N 123.441 0.463 . . . . 73.12 112.092 -175.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.93 -147.09 25.98 Favored Glycine 0 C--N 1.345 1.041 0 O-C-N 123.687 0.286 . . . . 74.13 112.808 177.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -85.09 121.9 28.52 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.236 0.614 . . . . 74.45 109.78 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.591 HH12 ' HB2' ' A' ' 94' ' ' MET . 5.0 tpm_? -112.03 123.44 50.27 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 108.912 -0.774 . . . . 73.11 108.912 175.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.468 ' HB ' ' NH2' ' A' ' 136' ' ' ARG . 84.8 t -76.11 111.4 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 114.88 -1.055 . . . . 71.12 109.519 173.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 32.0 t -107.7 129.56 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 107.359 -1.348 . . . . 72.42 107.359 172.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -115.58 116.48 28.22 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 109.36 -0.607 . . . . 74.21 109.36 175.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.8 p -150.02 142.47 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 123.87 0.868 . . . . 54.01 109.179 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 63.69 19.16 11.58 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.239 1.016 . . . . 55.41 112.156 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 82.28 7.41 87.71 Favored Glycine 0 C--N 1.353 1.499 0 CA-C-N 116.214 -0.448 . . . . 53.02 113.04 -176.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 19.9 ttm-85 -114.58 143.02 45.66 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.056 0.943 . . . . 74.24 110.388 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.442 ' HG3' HG13 ' A' ' 137' ' ' VAL . 12.4 ttp180 -96.4 113.72 25.33 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.592 -0.892 . . . . 72.1 108.592 173.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 25.8 t -105.41 112.09 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 108.243 -1.021 . . . . 73.12 108.243 172.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 35.8 t -90.29 108.59 19.86 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 107.961 -1.126 . . . . 62.01 107.961 175.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 34.3 m -104.61 145.69 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.508 0.723 . . . . 65.21 110.656 -176.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -93.19 96.04 9.77 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 108.791 -0.818 . . . . 73.24 108.791 175.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.479 HG13 ' HA2' ' A' ' 133' ' ' GLY . 24.0 pt -85.51 135.53 38.4 Favored Pre-proline 0 CA--C 1.554 1.131 0 CA-C-N 115.596 -0.729 . . . . 53.1 109.18 172.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.406 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 38.3 Cg_endo -68.07 141.07 51.63 Favored 'Trans proline' 0 CA--C 1.565 2.027 0 C-N-CA 122.338 2.025 . . . . 72.52 112.438 178.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 150' ' ' PRO . 47.2 Cg_exo -60.2 113.7 1.78 Allowed 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 123.148 2.566 . . . . 72.23 112.14 173.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 86.61 32.59 15.25 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.359 -0.696 . . . . 63.43 111.359 -173.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 5.5 p -62.67 144.49 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 123.608 0.763 . . . . 75.12 109.682 172.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -132.01 161.36 33.36 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.77 0.428 . . . . 73.12 110.473 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -43.17 129.04 4.7 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 125.536 1.773 . . . . 72.02 112.91 -176.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 102.68 -13.06 56.58 Favored Glycine 0 C--N 1.347 1.166 0 CA-C-O 119.259 -0.745 . . . . 74.42 114.119 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.0 t -62.46 120.6 11.4 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 117.589 0.695 . . . . 74.25 109.698 178.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 176' ' ' LEU . 3.1 p -115.01 112.31 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 121.539 0.685 . . . . 62.25 110.36 -172.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 59.1 mt -90.23 102.92 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 107.965 -1.124 . . . . 55.23 107.965 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -81.21 99.96 8.86 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.8 -0.815 . . . . 75.23 108.8 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.2 p -103.73 118.86 56.35 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 122.845 0.458 . . . . 60.43 109.953 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.51 155.71 59.15 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.9 2.4 . . . . 75.42 112.287 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 81.24 -24.4 4.13 Favored Glycine 0 CA--C 1.535 1.3 0 N-CA-C 114.31 0.484 . . . . 62.24 114.31 176.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.1 mmt -88.17 -27.26 21.96 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.727 0.811 . . . . 74.15 112.024 -172.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -70.27 -78.36 0.4 Allowed Glycine 0 C--N 1.345 1.053 0 N-CA-C 111.361 -0.696 . . . . 75.31 111.361 175.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -71.16 110.84 3.41 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 111.0 -0.84 . . . . 42.52 111.0 167.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -89.45 151.61 21.92 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.709 0.804 . . . . 43.44 110.457 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 81.29 -125.77 7.05 Favored Glycine 0 C--N 1.342 0.902 0 CA-C-N 115.831 -0.622 . . . . 60.1 113.224 174.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.44 ' O ' ' HD3' ' A' ' 171' ' ' PRO . 28.3 t-20 -62.84 -48.64 84.89 Favored Pre-proline 0 CA--C 1.564 1.49 0 C-N-CA 123.972 0.909 . . . . 71.24 113.01 -174.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -96.84 95.58 0.08 OUTLIER 'Trans proline' 0 C--N 1.392 2.834 0 C-N-CA 122.633 2.222 . . . . 73.43 113.082 176.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 169' ' ' ASN . 11.3 Cg_exo -70.33 121.96 8.51 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 121.988 1.792 . . . . 75.31 110.239 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -134.93 179.76 17.32 Favored Glycine 0 C--N 1.343 0.919 0 C-N-CA 121.67 -0.3 . . . . 65.11 113.108 -172.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -96.11 119.79 35.23 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.51 0.671 . . . . 63.01 112.124 -167.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.3 tp -89.38 111.66 22.57 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.018 -0.992 . . . . 61.55 108.529 173.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 60.8 mt -83.95 99.55 10.46 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.562 0.745 . . . . 74.0 109.048 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 158' ' ' VAL . 91.7 mt -91.05 98.67 11.91 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 123.633 0.583 . . . . 72.24 110.884 -175.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 23.7 t -90.71 123.05 42.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 109.161 -0.681 . . . . 45.34 109.161 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.6 p -74.94 132.94 32.51 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 109.125 -0.694 . . . . 74.21 109.125 177.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.418 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 34.6 mmt180 -118.57 92.9 3.93 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.323 -0.991 . . . . 75.52 108.323 -179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 26.3 mt -101.02 131.48 46.87 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.616 -0.72 . . . . 63.34 110.608 -176.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.47 136.25 96.62 Favored Pre-proline 0 CA--C 1.549 0.919 0 CA-C-N 114.778 -1.101 . . . . 74.43 109.889 178.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.4 5.4 1.57 Allowed 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 122.759 2.306 . . . . 74.12 113.683 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 . . . . . 0 C--O 1.25 1.113 0 C-N-CA 123.897 0.879 . . . . 74.2 108.77 170.796 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.416 ' HB3' ' NH2' ' A' ' 136' ' ' ARG . 1.1 mpt? . . . . . 0 N--CA 1.484 1.269 0 N-CA-C 109.267 -0.642 . . . . 73.35 109.267 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.4 t -69.92 140.41 53.08 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-N 115.734 -0.667 . . . . 64.41 111.058 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.461 ' HA ' HH11 ' A' ' 136' ' ' ARG . 28.6 m -78.39 148.62 33.59 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.775 0.83 . . . . 62.52 109.596 174.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.743 HD12 ' HB2' ' A' ' 123' ' ' LEU . 26.1 pt -118.03 168.61 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 123.334 0.653 . . . . 55.33 110.382 -171.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -136.74 127.38 27.05 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.37 0.668 . . . . 54.2 110.258 -176.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.549 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.5 tp -80.57 157.02 26.18 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 124.07 0.948 . . . . 54.52 110.866 -168.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.457 ' HB3' ' H ' ' A' ' 122' ' ' GLU . . . -77.18 -54.08 6.95 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.631 0.372 . . . . 64.44 110.852 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.0 mt 55.46 84.71 0.07 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.187 0.995 . . . . 73.35 110.796 -168.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.5 mt -100.6 122.43 49.53 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 125.103 1.361 . . . . 44.11 109.219 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -69.41 161.67 44.96 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.678 2.252 . . . . 72.22 112.869 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -74.62 110.16 8.69 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.895 0.878 . . . . 72.24 111.447 -175.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.6 55.41 11.92 Favored Glycine 0 C--N 1.343 0.944 0 O-C-N 123.945 0.778 . . . . 63.31 113.138 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.7 m -71.9 -32.83 67.8 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.028 0.531 . . . . 71.35 109.885 174.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -164.83 40.49 0.3 Allowed Glycine 0 C--N 1.342 0.885 0 N-CA-C 109.553 -1.419 . . . . 52.43 109.553 171.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.31 -167.29 12.34 Favored Glycine 0 C--N 1.35 1.344 0 N-CA-C 111.224 -0.751 . . . . 73.13 111.224 -169.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.41 ' HB3' HH11 ' A' ' 120' ' ' ARG . 51.0 m 59.26 29.45 19.02 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.915 0.886 . . . . 51.4 112.598 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -140.38 96.06 0.21 Allowed Glycine 0 C--N 1.347 1.154 0 N-CA-C 110.231 -1.148 . . . . 75.53 110.231 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -70.08 -76.34 0.52 Allowed Glycine 0 C--N 1.349 1.292 0 N-CA-C 111.911 -0.476 . . . . 61.11 111.911 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.7 m -154.09 166.17 33.89 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.783 0.833 . . . . 65.32 109.894 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 170.23 74.79 0.04 OUTLIER Glycine 0 C--N 1.348 1.245 0 C-N-CA 121.726 -0.273 . . . . 70.14 112.882 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -92.77 -71.79 1.18 Allowed Glycine 0 C--N 1.349 1.257 0 N-CA-C 111.872 -0.491 . . . . 72.21 111.872 177.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 31.6 p -77.73 -27.59 50.55 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.583 0.753 . . . . 74.32 111.905 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -135.46 79.81 0.32 Allowed Glycine 0 C--N 1.336 0.561 0 N-CA-C 109.847 -1.301 . . . . 74.54 109.847 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.8 ttp180 -72.19 117.49 13.89 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.238 0.542 . . . . 75.52 111.132 -177.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -91.7 107.28 19.1 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.71 -1.132 . . . . 72.55 107.974 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.8 tt -91.95 129.84 37.83 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 106.237 -1.764 . . . . 75.21 106.237 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.41 HH11 ' HB3' ' A' ' 109' ' ' SER . 56.8 ttt180 -90.55 120.57 31.75 Favored 'General case' 0 C--O 1.213 -0.854 0 N-CA-C 107.998 -1.112 . . . . 73.12 107.998 -174.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.549 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -140.37 130.74 25.26 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.331 -0.618 . . . . 72.5 109.331 -174.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.496 ' HG2' ' HB ' ' A' ' 177' ' ' VAL . 84.9 mt-10 -120.63 120.96 37.26 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.316 -0.624 . . . . 64.35 109.316 -167.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.743 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.4 pp -103.13 118.71 57.34 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 109.522 -0.547 . . . . 74.53 109.522 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -74.27 113.76 3.87 Favored 'Trans proline' 0 C--N 1.368 1.601 0 C-N-CA 122.819 2.346 . . . . 74.53 109.37 169.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.573 HD21 HD12 ' A' ' 149' ' ' ILE . 29.4 tp -103.75 143.92 32.17 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 110.151 -0.314 . . . . 73.25 110.151 -166.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 3.4 t -83.35 155.89 23.31 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 115.446 -0.797 . . . . 71.14 109.856 -176.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.2 mt -63.52 -30.98 72.02 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 124.072 0.949 . . . . 63.23 112.304 -173.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.55 -43.59 89.42 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.763 0.664 . . . . 74.05 109.52 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.414 ' HB3' HD11 ' A' ' 149' ' ' ILE . 69.6 mm-40 -77.74 -32.65 52.87 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.014 -0.994 . . . . 64.44 111.904 -178.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.46 -49.19 74.65 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.489 0.661 . . . . 54.45 111.152 177.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -74.21 -59.76 2.58 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.251 -1.341 . . . . 73.42 110.595 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -72.81 -44.26 61.69 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.662 -0.699 . . . . 74.13 111.727 -172.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.39 178.12 50.82 Favored Glycine 0 C--N 1.351 1.399 0 O-C-N 123.629 0.581 . . . . 74.12 113.161 -175.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 127.76 -156.79 20.77 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.934 -0.466 . . . . 53.02 111.934 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.419 ' HB3' ' OG ' ' A' ' 146' ' ' SER . 3.1 mp0 -88.47 123.07 32.63 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.822 -0.807 . . . . 64.33 108.822 173.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.461 HH11 ' HA ' ' A' ' 96' ' ' THR . 8.3 tpp180 -116.29 122.42 44.89 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.484 0.714 . . . . 74.22 109.89 176.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.6 t -70.49 126.64 31.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 O-C-N 124.105 0.878 . . . . 75.42 109.783 175.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.74 134.83 64.76 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 124.699 1.2 . . . . 71.22 108.667 174.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -124.77 125.11 43.52 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.429 1.092 . . . . 71.15 109.763 -174.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.3 p -151.63 129.93 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 123.14 0.576 . . . . 75.02 110.785 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.82 20.04 11.1 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 123.997 0.919 . . . . 73.13 112.71 176.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 94.07 -13.29 67.69 Favored Glycine 0 C--N 1.353 1.498 0 CA-C-N 116.403 -0.362 . . . . 71.22 112.989 -175.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -90.82 117.97 29.86 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.565 1.146 . . . . 73.04 109.237 -175.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 59.7 ttp180 -114.92 129.61 56.74 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.566 0.746 . . . . 65.24 110.197 -176.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.14 144.78 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.974 0.909 . . . . 75.54 109.506 177.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.419 ' OG ' ' HB3' ' A' ' 135' ' ' GLU . 11.0 t -100.8 120.75 40.58 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 109.017 -0.734 . . . . 52.03 109.017 177.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 6.3 p -100.11 129.53 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.446 0.698 . . . . 71.14 110.332 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -75.92 99.51 4.54 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 109.206 -0.665 . . . . 73.13 109.206 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.573 HD12 HD21 ' A' ' 125' ' ' LEU . 10.4 pt -86.32 142.79 35.84 Favored Pre-proline 0 CA--C 1.555 1.162 0 CA-C-N 115.356 -0.838 . . . . 74.42 110.063 173.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -66.05 135.62 41.39 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.449 2.1 . . . . 72.44 112.11 172.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -55.57 124.42 16.23 Favored 'Trans proline' 0 C--N 1.367 1.504 0 C-N-CA 122.619 2.213 . . . . 65.04 111.524 166.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 81.51 24.42 56.47 Favored Glycine 0 CA--C 1.533 1.196 0 O-C-N 123.314 0.384 . . . . 62.11 112.63 -174.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 6.7 p -62.29 139.19 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.622 0.769 . . . . 74.21 109.7 173.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 74.2 mtt85 -127.34 152.57 47.3 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.339 0.656 . . . . 72.05 110.419 -174.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -40.67 132.01 2.25 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.475 1.91 . . . . 74.43 113.144 -178.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.86 -6.94 77.03 Favored Glycine 0 C--N 1.352 1.434 0 CA-C-O 119.658 -0.523 . . . . 63.22 113.992 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 29.2 m -63.0 130.27 43.97 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.216 0.606 . . . . 55.12 110.24 172.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 5.8 p -117.91 116.48 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 CA-C-O 121.312 0.577 . . . . 70.5 110.37 -177.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.412 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 58.8 mt -95.3 103.04 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.864 0.866 . . . . 54.55 108.672 176.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -80.16 109.85 15.01 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.142 0.577 . . . . 72.23 109.742 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.548 HG13 ' HB3' ' A' ' 174' ' ' LEU . 1.7 p -109.04 111.32 60.55 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 123.489 0.716 . . . . 50.45 109.266 173.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -67.56 151.7 79.29 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 123.239 2.626 . . . . 75.44 113.571 -177.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 66.6 24.7 72.63 Favored Glycine 0 C--N 1.356 1.673 0 O-C-N 123.772 0.67 . . . . 61.33 113.662 175.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.447 ' HB3' ' HB2' ' A' ' 174' ' ' LEU . 8.2 tpt -119.81 -33.79 3.91 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.263 0.625 . . . . 75.02 110.154 -171.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -91.69 -69.73 1.17 Allowed Glycine 0 C--N 1.35 1.341 0 CA-C-N 116.44 -0.346 . . . . 65.31 112.31 -177.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -62.77 90.42 0.07 OUTLIER Glycine 0 C--N 1.349 1.274 0 N-CA-C 111.46 -0.656 . . . . 54.34 111.46 169.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 10.8 mm-40 -92.28 170.37 9.85 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.249 1.02 . . . . 74.52 111.195 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 89.74 -145.5 18.33 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 115.251 -0.886 . . . . 74.24 112.179 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -78.99 -36.98 1.21 Allowed Pre-proline 0 CA--C 1.565 1.542 0 CA-C-O 118.288 -0.863 . . . . 50.51 112.083 177.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -82.68 110.38 1.88 Allowed 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 121.725 1.617 . . . . 74.14 111.314 166.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -74.62 166.82 28.52 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.619 2.213 . . . . 74.43 112.583 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 173.34 174.75 40.6 Favored Glycine 0 C--N 1.346 1.109 0 N-CA-C 114.079 0.392 . . . . 63.52 114.079 170.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -91.04 166.8 12.81 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.639 1.176 . . . . 64.53 111.088 -167.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.548 ' HB3' HG13 ' A' ' 161' ' ' VAL . 34.8 tp -124.11 118.27 26.54 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 108.562 -0.903 . . . . 74.11 108.562 177.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 82.6 mt -92.91 101.88 14.24 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.522 0.729 . . . . 64.11 109.649 -178.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.412 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 94.9 mt -89.21 99.75 12.67 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.25 0.62 . . . . 72.23 111.028 -177.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.496 ' HB ' ' HG2' ' A' ' 122' ' ' GLU . 49.5 t -89.23 112.61 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 123.373 0.669 . . . . 75.24 109.493 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.3 p -68.02 133.56 31.49 Favored 'Isoleucine or valine' 0 C--O 1.249 1.074 0 N-CA-C 109.712 -0.477 . . . . 71.03 109.712 177.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -123.43 96.04 4.82 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.353 1.061 . . . . 73.52 108.471 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 180' ' ' LEU . 35.7 mt -96.84 140.81 30.84 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.642 -0.708 . . . . 74.05 111.756 -174.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 71.0 mt -61.93 146.79 90.92 Favored Pre-proline 0 CA--C 1.553 1.058 0 CA-C-N 114.303 -1.317 . . . . 73.34 110.07 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -77.16 31.56 0.42 Allowed 'Trans proline' 0 CA--C 1.559 1.726 0 C-N-CA 122.849 2.366 . . . . 74.42 113.859 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 . . . . . 0 C--O 1.251 1.154 0 C-N-CA 123.812 0.845 . . . . 71.12 109.756 173.373 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 35.2 mtp . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 108.022 -1.103 . . . . 73.44 108.022 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.477 ' H ' HG21 ' A' ' 126' ' ' THR . 16.3 m -60.28 -22.31 62.96 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.065 1.135 . . . . 64.32 114.065 -172.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 45.0 m 71.3 145.91 0.07 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.754 1.222 . . . . 43.53 110.842 -172.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.727 HD12 ' HB2' ' A' ' 123' ' ' LEU . 15.3 pt -128.08 166.19 25.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.728 0 C-N-CA 123.348 0.659 . . . . 75.05 110.861 -170.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.407 ' O ' ' HD2' ' A' ' 124' ' ' PRO . . . -126.4 151.33 47.81 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.333 1.053 . . . . 73.4 109.649 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.617 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.5 tp -100.91 155.14 18.12 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.892 0.477 . . . . 62.34 109.936 -170.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.44 ' HB3' ' H ' ' A' ' 122' ' ' GLU . . . -84.14 -40.54 18.08 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.249 0.619 . . . . 62.1 111.929 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 57.0 mt 48.69 66.18 1.15 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.004 0.922 . . . . 75.21 111.283 -172.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 76.1 mt -73.43 151.03 89.57 Favored Pre-proline 0 CA--C 1.548 0.89 0 CA-C-N 115.35 -0.841 . . . . 63.14 110.492 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.12 179.65 1.08 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.247 1.965 . . . . 50.33 112.595 171.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.8 pp -122.88 -169.72 1.97 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.963 0.905 . . . . 64.23 110.313 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 140.33 -41.18 1.31 Allowed Glycine 0 C--N 1.337 0.616 0 N-CA-C 110.13 -1.188 . . . . 62.43 110.13 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 13.6 t -145.99 -172.52 3.94 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.281 1.032 . . . . 73.14 108.475 175.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 112.21 -0.22 26.75 Favored Glycine 0 N--CA 1.47 0.961 0 N-CA-C 111.657 -0.577 . . . . 62.24 111.657 -174.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 148.89 165.49 12.27 Favored Glycine 0 C--N 1.351 1.364 0 N-CA-C 111.398 -0.681 . . . . 74.3 111.398 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.3 t -76.94 -8.86 58.14 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.31 0.644 . . . . 71.14 110.942 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 71.77 -149.25 44.53 Favored Glycine 0 C--N 1.356 1.654 0 N-CA-C 110.995 -0.842 . . . . 71.32 110.995 -174.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -106.34 9.95 42.51 Favored Glycine 0 N--CA 1.466 0.673 0 N-CA-C 111.47 -0.652 . . . . 61.25 111.47 173.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.2 m 64.25 178.98 0.17 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.91 1.284 . . . . 74.04 111.963 -177.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.93 -83.0 0.83 Allowed Glycine 0 C--N 1.349 1.271 0 CA-C-N 116.003 -0.544 . . . . 70.32 112.578 178.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 168.4 -45.96 0.23 Allowed Glycine 0 C--N 1.341 0.815 0 N-CA-C 111.78 -0.528 . . . . 64.51 111.78 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 28.3 p -64.55 136.88 57.48 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.801 0.84 . . . . 71.12 110.835 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.56 40.17 6.07 Favored Glycine 0 C--N 1.345 1.067 0 O-C-N 123.802 0.689 . . . . 55.13 111.679 -176.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.434 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 43.3 ttt180 -56.43 119.58 6.27 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.537 1.135 . . . . 71.51 112.556 -174.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -78.35 139.38 38.82 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.433 -0.803 . . . . 72.13 109.425 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.9 tt -132.7 126.1 31.78 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.175 -1.417 . . . . 44.21 107.175 177.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -91.59 136.14 33.35 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.361 0.665 . . . . 65.02 109.321 -176.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.617 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -154.37 146.87 24.04 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.466 0.706 . . . . 75.31 110.11 -176.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.44 ' H ' ' HB3' ' A' ' 100' ' ' ALA . 29.4 mt-10 -120.79 124.98 46.4 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 109.179 -0.674 . . . . 73.03 109.179 -176.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.727 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.5 pp -108.94 115.06 57.72 Favored Pre-proline 0 CA--C 1.551 0.981 0 N-CA-C 108.672 -0.862 . . . . 73.43 108.672 174.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.475 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 82.4 Cg_endo -78.15 114.74 3.62 Favored 'Trans proline' 0 C--N 1.365 1.437 0 C-N-CA 122.673 2.249 . . . . 73.12 109.124 170.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.525 HD21 HD12 ' A' ' 149' ' ' ILE . 25.5 tp -103.78 147.18 27.59 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.393 -0.595 . . . . 65.32 109.393 -166.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.477 HG21 ' H ' ' A' ' 95' ' ' SER . 11.3 t -92.63 162.97 13.96 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 109.718 -0.475 . . . . 63.22 109.718 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.5 mt -64.65 -37.02 86.15 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.85 0.86 . . . . 54.14 112.188 -168.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -59.83 -40.18 87.62 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 124.177 0.923 . . . . 75.42 109.68 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -76.92 -37.06 56.09 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-N 114.892 -1.049 . . . . 75.11 111.567 -173.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.9 -36.15 74.22 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-O 121.104 0.478 . . . . 64.43 110.384 172.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -77.16 -34.7 56.39 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 114.751 -1.113 . . . . 73.2 111.822 177.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 27.4 m80 -74.76 -51.16 14.9 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 117.926 0.33 . . . . 71.31 110.983 -176.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.429 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 58.62 68.11 1.86 Allowed Glycine 0 C--N 1.344 0.994 0 O-C-N 124.239 0.962 . . . . 44.35 112.307 -172.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.423 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -155.51 -146.33 4.41 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-O 120.055 -0.303 . . . . 72.5 112.529 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.3 mp0 -75.12 117.08 16.56 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.406 0.682 . . . . 72.23 109.685 -178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.667 HH21 ' HB ' ' A' ' 137' ' ' VAL . 4.5 tpm_? -116.56 123.74 48.12 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.113 0.965 . . . . 74.23 108.674 173.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.667 ' HB ' HH21 ' A' ' 136' ' ' ARG . 87.8 t -72.49 122.8 25.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 124.079 0.952 . . . . 64.51 110.341 174.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.601 ' HB ' HG13 ' A' ' 145' ' ' VAL . 21.4 t -112.6 126.95 70.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.551 -0.907 . . . . 72.14 108.551 174.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -109.16 110.43 21.66 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.831 0.853 . . . . 61.11 109.466 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 10.8 p -149.75 133.22 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 123.018 0.527 . . . . 75.41 110.541 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.64 18.68 10.75 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.513 1.125 . . . . 73.32 112.645 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.79 5.57 86.27 Favored Glycine 0 C--N 1.348 1.244 0 O-C-N 123.158 0.286 . . . . 40.2 113.232 -176.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -112.12 131.46 55.44 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.406 1.082 . . . . 72.13 109.806 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.556 ' HG3' HG13 ' A' ' 137' ' ' VAL . 39.6 ttm180 -90.22 113.98 25.89 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.124 0.97 . . . . 71.33 109.618 172.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.601 HG13 ' HB ' ' A' ' 138' ' ' VAL . 2.5 p -111.3 115.14 49.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 123.398 0.679 . . . . 54.24 109.21 169.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.6 t -86.78 115.23 24.07 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 109.19 -0.67 . . . . 74.44 109.19 175.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.6 p -100.83 124.38 54.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 123.612 0.765 . . . . 71.35 109.795 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 54.2 ttt85 -80.43 93.93 6.1 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.747 -1.205 . . . . 73.53 107.747 168.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.525 HD12 HD21 ' A' ' 125' ' ' LEU . 13.8 pt -74.31 143.94 80.64 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 123.824 0.85 . . . . 64.51 109.753 177.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.429 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 59.9 Cg_endo -72.8 149.07 47.39 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 122.225 1.95 . . . . 73.11 111.993 177.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 150' ' ' PRO . 31.9 Cg_exo -60.54 134.45 54.75 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 123.137 2.558 . . . . 70.15 112.122 177.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 65.83 29.31 74.81 Favored Glycine 0 C--N 1.353 1.506 0 O-C-N 123.697 0.623 . . . . 74.01 112.63 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -58.21 145.65 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 C-N-CA 124.053 0.941 . . . . 74.45 109.72 176.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -136.64 158.75 43.71 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.53 0.732 . . . . 72.12 110.415 -173.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -42.69 127.18 3.87 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 125.895 1.678 . . . . 52.21 112.838 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 91.27 -4.82 80.92 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 114.385 0.514 . . . . 64.02 114.385 177.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.6 t -67.62 122.32 17.8 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.242 -0.651 . . . . 71.2 109.242 176.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 46.5 t -101.99 117.06 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 109.427 -0.583 . . . . 73.53 109.427 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 37.5 mt -91.92 144.1 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 124.813 1.245 . . . . 71.42 107.968 173.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.547 HH11 HD21 ' A' ' 175' ' ' LEU . 49.0 ttt85 -118.09 116.75 27.49 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.188 -0.671 . . . . 73.32 109.188 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 174' ' ' LEU . 5.0 p -124.17 109.62 29.3 Favored Pre-proline 0 CA--C 1.558 1.266 0 C-N-CA 123.693 0.797 . . . . 53.14 110.531 -177.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -70.72 153.62 64.41 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 122.974 2.449 . . . . 72.44 112.628 -176.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.77 -13.83 54.67 Favored Glycine 0 C--N 1.339 0.719 0 CA-C-N 115.702 -0.681 . . . . 72.44 113.954 174.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 84.7 mmm -100.14 -12.42 19.64 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 117.404 0.602 . . . . 65.22 111.452 -176.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -83.04 -111.5 0.5 Allowed Glycine 0 C--N 1.353 1.485 0 CA-C-O 119.312 -0.716 . . . . 61.12 111.936 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.434 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -53.85 108.32 0.81 Allowed Glycine 0 C--N 1.353 1.489 0 O-C-N 124.003 0.472 . . . . 53.25 113.128 174.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -91.22 169.54 10.75 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.616 1.167 . . . . 73.4 110.396 175.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 94.59 -145.41 17.68 Favored Glycine 0 C--N 1.338 0.65 0 CA-C-N 115.388 -0.824 . . . . 73.02 112.147 175.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -69.13 -47.66 28.58 Favored Pre-proline 0 CA--C 1.561 1.384 0 CA-C-O 118.13 -0.938 . . . . 73.24 110.872 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.3 113.59 2.67 Favored 'Trans proline' 0 C--N 1.395 3.011 0 C-N-CA 122.232 1.955 . . . . 62.0 111.087 172.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -72.39 160.17 47.55 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.45 2.1 . . . . 74.34 111.418 177.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -161.01 -179.13 35.56 Favored Glycine 0 CA--C 1.504 -0.632 0 N-CA-C 114.732 0.653 . . . . 44.15 114.732 176.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -120.52 150.18 41.25 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.531 1.132 . . . . 75.31 109.641 -169.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.421 ' HB3' HG13 ' A' ' 161' ' ' VAL . 37.2 tp -117.1 114.1 23.24 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.563 0.745 . . . . 73.34 110.1 -172.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.547 HD21 HH11 ' A' ' 160' ' ' ARG . 92.8 mt -88.37 103.28 15.69 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.063 0.945 . . . . 74.21 110.162 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.534 HD22 HD11 ' A' ' 99' ' ' LEU . 77.0 mt -95.41 99.18 11.13 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.085 0.954 . . . . 74.24 110.615 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 8.5 p -90.37 133.4 32.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 109.372 -0.603 . . . . 74.14 109.372 175.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.3 p -87.58 144.81 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 123.238 0.615 . . . . 72.43 111.165 -171.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.475 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 35.5 mmt180 -119.25 99.74 6.89 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.742 1.217 . . . . 62.33 108.44 174.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 16.0 mt -118.86 145.86 45.35 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.973 0.909 . . . . 54.11 111.119 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 65.2 mt -70.25 132.07 88.23 Favored Pre-proline 0 CA--C 1.551 0.991 0 CA-C-N 114.541 -1.209 . . . . 73.32 109.423 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.15 -19.01 67.77 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.7 2.267 . . . . 51.2 113.118 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 . . . . . 0 C--O 1.252 1.215 0 C-N-CA 124.89 1.276 . . . . 71.43 108.24 177.699 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 49.8 mtt . . . . . 0 N--CA 1.484 1.264 0 N-CA-C 108.927 -0.768 . . . . 74.54 108.927 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.4 m -71.48 121.68 19.07 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.915 -0.772 . . . . 51.14 108.915 174.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 86.8 m -68.2 141.56 55.94 Favored 'General case' 0 C--N 1.35 0.63 0 C-N-CA 123.392 0.677 . . . . 72.05 110.39 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.588 HD12 ' HB2' ' A' ' 123' ' ' LEU . 14.2 pt -114.88 163.41 12.19 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 C-N-CA 123.057 0.543 . . . . 52.41 110.818 -170.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -123.15 -162.93 1.06 Allowed 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.399 -0.963 . . . . 45.44 108.399 170.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.488 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.5 tp -136.64 155.93 49.23 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.937 -0.764 . . . . 75.13 108.937 -175.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.87 -48.92 33.32 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 123.044 0.538 . . . . 50.1 110.723 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.585 HD11 ' HB ' ' A' ' 140' ' ' VAL . 60.2 mt 53.68 78.05 0.16 Allowed 'General case' 0 CA--C 1.546 0.809 0 O-C-N 124.469 1.106 . . . . 63.45 110.348 -171.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 60.9 mt -84.65 143.2 40.61 Favored Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 114.984 -1.007 . . . . 75.53 109.636 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.47 -173.48 0.56 Allowed 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 122.571 2.18 . . . . 72.21 112.952 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -53.76 133.21 42.23 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.944 0.898 . . . . 73.33 111.712 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -172.3 -110.68 0.25 Allowed Glycine 0 C--N 1.347 1.144 0 N-CA-C 111.94 -0.464 . . . . 51.32 111.94 -178.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.3 m -74.4 96.53 2.89 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.148 0.579 . . . . 74.12 110.06 177.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -160.67 -112.08 0.29 Allowed Glycine 0 C--N 1.35 1.359 0 CA-C-N 115.849 -0.614 . . . . 54.54 111.734 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.12 27.63 73.52 Favored Glycine 0 C--N 1.356 1.647 0 N-CA-C 112.21 -0.356 . . . . 44.5 112.21 -174.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.2 m -100.93 151.29 21.93 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.18 0.992 . . . . 74.34 112.156 -167.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -151.03 -161.07 9.78 Favored Glycine 0 C--N 1.346 1.136 0 CA-C-N 115.674 -0.694 . . . . 53.24 111.847 178.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 165.41 -144.52 9.33 Favored Glycine 0 C--N 1.343 0.944 0 N-CA-C 112.099 -0.4 . . . . 62.25 112.099 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 60.3 p -78.71 -51.02 10.41 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 123.649 0.779 . . . . 74.33 110.91 -178.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -143.16 98.53 0.21 Allowed Glycine 0 C--N 1.352 1.431 0 N-CA-C 111.202 -0.759 . . . . 50.33 111.202 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.605 ' HA3' ' HB2' ' A' ' 162' ' ' PRO . . . 146.91 20.53 0.11 Allowed Glycine 0 N--CA 1.473 1.165 0 C-N-CA 123.03 0.348 . . . . 32.44 112.26 178.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 36.5 m -79.51 103.26 9.31 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.29 0.636 . . . . 74.34 109.499 176.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -169.88 -159.54 15.96 Favored Glycine 0 C--N 1.339 0.726 0 N-CA-C 110.936 -0.866 . . . . 42.21 110.936 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.706 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 32.8 ttm180 -58.81 119.66 7.56 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 117.191 0.496 . . . . 75.43 111.01 -178.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -76.11 139.33 41.29 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.519 0.728 . . . . 74.22 109.539 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.3 tt -141.38 115.5 9.3 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 106.393 -1.706 . . . . 71.33 106.393 -177.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -90.24 143.08 27.1 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 107.052 -1.462 . . . . 73.42 107.052 177.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.488 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -149.51 137.16 20.2 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 120.684 0.278 . . . . 62.53 110.522 -169.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -120.53 112.41 18.91 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.146 -1.057 . . . . 73.45 108.146 -172.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.588 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.6 pp -99.31 117.79 63.43 Favored Pre-proline 0 C--N 1.354 0.78 0 N-CA-C 108.396 -0.964 . . . . 70.05 108.396 177.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.417 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 95.6 Cg_endo -75.48 113.68 3.81 Favored 'Trans proline' 0 C--N 1.364 1.36 0 C-N-CA 122.208 1.939 . . . . 71.53 109.166 170.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.512 HD21 HD12 ' A' ' 149' ' ' ILE . 33.0 tp -102.0 153.08 20.22 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.615 -0.513 . . . . 73.13 109.615 -172.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 4.8 t -91.43 155.16 18.65 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 109.224 -0.658 . . . . 74.1 109.224 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.1 mt -63.12 -34.43 77.59 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.461 0.704 . . . . 72.45 111.947 -173.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.93 -46.39 90.87 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.834 0.853 . . . . 75.23 110.022 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -79.09 -26.59 42.96 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.24 -0.891 . . . . 65.31 112.519 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.38 -40.94 92.65 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.533 0.683 . . . . 71.14 110.064 171.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -77.62 -48.91 15.71 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 114.224 -1.353 . . . . 73.33 111.093 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -69.68 -49.43 53.57 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 122.802 0.441 . . . . 54.14 111.592 -173.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.569 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 75.11 -170.42 54.36 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 115.805 -0.634 . . . . 74.13 111.702 -163.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.462 ' O ' HG12 ' A' ' 149' ' ' ILE . . . 90.54 -166.29 31.62 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 116.557 0.179 . . . . 55.02 112.74 -177.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.445 ' HB3' ' OG ' ' A' ' 146' ' ' SER . 3.6 mp0 -71.62 130.69 41.8 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.226 0.61 . . . . 63.02 110.275 -175.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -131.24 128.58 40.17 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.19 -0.67 . . . . 75.11 109.19 172.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 38.7 t -72.39 113.08 9.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 O-C-N 124.627 1.205 . . . . 71.52 110.63 -172.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.5 t -106.44 112.16 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.687 1.195 . . . . 74.32 107.878 176.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -94.18 117.35 29.99 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.276 0.63 . . . . 73.41 109.44 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.585 ' HB ' HD11 ' A' ' 101' ' ' LEU . 19.5 m -135.64 120.84 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 C-N-CA 124.502 1.121 . . . . 73.23 112.048 -169.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 57.88 20.34 6.56 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.55 1.14 . . . . 73.44 113.603 169.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.67 27.76 18.59 Favored Glycine 0 CA--C 1.535 1.342 0 N-CA-C 112.461 -0.256 . . . . 33.45 112.461 -175.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -133.64 154.02 51.23 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.405 1.082 . . . . 55.43 109.24 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -112.31 114.79 27.73 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.36 1.064 . . . . 75.31 109.044 176.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 5.7 p -130.26 124.29 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.536 -0.913 . . . . 74.33 108.536 174.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.445 ' OG ' ' HB3' ' A' ' 135' ' ' GLU . 12.7 t -103.44 122.8 45.64 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 109.228 -0.656 . . . . 63.55 109.228 -177.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.1 p -100.94 129.56 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 122.933 0.493 . . . . 71.51 110.092 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.9 ttp180 -74.73 98.82 3.55 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.573 -0.899 . . . . 61.2 108.573 170.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.569 HG13 ' HA2' ' A' ' 133' ' ' GLY . 10.7 pt -78.72 145.55 67.03 Favored Pre-proline 0 CA--C 1.563 1.444 0 C-N-CA 124.042 0.937 . . . . 75.34 109.796 171.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -61.86 141.34 89.58 Favored 'Trans proline' 0 CA--C 1.564 1.985 0 C-N-CA 122.78 2.32 . . . . 72.44 113.388 174.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -62.73 114.78 2.55 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.718 2.279 . . . . 70.03 111.115 168.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 87.59 30.03 19.82 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 111.444 -0.662 . . . . 72.53 111.444 -174.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.2 p -70.21 137.34 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.428 0.691 . . . . 74.41 109.358 174.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -135.11 157.56 46.61 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 122.997 0.519 . . . . 64.04 111.04 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -39.86 122.06 1.38 Allowed 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.915 2.086 . . . . 41.21 113.202 -175.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 107.9 -12.08 38.04 Favored Glycine 0 C--N 1.348 1.213 0 CA-C-O 119.366 -0.685 . . . . 55.0 113.846 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 13.7 t -70.04 122.14 18.8 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 117.382 0.591 . . . . 74.21 110.138 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 46.5 t -104.41 111.24 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 123.848 0.859 . . . . 74.01 109.628 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 61.1 mt -89.69 103.63 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.912 -1.144 . . . . 54.3 107.912 171.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -82.15 119.55 24.2 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.397 -0.594 . . . . 71.24 109.397 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.542 HG13 ' HB3' ' A' ' 174' ' ' LEU . 6.5 p -124.51 98.2 38.17 Favored Pre-proline 0 CA--C 1.561 1.374 0 C-N-CA 123.68 0.792 . . . . 54.55 109.476 177.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.605 ' HB2' ' HA3' ' A' ' 114' ' ' GLY . 73.5 Cg_endo -72.35 146.68 45.67 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.954 2.436 . . . . 63.24 112.503 179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 93.45 -18.51 56.23 Favored Glycine 0 CA--C 1.537 1.43 0 CA-C-O 120.058 -0.301 . . . . 70.12 113.726 -179.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 69.9 mmm -97.87 -9.87 25.62 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.935 0.894 . . . . 62.01 112.904 -174.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -79.74 -100.07 0.28 Allowed Glycine 0 C--N 1.342 0.889 0 O-C-N 123.181 0.3 . . . . 73.31 112.68 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.706 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -67.56 103.04 0.89 Allowed Glycine 0 C--N 1.344 1.022 0 N-CA-C 112.416 -0.273 . . . . 75.53 112.416 175.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -79.8 131.71 35.97 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.591 0.756 . . . . 65.11 109.813 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 154.06 -163.73 31.09 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 111.495 -0.642 . . . . 72.32 111.495 -177.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -58.83 -47.17 99.2 Favored Pre-proline 0 CA--C 1.562 1.422 0 CA-C-O 118.749 -0.643 . . . . 75.33 111.524 177.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.93 119.28 3.55 Favored 'Trans proline' 0 C--N 1.39 2.733 0 C-N-CA 121.481 1.454 . . . . 54.43 110.967 168.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.6 121.96 9.3 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 121.568 1.512 . . . . 71.52 109.702 174.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -97.59 149.25 19.19 Favored Glycine 0 C--N 1.339 0.728 0 CA-C-O 119.769 -0.462 . . . . 65.33 112.539 -173.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.449 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 37.6 t70 -83.03 139.78 33.08 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 122.764 0.426 . . . . 63.33 110.575 -175.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.542 ' HB3' HG13 ' A' ' 161' ' ' VAL . 33.4 tp -122.88 130.67 53.14 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.643 0.777 . . . . 75.32 109.347 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 80.9 mt -109.34 101.9 10.86 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.602 0.761 . . . . 72.34 109.307 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 77.3 mt -88.07 101.07 13.43 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 109.583 -0.525 . . . . 72.01 109.583 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 36.5 t -95.77 124.98 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 109.116 -0.698 . . . . 44.11 109.116 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.8 p -74.96 127.61 36.66 Favored 'Isoleucine or valine' 0 C--O 1.249 1.064 0 C-N-CA 123.117 0.567 . . . . 65.25 109.966 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.417 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 5.1 mmm180 -114.42 100.61 8.44 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.769 -0.826 . . . . 74.34 108.769 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 40.3 mt -116.38 139.86 49.96 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.373 1.069 . . . . 65.52 110.035 -177.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 59.3 mt -91.35 131.76 35.63 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-N 115.347 -0.842 . . . . 54.31 108.891 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.84 -30.33 91.64 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 123.485 2.79 . . . . 64.12 112.951 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 49.5 t-80 . . . . . 0 C--O 1.256 1.401 0 N-CA-C 108.093 -1.077 . . . . 72.54 108.093 169.776 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.481 ' SD ' ' N ' ' A' ' 94' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 108.108 -1.071 . . . . 52.33 108.108 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.9 t -62.2 121.56 13.41 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.067 0.547 . . . . 61.34 111.228 -172.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.521 ' HA ' ' HD2' ' A' ' 136' ' ' ARG . 56.6 m -72.59 149.65 43.78 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.534 0.733 . . . . 72.42 110.323 177.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.725 HD12 ' HB2' ' A' ' 123' ' ' LEU . 14.1 pt -118.09 161.75 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.029 0.532 . . . . 74.33 111.41 -164.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -113.18 -162.87 0.82 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.954 0.902 . . . . 42.41 109.186 173.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.762 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.6 tp -150.66 147.42 27.36 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.125 -0.694 . . . . 73.15 109.125 -172.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.14 -51.91 14.13 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.406 0.283 . . . . 73.34 111.147 -178.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 89.9 mt 60.59 73.77 0.47 Allowed 'General case' 0 N--CA 1.477 0.912 0 O-C-N 124.339 1.025 . . . . 71.53 110.435 -174.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 46.9 mt -77.02 109.72 9.86 Favored Pre-proline 0 CA--C 1.555 1.151 0 CA-C-N 114.986 -1.006 . . . . 44.44 109.18 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -55.28 -32.35 80.58 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 123.53 2.82 . . . . 70.3 114.716 -173.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -154.18 19.93 0.5 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.634 0.774 . . . . 70.34 111.078 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -78.28 85.5 1.13 Allowed Glycine 0 C--N 1.347 1.162 0 CA-C-O 119.933 -0.37 . . . . 74.05 112.668 -177.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 50.7 m 62.45 84.69 0.14 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.87 1.268 . . . . 75.13 110.969 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -169.92 103.13 0.19 Allowed Glycine 0 C--N 1.346 1.092 0 CA-C-N 115.906 -0.588 . . . . 65.2 111.76 -177.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -174.75 106.55 0.22 Allowed Glycine 0 C--N 1.348 1.208 0 N-CA-C 111.169 -0.772 . . . . 42.43 111.169 176.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.8 t -141.07 177.44 8.06 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.261 1.025 . . . . 72.33 109.14 178.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 169.8 -79.87 0.1 OUTLIER Glycine 0 C--N 1.341 0.851 0 N-CA-C 110.985 -0.846 . . . . 41.25 110.985 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 63.27 -113.8 6.25 Favored Glycine 0 C--N 1.352 1.429 0 C-N-CA 123.318 0.485 . . . . 71.32 113.233 177.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 25.3 p -90.07 90.29 8.06 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.536 0.734 . . . . 65.2 110.668 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.83 78.22 0.74 Allowed Glycine 0 C--N 1.353 1.505 0 CA-C-N 115.754 -0.657 . . . . 62.34 113.658 175.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -123.47 -87.13 0.79 Allowed Glycine 0 C--N 1.348 1.197 0 N-CA-C 111.839 -0.504 . . . . 63.41 111.839 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 39.9 m 72.21 -10.81 0.86 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 125.547 1.539 . . . . 73.33 114.198 176.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -96.78 143.45 16.74 Favored Glycine 0 C--N 1.35 1.357 0 N-CA-C 112.139 -0.384 . . . . 64.43 112.139 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.605 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 17.4 ttm180 -79.06 120.05 23.07 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.98 0.512 . . . . 60.42 111.064 -177.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -71.44 134.29 46.5 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.0 0.52 . . . . 70.43 110.094 173.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.7 tt -133.93 120.3 20.17 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 106.298 -1.741 . . . . 75.43 106.298 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -91.83 144.24 25.7 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 108.931 -0.766 . . . . 74.12 108.931 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.762 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -154.73 133.25 11.98 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.86 0.464 . . . . 53.25 110.037 -172.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -107.02 116.24 31.57 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.493 0.717 . . . . 73.11 109.365 -168.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.725 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.2 pp -101.36 115.21 65.38 Favored Pre-proline 0 C--N 1.35 0.604 0 N-CA-C 108.694 -0.854 . . . . 70.04 108.694 177.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -80.26 111.43 2.64 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.533 2.155 . . . . 70.43 110.984 172.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.605 HD21 HD12 ' A' ' 149' ' ' ILE . 30.0 tp -104.6 152.15 22.78 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 121.899 -0.501 . . . . 64.12 110.644 -166.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 2.9 t -90.35 154.11 19.94 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 123.498 0.719 . . . . 75.01 109.127 178.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 81.7 mt -68.64 -30.85 69.65 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.499 0.72 . . . . 52.44 112.251 -170.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -64.49 -48.58 74.65 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.14 0.576 . . . . 73.32 109.575 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -63.21 -38.45 91.2 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 114.695 -1.139 . . . . 52.25 112.0 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.475 ' HB2' HD21 ' A' ' 180' ' ' LEU . . . -60.02 -38.47 82.8 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 123.616 0.573 . . . . 74.14 111.505 176.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -76.32 -32.76 58.88 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 115.077 -0.965 . . . . 73.15 111.077 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -74.5 -49.75 20.91 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.096 0.474 . . . . 73.21 111.437 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.449 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 66.63 44.54 89.52 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.163 -0.926 . . . . 54.22 112.036 -164.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -97.09 -161.5 31.8 Favored Glycine 0 C--N 1.351 1.367 0 O-C-N 123.894 0.408 . . . . 75.34 112.244 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -95.71 116.68 29.23 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.772 -0.825 . . . . 74.12 108.772 176.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.521 ' HD2' ' HA ' ' A' ' 96' ' ' THR . 10.0 tpp180 -111.0 126.23 54.57 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.159 0.584 . . . . 64.21 109.527 178.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 91.6 t -73.56 132.89 32.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 114.433 -1.258 . . . . 61.2 110.333 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 28.2 t -116.59 126.76 74.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 107.302 -1.37 . . . . 65.32 107.302 174.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -126.06 110.11 13.16 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.994 0.518 . . . . 62.4 110.27 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -149.25 137.03 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 124.391 1.076 . . . . 72.11 111.072 -177.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.85 17.33 9.86 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 125.246 1.419 . . . . 44.04 112.732 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.33 1.68 74.82 Favored Glycine 0 C--N 1.351 1.395 0 CA-C-N 116.404 -0.362 . . . . 51.31 112.987 -176.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -102.38 121.26 41.96 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.385 1.074 . . . . 71.12 110.109 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -98.48 105.49 17.64 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 109.522 -0.548 . . . . 73.11 109.522 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.459 HG12 HG13 ' A' ' 147' ' ' VAL . 49.6 t -106.17 111.86 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.778 0.831 . . . . 55.21 109.062 176.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.6 t -92.39 121.11 33.56 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.191 -1.041 . . . . 65.42 108.191 176.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.459 HG13 HG12 ' A' ' 145' ' ' VAL . 29.8 m -126.16 144.01 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.142 0.577 . . . . 72.11 110.785 -176.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 63.5 ttp85 -88.32 124.59 34.06 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.677 -0.86 . . . . 73.52 108.677 172.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.605 HD12 HD21 ' A' ' 125' ' ' LEU . 4.5 pt -93.47 149.26 36.96 Favored Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 124.295 1.038 . . . . 64.41 109.752 176.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.412 ' HA ' ' HD3' ' A' ' 151' ' ' PRO . 33.7 Cg_exo -61.0 140.37 89.72 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 123.013 2.476 . . . . 55.34 113.74 174.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 150' ' ' PRO . 22.4 Cg_exo -67.58 113.88 3.1 Favored 'Trans proline' 0 C--N 1.375 1.973 0 C-N-CA 122.89 2.393 . . . . 53.51 111.199 170.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 86.07 26.38 34.34 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 116.083 -0.508 . . . . 45.1 112.107 -173.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.21 137.22 22.92 Favored 'Isoleucine or valine' 0 C--N 1.358 0.958 0 C-N-CA 123.546 0.738 . . . . 71.1 110.671 176.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 65.3 mtm180 -134.37 164.82 26.58 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.861 0.864 . . . . 72.4 110.642 -174.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -43.29 122.28 2.5 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.177 1.791 . . . . 75.35 114.685 -171.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.18 -6.71 72.39 Favored Glycine 0 C--N 1.352 1.431 0 CA-C-O 119.376 -0.68 . . . . 73.41 114.52 176.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.1 m -60.61 123.33 17.09 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.382 0.673 . . . . 64.3 111.865 175.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.1 p -101.85 132.88 46.89 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.041 0 C-N-CA 123.172 0.589 . . . . 72.15 110.744 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.595 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 75.7 mt -106.32 104.74 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 107.465 -1.309 . . . . 62.52 107.465 176.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -78.94 105.42 10.26 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.723 -0.473 . . . . 63.22 109.723 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.553 HG13 ' HB3' ' A' ' 174' ' ' LEU . 5.8 p -113.44 100.17 51.16 Favored Pre-proline 0 CA--C 1.558 1.277 0 C-N-CA 122.717 0.407 . . . . 62.14 110.166 174.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -64.3 150.73 87.74 Favored 'Trans proline' 0 C--N 1.387 2.592 0 C-N-CA 123.713 2.942 . . . . 51.24 113.168 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 83.35 -25.38 4.99 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 116.223 -0.444 . . . . 73.0 113.988 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -85.54 -12.84 50.67 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.02 0.928 . . . . 62.41 111.617 -178.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -84.73 -111.87 0.66 Allowed Glycine 0 C--N 1.349 1.279 0 O-C-N 123.511 0.507 . . . . 44.2 112.654 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.605 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -61.34 120.59 23.24 Favored Glycine 0 C--N 1.346 1.136 0 O-C-N 123.818 0.364 . . . . 73.42 112.469 177.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 11.7 mm-40 -88.18 155.42 19.77 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.354 0.662 . . . . 73.42 111.269 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 129.47 -171.4 20.14 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 115.069 -0.969 . . . . 61.33 111.466 -175.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -60.5 -45.27 97.29 Favored Pre-proline 0 CA--C 1.564 1.487 0 CA-C-O 118.451 -0.785 . . . . 62.11 112.209 175.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -82.73 112.74 2.15 Favored 'Trans proline' 0 C--N 1.395 2.98 0 C-N-CA 121.902 1.735 . . . . 75.43 111.066 171.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.76 127.43 12.31 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.418 2.079 . . . . 74.35 112.068 -177.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -105.12 156.13 16.88 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.973 -0.558 . . . . 73.15 112.785 -175.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -84.91 135.27 34.13 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.709 0.804 . . . . 72.22 111.241 -176.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.553 ' HB3' HG13 ' A' ' 161' ' ' VAL . 23.4 tp -102.21 107.79 18.97 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.457 -0.942 . . . . 64.12 108.457 177.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 78.9 mt -86.49 100.22 12.22 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.606 0.762 . . . . 72.51 109.909 -176.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.649 ' HB3' HD23 ' A' ' 123' ' ' LEU . 75.4 mt -91.42 98.95 12.0 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.059 0.544 . . . . 71.3 110.927 -175.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 47.9 t -91.0 117.34 34.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 109.461 -0.57 . . . . 74.3 109.461 -178.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.5 p -69.73 135.43 28.28 Favored 'Isoleucine or valine' 0 C--O 1.245 0.817 0 C-N-CA 123.339 0.656 . . . . 62.53 110.514 -176.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -127.69 85.64 2.38 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.189 -1.041 . . . . 71.34 108.189 -178.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.475 HD21 ' HB2' ' A' ' 130' ' ' ALA . 43.5 mt -82.36 147.52 28.78 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 114.975 -1.012 . . . . 75.24 110.27 -178.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 60.4 mt -67.01 116.0 31.17 Favored Pre-proline 0 CA--C 1.551 1.0 0 N-CA-C 108.644 -0.873 . . . . 60.33 108.644 176.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -65.05 -24.73 59.43 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.552 2.168 . . . . 72.01 112.359 176.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 . . . . . 0 CA--C 1.549 0.913 0 C-N-CA 124.806 1.242 . . . . 62.41 107.688 171.355 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 3.7 mpp? . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 108.501 -0.926 . . . . 64.14 108.501 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.5 m -62.82 132.12 51.11 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.555 0.742 . . . . 51.21 111.741 -171.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.413 ' HA ' ' HD2' ' A' ' 136' ' ' ARG . 39.5 m -77.14 151.75 35.21 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.728 0.811 . . . . 73.52 110.262 176.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.743 HD12 ' HB2' ' A' ' 123' ' ' LEU . 26.7 pt -112.46 165.09 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 123.173 0.589 . . . . 73.32 110.985 -174.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -135.25 123.64 23.29 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.936 0.895 . . . . 75.42 109.528 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.544 ' HB2' HG21 ' A' ' 138' ' ' VAL . 13.2 tp -76.69 149.44 36.41 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 124.845 1.258 . . . . 73.31 110.231 -172.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.34 -51.37 20.92 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.951 0.501 . . . . 71.14 111.115 -175.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.1 mt 57.72 82.36 0.13 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.357 1.063 . . . . 71.4 111.236 -174.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 45.9 mt -96.6 150.47 37.04 Favored Pre-proline 0 N--CA 1.479 1.008 0 C-N-CA 124.613 1.165 . . . . 71.42 109.664 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -83.49 -176.34 2.71 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.375 2.05 . . . . 70.41 112.714 176.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 74.0 mt -74.22 125.66 28.89 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.138 -0.937 . . . . 74.2 111.889 -176.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 60.49 40.96 98.44 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 124.45 1.094 . . . . 71.01 113.39 173.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 25.6 p -77.38 -43.22 33.5 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.923 0.889 . . . . 54.23 110.661 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 167.84 128.89 1.02 Allowed Glycine 0 C--N 1.342 0.873 0 N-CA-C 110.685 -0.966 . . . . 72.53 110.685 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 101.62 -132.55 11.0 Favored Glycine 0 C--N 1.349 1.252 0 N-CA-C 111.711 -0.556 . . . . 74.23 111.711 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 48.1 m -143.76 149.6 37.33 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.284 0.634 . . . . 73.1 111.018 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -141.39 -146.6 4.75 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 114.806 -1.088 . . . . 64.02 110.995 172.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -92.91 -161.53 36.3 Favored Glycine 0 C--N 1.342 0.883 0 N-CA-C 111.998 -0.441 . . . . 74.23 111.998 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 57.8 m -148.34 113.13 5.41 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.625 -0.88 . . . . 74.42 108.625 174.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -127.25 138.5 10.56 Favored Glycine 0 C--N 1.347 1.148 0 N-CA-C 111.968 -0.453 . . . . 53.43 111.968 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -103.45 -65.93 0.72 Allowed Glycine 0 C--N 1.353 1.491 0 N-CA-C 111.452 -0.659 . . . . 53.43 111.452 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.2 m -98.94 60.73 1.24 Allowed 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.624 0.726 . . . . 74.45 109.087 173.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 151.48 90.66 0.08 OUTLIER Glycine 0 C--N 1.339 0.734 0 N-CA-C 109.641 -1.383 . . . . 72.24 109.641 -175.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.501 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 68.4 ttt180 -64.12 127.5 31.73 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.216 1.006 . . . . 73.24 112.459 -171.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -77.21 148.71 35.71 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.263 -0.881 . . . . 63.35 109.114 174.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.2 tt -140.62 131.14 25.4 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.329 -0.989 . . . . 63.12 108.329 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -93.32 115.99 28.56 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 108.895 -0.78 . . . . 73.02 108.895 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.543 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -129.15 144.24 51.14 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.339 -0.615 . . . . 72.32 109.339 -176.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -126.12 120.12 29.34 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 107.962 -1.125 . . . . 74.55 107.962 -176.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.743 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.0 pp -100.98 110.62 61.58 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 107.519 -1.289 . . . . 73.41 107.519 177.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.99 112.8 3.61 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.794 2.329 . . . . 73.41 108.876 168.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.546 HD21 HD12 ' A' ' 149' ' ' ILE . 22.9 tp -103.21 140.83 36.85 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.149 -0.686 . . . . 72.23 109.149 -168.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 5.7 t -78.22 162.69 26.39 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 110.101 -0.333 . . . . 60.5 110.101 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.1 mt -64.01 -36.66 84.72 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.014 0.925 . . . . 73.41 112.014 -174.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -62.19 -46.48 88.74 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.487 0.715 . . . . 73.15 109.842 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -71.87 -40.05 69.22 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.398 -1.273 . . . . 70.01 111.833 -178.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.8 -58.34 8.99 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.57 0.7 . . . . 74.4 111.187 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -67.44 -56.7 8.54 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.441 -1.254 . . . . 65.4 111.121 -175.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 53.7 m80 -77.62 -41.41 38.6 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 122.246 0.219 . . . . 73.11 111.314 -170.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.59 165.03 38.96 Favored Glycine 0 C--N 1.351 1.366 0 CA-C-N 116.826 -0.17 . . . . 53.11 112.986 -176.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.05 -154.69 25.83 Favored Glycine 0 C--N 1.343 0.954 0 N-CA-C 111.796 -0.522 . . . . 51.2 111.796 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -105.89 121.26 43.72 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.416 -0.957 . . . . 74.12 108.416 172.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.413 ' HD2' ' HA ' ' A' ' 96' ' ' THR . 10.2 tpp180 -113.2 122.02 46.23 Favored 'General case' 0 C--N 1.342 0.276 0 N-CA-C 109.575 -0.528 . . . . 64.43 109.575 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 71.7 t -73.32 142.04 15.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 124.145 0.978 . . . . 64.23 110.263 175.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.544 HG21 ' HB2' ' A' ' 99' ' ' LEU . 3.1 p -135.07 126.13 45.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.866 1.266 . . . . 44.42 108.073 175.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -114.02 109.77 18.98 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.129 0.972 . . . . 74.23 109.461 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 2.6 m -142.72 141.83 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 124.238 1.015 . . . . 54.24 110.065 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 65.0 19.37 11.84 Favored 'General case' 0 CA--C 1.554 1.134 0 O-C-N 124.632 1.208 . . . . 72.01 111.429 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 79.99 11.34 84.6 Favored Glycine 0 C--N 1.359 1.856 0 CA-C-N 116.066 -0.515 . . . . 64.13 113.1 -174.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -116.31 124.69 50.75 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.402 1.081 . . . . 73.33 110.555 -172.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -98.21 134.22 41.56 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.894 0.877 . . . . 71.21 110.125 -179.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.1 p -147.96 141.15 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.921 0 C-N-CA 123.544 0.738 . . . . 63.23 109.492 171.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.7 t -107.51 125.3 51.1 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.228 0.611 . . . . 32.14 109.472 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.7 p -106.96 125.9 63.0 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 123.381 0.672 . . . . 74.1 110.769 -177.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -78.33 102.14 7.55 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.52 0.676 . . . . 64.31 109.68 177.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.546 HD12 HD21 ' A' ' 125' ' ' LEU . 11.2 pt -92.38 144.42 28.87 Favored Pre-proline 0 CA--C 1.556 1.182 0 CA-C-N 114.507 -1.224 . . . . 73.54 109.611 174.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.2 162.12 34.41 Favored 'Trans proline' 0 CA--C 1.563 1.945 0 C-N-CA 122.636 2.224 . . . . 64.32 112.18 176.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.87 125.5 12.16 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.704 2.27 . . . . 73.03 111.803 175.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 81.81 25.81 51.83 Favored Glycine 0 C--N 1.35 1.339 0 CA-C-O 119.892 -0.393 . . . . 71.5 112.127 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.3 p -63.94 119.92 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 C-N-CA 123.452 0.701 . . . . 75.11 110.212 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 68.4 mtp180 -103.63 165.89 10.76 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.126 0.97 . . . . 65.4 110.291 -171.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -49.14 134.63 17.51 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 125.37 1.669 . . . . 74.03 111.786 178.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.51 -11.66 68.4 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-O 119.141 -0.811 . . . . 75.24 114.35 174.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.9 t -65.54 121.19 14.35 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 117.589 0.695 . . . . 41.41 109.392 178.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 55.9 t -100.54 111.46 30.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 108.927 -0.768 . . . . 75.42 108.927 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 56.5 mt -88.61 103.89 14.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 N-CA-C 107.262 -1.384 . . . . 74.34 107.262 169.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.433 ' HG3' HD23 ' A' ' 175' ' ' LEU . 59.4 ttt180 -90.44 124.7 35.18 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.249 -0.648 . . . . 73.43 109.249 -176.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.5 p -124.74 107.14 29.04 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 123.447 0.699 . . . . 73.15 109.469 174.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.2 155.19 61.33 Favored 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 122.485 2.124 . . . . 60.12 111.534 172.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.553 ' HA2' ' HB2' ' A' ' 171' ' ' PRO . . . 85.21 0.35 88.66 Favored Glycine 0 CA--C 1.535 1.333 0 N-CA-C 114.574 0.59 . . . . 71.11 114.574 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 55.4 mtp -121.84 -7.26 9.01 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 113.623 0.972 . . . . 73.43 113.623 -173.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -82.65 -91.12 0.64 Allowed Glycine 0 N--CA 1.471 0.981 0 CA-C-N 118.013 0.369 . . . . 75.42 112.67 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.501 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -66.09 95.4 0.24 Allowed Glycine 0 C--N 1.345 1.074 0 N-CA-C 111.527 -0.629 . . . . 72.44 111.527 173.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -83.31 110.87 18.48 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.383 0.673 . . . . 75.3 110.398 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -172.9 -146.21 5.33 Favored Glycine 0 C--O 1.241 0.563 0 N-CA-C 110.526 -1.029 . . . . 61.12 110.526 -177.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 -75.86 -50.97 3.08 Favored Pre-proline 0 CA--C 1.565 1.539 0 CA-C-O 118.844 -0.598 . . . . 75.24 110.432 175.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.402 ' HA ' ' HD2' ' A' ' 171' ' ' PRO . 93.7 Cg_endo -83.6 116.68 2.29 Favored 'Trans proline' 0 C--N 1.397 3.131 0 C-N-CA 121.508 1.472 . . . . 62.41 110.751 170.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.553 ' HB2' ' HA2' ' A' ' 163' ' ' GLY . 29.4 Cg_endo -60.94 125.94 18.38 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.35 2.033 . . . . 74.54 111.368 -179.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -99.2 163.14 20.05 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 113.864 0.306 . . . . 74.21 113.864 -174.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -86.26 144.46 27.41 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.584 0.754 . . . . 72.3 110.637 -176.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 30.7 tp -130.63 122.28 27.13 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.22 0.608 . . . . 70.55 109.525 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.433 HD23 ' HG3' ' A' ' 160' ' ' ARG . 61.6 mt -99.39 114.64 27.67 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.716 -0.846 . . . . 74.35 108.716 177.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.648 ' HB3' HD23 ' A' ' 123' ' ' LEU . 36.9 mt -102.02 100.41 10.68 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 108.839 -0.8 . . . . 74.4 108.839 175.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.3 p -95.53 126.09 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 109.38 -0.6 . . . . 64.13 109.38 176.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.7 p -73.23 136.05 26.32 Favored 'Isoleucine or valine' 0 C--O 1.247 0.974 0 C-N-CA 123.279 0.632 . . . . 74.13 110.256 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -123.64 103.82 8.64 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.61 -1.255 . . . . 73.11 107.61 -176.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 92.7 mt -105.8 148.29 27.68 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.995 0.918 . . . . 64.44 110.546 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 96.4 mt -54.3 142.04 50.29 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.411 1.084 . . . . 72.22 111.465 -176.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -56.38 -31.04 83.85 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.045 2.496 . . . . 53.43 112.678 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 . . . . . 0 N--CA 1.478 0.932 0 N-CA-C 109.359 -0.608 . . . . 64.23 109.359 171.172 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.505 ' HA ' HG21 ' A' ' 126' ' ' THR . 23.7 ptp . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 110.085 -0.339 . . . . 65.05 110.085 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.8 m -143.3 144.86 32.28 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.394 0.678 . . . . 71.22 109.885 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.0 p -75.4 148.01 39.52 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.653 -0.703 . . . . 75.2 110.384 170.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.564 HD12 ' HB2' ' A' ' 123' ' ' LEU . 24.0 pt -128.29 162.65 34.3 Favored 'Isoleucine or valine' 0 C--O 1.245 0.857 0 CA-C-N 114.521 -1.218 . . . . 73.21 109.729 -167.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -128.12 129.07 45.98 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.277 0.631 . . . . 71.01 110.122 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.687 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.8 tp -72.84 155.84 39.5 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.137 1.375 . . . . 75.41 109.331 -175.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -79.25 -38.27 35.92 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.309 0.504 . . . . 32.45 111.371 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.7 mt 54.04 75.77 0.26 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.438 1.095 . . . . 73.42 111.485 -175.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 31.5 mt -86.35 136.05 35.91 Favored Pre-proline 0 CA--C 1.553 1.092 0 CA-C-N 115.35 -0.841 . . . . 64.34 109.277 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.43 167.04 13.78 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.548 2.165 . . . . 75.2 112.439 175.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 pp -73.8 175.8 6.92 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.916 0.486 . . . . 74.41 112.282 -175.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 170.54 -54.25 0.19 Allowed Glycine 0 C--N 1.339 0.712 0 N-CA-C 110.145 -1.182 . . . . 72.03 110.145 176.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 27.0 t -168.04 121.2 0.89 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.541 -1.281 . . . . 70.0 107.541 177.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -175.17 -48.75 0.05 OUTLIER Glycine 0 C--N 1.345 1.039 0 N-CA-C 112.036 -0.426 . . . . 34.35 112.036 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -87.52 57.42 4.46 Favored Glycine 0 C--N 1.343 0.924 0 N-CA-C 112.45 -0.26 . . . . 54.4 112.45 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.7 m -68.49 147.91 51.34 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.61 0.764 . . . . 52.14 109.894 177.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 95.58 -63.74 1.33 Allowed Glycine 0 C--N 1.335 0.501 0 N-CA-C 110.637 -0.985 . . . . 44.4 110.637 -170.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 71.94 31.58 64.36 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 123.891 0.406 . . . . 55.03 112.884 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.6 m -70.81 109.36 4.95 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.595 0.758 . . . . 70.34 109.975 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 134.87 -13.6 4.43 Favored Glycine 0 C--N 1.342 0.864 0 CA-C-N 114.689 -1.141 . . . . 63.04 110.884 -168.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.0 -127.56 8.24 Favored Glycine 0 C--N 1.351 1.378 0 N-CA-C 111.542 -0.623 . . . . 71.42 111.542 -177.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 29.5 m -76.81 125.99 30.22 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.217 0.607 . . . . 51.3 110.254 179.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 179.49 105.63 0.2 Allowed Glycine 0 C--N 1.342 0.898 0 N-CA-C 110.989 -0.845 . . . . 72.53 110.989 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.415 ' NH2' HD12 ' A' ' 119' ' ' LEU . 6.9 tmm_? -62.79 117.48 6.39 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.805 0.842 . . . . 62.54 110.195 -175.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -78.95 128.73 33.66 Favored 'General case' 0 C--O 1.244 0.792 0 C-N-CA 122.981 0.512 . . . . 71.43 109.636 178.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.415 HD12 ' NH2' ' A' ' 117' ' ' ARG . 2.8 tt -119.44 117.25 27.96 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 106.555 -1.646 . . . . 63.52 106.555 178.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 44.9 ttt180 -90.4 133.38 35.04 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.272 -1.381 . . . . 75.33 107.272 176.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.687 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -156.99 140.24 15.58 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.467 -0.568 . . . . 72.04 109.467 -174.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -127.19 129.24 47.46 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 110.181 -0.303 . . . . 73.41 110.181 -172.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.564 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.1 pp -102.09 127.17 31.48 Favored Pre-proline 0 C--N 1.352 0.688 0 N-CA-C 109.575 -0.528 . . . . 51.14 109.575 -179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.409 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 63.0 Cg_endo -75.05 116.22 4.51 Favored 'Trans proline' 0 C--N 1.362 1.272 0 C-N-CA 122.724 2.282 . . . . 54.13 109.015 168.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.637 HD21 HD12 ' A' ' 149' ' ' ILE . 37.5 tp -103.37 146.2 28.84 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.63 0.65 . . . . 71.11 111.168 -168.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.505 HG21 ' HA ' ' A' ' 94' ' ' MET . 92.8 m -75.32 143.69 42.79 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 114.695 -1.139 . . . . 75.11 109.228 175.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.404 ' HG ' HD12 ' A' ' 181' ' ' LEU . 88.3 mt -68.26 -35.03 77.27 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.721 0.808 . . . . 72.24 112.306 -172.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -68.28 -34.46 76.2 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.023 0.529 . . . . 74.23 109.836 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.443 ' HB3' HD11 ' A' ' 149' ' ' ILE . 57.5 mm-40 -68.19 -40.13 82.29 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.342 -0.844 . . . . 74.12 110.98 176.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.514 ' HB2' HD21 ' A' ' 180' ' ' LEU . . . -68.96 -38.03 79.18 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.811 0.444 . . . . 44.21 111.96 177.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -70.66 -53.31 16.25 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.089 -0.96 . . . . 75.52 110.239 -176.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -77.16 -46.02 24.79 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.796 -0.638 . . . . 75.32 110.828 -176.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 75.72 94.65 0.16 Allowed Glycine 0 C--N 1.347 1.142 0 O-C-N 123.467 0.479 . . . . 61.45 112.499 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.495 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -153.17 -160.34 9.63 Favored Glycine 0 C--N 1.341 0.81 0 N-CA-C 111.989 -0.445 . . . . 55.14 111.989 -178.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -81.3 114.9 20.4 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.556 -0.535 . . . . 63.54 109.556 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.4 tpp180 -113.26 124.43 52.5 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.227 1.011 . . . . 63.21 109.163 177.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 77.3 t -78.93 111.08 15.36 Favored 'Isoleucine or valine' 0 C--O 1.245 0.824 0 CA-C-N 114.673 -1.149 . . . . 74.2 109.916 176.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.426 HG13 ' HB ' ' A' ' 145' ' ' VAL . 3.7 p -108.78 109.93 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 124.504 1.121 . . . . 64.31 108.19 170.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -110.64 133.59 53.18 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.886 0.474 . . . . 64.21 110.531 -177.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.46 141.09 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 125.178 1.391 . . . . 70.04 110.537 175.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 60.69 25.94 15.71 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.624 1.17 . . . . 61.01 112.163 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 79.49 8.42 87.77 Favored Glycine 0 C--N 1.355 1.621 0 CA-C-N 116.062 -0.517 . . . . 55.13 113.075 -178.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.414 HH22 ' HG3' ' A' ' 167' ' ' GLN . 39.9 ttm180 -103.31 117.77 35.25 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.957 0.903 . . . . 74.1 109.475 178.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -89.53 108.34 19.6 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 108.908 -0.775 . . . . 74.15 108.908 178.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.448 HG12 HG13 ' A' ' 147' ' ' VAL . 19.0 t -104.94 112.88 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 107.9 -1.148 . . . . 63.24 107.9 178.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.1 t -101.04 107.78 19.32 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.791 -0.818 . . . . 72.11 108.791 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.448 HG13 HG12 ' A' ' 145' ' ' VAL . 27.1 m -114.27 132.35 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 123.251 0.62 . . . . 53.14 111.432 -174.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -88.19 97.6 11.09 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.0 0.92 . . . . 73.33 109.17 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.637 HD12 HD21 ' A' ' 125' ' ' LEU . 10.7 pt -79.96 139.05 53.27 Favored Pre-proline 0 CA--C 1.562 1.413 0 CA-C-N 115.153 -0.93 . . . . 62.33 109.652 178.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.32 149.59 63.56 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.458 2.106 . . . . 74.33 112.657 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -64.31 112.06 1.8 Allowed 'Trans proline' 0 C--N 1.377 2.038 0 C-N-CA 122.525 2.15 . . . . 72.34 110.91 172.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 96.98 23.34 15.27 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-N 115.824 -0.625 . . . . 41.1 112.364 -173.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.491 HG11 ' HB ' ' A' ' 149' ' ' ILE . 6.3 p -66.78 120.17 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 108.479 -0.934 . . . . 72.54 108.479 168.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.408 ' HA ' HD12 ' A' ' 180' ' ' LEU . 24.7 mtp180 -122.45 162.52 21.52 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.235 0.614 . . . . 64.34 110.948 -173.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -42.37 128.15 3.79 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 126.276 1.83 . . . . 72.5 113.201 -175.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.46 -5.83 74.41 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-N 115.746 -0.661 . . . . 73.14 114.264 178.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 17.0 m -64.83 124.09 21.07 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.499 0.72 . . . . 70.0 111.08 174.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 176' ' ' LEU . 3.8 p -105.6 110.88 32.61 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 123.357 0.663 . . . . 53.44 110.079 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 58.7 mt -90.61 103.5 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 N-CA-C 107.951 -1.129 . . . . 73.12 107.951 173.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -78.2 100.27 6.56 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.146 -0.687 . . . . 54.43 109.146 177.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.508 HG13 ' HB3' ' A' ' 174' ' ' LEU . 7.6 p -99.68 108.19 49.82 Favored Pre-proline 0 CA--C 1.56 1.357 0 N-CA-C 109.221 -0.659 . . . . 65.43 109.221 176.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.03 151.47 61.87 Favored 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 123.255 2.636 . . . . 62.33 113.539 -172.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 69.53 8.52 59.97 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-N 115.84 -0.618 . . . . 45.13 114.502 172.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 96.8 mmm -104.88 -19.72 13.79 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.127 0.971 . . . . 73.14 110.167 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -78.43 -94.73 0.27 Allowed Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.667 -0.697 . . . . 64.15 111.691 176.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -59.29 98.76 0.12 Allowed Glycine 0 C--N 1.352 1.471 0 C-N-CA 123.179 0.418 . . . . 62.01 113.4 175.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.414 ' HG3' HH22 ' A' ' 143' ' ' ARG . 12.8 mm-40 -89.51 113.55 24.95 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.38 1.072 . . . . 72.11 110.632 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 157.38 -135.19 4.27 Favored Glycine 0 C--N 1.338 0.64 0 O-C-N 123.121 0.263 . . . . 54.02 112.49 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -81.91 -43.13 1.05 Allowed Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 123.59 0.756 . . . . 73.2 111.602 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -91.69 107.24 0.26 Allowed 'Trans proline' 0 C--N 1.396 3.077 0 C-N-CA 122.337 2.025 . . . . 54.31 112.066 169.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -70.96 125.33 11.42 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 122.343 2.029 . . . . 70.42 111.499 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 117' ' ' ARG . . . -114.49 158.67 14.17 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-N 116.379 -0.373 . . . . 25.13 112.502 -177.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -83.64 148.83 26.91 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.583 0.753 . . . . 71.13 110.701 -177.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.508 ' HB3' HG13 ' A' ' 161' ' ' VAL . 39.3 tp -113.72 103.78 11.56 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 107.208 -1.404 . . . . 74.13 107.208 177.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 81.5 mt -87.04 100.67 12.8 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.786 0.834 . . . . 70.33 109.595 -173.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 158' ' ' VAL . 63.5 mt -89.34 101.66 14.34 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.874 0.87 . . . . 75.24 111.517 -172.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 24.8 t -87.3 118.46 33.28 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 108.693 -0.854 . . . . 73.3 108.693 177.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 7.6 p -74.59 137.08 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 C-N-CA 122.681 0.393 . . . . 61.23 110.22 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.409 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 32.0 mmt180 -124.87 89.45 3.07 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.192 0.997 . . . . 73.23 109.172 -178.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.514 HD21 ' HB2' ' A' ' 130' ' ' ALA . 32.7 mt -85.65 149.88 25.01 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.593 -0.731 . . . . 70.24 111.711 -178.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.404 HD12 ' HG ' ' A' ' 127' ' ' LEU . 55.9 mt -64.41 139.69 97.78 Favored Pre-proline 0 CA--C 1.561 1.403 0 CA-C-N 114.095 -1.411 . . . . 70.4 109.374 178.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -63.34 -5.87 9.03 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 123.726 2.95 . . . . 72.11 115.006 -171.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 62.7 t-80 . . . . . 0 C--O 1.252 1.218 0 N-CA-C 107.795 -1.187 . . . . 71.41 107.795 171.101 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 109.095 -0.706 . . . . 74.1 109.095 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.479 ' H ' HG21 ' A' ' 126' ' ' THR . 32.5 t -111.57 128.14 55.94 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 109.103 -0.703 . . . . 63.32 109.103 177.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 26.3 m -76.71 149.23 36.41 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.361 0.664 . . . . 60.23 110.652 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.718 HD12 ' HB2' ' A' ' 123' ' ' LEU . 25.1 pt -112.77 155.49 13.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.709 0 C-N-CA 123.452 0.701 . . . . 75.11 109.707 -166.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -126.51 129.58 48.92 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.97 -0.752 . . . . 24.53 108.97 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.595 ' HB3' HG21 ' A' ' 140' ' ' VAL . 12.4 tp -75.53 162.02 28.67 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.8 1.24 . . . . 75.43 109.848 -172.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.441 ' HB3' ' H ' ' A' ' 122' ' ' GLU . . . -83.06 -44.49 15.11 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.399 0.28 . . . . 53.15 111.055 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 41.7 mt 46.68 69.05 0.52 Allowed 'General case' 0 N--CA 1.482 1.159 0 O-C-N 124.313 1.008 . . . . 74.3 110.214 -169.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.432 HD12 ' HG3' ' A' ' 120' ' ' ARG . 80.8 mt -65.75 119.75 63.17 Favored Pre-proline 0 CA--C 1.549 0.929 0 CA-C-N 115.152 -0.931 . . . . 71.11 108.867 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -54.95 125.16 18.22 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.004 2.47 . . . . 60.15 112.334 -174.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.455 ' HG ' ' H ' ' A' ' 105' ' ' GLY 0.288 1.0 OUTLIER 50.94 -73.13 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.418 0 C-N-CA 127.167 2.187 . . . . 63.53 114.644 -175.275 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.455 ' H ' ' HG ' ' A' ' 104' ' ' LEU . . . 102.31 -2.18 50.45 Favored Glycine 0 N--CA 1.482 1.722 0 CA-C-O 119.864 -0.409 . . . . 55.14 112.351 -174.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 46.6 m 58.7 51.03 8.11 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.51 1.524 . . . . 63.45 111.735 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -82.22 -53.81 3.55 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 114.915 -1.039 . . . . 41.22 112.704 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 63.83 23.29 67.25 Favored Glycine 0 C--N 1.352 1.457 0 O-C-N 123.862 0.389 . . . . 62.33 112.539 -173.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.7 m -125.49 128.14 47.55 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.619 1.168 . . . . 74.14 109.868 -172.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -179.21 56.27 0.09 OUTLIER Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.35 -1.1 . . . . 64.04 110.35 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 176.46 33.84 0.05 OUTLIER Glycine 0 C--N 1.341 0.854 0 CA-C-N 115.228 -0.486 . . . . 34.53 111.94 -177.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.0 p -117.21 110.51 18.23 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.383 1.073 . . . . 64.31 108.171 174.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.38 -6.61 56.88 Favored Glycine 0 C--N 1.351 1.409 0 O-C-N 123.541 0.526 . . . . 35.33 113.945 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 149.66 178.87 25.02 Favored Glycine 0 C--N 1.354 1.531 0 CA-C-N 116.915 0.358 . . . . 54.13 112.619 178.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 35.6 m -78.1 115.42 17.82 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.365 1.066 . . . . 71.15 110.443 178.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 177.42 73.17 0.06 OUTLIER Glycine 0 C--N 1.34 0.775 0 N-CA-C 111.622 -0.591 . . . . 71.03 111.622 -178.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -70.35 116.43 10.68 Favored 'General case' 0 C--O 1.252 1.224 0 N-CA-C 108.746 -0.835 . . . . 73.12 108.746 175.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' A' ' 173' ' ' ASP . 8.9 p-10 -84.34 149.23 26.18 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.015 -0.993 . . . . 73.21 110.81 -171.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.5 tt -130.07 136.95 49.92 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 106.998 -1.482 . . . . 40.55 106.998 -179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.432 ' HG3' HD12 ' A' ' 102' ' ' LEU . 10.1 tpt180 -91.43 124.89 35.95 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.766 -0.827 . . . . 61.42 108.766 -174.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.567 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -145.7 135.58 23.54 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 122.66 0.384 . . . . 51.15 110.618 -172.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.441 ' H ' ' HB3' ' A' ' 100' ' ' ALA . 9.1 mm-40 -114.13 121.86 45.08 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.544 -0.91 . . . . 64.5 108.544 -172.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.718 ' HB2' HD12 ' A' ' 97' ' ' ILE . 3.1 pp -100.37 113.61 65.48 Favored Pre-proline 0 CA--C 1.546 0.823 0 N-CA-C 107.786 -1.191 . . . . 73.13 107.786 174.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.486 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 71.9 Cg_endo -75.48 116.28 4.45 Favored 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.601 2.201 . . . . 61.31 109.391 169.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.44 HD21 HD12 ' A' ' 149' ' ' ILE . 27.1 tp -101.57 145.37 29.13 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 109.459 -0.571 . . . . 72.42 109.459 -170.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.479 HG21 ' H ' ' A' ' 95' ' ' SER . 4.7 t -91.02 156.09 18.2 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 109.145 -0.687 . . . . 71.44 109.145 -177.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 93.5 mt -60.8 -34.77 75.01 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.864 0.866 . . . . 73.34 111.765 -175.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 131' ' ' PHE . 2.1 mp0 -60.41 -48.45 81.69 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.911 0.885 . . . . 54.3 110.199 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -75.47 -34.33 60.9 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.307 -0.861 . . . . 61.34 111.891 -175.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.1 -39.8 79.55 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.113 0.483 . . . . 61.31 110.319 171.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.407 ' HB3' ' O ' ' A' ' 128' ' ' GLU . 68.8 t80 -66.07 -49.17 68.55 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.865 1.266 . . . . 73.2 111.313 177.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -74.51 -50.72 17.08 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.626 0.37 . . . . 72.42 111.829 -171.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.531 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 66.32 75.73 0.41 Allowed Glycine 0 CA--C 1.532 1.114 0 CA-C-N 115.768 -0.651 . . . . 75.32 111.603 -166.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -148.15 -165.44 12.03 Favored Glycine 0 C--N 1.343 0.946 0 N-CA-C 112.08 -0.408 . . . . 54.32 112.08 -176.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -71.92 115.18 10.83 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.513 -0.551 . . . . 74.53 109.513 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -116.01 121.23 41.62 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.33 -0.989 . . . . 71.42 108.33 174.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 70.7 t -81.29 141.73 14.76 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 C-N-CA 124.489 1.115 . . . . 75.04 109.386 -179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.7 p -141.45 123.6 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 123.944 0.898 . . . . 73.35 108.964 174.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -124.73 125.47 44.12 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.667 0.787 . . . . 64.11 110.345 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.595 HG21 ' HB3' ' A' ' 99' ' ' LEU . 1.6 m -151.15 131.81 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.967 1.307 . . . . 72.21 109.808 -177.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 59.14 24.28 12.62 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.236 1.015 . . . . 75.53 112.587 176.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 89.6 -7.14 82.49 Favored Glycine 0 C--N 1.356 1.651 0 CA-C-N 116.53 -0.304 . . . . 42.42 113.499 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -94.63 114.68 26.66 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 109.088 -0.708 . . . . 75.34 109.088 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.1 ttm180 -114.57 127.89 56.03 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.179 0.591 . . . . 74.44 109.616 177.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.28 132.31 45.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 123.76 0.824 . . . . 34.42 108.826 173.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 40.9 t -94.37 127.8 40.49 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 107.459 -1.312 . . . . 65.33 107.459 170.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 19.7 m -120.98 127.89 76.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 109.468 -0.567 . . . . 70.05 109.468 175.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 56.1 ttt85 -76.59 109.87 10.7 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.981 -1.118 . . . . 74.33 107.981 173.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.531 HG13 ' HA2' ' A' ' 133' ' ' GLY . 12.2 pt -84.01 148.44 53.72 Favored Pre-proline 0 CA--C 1.557 1.243 0 CA-C-N 115.135 -0.939 . . . . 73.13 109.371 177.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -67.58 150.36 79.87 Favored 'Trans proline' 0 C--N 1.369 1.654 0 C-N-CA 122.485 2.123 . . . . 62.34 112.941 172.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -63.4 121.11 8.79 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.652 2.235 . . . . 50.01 111.341 171.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 76.72 30.69 55.79 Favored Glycine 0 N--CA 1.465 0.614 0 CA-C-N 116.288 -0.415 . . . . 65.43 112.115 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 3.9 p -61.87 125.24 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 108.967 -0.753 . . . . 72.02 108.967 170.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.476 ' HA ' HD12 ' A' ' 180' ' ' LEU . 95.6 mtt180 -116.66 153.87 31.56 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.589 0.756 . . . . 71.3 110.055 -169.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -37.56 123.28 0.99 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 126.446 1.899 . . . . 73.23 113.013 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 106.63 -20.07 35.06 Favored Glycine 0 N--CA 1.473 1.161 0 CA-C-O 119.207 -0.774 . . . . 71.44 113.726 178.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.1 t -61.95 121.42 12.92 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 117.491 0.645 . . . . 74.01 110.423 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.441 HG22 HG22 ' A' ' 177' ' ' VAL . 55.1 t -101.11 115.3 42.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 109.703 -0.48 . . . . 45.33 109.703 -178.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 57.7 mt -90.02 105.13 15.86 Favored 'Isoleucine or valine' 0 C--N 1.343 0.306 0 N-CA-C 107.391 -1.337 . . . . 63.14 107.391 173.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -84.52 119.44 25.18 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.037 -0.727 . . . . 71.42 109.037 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.493 HG13 ' HB3' ' A' ' 174' ' ' LEU . 6.3 p -124.48 98.16 38.31 Favored Pre-proline 0 CA--C 1.558 1.269 0 C-N-CA 123.394 0.678 . . . . 73.52 109.691 177.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 32.4 Cg_exo -61.92 150.07 87.66 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.99 2.46 . . . . 61.0 112.679 172.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 88.47 -16.94 51.66 Favored Glycine 0 N--CA 1.474 1.208 0 CA-C-O 119.963 -0.354 . . . . 73.33 113.807 178.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -102.14 -4.4 25.92 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.94 0.896 . . . . 52.34 111.979 -176.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.491 ' HA2' HD13 ' A' ' 174' ' ' LEU . . . -88.19 -111.59 1.09 Allowed Glycine 0 C--N 1.35 1.347 0 CA-C-O 119.397 -0.668 . . . . 73.21 113.064 -175.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -61.62 102.39 0.44 Allowed Glycine 0 C--N 1.359 1.852 0 CA-C-N 117.01 0.405 . . . . 54.44 112.739 173.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -80.69 135.29 35.99 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.953 0.501 . . . . 64.15 109.95 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 152.26 -155.75 26.31 Favored Glycine 0 C--N 1.343 0.956 0 N-CA-C 111.566 -0.613 . . . . 42.05 111.566 -178.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -66.78 -49.7 47.82 Favored Pre-proline 0 CA--C 1.559 1.297 0 CA-C-O 118.309 -0.853 . . . . 65.11 110.76 178.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.56 114.34 2.98 Favored 'Trans proline' 0 C--N 1.397 3.119 0 C-N-CA 121.392 1.395 . . . . 74.33 110.375 168.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -69.75 123.93 10.59 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 121.962 1.775 . . . . 74.43 110.036 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -100.01 159.24 19.53 Favored Glycine 0 CA--C 1.507 -0.44 0 CA-C-N 116.091 -0.504 . . . . 65.15 113.391 -171.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.491 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 34.6 t70 -91.46 151.54 20.75 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.967 0.907 . . . . 64.1 110.017 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.493 ' HB3' HG13 ' A' ' 161' ' ' VAL . 19.5 tp -127.71 119.19 25.28 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 118.104 0.411 . . . . 54.33 110.197 -179.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 97.6 mt -93.53 101.19 13.37 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.639 0.776 . . . . 75.33 109.347 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.661 ' HB3' HD23 ' A' ' 123' ' ' LEU . 48.0 mt -88.68 101.38 13.93 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.276 0.631 . . . . 74.32 109.843 179.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.441 HG22 HG22 ' A' ' 158' ' ' VAL . 60.7 t -86.1 115.45 27.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 109.406 -0.59 . . . . 74.31 109.406 176.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 9.6 p -67.64 136.69 26.11 Favored 'Isoleucine or valine' 0 C--O 1.245 0.85 0 N-CA-C 109.346 -0.612 . . . . 62.22 109.346 178.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.486 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 34.4 mmt180 -125.16 91.23 3.38 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.593 0.757 . . . . 65.5 109.406 -175.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.476 HD12 ' HA ' ' A' ' 154' ' ' ARG . 26.2 mt -97.0 132.87 42.38 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 114.759 -1.11 . . . . 72.45 109.333 173.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 75.1 mt -64.46 115.71 22.36 Favored Pre-proline 0 CA--C 1.555 1.154 0 CA-C-N 115.14 -0.937 . . . . 64.34 109.914 -178.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -85.9 44.43 1.31 Allowed 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 123.582 2.854 . . . . 65.41 114.286 -165.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 27.5 p-80 . . . . . 0 CA--C 1.56 1.338 0 N-CA-C 109.576 -0.528 . . . . 75.14 109.576 174.271 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 109.263 -0.643 . . . . 61.52 109.263 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.4 m -59.9 124.12 19.18 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.051 0.941 . . . . 23.34 111.666 -171.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.516 ' HA ' ' NH1' ' A' ' 136' ' ' ARG . 81.3 m -70.76 127.9 34.23 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 123.197 0.599 . . . . 74.2 110.345 179.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.613 HD12 ' HB2' ' A' ' 123' ' ' LEU . 26.2 pt -102.87 153.62 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.588 -0.733 . . . . 70.32 110.798 -169.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -101.79 157.97 16.45 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.299 -1.0 . . . . 64.41 108.299 170.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.548 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.7 tp -90.08 -103.81 0.09 Allowed 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 109.71 -0.478 . . . . 62.44 109.71 -177.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 177.48 -56.26 0.01 OUTLIER 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.036 0.934 . . . . 63.03 108.946 -172.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.536 HD11 ' HB ' ' A' ' 140' ' ' VAL . 75.3 mt 53.21 78.55 0.14 Allowed 'General case' 0 C--N 1.361 1.099 0 C-N-CA 124.658 1.183 . . . . 64.41 110.449 -171.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 61.7 mt -83.99 139.14 39.79 Favored Pre-proline 0 C--O 1.243 0.711 0 CA-C-N 114.705 -1.134 . . . . 74.42 109.665 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -59.04 172.36 1.73 Allowed 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 122.987 2.458 . . . . 75.44 113.604 173.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.58 157.42 36.11 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 114.71 -1.132 . . . . 74.05 111.511 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.86 -51.25 3.51 Favored Glycine 0 C--N 1.341 0.835 0 CA-C-N 115.697 -0.683 . . . . 73.53 112.433 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.0 p -73.02 93.88 1.82 Allowed 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.443 0.697 . . . . 73.34 110.614 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 158.46 108.63 0.26 Allowed Glycine 0 C--N 1.341 0.808 0 N-CA-C 109.628 -1.389 . . . . 61.53 109.628 -178.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -69.08 79.71 0.27 Allowed Glycine 0 C--N 1.357 1.712 0 C-N-CA 123.327 0.489 . . . . 54.21 114.16 -172.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.572 ' HB2' HH22 ' A' ' 120' ' ' ARG . 43.7 m -152.3 -25.67 0.17 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.278 1.031 . . . . 52.43 110.588 179.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.55 -144.4 16.72 Favored Glycine 0 C--N 1.35 1.356 0 N-CA-C 110.908 -0.877 . . . . 74.43 110.908 -171.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 171.45 50.35 0.04 OUTLIER Glycine 0 C--N 1.344 0.977 0 CA-C-N 117.113 0.457 . . . . 51.01 112.617 178.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 34.8 p -150.17 109.6 3.99 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.845 -0.798 . . . . 73.51 108.845 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 170.65 59.47 0.04 OUTLIER Glycine 0 C--N 1.342 0.888 0 N-CA-C 111.269 -0.733 . . . . 73.33 111.269 -178.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.1 171.58 28.59 Favored Glycine 0 C--N 1.345 1.057 0 O-C-N 123.951 0.442 . . . . 73.03 112.342 177.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.5 m -83.28 65.61 8.36 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.918 0.887 . . . . 63.13 110.142 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -140.41 89.25 0.19 Allowed Glycine 0 CA--C 1.508 -0.367 0 N-CA-C 109.646 -1.382 . . . . 72.12 109.646 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.468 ' HB3' ' HA3' ' A' ' 166' ' ' GLY . 14.9 tpp85 -63.97 114.32 4.03 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 109.5 -0.555 . . . . 73.05 109.5 -179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -83.46 145.9 28.7 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.955 -1.128 . . . . 73.14 107.955 175.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.2 tt -127.62 125.93 41.11 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.789 -1.56 . . . . 72.41 106.789 173.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.572 HH22 ' HB2' ' A' ' 109' ' ' SER . 2.0 tpp180 -91.01 131.79 36.39 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 108.042 -1.095 . . . . 75.31 108.042 -172.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.548 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -158.53 141.86 14.99 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 109.413 -0.588 . . . . 74.03 109.413 -176.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -128.87 131.45 47.65 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.725 -0.472 . . . . 73.55 109.725 -174.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.613 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.1 pp -104.2 113.79 64.91 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 120.643 0.259 . . . . 50.3 110.309 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 179' ' ' ARG . 36.2 Cg_endo -68.44 115.73 4.03 Favored 'Trans proline' 0 C--N 1.364 1.35 0 C-N-CA 122.411 2.074 . . . . 75.25 108.962 163.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.572 HD21 HD12 ' A' ' 149' ' ' ILE . 56.6 tp -102.83 146.11 28.76 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 109.692 -0.484 . . . . 71.14 109.692 -166.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.7 t -80.99 149.9 29.12 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 123.732 0.645 . . . . 70.15 109.612 -175.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.41 -33.92 71.82 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.187 0.995 . . . . 75.44 112.373 -170.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -61.32 -51.8 67.32 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 124.139 0.899 . . . . 75.11 110.004 178.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.449 ' HB3' HD11 ' A' ' 149' ' ' ILE . 21.4 mm-40 -73.19 -29.87 63.14 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.838 -1.074 . . . . 71.42 112.428 -174.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -64.23 -48.71 74.79 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-O 121.639 0.733 . . . . 43.23 110.52 174.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -67.74 -53.94 23.34 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 113.967 -1.469 . . . . 75.33 111.089 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -86.66 -46.72 9.8 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.696 -0.684 . . . . 63.34 111.258 -171.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 74.71 144.42 0.99 Allowed Glycine 0 C--N 1.353 1.517 0 N-CA-C 113.996 0.358 . . . . 42.04 113.996 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.409 ' O ' HG12 ' A' ' 149' ' ' ILE . . . 158.76 -152.23 23.3 Favored Glycine 0 C--N 1.341 0.815 0 N-CA-C 111.586 -0.606 . . . . 74.32 111.586 -178.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -76.46 116.69 17.38 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.297 -0.631 . . . . 70.11 109.297 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.516 ' NH1' ' HA ' ' A' ' 96' ' ' THR . 0.0 OUTLIER -112.06 133.41 54.24 Favored 'General case' 0 C--N 1.346 0.452 0 C-N-CA 123.173 0.589 . . . . 70.51 110.428 179.525 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 85.8 t -90.91 124.97 43.69 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 C-N-CA 124.487 1.115 . . . . 73.3 110.088 177.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 97' ' ' ILE . 5.8 p -134.24 126.23 49.08 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 124.606 1.162 . . . . 75.41 108.796 177.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -99.33 140.04 34.09 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.222 0.609 . . . . 74.44 110.726 -174.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.536 ' HB ' HD11 ' A' ' 101' ' ' LEU . 15.4 m -138.75 101.11 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 124.672 1.189 . . . . 75.5 110.303 -178.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.0 26.63 16.09 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.924 0.89 . . . . 55.31 111.679 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.0 -6.12 58.21 Favored Glycine 0 C--N 1.352 1.462 0 CA-C-N 116.014 -0.539 . . . . 64.22 113.741 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.478 ' HB3' HG23 ' A' ' 140' ' ' VAL . 18.0 tpp85 -93.31 119.81 32.88 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.54 0.736 . . . . 75.3 109.853 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -84.08 114.31 21.66 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.25 0.62 . . . . 73.55 109.764 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.415 ' HB ' HG13 ' A' ' 138' ' ' VAL . 36.3 t -107.35 117.57 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.26 1.024 . . . . 73.11 108.698 177.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.5 t -103.5 119.08 38.19 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 108.442 -0.948 . . . . 62.02 108.442 175.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.6 m -125.72 135.84 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.79 0.836 . . . . 71.44 109.678 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 45.4 ttt85 -81.43 103.48 11.21 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.437 -0.579 . . . . 74.45 109.437 177.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.572 HD12 HD21 ' A' ' 125' ' ' LEU . 13.4 pt -79.93 142.05 55.7 Favored Pre-proline 0 CA--C 1.557 1.23 0 CA-C-N 115.032 -0.986 . . . . 74.3 109.218 172.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.61 138.79 42.67 Favored 'Trans proline' 0 CA--C 1.562 1.906 0 C-N-CA 121.979 1.786 . . . . 65.53 112.146 176.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -55.45 123.98 15.15 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 123.169 2.58 . . . . 73.31 112.88 171.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 76.56 32.17 51.77 Favored Glycine 0 C--N 1.351 1.413 0 N-CA-C 112.23 -0.348 . . . . 40.32 112.23 -177.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.87 140.28 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 C-N-CA 123.659 0.784 . . . . 64.42 109.707 174.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 21.0 mtp180 -118.14 152.67 35.17 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.816 0.846 . . . . 73.22 109.75 -175.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -45.4 129.24 8.33 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 124.966 1.416 . . . . 64.31 111.952 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 104.75 -16.81 46.89 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-O 119.261 -0.744 . . . . 65.42 113.742 177.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.7 m -60.48 119.72 8.57 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 117.652 0.726 . . . . 71.32 111.036 177.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.431 HG22 HG22 ' A' ' 177' ' ' VAL . 49.2 t -101.24 112.34 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 109.383 -0.599 . . . . 74.32 109.383 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 63.7 mt -91.82 106.99 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 108.176 -1.046 . . . . 73.33 108.176 173.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 -87.46 107.24 18.47 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.173 0.589 . . . . 75.24 109.452 -177.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.59 HG13 ' HB3' ' A' ' 174' ' ' LEU . 3.3 p -104.39 100.66 23.12 Favored Pre-proline 0 CA--C 1.56 1.341 0 N-CA-C 109.706 -0.479 . . . . 60.31 109.706 175.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 58.2 Cg_endo -68.52 156.34 65.91 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.0 2.467 . . . . 64.13 112.709 -178.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 81.91 -8.33 60.32 Favored Glycine 0 C--N 1.349 1.261 0 N-CA-C 114.37 0.508 . . . . 50.25 114.37 176.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 39.3 mtp -106.29 -13.0 15.51 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.387 0.675 . . . . 51.35 112.555 -175.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -84.04 -86.1 0.88 Allowed Glycine 0 C--N 1.344 1.005 0 N-CA-C 111.539 -0.625 . . . . 30.54 111.539 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.468 ' HA3' ' HB3' ' A' ' 117' ' ' ARG . . . -73.32 106.15 1.93 Allowed Glycine 0 C--N 1.342 0.876 0 O-C-N 123.906 0.415 . . . . 41.21 112.58 175.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -88.25 158.92 18.34 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 123.509 0.724 . . . . 60.42 109.055 175.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 132.67 -117.29 1.95 Allowed Glycine 0 C--N 1.34 0.803 0 N-CA-C 111.181 -0.768 . . . . 75.35 111.181 -179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.56 ' H ' ' HD2' ' A' ' 170' ' ' PRO . 95.4 m-20 -118.87 -46.16 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 CA-C-O 118.019 -0.991 . . . . 52.24 111.565 175.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.56 ' HD2' ' H ' ' A' ' 169' ' ' ASN . 74.1 Cg_endo -75.53 111.13 3.23 Favored 'Trans proline' 0 C--N 1.392 2.864 0 CA-C-N 121.083 1.422 . . . . 74.14 110.7 168.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.85 127.92 15.21 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.336 2.024 . . . . 74.41 112.051 -175.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -115.13 159.26 13.85 Favored Glycine 0 C--N 1.338 0.687 0 CA-C-N 115.876 -0.602 . . . . 45.21 112.297 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.519 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 9.2 p-10 -96.12 153.18 17.93 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.876 0.87 . . . . 53.12 111.341 -171.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.59 ' HB3' HG13 ' A' ' 161' ' ' VAL . 48.1 tp -115.02 106.97 14.76 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 107.723 -1.214 . . . . 74.13 107.723 178.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 85.5 mt -84.85 104.87 15.19 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.749 0.82 . . . . 65.33 109.834 -175.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.42 HD22 HD11 ' A' ' 99' ' ' LEU . 58.4 mt -96.42 102.07 13.8 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.449 0.699 . . . . 71.55 110.528 -177.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.431 HG22 HG22 ' A' ' 158' ' ' VAL . 25.3 t -86.42 119.22 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 108.977 -0.749 . . . . 72.5 108.977 176.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 5.4 p -71.06 138.12 22.42 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 N-CA-C 108.971 -0.752 . . . . 73.45 108.971 178.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 124' ' ' PRO . 22.0 mmm180 -127.84 100.77 6.06 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.955 0.902 . . . . 75.4 109.015 -173.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 91.8 mt -109.24 130.23 55.49 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.629 -0.714 . . . . 71.21 109.545 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 75.3 mt -60.3 145.28 86.42 Favored Pre-proline 0 CA--C 1.548 0.871 0 O-C-N 124.449 1.093 . . . . 72.51 110.926 -176.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -50.73 -29.86 27.28 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 123.671 2.914 . . . . 73.31 113.672 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 . . . . . 0 C--O 1.249 1.07 0 N-CA-C 108.674 -0.862 . . . . 74.2 108.674 170.807 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 69.8 mtm . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 108.749 -0.834 . . . . 73.04 108.749 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.1 p -75.87 146.24 39.94 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.763 0.825 . . . . 75.15 111.654 -173.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 42.9 m -81.28 145.99 30.63 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.068 0.947 . . . . 74.45 110.396 179.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.6 pt -128.75 172.19 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.971 0.908 . . . . 72.32 110.344 -176.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -134.15 147.98 50.87 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.234 1.013 . . . . 74.43 110.044 -176.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.555 ' HB3' HG11 ' A' ' 140' ' ' VAL . 11.5 tp -85.2 173.91 10.05 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 108.69 -0.856 . . . . 73.24 108.69 -177.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -97.19 -33.47 11.47 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.974 -0.454 . . . . 74.11 111.855 175.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.2 mt 49.98 61.96 2.91 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.706 0.803 . . . . 74.45 110.668 -171.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 71.6 mt -64.46 111.0 4.67 Favored Pre-proline 0 CA--C 1.556 1.203 0 CA-C-N 115.616 -0.72 . . . . 54.12 109.289 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.25 166.22 17.58 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.205 1.937 . . . . 62.44 112.085 -173.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.53 83.64 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.194 0 CA-C-O 121.782 0.801 . . . . 62.34 111.827 177.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.72 -30.16 45.04 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 114.955 -1.02 . . . . 64.53 111.286 174.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.1 t -120.21 166.35 13.58 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.421 1.088 . . . . 75.23 108.696 173.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.7 150.09 34.08 Favored Glycine 0 C--N 1.342 0.902 0 CA-C-N 116.251 -0.431 . . . . 75.31 112.56 178.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -85.99 -168.5 44.84 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-O 121.164 0.313 . . . . 73.15 112.978 175.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.8 m -106.0 150.69 25.48 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.89 0.876 . . . . 73.3 109.981 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -156.15 -157.74 8.47 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 111.851 -0.5 . . . . 61.31 111.851 178.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 164.78 -155.13 26.35 Favored Glycine 0 C--N 1.349 1.288 0 CA-C-N 117.113 0.457 . . . . 70.1 112.873 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.0 t -64.03 -42.43 97.1 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.271 1.028 . . . . 73.02 110.965 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -119.58 14.85 10.68 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.494 -0.642 . . . . 73.43 111.494 172.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -91.53 91.88 1.67 Allowed Glycine 0 C--N 1.346 1.107 0 N-CA-C 111.331 -0.707 . . . . 71.34 111.331 178.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 54.6 m -132.65 104.3 6.57 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.947 0.899 . . . . 64.53 109.368 177.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 171.81 108.83 0.22 Allowed Glycine 0 C--N 1.344 0.986 0 N-CA-C 110.801 -0.92 . . . . 32.53 110.801 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.483 ' O ' ' HA3' ' A' ' 172' ' ' GLY . 28.6 ttm180 -72.79 122.81 22.16 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.536 0.735 . . . . 73.11 111.132 -178.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -84.65 135.76 34.04 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.191 -1.04 . . . . 71.11 108.191 174.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.8 tt -110.33 125.58 53.33 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 105.688 -1.967 . . . . 73.43 105.688 174.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.463 ' HG2' HD12 ' A' ' 175' ' ' LEU . 27.5 mtp180 -91.96 144.54 25.36 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.361 -0.977 . . . . 64.43 108.361 -175.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.545 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -158.75 156.44 29.83 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.625 -0.509 . . . . 64.41 109.625 -174.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -129.37 138.85 51.76 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.994 -0.743 . . . . 73.04 108.994 176.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 55.7 tp -110.43 101.7 49.3 Favored Pre-proline 0 CA--C 1.538 0.482 0 O-C-N 123.815 0.697 . . . . 71.21 109.842 -175.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.9 112.47 3.11 Favored 'Trans proline' 0 C--N 1.372 1.81 0 N-CA-C 108.253 -1.479 . . . . 53.33 108.253 169.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.499 HD21 HD12 ' A' ' 149' ' ' ILE . 35.1 tp -104.87 138.02 41.75 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.47 -0.567 . . . . 73.32 109.47 -168.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 6.0 t -81.76 153.94 26.24 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 109.124 -0.695 . . . . 71.44 109.124 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 74.2 mt -61.67 -33.61 74.28 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.525 0.73 . . . . 74.33 112.195 -169.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.0 -44.16 97.82 Favored 'General case' 0 C--O 1.22 -0.488 0 O-C-N 124.311 1.007 . . . . 63.1 109.477 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -79.15 -29.22 42.95 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.369 -0.832 . . . . 74.53 112.101 -175.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -60.52 -39.8 89.16 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.342 0.591 . . . . 62.54 110.21 172.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -74.07 -57.22 4.11 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 114.715 -1.13 . . . . 72.31 110.748 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -61.32 -50.61 72.26 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.122 0.569 . . . . 72.03 110.923 -173.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.609 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 63.71 67.7 1.95 Allowed Glycine 0 C--N 1.337 0.616 0 CA-C-N 114.763 -1.108 . . . . 65.12 112.128 -172.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -134.15 -160.0 9.09 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 112.508 -0.237 . . . . 63.45 112.508 -177.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -82.42 116.75 22.02 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.081 -0.711 . . . . 62.14 109.081 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -114.13 126.68 55.35 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 123.277 0.631 . . . . 74.1 109.338 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 83.0 t -70.52 110.61 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 O-C-N 124.305 1.003 . . . . 74.44 108.85 173.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 60.9 t -113.87 109.75 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 108.286 -1.005 . . . . 62.24 108.286 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -117.15 124.52 49.36 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.351 -0.611 . . . . 73.3 109.351 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.555 HG11 ' HB3' ' A' ' 99' ' ' LEU . 5.8 p -149.63 136.09 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.71 1.204 . . . . 74.31 108.601 -175.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 61.89 18.76 10.09 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.086 0.954 . . . . 75.01 112.322 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 88.01 -5.93 84.19 Favored Glycine 0 C--N 1.35 1.344 0 CA-C-N 116.075 -0.511 . . . . 61.0 113.183 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -94.99 121.87 37.06 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.265 1.026 . . . . 75.51 109.525 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -108.14 115.28 29.84 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.031 0.933 . . . . 75.43 110.31 -174.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.8 p -126.04 119.37 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.239 1.015 . . . . 74.23 109.601 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 39.5 t -88.32 108.71 19.47 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 109.205 -0.665 . . . . 73.35 109.205 176.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 7.2 p -100.76 127.61 53.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 123.014 0.526 . . . . 71.44 110.802 -178.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -85.01 103.04 13.69 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.792 -0.818 . . . . 71.55 108.792 172.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.609 HG13 ' HA2' ' A' ' 133' ' ' GLY . 11.6 pt -86.64 151.79 53.4 Favored Pre-proline 0 CA--C 1.562 1.424 0 C-N-CA 124.518 1.127 . . . . 71.43 109.507 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.442 ' HG2' ' HB ' ' A' ' 153' ' ' VAL . 55.2 Cg_endo -71.37 146.32 50.22 Favored 'Trans proline' 0 CA--C 1.565 2.049 0 C-N-CA 122.108 1.872 . . . . 53.35 112.514 174.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.407 ' HA ' ' HA3' ' A' ' 133' ' ' GLY . 23.6 Cg_exo -67.11 124.92 12.79 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.991 2.461 . . . . 62.4 112.036 174.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 81.18 24.52 57.14 Favored Glycine 0 C--N 1.35 1.318 0 O-C-N 123.478 0.486 . . . . 30.12 112.101 -175.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.442 ' HB ' ' HG2' ' A' ' 150' ' ' PRO . 4.4 p -60.65 128.83 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 C-N-CA 123.959 0.903 . . . . 72.34 109.413 173.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.468 ' HA ' HD12 ' A' ' 180' ' ' LEU . 76.9 mtp180 -123.56 166.43 15.46 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.118 0.567 . . . . 62.03 110.047 -175.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -45.31 129.62 8.16 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 125.709 1.604 . . . . 75.44 113.357 -172.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.92 -2.66 66.6 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-O 119.404 -0.664 . . . . 65.02 114.623 175.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.6 t -69.56 122.34 18.87 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 117.651 0.725 . . . . 61.44 109.57 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 45.6 t -101.2 113.18 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.186 0.594 . . . . 75.5 109.886 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 51.6 mt -91.52 117.63 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 107.886 -1.153 . . . . 72.31 107.886 170.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -104.97 101.11 10.7 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.924 -0.769 . . . . 73.03 108.924 -173.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.4 p -107.76 107.72 60.64 Favored Pre-proline 0 CA--C 1.556 1.199 0 C-N-CA 123.148 0.579 . . . . 70.52 110.722 -176.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.553 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 59.8 Cg_endo -69.37 147.34 65.19 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.561 2.174 . . . . 44.44 112.709 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 85.41 -3.14 87.64 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 115.794 -0.639 . . . . 64.53 113.527 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 24.7 mmt -103.42 -16.94 15.45 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.304 0.641 . . . . 73.3 110.772 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -91.58 -108.17 1.56 Allowed Glycine 0 C--N 1.349 1.302 0 CA-C-O 119.541 -0.589 . . . . 53.44 113.173 -175.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -60.43 100.39 0.22 Allowed Glycine 0 C--N 1.349 1.28 0 O-C-N 123.861 0.389 . . . . 65.14 112.661 177.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -88.34 116.26 26.43 Favored 'General case' 0 C--O 1.243 0.738 0 C-N-CA 124.04 0.936 . . . . 54.04 109.169 177.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 160.15 -149.21 18.5 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.5 -0.64 . . . . 54.22 111.5 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -70.97 -48.96 13.68 Favored Pre-proline 0 CA--C 1.561 1.369 0 CA-C-O 117.9 -1.047 . . . . 75.34 111.822 177.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.425 ' HA ' ' HD3' ' A' ' 171' ' ' PRO . 87.0 Cg_endo -81.81 110.62 2.14 Favored 'Trans proline' 0 C--N 1.391 2.801 0 C-N-CA 121.572 1.514 . . . . 74.0 110.749 174.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 170' ' ' PRO . 14.4 Cg_exo -67.79 123.6 10.91 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.358 2.039 . . . . 75.52 110.807 -174.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 117' ' ' ARG . . . -115.67 152.09 18.16 Favored Glycine 0 C--N 1.335 0.477 0 N-CA-C 114.004 0.361 . . . . 43.22 114.004 -172.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.553 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 6.8 p-10 -91.66 155.64 18.17 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.516 1.126 . . . . 71.02 110.53 178.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 41.3 tp -112.97 115.52 28.52 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.947 -0.76 . . . . 51.41 108.947 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.463 HD12 ' HG2' ' A' ' 120' ' ' ARG . 73.5 mt -84.53 106.93 16.48 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.102 0.961 . . . . 70.43 109.513 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 27.2 mt -99.54 98.75 9.6 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.843 -0.799 . . . . 72.42 108.843 178.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 8.5 p -95.75 110.69 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 109.092 -0.706 . . . . 74.23 109.092 178.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 11.0 p -66.67 143.77 15.28 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 C-N-CA 123.299 0.64 . . . . 53.11 111.275 -172.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 -126.14 103.11 7.52 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 125.042 1.337 . . . . 75.44 108.192 -174.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 154' ' ' ARG . 91.8 mt -113.45 131.42 56.03 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.53 0.732 . . . . 55.34 109.984 177.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 81.4 mt -71.04 125.81 92.02 Favored Pre-proline 0 CA--C 1.548 0.896 0 N-CA-C 108.374 -0.972 . . . . 72.31 108.374 173.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.37 -28.7 73.82 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.842 2.361 . . . . 62.25 113.107 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 . . . . . 0 C--O 1.246 0.897 0 C-N-CA 124.734 1.214 . . . . 62.54 107.961 174.998 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.509 ' HB3' ' NH2' ' A' ' 136' ' ' ARG . 59.1 mtt . . . . . 0 N--CA 1.477 0.886 0 N-CA-C 109.299 -0.63 . . . . 52.51 109.299 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.1 m -70.66 134.17 47.3 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.454 0.702 . . . . 73.12 111.062 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 20.6 m -73.55 138.35 44.93 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.938 0.495 . . . . 71.13 109.73 174.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.64 HD12 ' HB2' ' A' ' 123' ' ' LEU . 21.3 pt -109.53 175.42 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 122.992 0.517 . . . . 64.11 111.547 -166.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -122.81 -167.62 1.61 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.388 1.075 . . . . 72.02 109.617 173.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.689 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.9 tp -142.06 156.26 45.4 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 108.655 -0.868 . . . . 72.24 108.655 -175.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.415 ' HB3' ' H ' ' A' ' 122' ' ' GLU . . . -78.44 -56.99 4.01 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.269 0.228 . . . . 43.02 110.468 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 95.9 mt 60.19 73.49 0.48 Allowed 'General case' 0 CA--C 1.553 1.078 0 O-C-N 124.366 1.041 . . . . 74.32 109.902 -170.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 79.5 mt -70.89 155.94 92.69 Favored Pre-proline 0 CA--C 1.561 1.382 0 C-N-CA 125.251 1.421 . . . . 75.52 111.766 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.16 -170.64 0.43 Allowed 'Trans proline' 0 C--N 1.386 2.532 0 C-N-CA 123.307 2.671 . . . . 73.03 113.646 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 pp -72.12 2.4 5.89 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 114.393 1.257 . . . . 74.23 114.393 -169.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -73.59 81.75 0.72 Allowed Glycine 0 C--N 1.352 1.465 0 CA-C-N 118.192 0.451 . . . . 64.12 112.606 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 73.1 p -157.19 127.55 6.44 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.774 0.83 . . . . 72.43 110.822 -178.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -89.44 77.56 1.68 Allowed Glycine 0 C--N 1.341 0.844 0 N-CA-C 110.7 -0.96 . . . . 62.1 110.7 172.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -60.54 89.17 0.04 OUTLIER Glycine 0 C--N 1.355 1.629 0 C-N-CA 123.874 0.749 . . . . 64.31 112.539 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.3 m -96.13 119.89 35.43 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.252 1.021 . . . . 44.31 110.572 -176.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -141.53 159.7 26.82 Favored Glycine 0 C--N 1.343 0.931 0 N-CA-C 111.541 -0.624 . . . . 33.24 111.541 176.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -65.64 -50.53 53.73 Favored Glycine 0 C--N 1.35 1.339 0 O-C-N 123.766 0.333 . . . . 73.03 112.525 -177.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 65.1 p -89.27 141.48 28.49 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.425 0.69 . . . . 53.35 109.844 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -98.43 136.71 12.86 Favored Glycine 0 C--N 1.345 1.047 0 O-C-N 123.265 0.353 . . . . 43.33 112.397 -177.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -171.69 163.86 36.51 Favored Glycine 0 C--N 1.344 1.017 0 N-CA-C 112.244 -0.342 . . . . 74.2 112.244 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.0 t -84.27 143.26 29.67 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.285 0.634 . . . . 73.22 110.274 177.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 144.33 96.45 0.22 Allowed Glycine 0 C--N 1.34 0.769 0 N-CA-C 109.894 -1.282 . . . . 55.12 109.894 -176.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -61.2 123.69 18.41 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.584 0.753 . . . . 74.12 111.293 -175.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -74.63 116.23 15.09 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 108.736 -0.838 . . . . 62.34 108.736 172.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.7 tt -94.9 118.89 32.53 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 106.735 -1.58 . . . . 64.21 106.735 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -90.98 141.66 28.61 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 108.726 -0.842 . . . . 71.41 108.726 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.689 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -153.25 142.77 21.77 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.821 -0.627 . . . . 64.03 109.545 -171.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.459 ' HB3' ' HG3' ' A' ' 179' ' ' ARG . 35.3 mt-10 -119.69 118.3 30.56 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.181 -1.044 . . . . 62.03 108.181 -174.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.64 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.6 pp -100.74 113.91 65.71 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 108.914 -0.772 . . . . 74.33 108.914 176.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.13 113.95 3.91 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 121.864 1.709 . . . . 41.04 109.335 170.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.571 HD21 HD12 ' A' ' 149' ' ' ILE . 36.1 tp -103.12 151.05 23.03 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 122.004 -0.435 . . . . 70.43 110.601 -167.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 13.4 t -85.61 154.61 21.59 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.955 -0.757 . . . . 72.05 108.955 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 39.3 mt -70.78 -26.68 63.45 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.215 0.606 . . . . 72.23 111.805 -167.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -73.49 -41.82 62.63 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.397 -0.82 . . . . 62.22 110.08 -178.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.471 ' HB3' HD11 ' A' ' 149' ' ' ILE . 34.1 mm-40 -74.4 -31.26 62.27 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.185 -0.916 . . . . 72.13 111.158 177.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.71 -50.83 70.87 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.425 0.69 . . . . 73.53 110.5 176.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -66.67 -62.89 1.22 Allowed 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 114.223 -1.353 . . . . 72.1 110.641 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -70.32 -43.75 69.65 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.929 0.491 . . . . 71.24 111.89 -171.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.43 97.56 0.05 OUTLIER Glycine 0 C--N 1.346 1.103 0 O-C-N 123.816 0.697 . . . . 61.34 113.063 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.4 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -144.06 -143.64 4.09 Favored Glycine 0 C--N 1.342 0.883 0 N-CA-C 111.097 -0.801 . . . . 70.01 111.097 178.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -96.26 119.07 34.09 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 108.845 -0.798 . . . . 72.14 108.845 176.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.509 ' NH2' ' HB3' ' A' ' 94' ' ' MET . 11.0 tpp180 -116.98 123.79 47.78 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.412 0.685 . . . . 71.12 109.386 176.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 146' ' ' SER . 76.2 t -74.47 136.9 24.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 C-N-CA 123.621 0.768 . . . . 72.31 110.683 177.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.455 ' HB ' HG13 ' A' ' 145' ' ' VAL . 39.1 t -115.59 126.17 73.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.29 1.436 . . . . 61.51 107.615 174.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -115.23 101.51 9.02 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.632 -0.507 . . . . 72.14 109.632 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.66 144.16 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 123.719 0.808 . . . . 74.32 110.907 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 65.32 18.69 11.45 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 125.283 1.433 . . . . 64.54 111.746 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.19 21.76 69.71 Favored Glycine 0 C--N 1.351 1.37 0 CA-C-N 116.016 -0.538 . . . . 72.44 112.257 -175.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -122.45 140.06 53.15 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.923 0.889 . . . . 63.01 110.204 -177.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -102.69 125.32 49.38 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.206 1.002 . . . . 71.42 108.719 177.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.455 HG13 ' HB ' ' A' ' 138' ' ' VAL . 3.5 p -137.78 112.26 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.996 0 CA-C-O 121.54 0.686 . . . . 73.0 110.2 176.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 137' ' ' VAL . 46.4 t -90.43 106.0 18.2 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 109.189 -0.671 . . . . 53.31 109.189 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 28.7 m -100.62 141.15 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.232 0.613 . . . . 72.15 110.13 -178.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.1 ttp180 -90.84 117.47 29.48 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.284 -0.635 . . . . 73.32 109.284 177.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.571 HD12 HD21 ' A' ' 125' ' ' LEU . 9.1 pt -100.49 139.77 20.89 Favored Pre-proline 0 CA--C 1.561 1.378 0 C-N-CA 124.871 1.268 . . . . 73.24 109.307 176.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -63.14 152.46 79.52 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 123.083 2.522 . . . . 74.11 113.695 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.47 121.3 9.04 Favored 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 122.272 1.981 . . . . 62.51 111.228 171.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 85.21 23.64 47.51 Favored Glycine 0 C--N 1.346 1.084 0 N-CA-C 112.13 -0.388 . . . . 45.51 112.13 -176.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.493 HG11 ' HB ' ' A' ' 149' ' ' ILE . 4.1 p -63.53 117.45 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 C-N-CA 123.784 0.833 . . . . 61.11 109.853 177.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.528 ' HA ' HD12 ' A' ' 180' ' ' LEU . 82.0 mtm180 -132.89 161.93 32.93 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-N 115.923 -0.58 . . . . 74.31 110.847 -172.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -35.29 119.77 0.51 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.881 2.072 . . . . 55.24 113.838 -169.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 105.24 -12.14 48.13 Favored Glycine 0 N--CA 1.473 1.145 0 CA-C-O 119.297 -0.724 . . . . 71.43 114.552 177.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 33.5 t -66.22 122.3 17.15 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 117.832 0.816 . . . . 51.05 109.243 176.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 48.0 t -110.0 114.55 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.347 0.659 . . . . 74.14 110.402 -176.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 56.0 mt -92.48 120.6 42.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 108.355 -0.98 . . . . 72.33 108.355 172.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -104.67 116.63 32.38 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.305 0.642 . . . . 74.32 110.143 -176.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.489 HG13 ' HB3' ' A' ' 174' ' ' LEU . 3.3 p -120.45 108.58 37.52 Favored Pre-proline 0 CA--C 1.559 1.316 0 C-N-CA 123.031 0.532 . . . . 70.51 110.725 176.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.418 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 16.7 Cg_exo -67.59 153.46 76.23 Favored 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.886 2.391 . . . . 65.4 112.267 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 86.01 -24.19 8.3 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-O 119.864 -0.409 . . . . 72.24 113.909 177.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 92.9 mmm -92.44 -4.92 52.96 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.66 0.784 . . . . 60.23 111.224 -177.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -91.21 -103.02 1.3 Allowed Glycine 0 C--N 1.344 1.007 0 CA-C-O 119.719 -0.49 . . . . 64.52 112.409 -177.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -65.52 103.8 0.88 Allowed Glycine 0 C--N 1.352 1.418 0 N-CA-C 111.467 -0.653 . . . . 72.11 111.467 175.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.544 HE21 ' HA ' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -87.76 121.47 30.22 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.484 0.714 . . . . 71.34 110.72 -174.923 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 169.88 -146.21 9.82 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 110.633 -0.987 . . . . 75.44 110.633 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -76.79 -49.15 2.68 Favored Pre-proline 0 CA--C 1.56 1.331 0 CA-C-O 118.075 -0.964 . . . . 72.32 109.332 172.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -81.61 112.62 2.46 Favored 'Trans proline' 0 C--N 1.4 3.243 0 C-N-CA 122.173 1.915 . . . . 61.43 111.316 170.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -74.43 127.75 11.36 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 122.502 2.135 . . . . 52.34 112.239 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -104.88 165.88 14.62 Favored Glycine 0 C--N 1.344 1.022 0 CA-C-N 116.365 -0.38 . . . . 73.34 112.256 179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 15.2 m-20 -86.25 142.71 28.37 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.855 0.862 . . . . 51.24 110.773 -177.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.489 ' HB3' HG13 ' A' ' 161' ' ' VAL . 34.5 tp -105.35 104.62 14.39 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 107.934 -1.136 . . . . 75.04 107.934 175.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 51.1 mt -88.46 101.17 13.66 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.197 -0.91 . . . . 73.21 109.282 -175.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 48.0 mt -97.1 101.11 12.61 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.896 0.878 . . . . 71.2 110.455 -174.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.3 p -92.48 130.33 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 109.893 -0.41 . . . . 63.15 109.893 175.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 14.1 p -77.54 133.81 29.83 Favored 'Isoleucine or valine' 0 C--O 1.248 0.999 0 C-N-CA 123.338 0.655 . . . . 72.32 110.053 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.459 ' HG3' ' HB3' ' A' ' 122' ' ' GLU . 9.1 mmm180 -122.6 96.38 5.01 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.167 0.987 . . . . 74.45 108.795 -174.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.528 HD12 ' HA ' ' A' ' 154' ' ' ARG . 64.5 mt -101.23 147.65 26.03 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.657 -0.701 . . . . 71.52 110.588 177.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 61.4 mt -74.83 157.09 86.08 Favored Pre-proline 0 CA--C 1.556 1.186 0 CA-C-N 114.998 -1.001 . . . . 74.44 108.717 171.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.13 2.26 5.11 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.267 1.978 . . . . 73.35 112.991 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 . . . . . 0 CA--C 1.554 1.117 0 C-N-CA 124.672 1.189 . . . . 73.31 108.968 174.01 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 CA--C 1.545 0.766 0 N-CA-C 109.719 -0.474 . . . . 52.3 109.719 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.431 ' H ' HG21 ' A' ' 126' ' ' THR . 23.0 t -82.01 132.65 35.26 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.397 0.679 . . . . 72.33 110.251 178.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.425 ' HA ' HH11 ' A' ' 136' ' ' ARG . 63.9 m -76.05 143.04 41.61 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.607 0.763 . . . . 71.24 110.052 174.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.624 HD12 ' HB2' ' A' ' 123' ' ' LEU . 15.6 pt -121.4 173.02 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 C-N-CA 123.012 0.525 . . . . 75.24 111.651 -165.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -124.86 -172.39 2.56 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.321 1.048 . . . . 42.52 109.541 174.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.649 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 11.6 tp -131.65 148.91 52.63 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 107.677 -1.231 . . . . 75.33 107.677 -177.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.48 -43.16 67.1 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 117.983 0.356 . . . . 65.32 110.949 178.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 41.8 mt 53.01 79.62 0.12 Allowed 'General case' 0 N--CA 1.477 0.916 0 O-C-N 124.473 1.108 . . . . 75.13 110.907 -173.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 35.0 mt -86.37 121.26 72.47 Favored Pre-proline 0 CA--C 1.544 0.726 0 N-CA-C 108.29 -1.004 . . . . 74.01 108.29 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.46 87.35 0.27 Allowed 'Trans proline' 0 C--N 1.378 2.126 0 C-N-CA 122.512 2.141 . . . . 73.52 112.497 -177.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.466 ' HG ' ' HA2' ' A' ' 110' ' ' GLY . 2.9 mm? 64.84 -81.33 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.403 1.481 . . . . 73.54 112.212 174.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -145.55 -175.62 18.8 Favored Glycine 0 C--N 1.34 0.792 0 O-C-N 123.473 0.483 . . . . 64.22 112.125 -176.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 23.2 t -65.46 130.62 43.97 Favored 'General case' 0 CA--C 1.546 0.788 0 C-N-CA 123.55 0.74 . . . . 73.34 111.189 -176.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 82.0 7.96 87.21 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 115.904 -0.589 . . . . 41.42 112.792 -177.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.38 32.76 59.56 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-N 116.76 0.28 . . . . 70.23 112.575 -176.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 35.3 p -73.78 96.55 2.57 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.071 0.548 . . . . 72.42 110.251 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.466 ' HA2' ' HG ' ' A' ' 104' ' ' LEU . . . -77.37 69.2 2.58 Favored Glycine 0 C--N 1.35 1.351 0 CA-C-N 115.872 -0.604 . . . . 24.35 112.305 177.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -92.44 49.36 2.64 Favored Glycine 0 C--N 1.343 0.971 0 C-N-CA 123.031 0.348 . . . . 71.43 113.089 -173.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 27.5 p -98.28 137.43 37.03 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 109.278 -0.638 . . . . 53.4 109.278 175.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -73.54 -81.3 0.41 Allowed Glycine 0 C--N 1.351 1.388 0 O-C-N 123.638 0.586 . . . . 73.4 113.481 -173.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -115.34 -150.82 9.84 Favored Glycine 0 C--N 1.346 1.132 0 N-CA-C 111.935 -0.466 . . . . 54.34 111.935 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 47.6 p -65.47 91.94 0.13 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.302 1.041 . . . . 55.12 111.071 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 153.93 55.94 0.01 OUTLIER Glycine 0 C--N 1.344 1.012 0 CA-C-N 115.849 -0.614 . . . . 73.44 112.132 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.457 ' HD2' HD21 ' A' ' 104' ' ' LEU . 21.4 ttp180 -68.49 124.08 22.58 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.67 0.788 . . . . 74.52 111.327 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -91.38 111.19 22.58 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.627 0.771 . . . . 73.33 109.984 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.0 tt -95.18 127.32 41.14 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 106.885 -1.524 . . . . 61.01 106.885 173.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.6 tpt180 -90.04 124.03 34.42 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 107.831 -1.174 . . . . 64.43 107.831 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.649 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -146.15 144.85 30.23 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.156 0.582 . . . . 73.3 110.121 -173.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -128.75 131.11 47.84 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.655 0.382 . . . . 75.51 110.144 -177.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.624 ' HB2' HD12 ' A' ' 97' ' ' ILE . 4.2 pp -107.61 119.71 49.66 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 109.223 -0.658 . . . . 74.33 109.223 177.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.562 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 66.9 Cg_endo -74.14 113.94 3.91 Favored 'Trans proline' 0 C--N 1.364 1.385 0 C-N-CA 122.512 2.142 . . . . 45.53 109.404 169.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 42.1 tp -102.66 154.17 19.41 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 109.326 -0.62 . . . . 74.2 109.326 -168.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.431 HG21 ' H ' ' A' ' 95' ' ' SER . 1.5 t -91.27 148.02 22.64 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 108.154 -1.054 . . . . 74.45 108.154 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.401 HD23 HD22 ' A' ' 180' ' ' LEU . 89.4 mt -64.41 -27.47 69.02 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.106 0.562 . . . . 65.44 111.883 -172.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -67.24 -41.76 85.1 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.799 0.839 . . . . 74.51 110.035 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.417 ' HG3' ' HE ' ' A' ' 136' ' ' ARG . 21.5 mm-40 -75.07 -34.78 61.84 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.384 0.674 . . . . 73.21 111.345 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -59.72 -34.62 73.16 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.287 0.635 . . . . 62.13 110.817 171.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -76.34 -46.81 25.85 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 114.773 -1.103 . . . . 74.41 111.437 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 34.3 m80 -73.54 -49.97 23.75 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 120.804 0.335 . . . . 74.25 111.457 -173.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.444 ' HA2' HG13 ' A' ' 149' ' ' ILE . . . 70.44 66.22 2.26 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-N 115.422 -0.808 . . . . 52.51 112.226 -173.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -134.44 -158.76 8.58 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 112.45 -0.26 . . . . 54.53 112.45 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -74.98 115.1 14.21 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.594 0.758 . . . . 62.21 109.058 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.425 HH11 ' HA ' ' A' ' 96' ' ' THR . 5.0 tpp180 -114.34 120.61 40.96 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.233 0.54 . . . . 62.3 109.72 178.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 88.1 t -77.17 111.73 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.712 0 CA-C-N 114.825 -1.08 . . . . 50.32 110.124 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 43.6 t -102.89 112.07 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.97 1.308 . . . . 73.02 107.905 172.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -115.13 115.2 26.37 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.008 -0.738 . . . . 74.51 109.008 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.547 HG11 ' HB3' ' A' ' 99' ' ' LEU . 7.6 p -151.61 138.29 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 124.209 1.004 . . . . 63.45 110.035 -178.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 62.88 18.59 10.92 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.529 1.132 . . . . 64.3 113.472 171.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.63 -2.63 80.62 Favored Glycine 0 C--N 1.351 1.369 0 C-N-CA 122.831 0.253 . . . . 73.14 112.891 -176.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 18.6 tpp180 -99.01 117.51 33.68 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.279 1.031 . . . . 73.14 108.766 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -106.56 105.62 15.74 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 108.393 -0.966 . . . . 71.32 108.393 172.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.4 p -114.16 137.1 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.845 0.858 . . . . 72.22 109.225 178.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.8 t -97.89 114.89 27.09 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.51 -0.922 . . . . 73.53 108.51 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 33.7 t -100.45 111.6 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.479 1.112 . . . . 71.51 109.131 -178.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -79.88 96.66 6.42 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.589 -0.893 . . . . 72.42 108.589 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.449 ' HB ' HG11 ' A' ' 153' ' ' VAL . 10.1 pt -81.04 147.6 61.83 Favored Pre-proline 0 CA--C 1.56 1.348 0 CA-C-N 114.755 -1.111 . . . . 75.3 110.442 -179.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.43 145.15 42.18 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.41 2.073 . . . . 61.41 112.389 176.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.26 113.29 2.37 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 122.508 2.139 . . . . 61.11 111.879 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 105.14 13.65 24.46 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-N 115.514 -0.766 . . . . 35.23 112.601 -176.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.449 HG11 ' HB ' ' A' ' 149' ' ' ILE . 7.3 p -63.33 127.97 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.529 0.731 . . . . 63.42 110.546 177.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.648 ' HA ' HD12 ' A' ' 180' ' ' LEU . 28.7 mtm180 -134.78 164.26 27.95 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.312 0.645 . . . . 65.12 111.581 -172.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -38.86 125.14 1.46 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 126.314 1.846 . . . . 75.52 113.641 -174.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.25 -11.22 60.09 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-O 119.293 -0.726 . . . . 70.02 114.241 176.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.6 t -67.4 121.79 16.53 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 117.432 0.616 . . . . 71.12 110.191 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 40.6 t -104.23 111.14 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.55 0.74 . . . . 75.43 110.435 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 75.7 mt -93.6 106.45 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 C-N-CA 125.236 1.414 . . . . 63.42 109.521 175.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 30.8 ttt-85 -79.67 106.29 11.59 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.26 0.624 . . . . 73.43 109.777 175.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.437 HG13 ' HB3' ' A' ' 174' ' ' LEU . 7.6 p -106.05 104.89 51.64 Favored Pre-proline 0 CA--C 1.562 1.432 0 N-CA-C 109.175 -0.676 . . . . 71.12 109.175 171.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 173' ' ' ASP . 59.6 Cg_endo -69.29 154.18 69.98 Favored 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 123.04 2.494 . . . . 72.25 113.615 -175.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 75.82 2.88 72.03 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 115.47 -0.787 . . . . 72.24 113.881 177.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 92.7 mmm -110.37 -25.95 9.81 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.553 0.741 . . . . 54.53 111.916 -172.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -83.18 -73.17 1.25 Allowed Glycine 0 C--N 1.345 1.06 0 N-CA-C 111.313 -0.715 . . . . 60.44 111.313 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -62.47 96.29 0.14 Allowed Glycine 0 C--N 1.345 1.035 0 N-CA-C 111.8 -0.52 . . . . 53.21 111.8 165.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -88.79 170.58 10.63 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.458 1.103 . . . . 72.15 110.288 176.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 97.49 -147.88 18.78 Favored Glycine 0 C--N 1.341 0.807 0 CA-C-N 116.14 -0.482 . . . . 53.12 112.166 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -64.64 -49.16 71.68 Favored Pre-proline 0 CA--C 1.57 1.723 0 CA-C-O 118.458 -0.782 . . . . 72.24 111.907 177.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -84.13 129.58 4.58 Favored 'Trans proline' 0 C--N 1.392 2.832 0 C-N-CA 122.046 1.831 . . . . 74.13 111.409 175.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.33 145.52 34.39 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 121.959 1.773 . . . . 64.33 111.168 170.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -152.55 164.4 30.65 Favored Glycine 0 N--CA 1.47 0.925 0 CA-C-O 120.195 -0.225 . . . . 60.3 112.636 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 29.8 m-20 -84.23 146.33 27.86 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.143 0.577 . . . . 75.14 111.498 -167.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.437 ' HB3' HG13 ' A' ' 161' ' ' VAL . 33.7 tp -114.87 104.24 11.74 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.458 -1.312 . . . . 52.32 107.458 176.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 68.5 mt -85.82 100.36 12.0 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.613 0.765 . . . . 74.02 109.392 -174.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 67.1 mt -92.79 99.25 11.96 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.817 0.847 . . . . 74.5 110.786 -174.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 5.8 p -89.22 123.5 41.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 N-CA-C 109.037 -0.727 . . . . 62.44 109.037 173.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.5 p -77.7 143.76 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.848 0 C-N-CA 123.437 0.695 . . . . 61.54 110.59 -176.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.562 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 30.0 mmt180 -123.99 96.94 5.13 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.066 0.947 . . . . 64.41 109.656 -177.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.648 HD12 ' HA ' ' A' ' 154' ' ' ARG . 49.1 mt -100.53 114.84 28.81 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.261 -0.644 . . . . 74.21 109.261 173.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 69.0 mt -64.59 130.15 94.59 Favored Pre-proline 0 CA--C 1.548 0.9 0 O-C-N 123.917 0.761 . . . . 72.24 109.282 176.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -58.36 -48.46 15.51 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.938 2.426 . . . . 62.53 111.604 -176.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 . . . . . 0 C--O 1.251 1.179 0 C-N-CA 125.058 1.343 . . . . 63.22 107.448 171.811 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.418 ' HB3' ' NH2' ' A' ' 136' ' ' ARG . 65.8 mtt . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 109.082 -0.71 . . . . 72.43 109.082 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.2 m -66.82 120.37 13.44 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 116.192 -0.458 . . . . 55.31 109.956 176.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.2 m -85.8 137.03 33.08 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 109.305 -0.628 . . . . 74.22 109.305 177.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.517 HD12 ' HB2' ' A' ' 123' ' ' LEU . 9.1 pt -123.73 166.29 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 112.359 0.503 . . . . 71.32 112.359 -155.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -112.37 176.63 4.94 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.783 1.233 . . . . 64.14 109.269 175.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.657 ' HG ' ' HB1' ' A' ' 121' ' ' ALA . 12.3 tp -126.52 150.81 48.55 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.745 -0.835 . . . . 70.14 108.745 -174.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.7 -34.33 71.83 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 122.881 0.472 . . . . 75.42 112.134 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.661 HD11 ' HB ' ' A' ' 140' ' ' VAL . 21.7 mt 47.35 56.35 7.06 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.146 0.978 . . . . 74.31 112.065 -176.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.6 mt -71.25 117.28 55.31 Favored Pre-proline 0 CA--C 1.553 1.064 0 N-CA-C 108.926 -0.768 . . . . 54.42 108.926 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -61.74 177.25 1.01 Allowed 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.149 1.899 . . . . 62.1 112.447 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.588 HD23 ' HG3' ' A' ' 117' ' ' ARG . 1.4 pp -66.19 -15.14 62.9 Favored 'General case' 0 CA--C 1.554 1.114 0 O-C-N 122.184 -0.323 . . . . 75.11 111.581 176.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.07 -90.18 0.59 Allowed Glycine 0 C--N 1.363 2.07 0 N-CA-C 110.813 -0.915 . . . . 71.33 110.813 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 49.8 m -128.89 87.66 2.61 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.652 -1.24 . . . . 72.32 107.652 172.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -126.44 156.86 20.07 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-N 116.086 -0.506 . . . . 75.22 111.977 -177.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -71.35 104.53 1.45 Allowed Glycine 0 C--N 1.349 1.263 0 N-CA-C 111.316 -0.714 . . . . 75.34 111.316 176.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.1 t -68.65 98.34 0.88 Allowed 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.634 0.774 . . . . 33.4 109.916 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -171.95 -107.98 0.21 Allowed Glycine 0 C--N 1.342 0.883 0 CA-C-N 115.695 -0.684 . . . . 33.04 111.96 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.491 ' HA3' ' HA2' ' A' ' 116' ' ' GLY . . . 86.73 167.24 43.46 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 111.846 -0.501 . . . . 62.1 111.846 -171.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 42.2 t -149.98 -52.59 0.15 Allowed 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.627 0.771 . . . . 64.0 109.234 -175.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -155.9 152.15 23.61 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.543 -0.753 . . . . 75.03 111.263 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.13 -63.51 4.47 Favored Glycine 0 C--N 1.343 0.965 0 N-CA-C 111.59 -0.604 . . . . 53.31 111.59 -176.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 17.3 m -135.08 116.0 14.08 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 123.916 0.887 . . . . 75.53 109.273 176.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.491 ' HA2' ' HA3' ' A' ' 111' ' ' GLY . . . -72.66 -89.62 0.14 Allowed Glycine 0 C--N 1.343 0.946 0 N-CA-C 109.456 -1.458 . . . . 53.21 109.456 166.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.588 ' HG3' HD23 ' A' ' 104' ' ' LEU . 23.7 ttm180 -97.87 125.48 42.77 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.055 -1.091 . . . . 73.41 108.055 158.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -91.59 121.6 33.41 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 107.542 -1.281 . . . . 53.4 107.542 168.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.4 tt -108.37 121.6 45.27 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 106.943 -1.503 . . . . 53.22 106.943 -177.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -92.48 135.02 34.4 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.871 -0.789 . . . . 72.13 108.871 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.657 ' HB1' ' HG ' ' A' ' 99' ' ' LEU . . . -156.28 138.1 14.32 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 122.921 0.488 . . . . 71.52 109.8 -174.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -126.77 128.63 46.91 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 110.166 -0.309 . . . . 75.22 110.166 -170.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.517 ' HB2' HD12 ' A' ' 97' ' ' ILE . 3.5 pp -103.13 133.36 20.38 Favored Pre-proline 0 C--N 1.349 0.583 0 C-N-CA 123.342 0.657 . . . . 63.23 109.816 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.497 ' HA ' ' HB2' ' A' ' 179' ' ' ARG . 71.9 Cg_endo -78.13 115.93 3.84 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 122.418 2.079 . . . . 64.51 109.172 166.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.537 HD21 HD12 ' A' ' 149' ' ' ILE . 39.3 tp -102.72 147.38 26.91 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.554 -0.536 . . . . 54.1 109.554 -169.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 1.7 t -86.59 145.22 26.83 Favored 'General case' 0 C--O 1.245 0.839 0 N-CA-C 107.833 -1.173 . . . . 62.4 107.833 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 96.2 mt -67.39 -20.75 65.59 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 112.766 0.654 . . . . 73.3 112.766 -170.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -67.61 -48.15 67.61 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.424 -0.584 . . . . 75.1 109.424 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -64.32 -38.41 90.93 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.081 -0.963 . . . . 54.43 111.149 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.434 ' HB2' HD21 ' A' ' 180' ' ' LEU . . . -59.97 -48.02 83.43 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 123.849 0.718 . . . . 73.44 111.569 179.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -67.86 -60.0 2.85 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.931 -1.031 . . . . 71.32 111.078 -178.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -67.14 -36.9 82.85 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.218 0.607 . . . . 74.54 111.437 -173.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.0 79.11 0.34 Allowed Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.568 -0.742 . . . . 73.21 111.572 -173.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.444 ' O ' HG12 ' A' ' 149' ' ' ILE . . . -118.05 -172.16 15.62 Favored Glycine 0 C--N 1.339 0.696 0 N-CA-C 112.731 -0.148 . . . . 73.45 112.731 -177.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -91.82 120.08 32.2 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 107.564 -1.273 . . . . 54.41 107.564 171.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.418 ' NH2' ' HB3' ' A' ' 94' ' ' MET . 8.5 tpp180 -113.1 122.11 46.59 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 109.377 -0.601 . . . . 70.42 109.377 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.508 HG13 ' HG3' ' A' ' 144' ' ' ARG . 99.5 t -72.55 132.1 33.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.179 0.992 . . . . 51.23 109.985 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.477 ' HB ' HG13 ' A' ' 145' ' ' VAL . 28.8 t -127.64 128.2 69.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 107.018 -1.475 . . . . 72.33 107.018 175.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.65 99.61 9.2 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.662 0.744 . . . . 70.32 111.069 -175.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.661 ' HB ' HD11 ' A' ' 101' ' ' LEU . 14.4 m -132.79 134.56 58.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 112.415 0.524 . . . . 70.45 112.415 -173.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . 59.84 25.44 14.53 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.929 1.291 . . . . 73.4 112.298 173.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 80.32 22.39 62.88 Favored Glycine 0 C--N 1.355 1.626 0 CA-C-N 115.813 -0.631 . . . . 41.24 112.964 -178.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 24.5 tpp180 -133.8 126.54 30.79 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.309 1.044 . . . . 60.15 109.692 -175.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.508 ' HG3' HG13 ' A' ' 137' ' ' VAL . 13.6 ttm180 -73.21 120.46 18.86 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 109.234 -0.654 . . . . 75.23 109.234 167.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.477 HG13 ' HB ' ' A' ' 138' ' ' VAL . 3.5 p -118.7 112.14 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 108.244 -1.021 . . . . 55.43 108.244 169.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.2 t -94.42 109.65 21.5 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.167 -1.049 . . . . 62.23 108.167 176.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 3.5 p -97.56 118.44 44.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 CA-C-O 121.572 0.701 . . . . 74.25 109.946 -177.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -82.83 114.76 21.37 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.585 -0.894 . . . . 71.0 108.585 173.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.537 HD12 HD21 ' A' ' 125' ' ' LEU . 6.6 pt -99.47 149.9 36.28 Favored Pre-proline 0 CA--C 1.555 1.165 0 C-N-CA 124.506 1.123 . . . . 63.33 109.542 179.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.99 149.84 77.52 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.246 1.964 . . . . 75.34 112.029 176.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -66.23 113.71 2.75 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 122.406 2.071 . . . . 62.24 110.845 175.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 89.44 31.34 11.72 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-N 115.836 -0.62 . . . . 72.42 113.023 -175.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.26 138.09 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.333 0.653 . . . . 75.13 109.767 173.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -127.05 162.36 26.22 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.38 0.672 . . . . 75.42 111.063 -174.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -46.78 131.84 11.56 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 126.343 1.857 . . . . 64.44 113.344 -172.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.93 -2.55 84.24 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-O 119.554 -0.581 . . . . 72.13 114.434 177.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.1 t -66.87 122.51 17.86 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 117.474 0.637 . . . . 72.42 109.443 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.7 p -101.94 135.94 36.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 123.491 0.717 . . . . 64.01 109.991 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' A' ' 176' ' ' LEU . 45.4 mt -120.55 103.67 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.362 1.065 . . . . 73.45 108.734 -176.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -80.25 110.88 16.1 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.352 0.661 . . . . 74.0 109.702 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 4.5 p -115.21 110.15 45.84 Favored Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 122.904 0.482 . . . . 73.11 110.101 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.84 145.08 49.97 Favored 'Trans proline' 0 C--N 1.383 2.347 0 C-N-CA 122.885 2.39 . . . . 63.41 113.392 -175.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 80.08 15.51 78.67 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-N 115.557 -0.747 . . . . 71.23 113.565 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 87.3 mmm -113.18 -18.19 12.18 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.462 0.705 . . . . 63.13 111.026 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -96.84 -89.58 1.84 Allowed Glycine 0 C--N 1.349 1.295 0 N-CA-C 112.155 -0.378 . . . . 74.14 112.155 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -76.03 98.48 1.21 Allowed Glycine 0 C--N 1.345 1.033 0 C-N-CA 122.848 0.261 . . . . 75.3 112.527 176.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.585 HE21 ' HA ' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -88.56 113.53 24.24 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.444 0.698 . . . . 75.5 110.065 177.759 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 166.83 -154.53 25.03 Favored Glycine 0 C--O 1.241 0.551 0 N-CA-C 111.821 -0.512 . . . . 52.22 111.821 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -73.37 -50.92 5.98 Favored Pre-proline 0 CA--C 1.563 1.454 0 CA-C-O 117.97 -1.014 . . . . 73.05 110.992 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.14 111.6 3.31 Favored 'Trans proline' 0 C--N 1.393 2.878 0 CA-C-N 121.572 1.597 . . . . 73.11 110.315 168.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -67.11 125.36 13.46 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 122.526 2.151 . . . . 64.44 111.901 -173.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . -120.25 146.34 17.76 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 111.908 -0.477 . . . . 72.33 111.908 -176.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -105.29 170.77 7.69 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.057 0.943 . . . . 42.24 112.024 -172.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 45.4 tp -121.99 113.8 20.09 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.792 1.237 . . . . 64.23 108.758 -177.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 69.4 mt -85.25 99.99 11.48 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.7 0.8 . . . . 63.53 110.032 -176.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . 0.577 ' HB2' ' HB ' ' A' ' 159' ' ' ILE . 87.9 mt -88.93 100.43 13.18 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.244 0.618 . . . . 74.34 111.274 -175.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 71.4 t -89.2 124.83 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 109.198 -0.668 . . . . 74.42 109.198 177.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 12.4 p -80.53 137.82 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 122.727 0.411 . . . . 74.13 110.524 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.497 ' HB2' ' HA ' ' A' ' 124' ' ' PRO . 33.7 mmt180 -122.09 91.6 3.54 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.201 1.0 . . . . 64.34 109.255 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.434 HD21 ' HB2' ' A' ' 130' ' ' ALA . 43.2 mt -93.74 140.33 29.78 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.334 0.654 . . . . 61.44 111.355 -178.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 70.7 mt -75.4 119.11 75.5 Favored Pre-proline 0 CA--C 1.548 0.893 0 CA-C-N 114.869 -1.059 . . . . 75.11 109.182 177.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.35 -31.85 17.16 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.634 2.223 . . . . 74.44 111.977 -176.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 85.6 t60 . . . . . 0 CA--C 1.544 0.736 0 C-N-CA 125.034 1.333 . . . . 71.23 108.189 168.653 . . . . . . . . 0 0 . 1 stop_ save_